Citrus Sinensis ID: 015094
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 413 | 2.2.26 [Sep-21-2011] | |||||||
| P27450 | 419 | Probable serine/threonine | no | no | 0.905 | 0.892 | 0.561 | 1e-126 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.869 | 0.922 | 0.568 | 1e-118 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.755 | 0.757 | 0.624 | 1e-117 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.748 | 0.753 | 0.639 | 1e-117 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.799 | 0.835 | 0.588 | 1e-113 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.842 | 0.816 | 0.535 | 1e-112 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.849 | 0.823 | 0.548 | 1e-111 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.760 | 0.807 | 0.593 | 1e-111 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.864 | 0.728 | 0.522 | 1e-107 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.716 | 0.600 | 0.605 | 1e-107 |
| >sp|P27450|CX32_ARATH Probable serine/threonine-protein kinase Cx32, chloroplastic OS=Arabidopsis thaliana GN=At4g35600 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 451 bits (1159), Expect = e-126, Method: Compositional matrix adjust.
Identities = 214/381 (56%), Positives = 289/381 (75%), Gaps = 7/381 (1%)
Query: 15 HLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELR 74
H ++ S T +++TG + S+V S+FS S +G++L +PNL+++ F++L+
Sbjct: 21 HATTNNHSNGTEFSSTTGATTNSSVGQQSQFSDISTGIISDSGKLLESPNLKVYNFLDLK 80
Query: 75 AATRNFKSDTVLGEGGFGKVFKGWLDEK--APGKSGSGTVIAVKKLNSESLQGFEEWQSE 132
AT+NFK D++LG+GGFGKV++GW+D AP + GSG ++A+K+LNSES+QGF EW+SE
Sbjct: 81 TATKNFKPDSMLGQGGFGKVYRGWVDATTLAPSRVGSGMIVAIKRLNSESVQGFAEWRSE 140
Query: 133 VNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
VNFLG LSH NLV+LLGYC EDKELLLVYEFM KGSLE+HLF R P W++R+KI
Sbjct: 141 VNFLGMLSHRNLVKLLGYCREDKELLLVYEFMPKGSLESHLFRRN---DPFPWDLRIKIV 197
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
IGAARGLAFLH+ ++VIYRDFKASNILLD +Y AK+SDFGLAKLGP+ +SHVTTR+MG
Sbjct: 198 IGAARGLAFLHSLQREVIYRDFKASNILLDSNYDAKLSDFGLAKLGPADEKSHVTTRIMG 257
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312
TYGYAAPEY+ATGHLYVKSDV+ FGVVL+EI+TGL A +T RP GQ +LVDW++P LS K
Sbjct: 258 TYGYAAPEYMATGHLYVKSDVFAFGVVLLEIMTGLTAHNTKRPRGQESLVDWLRPELSNK 317
Query: 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQ 372
+ + I+D ++GQY K A ++A+++L C+E +PK+RP M+EVVE LE +Q + P +
Sbjct: 318 HRVKQIMDKGIKGQYTTKVATEMARITLSCIEPDPKNRPHMKEVVEVLEHIQGLNVVPNR 377
Query: 373 PRVRPTHSMAHRQGQQPLHHR 393
+ ++A+ P H+R
Sbjct: 378 SSTK--QAVANSSRSSPHHYR 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 426 bits (1096), Expect = e-118, Method: Compositional matrix adjust.
Identities = 213/375 (56%), Positives = 270/375 (72%), Gaps = 16/375 (4%)
Query: 1 MGICWSDTPHDTIGHLSSTGISQTTSQTTSTGVSR-GSNVSGNSRFSASSGDESYPNGQI 59
MG C+S+ I SST +S S +SR GS S + FS E G+I
Sbjct: 1 MGGCFSNRIKTDIA--SSTWLS-------SKFLSRDGSKGSSTASFSYMPRTE----GEI 47
Query: 60 LPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK--APGKSGSGTVIAVKK 117
L NL+ F+ EL++ATRNF+ D+V+GEGGFG VFKGW+DE AP K G+G VIAVK+
Sbjct: 48 LQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKR 107
Query: 118 LNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG 177
LN E QG EW +E+N+LG+L HPNLV+L+GYC E++ LLVYEFM +GSLENHLF RG
Sbjct: 108 LNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRG 167
Query: 178 ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237
QPL+WN R+++A+GAARGLAFLH + QVIYRDFKASNILLD +Y AK+SDFGLA+
Sbjct: 168 TFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARD 227
Query: 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297
GP SHV+TRVMGT GYAAPEY+ATGHL VKSDVY FGVVL+E+L+G RA+D N+P G
Sbjct: 228 GPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVG 287
Query: 298 QHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
+HNLVDW +PYL+ KR+ ++D RLQGQY A +IA L+L C+ + K RP+M E+V
Sbjct: 288 EHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIV 347
Query: 358 ETLERLQASDQKPKQ 372
+T+E L + K+
Sbjct: 348 KTMEELHIQKEASKE 362
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 422 bits (1086), Expect = e-117, Method: Compositional matrix adjust.
Identities = 196/314 (62%), Positives = 247/314 (78%), Gaps = 2/314 (0%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL +PNL+ FTF EL+AATRNF+ D+VLGEGGFG VFKGW+DE+ K G+G VIA
Sbjct: 46 GEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIA 105
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VKKLN + QG +EW +EVN+LG+ SHPNLV+L+GYC ED+ LLVYEFM +GSLENHLF
Sbjct: 106 VKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 165
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
RG+ QPL+W +RLK+A+GAA+GLAFLH ++ VIYRDFK SNILLD Y AK+SDFGL
Sbjct: 166 RRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGL 225
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
AK GP+ +SHV+TR+MGTYGYAAPEY+ATGHL KSDVY +GVVL+E+L+G RA+D NR
Sbjct: 226 AKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNR 285
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
P G+ LV+W +P L+ KRK +ID RLQ QY + A ++A L+L+CL E K RP+M
Sbjct: 286 PPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMN 345
Query: 355 EVVETLERLQASDQ 368
EVV LE +Q ++
Sbjct: 346 EVVSHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1084), Expect = e-117, Method: Compositional matrix adjust.
Identities = 199/311 (63%), Positives = 248/311 (79%), Gaps = 2/311 (0%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL +PNL+ F+F EL++ATRNF+ D+VLGEGGFG VFKGW+DEK+ + G+G VIA
Sbjct: 45 GEILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIA 104
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VKKLN + QG +EW +EVN+LG+ SH +LV+L+GYC ED+ LLVYEFM +GSLENHLF
Sbjct: 105 VKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 164
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
RG QPL+W +RLK+A+GAA+GLAFLH+S+ +VIYRDFK SNILLD Y AK+SDFGL
Sbjct: 165 RRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGL 224
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
AK GP +SHV+TRVMGT+GYAAPEY+ATGHL KSDVY FGVVL+E+L+G RA+D NR
Sbjct: 225 AKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNR 284
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
PSG+ NLV+W KPYL KRK +ID RLQ QY + A ++A LSL+CL E K RP+M
Sbjct: 285 PSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMS 344
Query: 355 EVVETLERLQA 365
EVV LE +Q+
Sbjct: 345 EVVSHLEHIQS 355
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1047), Expect = e-113, Method: Compositional matrix adjust.
Identities = 196/333 (58%), Positives = 251/333 (75%), Gaps = 3/333 (0%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL + ++ FTF EL+ ATRNF+ D+V+GEGGFG VFKGWLDE P K G+G VIA
Sbjct: 44 GEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIA 103
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VKKLN E QG EW +E+N+LG+LSHPNLV+L+GYC ED+ LLVYEFMQKGSLENHLF
Sbjct: 104 VKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLF 163
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
RGA +PL W +R+ +A+ AA+GLAFLH+ +VIYRD KASNILLD Y AK+SDFGL
Sbjct: 164 RRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGL 223
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
A+ GP S+V+TRVMGTYGYAAPEY+++GHL +SDVY FGV+L+EIL+G RALD NR
Sbjct: 224 ARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNR 283
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
P+ + NLVDW +PYL+ KRK I+D RL QY + A ++A ++++CL EPK RP+M
Sbjct: 284 PAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMD 343
Query: 355 EVVETLERLQASDQKPKQPR-VRPTHSMAHRQG 386
+VV L++LQ + KP Q V+ T + + G
Sbjct: 344 QVVRALQQLQDNLGKPSQTNPVKDTKKLGFKTG 376
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1043), Expect = e-112, Method: Compositional matrix adjust.
Identities = 209/390 (53%), Positives = 266/390 (68%), Gaps = 42/390 (10%)
Query: 52 ESYPN----GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PG 105
ES P G+IL +PNL+ FTF EL+ ATRNF+ D++LGEGGFG VFKGW+D
Sbjct: 51 ESLPTPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTAS 110
Query: 106 KSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ 165
K GSG V+AVKKL +E QG +EW +EVN+LG+LSHPNLV+L+GYC E + LLVYEFM
Sbjct: 111 KPGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMP 170
Query: 166 KGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225
KGSLENHLF RGA QPL W IR+K+AIGAA+GL FLH + QVIYRDFKA+NILLD +
Sbjct: 171 KGSLENHLFRRGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEF 228
Query: 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
+K+SDFGLAK GP+ ++HV+T+VMGT+GYAAPEYVATG L KSDVY FGVVL+E+L+
Sbjct: 229 NSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 288
Query: 286 GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEA 345
G RA+D ++ + +LVDW PYL +KRK I+D RL GQYP K AY A L+L+CL
Sbjct: 289 GRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNP 348
Query: 346 EPKHRPSMREVVETLERLQASDQKPKQPRVRPTHSMAHRQGQ------------------ 387
+ K RP M EV+ L++L+++ +P + +RQ Q
Sbjct: 349 DAKLRPKMSEVLAKLDQLEST---------KPGTGVGNRQAQIDSPRGSNGSIVQKSPRR 399
Query: 388 ----QPLHHRSPLHTNLDRNRGYQHSPRVR 413
+PL H +P + L + HSPRVR
Sbjct: 400 YSYDRPLLHITPGASPLPT---HNHSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 203/370 (54%), Positives = 260/370 (70%), Gaps = 19/370 (5%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL +PNL+ FTF EL+ AT+NF+ D +LGEGGFG VFKGW+D+ + + GSG V+A
Sbjct: 63 GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VK+L E QG +EW +EVN+LG+LSHPNLV L+GYC E + LLVYEFM KGSLENHLF
Sbjct: 123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
RGA QPL W IR+K+A+GAA+GL FLH + QVIYRDFKA+NILLD + AK+SDFGL
Sbjct: 183 RRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGL 240
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
AK GP+ +HV+T+V+GT+GYAAPEYVATG L KSDVY FGVVL+E+++G RA+D +
Sbjct: 241 AKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSN 300
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
+++LVDW PYL +KRK I+D +L GQYP K A+ A L+L+CL + K RP M
Sbjct: 301 GGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMS 360
Query: 355 EVVETLERLQASDQKP-------KQPRVRPTHSM----AHRQGQQPLHHRSPLHTNLDRN 403
EV+ TLE+L+ S KP + PR + M +PL H +P + L
Sbjct: 361 EVLVTLEQLE-SVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLP-- 417
Query: 404 RGYQHSPRVR 413
Y SPRVR
Sbjct: 418 -SYTQSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 400 bits (1029), Expect = e-111, Method: Compositional matrix adjust.
Identities = 188/317 (59%), Positives = 244/317 (76%), Gaps = 3/317 (0%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL + ++ F+F EL+ ATRNF+SD+V+GEGGFG VF+GWLDE P KS SG VIA
Sbjct: 38 GEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIA 97
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VK+LN + QG EW +E+N+LG+LSHPNLV+L+GYC ED++ LLVYEFM KGSLENHLF
Sbjct: 98 VKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLF 157
Query: 175 GRG-ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233
G +PL+W +R+K+A+ AA+GLAFLH+ +VIYRD KASNILLD + AK+SDFG
Sbjct: 158 ANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFG 217
Query: 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTN 293
LA+ GP QS+V+TRVMGT+GYAAPEYV+TGHL +SDVY FGVVL+E+L G +ALD N
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353
RP+ + NLVDW +PYL+ +RK I+D RL QY + A ++A ++++CL EPK RP+M
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337
Query: 354 REVVETLERLQASDQKP 370
+VV L +LQ S KP
Sbjct: 338 DQVVRALVQLQDSVVKP 354
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (997), Expect = e-107, Method: Compositional matrix adjust.
Identities = 196/375 (52%), Positives = 262/375 (69%), Gaps = 18/375 (4%)
Query: 4 CWSDTPHDTIGHLSSTGISQTTSQTTSTGVSRGSNVSGN-------SRFSASSGDESYPN 56
CW + S++ + + + +TST S+ + V N S + +S ES +
Sbjct: 48 CWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSLS 107
Query: 57 GQILPT-----PNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK--APGKSGS 109
I+ +L+ F+F++L+ ATRNF+ +++LGEGGFG VFKGW++E AP K G+
Sbjct: 108 TPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 167
Query: 110 GTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSL 169
G +AVK LN + LQG +EW +E+N+LG L HPNLV+L+GYC ED + LLVYEFM +GSL
Sbjct: 168 GLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 227
Query: 170 ENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD-KQVIYRDFKASNILLDGSYTAK 228
ENHLF R PL W+IR+KIA+GAA+GL+FLH K VIYRDFK SNILLDG Y AK
Sbjct: 228 ENHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAK 284
Query: 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLR 288
+SDFGLAK P ++HV+TRVMGTYGYAAPEYV TGHL KSDVY FGVVL+E+LTG R
Sbjct: 285 LSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
Query: 289 ALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPK 348
++D NRP+G+HNLV+W +P+L +KR+F ++D RL+G + K A ++ QL+ +CL + K
Sbjct: 345 SMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSK 404
Query: 349 HRPSMREVVETLERL 363
RP M EVVE L+ L
Sbjct: 405 IRPKMSEVVEVLKPL 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-107, Method: Compositional matrix adjust.
Identities = 183/302 (60%), Positives = 233/302 (77%), Gaps = 6/302 (1%)
Query: 65 LRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK--APGKSGSGTVIAVKKLNSES 122
LR FTF +L+ +TRNF+ +++LGEGGFG VFKGW++E AP K G+G +AVK LN +
Sbjct: 127 LRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDG 186
Query: 123 LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQP 182
LQG +EW +E+NFLG L HPNLV+L+GYC ED + LLVYEFM +GSLENHLF R P
Sbjct: 187 LQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---P 243
Query: 183 LAWNIRLKIAIGAARGLAFLHTSD-KQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241
L W+IR+KIA+GAA+GL+FLH K VIYRDFK SNILLD Y AK+SDFGLAK P
Sbjct: 244 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDE 303
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301
++HV+TRVMGTYGYAAPEYV TGHL KSDVY FGVVL+E+LTG R++D NRP+G+HNL
Sbjct: 304 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 363
Query: 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
V+W +P+L +KR+F ++D RL+G + K A ++ QL+ +CL +PK RP M +VVE L+
Sbjct: 364 VEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALK 423
Query: 362 RL 363
L
Sbjct: 424 PL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 413 | ||||||
| 255572432 | 430 | serine/threonine-protein kinase cx32, pu | 1.0 | 0.960 | 0.769 | 0.0 | |
| 359474965 | 417 | PREDICTED: probable serine/threonine-pro | 0.995 | 0.985 | 0.770 | 0.0 | |
| 359474963 | 415 | PREDICTED: probable serine/threonine-pro | 0.987 | 0.983 | 0.778 | 0.0 | |
| 224102793 | 404 | predicted protein [Populus trichocarpa] | 0.920 | 0.940 | 0.794 | 0.0 | |
| 224132438 | 384 | predicted protein [Populus trichocarpa] | 0.905 | 0.973 | 0.791 | 1e-179 | |
| 297744479 | 453 | unnamed protein product [Vitis vinifera] | 0.893 | 0.814 | 0.805 | 1e-173 | |
| 351726644 | 412 | protein kinase [Glycine max] gi|22345241 | 0.852 | 0.854 | 0.805 | 1e-170 | |
| 356501767 | 403 | PREDICTED: probable serine/threonine-pro | 0.951 | 0.975 | 0.756 | 1e-169 | |
| 356501765 | 412 | PREDICTED: probable serine/threonine-pro | 0.847 | 0.849 | 0.812 | 1e-168 | |
| 297836446 | 414 | hypothetical protein ARALYDRAFT_480605 [ | 0.963 | 0.961 | 0.701 | 1e-161 |
| >gi|255572432|ref|XP_002527153.1| serine/threonine-protein kinase cx32, putative [Ricinus communis] gi|223533492|gb|EEF35235.1| serine/threonine-protein kinase cx32, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1765), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/430 (76%), Positives = 374/430 (86%), Gaps = 17/430 (3%)
Query: 1 MGICW----SDTPHDTIGHLSSTGISQTTS-------------QTTSTGVSRGSNVSGNS 43
MG CW ++ +T G +SS G+SQTTS ++T+T S+GSN+SGNS
Sbjct: 1 MGNCWGSPATNPTANTTGQVSSAGLSQTTSNTTSSGGSNTTSSRSTNTASSQGSNISGNS 60
Query: 44 RFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA 103
RFS SGDE++PNGQILPTPNL++FTF EL+AAT+NF+SDTVLGEGGFGKVFKGWLDEK
Sbjct: 61 RFSGGSGDEAFPNGQILPTPNLKVFTFQELKAATKNFRSDTVLGEGGFGKVFKGWLDEKG 120
Query: 104 PGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEF 163
GK GSGTVIAVKKLNSESLQGFEEWQSEV+FLGRLSHPNLVRLLGYCWEDKELLLVYEF
Sbjct: 121 SGKPGSGTVIAVKKLNSESLQGFEEWQSEVHFLGRLSHPNLVRLLGYCWEDKELLLVYEF 180
Query: 164 MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223
MQKGSLENHLFGRG++VQPL W+IR+KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG
Sbjct: 181 MQKGSLENHLFGRGSTVQPLPWDIRIKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 240
Query: 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEI 283
SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVL EI
Sbjct: 241 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLAEI 300
Query: 284 LTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCL 343
LTGL ALDTNRPSG+HNLV+WIKPYL +KRK + I+D+RL+G+YP K A++IAQL+L C+
Sbjct: 301 LTGLHALDTNRPSGRHNLVEWIKPYLYDKRKLKTIMDSRLEGRYPSKPAFRIAQLALNCI 360
Query: 344 EAEPKHRPSMREVVETLERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSPLHTNLDRN 403
E+EPKHRPSM+EVVETLER++ S++K +PRVRP+ H+ GQQPL HRSPLH D N
Sbjct: 361 ESEPKHRPSMKEVVETLERIEGSNEKSIEPRVRPSRPRTHQHGQQPLQHRSPLHLRQDGN 420
Query: 404 RGYQHSPRVR 413
R YQ SPRVR
Sbjct: 421 RAYQQSPRVR 430
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474965|ref|XP_003631561.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/419 (77%), Positives = 367/419 (87%), Gaps = 8/419 (1%)
Query: 1 MGICWSDTPHDTIGHLS----STGISQTTSQTTSTGVSRGSNVSGNSRFSASSG--DESY 54
MGICWS + DTI ++ STG+ + +TT+T SRGSN S NS+FSA+SG DE++
Sbjct: 1 MGICWSSS-KDTITPITTGNLSTGMGFSVDRTTNTTSSRGSNFSRNSQFSAASGGSDEAF 59
Query: 55 PNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIA 114
PNGQILP PNLRIFTF EL+AAT+NF+ DTVLGEGGFGKVFKGWLDEK KSGSGTVIA
Sbjct: 60 PNGQILPHPNLRIFTFSELKAATKNFRPDTVLGEGGFGKVFKGWLDEKV-SKSGSGTVIA 118
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VKKLNSES+QGFEEWQSEVNFLGRLSHPNLV+LLGYCWEDKELLLVYEFMQKGSLENHLF
Sbjct: 119 VKKLNSESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEFMQKGSLENHLF 178
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
GRGA+VQPL W+IRLKI+IGAARGL FLHTS+KQVIYRDFKASNILLDGSYTAKISDFGL
Sbjct: 179 GRGATVQPLPWDIRLKISIGAARGLTFLHTSEKQVIYRDFKASNILLDGSYTAKISDFGL 238
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
AKLGP+ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVE+LTGLRALDT R
Sbjct: 239 AKLGPTASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEMLTGLRALDTTR 298
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
PSGQHNLVDWIKP+LS++RK + I+DARL+G+YP KAA QIAQLSL+C+ +E K RPSM+
Sbjct: 299 PSGQHNLVDWIKPHLSDRRKLKTIMDARLEGRYPSKAANQIAQLSLRCIGSEHKSRPSMK 358
Query: 355 EVVETLERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSPLHTNLDRNRGYQHSPRVR 413
EV+ETLER++A +++P++PRVRP R GQ PLHHRSPLH + ++ QHSP R
Sbjct: 359 EVLETLERIEAYNERPREPRVRPARPAVQRHGQPPLHHRSPLHPRQNGSQANQHSPWAR 417
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474963|ref|XP_002279800.2| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/420 (77%), Positives = 370/420 (88%), Gaps = 12/420 (2%)
Query: 1 MGICWSDTPHDTI-----GHLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSG--DES 53
MGICWS + DTI G+LS+ G+SQTT+ TTS+ RGSN S NS+FSA+SG DE+
Sbjct: 1 MGICWSSS-KDTITPITTGNLSTAGVSQTTTNTTSS---RGSNFSRNSQFSAASGGSDEA 56
Query: 54 YPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVI 113
+PNGQILP PNLRIFTF EL+AAT+NF+ DTVLGEGGFGKVFKGWLDEK KSGSGTVI
Sbjct: 57 FPNGQILPHPNLRIFTFSELKAATKNFRPDTVLGEGGFGKVFKGWLDEKV-SKSGSGTVI 115
Query: 114 AVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL 173
AVKKLNSES+QGFEEWQSEVNFLGRLSHPNLV+LLGYCWEDKELLLVYEFMQKGSLENHL
Sbjct: 116 AVKKLNSESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEFMQKGSLENHL 175
Query: 174 FGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233
FGRGA+VQPL W+IRLKI+IGAARGL FLHTS+KQVIYRDFKASNILLDGSYTAKISDFG
Sbjct: 176 FGRGATVQPLPWDIRLKISIGAARGLTFLHTSEKQVIYRDFKASNILLDGSYTAKISDFG 235
Query: 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTN 293
LAKLGP+ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVE+LTGLRALDT
Sbjct: 236 LAKLGPTASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEMLTGLRALDTT 295
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353
RPSGQHNLVDWIKP+LS++RK + I+DARL+G+YP KAA QIAQLSL+C+ +E K RPSM
Sbjct: 296 RPSGQHNLVDWIKPHLSDRRKLKTIMDARLEGRYPSKAANQIAQLSLRCIGSEHKSRPSM 355
Query: 354 REVVETLERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSPLHTNLDRNRGYQHSPRVR 413
+EV+ETLER++A +++P++PRVRP R GQ PLHHRSPLH + ++ QHSP R
Sbjct: 356 KEVLETLERIEAYNERPREPRVRPARPAVQRHGQPPLHHRSPLHPRQNGSQANQHSPWAR 415
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102793|ref|XP_002312803.1| predicted protein [Populus trichocarpa] gi|222849211|gb|EEE86758.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/390 (79%), Positives = 347/390 (88%), Gaps = 10/390 (2%)
Query: 1 MGICWSDTPHD-----TIGHLSSTGISQTTSQTTSTGVS-----RGSNVSGNSRFSASSG 50
MGICW + H T GHLS+ GISQTTS T S+GVS RGSN+S +SRFSA SG
Sbjct: 1 MGICWGSSAHSPTTPSTTGHLSTAGISQTTSDTASSGVSNATSSRGSNISAHSRFSAGSG 60
Query: 51 DESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSG 110
DE +PNGQILPTPNLRIF+F EL+ ATRNFKSDT+LGEGGFG+V+KGWLDEKAPG+ GSG
Sbjct: 61 DEEFPNGQILPTPNLRIFSFAELKVATRNFKSDTLLGEGGFGQVYKGWLDEKAPGRIGSG 120
Query: 111 TVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLE 170
T+IAVK+LNSESLQGFEEWQSEVNFLGRLSHP+LVRL+GYCWE KELLLVYEFMQKGSLE
Sbjct: 121 TIIAVKRLNSESLQGFEEWQSEVNFLGRLSHPHLVRLIGYCWEVKELLLVYEFMQKGSLE 180
Query: 171 NHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230
NHLFGRG++VQPL W+ RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG+YTAK+S
Sbjct: 181 NHLFGRGSAVQPLPWDTRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGAYTAKLS 240
Query: 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRAL 290
DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRAL
Sbjct: 241 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRAL 300
Query: 291 DTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
D NRPSG+H+LVDWIKPYLS+KRK + I+D+ L+G+YP KAA QIAQL+L CLE+EPKHR
Sbjct: 301 DINRPSGRHSLVDWIKPYLSDKRKLKSIMDSHLEGRYPSKAALQIAQLALNCLESEPKHR 360
Query: 351 PSMREVVETLERLQASDQKPKQPRVRPTHS 380
P M++VVETLER++AS ++ Q R HS
Sbjct: 361 PHMKQVVETLERIEASKERQGQTRTPYNHS 390
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132438|ref|XP_002328270.1| predicted protein [Populus trichocarpa] gi|222837785|gb|EEE76150.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1638), Expect = e-179, Method: Compositional matrix adjust.
Identities = 304/384 (79%), Positives = 340/384 (88%), Gaps = 10/384 (2%)
Query: 1 MGICWSDTPHD-----TIGHLSSTGISQTTSQTTSTGVS-----RGSNVSGNSRFSASSG 50
MG CW + H T G LSS GIS TTS TTS GVS RGSN+S +SRFSA SG
Sbjct: 1 MGNCWGFSAHSPTTPSTTGQLSSAGISHTTSNTTSFGVSNATSSRGSNISAHSRFSAGSG 60
Query: 51 DESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSG 110
DE +PNGQILPTPNLR+F+F EL+ ATRNFKSDT+LGEGGFG+V+KGWLDEKAPG++GSG
Sbjct: 61 DEEFPNGQILPTPNLRVFSFAELKVATRNFKSDTLLGEGGFGQVYKGWLDEKAPGRNGSG 120
Query: 111 TVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLE 170
TVIAVK+LNSESLQGFEEWQ+EVNFLGRLSHP+LVRL+GYCWEDKELLLVYEFMQKGSLE
Sbjct: 121 TVIAVKRLNSESLQGFEEWQAEVNFLGRLSHPHLVRLIGYCWEDKELLLVYEFMQKGSLE 180
Query: 171 NHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230
NHLFGRG++VQPL W+ RLKIAIGAARGL+FLH SDKQVIYRDFKASNIL+DGSYTAK+S
Sbjct: 181 NHLFGRGSAVQPLPWDTRLKIAIGAARGLSFLHASDKQVIYRDFKASNILIDGSYTAKLS 240
Query: 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRAL 290
DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRAL
Sbjct: 241 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRAL 300
Query: 291 DTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
D NRPSG+H LVDWIKP+LS+KRK + I+D RL+G+YP KAA +IAQL+L CLE E +HR
Sbjct: 301 DANRPSGRHTLVDWIKPFLSDKRKLKSIMDIRLEGRYPAKAALRIAQLALNCLEQEHRHR 360
Query: 351 PSMREVVETLERLQASDQKPKQPR 374
P MREVV TLER++A+ KP +PR
Sbjct: 361 PHMREVVATLERIEAAKDKPVEPR 384
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297744479|emb|CBI37741.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 307/381 (80%), Positives = 347/381 (91%), Gaps = 12/381 (3%)
Query: 1 MGICWSDTPHDTI-----GHLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSG--DES 53
MGICWS + DTI G+LS+ G+SQTT+ TTS+ RGSN S NS+FSA+SG DE+
Sbjct: 1 MGICWSSS-KDTITPITTGNLSTAGVSQTTTNTTSS---RGSNFSRNSQFSAASGGSDEA 56
Query: 54 YPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVI 113
+PNGQILP PNLRIFTF EL+AAT+NF+ DTVLGEGGFGKVFKGWLDEK KSGSGTVI
Sbjct: 57 FPNGQILPHPNLRIFTFSELKAATKNFRPDTVLGEGGFGKVFKGWLDEKV-SKSGSGTVI 115
Query: 114 AVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL 173
AVKKLNSES+QGFEEWQSEVNFLGRLSHPNLV+LLGYCWEDKELLLVYEFMQKGSLENHL
Sbjct: 116 AVKKLNSESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEFMQKGSLENHL 175
Query: 174 FGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233
FGRGA+VQPL W+IRLKI+IGAARGL FLHTS+KQVIYRDFKASNILLDGSYTAKISDFG
Sbjct: 176 FGRGATVQPLPWDIRLKISIGAARGLTFLHTSEKQVIYRDFKASNILLDGSYTAKISDFG 235
Query: 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTN 293
LAKLGP+ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVE+LTGLRALDT
Sbjct: 236 LAKLGPTASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEMLTGLRALDTT 295
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353
RPSGQHNLVDWIKP+LS++RK + I+DARL+G+YP KAA QIAQLSL+C+ +E K RPSM
Sbjct: 296 RPSGQHNLVDWIKPHLSDRRKLKTIMDARLEGRYPSKAANQIAQLSLRCIGSEHKSRPSM 355
Query: 354 REVVETLERLQASDQKPKQPR 374
+EV+ETLER++A +++P++PR
Sbjct: 356 KEVLETLERIEAYNERPREPR 376
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351726644|ref|NP_001235086.1| protein kinase [Glycine max] gi|223452418|gb|ACM89536.1| protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1558), Expect = e-170, Method: Compositional matrix adjust.
Identities = 285/354 (80%), Positives = 326/354 (92%), Gaps = 2/354 (0%)
Query: 42 NSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDE 101
NS+FS SSG + YPNGQILPT NLRIFTF EL+AATRNF++DTVLGEGGFGKV+KGWL+E
Sbjct: 55 NSKFSVSSGGQPYPNGQILPTSNLRIFTFAELKAATRNFRADTVLGEGGFGKVYKGWLEE 114
Query: 102 KAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVY 161
KA K+GSGTVIAVKKLNSESLQG EEWQSEVNFLGRLSHPNLV+LLGYC E+ ELLLVY
Sbjct: 115 KATSKTGSGTVIAVKKLNSESLQGLEEWQSEVNFLGRLSHPNLVKLLGYCLEESELLLVY 174
Query: 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221
EFMQKGSLENHLFGRG++VQPL W+IRLKIAIGAARGLAFLHTS+K VIYRDFKASNILL
Sbjct: 175 EFMQKGSLENHLFGRGSAVQPLPWDIRLKIAIGAARGLAFLHTSEK-VIYRDFKASNILL 233
Query: 222 DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLV 281
DGSY AKISDFGLAKLGPSASQSHVTTRVMGT+GYAAPEYVATGHLYVKSDVYGFGVVLV
Sbjct: 234 DGSYNAKISDFGLAKLGPSASQSHVTTRVMGTHGYAAPEYVATGHLYVKSDVYGFGVVLV 293
Query: 282 EILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLK 341
EILTGLRALD+NRPSGQH L +W+KPYL ++RK + I+D+RL+G++P KAA++IAQLS+K
Sbjct: 294 EILTGLRALDSNRPSGQHKLTEWVKPYLHDRRKLKGIMDSRLEGKFPSKAAFRIAQLSMK 353
Query: 342 CLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSP 395
CL +EPKHRPSM++V+E LER+QA+++KP +P+ R TH+ A RQG Q +HHRSP
Sbjct: 354 CLASEPKHRPSMKDVLENLERIQAANEKPVEPKFRSTHA-ASRQGHQAVHHRSP 406
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501767|ref|XP_003519695.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 599 bits (1545), Expect = e-169, Method: Compositional matrix adjust.
Identities = 302/399 (75%), Positives = 343/399 (85%), Gaps = 6/399 (1%)
Query: 1 MGICW----SDTPHDTIGHLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPN 56
MG CW + T G+LSS+ + + TT+T S + S NS+FS SSGD+ YPN
Sbjct: 1 MGNCWGPPPHNPTPTTTGNLSSSTGCISYTTTTTTNSSGSGSSSINSKFSVSSGDQPYPN 60
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK 116
GQILPT NLRIFTF EL+AATRNFK+DTVLGEGGFGKVFKGWL+EKA K GSGTVIAVK
Sbjct: 61 GQILPTSNLRIFTFAELKAATRNFKADTVLGEGGFGKVFKGWLEEKATSKGGSGTVIAVK 120
Query: 117 KLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGR 176
KLNSESLQG EEWQSEVNFLGRLSH NLV+LLGYC E+ ELLLVYEFMQKGSLENHLFGR
Sbjct: 121 KLNSESLQGLEEWQSEVNFLGRLSHTNLVKLLGYCLEESELLLVYEFMQKGSLENHLFGR 180
Query: 177 GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236
G++VQPL W+IRLKIAIGAARGLAFLHTS+K VIYRDFKASNILLDGSY AKISDFGLAK
Sbjct: 181 GSAVQPLPWDIRLKIAIGAARGLAFLHTSEK-VIYRDFKASNILLDGSYNAKISDFGLAK 239
Query: 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPS 296
LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG RALDTNRPS
Sbjct: 240 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGQRALDTNRPS 299
Query: 297 GQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
G H+L +W+KPYL ++RK + I+D RL+G++P KAA++IAQLSLKCL +EPK RPSM+EV
Sbjct: 300 GLHSLTEWVKPYLHDRRKLKGIMDPRLEGKFPSKAAFRIAQLSLKCLASEPKQRPSMKEV 359
Query: 357 VETLERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSP 395
+E LER+QA+++KP +P+ R TH+ A RQG Q +HHRSP
Sbjct: 360 LENLERIQAANEKPVEPKFRSTHA-ASRQGHQAVHHRSP 397
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501765|ref|XP_003519694.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1539), Expect = e-168, Method: Compositional matrix adjust.
Identities = 286/352 (81%), Positives = 320/352 (90%), Gaps = 2/352 (0%)
Query: 44 RFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA 103
+FS SSGD+ YPNGQILPT NLRIFTF EL+AATRNFK+DTVLGEGGFGKVFKGWL+EKA
Sbjct: 57 KFSVSSGDQPYPNGQILPTSNLRIFTFAELKAATRNFKADTVLGEGGFGKVFKGWLEEKA 116
Query: 104 PGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEF 163
K GSGTVIAVKKLNSESLQG EEWQSEVNFLGRLSH NLV+LLGYC E+ ELLLVYEF
Sbjct: 117 TSKGGSGTVIAVKKLNSESLQGLEEWQSEVNFLGRLSHTNLVKLLGYCLEESELLLVYEF 176
Query: 164 MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223
MQKGSLENHLFGRG++VQPL W+IRLKIAIGAARGLAFLHTS+K VIYRDFKASNILLDG
Sbjct: 177 MQKGSLENHLFGRGSAVQPLPWDIRLKIAIGAARGLAFLHTSEK-VIYRDFKASNILLDG 235
Query: 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEI 283
SY AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEI
Sbjct: 236 SYNAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEI 295
Query: 284 LTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCL 343
LTG RALDTNRPSG H+L +W+KPYL ++RK + I+D RL+G++P KAA++IAQLSLKCL
Sbjct: 296 LTGQRALDTNRPSGLHSLTEWVKPYLHDRRKLKGIMDPRLEGKFPSKAAFRIAQLSLKCL 355
Query: 344 EAEPKHRPSMREVVETLERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSP 395
+EPK RPSM+EV+E LER+QA+++KP +P+ R TH+ A RQG Q +HHRSP
Sbjct: 356 ASEPKQRPSMKEVLENLERIQAANEKPVEPKFRSTHA-ASRQGHQAVHHRSP 406
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297836446|ref|XP_002886105.1| hypothetical protein ARALYDRAFT_480605 [Arabidopsis lyrata subsp. lyrata] gi|297331945|gb|EFH62364.1| hypothetical protein ARALYDRAFT_480605 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1483), Expect = e-161, Method: Compositional matrix adjust.
Identities = 287/409 (70%), Positives = 346/409 (84%), Gaps = 11/409 (2%)
Query: 1 MGICW---SDTPHD----TIGHLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSGDES 53
MG+CW SD+P + G++SS G ++++ TT+TG SRGSN+S NS FS +SG+++
Sbjct: 1 MGLCWGSPSDSPPTATPTSTGNISSVGTFKSSNNTTTTGTSRGSNISSNSGFSVASGEDA 60
Query: 54 YPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVI 113
YP+GQILP PNLRIF+ ELRAATRNF+S+ VLGEGGFGKVFKGWL++K GK +GTVI
Sbjct: 61 YPDGQILPIPNLRIFSLTELRAATRNFRSENVLGEGGFGKVFKGWLEDKTAGKHSNGTVI 120
Query: 114 AVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL 173
AVKKLN+ES QGFEEWQ EVNFLGR+SHPNLV+LLGYC E +ELLLVYE+MQKGSLENHL
Sbjct: 121 AVKKLNAESFQGFEEWQCEVNFLGRVSHPNLVKLLGYCLEGEELLLVYEYMQKGSLENHL 180
Query: 174 FGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233
F +G+SVQPL+W IRLKIAIGAA+GLAFLH S+KQVIYRDFKASNILLDGSY AKISDFG
Sbjct: 181 FRKGSSVQPLSWEIRLKIAIGAAKGLAFLHASEKQVIYRDFKASNILLDGSYNAKISDFG 240
Query: 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTN 293
LAKLGPSASQSH+TTRVMGT+GYAAPEYVATGHLYVKSDVYGFGVVL EILTGL ALD
Sbjct: 241 LAKLGPSASQSHITTRVMGTHGYAAPEYVATGHLYVKSDVYGFGVVLAEILTGLHALDPT 300
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353
RP+GQHNL +WIKP+LSE+RK R I+D RL+G+YP+K+A+++AQL+LKCL EPK+RPSM
Sbjct: 301 RPTGQHNLTEWIKPHLSERRKLRSIMDPRLEGKYPFKSAFRVAQLALKCLGPEPKNRPSM 360
Query: 354 REVVETLERLQASDQKPKQPR-VRPTHSMAHRQGQ---QPLHHRSPLHT 398
+EVVE+LE ++A+++KP + R R + S+ +QG Q L P HT
Sbjct: 361 KEVVESLELIEAANEKPLERRTTRASPSIRQQQGHYRPQQLSSFRPRHT 409
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 413 | ||||||
| TAIR|locus:2059642 | 414 | Kin3 "kinase 3" [Arabidopsis t | 0.934 | 0.932 | 0.677 | 1.7e-144 | |
| TAIR|locus:2014614 | 484 | AT1G76360 [Arabidopsis thalian | 0.767 | 0.654 | 0.624 | 6.3e-108 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.789 | 0.838 | 0.601 | 5.7e-107 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.755 | 0.737 | 0.624 | 7.2e-107 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.799 | 0.835 | 0.588 | 9.8e-103 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.874 | 0.847 | 0.545 | 6.9e-102 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.857 | 0.830 | 0.547 | 1.1e-101 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.760 | 0.693 | 0.579 | 2.8e-98 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.777 | 0.829 | 0.568 | 3.5e-98 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.719 | 0.602 | 0.603 | 9.4e-98 |
| TAIR|locus:2059642 Kin3 "kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1412 (502.1 bits), Expect = 1.7e-144, P = 1.7e-144
Identities = 267/394 (67%), Positives = 321/394 (81%)
Query: 1 MGICW---SDTPHDTI----GHLXXXXXXXXXXXXXXXXXXXXXXXXXXXXFSASSGDES 53
MG+CW SD+P T G++ FS +SG+++
Sbjct: 1 MGLCWGSPSDSPPTTTPSSTGNISSVGTFKSSNNTTTTGTSRGSNISSNSGFSVASGEDA 60
Query: 54 YPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVI 113
YP+GQILP PNLRIF+ ELRA+TRNF+S+ VLGEGGFGKVFKGWL++K PGK +GTVI
Sbjct: 61 YPDGQILPIPNLRIFSLAELRASTRNFRSENVLGEGGFGKVFKGWLEDKTPGKQSNGTVI 120
Query: 114 AVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL 173
AVKKLN+ES QGFEEWQ EVNFLGR+SHPNLV+LLGYC E +ELLLVYE+MQKGSLENHL
Sbjct: 121 AVKKLNAESFQGFEEWQCEVNFLGRVSHPNLVKLLGYCLEGEELLLVYEYMQKGSLENHL 180
Query: 174 FGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233
F +G++VQPL+W IRLKIAIGAA+GLAFLH S+KQVIYRDFKASNILLDGSY AKISDFG
Sbjct: 181 FRKGSAVQPLSWEIRLKIAIGAAKGLAFLHASEKQVIYRDFKASNILLDGSYNAKISDFG 240
Query: 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTN 293
LAKLGPSASQSH+TTRVMGT+GYAAPEYVATGHLYVKSDVYGFGVVL EILTGL ALD
Sbjct: 241 LAKLGPSASQSHITTRVMGTHGYAAPEYVATGHLYVKSDVYGFGVVLAEILTGLHALDPT 300
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353
RP+GQHNL +WIKP+LSE+RK R I+D RL+G+YP+K+A+++AQL+LKCL EPK+RPSM
Sbjct: 301 RPTGQHNLTEWIKPHLSERRKLRSIMDPRLEGKYPFKSAFRVAQLALKCLGPEPKNRPSM 360
Query: 354 REVVETLERLQASDQKPKQPRV-RPTHSMAHRQG 386
+EVVE+LE ++A+++KP + R R + S+ +QG
Sbjct: 361 KEVVESLELIEAANEKPLERRTTRASPSIRQQQG 394
|
|
| TAIR|locus:2014614 AT1G76360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 201/322 (62%), Positives = 256/322 (79%)
Query: 55 PNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK--APGKSGSGTV 112
P+G+I+ TPNL++FT VEL+ AT+NF+ ++V+GEGGFG+VFKGW+DEK AP ++G G
Sbjct: 139 PSGKIV-TPNLKMFTLVELKTATKNFRPESVIGEGGFGQVFKGWVDEKTLAPSRAGVGIP 197
Query: 113 IAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENH 172
+AVKK N +S QG EWQ EV FLG+ HPNLV+LLGYCWE+ + LLVYE++ KGSLENH
Sbjct: 198 VAVKKSNPDSEQGLHEWQCEVRFLGKFHHPNLVKLLGYCWEENQFLLVYEYLPKGSLENH 257
Query: 173 LFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232
LF +GA P W+ RLKIAI AA+GL FLH S+K VIYRDFKASNILLD ++ AK+SDF
Sbjct: 258 LFSKGAEALP--WDTRLKIAIEAAQGLTFLHNSEKSVIYRDFKASNILLDSNFHAKLSDF 315
Query: 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDT 292
GLAK GP SHVTTRVMGT GYAAPEY+ATGHLYV+SDVYGFGVVL+E+LTGLRALD
Sbjct: 316 GLAKNGPINGFSHVTTRVMGTQGYAAPEYMATGHLYVRSDVYGFGVVLLELLTGLRALDP 375
Query: 293 NRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352
NRPS Q NLV+W KP L++K+K + ++D RL+ +YP A + A+L L+CLEA+PK+RP
Sbjct: 376 NRPSAQQNLVEWAKPGLNQKKKVQKMMDPRLEQKYPLLAVTKTAELILRCLEADPKNRPP 435
Query: 353 MREVVETLERLQASDQKPKQPR 374
M +V+ LE ++ +P++ R
Sbjct: 436 MDDVLRELEVVRTIRDQPQEER 457
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 5.7e-107, P = 5.7e-107
Identities = 199/331 (60%), Positives = 253/331 (76%)
Query: 47 ASSGDESY-PN--GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK- 102
+S+ SY P G+IL NL+ F+ EL++ATRNF+ D+V+GEGGFG VFKGW+DE
Sbjct: 32 SSTASFSYMPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESS 91
Query: 103 -APGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVY 161
AP K G+G VIAVK+LN E QG EW +E+N+LG+L HPNLV+L+GYC E++ LLVY
Sbjct: 92 LAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVY 151
Query: 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221
EFM +GSLENHLF RG QPL+WN R+++A+GAARGLAFLH + QVIYRDFKASNILL
Sbjct: 152 EFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILL 211
Query: 222 DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLV 281
D +Y AK+SDFGLA+ GP SHV+TRVMGT GYAAPEY+ATGHL VKSDVY FGVVL+
Sbjct: 212 DSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLL 271
Query: 282 EILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLK 341
E+L+G RA+D N+P G+HNLVDW +PYL+ KR+ ++D RLQGQY A +IA L+L
Sbjct: 272 ELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALD 331
Query: 342 CLEAEPKHRPSMREVVETLERLQASDQKPKQ 372
C+ + K RP+M E+V+T+E L + K+
Sbjct: 332 CISIDAKSRPTMNEIVKTMEELHIQKEASKE 362
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
Identities = 196/314 (62%), Positives = 247/314 (78%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL +PNL+ FTF EL+AATRNF+ D+VLGEGGFG VFKGW+DE+ K G+G VIA
Sbjct: 57 GEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIA 116
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VKKLN + QG +EW +EVN+LG+ SHPNLV+L+GYC ED+ LLVYEFM +GSLENHLF
Sbjct: 117 VKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 176
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
RG+ QPL+W +RLK+A+GAA+GLAFLH ++ VIYRDFK SNILLD Y AK+SDFGL
Sbjct: 177 RRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGL 236
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
AK GP+ +SHV+TR+MGTYGYAAPEY+ATGHL KSDVY +GVVL+E+L+G RA+D NR
Sbjct: 237 AKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNR 296
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
P G+ LV+W +P L+ KRK +ID RLQ QY + A ++A L+L+CL E K RP+M
Sbjct: 297 PPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMN 356
Query: 355 EVVETLERLQASDQ 368
EVV LE +Q ++
Sbjct: 357 EVVSHLEHIQTLNE 370
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
Identities = 196/333 (58%), Positives = 251/333 (75%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL + ++ FTF EL+ ATRNF+ D+V+GEGGFG VFKGWLDE P K G+G VIA
Sbjct: 44 GEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIA 103
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VKKLN E QG EW +E+N+LG+LSHPNLV+L+GYC ED+ LLVYEFMQKGSLENHLF
Sbjct: 104 VKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLF 163
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
RGA +PL W +R+ +A+ AA+GLAFLH+ +VIYRD KASNILLD Y AK+SDFGL
Sbjct: 164 RRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGL 223
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
A+ GP S+V+TRVMGTYGYAAPEY+++GHL +SDVY FGV+L+EIL+G RALD NR
Sbjct: 224 ARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNR 283
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
P+ + NLVDW +PYL+ KRK I+D RL QY + A ++A ++++CL EPK RP+M
Sbjct: 284 PAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMD 343
Query: 355 EVVETLERLQASDQKPKQPR-VRPTHSMAHRQG 386
+VV L++LQ + KP Q V+ T + + G
Sbjct: 344 QVVRALQQLQDNLGKPSQTNPVKDTKKLGFKTG 376
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 6.9e-102, P = 6.9e-102
Identities = 209/383 (54%), Positives = 271/383 (70%)
Query: 49 SGDESYPN----GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA- 103
S ES P G+IL +PNL+ FTF EL+ ATRNF+ D++LGEGGFG VFKGW+D
Sbjct: 48 SSVESLPTPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTL 107
Query: 104 -PGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162
K GSG V+AVKKL +E QG +EW +EVN+LG+LSHPNLV+L+GYC E + LLVYE
Sbjct: 108 TASKPGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYE 167
Query: 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222
FM KGSLENHLF RGA QPL W IR+K+AIGAA+GL FLH + QVIYRDFKA+NILLD
Sbjct: 168 FMPKGSLENHLFRRGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLD 225
Query: 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVE 282
+ +K+SDFGLAK GP+ ++HV+T+VMGT+GYAAPEYVATG L KSDVY FGVVL+E
Sbjct: 226 AEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLE 285
Query: 283 ILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKC 342
+L+G RA+D ++ + +LVDW PYL +KRK I+D RL GQYP K AY A L+L+C
Sbjct: 286 LLSGRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQC 345
Query: 343 LEAEPKHRPSMREVVETLERLQASDQKP------KQPRV---RPTH-SMAHRQGQQPLHH 392
L + K RP M EV+ L++L+++ KP +Q ++ R ++ S+ + ++ +
Sbjct: 346 LNPDAKLRPKMSEVLAKLDQLEST--KPGTGVGNRQAQIDSPRGSNGSIVQKSPRRYSYD 403
Query: 393 RSPLHTNLDRNR--GYQHSPRVR 413
R LH + + HSPRVR
Sbjct: 404 RPLLHITPGASPLPTHNHSPRVR 426
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 1.1e-101, P = 1.1e-101
Identities = 201/367 (54%), Positives = 257/367 (70%)
Query: 57 GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKA--PGKSGSGTVIA 114
G+IL +PNL+ FTF EL+ AT+NF+ D +LGEGGFG VFKGW+D+ + + GSG V+A
Sbjct: 63 GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122
Query: 115 VKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF 174
VK+L E QG +EW +EVN+LG+LSHPNLV L+GYC E + LLVYEFM KGSLENHLF
Sbjct: 123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182
Query: 175 GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
RGA QPL W IR+K+A+GAA+GL FLH + QVIYRDFKA+NILLD + AK+SDFGL
Sbjct: 183 RRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGL 240
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
AK GP+ +HV+T+V+GT+GYAAPEYVATG L KSDVY FGVVL+E+++G RA+D +
Sbjct: 241 AKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSN 300
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
+++LVDW PYL +KRK I+D +L GQYP K A+ A L+L+CL + K RP M
Sbjct: 301 GGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMS 360
Query: 355 EVVETLERLQASDQKPKQPRVRPTHSMAHRQG---QQPL---HHRSPLHTNLDRNR--GY 406
EV+ TLE+L+ S KP + H + P+ H R LH + Y
Sbjct: 361 EVLVTLEQLE-SVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPSY 419
Query: 407 QHSPRVR 413
SPRVR
Sbjct: 420 TQSPRVR 426
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 186/321 (57%), Positives = 243/321 (75%)
Query: 47 ASSGDES-YPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK--A 103
A SG + +G++ + LRIF F +L+ ATRNF+ +++LGEGGFG VFKGW++E A
Sbjct: 69 AESGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 128
Query: 104 PGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEF 163
P K G+G +AVK LN + LQG +EW +E+NFLG L HP+LV+L+GYC E+ + LLVYEF
Sbjct: 129 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEF 188
Query: 164 MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT-SDKQVIYRDFKASNILLD 222
M +GSLENHLF R PL W++R+KIA+GAA+GLAFLH ++K VIYRDFK SNILLD
Sbjct: 189 MPRGSLENHLFRR---TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 245
Query: 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVE 282
G Y AK+SDFGLAK P +SHV+TRVMGTYGYAAPEYV TGHL KSDVY FGVVL+E
Sbjct: 246 GEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLE 305
Query: 283 ILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKC 342
ILTG R++D +RP+G+ NLV+W++P+L +K++F ++D RL+G Y K A + Q++ +C
Sbjct: 306 ILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQC 365
Query: 343 LEAEPKHRPSMREVVETLERL 363
L + K RP M EVVE L+ L
Sbjct: 366 LNRDSKARPKMSEVVEALKPL 386
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 975 (348.3 bits), Expect = 3.5e-98, P = 3.5e-98
Identities = 187/329 (56%), Positives = 246/329 (74%)
Query: 45 FSASSGDESYPN--GQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK 102
F+ SS P G++LP+P L+ FTF EL+ ATRNFK ++++GEGGFG V+KGW+ E+
Sbjct: 47 FTTSSWSNLTPRSEGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGER 106
Query: 103 A--PGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160
+ P K GSG V+AVKKL SE QG +EW +EV++LGRL H NLV+L+GYC E ++ LLV
Sbjct: 107 SLSPSKPGSGMVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLV 166
Query: 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNIL 220
YE+M KGSLENHLF RGA +P+ W R+K+A AARGL+FLH + +VIYRDFKASNIL
Sbjct: 167 YEYMPKGSLENHLFRRGA--EPIPWKTRMKVAFSAARGLSFLH--EAKVIYRDFKASNIL 222
Query: 221 LDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVL 280
LD + AK+SDFGLAK GP+ ++HVTT+V+GT GYAAPEY+ATG L KSDVY FGVVL
Sbjct: 223 LDVDFNAKLSDFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVL 282
Query: 281 VEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSL 340
+E+L+G LD ++ + NLVDW PYL ++RK I+D +L GQYP+K A A ++L
Sbjct: 283 LELLSGRPTLDKSKVGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIAL 342
Query: 341 KCLEAEPKHRPSMREVVETLERLQASDQK 369
+CL EPK RP M +V+ TL++L+ S +K
Sbjct: 343 RCLNTEPKLRPDMADVLSTLQQLETSSKK 371
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 9.4e-98, P = 9.4e-98
Identities = 183/303 (60%), Positives = 234/303 (77%)
Query: 64 NLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEK--APGKSGSGTVIAVKKLNSE 121
+LR FTF +L+ +TRNF+ +++LGEGGFG VFKGW++E AP K G+G +AVK LN +
Sbjct: 126 HLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPD 185
Query: 122 SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQ 181
LQG +EW +E+NFLG L HPNLV+L+GYC ED + LLVYEFM +GSLENHLF R
Sbjct: 186 GLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--- 242
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSD-KQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240
PL W+IR+KIA+GAA+GL+FLH K VIYRDFK SNILLD Y AK+SDFGLAK P
Sbjct: 243 PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPD 302
Query: 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300
++HV+TRVMGTYGYAAPEYV TGHL KSDVY FGVVL+E+LTG R++D NRP+G+HN
Sbjct: 303 EGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 362
Query: 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
LV+W +P+L +KR+F ++D RL+G + K A ++ QL+ +CL +PK RP M +VVE L
Sbjct: 363 LVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEAL 422
Query: 361 ERL 363
+ L
Sbjct: 423 KPL 425
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 413 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-48 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-34 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-17 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 92/286 (32%), Positives = 137/286 (47%), Gaps = 43/286 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LGEG FG+V+KG L G+ T +AVK L S + EE+ E + + +LSHPN
Sbjct: 6 KLGEGAFGEVYKGTLK---GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+VRLLG C + + L +V E+M G L + L G + L L++A+ A+G+ +L
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLE 119
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT------RVMGTYGYA 257
K ++RD A N L+ + KISDFGL++ + M
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKF 315
APE + G KSDV+ FGV+L EI T G+ +PY +S +
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTL----------GE-------QPYPGMSNEEVL 214
Query: 316 RHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
+ D RL P ++ +L L+C +P+ RP+ E+VE L
Sbjct: 215 ELLEDGYRL--PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-55
Identities = 91/284 (32%), Positives = 135/284 (47%), Gaps = 39/284 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LGEG FG+V+KG L G +AVK L + S Q EE+ E + +L HPN
Sbjct: 6 KLGEGAFGEVYKGTLK---GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+LLG C E++ L++V E+M G L ++L R + L+ + L A+ ARG+ +L
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS-----ASQSHVTTRVMGTYGYAA 258
K I+RD A N L+ + KISDFGL++ + R M A
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM------A 172
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFR 316
PE + G KSDV+ FGV+L EI T G+ +PY +S
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTL----------GE-------EPYPGMSNAEVLE 215
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
++ + P + +L L+C +P+ RP+ E+VE L
Sbjct: 216 YLKKGYRLPKPPNCPPE-LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 8e-54
Identities = 90/283 (31%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LGEG FG+V+KG L K K +AVK L + S Q EE+ E + +L HPN
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKK---VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+LLG C E++ L +V E+M+ G L ++L + L+ + L A+ ARG+ +L
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPE 260
K I+RD A N L+ + KISDFGL++ R G + APE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPE 173
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
+ G KSDV+ FGV+L EI T G+ +PY +++
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTL----------GE-------QPY--PGMSNEEVLE 214
Query: 321 ARLQGQYPYKAAY---QIAQLSLKCLEAEPKHRPSMREVVETL 360
G + ++ L L+C +P+ RP+ E+VE L
Sbjct: 215 YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-53
Identities = 79/278 (28%), Positives = 124/278 (44%), Gaps = 66/278 (23%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPNL 144
LGEGGFG V+ + +G +A+K + E EE E+ L +L+HPN+
Sbjct: 1 LGEGGFGTVYLARDKK-------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI 53
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L G ++ L LV E+ + GSL++ L L+ + L+I + GL +LH
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLH- 109
Query: 205 SDKQVIYRDFKASNILLD-GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+I+RD K NILLD + K++DFGL+KL S + ++GT Y APE +
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLL 166
Query: 264 TGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
Y KSD++ GV+L E+ + + +I
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL-----------------------------PELKDLIR-- 195
Query: 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
K L+ +P+ RPS +E++E L
Sbjct: 196 ------------------KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 96/294 (32%), Positives = 136/294 (46%), Gaps = 50/294 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHPN 143
LGEG FG+V+KG K GK G T +AVK L S + +++ E + +L HPN
Sbjct: 2 KLGEGAFGEVYKG----KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHL-----FGRGASVQPLAWNIRLKIAIGAARG 198
+VRLLG C E++ L LV E+M+ G L ++L L+ L AI A+G
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT------RVMG 252
+ +L K+ ++RD A N L+ KISDFGL++ T R M
Sbjct: 118 MEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LS 310
APE + G KSDV+ FGV+L EI T G PY LS
Sbjct: 175 -----APESLKDGIFTSKSDVWSFGVLLWEIFTL----------GA-------TPYPGLS 212
Query: 311 EKRKFRHIIDARLQGQYPYKAAY---QIAQLSLKCLEAEPKHRPSMREVVETLE 361
+ ++ G K Y ++ +L L C + +P+ RP+ E+VE LE
Sbjct: 213 NEEVLEYLRK----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 99/279 (35%), Positives = 141/279 (50%), Gaps = 33/279 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN--SESLQGFEEWQSEVNFLGRLSHP 142
LG G FG V+K G+G ++AVK L SE + + + E+ L RLSHP
Sbjct: 6 KLGSGSFGTVYKAK-------HKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHP 58
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N+VRL+ + L LV E+ + G L ++L G PL+ + KIA+ RGL +L
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYL 114
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H +I+RD K NILLD + KI+DFGLAK S S +TT V GT Y APE +
Sbjct: 115 H--SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVL 170
Query: 263 ATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
G+ Y K DV+ GV+L E+LTG P N++D + + R I+
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTG------KPPFSGENILD-------QLQLIRRILGP 217
Query: 322 RLQGQYPYKAAYQIAQLSL--KCLEAEPKHRPSMREVVE 358
L+ P ++ L KCL +P RP+ E+++
Sbjct: 218 PLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 5e-48
Identities = 81/282 (28%), Positives = 123/282 (43%), Gaps = 45/282 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFLGRLSHPN 143
LGEG FGKV+ +G ++A+K + + ++ E E+ L +L HPN
Sbjct: 6 KLGEGSFGKVYLAR-------DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN 58
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG----ASVQPLAWNIRLKIAIGAARGL 199
+VRL ++ +L LV E+ + G L + L RG + I L
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI--------LSAL 110
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
+LH K +++RD K NILLD K++DFGLA+ +TT V GT Y AP
Sbjct: 111 EYLH--SKGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAP 165
Query: 260 EYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRP--SGQHNLVDWIKPYLSEKRKFR 316
E V G Y D++ GV+L E+LTG +P G L++ K K F
Sbjct: 166 E-VLLGKGYGKAVDIWSLGVILYELLTG-------KPPFPGDDQLLELFKKIGKPKPPFP 217
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ + + L K L +P+ R + E ++
Sbjct: 218 P---------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 86/284 (30%), Positives = 136/284 (47%), Gaps = 47/284 (16%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKL--NSESLQGFEEWQSEVNFLGRLSHP 142
+G+G FG V G + +K +AVK L +S + Q F +E + + L HP
Sbjct: 14 IGKGEFGDVMLGDYRGQK----------VAVKCLKDDSTAAQAF---LAEASVMTTLRHP 60
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
NLV+LLG + L +V E+M KGSL ++L RG +V LA +L A+ G+ +L
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYL 118
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
+K ++RD A N+L+ AK+SDFGLAK ASQ + ++ + APE +
Sbjct: 119 E--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEAL 171
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHIID 320
KSDV+ FG++L EI + R PY + K H+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLKDVVPHVEK 214
Query: 321 A-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
R++ P ++ ++ C E +P RP+ +++ E L +
Sbjct: 215 GYRMEA--PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 83/283 (29%), Positives = 123/283 (43%), Gaps = 48/283 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK--LNSESLQGFEEWQSEVNFLGRLSHP 142
+LG G FG V+ LD+ +G ++AVK L+ +S + E + E+ L L HP
Sbjct: 7 LLGRGSFGSVYLA-LDKD------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHP 59
Query: 143 NLVRLLGYCW--EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
N+VR G E L + E++ GSL + L G +P+ IR K GLA
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IR-KYTRQILEGLA 115
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+LH +++RD K +NIL+D K++DFG AK T V GT + APE
Sbjct: 116 YLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 261 YVATGHLY-VKSDVYGFGVVLVEILTGLRAL-DTNRPS------GQHNLVDWIKPYLSEK 312
V G Y +D++ G ++E+ TG + P G I +LSE
Sbjct: 174 -VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE- 231
Query: 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
+ + + KCL +PK RP+ E
Sbjct: 232 -EAKDFLR--------------------KCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 86/300 (28%), Positives = 133/300 (44%), Gaps = 34/300 (11%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFL 136
R+ K LGEG FGKV D P +G +AVK LN Q +++ E+ L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYD---PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60
Query: 137 GRLSHPNLVRLLGYCWED--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L H N+V+ G C + + L L+ E++ GSL ++L + Q + L +
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRL-LLFSSQ 117
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG-- 252
+G+ +L ++ I+RD A NIL++ KISDFGLAK+ + + + G
Sbjct: 118 ICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKV-LPEDKDYYYVKEPGES 174
Query: 253 -TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
+ Y APE + T SDV+ FGV L E+ T G + +
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFT----------YGDPSQSPPAEFLRMI 223
Query: 312 KRKFRHIIDARLQ-----GQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+I RL G+ P ++ L C EAEP+ RPS +++ ++RL
Sbjct: 224 GIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 42/281 (14%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG+V++G W + +A+K L S+ L +++Q EV L RL H +L
Sbjct: 14 LGSGYFGEVWEGLWKNRVR---------VAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIAIGAARGLAF 201
+ L C + + ++ E M+KGSL L G+ V L + +A A G+A+
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAY 119
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
L ++ I+RD A NIL+ K++DFGLA+L ++ Y + APE
Sbjct: 120 LE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEA 175
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHII 319
+ G KSDV+ FG++L E+ T GQ PY ++ + I
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT----------YGQ-------VPYPGMNNHEVYDQ-I 217
Query: 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
A + P K +I ++ L+C AEP+ RPS + + E L
Sbjct: 218 TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G+GGFG+V+K +G +A+K + ES + E+ +E+ L + HPN+
Sbjct: 7 KIGKGGFGEVYKARHKR-------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI 59
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+ G + EL +V EF GSL++ L Q L + + +GL +LH
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLH- 115
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
+I+RD KA+NILL K+ DFGL+ S + ++GT + APE +
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVING 171
Query: 265 GHLYVKSDVYGFGVVLVEILTG 286
K+D++ G+ +E+ G
Sbjct: 172 KPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 96/308 (31%), Positives = 130/308 (42%), Gaps = 56/308 (18%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFL 136
R K VLGEG FGKV D P G+G ++AVK L E Q W+ E+N L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINIL 60
Query: 137 GRLSHPNLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L H N+V+ G C E K L L+ E++ GSL ++L ++ L L A
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQ 115
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM--- 251
G+A+LH+ + I+RD A N+LLD KI DFGLAK P + H RV
Sbjct: 116 ICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP---EGHEYYRVREDG 170
Query: 252 -GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
+ A E + SDV+ FGV L E+LT S
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH------------------CDSKQS 212
Query: 311 EKRKFRHIIDARLQGQY-----------------PYKAAYQIAQLSLKCLEAEPKHRPSM 353
+KF +I + QGQ P ++ L C E E K RP+
Sbjct: 213 PPKKFEEMIGPK-QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271
Query: 354 REVVETLE 361
R ++ L+
Sbjct: 272 RSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 29/216 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFL 136
N++ ++G G FG V+KG L+ + +G +A+K+++ E + + + E++ L
Sbjct: 1 NYQLGDLIGRGAFGVVYKG-LNLE------TGDFVAIKQISLEKIKEEALKSIMQEIDLL 53
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQPLAWNIRLKIAIG 194
L HPN+V+ +G L ++ E+ + GSL + FG P ++ +A+
Sbjct: 54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG------PFPESL---VAVY 104
Query: 195 AA---RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRV 250
+GLA+LH VI+RD KA+NIL K++DFG+A KL S V
Sbjct: 105 VYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASV 159
Query: 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
+GT + APE + SD++ G ++E+LTG
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNL 144
LGEG FGKV+KG L S T +A+K L + +E++ E + L HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSA--TSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGR------------GASVQPLAWNIRLKIA 192
V LLG C +++ +++E++ G L L L + L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
I A G+ +L S ++RD A N L+ T KISDFGL++ SA V ++ +
Sbjct: 131 IQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEI 283
+ PE + G +SD++ FGVVL EI
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 85/282 (30%), Positives = 134/282 (47%), Gaps = 45/282 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
++GEG FG V +G +G +AVK + + + Q F E E + +L H N
Sbjct: 13 IIGEGEFGAVLQG---------EYTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKN 60
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
LVRLLG + L +V E M KG+L N L RG ++ + L+ ++ A G+ +L
Sbjct: 61 LVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQ--LLQFSLDVAEGMEYLE 117
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ K++++RD A NIL+ AK+SDFGLA++G +++ + APE +
Sbjct: 118 S--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPEALK 170
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
KSDV+ +GV+L E+ + RA PY K + + +
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRA-----------------PY--PKMSLKEVKECVE 211
Query: 324 QG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
+G + P + L C E EPK RPS ++ E LE+
Sbjct: 212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 86/287 (29%), Positives = 131/287 (45%), Gaps = 52/287 (18%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLN--SESLQGFEEWQSEVNFLGRLSHP 142
LG G FG+V+ G W G+ T +AVK L + S + F + E + +L H
Sbjct: 14 LGAGQFGEVWMGTWN--------GT-TKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHD 61
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
LV+L C E++ + +V E+M KGSL + L L + +A A G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYL 119
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAP 259
+ + I+RD A NIL+ + KI+DFGLA+L T R G + AP
Sbjct: 120 ES--RNYIHRDLAARNILVGENLVCKIADFGLARL---IEDDEYTAR-EGAKFPIKWTAP 173
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRP-SGQHNLVDWIKPYLSEKRKFRHI 318
E G +KSDV+ FG++L EI+T R P G N R +
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN---------------REV 213
Query: 319 IDARLQGQY----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
++ +G Y P ++ L L+C + +P+ RP+ + LE
Sbjct: 214 LEQVERG-YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (287), Expect = 1e-28
Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 32/293 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNF 135
+++ LGEG FG+V+ + +A+K L + + E + E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL----------VALKVLAKKLESKSKEVERFLREIQI 50
Query: 136 LGRLSHP-NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L L+HP N+V+L + ++ L LV E++ GSLE L + PL+ + L I
Sbjct: 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQ 109
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYT-AKISDFGLAKL----GPSASQSHVTTR 249
L +LH+ K +I+RD K NILLD K+ DFGLAKL G ++S + +
Sbjct: 110 ILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 250 VMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALD-TNRPSGQHNLVDWI 305
+GT GY APE + + SD++ G+ L E+LTGL + S + I
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227
Query: 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ P + + L K L +PK+R S +
Sbjct: 228 LELPTPSLASPLSPS------NPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 79/292 (27%), Positives = 141/292 (48%), Gaps = 46/292 (15%)
Query: 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ--SEVNFLGRLS 140
+ V+G G FG+V +G L K PGK +A+K L + S + +E + +G+
Sbjct: 9 EKVIGGGEFGEVCRGRL--KLPGKKE--IDVAIKTLKAGS-SDKQRLDFLTEASIMGQFD 63
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HPN++RL G + + ++++ E+M+ GSL+ L + + G A G+
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMK 120
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG----- 255
+L S+ ++RD A NIL++ + K+SDFGL++ S++ TT+ G
Sbjct: 121 YL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED-SEATYTTK-----GGKIPI 172
Query: 256 -YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEK 312
+ APE +A SDV+ FG+V+ E+++ G+ +PY +S +
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS----------YGE-------RPYWDMSNQ 215
Query: 313 RKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + D RL P + QL L C + + RP+ ++V TL+++
Sbjct: 216 DVIKAVEDGYRLPP--PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 43/292 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G FG V++G G T +A+K +N + S++ E+ +E + + + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKG--EPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGR------GASVQPLAWNIRLKIAIGAARG 198
VRLLG + L+V E M KG L+++L R + P +++A A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL------GPSASQSHVTTRVMG 252
+A+L K+ ++RD A N ++ T KI DFG+ + + + R M
Sbjct: 132 MAYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 188
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LS 310
APE + G KSDV+ FGVVL E+ T L PY LS
Sbjct: 189 -----APESLKDGVFTTKSDVWSFGVVLWEMAT-LAEQ----------------PYQGLS 226
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
+ + +ID P ++ +L C + PK RP+ E+V +L+
Sbjct: 227 NEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-28
Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPNL 144
+G+G FG V+KG L T +AVK S ++ E L + HPN+
Sbjct: 3 IGKGNFGDVYKGVLK--------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L+G C + + + +V E + GSL L + L L++++ AA G+ +L +
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLES 111
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
K I+RD A N L+ + KISDFG+++ + + APE +
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQ 324
G +SDV+ +G++L E + DT P G N ++ R I++ +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL---GDTPYP-GMSN------------QQTRERIESGYR 213
Query: 325 GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
P +I +L L+C +P++RPS E+ L+
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 81/301 (26%), Positives = 130/301 (43%), Gaps = 49/301 (16%)
Query: 86 LGEGGFGKVFKGWLDEKAPG--KSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHP 142
+G+G FG+VF+ +APG T++AVK L E S ++Q E + HP
Sbjct: 13 IGQGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQ------------------PLA 184
N+V+LLG C K + L++E+M G L L R Q PL+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS 244
+L IA A G+A+L S+++ ++RD N L+ + KI+DFGL++ SA
Sbjct: 129 CTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 245 HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVD 303
+ + PE + +SDV+ +GVVL EI + G+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM---------------- 230
Query: 304 WIKPY--LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
+PY ++ + ++ D + P ++ L C P RPS + L+
Sbjct: 231 --QPYYGMAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
Query: 362 R 362
R
Sbjct: 288 R 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 86/315 (27%), Positives = 145/315 (46%), Gaps = 59/315 (18%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLG 137
N LGEG FGKV K G++G TV AVK L + + SE N L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLK-GRAGYTTV-AVKMLKENASSSELRDLLSEFNLLK 58
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL----------FGRGAS-------- 179
+++HP++++L G C +D LLL+ E+ + GSL + L G +
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 180 --VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK- 236
+ L + A +RG+ +L ++ ++++RD A N+L+ KISDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 237 -----LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYV-KSDVYGFGVVLVEILTGLRAL 290
S+ + + M A E + H+Y +SDV+ FGV+L EI+T L
Sbjct: 177 VYEEDSYVKRSKGRIPVKWM------AIESLFD-HIYTTQSDVWSFGVLLWEIVT----L 225
Query: 291 DTNRPSGQHNLVDWIKPY--LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPK 348
N PY ++ +R F +++ + + P + ++ L L C + EP
Sbjct: 226 GGN-------------PYPGIAPERLF-NLLKTGYRMERPENCSEEMYNLMLTCWKQEPD 271
Query: 349 HRPSMREVVETLERL 363
RP+ ++ + LE++
Sbjct: 272 KRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 88/283 (31%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V KG K SG +AVK L G +E+ E + + +L HP +
Sbjct: 3 LGHGNFGSVVKGVYLMK----SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI-AIGAARGLAFLH 203
VRL+G C + L+LV E G L +L R LK A A G+A+L
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE 112
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAAPEYV 262
K ++RD A N+LL + AKISDFG+++ LG + TT + APE +
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
G KSDV+ +GV L E + G KPY + K +I
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS----------YGA-------KPY--GEMKGAEVIAML 211
Query: 323 LQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
G+ P + +I + L C + P+ RP+ E+ T R
Sbjct: 212 ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 81/313 (25%), Positives = 136/313 (43%), Gaps = 47/313 (15%)
Query: 65 LRIFTFVELRAATRNFKSDTVLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKL-NSES 122
LRI EL VLG G FG V+KG W+ E K +A+K L S
Sbjct: 1 LRILKETELEKIK-------VLGSGAFGTVYKGVWIPEGEKVK----IPVAIKVLREETS 49
Query: 123 LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGAS 179
+ +E E + + HP++VRLLG C ++ L+ + M G L +++ S
Sbjct: 50 PKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGS 108
Query: 180 VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239
L W +++ A+G+++L +K++++RD A N+L+ KI+DFGLAKL
Sbjct: 109 QYLLNWCVQI------AKGMSYL--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
Query: 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299
+ + + A E + KSDV+ +GV + E++T G
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT----------FGA- 209
Query: 300 NLVDWIKPYLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
KPY E I D +G+ P + + +KC + + RP+ +E+
Sbjct: 210 ------KPY--EGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261
Query: 357 VETLERLQASDQK 369
+ ++ Q+
Sbjct: 262 INEFSKMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-27
Identities = 83/288 (28%), Positives = 138/288 (47%), Gaps = 41/288 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ-----SEVNFLGRL 139
V+G G FG+VF+G L K PG+ +A+K L G+ E Q SE + +G+
Sbjct: 12 VIGAGEFGEVFRGIL--KMPGRKEV--AVAIKTLKP----GYTEKQRQDFLSEASIMGQF 63
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
SH N++RL G + K +++ E+M+ G+L+ +L L+ G A G+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAA 258
+L SD ++RD A NIL++ + K+SDFGL++ L ++ T+ + A
Sbjct: 121 KYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFR 316
PE +A SDV+ FG+V+ E+++ G+ +PY +S +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS----------FGE-------RPYWDMSNHEVMK 221
Query: 317 HIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
I D RL P + QL L+C + + RP ++V L++L
Sbjct: 222 AINDGFRLPA--PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 81/282 (28%), Positives = 122/282 (43%), Gaps = 64/282 (22%)
Query: 86 LGEGGFGKVF--KGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLS 140
LG+G FGKV + K +G + A+K L + + + E +E N L R++
Sbjct: 1 LGKGSFGKVLLVR---------KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR-- 197
HP +V+L Y ++ +E L LV E+ G L +HL + + + AR
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL------------SKEGRFSEERARFY 98
Query: 198 ------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
L +LH+ +IYRD K NILLD K++DFGLAK S T
Sbjct: 99 AAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFC 154
Query: 252 GTYGYAAPEYV-ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
GT Y APE + G+ D + GV+L E+LTG P+ +
Sbjct: 155 GTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKP------------------PFYA 195
Query: 311 EKRK--FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
E RK + I+ L ++P + + L L+ +P R
Sbjct: 196 EDRKEIYEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 31/288 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFLGRLSHPN 143
LGEG FGKVF G P ++AVK L + + ++ E L H N
Sbjct: 12 ELGEGAFGKVFLGECYHLEPE--NDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHL----------FGRGASVQPLAWNIRLKIAI 193
+V+ G C E ++V+E+M+ G L L + + L + L+IA+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
A G+ +L + + ++RD N L+ KI DFG+++ + V M
Sbjct: 130 QIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
+ PE + +SDV+ FGVVL EI T + +P + + I
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK-----QPWYGLSNEEVI-------- 234
Query: 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
I Q P ++ + L C + +P+ R +++++ E L+
Sbjct: 235 ---ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 86/283 (30%), Positives = 136/283 (48%), Gaps = 29/283 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS-ESLQGFEEWQSEVNFLGRLSHPN 143
V+G+G FG V+ G L + K AVK LN L+ E++ E + SHPN
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQK----IHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57
Query: 144 LVRLLGYCWEDKEL-LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
++ LLG C + L+V +M+ G L N F R + P ++ + + A+G+ +L
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDL-IGFGLQVAKGMEYL 114
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK--LGPSASQSHVTTRVMGTYGYAAPE 260
+ K+ ++RD A N +LD S+T K++DFGLA+ H T + A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
+ T KSDV+ FGV+L E++T R P + D I YL + R+
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT--RGAP---PYPDVDSFD-ITVYLLQGRRL----- 221
Query: 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
LQ +Y Y++ L C +P+ RP+ E+V +E++
Sbjct: 222 --LQPEYCPDPLYEVM---LSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 84/294 (28%), Positives = 129/294 (43%), Gaps = 42/294 (14%)
Query: 85 VLGEGGFGKVFKGWL--DEKAPGKSGSGTVIAVK--KLNSESLQGFEEWQSEVNFLGRLS 140
+LGEG FG V +G L D+ + K +AVK KL+ + EE+ SE +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 141 HPNLVRLLGYCWEDKEL------LLVYEFMQKGSLENHLFGRGASVQP--LAWNIRLKIA 192
HPN+++L+G C+E L +++ FM+ G L + L P L LK
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS---QSHVTTR 249
+ A G+ +L S++ I+RD A N +L T ++DFGL+K S Q +
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309
+ + A E +A KSDV+ FGV + EI T R H + D YL
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYD----YL 228
Query: 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + P ++ L C A+PK RP+ ++ E LE +
Sbjct: 229 RHGNRLKQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 79/301 (26%), Positives = 125/301 (41%), Gaps = 82/301 (27%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFE---EWQSEVNFLGRLS 140
LG G FG V++G G AVK L + G E + + E+ L +L
Sbjct: 8 LGSGSFGSVYEGL-------NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HPN+V+ LG E+ L + E + GSL L G+ +P+ +I + GL
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLE 116
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-----GTYG 255
+LH D+ ++RD K +NIL+D + K++DFG+AK V G+
Sbjct: 117 YLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPY 166
Query: 256 YAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ APE +A Y + +D++ G ++E+ TG KP S+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATG-------------------KPPWSQ--- 204
Query: 315 FRHIIDARLQGQYPYKAAYQIAQ----------LS-------LKCLEAEPKHRPSMREVV 357
A ++I + LS LKCL+ +P RP+ E++
Sbjct: 205 -----------LEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELL 253
Query: 358 E 358
E
Sbjct: 254 E 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 50/284 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGS-GTVIAVKKLNSESLQGFE--EWQSEVNFLGRLSH 141
+G+G FGKV+ + S G + +K+++ ++ E + +EV L +L+H
Sbjct: 7 QIGKGSFGKVYLV--------RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH 58
Query: 142 PNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPL----AWNIRLKIAIGAA 196
PN+++ +E+K L +V E+ G L + + +P + +++ +
Sbjct: 59 PNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA-- 115
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
L +LH +++++RD K NI L + K+ DFG++K+ S++ T V GT Y
Sbjct: 116 --LKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYY 169
Query: 257 AAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
+PE + Y KSD++ G VL E+ T + L I
Sbjct: 170 LSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALKI---------- 215
Query: 316 RHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
L+GQY P + + ++ L L+ +P+ RPS+ ++
Sbjct: 216 -------LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 83/295 (28%), Positives = 139/295 (47%), Gaps = 45/295 (15%)
Query: 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ-----SEVNF 135
K + V+G G FG+V +G L K PGK +A+K L S G+ E Q SE +
Sbjct: 7 KIEEVIGAGEFGEVCRGRL--KLPGKRE--IFVAIKTLKS----GYTEKQRRDFLSEASI 58
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
+G+ HPN++ L G + + ++++ EFM+ G+L++ L + L+ G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GI 115
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG--- 252
A G+ +L S+ ++RD A NIL++ + K+SDFGL++ + T +G
Sbjct: 116 AAGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY--L 309
+ APE +A SDV+ +G+V+ E+++ G R PY +
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWDM 215
Query: 310 SEKRKFRHI-IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
S + I D RL P + QL L C + + RP ++V TL+++
Sbjct: 216 SNQDVINAIEQDYRLPP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 87/299 (29%), Positives = 142/299 (47%), Gaps = 51/299 (17%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ-----SEV 133
K + V+G G FG+V G L K PGK +A+K L + G+ E Q SE
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRL--KLPGKRE--IPVAIKTLKA----GYTEKQRRDFLSEA 56
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLK 190
+ +G+ HPN++ L G + K +++V E+M+ GSL+ L G+ +Q L +R
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ-LVGMLR-- 113
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
G A G+ +L SD ++RD A NIL++ + K+SDFGL+++ ++ TTR
Sbjct: 114 ---GIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR- 167
Query: 251 MGTYG------YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304
G + APE +A SDV+ +G+V+ E+++ RP + + D
Sbjct: 168 ----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY-----GERPYWEMSNQDV 218
Query: 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
IK I+ + P + QL L C + + RP ++V L++L
Sbjct: 219 IKA-----------IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 77/272 (28%), Positives = 119/272 (43%), Gaps = 40/272 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE--EWQSEVNFLGRLSHPN 143
+G+G FG VFK K+ V A+K+++ + E E E L +L
Sbjct: 8 IGKGSFGVVFK------VVRKA-DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++R + +L +V E+ + G L L + +PL + + I GLA LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAAPEYV 262
+ K++++RD K+ N+ LD KI D G+AK L ++ ++GT Y +PE
Sbjct: 119 S--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD---NTNFANTIVGTPYYLSPELC 173
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
KSDV+ GVVL E TG D N Q L+ K
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI----------LKI------- 213
Query: 323 LQGQY-PYKAAY--QIAQLSLKCLEAEPKHRP 351
++G + P Y Q+AQL +CL + + RP
Sbjct: 214 IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 84/287 (29%), Positives = 126/287 (43%), Gaps = 32/287 (11%)
Query: 86 LGEGGFGKVFKGWL-DEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPN 143
LG G FG+V++G D PG SG V AVK L + Q +E+ E + + +HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPG-SGPIRV-AVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFG-RGASVQP--LAWNIRLKIAIGAARGLA 200
+V+LLG C ++ ++ E M+ G L ++L R P L L I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 201 FLHTSDKQVIYRDFKASNILL-----DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
+L I+RD A N L+ D KI DFGLA+ + +
Sbjct: 121 YLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ APE + G +SDV+ FGV++ EILT G +P N + ++ + R
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLG------QQPYPALNNQEVLQHVTAGGRL 232
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
Q P +I QL C +P RP+ + E L+
Sbjct: 233 -----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 91/297 (30%), Positives = 129/297 (43%), Gaps = 33/297 (11%)
Query: 86 LGEGGFGKV-------FKGWLDEKAP---GKSGSGTVIAVKKLN-SESLQGFEEWQSEVN 134
LGEG FG+V + EKA + + ++AVK L S E++ EV
Sbjct: 13 LGEGQFGEVHLCEADGLQD-FSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------ 188
L RLS PN+ RLLG C D L ++ E+M+ G L L A LA N +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 189 -LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT 247
L +A A G+ +L ++RD N L+ +YT KI+DFG+++ S+ V
Sbjct: 132 LLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 248 TRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307
R + A E V G KSDV+ FGV L EILT R +H +
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR-----EQPYEHLTDQQVIE 244
Query: 308 YLSE--KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
+ R I R P I +L L+C + + RP+ RE+ L+R
Sbjct: 245 NAGHFFRDDGRQIYLPR-----PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 80/286 (27%), Positives = 120/286 (41%), Gaps = 44/286 (15%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVI--AVKKLNSESLQG-FEEWQSEVNFLGRLSH 141
LG+G FG V +G W + G VI AVK L S+ L +++ E + L H
Sbjct: 3 LGDGSFGVVRRGEW-------STSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLA--WNIRLKIAIGAARGL 199
NL+RL G L++V E GSL + L ++ + ++IA G+
Sbjct: 56 ENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGM 110
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT---RVMGTYGY 256
+L + K+ I+RD A NILL KI DFGL + P +V +V + +
Sbjct: 111 RYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAW 166
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS-EKRKF 315
APE + T SDV+ FGV L E+ T G+ +P+ +
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT----------YGE-------EPWAGLSGSQI 209
Query: 316 RHIIDARLQG-QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
ID + + P I + L+C P RP+ + E L
Sbjct: 210 LKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 76/284 (26%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G +G+V++G W +AVK L ++++ EE+ E + + HPNL
Sbjct: 14 LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 64
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+LLG C + ++ EFM G+L ++L R + Q + + L +A + + +L
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPEY 261
K I+RD A N L+ ++ K++DFGL++L T G + APE
Sbjct: 123 --KNFIHRDLAARNCLVGENHLVKVADFGLSRL----MTGDTYTAHAGAKFPIKWTAPES 176
Query: 262 VATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLS-EKRKFRHII 319
+A +KSDV+ FGV+L EI T G+ PY + + ++
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGM------------------SPYPGIDLSQVYELL 218
Query: 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + + P ++ +L C + P RPS E+ + E +
Sbjct: 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 77/269 (28%), Positives = 129/269 (47%), Gaps = 35/269 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+G G FG V+ G+ EK +A+K + E E++ E + +LSHP LV
Sbjct: 12 IGSGQFGLVWLGYWLEK--------RKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
+L G C E + LV+EFM+ G L ++L + + L + + G+A+L +S
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS 119
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAK--LGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ VI+RD A N L+ + K+SDFG+ + L + S T + +++PE +
Sbjct: 120 N--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV---KWSSPEVFS 174
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
KSDV+ FGV++ E+ + + NR + + +V+ I FR + RL
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVETINA------GFR-LYKPRL 225
Query: 324 QGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352
Q + Y++ Q C + P+ RPS
Sbjct: 226 ASQ----SVYELMQ---HCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG G FG+V++G + P +AVK L ++ +++ +E + +L HP L+
Sbjct: 14 LGAGQFGEVWEGLWNNTTP--------VAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLI 64
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
+L C ++ + +V E M+ GSL +L G L I +A A G+A+L
Sbjct: 65 QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEA- 121
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAAPEYVAT 264
+ I+RD A N+L+ + K++DFGLA+ + ++ + + APE
Sbjct: 122 -QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALY 178
Query: 265 GHLYVKSDVYGFGVVLVEILT 285
+KSDV+ FG++L EI+T
Sbjct: 179 NRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 79/289 (27%), Positives = 136/289 (47%), Gaps = 37/289 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL----NSESLQG--FEEWQSE 132
+ LG G F + +GT++AVK++ N+ S Q E + E
Sbjct: 1 EWLKGQQLGTGAFSSCY-------QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKE 53
Query: 133 VNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
+ + RL+HP+++R+LG ED L E+M GS+ + L G + +
Sbjct: 54 IRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYT 109
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFGLA-KLGPSASQS-HVTTR 249
RGL++LH + Q+I+RD K +N+L+D + +I+DFG A +L + + +
Sbjct: 110 EQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
++GT + APE V G Y +S DV+ G V++E+ T + + S L+
Sbjct: 168 LLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------ 220
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
F+ I A P + + ++L+CLE +P+ RP RE++
Sbjct: 221 ------FK-IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-24
Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG G FG+V+ G+ + T +A+K L S+ E + +E N + +L HP LV
Sbjct: 14 LGAGQFGEVWMGYYN--------GHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLV 64
Query: 146 RLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
RL Y +E + ++ E+M+ GSL + L + L N + +A A G+AF+
Sbjct: 65 RL--YAVVTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GYAAPEYV 262
K I+RD +A+NIL+ + KI+DFGLA+L + T R + + APE +
Sbjct: 121 --KNYIHRDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 263 ATGHLYVKSDVYGFGVVLVEILT 285
G +KSDV+ FG++L EI+T
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 28/209 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----EVNFLGRLSH 141
LGEG +G V+K D+K +G ++A+KK+ ++ + E S E++ L L H
Sbjct: 7 LGEGTYGVVYKAR-DKK------TGEIVALKKIRLDNEE--EGIPSTALREISLLKELKH 57
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
PN+V+LL +++L LV+E+ K L+ PL+ N+ I RG
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-------GPLSPNLIKSIMYQLLRG 110
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
LA+ H+ ++++RD K NIL++ K++DFGLA+ +++ T V+ T Y A
Sbjct: 111 LAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRA 166
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTG 286
PE + Y + D++ G + E++TG
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-24
Identities = 88/288 (30%), Positives = 137/288 (47%), Gaps = 39/288 (13%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFL 136
+ K +G+G FG V G G +AVK + N + Q F +E + +
Sbjct: 6 KELKLLQTIGKGEFGDVMLG---------DYRGNKVAVKCIKNDATAQAF---LAEASVM 53
Query: 137 GRLSHPNLVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
+L H NLV+LLG E+K L +V E+M KGSL ++L RG SV L + LK ++
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDV 111
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
+ +L ++ ++RD A N+L+ AK+SDFGL K AS + T ++
Sbjct: 112 CEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVK 164
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
+ APE + KSDV+ FG++L EI + R P + L D + P + + K
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKD-VVPRVEKGYK- 217
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+DA G P Y + + +C + RPS ++ E LE +
Sbjct: 218 ---MDAP-DGCPP--VVYDVMK---QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 86 LGEGGFGKV-------FKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLG 137
LGEG FG+V +L E AP G ++AVK L ++ + ++ E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL--------FGRGASVQPLAWNIRL 189
RL +PN++RLLG C D L ++ E+M+ G L L F ++ ++ L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
+A+ A G+ +L + + ++RD N L+ YT KI+DFG+++ S + R
Sbjct: 133 YMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
+ + A E + G SDV+ FGV L E+ T
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 42/290 (14%)
Query: 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTV-IAVKKLN-SESLQGFEEWQSEVNFLGR 138
K + V+ G G +KG KS + VK++N S+ SE+ +G+
Sbjct: 693 KEENVISRGKKGASYKG--------KSIKNGMQFVVKEINDVNSIP-----SSEIADMGK 739
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L HPN+V+L+G C +K L++E+++ +L L L+W R KIAIG A+
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKA 792
Query: 199 LAFLHTS-DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
L FLH V+ + I++DG + +L T + + Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYV 845
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH-NLVDWIKPYLSEKRKFR 316
APE T + KSD+YGFG++L+E+LTG D G H ++V+W + S+
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVEWARYCYSDC---- 899
Query: 317 HI---IDARLQGQYPY--KAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
H+ ID ++G ++ L+L C +P RP +V++TLE
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 31/285 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVI--AVKKLNSES-LQGFEEWQSEVNFLGRL-S 140
LG G FGKV + A G S S V+ AVK L + E SE+ + L +
Sbjct: 42 TLGAGAFGKVVEA----TAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
H N+V LLG C +L++ E+ G L N L R L L + A+G+A
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
FL + K I+RD A N+LL KI DFGLA+ + S V + APE
Sbjct: 156 FL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHI 318
+ +SDV+ +G++L EI + L +N PY + KF +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS----LGSN-------------PYPGMPVDSKFYKL 256
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
I + P A +I + C +A+P RP+ +++V+ + +
Sbjct: 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-23
Identities = 82/283 (28%), Positives = 127/283 (44%), Gaps = 36/283 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW--QSEVNFL 136
++ V+G G FG V L K+ VI +K++ E + E Q+E L
Sbjct: 1 KYEKIRVVGRGAFGIV---HL---CRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQVL 53
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
LSHPN++ EDK L++V E+ G+L ++ R S+ + + I
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI--- 110
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYT-AKISDFGLAKLGPSASQSHVTTRVMGTYG 255
LA H K +++RD K NILLD KI DFG++K+ S S+++ V+GT
Sbjct: 111 -LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPC 166
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD-TNRPSGQHNLVDWIKPYLSEKRK 314
Y +PE KSD++ G VL E+ + RA + N P+ LV I
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LVLKIM-----SGT 217
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
F I D + + + QL L L +P RP + +++
Sbjct: 218 FAPISD---------RYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 56/292 (19%)
Query: 86 LGEGGFGKVFKGW-LDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHP 142
+G G FGKV+ LD +G ++AVK++ + +E E+ L L HP
Sbjct: 8 IGGGTFGKVYTAVNLD--------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
NLV+ G +++ + E+ G+LE L + + + GLA+L
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQL--LEGLAYL 115
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT--RVMGTYGYAAPE 260
H+ +++RD K +NI LD + K+ DFG A + + + + GT Y APE
Sbjct: 116 HS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 261 YV--ATGHLYVKS-DVYGFGVVLVEILTGLR---ALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ G + ++ D++ G V++E+ TG R LD ++
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIM------------ 216
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSL-------KCLEAEPKHRPSMREVVET 359
F + A + P QLS +CLE++PK RP+ E+++
Sbjct: 217 FH--VGAGHKPPIP-----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 38/293 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LGEG FGKVF +P K ++AVK L +L +++Q E L L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASV------QPLAWNIR------LKIAI 193
+ G C + L++V+E+M+ G L L G QP L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
A G+ +L + + ++RD N L+ + KI DFG+++ S V M
Sbjct: 131 QIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
+ PE + +SDV+ FGV+L EI T + W + +E
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT-------------YGKQPWFQLSNTE-- 233
Query: 314 KFRHIIDARLQG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+I+ QG + P ++ + L C + EP+ R +++E+ + L L
Sbjct: 234 ----VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 81/296 (27%), Positives = 126/296 (42%), Gaps = 42/296 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRL-SHPN 143
LGEG FG+V K + + +AVK L ++ + + SE+ + + H N
Sbjct: 20 LGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGR--------GASVQPLAWNIRLK----I 191
++ LLG C ++ L +V E+ G+L + L R +P + K
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
A ARG+ FL + K+ I+RD A N+L+ + KI+DFGLA+ TT
Sbjct: 138 AYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT--GLRALDTNRPS-GQHNLVDWIKP- 307
+ APE + +SDV+ FGV+L EI T G + P L +K
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG-----SPYPGIPVEELFKLLKEG 250
Query: 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
Y EK P ++ L C P RP+ +++VE L+R+
Sbjct: 251 YRMEK---------------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 77/288 (26%), Positives = 119/288 (41%), Gaps = 31/288 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LGEG FGKVF P + ++AVK L S +++Q E L L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLF-----------GRGASVQPLAWNIRLKIAIG 194
R G C E + LL+V+E+M+ G L L G + L L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
A G+ +L + ++RD N L+ KI DFG+++ S V R M
Sbjct: 131 IASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ PE + +SD++ FGVVL EI T + W + LS
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT-------------YGKQPWYQ--LSNTEA 233
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
I R + + P ++ + C + EP+ R ++++ L+
Sbjct: 234 IECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 7e-23
Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 44/281 (15%)
Query: 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ--SEVNFLGRLSH 141
VLG+G G V+K +G + A+KK++ + + F + Q E+ L
Sbjct: 7 KVLGQGSSGVVYKVRHK-------PTGKIYALKKIHVDGDEEFRK-QLLRELKTLRSCES 58
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
P +V+ G +++ E+ +V E+M GSL + L V + + IA +GL +
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDY 114
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
LHT + +I+RD K SN+L++ KI+DFG++K+ + T +GT Y +PE
Sbjct: 115 LHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPER 171
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI----KPYLSEKR---K 314
+ +D++ G+ L+E G L+ I P L + +
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
FR I A CL+ +PK RPS E
Sbjct: 232 FRDFISA--------------------CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 7e-23
Identities = 84/291 (28%), Positives = 132/291 (45%), Gaps = 32/291 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNL 144
LGEG FGKV L P +G +AVK L ES + + E+ L L H N+
Sbjct: 12 LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 145 VRLLGYCWED--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
V+ G C ED + L+ EF+ GSL+ +L + + +LK A+ +G+ +L
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL 125
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH-VTTRVMGTYGYAAPEY 261
+Q ++RD A N+L++ + KI DFGL K + + + V + + APE
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRA--------LDTNRPS-GQHNLVDWIKPYLSEK 312
+ Y+ SDV+ FGV L E+LT + L P+ GQ + ++ K
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
R R P ++ QL KC E +P R + + ++E E +
Sbjct: 244 RLPR-----------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 30/291 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE-EWQSEVNFLG 137
N + T LG G FG+VF K + G T++ VK L + + E++ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKA--KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFR 63
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF-----GRGASVQPLAWNIRLKIA 192
+LSH N+VRLLG C E + ++ E+ G L+ L PL+ ++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
A G+ L + + ++RD A N L+ K+S L+K S+ + +
Sbjct: 124 TQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALI 180
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LS 310
+ APE V KSDV+ FGV++ E+ T G+ P+ LS
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGE-------LPFYGLS 223
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
++ + +L+ P ++ +L +C PK RPS E+V L
Sbjct: 224 DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 8e-23
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN--SESLQGFEEWQSEVNFLGRLSHPN 143
LG G FG+V+ G+ + + T +AVK L + S+Q F E E N + L H
Sbjct: 14 LGAGQFGEVWMGYYN--------NSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDK 62
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
LVRL +++ + ++ E+M KGSL + L L I I A G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GYAAPEY 261
K I+RD +A+N+L+ S KI+DFGLA++ + T R + + APE
Sbjct: 121 R--KNYIHRDLRAANVLVSESLMCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEA 175
Query: 262 VATGHLYVKSDVYGFGVVLVEILT 285
+ G +KSDV+ FG++L EI+T
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 79/301 (26%), Positives = 121/301 (40%), Gaps = 86/301 (28%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL 139
+K+ +GEG G+V+K +G +A+KK+ Q E +E+ +
Sbjct: 21 YKNLEKIGEGASGEVYKAT-------DRATGKEVAIKKMRLRK-QNKELIINEILIMKDC 72
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWN-IRLKIAIGAA-- 196
HPN+V EL +V E+M GSL + + N +R+ A
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVC 122
Query: 197 ----RGLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPSASQSHVTTRV 250
+GL +LH+ + VI+RD K+ NILL DGS K++DFG A + +S + V
Sbjct: 123 REVLQGLEYLHS--QNVIHRDIKSDNILLSKDGS--VKLADFGFAAQL-TKEKSKRNSVV 177
Query: 251 MGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309
GT + APE V Y K D++ G++ +E+ G P PYL
Sbjct: 178 -GTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYL 217
Query: 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSL------------------KCLEAEPKHRP 351
E P +A + I + KCL +P+ RP
Sbjct: 218 REP---------------PLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP 262
Query: 352 S 352
S
Sbjct: 263 S 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 83/314 (26%), Positives = 130/314 (41%), Gaps = 60/314 (19%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
R+ K LG+G FG V D P + +G V+AVKKL + + +++ E+ L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYD---PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 138 RLSHPNLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQP-----LAWNIRLK 190
L H N+V+ G C+ + L LV E++ GSL ++L + A I
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--- 117
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
+G+ +L K+ ++RD NIL++ KI DFGL K+ P + + R
Sbjct: 118 -----CKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVRE 169
Query: 251 MG---TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307
G + Y APE + V SDV+ FGVVL E+ T D +
Sbjct: 170 PGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT---YSDKSC------------- 212
Query: 308 YLSEKRKFRHIIDARLQGQY-----------------PYKAAYQIAQLSLKCLEAEPKHR 350
S +F ++ QGQ P +I + +C +P R
Sbjct: 213 --SPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270
Query: 351 PSMREVVETLERLQ 364
PS E+ +E ++
Sbjct: 271 PSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 79/298 (26%), Positives = 121/298 (40%), Gaps = 51/298 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK-LNSESLQGFEEW-QSEVNFLGRLSHP 142
V+GEG +G V K KA +G ++A+KK SE + ++ EV L +L H
Sbjct: 8 VVGEGAYGVVLK--CRNKA-----TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLEN-HLFGRG---ASVQPLAWNIRLKIAIGAARG 198
N+V L L LV+E++++ LE G +V+ W + +
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQA 112
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+A+ H+ +I+RD K NIL+ S K+ DFG A+ + S +T V T Y A
Sbjct: 113 IAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRA 169
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTG----------------LRALDTNRPSGQ--- 298
PE + Y K DV+ G ++ E+L G + L PS Q
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 299 -HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
N P + L+ +YP K + CL +PK R + E
Sbjct: 230 SSN------PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL------GR 138
LG G FG+V++G L G + +AVK L + Q E +FL +
Sbjct: 13 ALGHGAFGEVYEG-LYRGRDGDA-VELQVAVKTLPESCSE-----QDESDFLMEALIMSK 65
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL-FGRGASVQP--LAWNIRLKIAIGA 195
+H N+VRL+G +E ++ E M G L++ L R +P L L A
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDG---SYTAKISDFGLAKLGPSASQSHVTTRVMG 252
A+G +L I+RD A N LL AKI+DFG+A+ AS R M
Sbjct: 126 AKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312
+ PE G K+DV+ FGV+L EI + L G+ N
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS----LGYMPYPGRTN------------ 227
Query: 313 RKFRHIIDARLQG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
+ +++ G P + ++ C + P+ RP+ ++E ++
Sbjct: 228 ---QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS-ESLQGFEEWQSEVNFLGRLSHPNL 144
LGE FGK++KG L PG ++A+K L + Q + E+Q E + + L HPN+
Sbjct: 13 LGECAFGKIYKGHL--YLPGMD-HAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGR-------------GASVQPLAWNIRLKI 191
V LLG +++ + +++E++ +G L L R G L L I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
AI A G+ +L S +++D A NIL+ KISD GL++ SA V + +
Sbjct: 130 AIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
+ PE + G SD++ FGVVL EI +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 66/232 (28%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNF--- 135
+FK ++GEG F V EK K A+K L+ L E+ V
Sbjct: 2 DFKFGKIIGEGSFSTVVLAK--EKETNK-----EYAIKILDKRQLIK-EKKVKYVKIEKE 53
Query: 136 -LGRLS-HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
L RL+ HP +++L Y ++D+E L V E+ G L ++ G+ + +I
Sbjct: 54 VLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS------------ 240
+ L +LH K +I+RD K NILLD KI+DFG AK+
Sbjct: 113 LA----LEYLH--SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 241 --ASQSHVTTR----VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
SQ R +GT Y +PE + SD++ G ++ ++LTG
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 53/286 (18%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V G W + +A+K + ++ +++ E + +LSHPNL
Sbjct: 12 LGSGQFGVVHLGKWRGKID---------VAIKMIREGAMSE-DDFIEEAKVMMKLSHPNL 61
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L G C + + + +V E+M G L N+L R L L + + +L
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLE- 117
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT----TRVMGT---YGYA 257
I+RD A N L+ K+SDFGLA+ +V T GT +A
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR--------YVLDDQYTSSQGTKFPVKWA 168
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
PE KSDV+ FGV++ E+ + + PY E+
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM-----------------PY--ERFSNSE 209
Query: 318 IIDARLQG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
++++ G P A ++ + C +P+ RP+ ++++ L
Sbjct: 210 VVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 31/277 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE-EWQSEVNFLGRLSHPN 143
+LG+G FG+VFKG L +K P +AVK + Q + ++ SE L + HPN
Sbjct: 2 LLGKGNFGEVFKGTLKDKTP--------VAVKTCKEDLPQELKIKFLSEARILKQYDHPN 53
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+L+G C + + + +V E + G + L + L +K A+ AA G+A+L
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLE 110
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ K I+RD A N L+ + KISDFG+++ S + + + APE +
Sbjct: 111 S--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALN 167
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
G +SDV+ +G++L E + L G N ++ R ++
Sbjct: 168 YGRYSSESDVWSYGILLWETFS----LGVCPYPGMTN------------QQAREQVEKGY 211
Query: 324 QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
+ P K + ++ +C + +P++RP E+ + L
Sbjct: 212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 75/298 (25%), Positives = 122/298 (40%), Gaps = 56/298 (18%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGR 138
++ V+G G V+ P +A+K+++ E Q +E + EV + +
Sbjct: 3 YELIEVIGVGATAVVYAAIC---LPNNE----KVAIKRIDLEKCQTSVDELRKEVQAMSQ 55
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLEN---HLFGRGASVQPLAWNIRLKIAIGA 195
+HPN+V+ EL LV ++ GSL + + RG + + + LK
Sbjct: 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV-LK---EV 111
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK--LGPSASQSHVTTRVMGT 253
+GL +LH I+RD KA NILL + KI+DFG++ V +GT
Sbjct: 112 LKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 254 YGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTG------------LRALDTNRPSGQHN 300
+ APE + H Y K+D++ FG+ +E+ TG L N P
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLET 229
Query: 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
D+ K Y FR +I CL+ +P RP+ E+++
Sbjct: 230 GADY-KKYSKS---FRKMIS--------------------LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 79/287 (27%), Positives = 120/287 (41%), Gaps = 29/287 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LGEG FGKVF P + ++AVK L S +++ E L L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDK--ILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRG------ASVQP---LAWNIRLKIAIGAA 196
+ G C E L++V+E+M+ G L L G A L + L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
G+ +L + + ++RD N L+ + KI DFG+++ S V M +
Sbjct: 131 AGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
PE + +SDV+ GVVL EI T + W + LS
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT-------------YGKQPWYQ--LSNNEVIE 233
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
I R+ Q P ++ L L C + EP R +++E+ L+ L
Sbjct: 234 CITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 30/215 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--------KLNSESLQGFEEWQSEVNFL 136
VLG+G +G V+ G ++ G +IAVK L +E + +E+ Q EV+ L
Sbjct: 7 VLGKGAYGTVYCGLTNQ--------GQLIAVKQVELDTSNVLAAE--KEYEKLQEEVDLL 56
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
L H N+V+ LG C +D + + EF+ GS+ + L G +P+ +I
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----L 112
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK----LGPSASQSHVTTRVMG 252
G+A+LH + V++RD K +N++L + K+ DFG A+ +G + S++ + G
Sbjct: 113 DGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 253 TYGYAAPEYV-ATGHLYVKSDVYGFGVVLVEILTG 286
T + APE + +G+ KSD++ G + E+ TG
Sbjct: 171 TPYWMAPEVINESGYGR-KSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 6e-21
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPN 143
LG G G V K +G ++AVK + E ++ E++ L + + P
Sbjct: 8 ELGAGNSGVVSKVL-------HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V G + + ++ + E+M GSL+ L + I KIA+ +GL +LH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGYAAPEYV 262
++I+RD K SNIL++ K+ DFG++ +L S +++ V GT Y APE +
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171
Query: 263 ATGHLYVKSDVYGFGVVLVEILTG 286
VKSD++ G+ L+E+ TG
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-21
Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 41/280 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG G FG V G K + +A+K +N ++ E++ E + +LSHP LV
Sbjct: 12 LGSGQFGVVHLG--------KWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLV 62
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
+L G C + K L +V EFM+ G L N+L R + ++ L + G+ +L +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN 119
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKL-----GPSASQSHVTTRVMGTYGYAAPE 260
I+RD A N L+ + K+SDFG+ + S+S + + ++ PE
Sbjct: 120 S--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK------WSPPE 171
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
KSDV+ FGV++ E+ T + P + + + ++ R +R
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFT-----EGKMPFEKKSNYEVVEMISRGFRLYR---- 222
Query: 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
P A+ + ++ C +P+ RP+ E++ +
Sbjct: 223 -------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+ K + LG G FG+V W+ T +AVK + S+ E + +E N +
Sbjct: 7 SLKLEKKLGAGQFGEV---WM-----ATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKT 57
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L H LV+L ++ + ++ EFM KGSL + L S QPL I I A G
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEG 114
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GY 256
+AF+ + I+RD +A+NIL+ S KI+DFGLA++ + T R + +
Sbjct: 115 MAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKW 169
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILT 285
APE + G +KSDV+ FG++L+EI+T
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 43/283 (15%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--------KLNSESLQGFEEWQSEVNFLG 137
+G G FG+VF G L T +AVK L ++ LQ E L
Sbjct: 3 IGRGNFGEVFSGRL-------RADNTPVAVKSCRETLPPDLKAKFLQ-------EARILK 48
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
+ SHPN+VRL+G C + + + +V E +Q G L G L +++ AA
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAA 105
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
G+ +L + K I+RD A N L+ KISDFG+++ + +
Sbjct: 106 GMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT 163
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
APE + G +SDV+ FG++L E + L A+ S Q R
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFS-LGAVPYANLSNQQT---------------RE 207
Query: 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
I+ ++ P + +L +C E +P RPS V + L
Sbjct: 208 AIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 84/297 (28%), Positives = 135/297 (45%), Gaps = 38/297 (12%)
Query: 86 LGEGGFGKVFKG---WLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRL-S 140
LGEG FG+V LD++ P + T +AVK L S++ + + SE+ + +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRV---TKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGR------------GASVQPLAWNIR 188
H N++ LLG C +D L ++ E+ KG+L +L R + L++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
+ A ARG+ +L + K+ I+RD A N+L+ KI+DFGLA+ TT
Sbjct: 143 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ APE + +SDV+ FGV+L EI T + P V+ +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKL 254
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365
L E H +D P ++ + C A P RP+ +++VE L+R+ A
Sbjct: 255 LKEG----HRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS---EVNF 135
+F+ V+G+G FGKV K + + A+K +N + ++ E
Sbjct: 1 HFELLRVIGKGAFGKVCI-------VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRI 53
Query: 136 LGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-I 193
L L+HP LV L Y ++D+E + LV + + G L HL + + ++ I I
Sbjct: 54 LQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWICEI 109
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
A L +LH+ K +I+RD K NILLD I+DF +A + TT GT
Sbjct: 110 VLA--LEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGT 162
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLR 288
GY APE + V D + GV E L G R
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 25/216 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGW-LDEKAPGKSGSGTVIAVKK-----LNSESLQGFEEWQSE 132
N++ +LG+G FG+V+ + +D +G +AVK+ + E+ + + E
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD--------TGRELAVKQVPFDPDSPETKKEVNALECE 54
Query: 133 VNFLGRLSHPNLVRLLGYCWEDKELLLVY-EFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
+ L L H +V+ G C D E L ++ E+M GS+++ L GA L + K
Sbjct: 55 IQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA----LTETVTRKY 109
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRV 250
G+ +LH++ +++RD K +NIL D + K+ DFG +K L S V
Sbjct: 110 TRQILEGVEYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 251 MGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILT 285
GT + +PE V +G Y K+DV+ G +VE+LT
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-20
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 66 RIFTFVELRAATRNFKSDTVLGEGGFGKVFKG-WLDE----KAPGKSGSGTVIAVKKL-N 119
RI ELR +LG G FG V KG W+ E K P +A+K + +
Sbjct: 2 RILKETELRKLK-------LLGSGVFGTVHKGIWIPEGDSIKIP--------VAIKTIQD 46
Query: 120 SESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGAS 179
Q F+E + +G L H +VRLLG C L LV + GSL +H+ S
Sbjct: 47 RSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDS 105
Query: 180 VQP---LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236
+ P L W +++ A+G+ +L + ++++R+ A NILL +I+DFG+A
Sbjct: 106 LDPQRLLNWCVQI------AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVAD 157
Query: 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
L + + + + A E + G +SDV+ +GV + E+++
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 47/220 (21%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS------EVNFLGRL 139
+GEG +G+V+K +G ++A+KK+ E+ E+ E+ L +L
Sbjct: 7 IGEGTYGQVYKA-------RNKKTGELVALKKIRMEN----EKEGFPITAIREIKLLQKL 55
Query: 140 SHPNLVRLLGYCWEDK--ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
HPN+VRL + +V+E+M ++ L G L + +K +
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYM-----DHDLTG-------LLDSPEVKFTESQIK 103
Query: 198 --------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
GL +LH +++RD K SNIL++ K++DFGLA+ + + T R
Sbjct: 104 CYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 250 VMGTYGYAAPEYV--ATGHLY-VKSDVYGFGVVLVEILTG 286
V+ T Y PE + AT Y + D++ G +L E+ G
Sbjct: 162 VI-TLWYRPPELLLGAT--RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 80 FKSDTVLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
F LGEG +G V+K + +G V+A+K + E +E E++ L +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKE--------TGQVVAIKVVPVEE--DLQEIIKEISILKQ 54
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK---IAI-- 193
P +V+ G +++ +L +V E+ GS+ + + N L IA
Sbjct: 55 CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---------NKTLTEEEIAAIL 105
Query: 194 -GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVM 251
+GL +LH + I+RD KA NILL+ AK++DFG++ +L + ++ + V+
Sbjct: 106 YQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VI 160
Query: 252 GTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEILTG 286
GT + APE + G+ K+D++ G+ +E+ G
Sbjct: 161 GTPFWMAPEVIQEIGYNN-KADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 44/286 (15%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFL 136
+FK LG+G +G V+K + A+K+++ S+ E + E+ L
Sbjct: 1 DFKVLKKLGKGSYGSVYK-------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRIL 53
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
++HPN++ + +L +V E+ G L + R + + +I I
Sbjct: 54 ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
RGL LH ++++++RD K++NILL + KI D G++K+ + ++ +GT Y
Sbjct: 114 RGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHY 167
Query: 257 AAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
APE V G Y KSD++ G +L E+ T P P+ E R
Sbjct: 168 MAPE-VWKGRPYSYKSDIWSLGCLLYEMATF-------AP-----------PF--EARSM 206
Query: 316 RHIIDARLQGQYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREV 356
+ + +G+YP Y Q L+ +PK RP+ ++
Sbjct: 207 QDLRYKVQRGKYPPIPPIYSQDLQ--NFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK--LNSESLQG-------FEEWQSEVNF 135
++G G FG V+ G + SG ++AVK+ L S S + E+
Sbjct: 7 LIGSGSFGSVYLGM-------NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIAL 59
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L L H N+V+ LG + L + E++ GS+ L GA + L N +I
Sbjct: 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL--- 116
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR----VM 251
+GL +LH + +I+RD K +NIL+D KISDFG++K + S S T +
Sbjct: 117 -KGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
G+ + APE V K+D++ G ++VE+LTG
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN----------SESLQGFEEWQSEVNF 135
LG G FG V+K K+ ++A+K++N E + + SEV
Sbjct: 8 LGSGAFGCVYK------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 136 LG-RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFG----RGASVQPLAWNIRLK 190
+ +L HPN+VR E+ L +V + ++ L H + + WNI ++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
+ + L +LH +K++++RD +NI+L I+DFGLAK T V
Sbjct: 122 MVLA----LRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSV 173
Query: 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
+GT Y+ PE V K+DV+ FG +L ++ T
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 50/286 (17%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G FG+V+ G W T +A+K L ++ E + E + +L H L
Sbjct: 14 LGQGCFGEVWMGTW---------NGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKL 63
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L E+ + +V E+M KGSL + L G L + + I A G+A++
Sbjct: 64 VQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER 120
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GYAAPEYV 262
+ ++RD +A+NIL+ + K++DFGLA+L + T R + + APE
Sbjct: 121 MN--YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
G +KSDV+ FG++L E+ T R PY R ++D
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVN--REVLDQV 216
Query: 323 LQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365
+G P + + L +C EP+ RP T E LQA
Sbjct: 217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERP-------TFEYLQA 255
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFLGRLSHPN 143
+GEG +G V+K +G ++A+KK+ + E+ L L+HPN
Sbjct: 7 IGEGTYGVVYKARDKL-------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN 59
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASV-QPLAWNIRLKIAIGAARGLAFL 202
+++LL +L LV+EFM L + R + + L + ++ +GLAF
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLL----QGLAFC 114
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H+ +++RD K N+L++ K++DFGLA+ S T + T Y APE +
Sbjct: 115 HSHG--ILHRDLKPENLLINTEGVLKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELL 170
Query: 263 ATGHLYVKS-DVYGFGVVLVEILTG 286
Y D++ G + E+L+
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG+V+ G W T +AVK L ++ E + E + +L H L
Sbjct: 14 LGNGQFGEVWMGTW---------NGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKL 63
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIAIGAARGLAF 201
V+L E + + +V E+M KGSL + L GR + L + +A A G+A+
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAY 117
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GYAAP 259
+ + I+RD +++NIL+ KI+DFGLA+L + T R + + AP
Sbjct: 118 IERMN--YIHRDLRSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKFPIKWTAP 172
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS-EKRKFRHI 318
E G +KSDV+ FG++L E++T R PY R+
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRV-----------------PYPGMNNREVLEQ 215
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
++ + P + +L L+C + +P+ RP+ + LE
Sbjct: 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 85/290 (29%), Positives = 129/290 (44%), Gaps = 39/290 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFEEWQSEVNFLGRLSHPN 143
LGEG FG V +G L++ S +AVK K+ + E++ SE + HPN
Sbjct: 7 LGEGEFGSVMEGQLNQDD-----SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 144 LVRLLGYCWEDKEL------LLVYEFMQKGSLENHL-FGR-GASVQPLAWNIRLKIAIGA 195
++RL+G C + E +++ FM+ G L + L + R G Q L + +K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL---GPSASQSHVTTRVMG 252
A G+ +L S K I+RD A N +L+ + ++DFGL+K G Q + +
Sbjct: 122 ASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV- 178
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312
+ A E +A KSDV+ FGV + EI T R T P +++ I YL +
Sbjct: 179 --KWIAIESLADRVYTTKSDVWSFGVTMWEIAT--RG-QTPYPGVENS---EIYDYLRQG 230
Query: 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
+ + D L G Y L C PK RPS + LE+
Sbjct: 231 NRLKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 74/285 (25%), Positives = 137/285 (48%), Gaps = 31/285 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G FG V++G K K T +A+K +N + S++ E+ +E + + + ++
Sbjct: 14 LGQGSFGMVYEGI--AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFG-----RGASVQ-PLAWNIRLKIAIGAARG 198
VRLLG + + L++ E M +G L+++L VQ P + +++A A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+A+L+ + + ++RD A N ++ +T KI DFG+ + + + + +
Sbjct: 132 MAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFR 316
PE + G SDV+ FGVVL EI T L + +PY +S ++ R
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGMSNEQVLR 232
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
+++ L + P + +L C + PK RPS E++ +++
Sbjct: 233 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 42/281 (14%)
Query: 85 VLGEGGFGK--VFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLS 140
VLG+G FG+ +++ ++ +++ K++N L + + +E+ L L
Sbjct: 7 VLGKGAFGEATLYR---------RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HPN++ + +D LL+ E+ G+L + + + + + I +A ++
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VS 115
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
++H + +++RD K NI L + K+ DFG++K+ + S T V+GT Y +PE
Sbjct: 116 YIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAET-VVGTPYYMSPE 171
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
KSD++ G VL E+LT R D P NLV I
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKI--------------- 213
Query: 321 ARLQGQY-PYKAAYQIAQLSL--KCLEAEPKHRPSMREVVE 358
+QG Y P + Y +SL L+ +P+ RP+ EV++
Sbjct: 214 --VQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-19
Identities = 75/281 (26%), Positives = 129/281 (45%), Gaps = 41/281 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG G FG V G K G+ +A+K + S+ +E+ E + +LSH LV
Sbjct: 12 LGTGQFGVVKYG----KWRGQYD----VAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLV 62
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
+L G C + + + +V E+M G L N+L G QP L++ G+A+L +
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLES- 118
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GYAAPEYVA 263
KQ I+RD A N L+D K+SDFGL++ T+ V + ++ PE +
Sbjct: 119 -KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSPPEVLL 174
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
KSDV+ FGV++ E+ + G+ PY E+ ++
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYS----------LGK-------MPY--ERFNNSETVEKVS 215
Query: 324 QGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
QG P+ A+ ++ + C + + RP+ ++++ ++E
Sbjct: 216 QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 74/295 (25%), Positives = 132/295 (44%), Gaps = 38/295 (12%)
Query: 86 LGEGGFGKVFKG---WLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLS- 140
LGEG FG+V +D+ P ++ +AVK L ++ + + SE+ + +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEA---VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGR------------GASVQPLAWNIR 188
H N++ LLG C +D L ++ E+ KG+L +L R + + +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
+ ARG+ +L + ++ I+RD A N+L+ + KI+DFGLA+ + TT
Sbjct: 140 VSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ APE + +SDV+ FGV++ EI T L P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------------LGGSPYPG 242
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + F+ + + + P ++ + C A P HRP+ +++VE L+R+
Sbjct: 243 IPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 39/286 (13%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGR 138
++ ++G G +G V++G +G V+A+K +N ++ + Q EV L +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVP-------TGRVVALKIINLDTPDDDVSDIQREVALLSQ 55
Query: 139 LSH---PNLVRLLGYCW-EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L PN+ + G + + L ++ E+ + GS+ L G + I ++ +
Sbjct: 56 LRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVA 113
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
L ++H VI+RD KA+NIL+ + K+ DFG+A L S T +GT
Sbjct: 114 ----LKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTP 165
Query: 255 GYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
+ APE + G Y K+D++ G+ + E+ TG N P + + L K
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSDVDAFRAM--MLIPKS 217
Query: 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359
K RL+ Y + + CL+ EPK R S E++++
Sbjct: 218 K-----PPRLEDNG-YSKLLR--EFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL---------NSESLQGF-EEWQSEVN 134
++G+G +G+V+ +G ++AVK++ + + + +SE+
Sbjct: 8 LIGKGTYGRVYLAL-------NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L L H N+V+ LG+ ++ L + E++ GS+ + L G + L ++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-- 118
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
GLA+LH+ K +++RD KA N+L+D KISDFG++K + + G+
Sbjct: 119 --EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 255 GYAAPEYVATGH--LYVKSDVYGFGVVLVEILTGLR 288
+ APE + + K D++ G V++E+ G R
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 25/230 (10%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQ 130
E+ +T F + LGE FGKV+KG L APG+ I K +E L+ EE++
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFK 56
Query: 131 SEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG------------- 177
E RL HPN+V LLG +++ L +++ + L L R
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 178 --ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235
++++P + + I A G+ FL S V+++D N+L+ KISD GL
Sbjct: 117 VKSTLEPADF---VHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
+ +A + + + +PE + G + SD++ +GVVL E+ +
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 41/299 (13%)
Query: 86 LGEGGFGKVFKGWLD--EKAPG-------KSGSGTVIAVKKLNSE-SLQGFEEWQSEVNF 135
LGEG FG+V + + P + G ++AVK L + + ++ EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGR--------GASVQPLA--- 184
L RL PN++RLLG C ++ L ++ E+M+ G L L G P A
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 185 ----WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240
++ L +A+ A G+ +L + + ++RD N L+ + T KI+DFG+++ +
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ-- 298
+ R + + A E + G SDV+ FGV L EIL + +P G+
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE----QPYGELT 246
Query: 299 -HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
+++ + ++ R + R P + +L L+C + + RPS ++
Sbjct: 247 DEQVIENAGEFFRDQG--RQVYLFR-----PPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 83/298 (27%), Positives = 142/298 (47%), Gaps = 40/298 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G FG V++G + G++ T +AVK +N S SL+ E+ +E + + + ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAE--TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWN--------IRLKIAIGA- 195
VRLLG + + L+V E M G L+++L S++P A N ++ I + A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 196 -ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
A G+A+L+ K+ ++RD A N ++ +T KI DFG+ + + +
Sbjct: 128 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEK 312
+ APE + G SD++ FGVVL EI + L + +PY LS +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAE--QPYQGLSNE 228
Query: 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL-ERLQASDQK 369
+ + ++D Q P ++ L C + PK RP+ E+V L + L S +
Sbjct: 229 QVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 73/209 (34%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLS 140
VLG+G FGKV L E+ G+ + A+K L + + E E L
Sbjct: 6 MVLGKGSFGKVM---LAER----KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG 58
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
P + L C++ + L V E++ G L H+ G +P A +IAIG L
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----L 114
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GTYGYAA 258
FLH+ K +IYRD K N++LD KI+DFG+ K TTR GT Y A
Sbjct: 115 FFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDYIA 169
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTG 286
PE +A Y KS D + FGV+L E+L G
Sbjct: 170 PEIIAY-QPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 9e-19
Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHP 142
LG+GGFG+V A +G + A KKL+ + L +G + +E L ++S
Sbjct: 1 LGKGGFGEVC-------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR 53
Query: 143 NLVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
+V L Y +E K +L LV M G L+ H++ G P A I I GL
Sbjct: 54 FIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI--ICGLEH 110
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
LH ++++YRD K N+LLD +ISD GLA + R GT GY APE
Sbjct: 111 LH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKIKGRA-GTPGYMAPEV 165
Query: 262 VATGHLYVKSDVYGFGVVLVEILTG 286
+ D + G L E++ G
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 36/291 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHP 142
+LG+G FG V + L + GS +AVK L ++ S EE+ E + HP
Sbjct: 6 MLGKGEFGSVREAQLKSE----DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHP 61
Query: 143 NLVRLLGYCWEDKEL------LLVYEFMQKGSLENHLFGRGASVQP--LAWNIRLKIAIG 194
N+++L+G + +++ FM+ G L L +P L ++ I
Sbjct: 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
A G+ +L S K I+RD A N +L+ + T ++DFGL+K S
Sbjct: 122 IASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEK 312
+ A E +A SDV+ FGV + EI+T GQ PY +
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMT----------RGQ-------TPYAGVENS 222
Query: 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ ++I Q P + +L +C EPK RPS + + + LE +
Sbjct: 223 EIYNYLIKGNRLKQ-PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS---- 140
VLG+G FGKV L E G+ + AVK L + + ++ + + L+
Sbjct: 2 VLGKGSFGKVL---LAEL----KGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK 54
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
HP L +L C++ K+ L V E++ G L H+ G +P A +I +G L
Sbjct: 55 HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----L 109
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
FLH ++ +IYRD K N+LLD KI+DFG+ K G + T+ GT Y AP
Sbjct: 110 QFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165
Query: 260 EYVATGHLYVKS-DVYGFGVVLVEILTG 286
E + + Y + D + GV+L E+L G
Sbjct: 166 E-ILSYQPYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 42/297 (14%)
Query: 86 LGEGGFGKVFKG---WLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRL-S 140
LGEG FG+V +D+ P K +AVK L ++ + + SE+ + +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKP---VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIR 188
H N++ LLG C +D L ++ E+ KG+L +L R + L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
+ A ARG+ +L + ++ I+RD A N+L+ KI+DFGLA+ + TT
Sbjct: 137 VSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ APE + +SDV+ FGV+L EI T G PY
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LGGS--------PY 237
Query: 309 --LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + F+ + + + P +++ + +C A P RP+ +++VE L+R+
Sbjct: 238 PGIPVEELFKLLKEGHRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 37/286 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+ + D LG+G FG+V W+ G T +A+K L ++ E + E + +
Sbjct: 7 SLRLDVKLGQGCFGEV---WM-----GTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKK 57
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L H LV L E+ + +V EFM KGSL + L + + L + +A A G
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADG 114
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GY 256
+A++ + I+RD +A+NIL+ + KI+DFGLA+L + T R + +
Sbjct: 115 MAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARL---IEDNEYTARQGAKFPIKW 169
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE-KRKF 315
APE G +KSDV+ FG++L E++T R PY R+
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRV-----------------PYPGMVNREV 212
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
++ + P + +L C + +P RP+ + LE
Sbjct: 213 LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 51/291 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ--SEVNFLGRLSHP 142
+G+G FG V K + K+ GK ++ K+++ ++ E+ Q SEVN L L HP
Sbjct: 7 TIGKGSFGTVRK--VRRKSDGK-----ILVWKEIDYGNMTEKEKQQLVSEVNILRELKHP 59
Query: 143 NLVRLLGYCWE-DKE---LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
N+VR Y D+ L +V E+ + G L + + + +I
Sbjct: 60 NIVRY--YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 199 LAFLHT---SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ---SHVTTRVMG 252
L H V++RD K +NI LD + K+ DFGLAK+ S ++V G
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----G 172
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRP----SGQHNLVDWIKPY 308
T Y +PE + KSD++ G ++ E+ P Q L IK
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-------SPPFTARNQLQLASKIK-- 223
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359
+ KFR I PY+ + ++ ++ L +P RPS E+++
Sbjct: 224 ---EGKFRRI---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 3e-18
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 55/226 (24%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS-----EVNFLGRL 139
LG+G FG V+ + +G ++A+KK+ + F W+ EV L +L
Sbjct: 7 LGDGTFGSVYLARNKE--------TGELVAIKKMK----KKFYSWEECMNLREVKSLRKL 54
Query: 140 -SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFG--RGASVQPLA----WNIRLKIA 192
HPN+V+L E+ EL V+E+M E +L+ + +P + +I +I
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 193 IGAARGLAFLHTSDKQ-VIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
+GLA +H K +RD K N+L+ G KI+DFGLA+ S+ T V
Sbjct: 110 ----QGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYV- 159
Query: 252 GTYGYAAPEYVATGHLYVKS-------DVYGFGVVLVEILTGLRAL 290
T Y APE + ++S D++ G ++ E+ T LR L
Sbjct: 160 STRWYRAPE------ILLRSTSYSSPVDIWALGCIMAELYT-LRPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS-----EVNFLGRLS 140
LGEG + V+K D++ +G ++A+KK+ + ++ + E+ L L
Sbjct: 8 LGEGTYAVVYKA-RDKE------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HPN++ LL + LV+EFM+ LE + + V A +I+ + RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPA-DIK-SYMLMTLRGLE 116
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+LH +++RD K +N+L+ K++DFGLA+ S + +T +V+ T Y APE
Sbjct: 117 YLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQVV-TRWYRAPE 172
Query: 261 YVATGHLY-VKSDVYGFGVVLVEIL 284
+ Y V D++ G + E+L
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFLGRLSHP 142
VLG+G FGKVF L K G +G + A+K L +L+ + ++ E + L ++HP
Sbjct: 3 VLGQGSFGKVF---LVRKITGPD-AGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
+V+L + +L L+ +F++ G L L V +++ +A A LA
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA---LALD 112
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H +IYRD K NILLD K++DFGL+K S GT Y APE V
Sbjct: 113 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 263 -ATGHLYVKSDVYGFGVVLVEILTG 286
GH +D + FGV++ E+LTG
Sbjct: 171 NRRGHTQ-SADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 68/224 (30%), Positives = 94/224 (41%), Gaps = 45/224 (20%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVN 134
+F+ LG G FG+V + K GK A+K L+ L+ E +E
Sbjct: 1 DDFEFIKTLGTGSFGRVML--VRHKGSGK-----YYALKILSKAKIVKLKQVEHVLNEKR 53
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L + HP LV L G +D L LV E++ G L +HL G +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG------------RFPEP 101
Query: 195 AAR--------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHV 246
AR L +LH ++YRD K N+LLD KI+DFG AK V
Sbjct: 102 VARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RV 151
Query: 247 TTRVM---GTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
R GT Y APE + Y K+ D + G+++ E+L G
Sbjct: 152 KGRTYTLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK-LNSESLQGFEEWQ-SEVNFLGRLSHP 142
++GEG +G V K E +G ++A+KK L SE + ++ E+ L +L H
Sbjct: 8 LVGEGSYGMVMKCKHKE-------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 143 NLVRLLGYCWEDKELLLVYEFMQK---GSLENHLFGRGAS-VQPLAWNIRLKIAIGAARG 198
NLV L+ K L LV+EF+ LE + G S V+ + I RG
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI--------LRG 112
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+ F H+ + +I+RD K NIL+ S K+ DFG A+ A+ V T + T Y A
Sbjct: 113 IEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRA 168
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTG 286
PE + Y ++ D++ G ++ E+LTG
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 7e-18
Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 42/280 (15%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+GEG FGK + K GK I + K++ + EE + EV L + HPN+V
Sbjct: 8 IGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKER---EESRKEVAVLSNMKHPNIV 62
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASV----QPLAWNIRLKIAIGAARGLAF 201
+ E+ L +V ++ + G L + + + Q L W +++ LA
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI--------CLAL 114
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
H D+++++RD K+ NI L T K+ DFG+A++ S + T +GT Y +PE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
KSD++ G VL E+ T A + NLV I
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLVLKI---------------- 213
Query: 322 RLQGQYP---YKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
++G YP +Y + L + + P+ RPS+ ++E
Sbjct: 214 -IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 33/295 (11%)
Query: 86 LGEGGFGKV-------FKGWLDEK--APGKSGSGTVIAVKKLNSESLQGFE-EWQSEVNF 135
LGEG FG+V + ++D+ ++AVK L ++ + ++ E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF-------GRGASVQPLAWNIR 188
+ RL PN++RLL C L ++ E+M+ G L L A V ++++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
+ +A A G+ +L S ++RD N L+ +YT KI+DFG+++ S +
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ---HNLVDWI 305
R + + + E + G SDV+ FGV L EILT L +P Q +++
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQPYSQLSDEQVIENT 246
Query: 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
+ ++ + ++ L YK L L C K RPS +E+ TL
Sbjct: 247 GEFFRDQGRQVYLPKPALCPDSLYK-------LMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG+G FGKV KA K +G A K + ES + E++ E++ L HPN+V
Sbjct: 13 LGDGAFGKV------YKAQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIV 65
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
L + + +L ++ EF G+L++ + RG + + + R + L FLH
Sbjct: 66 GLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLH 120
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+VI+RD KA NILL K++DFG++ S Q T +GT + APE VA
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVA 176
Query: 264 TGHL----Y-VKSDVYGFGVVLVEI 283
Y K+D++ G+ L+E+
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 87/319 (27%), Positives = 128/319 (40%), Gaps = 81/319 (25%)
Query: 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSE 132
L T F+ V+GEG +GKV+K +K G ++A+K ++ + EE + E
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT------GQLVAIKIMDIIEDEE-EEIKEE 52
Query: 133 VNFLGRLS-HPNLVRLLG------YCWEDKELLLVYEFMQKGS---LENHLFGRGASVQP 182
N L + S HPN+ G D +L LV E GS L L +G +
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG---KR 109
Query: 183 LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242
L I RGLA+LH + +VI+RD K NILL + K+ DFG++ +
Sbjct: 110 LKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVS----AQL 163
Query: 243 QSHVTTR--VMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTG--------- 286
S + R +GT + APE +A +SDV+ G+ +E+ G
Sbjct: 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
Query: 287 LRAL---DTNRPSGQHNLVDWIKPYLSEK----RKFRHIIDARLQGQYPYKAAYQIAQLS 339
+RAL N P P L +KF I
Sbjct: 224 MRALFKIPRNPP-----------PTLKSPENWSKKFNDFIS------------------- 253
Query: 340 LKCLEAEPKHRPSMREVVE 358
+CL + RP M E++E
Sbjct: 254 -ECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 26/222 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+ K + V+GEG FG+V + + K G + + +K+ SE+ ++ E+ L +
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMI--KKDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCK 58
Query: 139 LS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL-----------FGR-GASVQPLAW 185
L HPN++ LLG C L + E+ G+L + L F + + L
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH 245
L+ A A G+ +L S+KQ I+RD A N+L+ + +KI+DFGL++ +
Sbjct: 119 QQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEV 171
Query: 246 VTTRVMGTYG--YAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
+ MG + A E + KSDV+ FGV+L EI++
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 82/282 (29%), Positives = 121/282 (42%), Gaps = 49/282 (17%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSHP 142
+G G FG V+ S + V+AVKK++ Q E+WQ EV FL +L HP
Sbjct: 29 IGHGSFGAVYFA-------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHP 81
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N + G ++ LV E+ GS + L +PL I GA +GLA+L
Sbjct: 82 NTIEYKGCYLKEHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H+ + I+RD KA NILL K++DFG SAS+S +GT + APE +
Sbjct: 138 HSHNM--IHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEVI 189
Query: 263 AT---GHLYVKSDVYGFGVVLVEILTGLRAL-DTNRPSGQHNLVDWIKPYLSEKR---KF 315
G K DV+ G+ +E+ L + N S +++ P L F
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
R +D CL+ P+ RP+ E++
Sbjct: 250 RGFVDY--------------------CLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF--EEWQSEVNFLGRLSHPN 143
+GEG G VFK +G +A+KK+ L+G + E+ L HP
Sbjct: 8 IGEGAHGIVFKA-------KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+LL +LV E+M L L +PL +G+A++H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMP-SDLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL---GPSASQSH-VTTRVMGTYGYAAP 259
+++RD K +N+L+ KI+DFGLA+L SH V TR Y AP
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYRAP 169
Query: 260 EYVATGHLYVKS-DVYGFGVVLVEILTG 286
E + Y D++ G + E+L G
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 37/281 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG G FG V KG + K I V K +E +E E + +L +P +V
Sbjct: 3 LGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIV 58
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
R++G C E + L+LV E G L L G+ + N+ +++ + G+ +L
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEIT--VSNV-VELMHQVSMGMKYLE-- 112
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTY--GYAAPEYV 262
K ++RD A N+LL + AKISDFGL+K LG A S+ R G + + APE +
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECI 170
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
+SDV+ +G+ + E + GQ KPY +K K ++
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS----------YGQ-------KPY--KKMKGPEVMSFI 211
Query: 323 LQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
QG+ P + ++ L C + + RP+ +V E +
Sbjct: 212 EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 73/298 (24%), Positives = 136/298 (45%), Gaps = 38/298 (12%)
Query: 86 LGEGGFGKVFKG---WLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLS- 140
LGEG FG+V + +D+ P ++ +AVK L ++ + + + SE+ + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQT---VTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGR------------GASVQPLAWNIR 188
H N++ LLG C ++ L ++ E+ KG+L L R + L++
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
+ A ARG+ +L + ++ I+RD A N+L+ KI+DFGLA+ T+
Sbjct: 137 VSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ APE + +SDV+ FG+++ EI T L P
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT---------------LGGSPYPG 239
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
+ + F+ + + + P +++ L +C A P RP+ +++VE L+++ A+
Sbjct: 240 IPVEELFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 61/291 (20%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLGR 138
F +G+G FG+V+K +D++ + V+A+K ++ E+ E+ Q E+ FL +
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKR------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ 55
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
P + + G + +L ++ E+ GS + L +A+ +R + G
Sbjct: 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LG 110
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGYA 257
L +LH K I+RD KA+NILL K++DFG++ +L +++ S T V GT +
Sbjct: 111 LEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFV-GTPFWM 165
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTG---------LRAL----DTNRPSGQHNLVDW 304
APE + K+D++ G+ +E+ G +R L N PS + N +
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGN--KF 223
Query: 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
KP F+ + CL +PK RPS +E
Sbjct: 224 SKP-------FKDFVSL--------------------CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 66/298 (22%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHP 142
LGEG G V K L +G + A+K + ++ LQ ++ E+ P
Sbjct: 9 LGEGAGGSVTKCRL-------KNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSP 59
Query: 143 NLVRLLGYCWEDKE--LLLVYEFMQKGSLEN---HLFGRGASVQPLAWNIRLKIAIGAAR 197
+V+ G ++ + + E+ + GSL++ + RG + + KIA +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE---KVLGKIAESVLK 116
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGY 256
GL++LH +++I+RD K SNILL K+ DFG++ +L S + + GT Y
Sbjct: 117 GLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFY 169
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTG----------------LRALDTNRPSGQHN 300
APE + + SDV+ G+ L+E+ L + N P+ +
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE-- 227
Query: 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
L D + +F+ I +CLE +P RP+ +++E
Sbjct: 228 LKDEPGNGIKWSEEFKDFIK--------------------QCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 86/295 (29%), Positives = 124/295 (42%), Gaps = 75/295 (25%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSHP 142
+G G FG V+ + V+A+KK++ Q E+WQ EV FL +L HP
Sbjct: 23 IGHGSFGAVYFAR-------DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGS----LENHLFGRGASVQPLAWNIRLKIAIGAARG 198
N + G + LV E+ GS LE H +PL I GA +G
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-------KKPLQEVEIAAICHGALQG 127
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
LA+LH+ ++ I+RD KA NILL T K++DFG A L S + S V GT + A
Sbjct: 128 LAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASL-VSPANSFV-----GTPYWMA 179
Query: 259 PEYVAT---GHLYVKSDVYGFGVVLVEI---------LTGLRAL----DTNRPSGQHNLV 302
PE + G K DV+ G+ +E+ + + AL + P+ N
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN-- 237
Query: 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
DW FR+ +D CL+ P+ RPS E++
Sbjct: 238 DW-------SDYFRNFVD--------------------SCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 84/301 (27%), Positives = 130/301 (43%), Gaps = 44/301 (14%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLG 137
+ K V+GEG FG+V K + K G A+K++ + + ++ E+ L
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 138 RLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF-GRGASVQP-----------LA 184
+L HPN++ LLG C L L E+ G+L + L R P L+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS 244
L A ARG+ +L S KQ I+RD A NIL+ +Y AKI+DFGL++ Q
Sbjct: 123 SQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQE 175
Query: 245 HVTTRVMGTYG--YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302
+ MG + A E + SDV+ +GV+L EI++ G
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGTPYC 225
Query: 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
L EK + RL+ P ++ L +C +P RPS +++ +L R
Sbjct: 226 GMTCAELYEKLPQGY----RLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279
Query: 363 L 363
+
Sbjct: 280 M 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 49/290 (16%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGT--VIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN 143
LG+G F ++KG L ++ V V K+ + + + + +LSH +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
LV+L G C D E ++V E+++ G L+ L +V L W +L +A A L +L
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNV-SLHW--KLDVAKQLASALHYLE 118
Query: 204 TSDKQVIYRDFKASNILL-----DGSYT--AKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
DK++++ + NIL+ + Y K+SD G+ S+ R+ +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----PW 170
Query: 257 AAPEYVATGH--LYVKSDVYGFGVVLVEILTG----LRALDTNRPSGQHNLVDWIKPYLS 310
APE + G L + +D + FG L+EI + L L S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-----------------SS 213
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
EK +F + Q + P ++A L +C +P RPS R ++ L
Sbjct: 214 EKERFY-----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 26/209 (12%)
Query: 89 GGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG---FEEWQSEVNFLGRLSHPNLV 145
G +G+VF L +K KS +G + A+K + + ++ +E + L + P +V
Sbjct: 4 GAYGRVF---LAKK---KS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV 56
Query: 146 RLLGYCWE-DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
+L Y ++ K L LV E++ G L + L G+ + +A +I + L +LH+
Sbjct: 57 KLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLHS 111
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHV------TTRVMGTYGYAA 258
+ +I+RD K NIL+D + K++DFGL+K+G Q ++ R++GT Y A
Sbjct: 112 NG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTG 286
PE V G + K+ D + G +L E L G
Sbjct: 170 PE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 87 GEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS---EVNFLGRLSHPN 143
G G +G+V+K GK A+KK + Q QS E+ L L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGK-----EYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 144 LVRLLGYCWE--DKELLLVYEFMQKGSLE---NHLFGRGASVQP-----LAWNIRLKIAI 193
+V L+ E DK + L++++ + + H + S+ P L W I
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI------ 117
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSY----TAKISDFGLAKLGPSASQSHVT-T 248
G+ +LH++ V++RD K +NIL+ G KI D GLA+L + +
Sbjct: 118 --LNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 249 RVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILT 285
V+ T Y APE + Y K+ D++ G + E+LT
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 9e-17
Identities = 75/312 (24%), Positives = 130/312 (41%), Gaps = 45/312 (14%)
Query: 65 LRIFTFVELRAATRNFKSDTVLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKL-NSES 122
+RI EL+ VLG G FG V+KG W P +A+K L + S
Sbjct: 1 MRILKETELKKVK-------VLGSGAFGTVYKGIW----IPDGENVKIPVAIKVLRENTS 49
Query: 123 LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGAS 179
+ +E E + + P + RLLG C + LV + M G L +++ R S
Sbjct: 50 PKANKEILDEAYVMAGVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGS 108
Query: 180 VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239
L W +++ A+G+++L + ++++RD A N+L+ KI+DFGLA+L
Sbjct: 109 QDLLNWCVQI------AKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160
Query: 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQ 298
+ + A E + +SDV+ +GV + E++T G
Sbjct: 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA----------- 209
Query: 299 HNLVDWIKPYLS-EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
KPY R+ +++ + P + + +KC + + RP RE+V
Sbjct: 210 -------KPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
Query: 358 ETLERLQASDQK 369
+ R+ +
Sbjct: 263 DEFSRMARDPSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 40/285 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG+G F K+FKG E T + +K L+ E + + + +LSH +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
G C E ++V E+++ GSL+ +L + ++W +L++A A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI-NISW--KLEVAKQLAWALHFLE-- 117
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT--YGYAAPEYVA 263
DK + + + A N+LL K + KL V + + + PE +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIE 177
Query: 264 TG-HLYVKSDVYGFGVVLVEILTG----LRALDTNRPSGQHNLVDWIKPYLSEKRKF--- 315
+L + +D + FG L EI +G L ALD+ + K +F
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----------------KLQFYED 220
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
RH Q P ++A L +C++ EP RPS R ++ L
Sbjct: 221 RH--------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 79/326 (24%), Positives = 141/326 (43%), Gaps = 47/326 (14%)
Query: 80 FKSDTVLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLG 137
FK VLG G FG V+KG W+ P +A+K+L + S + +E E +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI----PEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIAIG 194
+ +P++ RLLG C + L+ + M G L +++ S L W +++
Sbjct: 65 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 118
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
A+G+ +L ++++++RD A N+L+ KI+DFGLAKL + + +
Sbjct: 119 -AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313
+ A E + +SDV+ +GV + E++T G + D P+ + I L +
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISSILEKGE 228
Query: 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQP 373
+ P + + +KC + RP RE++ ++ A D
Sbjct: 229 RLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM-ARD------ 271
Query: 374 RVRPTHSMAHRQGQQPLHHRSPLHTN 399
P + QG + +H SP +N
Sbjct: 272 ---PQRYLV-IQGDERMHLPSPTDSN 293
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL----NSESLQGFEEWQSEVNFLGRLSH 141
LG G FG V KG K K +AVK L N +L+ +E E N + +L +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEK-----TVAVKILKNDNNDPALK--DELLREANVMQQLDN 55
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF-GRGASVQPLAWNIRLKIAIGAARGLA 200
P +VR++G C E + +LV E + G L L + + + + ++ + G+
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMK 109
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY--GYAA 258
+L ++ ++RD A N+LL + AKISDFGL+K A +++ + G + + A
Sbjct: 110 YLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYA 166
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK-RKFRH 317
PE + KSDV+ FGV++ E + GQ KPY K +
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFS----------YGQ-------KPYKGMKGNEVTQ 209
Query: 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
+I++ + + P + ++ L C RP V
Sbjct: 210 MIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 56/226 (24%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS---------EVNFL 136
LG+G +G V+K +D + + V+A+KK+ F+ +++ E+ FL
Sbjct: 15 LGKGAYGIVWKA-IDRR------TKEVVALKKI-------FDAFRNATDAQRTFREIMFL 60
Query: 137 GRLS-HPNLVRLLGY--CWEDKELLLVYEFM--------QKGSLEN-HLFGRGASVQPLA 184
L HPN+V+LL DK++ LV+E+M + LE+ H + +
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH-------KRYIM 113
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL---GPSA 241
+ + + L ++H+ VI+RD K SNILL+ K++DFGLA+
Sbjct: 114 YQL--------LKALKYIHSG--NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
++ V T + T Y APE + Y K D++ G +L E+L G
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ--SEVNFLGRLSH-P 142
+G G FG V K SGT++AVK++ S E+ + +++ + R S P
Sbjct: 12 IGRGAFGTVNKMLHKP-------SGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSSDCP 63
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLEN---HLFGRGASVQPLAWNIRLKIAIGAARGL 199
+V+ G + + + + E M SL+ +++ SV P I KIA+ + L
Sbjct: 64 YIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIP--EEILGKIAVATVKAL 120
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGYAA 258
+L + ++I+RD K SNILLD + K+ DFG++ +L S ++ TR G Y A
Sbjct: 121 NYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMA 175
Query: 259 PEYVATGHL--Y-VKSDVYGFGVVLVEILTG 286
PE + Y V+SDV+ G+ L E+ TG
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG+G FGKV+K E +G + A K ++++S + E++ E++ L HPN+V
Sbjct: 13 LGDGAFGKVYKAQNKE-------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 65
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
+LL + + L ++ EF G+++ + + + K + A L +LH
Sbjct: 66 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA---LNYLH-- 120
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR---VMGTYGYAAPEYV 262
+ ++I+RD KA NIL K++DFG+ SA + R +GT + APE V
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 263 ----ATGHLY-VKSDVYGFGVVLVEI 283
+ Y K+DV+ G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNL 144
+G+G FG+V+KG +D + + V+A+K ++ E + E+ Q E+ L + P +
Sbjct: 12 IGKGSFGEVYKG-IDNR------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
R G + +L ++ E++ GS + L PL I +GL +LH+
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 119
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
K I+RD KA+N+LL K++DFG+A G +GT + APE +
Sbjct: 120 ERK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQ 324
K+D++ G+ +E+ G P L+ P L+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 222
Query: 325 GQY--PYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
GQY P+K + CL +P+ RP+ +E+++
Sbjct: 223 GQYSKPFKEFVE------ACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 81/313 (25%), Positives = 135/313 (43%), Gaps = 47/313 (15%)
Query: 65 LRIFTFVELRAATRNFKSDTVLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSES- 122
LRI EL K VLG G FG V+KG W+ E K +A+K LN +
Sbjct: 1 LRILKETEL-------KRVKVLGSGAFGTVYKGIWVPEGETVK----IPVAIKILNETTG 49
Query: 123 LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQP 182
+ E+ E + + HP+LVRLLG C + LV + M G L +++ ++
Sbjct: 50 PKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGS 108
Query: 183 ---LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239
L W +++ A+G+ +L ++++++RD A N+L+ KI+DFGLA+L
Sbjct: 109 QLLLNWCVQI------AKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160
Query: 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299
+ + + A E + +SDV+ +GV + E++T G
Sbjct: 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTF---------GG-- 209
Query: 300 NLVDWIKPYLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
KPY + R I D +G+ P + + +KC + RP +E+
Sbjct: 210 ------KPY--DGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261
Query: 357 VETLERLQASDQK 369
R+ Q+
Sbjct: 262 AAEFSRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+G G +G V+K D +G ++A+K + E FE Q E++ L HPN+V
Sbjct: 11 IGSGTYGDVYKA-RDIA------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 146 RLLG-YCWEDKELLLVYEFMQKGSLEN-HLFGRGASVQPLAWNIRLKIAI---GAARGLA 200
G Y DK L +V E+ GSL++ + RG PL+ L+IA +GLA
Sbjct: 64 AYFGSYLRRDK-LWIVMEYCGGGSLQDIYQVTRG----PLS---ELQIAYVCRETLKGLA 115
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYAAP 259
+LH I+RD K +NILL K++DFG+ A+L +A+ + + + GT + AP
Sbjct: 116 YLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFI-GTPYWMAP 170
Query: 260 EYVA---TGHLYVKSDVYGFGVVLVE 282
E A G K D++ G+ +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSG-TVIAVKKLNSESLQGFEEWQSEVNFLG 137
++ +GEG FGK++ A KS S VI L ++ E + EV L
Sbjct: 1 RYEIIKKIGEGSFGKIYL------AKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA 54
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL-FGRG---ASVQPLAWNIRLKIAI 193
++ HPN+V E+ L +V E+ G L + RG + Q L+W +++ +
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL-- 112
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFGLAKLGPSASQSHVTTRVMG 252
GL +H D+++++RD K+ NI L + AK+ DFG+A+ + + T +G
Sbjct: 113 ----GLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVG 164
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
T Y +PE K+D++ G VL E+ T
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHP 142
LG+GGFG+V A +G + A KKLN + L +G+E E L ++ H
Sbjct: 1 LGKGGFGEVS-------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HS 52
Query: 143 NLVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
+ L Y ++ K +L LV M G L H++ GL
Sbjct: 53 RFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA---KLGPSASQSHVTTRVMGTYGYAA 258
LH +++IYRD K N+LLD +ISD GLA K G S ++ + GT G+ A
Sbjct: 113 LH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMA 165
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEIL 284
PE + D + GV L E++
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 79/286 (27%), Positives = 122/286 (42%), Gaps = 55/286 (19%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSHP 142
+G G FG V+ + V+A+KK++ Q E+WQ EV FL R+ HP
Sbjct: 33 IGHGSFGAVYFA-------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGS---LENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
N + G + LV E+ + LE H +PL I GA +GL
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAITHGALQGL 138
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
A+LH+ + +I+RD KA NILL K++DFG SAS + +GT + AP
Sbjct: 139 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG------SASIASPANSFVGTPYWMAP 190
Query: 260 EYVAT---GHLYVKSDVYGFGVVLVEILTGLRAL-DTNRPSGQHNLVDWIKPYLSEKR-- 313
E + G K DV+ G+ +E+ L + N S +++ P L
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250
Query: 314 -KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
FR+ +D+ CL+ P+ RP+ E+++
Sbjct: 251 DYFRNFVDS--------------------CLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG+G FGKV+K E +G + A K + ++S + E++ E+ L +HP +V
Sbjct: 20 LGDGAFGKVYKAKNKE-------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIV 72
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+LLG + D +L ++ EF G+++ + RG + +P I++ I L +LH
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT-EP---QIQV-ICRQMLEALQYLH 127
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ ++I+RD KA N+LL K++DFG++ Q + +GT + APE V
Sbjct: 128 S--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183
Query: 264 ------TGHLYVKSDVYGFGVVLVEI 283
T + Y K+D++ G+ L+E+
Sbjct: 184 CETMKDTPYDY-KADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNL 144
+G+G FG+VFKG +D + + V+A+K ++ E + E+ Q E+ L + P +
Sbjct: 12 IGKGSFGEVFKG-IDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
+ G +D +L ++ E++ GS + L PL I +GL +LH+
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 119
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
K I+RD KA+N+LL K++DFG+A G +GT + APE +
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQ 324
K+D++ G+ +E+ G P L+ P L+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLE 222
Query: 325 GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
G Y + + + CL EP RP+ +E+++
Sbjct: 223 GNY----SKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 22/217 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK--LNSESLQGFEEWQSEVNFL 136
NF+ +GEG +G V+K A K +G V+A+KK L++E+ E++ L
Sbjct: 1 NFQKVEKIGEGTYGVVYK------ARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLL 53
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
L+HPN+V+LL + +L LV+EF+ + L+ F + + + +
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKK--FMDASPLSGIPLPLIKSYLFQLL 110
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LG-PSASQSHVTTRVMGTY 254
+GLAF H+ +V++RD K N+L++ K++DFGLA+ G P + +H T
Sbjct: 111 QGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TL 164
Query: 255 GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRAL 290
Y APE + Y + D++ G + E++T RAL
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----QGFEEWQSEVN 134
NF+ VLG G +GKVF L K G +G + A+K L ++ + E ++E
Sbjct: 1 NFELLRVLGTGAYGKVF---LVRKVGGHD-AGKLYAMKVLKKATIVQKAKTAEHTRTERQ 56
Query: 135 FLGRL-SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
L + P LV L D +L L+ +++ G L HL+ R + +++ I
Sbjct: 57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYI 111
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK--LGPSASQSHVTTRVM 251
LA H +IYRD K NILLD ++DFGL+K L +++
Sbjct: 112 AEIV-LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFC 167
Query: 252 GTYGYAAPEYVATGHL-YVKS-DVYGFGVVLVEILTG 286
GT Y APE + G + K+ D + GV+ E+LTG
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 65/237 (27%), Positives = 102/237 (43%), Gaps = 45/237 (18%)
Query: 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK-LNSESLQGFE-EWQSEV 133
R+++ LGEG FG+V+K + +G V+A+KK L GF E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA--RQIK-----TGRVVALKKILMHNEKDGFPITALREI 58
Query: 134 NFLGRLSHPNLVRLLGYCWED--------KELLLVYEFMQK---GSLEN---HLFGRGAS 179
L +L HPN+V L+ E + +V +M G LEN L
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL------ 112
Query: 180 VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL-- 237
+ L++ G+ +LH + +++RD KA+NIL+D KI+DFGLA+
Sbjct: 113 TESQIKCYMLQLL----EGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 238 -------GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
G + T ++ T Y PE + Y + D++G G V E+ T
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 109 SGTVIAVKKLNSESLQG---FEEWQSEVNFLGRLSHPNLVRLL--GYCWEDKELLLVYEF 163
+G +A+K L +++ + ++ E RL HPN+V LL G L V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 164 MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL-- 221
+ +L L GA P RL + + LA H ++ +++RD K NI++
Sbjct: 61 VPGRTLREVLAADGA--LPAGETGRLMLQV--LDALACAH--NQGIVHRDLKPQNIMVSQ 114
Query: 222 -DGSYTAKISDFGLAKLGPSASQSHV-----TTRVMGTYGYAAPEYVATGHLYVKSDVYG 275
AK+ DFG+ L P + V TT V+GT Y APE + + SD+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 276 FGVVLVEILTGLRAL 290
+G++ +E LTG R +
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----QGFEEWQSEVNFLGRLS 140
VLG+GG+GKVF K G +G + A+K L ++ + ++E N L +
Sbjct: 3 VLGKGGYGKVF---QVRKVTGAD-TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK 58
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HP +V L+ +L L+ E++ G L HL G ++ A +I+ LA
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEIS------LA 112
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
H + +IYRD K NILLD K++DFGL K S + VT GT Y APE
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPE 170
Query: 261 YVA-TGHLYVKSDVYGFGVVLVEILTG 286
+ +GH D + G ++ ++LTG
Sbjct: 171 ILMRSGH-GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVN----F 135
F+ VLG G FGKV L E +G + A+K L + +E +S + F
Sbjct: 1 FRCLAVLGRGHFGKVL---LAEYKK----TGELYAIKALKKGDIIARDEVESLMCEKRIF 53
Query: 136 L--GRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
HP LV L C++ ++ + V E+ G L H+ +P A + A
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRA----VFYA 107
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
GL +LH + +++YRD K N+LLD KI+DFGL K G T+ G
Sbjct: 108 ACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCG 163
Query: 253 TYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
T + APE V T Y ++ D +G GV++ E+L G
Sbjct: 164 TPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 73/214 (34%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+F VLG+G FGKV L E+ G+ + A+K L + + E E
Sbjct: 1 DFNFLMVLGKGSFGKVM---LAER----KGTDELYAIKILKKDVVIQDDDVECTMVEKRV 53
Query: 136 LGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L P + L C++ + L V E++ G L + G +P A +IAIG
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GT 253
L FLH+ K +IYRD K N++LD KI+DFG+ K VTT+ GT
Sbjct: 114 ----LFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 254 YGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
Y APE +A Y KS D + FGV+L E+L G
Sbjct: 165 PDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 83/294 (28%), Positives = 123/294 (41%), Gaps = 48/294 (16%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHPNL 144
+G G FGKV G E G S + V VK+L S + + EV L+HPN+
Sbjct: 3 IGNGWFGKVLLG---EAHRGMSKARVV--VKELRASATPDEQLLFLQEVQPYRELNHPNV 57
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFG-RGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ LG C E LLV EF G L+N+L RG Q ++ ++A A GL +LH
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLA------KLGPSASQSHVTTRVMGTYGYA 257
+D I+ D N L + KI D+GLA + V R +
Sbjct: 118 QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WL 169
Query: 258 APEYVATGHLYV-------KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
APE V + KS+++ GV + E+ T ++P + +K +
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVVR 224
Query: 311 EKRKFRHIIDARL---QGQYPYKAA-YQIAQLSLKCLEAEPKHRPSMREVVETL 360
E+ D +L Q Y Y++ Q C +P+ RP+ EV E L
Sbjct: 225 EQ-------DIKLPKPQLDLKYSDRWYEVMQF---CW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 34/285 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
N++ +LG+G FG+V+ + + G+ + + + E+ + + E+ L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY--DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN 60
Query: 139 LSHPNLVRLLGYCWED---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L H +V+ G C D K L + E+M GS+++ L GA L ++ K
Sbjct: 61 LQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQI 115
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR-VMGTY 254
G+++LH++ +++RD K +NIL D + K+ DFG +K + S R V GT
Sbjct: 116 LEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ +PE ++ K+DV+ G +VE+LT KP +E
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTE-------------------KPPWAEYEA 214
Query: 315 FRHIIDARLQGQYPYKAAY--QIAQLSLKCLEAEPKHRPSMREVV 357
I Q P ++ + A+ L C+ E +HRPS E++
Sbjct: 215 MAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 69/300 (23%), Positives = 128/300 (42%), Gaps = 48/300 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKG--WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEV 133
NF+ + +G G F +V++ LD G +A+KK+ L + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLD---------GVPVALKKVQIFDLMDAKARADCIKEI 53
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQP--LAWNIRL 189
+ L +L+HPN+++ ED EL +V E G L + F + + P W +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
++ A H ++V++RD K +N+ + + K+ D GL + +S++
Sbjct: 114 QLCS------ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHS 165
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309
++GT Y +PE + KSD++ G +L E + AL + P+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE----MAALQS--------------PFY 207
Query: 310 SEKRKFRHIIDARLQGQYPY----KAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365
+K + Q YP + ++ QL C+ +P+ RP + V + +R+ A
Sbjct: 208 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 38/294 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPNL 144
LG G G V K + P +GTV+A K ++ + ++ E+ + P +
Sbjct: 13 LGAGNGGSVSKV---KHIP----TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI 65
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V G + + + EFM GSL+ G P+ I KIA+ GL +L+
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLY- 120
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ ++++RD K SNIL++ K+ DFG++ +L S + + V GT Y +PE +
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQ 175
Query: 264 TGHLYVKSDVYGFGVVLVEILTG-----LRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318
G VKSDV+ G+ ++E+ G +D + ++D ++ + E
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229
Query: 319 IDARL-QGQYPYKAAYQIAQLSL-KCLEAEPKHRPSMREVVETLERLQASDQKP 370
RL +P + + + CL +P RP+ +++ +QA
Sbjct: 230 -PPRLPSSDFP-----EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 69/218 (31%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+F VLG+G FGKV L E+ G+ + A+K L + + E E
Sbjct: 1 DFNFLMVLGKGSFGKVM---LAER----KGTDELYAIKILKKDVVIQDDDVECTMVEKRV 53
Query: 136 LGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L P + L C++ + L V E++ G L H+ G +P A +I++G
Sbjct: 54 LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG 113
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GT 253
L FLH + +IYRD K N++LD KI+DFG+ K VTTR GT
Sbjct: 114 ----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGT 164
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD 291
Y APE +A D + +GV+L E+L G D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 73/311 (23%), Positives = 131/311 (42%), Gaps = 66/311 (21%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGW-LDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS---- 131
NFK + +G+G F V+K L + G V+A+KK+ Q FE +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLD--------GRVVALKKV-----QIFEMMDAKARQ 47
Query: 132 ----EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLE---NHLFGRGASV-QPL 183
E++ L +L HPN+++ L E+ EL +V E G L H + + +
Sbjct: 48 DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107
Query: 184 AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS--- 240
W +++ L +H+ K++++RD K +N+ + + K+ D GL + S
Sbjct: 108 IWKYFVQL----CSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
Query: 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300
A+ S V GT Y +PE + KSD++ G +L E + AL +
Sbjct: 162 AAHSLV-----GTPYYMSPERIHENGYNFKSDIWSLGCLLYE----MAALQS-------- 204
Query: 301 LVDWIKPYLSEKRKFRHIIDARLQGQYP------YKAAYQIAQLSLKCLEAEPKHRPSMR 354
P+ +K + + YP Y ++ L +C+ +P+ RP +
Sbjct: 205 ------PFYGDKMNLYSLCKKIEKCDYPPLPADHYSE--ELRDLVSRCINPDPEKRPDIS 256
Query: 355 EVVETLERLQA 365
V++ + + A
Sbjct: 257 YVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 75/252 (29%), Positives = 113/252 (44%), Gaps = 35/252 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSHP 142
+G G FG V+ D + + V+A+KK++ Q E+WQ EV FL +L HP
Sbjct: 23 IGHGSFGAVYFA-RDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGS---LENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
N ++ G + LV E+ + LE H +PL + GA +GL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGL 128
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
A+LH+ + +I+RD KA NILL K+ DFG SAS +GT + AP
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPANXFVGTPYWMAP 180
Query: 260 EYVAT---GHLYVKSDVYGFGVVLVEILTGLRAL-DTNRPSGQHNLVDWIKPYLSEKR-- 313
E + G K DV+ G+ +E+ L + N S +++ P L
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 314 -KFRHIIDARLQ 324
FR+ +D+ LQ
Sbjct: 241 EYFRNFVDSCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH-PN 143
V+GEG FG+V K + K G + +K+ S+ ++ E+ L +L H PN
Sbjct: 2 VIGEGNFGQVLKARI--KKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPN 57
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHL-----------FGR-GASVQPLAWNIRLKI 191
++ LLG C L L E+ G+L + L F ++ L+ L
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
A ARG+ +L S KQ I+RD A NIL+ +Y AKI+DFGL++ Q + M
Sbjct: 118 AADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTM 170
Query: 252 GTYG--YAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
G + A E + SDV+ +GV+L EI++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 68/207 (32%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLG-RLS 140
VLG+G FGKV L E SG + AVK L + + E +E L +
Sbjct: 2 VLGKGSFGKVMLARLKE-------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 54
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
HP L +L C++ + L V EF+ G L H+ + A +I L
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SAL 109
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
FLH DK +IYRD K N+LLD K++DFG+ K G T+ GT Y AP
Sbjct: 110 MFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAP 165
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTG 286
E + D + GV+L E+L G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVN-FLGRL 139
V+G+G FGKV KA GK AVK L +++ +E + +E N L +
Sbjct: 1 KVIGKGSFGKVLLA--KHKADGK-----FYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 140 SHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
HP LV L Y ++ + L V +++ G L HL + +P A +IA
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA----SA 108
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
L +LH+ +IYRD K NILLD ++DFGL K G S++ T+ GT Y A
Sbjct: 109 LGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
PE V Y ++ D + G VL E+L GL
Sbjct: 165 PE-VLRKQPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 49/284 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--WQSEVNFLGRLSHP 142
V+G+G +G+V + + GK +KKLN + E + E L +L HP
Sbjct: 7 VVGKGSYGEV--SLVRHRTDGKQ-----YVIKKLNLRNASRRERKAAEQEAQLLSQLKHP 59
Query: 143 NLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQP----LAWNIRLKIAIGAA 196
N+V WE D L +V F + G L + L + + P + W +++ +A
Sbjct: 60 NIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
L +LH +K +++RD K N+ L + K+ D G+A++ +Q + + ++GT Y
Sbjct: 115 --LQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYY 168
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILT---GLRALDTNRPSGQHNLVDWIKPYLSEKR 313
+PE + KSDV+ G + E+ T A D N +LV
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLV----------- 211
Query: 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
+R II+ +L P + ++ +L L P+ RPS++ ++
Sbjct: 212 -YR-IIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
E+ L + P +V G + D E+ + E M GSL+ L + NI KI
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPENILGKI 104
Query: 192 AIGAARGLAFLHTSDK-QVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTR 249
+I RGL +L +K ++++RD K SNIL++ K+ DFG++ +L S + S V TR
Sbjct: 105 SIAVLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 162
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
Y +PE + H V+SD++ G+ LVE+ G
Sbjct: 163 -----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 77/297 (25%), Positives = 133/297 (44%), Gaps = 37/297 (12%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQ 130
EL + K + +LG G FG++ +G L K P K +A+ L S + +
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCL--KLPSKRE--LPVAIHTLRAGCSDKQRRGFL 54
Query: 131 SEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK 190
+E LG+ H N+VRL G +++V E+M G+L++ L R Q +A + +
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQL-MG 111
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT-R 249
+ G A G+ +L S+ +++ A +L++ KIS F +L S++ TT
Sbjct: 112 MLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMS 167
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY- 308
+AAPE + H SDV+ FG+V+ E+++ G+ +PY
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS----------YGE-------RPYW 210
Query: 309 -LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+S + + + D RL P + QL L C + E RP ++ L ++
Sbjct: 211 DMSGQDVIKAVEDGFRLPA--PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFL 136
F+ VLG+GGFG+V A +G + A KKL + ++ G +E L
Sbjct: 2 FRHYRVLGKGGFGEVC-------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 54
Query: 137 GRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRG------ASVQPLAWNIRL 189
+++ +V L Y +E K+ L LV M G L+ H++ G A I
Sbjct: 55 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
GL LH ++++YRD K NILLD +ISD GLA P + R
Sbjct: 114 --------GLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR 161
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
V GT GY APE V D +G G ++ E++ G
Sbjct: 162 V-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+GEG G V A KS +G +AVKK++ Q E +EV + HPN+V
Sbjct: 27 IGEGSTGIV------CIATDKS-TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
+ EL +V EF++ G+L + + + + +A + + + L+FLH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHA- 133
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR--VMGTYGYAAPEYVA 263
+ VI+RD K+ +ILL K+SDFG + V R ++GT + APE ++
Sbjct: 134 -QGVIHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 264 TGHLYVKSDVYGFGVVLVEILTG 286
+ D++ G++++E++ G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNF 135
+ + +G G FG+V + ++ S A+K + L+ + +E
Sbjct: 2 DLERIKTVGTGTFGRVHL--VRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRV 54
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L +SHP ++RL + + L ++ E++ G L ++L G L A
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEI 110
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
L +LH+ K+++YRD K NILLD K++DFG AK T + GT
Sbjct: 111 VCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPE 163
Query: 256 YAAPEYVA-TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297
Y APE + GH D + G+++ E+L G + P G
Sbjct: 164 YLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 70/211 (33%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR------ 138
VLG+G FGKV L G+ A+K L + + E+ E + R
Sbjct: 2 VLGKGSFGKVMLAEL-------KGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALA 52
Query: 139 LSHPNLVRLLGYC-WEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
HP L L +C ++ KE L V E++ G L H+ G + A +I G
Sbjct: 53 WEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG-- 108
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
L FLH K +IYRD K N+LLD KI+DFG+ K + + + GT Y
Sbjct: 109 --LQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162
Query: 257 AAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
APE + G Y +S D + FGV+L E+L G
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 80/279 (28%), Positives = 115/279 (41%), Gaps = 41/279 (14%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFL 136
F+ VLG+GGFG+V A +G + A KKL + ++ G +E L
Sbjct: 2 FRQYRVLGKGGFGEVC-------ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQIL 54
Query: 137 GRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
+++ V L Y +E K+ L LV M G L+ H++ G + + I
Sbjct: 55 EKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
GL LH ++++YRD K NILLD +ISD GLA P + RV GT G
Sbjct: 114 --GLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
Y APE V D + G +L E++ G P+ K+K
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ------------------SPFQQRKKKI 208
Query: 316 RHIIDARL----QGQYPYKAAYQIAQLSLKCLEAEPKHR 350
+ RL Q +Y K + L L +PK R
Sbjct: 209 KREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 9e-15
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 61/230 (26%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS------EVNFLGR 138
+G G +G V +D++ +G +A+KK+++ F++ E+ L
Sbjct: 7 PIGSGAYGVVCSA-VDKR------TGRKVAIKKISNV----FDDLIDAKRILREIKLLRH 55
Query: 139 LSHPNLVRLL-----GYCWEDKELLLVYEFMQ---------KGSLEN-HLFGRGASVQPL 183
L H N++ LL + ++ +V E M+ L + H +Q
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH-------IQYF 108
Query: 184 AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSAS 242
+ I RGL +LH+++ VI+RD K SNIL++ + KI DFGLA+ + P
Sbjct: 109 LYQI--------LRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 243 QS-----HVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ +V TR Y APE + + Y K+ D++ G + E+LT
Sbjct: 159 EKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 67/299 (22%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKG--WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEV 133
NF+ + +G G F +V++ LD K +A+KK+ + + Q E+
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKP---------VALKKVQIFEMMDAKARQDCVKEI 53
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQP--LAWNIRL 189
+ L +L+HPN+++ L ED EL +V E G L + F + + P W +
Sbjct: 54 DLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
++ A H ++V++RD K +N+ + + K+ D GL + +S++
Sbjct: 114 QLCS------AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHS 165
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309
++GT Y +PE + KSD++ G +L E + AL + P+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE----MAALQS--------------PFY 207
Query: 310 SEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364
+K + Q YP + ++ +L C+ +P RP + V + +++
Sbjct: 208 GDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEW-QSEVNFLGRLSHP 142
LG GGFG+V E KS A+K + + G +E SE L +HP
Sbjct: 1 LGVGGFGRV------ELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHP 53
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
+V+L + K + ++ E+ G L L RG + A R IA +L
Sbjct: 54 FIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA---RFYIA-CVVLAFEYL 109
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H ++ +IYRD K N+LLD + K+ DFG AK T GT Y APE +
Sbjct: 110 H--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAK---KLKSGQKTWTFCGTPEYVAPEII 164
Query: 263 -ATGHLYVKSDVYGFGVVLVEILTG 286
G+ + D + G++L E+LTG
Sbjct: 165 LNKGYDFS-VDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 66/208 (31%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSHP 142
LG G FG+V + G+G A+K L + ++ Q E + L LSHP
Sbjct: 26 LGTGSFGRV-------RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
+V ++ ++ + + EF+ G L HL R A P N K A LAF
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHL--RKAGRFP---NDVAKF-YHAELVLAFE 132
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM---GTYGYAAP 259
+ K +IYRD K N+LLD K++DFG AK V R GT Y AP
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPEYLAP 184
Query: 260 EYVAT-GHLYVKSDVYGFGVVLVEILTG 286
E + + GH D + GV+L E + G
Sbjct: 185 EVIQSKGHGKA-VDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 72/297 (24%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 66 RIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG 125
++ T V + + + +G+G G VF +G +A+K++N +
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTA-------IDVATGQEVAIKQINLQKQPK 59
Query: 126 FEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAW 185
E +E+ + L +PN+V L EL +V E++ GSL + + +A
Sbjct: 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA 119
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQS 244
R + L FLH + QVI+RD K+ N+LL + K++DFG A++ P S+
Sbjct: 120 VCR-----ECLQALEFLHAN--QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 245 HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304
+ ++GT + APE V K D++ G++ +E++ G P
Sbjct: 173 ---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-------EP--------- 213
Query: 305 IKPYLSE---KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
PYL+E + + + + Q P K + +CLE + + R S +E+++
Sbjct: 214 --PYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 73/212 (34%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS---- 140
+LG+G FGKVF L G+ A+K L + + ++ + + LS
Sbjct: 2 MLGKGSFGKVFLAEL-------KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 54
Query: 141 HPNLVRLLGYC-WEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
HP L L YC ++ KE L V E++ G L H+ P A +I G
Sbjct: 55 HPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG---- 108
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK---LGPSASQSHVTTRVMGTYG 255
L FLH+ K ++YRD K NILLD KI+DFG+ K LG + T GT
Sbjct: 109 LQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCTFCGTPD 161
Query: 256 YAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
Y APE + G Y S D + FGV+L E+L G
Sbjct: 162 YIAPE-ILLGQKYNTSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ-SEVNFLG 137
NFK LGEG + V+KG +G ++A+K+++ ++ +G E++ +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRT-------TGEIVALKEIHLDAEEGTPSTAIREISLMK 53
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
L H N+VRL + +L+LV+E+M K L+ ++ G L N +
Sbjct: 54 ELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVR-GALDPNTVKSFTYQLLK 111
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK---LGPSASQSHVTTRVMGTY 254
G+AF H + +V++RD K N+L++ K++DFGLA+ + + + V T
Sbjct: 112 GIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-----TL 164
Query: 255 GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
Y AP+ + Y S D++ G ++ E++TG
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 40/277 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNL 144
+G+G FG+VFKG +D + + V+A+K ++ E + E+ Q E+ L + P +
Sbjct: 12 IGKGSFGEVFKG-IDNR------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
+ G + +L ++ E++ GS + L R LK + +GL +LH+
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLDYLHS 119
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
K I+RD KA+N+LL K++DFG+A G +GT + APE +
Sbjct: 120 EKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV-DWIKPYLSEK--RKFRHIIDA 321
K+D++ G+ +E+ G P L+ P L+ + + F+ IDA
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
CL +P RP+ +E+++
Sbjct: 236 --------------------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 69/207 (33%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSH 141
+LG+G FGKV + EKA GK A+K L E + +E +E L H
Sbjct: 2 LLGKGTFGKVI--LVREKATGK-----YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH 54
Query: 142 PNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
P L L Y ++ + L V E+ G L HL + A +I L
Sbjct: 55 PFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SALG 109
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+LH+ D V+YRD K N++LD KI+DFGL K G S GT Y APE
Sbjct: 110 YLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPE 165
Query: 261 YVATGHLYVKS-DVYGFGVVLVEILTG 286
V + Y ++ D +G GVV+ E++ G
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
E+ L + P +V G + D E+ + E M GSL+ L + + I K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKV 108
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRV 250
+I RGLA+L Q+++RD K SNIL++ K+ DFG++ +L S + S V TR
Sbjct: 109 SIAVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR- 166
Query: 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
Y +PE + H V+SD++ G+ LVE+ G
Sbjct: 167 ----SYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-----NSESLQGFEEWQSEV 133
N++ +LG G FG+V+ + + +G +AVK++ + E+ + + E+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCY-------DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55
Query: 134 NFLGRLSHPNLVRLLGYCWED---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK 190
L L H +V+ G C D K+L + E+M GS+++ L GA L N+ +
Sbjct: 56 QLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTRR 110
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR- 249
+G+++LH++ +++RD K +NIL D + K+ DFG +K + S +
Sbjct: 111 YTRQILQGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
V GT + +PE ++ K+DV+ +VE+LT
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTV-IAVKKL---NSESLQGFEEWQSEVNFLGRLS 140
VLG+G +G V+ + S V IA+K++ +S +Q E E+ L
Sbjct: 15 VLGKGTYGIVYAA--------RDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLK 63
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA--RG 198
H N+V+ LG E+ + E + GSL L + PL N + I G
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEG 120
Query: 199 LAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFG----LAKLGPSASQSHVTTRVMGT 253
L +LH D Q+++RD K N+L++ S KISDFG LA + P T GT
Sbjct: 121 LKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGT 172
Query: 254 YGYAAPEYVATGH--LYVKSDVYGFGVVLVEILTG 286
Y APE + G +D++ G +VE+ TG
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 67/213 (31%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFL 136
F+ VLG+GGFG+V A +G + A KKL + ++ G +E L
Sbjct: 2 FRHYRVLGKGGFGEVC-------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRIL 54
Query: 137 GRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
++ + V L Y +E K+ L LV M G L+ H++ G ++ + I A
Sbjct: 55 EKV-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFDEQRAIFYAA 109
Query: 196 AR--GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
GL L ++++YRD K NILLD +ISD GLA P V RV GT
Sbjct: 110 ELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GT 164
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
GY APE + D +G G ++ E++ G
Sbjct: 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL--NSESLQGFEE---WQSEV 133
N++ +LG+G FG+V+ + + +G +AVK++ + ES + +E + E+
Sbjct: 3 NWRLGKLLGQGAFGRVYLCY-------DADTGRELAVKQVQFDPESPETSKEVNALECEI 55
Query: 134 NFLGRLSHPNLVRLLGYCWED---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK 190
L L H +V+ G C D + L + E M GS+++ L GA L N+ K
Sbjct: 56 QLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGA----LTENVTRK 110
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR- 249
G+++LH++ +++RD K +NIL D K+ DFG +K + S +
Sbjct: 111 YTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
V GT + +PE ++ K+D++ G +VE+LT
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 46/218 (21%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK-LNSE--------SLQGFEEWQSEVNFL 136
+GEG +G VFK E +G ++A+KK + SE +L+ E+ L
Sbjct: 9 IGEGSYGVVFKCRNRE-------TGQIVAIKKFVESEDDPVIKKIALR-------EIRML 54
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQK---GSLENHLFG-RGASVQPLAWNIRLKIA 192
+L HPNLV L+ ++L LV+E+ LE + G ++ + W
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT----- 109
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL---GPSASQSHVTTR 249
+ + F H I+RD K NIL+ K+ DFG A++ +V TR
Sbjct: 110 ---LQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
Y APE + Y DV+ G V E+LTG
Sbjct: 165 -----WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----EVNFLGRLSH 141
+GEG +G V+KG +G ++A+KK+ ES + E S E++ L L H
Sbjct: 8 IGEGTYGVVYKG-------RNKKTGQIVAMKKIRLESEE--EGVPSTAIREISLLKELQH 58
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQPLAWNIRLKIAIGAARGL 199
PN+V L ++ L L++EF+ L+ +L +G + L + +G+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL---QGI 114
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAA 258
F H+ ++V++RD K N+L+D K++DFGLA+ G V T + T Y A
Sbjct: 115 LFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---RVYTHEVVTLWYRA 169
Query: 259 PEYVATGHLY-VKSDVYGFGVVLVEILT 285
PE + Y D++ G + E+ T
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL----NSESLQGFEEWQSEVNFLGRL-- 139
+G G G+V+K K +G V+AVK++ N E + L L
Sbjct: 23 IGSGTCGQVYK------MRFKK-TGHVMAVKQMRRTGNKEENK---------RILMDLDV 66
Query: 140 ---SH--PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
SH P +V+ GY D ++ + E M + + L R P+ +I K+ +
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKR--IQGPIPEDILGKMTVA 122
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGT 253
+ L +L VI+RD K SNILLD S K+ DFG++ +L S++ TR G
Sbjct: 123 IVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGC 177
Query: 254 YGYAAPEYV----ATGHLYVKSDVYGFGVVLVEILTGL 287
Y APE + +++DV+ G+ LVE+ TG
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-14
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFLGRLSHP 142
LG+GGFG+V A +G + A KKL+ + L+ G + E L +++ P
Sbjct: 1 LGKGGFGEVC-------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53
Query: 143 NLVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
+V L Y +E K L LV M G L+ H++ G + I I G+
Sbjct: 54 FIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGILH 110
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
LH+ D ++YRD K N+LLD ++SD GLA T+ GT GY APE
Sbjct: 111 LHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEI 165
Query: 262 VATGHLYVKSDVYGFGVVLVEILTG 286
+ D + G + E++ G
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 69/207 (33%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVN-FLGRLS 140
V+G+G FGKV + G AVK L + + +E + +E N L +
Sbjct: 2 VIGKGSFGKVL-------LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK 54
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HP LV L ++L V +F+ G L HL + +P A R A A L
Sbjct: 55 HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA---RFYAA-EIASALG 110
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+LH+ ++YRD K NILLD ++DFGL K G +QS TT GT Y APE
Sbjct: 111 YLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPE 166
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGL 287
+ D + G VL E+L GL
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNL 144
+G+G +GKV+K G++ AVK L+ S EE ++E N L L HPN+
Sbjct: 30 IGKGTYGKVYK-------VTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNV 81
Query: 145 VRLLGYCWE-DK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
V+ G ++ DK +L LV E GS+ + G Q L + I GA GL
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
LH + ++I+RD K +NILL K+ DFG++ S T+ +GT + AP
Sbjct: 142 QHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 197
Query: 260 EYVATGHLY-----VKSDVYGFGVVLVEILTG 286
E +A Y + DV+ G+ +E+ G
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 45/276 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLGRLSHPN 143
V+GEG FG+ S A+K++ +S E+ + E L ++ HPN
Sbjct: 7 VVGEGSFGRAL-------LVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQP----LAWNIRLKIAIGAARGL 199
+V D L +V E+ G L + + + P L W +++ + +
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----- 114
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
H +K+V++RD K+ NI L + K+ DFG A+L ++ ++ T V GT Y P
Sbjct: 115 ---HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV-GTPYYVPP 169
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319
E KSD++ G +L E+ T N ++++I
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--------------------SWKNLI 209
Query: 320 DARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPS 352
QG Y P +Y++ L + + P+ RPS
Sbjct: 210 LKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 47/228 (20%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLG 137
+++ + +GEG +G V + +G +A+KK++ Q F + E+ L
Sbjct: 6 RYQNLSYIGEGAYGMVCSA-THKP------TGVKVAIKKISPFEHQTFCQRTLREIKILR 58
Query: 138 RLSHPNLVRLL------GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLA------- 184
R H N++ +L + ++ +V E M E L+ + Q L+
Sbjct: 59 RFKHENIIGILDIIRPPSFE-SFNDVYIVQELM-----ETDLY-KLIKTQHLSNDHIQYF 111
Query: 185 -WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ 243
+ I RGL ++H+++ V++RD K SN+LL+ + KI DFGLA+ A
Sbjct: 112 LYQI--------LRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IADP 158
Query: 244 SHVTTRVMGTY----GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
H T + Y Y APE + Y K+ D++ G +L E+L+
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 70/242 (28%), Positives = 103/242 (42%), Gaps = 51/242 (21%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNF 135
+F+ V+G G FG+V+ +K G+ V A+K L + + +E +
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR--DKDTGQ-----VYAMKVLRKSDMIKRNQIAHVRAERDI 54
Query: 136 LGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLA-WNI-RLKIA 192
L P +V+L Y ++D+E L LV E+M G L N L + + A + I L +A
Sbjct: 55 LADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS-------- 244
+ + L F+H RD K NIL+D K++DFGL K A
Sbjct: 114 LDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 245 --------------HVTTRVM-----GTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEIL 284
H RV GT Y APE V G Y ++ D + GV+L E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML 224
Query: 285 TG 286
G
Sbjct: 225 YG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 70/287 (24%), Positives = 126/287 (43%), Gaps = 49/287 (17%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ--SEVNFLGRLSH-P 142
LG G +G V +K +GT++AVK++ + ++ E+ + +++ R P
Sbjct: 9 LGRGAYGVV------DKMRHVP-TGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDCP 60
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLEN---HLFGRGASVQPLAWNIRLKIAIGAARGL 199
V G + + ++ + E M SL+ ++ +G ++ +I KIA+ + L
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPE---DILGKIAVSIVKAL 116
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
+LH+ VI+RD K SN+L++ + K+ DFG++ S T G Y AP
Sbjct: 117 EYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAP 172
Query: 260 EYV----ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
E + VKSDV+ G+ ++E+ TG PY S K F
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRF------------------PYDSWKTPF 214
Query: 316 RHIIDARLQGQYPY----KAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ + ++ P K + + KCL+ K RP+ E+++
Sbjct: 215 QQLKQV-VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK--LNSESLQGFEEWQS----EVNFLGRL 139
+GEG +G V+K +K +G ++A+KK L +E E S E++ L L
Sbjct: 7 IGEGTYGVVYKA--RDKL-----TGEIVALKKIRLETED----EGVPSTAIREISLLKEL 55
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
+HPN+VRLL + +L LV+EF+ L+ ++ + + L + +G+
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LG-PSASQSHVTTRVMGTYGYA 257
A+ H+ +V++RD K N+L+D K++DFGLA+ G P + +H T Y
Sbjct: 113 AYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYR 166
Query: 258 APEYVATGHLYVKS-DVYGFGVVLVEILT 285
APE + Y D++ G + E++
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 79/312 (25%), Positives = 131/312 (41%), Gaps = 69/312 (22%)
Query: 66 RIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG 125
++ T V + + + +G+G G V+ +G +A+K++N +
Sbjct: 7 KLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAI-------DVATGQEVAIKQMNLQQQPK 59
Query: 126 FEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAW 185
E +E+ + HPN+V L EL +V E++ GSL + + +A
Sbjct: 60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 119
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQS 244
R + L FLH+ QVI+RD K+ NILL + K++DFG A++ P QS
Sbjct: 120 VCR-----ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQS 170
Query: 245 HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304
+T V GT + APE V K D++ G++ +E++ G P
Sbjct: 171 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-------EP--------- 213
Query: 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIA-----------QLSL-------KCLEAE 346
PYL+E P +A Y IA +LS +CLE +
Sbjct: 214 --PYLNEN---------------PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256
Query: 347 PKHRPSMREVVE 358
+ R S +E+++
Sbjct: 257 VEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFL 136
F+ VLG+GGFG+V A +G + A K+L + ++ G +E L
Sbjct: 2 FRQYRVLGKGGFGEVC-------ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQIL 54
Query: 137 GRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIR-LKIAIG 194
+++ +V L Y +E K+ L LV M G L+ H++ G P R L A
Sbjct: 55 EKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMG---NPGFEEERALFYAAE 110
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
GL LH + +YRD K NILLD +ISD GLA P + RV GT
Sbjct: 111 ILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTV 165
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
GY APE + + D +G G ++ E++ G
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE-EWQSEVNFLG 137
+F+ + LG G G VFK SG ++A K ++ E + E+ L
Sbjct: 6 DFEKISELGAGNGGVVFK-------VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
+ P +V G + D E+ + E M GSL+ L G + I K++I +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIK 114
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGY 256
GL +L K +++RD K SNIL++ K+ DFG++ +L S + S V TR Y
Sbjct: 115 GLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SY 168
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
+PE + H V+SD++ G+ LVE+ G
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 53/238 (22%), Positives = 99/238 (41%), Gaps = 36/238 (15%)
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELL----LVYEFMQKGSLENHLFGRGASVQPLAWNI 187
E+ L R+ N++++ G+ + + L L+ E+ +G L L + L++
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKT 123
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT 247
+L +AI +GL L+ + Y++ + + L+ +Y KI GL K+ S +V
Sbjct: 124 KLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 248 TRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305
V Y + + + +K D+Y GVVL EI TG
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK------------------ 219
Query: 306 KPY--LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
P+ L+ K + II+ + P +I + C + RP+++E++ L
Sbjct: 220 IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 54/209 (25%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNL 144
LG+G +G V+K +G +A+K++ E + F + E++ L + P +
Sbjct: 9 LGKGNYGSVYKVL-------HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYI 61
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V G + + + + E+M GSL+ L+ G + + + ++ +I +GL FL
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL-K 119
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ +I+RD K +N+L++G+ K+ DFG++ L S +++++ G Y APE +
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIK 174
Query: 264 TGHLY------VKSDVYGFGVVLVEILTG 286
+G V+SDV+ G+ ++E+ G
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----EVNFLGRLSH 141
+GEG +G VFK E + ++A+K++ + E S E+ L L H
Sbjct: 8 IGEGTYGTVFKAKNRE-------THEIVALKRVRLDDDD--EGVPSSALREICLLKELKH 58
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
N+VRL DK+L LV+E+ + L+ + + P I +GLAF
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP---EIVKSFMFQLLKGLAF 114
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LG-PSASQSHVTTRVMGTYGYAAP 259
H+ V++RD K N+L++ + K++DFGLA+ G P S T Y P
Sbjct: 115 CHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWYRPP 168
Query: 260 EYVATGHLYVKS-DVYGFGVVLVEILTGLRAL 290
+ + LY S D++ G + E+ R L
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 66/207 (31%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLG-RLS 140
VLG+G FGKV L E G+ V A+K L + + + +E L
Sbjct: 2 VLGKGSFGKVM---LAEL----KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK 54
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
HP L L C++ K+ L V E++ G L +F S + R A L
Sbjct: 55 HPFLTALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF-YAAEVTLAL 109
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
FLH VIYRD K NILLD K++DFG+ K G TT GT Y AP
Sbjct: 110 MFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYIAP 165
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTG 286
E + D + GV++ E++ G
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 6e-13
Identities = 70/234 (29%), Positives = 106/234 (45%), Gaps = 46/234 (19%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSH 141
++G GGFG+V+ K+ +G + A+K L+ + + QG +E L +S
Sbjct: 1 IIGRGGFGEVY-------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 53
Query: 142 PN--LVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRG----ASVQPLAWNIRLKIAIG 194
+ + + Y + + L + + M G L HL G A ++ A I L
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL----- 108
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA----KLGPSASQSHVTTRV 250
GL +H ++ V+YRD K +NILLD +ISD GLA K P AS
Sbjct: 109 ---GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------- 155
Query: 251 MGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVD 303
+GT+GY APE + G Y S D + G +L ++L G + P QH D
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG------HSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVN----- 134
F+ T +G+GG+G+V +L +K +G ++A+K++ L +EV
Sbjct: 3 FQILTQVGQGGYGQV---FLAKK----KDTGEIVALKRMKKSLLF----KLNEVRHVLTE 51
Query: 135 --FLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLA--WNIRL 189
L LV+LL Y ++D E L L E++ G L G + A + +
Sbjct: 52 RDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM 110
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
A+ A L ++H RD K N L+D S K++DFGL+K + + S
Sbjct: 111 FEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----- 157
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
V+G+ Y APE V G Y + D + G +L E L G
Sbjct: 158 VVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL 139
+L EG FG++F G L ++ PGK V VK + S E L L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK--DHASEIQVTLLLQESCLLYGL 65
Query: 140 SHPNLVRLLGYCWEDKELLLV-YEFMQKGSLENHL----FGRGASVQPLAWNIRLKIAIG 194
SH N++ +L C ED E V Y +M G+L+ L G + Q L+ + +AI
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPS-----ASQSHVTT 248
A G+++LH + VI++D A N ++D KI+D L++ L P +
Sbjct: 126 IACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
+ M A E + SDV+ FGV+L E++T
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 72/209 (34%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLG-RLS 140
VLG+G FGKV L G G AVK L + + E E L
Sbjct: 2 VLGKGSFGKVLLAEL-------KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE 54
Query: 141 HPNLVRLLGYC-WEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
+P L L YC ++ KE L V EF+ G L H+ +G A +I G
Sbjct: 55 NPFLTHL--YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCG---- 108
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
L FLH+ K +IYRD K N++LD KI+DFG+ K + + + GT Y A
Sbjct: 109 LQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIA 164
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTG 286
PE + G Y S D + FGV+L E+L G
Sbjct: 165 PE-ILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSHP 142
+G+G FGKV + K + + A+K + + E +E L +++ P
Sbjct: 1 IGKGSFGKVMQ-------VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCP 53
Query: 143 NLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLF--GRGASVQPLAWNIRLKIAIGAARGL 199
+V L + ++ E L LV F+ G L +HL GR + + L A L
Sbjct: 54 FIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA------L 106
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKIS--DFGLAKLGPSASQSHVTTRVMGTYGYA 257
LH + VIYRD K NILLD Y I+ DFGL KL + T GT Y
Sbjct: 107 ENLHKFN--VIYRDLKPENILLD--YQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYL 160
Query: 258 APEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
APE + GH Y K+ D + GV+L E+LTGL
Sbjct: 161 APELL-LGHGYTKAVDWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 71/208 (34%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVN-FLGRLS 140
V+G+G FGKV A KS G+ AVK L +++ +E +E N L L
Sbjct: 2 VIGKGSFGKVLL------AKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK 54
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
HP LV L Y ++ E L V +++ G L HL ++P A R A A +
Sbjct: 55 HPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA---RF-YAAEVASAI 109
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
+LH+ + +IYRD K NILLD ++DFGL K G ++ T+ GT Y AP
Sbjct: 110 GYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGL 287
E + D + G VL E+L GL
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 77/301 (25%), Positives = 118/301 (39%), Gaps = 58/301 (19%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQS---EVNFLGRL-- 139
+GEG +G V+K D +G +A+KK+ S +G S E+ L +L
Sbjct: 7 IGEGAYGTVYKA-RDLN------TGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLES 57
Query: 140 -SHPNLVRLLGYC--WEDKE---LLLVYEFMQK---GSLENHLFGRGASVQPLAWNIRLK 190
HPN+VRLL C L LV+E + + L G + + +R
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLPPETIKDLMRQL 116
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
+ RG+ FLH+ ++++RD K NIL+ KI+DFGLA++ + + +T+ V
Sbjct: 117 L-----RGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVV 167
Query: 251 MGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRAL---------------DTNR 294
+ T Y APE V Y D++ G + E L R L
Sbjct: 168 V-TLWYRAPE-VLLQSSYATPVDMWSVGCIFAE-LFRRRPLFRGTSEADQLDKIFDVIGL 224
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
PS + +W + + F + P L K L P R S
Sbjct: 225 PSEE----EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG-LDLLKKMLTFNPHKRISAF 279
Query: 355 E 355
E
Sbjct: 280 E 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 69/277 (24%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+G+G G V+ +D +G +A+K++N + E +E+ + +PN+V
Sbjct: 27 IGQGASGTVYTA-ID------IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
L EL +V E++ GSL + + +A R + L FLH++
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN 134
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
QVI+RD K+ NILL + K++DFG A++ P S+ + ++GT + APE V
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 189
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE---KRKFRHIIDA 321
K D++ G++ +E++ G P PYL+E + + +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG-------EP-----------PYLNENPLRALYLIATNG 231
Query: 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ Q P + + +CLE + R S +E+++
Sbjct: 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 36/282 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPN 143
+GEG FG V++G K +AVK + + E++ E + + HP+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEK----IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+L+G + + +V E G L ++L S+ + + + LA+L
Sbjct: 69 IVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLA---SLILYSYQLSTALAYLE 124
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ K+ ++RD A N+L+ K+ DFGL++ S ++ + APE +
Sbjct: 125 S--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESIN 181
Query: 264 TGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
SDV+ FGV + EIL G +KP+ K +I
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLG------------------VKPFQGVKNN--DVIGRI 221
Query: 323 LQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
G+ P + L KC +P RP E+ L
Sbjct: 222 ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 68/234 (29%), Positives = 108/234 (46%), Gaps = 33/234 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFE-EWQSEVNFLGRLSHP 142
+GEG +G+V+K A K +G ++A+KK+ ++ +GF E+ L +L+H
Sbjct: 14 QIGEGTYGQVYK------ARDKD-TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 143 NLVRLLGYCWEDKELL----------LVYEFMQK---GSLENHLFGRGASVQPLAWNIRL 189
N+V L + ++ L LV+E+M G LE+ L V +I+
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL------VHFSEDHIK- 119
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
GL + H K ++RD K SNILL+ K++DFGLA+L S T +
Sbjct: 120 SFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302
V+ T Y PE + Y + DV+ G +L E+ T N+ Q L+
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+G+G G V+ +G +A++++N + E +E+ + +PN+V
Sbjct: 28 IGQGASGTVYTAM-------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
L EL +V E++ GSL + + +A R + L FLH++
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN 135
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
QVI+RD K+ NILL + K++DFG A++ P S+ + ++GT + APE V
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE---KRKFRHIIDA 321
K D++ G++ +E++ G P PYL+E + + +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPLRALYLIATNG 232
Query: 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ Q P K + +CL+ + + R S +E+++
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 94/346 (27%), Positives = 138/346 (39%), Gaps = 92/346 (26%)
Query: 85 VLGEGGFGKVFKGWLDEKAPG--KSGSGTVIAVKKLNSESLQGFEE--WQSEVNFLGRL- 139
VLG G FGKV ++ A G K S +AVK L E E SE+ L +
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLK-EGATASEHKALMSELKILIHIG 68
Query: 140 SHPNLVRLLGYCWE-DKELLLVYEFMQKGSLENHL------------------------- 173
+H N+V LLG C + + L+++ EF + G+L N L
Sbjct: 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMV 128
Query: 174 -----------------FGR-----GASVQPLA-----WNIRLKI------AIGAARGLA 200
F R S P W L + + ARG+
Sbjct: 129 EQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME 188
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK---LGPSASQSHVTTRVMGTYGYA 257
FL + ++ I+RD A NILL + KI DFGLA+ P + + R+ +
Sbjct: 189 FL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-SARL--PLKWM 243
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
APE + +SDV+ FGV+L EI + L A + P Q N +F
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFS-LGA--SPYPGVQIN------------EEFCQ 288
Query: 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + + P A +I ++ L C + +PK RP+ +VE L L
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 46/226 (20%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFL 136
F+ +GEG +G V++ D SG ++A+KK+ ++ + S E+ L
Sbjct: 8 EFEKLNRIGEGTYGIVYRA-RDTT------SGEIVALKKVRMDNERDGIPISSLREITLL 60
Query: 137 GRLSHPNLVRLL---------------GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQ 181
L HPN+V L YC +D LL + M E+ + + +Q
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQV--KCLMLQ 116
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241
L RGL +LH + +I+RD K SN+LL KI+DFGLA+
Sbjct: 117 LL-------------RGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLART-YGL 160
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+T +V+ T Y APE + Y + D++ G +L E+L
Sbjct: 161 PAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----QGFEEWQSEVN 134
NF+ VLG G +GKVF L K G SG + A+K L ++ + E ++E
Sbjct: 1 NFELLKVLGTGAYGKVF---LVRKVSGHD-SGKLYAMKVLKKATIVQKAKTTEHTRTERQ 56
Query: 135 FLGRLSHPNLVRLLGYCWE-DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
L + + L Y ++ D +L L+ +++ G L HL R + ++I
Sbjct: 57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQIYS 111
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
G LA H +IYRD K NILLD + ++DFGL+K + GT
Sbjct: 112 GEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGT 169
Query: 254 YGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTG 286
Y AP+ V GH D + GV++ E+LTG
Sbjct: 170 IEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 32/228 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSH 141
++G GGFG+V+ K+ +G + A+K L+ + + QG +E L +S
Sbjct: 1 IIGRGGFGEVY-------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 53
Query: 142 ---PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
P +V + +L + + M G L HL G + +I +G
Sbjct: 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE-- 111
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA----KLGPSASQSHVTTRVMGTY 254
H ++ V+YRD K +NILLD +ISD GLA K P AS +GT+
Sbjct: 112 ----HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTH 159
Query: 255 GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNL 301
GY APE + G Y S D + G +L ++L G ++ +H +
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSG-SGTVIAVK--KLNSESLQGFEEWQSEVNFLGRLSH 141
LGEG + V+KG +S +G ++A+K +L E F + E + L L H
Sbjct: 12 KLGEGSYATVYKG--------RSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKH 62
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
N+V L K L LV+E++ K +++ G G S+ N+RL RG
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--GGGLSMH----NVRL-FLFQLLRG 115
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL--AKLGPSASQSHVTTRVMGTYGY 256
LA+ H ++V++RD K N+L+ K++DFGL AK PS + S+ T Y
Sbjct: 116 LAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWY 169
Query: 257 AAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
P+ + Y S D++G G + E+ TG
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSH 141
+LG+G FGKV + EKA GK A+K L E + +E +E L H
Sbjct: 2 LLGKGTFGKVI--LVREKASGK-----YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH 54
Query: 142 PNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA--ARG 198
P L L Y ++ K+ L V E++ G L HL S + + R + GA
Sbjct: 55 PFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRF-YGAEIVSA 107
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
L +LH+ +++YRD K N++LD KI+DFGL K G + + + T GT Y A
Sbjct: 108 LDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLA 163
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTG 286
PE + D +G GVV+ E++ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSH- 141
+G+G FG+V++ K + + A+K L+ + + +E E N L R
Sbjct: 1 IGKGTFGQVYQ-------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD 53
Query: 142 --PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
P +V L D +L LV ++M G L HL G + R K I A L
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYI-AELVL 107
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
A H ++YRD K NILLD + + DFGL+K + + + T GT Y AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAP 165
Query: 260 EYVATGHLYVKS-DVYGFGVVLVEILTG 286
E + Y K D + GV++ E+ G
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 72/295 (24%), Positives = 135/295 (45%), Gaps = 53/295 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
+LG G G V+K + + ++AVK + + +++ ++ SE+ L + P
Sbjct: 8 ILGHGNGGTVYKAY-------HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLE------NHLFGRGASVQPLAWNIRLKIAIGAAR 197
++ G + + + + EFM GSL+ H+ GR IA+ +
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR--------------IAVAVVK 106
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGY 256
GL +L + ++++RD K SN+L++ K+ DFG++ +L S ++++V GT Y
Sbjct: 107 GLTYLWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAY 159
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
APE ++ + SDV+ G+ +E+ G P Q N + L + +
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPY----PQIQKN-----QGSLMPLQLLQ 210
Query: 317 HIID---ARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367
I+D L GQ+ K + I Q C+ +PK RP+ +++ +Q +D
Sbjct: 211 CIVDEDPPVLPVGQFSEKFVHFITQ----CMRKQPKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 56/262 (21%)
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
E+ L ++HPN+V+ + E+ ++ EFM GSLE + +A I
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI---- 177
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-----LGPSASQSHV 246
G+A+LH + +++RD K SN+L++ + KI+DFG+++ + P S
Sbjct: 178 ----LSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--- 228
Query: 247 TTRVMGTYGYAAPEYVATG---HLY--VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301
+GT Y +PE + T Y D++ GV ++E G R +L
Sbjct: 229 ----VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284
Query: 302 VDWI------KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
+ I + + R+FRH I CL+ EP R S +
Sbjct: 285 MCAICMSQPPEAPATASREFRHFISC--------------------CLQREPAKRWSAMQ 324
Query: 356 VVE---TLERLQASDQKPKQPR 374
+++ L Q
Sbjct: 325 LLQHPFILRAQPGQGQGGPNLH 346
|
Length = 353 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 67/206 (32%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSH 141
+LG+G FGKV + EKA +G A+K L E + +E +E L H
Sbjct: 2 LLGKGTFGKVI--LVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 54
Query: 142 PNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
P L L Y ++ + L V E+ G L HL + A +I L
Sbjct: 55 PFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV----SALE 109
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+LH+ D V+YRD K N++LD KI+DFGL K G S + T GT Y APE
Sbjct: 110 YLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 165
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTG 286
+ D +G GVV+ E++ G
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----QGFEEWQSEVN 134
NF+ VLG G +GKVF L K G +G + A+K L +L + E ++E N
Sbjct: 1 NFELLKVLGTGAYGKVF---LVRKVTGHD-TGKLYAMKVLQKAALVQKAKTVEHTRTERN 56
Query: 135 FLGRLSHPNLVRLLGYCWE-DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
L + + L Y ++ + +L L+ +++ G + HL+ R + ++
Sbjct: 57 VLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EVRFYS 111
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
G LA H ++YRD K NILLD ++DFGL+K S + T GT
Sbjct: 112 GEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGT 169
Query: 254 YGYAAPEYV--ATGHLYVKSDVYGFGVVLVEILTG 286
Y APE + GH D + G+++ E+LTG
Sbjct: 170 IEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----EVNFLGRLSH 141
+GEG +G V+K + IA+KK+ E Q E S E++ L + H
Sbjct: 10 IGEGTYGVVYKA-------RDRVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQH 60
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL--KIAIGAARGL 199
N+VRL +K L LV+E++ L+ H+ S A N RL RG+
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHM----DSSPDFAKNPRLIKTYLYQILRGI 115
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTA-KISDFGLAK-LG-PSASQSHVTTRVMGTYGY 256
A+ H+ +V++RD K N+L+D A K++DFGLA+ G P + +H T Y
Sbjct: 116 AYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWY 169
Query: 257 AAPEYVATGHLY-VKSDVYGFGVVLVEILT 285
APE + Y D++ G + E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 46/223 (20%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKK--LNSESLQGFE-EWQSEVNFLGRLSHP 142
+G+G FG+VFK A K + ++A+KK + +E +GF E+ L L H
Sbjct: 20 IGQGTFGEVFK------ARHKK-TKQIVALKKVLMENEK-EGFPITALREIKILQLLKHE 71
Query: 143 NLVRLLGYCWEDK--------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
N+V L+ C LV+EF E+ L G L N +K +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAG-------LLSNKNVKFTLS 119
Query: 195 AAR--------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK--LGPSASQS 244
+ GL ++H + ++++RD KA+NIL+ K++DFGLA+ S+
Sbjct: 120 EIKKVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 245 H-VTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILT 285
+ T RV+ T Y PE + Y D++G G ++ E+ T
Sbjct: 178 NRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 67/213 (31%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ-----SEVNFLGRLS 140
+GEG +GKVFK A G +A+K++ +Q EE EV L L
Sbjct: 9 IGEGAYGKVFK------ARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLE 59
Query: 141 ---HPNLVRLLGYCW---EDKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK-I 191
HPN+VRL C D+E L LV+E + + L +L +P +K +
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDM 115
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
RGL FLH+ +V++RD K NIL+ S K++DFGLA++ S T V+
Sbjct: 116 MFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 170
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEIL 284
T Y APE + D++ G + E+
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 40/214 (18%)
Query: 88 EGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFE-EWQSEVNFLGRLSHPNLV 145
EG +G V++ D+K +G ++A+KKL E +GF E+N L +L HPN+V
Sbjct: 15 EGTYGVVYRA-RDKK------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 146 RLLGYCWEDKELL---------LVYEFMQ---KGSLENHLFGRGASVQPLAWNIRLKIAI 193
+ KE++ +V E+++ K +E QP + + +
Sbjct: 68 TV-------KEVVVGSNLDKIYMVMEYVEHDLKSLMETM-------KQPFLQSEVKCLML 113
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
G+A LH D +++RD K SN+LL+ KI DFGLA+ S + + T+++ T
Sbjct: 114 QLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVT 169
Query: 254 YGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTG 286
Y APE + Y D++ G + E+LT
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSG-SGTVIAVKKLNSESLQGFE-EWQSEVNFLGRLSHPN 143
LGEG + V+KG +S + ++A+K++ E +G EV+ L L H N
Sbjct: 14 LGEGTYATVYKG--------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V L +K L LV+E++ K L+ +L G S+ N++L + RGL + H
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSIN--MHNVKLFL-FQLLRGLNYCH 121
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
++V++RD K N+L++ K++DFGLA+ ++++ V T Y P+ +
Sbjct: 122 R--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILL 177
Query: 264 TGHLY-VKSDVYGFGVVLVEILTG 286
Y + D++G G + E+ TG
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 41/194 (21%)
Query: 109 SGTVIAVKKLNSESLQGF------EEWQSEVNFLGRLSHPNLVRLLG-YCWEDKELLLVY 161
+G +A+KK+ ++ F + E+ L L H N++ L + +++ V
Sbjct: 34 TGQNVAIKKI----MKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89
Query: 162 EFM--------QKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRD 213
E + LE +Q + I RGL ++H++ V++RD
Sbjct: 90 ELLGTDLHRLLTSRPLEKQF------IQYFLYQI--------LRGLKYVHSAG--VVHRD 133
Query: 214 FKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSD 272
K SNIL++ + KI DFGLA++ +V+TR Y APE + T Y V+ D
Sbjct: 134 LKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVD 188
Query: 273 VYGFGVVLVEILTG 286
++ G + E+L G
Sbjct: 189 IWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE-EWQSEVNFLGRLSHPNL 144
LGEG + VFKG + ++A+K++ E +G EV+ L L H N+
Sbjct: 14 LGEGTYATVFKG-------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V L DK L LV+E++ K L+ ++ G + N+++ + RGLA+ H
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMS--MHNVKIFL-YQILRGLAYCHR 122
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
++V++RD K N+L++ K++DFGLA+ ++++ V T Y P+ +
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 265 GHLY-VKSDVYGFGVVLVEILTG 286
Y + D++G G + E+ +G
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 21/241 (8%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+GEG G V EK GK +AVKK++ Q E +EV + H N+V
Sbjct: 30 IGEGSTGIVCIA--TEKHTGKQ-----VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVV 82
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
+ EL +V EF++ G+L + + + + +A + + R L++LH
Sbjct: 83 DMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN- 136
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR--VMGTYGYAAPEYVA 263
+ VI+RD K+ +ILL K+SDFG + V R ++GT + APE ++
Sbjct: 137 -QGVIHRDIKSDSILLTSDGRIKLSDFGFC----AQVSKEVPKRKSLVGTPYWMAPEVIS 191
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRP-SGQHNLVDWIKPYLSEKRKFRHIIDAR 322
+ D++ G++++E++ G P + D + P + + K ++
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251
Query: 323 L 323
L
Sbjct: 252 L 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFLGRLS-HP 142
+GEG F +V K K +G A+K + + E+ + E+ L RLS HP
Sbjct: 7 IGEGTFSEVLKA-QSRK------TGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSPHP 58
Query: 143 NLVRLLGYCWEDKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
N++RL+ ++ K L LV+E M +L + GR +PL + L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLD 114
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+H + +RD K NIL+ K++DFG + T + T Y APE
Sbjct: 115 HMHR--NGIFHRDIKPENILIKD-DILKLADFGSCR---GIYSKPPYTEYISTRWYRAPE 168
Query: 261 YVATGHLY-VKSDVYGFGVVLVEILT 285
+ T Y K D++ G V EIL+
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 66/205 (32%), Positives = 89/205 (43%), Gaps = 17/205 (8%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSH 141
+LG+G FGKV + EKA +G A+K L E + +E +E L H
Sbjct: 2 LLGKGTFGKVI--LVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 54
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
P L L L V E+ G L HL + A +I L +
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SALDY 110
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
LH S+K V+YRD K N++LD KI+DFGL K G + T GT Y APE
Sbjct: 111 LH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEV 167
Query: 262 VATGHLYVKSDVYGFGVVLVEILTG 286
+ D +G GVV+ E++ G
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 21/185 (11%)
Query: 181 QPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240
PL + L+ + A+G+ FL + K I+RD A N+LL AKI DFGLA+ +
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300
S V + APE + V+SDV+ +G++L EI + ++
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS----------- 313
Query: 301 LVDWIKPY--LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
PY + KF ++ Q P A +I + C EP RP+ ++ +
Sbjct: 314 ------PYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367
Query: 359 TLERL 363
++R
Sbjct: 368 LIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 73/250 (29%), Positives = 112/250 (44%), Gaps = 29/250 (11%)
Query: 85 VLGEGGFGKVF--KGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVN-FLGR 138
V+G+G FGKV + +EK AVK L +++ +E + SE N L
Sbjct: 2 VIGKGSFGKVLLARHKAEEK---------FYAVKVLQKKAILKKKEEKHIMSERNVLLKN 52
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
+ HP LV L +L V +++ G L HL ++P A +IA
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SA 108
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
L +LH+ + ++YRD K NILLD ++DFGL K + + T+ GT Y A
Sbjct: 109 LGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLA 164
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRAL-DTNRPSGQHNLVD---WIKPYLSEKRK 314
PE + D + G VL E+L GL N N+++ +KP ++
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA- 223
Query: 315 FRHIIDARLQ 324
RH+++ LQ
Sbjct: 224 -RHLLEGLLQ 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHPN 143
LGEG + V+KG +G ++A+K ++ ++ +G F + E + L L H N
Sbjct: 13 LGEGSYATVYKGI-------SRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHAN 64
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V L + L V+E+M L ++ + P +N+RL RGLA++H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP--YNVRL-FMFQLLRGLAYIH 120
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ +++RD K N+L+ K++DFGLA+ SQ++ + V T Y P+ +
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 264 TGHLYVKS-DVYGFGVVLVEILTG 286
Y + D++G G + +E+L G
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE-EWQSEVNFLGRLSHPNL 144
LGEG + VFKG + ++A+K++ E +G EV+ L L H N+
Sbjct: 13 LGEGTYATVFKG-------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 145 VRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
V L ++ L LV+E++ K L+N G S+ N+++ RGL++
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSDLKQYLDN--CGNLMSMH----NVKI-FMFQLLRGLSY 118
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
H +++++RD K N+L++ K++DFGLA+ ++++ V T Y P+
Sbjct: 119 CH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 174
Query: 262 VATGHLYVKS-DVYGFGVVLVEILTG 286
+ Y D++G G +L E+ TG
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+G G +G V+K +G + AVK + E F Q E+ + H N+V
Sbjct: 17 VGSGTYGDVYKA-------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLEN--HLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
G ++L + E+ GSL++ H+ G + +Q +A+ R + +GLA+LH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ-IAYVCRETL-----QGLAYLH 123
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYAAPEYV 262
+ K ++RD K +NILL + K++DFG+ AK+ + ++ +GT + APE
Sbjct: 124 SKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVA 178
Query: 263 A---TGHLYVKSDVYGFGVVLVEI 283
A G D++ G+ +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 49/222 (22%)
Query: 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS--ESLQGFEEWQSEVNFLGRLSH 141
+ +G G +G+V + + +G +A+KKL+ +S + E+ L + H
Sbjct: 21 SPVGSGAYGQVCSAFD-------TKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 142 PNLVRLLGYCWEDKEL------LLVYEFM----------QKGSLENHLFGRGASVQPLAW 185
N++ LL L LV M QK S ++H +Q L +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDH-------IQFLVY 125
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH 245
I RGL ++H++ +I+RD K SNI ++ KI DFGLA+ +
Sbjct: 126 QI--------LRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175
Query: 246 VTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
V TR Y APE + Y ++ D++ G ++ E+LTG
Sbjct: 176 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 67/228 (29%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+F LG G FG+V A K+ +A+K+ + + + SE
Sbjct: 31 DFNFIRTLGTGSFGRVIL------ATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI 84
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG- 194
L ++HP V L G ++ L LV EF+ G E F L N R +G
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF--------LRRNKRFPNDVGC 134
Query: 195 ---AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR-- 249
A L F + ++YRD K N+LLD K++DFG AK+ V TR
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTY 186
Query: 250 -VMGTYGYAAPE-YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRP 295
+ GT Y APE + GH +D + G+ + EIL G N P
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LGEG + V+KG K GK + V +L E F + E + L L H N+V
Sbjct: 13 LGEGSYATVYKG--KSKVNGKL---VALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV 66
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
L + L LV+E++ L ++ + P N++L + RGL+++H
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE--NVKLFL-FQLLRGLSYIH-- 120
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG 265
+ +++RD K N+L+ + K++DFGLA+ + SH + + T Y P+ +
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 266 HLYVKS-DVYGFGVVLVEILTGLRAL 290
Y D++G G + VE++ G+ A
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 36/181 (19%)
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK---LGPSASQSHVTTRVMG 252
ARG+ FL + ++ I+RD A NILL + KI DFGLA+ P + R+
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-DARL-- 237
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY---- 308
+ APE + +SDV+ FGV+L EI + L A PY
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGA----------------SPYPGVQ 280
Query: 309 LSEK--RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL-ERLQA 365
+ E+ R+ + R P A +I + L C P+ RP+ E+VE L + LQ
Sbjct: 281 IDEEFCRRLKEGTRMR----APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
Query: 366 S 366
+
Sbjct: 337 N 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
A+G++FL + K I+RD A NILL KI DFGLA+ + S V
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
+ APE + +SDV+ +G++L EI + L P + KF
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSKF 326
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
+I + P A ++ + C +A+P RP+ +++V+ +E+
Sbjct: 327 YKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 23/164 (14%)
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
LA H K +I+RD K++NILL + K+ DFG +K+ + V GT Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318
PE K+D++ GV+L E+LT R D +
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------------------GENMEEV 253
Query: 319 IDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359
+ L G+Y P + ++ ++ L ++PK RPS +++
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 48/180 (26%), Positives = 89/180 (49%), Gaps = 13/180 (7%)
Query: 109 SGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGS 168
SG ++AVKK++ Q E +EV + H N+V + EL +V EF++ G+
Sbjct: 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 169 LENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228
L + + + + +A + + + L+ LH + VI+RD K+ +ILL K
Sbjct: 104 LTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVK 156
Query: 229 ISDFGLAKLGPSASQSHVTTR--VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
+SDFG + V R ++GT + APE ++ + D++ G++++E++ G
Sbjct: 157 LSDFGFC----AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 23/234 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--W-QSEVNFLGRLS- 140
V+G G + KV L + + + A+K + E + E+ W Q+E + + S
Sbjct: 2 VIGRGSYAKVLLVRLKK-------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS 54
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
+P LV L L LV E++ G L H+ + + A +I I L
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LN 110
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK--LGPSASQSHVTTRVMGTYGYAA 258
FLH ++ +IYRD K N+LLD K++D+G+ K LGP + T+ GT Y A
Sbjct: 111 FLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT----TSTFCGTPNYIA 164
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312
PE + D + GV++ E++ G D + N D++ + EK
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 32/272 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--W-QSEVNFLGRLS- 140
V+G G + KV L + + + A+K + E + E+ W Q+E + + S
Sbjct: 2 VIGRGSYAKVLLVRLKK-------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 54
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HP LV L + L V E++ G L H+ + + A +I++ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 110
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+LH ++ +IYRD K N+LLD K++D+G+ K G + T+ GT Y APE
Sbjct: 111 YLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPE 166
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ--HNLVDWIKPYLSEKRKFRHI 318
+ D + GV++ E++ G D S N D++ + EK
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------ 220
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
Q + P + + A + L +PK R
Sbjct: 221 -----QIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 14/130 (10%)
Query: 109 SGTVIAVKK--LNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQK 166
+ T++AVKK L+S S + + Q E+ +L HPN++ + D EL +V M
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 167 GS----LENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222
GS L+ H F G +A+ ++ L ++H+ K I+R KAS+ILL
Sbjct: 84 GSCEDLLKTH-FPEGLPELAIAFILK-----DVLNALDYIHS--KGFIHRSVKASHILLS 135
Query: 223 GSYTAKISDF 232
G +S
Sbjct: 136 GDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEV 133
R +F+ +G G +G V+K +G + A+K + E + F Q E+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKA-------RNVNTGELAAIKVIKLEPGEDFAVVQQEI 57
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLEN--HLFGRGASVQPLAWNIRLKI 191
+ H N+V G +L + EF GSL++ H+ G + Q +A+ R +
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ-IAYVSRETL 116
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRV 250
+GL +LH+ K ++RD K +NILL + K++DFG+ A++ + ++
Sbjct: 117 -----QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSF 166
Query: 251 MGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEI 283
+GT + APE A G D++ G+ +E+
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 51/233 (21%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLG------- 137
LGEG +GKV K D +G ++A+KK+ E + + V G
Sbjct: 17 LGEGTYGKVEKA-YDTL------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 138 ------RLSHPNLVRLLG-YCWEDKELLLVYEFMQ---KGSLENHLFGRGASVQPLAWNI 187
+ H N++ L+ Y D + LV + M K ++ + + V+ + I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF-INLVMDIMASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA------------ 235
GL LH ++RD +NI ++ KI+DFGLA
Sbjct: 129 --------LNGLNVLHKW--YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 236 -KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
K + +T++V+ T Y APE + Y + D++ G + E+LTG
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 36/225 (16%)
Query: 82 SDT-----VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL 136
SDT +G+G +GKVFK L++K K+ + + ++ EE ++E N L
Sbjct: 17 SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-------EEIEAEYNIL 68
Query: 137 GRLS-HPNLVRLLG-YCWEDK----ELLLVYEFMQKGSLENHLFG---RGASVQPLAWNI 187
LS HPN+V+ G Y +D +L LV E GS+ + + G RG ++ I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP---I 125
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHV 246
I A GL LH + + I+RD K +NILL K+ DFG+ A+L S
Sbjct: 126 IAYILHEALMGLQHLHVN--KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL---TSTRLR 180
Query: 247 TTRVMGTYGYAAPEYVATGHLY-----VKSDVYGFGVVLVEILTG 286
+GT + APE +A + DV+ G+ +E+ G
Sbjct: 181 RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFLGRLS--- 140
+G G +G V+K SG +A+K + ++ + + EV L RL
Sbjct: 8 IGVGAYGTVYKA-------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 141 HPNLVRLLGYCWE---DKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
HPN+VRL+ C D+E + LV+E + + L +L P I+ +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE-TIK-DLMRQF 117
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
RGL FLH + +++RD K NIL+ K++DFGLA++ S T V+ T
Sbjct: 118 LRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLW 172
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEIL 284
Y APE + D++ G + E+
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 19/169 (11%)
Query: 142 PNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
P + +L Y ++ K+ L LV E++ G + + G P W + IA G+
Sbjct: 57 PYVAKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDW-AKQYIA-EVVLGVE 111
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
LH + +I+RD K N+L+D + K++DFGL++ G + +GT Y APE
Sbjct: 112 DLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE 163
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG-----QHNLVDW 304
+ SD + G V+ E L G P ++W
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 50/234 (21%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS------E 132
+K +G G +G V +D + SG +A+KK+ F+ E
Sbjct: 6 RYKPIENIGSGAYGVVCSA-ID------TRSGKKVAIKKIP----HAFDVPTLAKRTLRE 54
Query: 133 VNFLGRLSHPNLVRLLGYCW----EDKELLLVYEFMQ---------KGSLENHLFGRGAS 179
+ L H N++ + + K++ +V + M+ L R
Sbjct: 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHI-RYFL 113
Query: 180 VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239
Q L RGL ++H+++ VI+RD K SN+L++ +I DFG+A+
Sbjct: 114 YQLL-------------RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158
Query: 240 SASQSH--VTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRAL 290
S+ H T + T Y APE + + Y + D++ G + E+L G R L
Sbjct: 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSG-SGTVIAVKKLN-SESLQGFEEWQSEVNFLGRLSHPN 143
+G G FGKV G ++ SG + + VK+L S S+Q ++ E L H N
Sbjct: 3 IGNGWFGKVILGEVN------SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSN 56
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFG-RGASVQPLAWNIRLKIAIGAARGLAFL 202
L++ LG C E LLV EF G L+ +L R A + ++A A GL L
Sbjct: 57 LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG------PSASQSHVTTRVMGTYGY 256
H ++ I+ D N LL T KI D+GL+ + Q V R +
Sbjct: 117 HKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR------W 168
Query: 257 AAPEYV--ATGHLYV-----KSDVYGFGVVLVEIL 284
APE V G+L V +S+V+ GV + E+
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 36/277 (12%)
Query: 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQS 131
LR F+ V+G G +G+V+KG +G + A+K ++ +E + EE +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTEDEE--EEIKL 61
Query: 132 EVNFLGRLSH-PNLVRLLGY------CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLA 184
E+N L + SH N+ G D +L LV EF GS+ + + +
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQ 243
W + I RGLA LH +VI+RD K N+LL + K+ DFG+ A+L + +
Sbjct: 122 WIAYICREI--LRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 244 SHVTTRVMGTYGYAAPEYVA------TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297
+ +GT + APE +A + Y +SD++ G+ +E+ G L P
Sbjct: 178 RNT---FIGTPYWMAPEVIACDENPDATYDY-RSDIWSLGITAIEMAEGAPPLCDMHPMR 233
Query: 298 QHNLVDW-IKPYLSEK---RKFRHIIDARLQGQYPYK 330
L+ P L K +KF I+ L Y +
Sbjct: 234 ALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 36/279 (12%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTV--IAVKKLN-SESLQGFEEWQSEVNFLGRLSHP 142
LG+G FG V+ D+KA + + I V +LN +E++Q +E Q L +L HP
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
+V+ E ++ E+ + L+ L + + L+ N + I G+ ++
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H +++++RD KA NI L + KI DFG+++L + T GT Y +PE +
Sbjct: 123 H--QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
KSD++ G +L E+ A E + F ++
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF--------------------EGQNFLSVVLRI 217
Query: 323 LQGQYPYKAAYQIAQLSL---KCLEAEPKHRPSMREVVE 358
++G P QL+ L +P RPS E++
Sbjct: 218 VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 23/236 (9%)
Query: 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--W-QSEVN-FLGRL 139
V+G G + KV L + + + A+K + E + E+ W Q+E + F
Sbjct: 1 RVIGRGSYAKVLLVELKK-------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS 53
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
+HP LV L + L V EF+ G L H+ + + A +I++ L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 109
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
FLH ++ +IYRD K N+LLD K++D+G+ K G T+ GT Y AP
Sbjct: 110 NFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAP 165
Query: 260 EYVATGHLYVKS-DVYGFGVVLVEILTGLRALD--TNRPSGQHNLVDWIKPYLSEK 312
E + G Y S D + GV++ E++ G D + N D++ + EK
Sbjct: 166 E-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 17/168 (10%)
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
ARG+ FL + K ++RD A N+LL KI DFGLA+ S
Sbjct: 247 ARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
+ APE + SDV+ +G++L EI + L P + F
Sbjct: 305 WMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDSTF 349
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ I + + P A ++ + +KC +EP+ RPS + + +E L
Sbjct: 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 51/260 (19%)
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELLLV--------YEFMQKGSLENHLFGRGASVQPL 183
E L ++HP+++R+ +V Y ++ K S +PL
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------------RPL 154
Query: 184 AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ 243
+ L I GL +LH +++I+RD K NI ++ I D G A+ P +
Sbjct: 155 PIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAP 211
Query: 244 SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG------ 297
+ + + GT APE +A K+D++ G+VL E+L + + PS
Sbjct: 212 AFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
Query: 298 --QHNLVDWIKPYLSEKRKFRHIIDARLQGQY---------PYKAAYQIAQLSL------ 340
+L+ I +F +RL + PY +++L
Sbjct: 270 SCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEF 329
Query: 341 ---KCLEAEPKHRPSMREVV 357
K L + RPS E++
Sbjct: 330 LVHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LG G G VF +D S +AVKK+ Q + E+ + RL H N+V
Sbjct: 13 LGCGSNGLVFSA-VD------SDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 146 RL--------------LGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWN-IRLK 190
++ +G E + +V E+M+ L N L PL+ RL
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-----EQGPLSEEHARL- 118
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGLAK-LGPSASQSHVTT 248
RGL ++H+++ V++RD K +N+ ++ KI DFGLA+ + P S +
Sbjct: 119 FMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 249 RVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ T Y +P + + + Y K+ D++ G + E+LTG
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 50/236 (21%)
Query: 69 TFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE 128
T E+ R+ K +G G +G V LD + +G +A+KKL +
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSA-LDRR------TGAKVAIKKL-------YRP 51
Query: 129 WQS---------EVNFLGRLSHPNLVRLLGYCWEDKEL------LLVYEFMQK--GSLEN 171
+QS E+ L + H N++ LL D L LV FM G L
Sbjct: 52 FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK 111
Query: 172 HLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231
H +Q L + + +GL ++H + +I+RD K N+ ++ KI D
Sbjct: 112 HEKLSEDRIQFLVYQM--------LKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILD 161
Query: 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
FGLA+ S +V TR Y APE + Y ++ D++ G ++ E+LTG
Sbjct: 162 FGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 8e-10
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSE 132
LR F+ ++G G +G+V+KG +G + A+K ++ + EE + E
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTGDEE-EEIKQE 52
Query: 133 VNFLGRLSH-PNLVRLLGYCWE------DKELLLVYEFMQKGSLENHLFGRGASVQPLAW 185
+N L + SH N+ G + D +L LV EF GS+ + + + W
Sbjct: 53 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 112
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQS 244
+ I RGL+ LH +VI+RD K N+LL + K+ DFG+ A+L + +
Sbjct: 113 IAYICREI--LRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168
Query: 245 HVTTRVMGTYGYAAPEYVATGH-----LYVKSDVYGFGVVLVEILTG 286
+ +GT + APE +A KSD++ G+ +E+ G
Sbjct: 169 NT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 46/179 (25%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 109 SGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGS 168
SG +AVK ++ Q E +EV + H N+V + +EL ++ EF+Q G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 169 LENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228
L + + + + +A + + L +LH+ + VI+RD K+ +ILL K
Sbjct: 105 LTDIVSQTRLNEEQIA-----TVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVK 157
Query: 229 ISDFGL-AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
+SDFG A++ + ++GT + APE ++ + D++ G++++E++ G
Sbjct: 158 LSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS--ESLQGFEEWQSEVNFLG 137
+++ + +G G +G V + D K +G +AVKKL+ +S+ + E+ L
Sbjct: 19 YQNLSPVGSGAYGSVCAAF-DTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGAS------------VQPLAW 185
+ H N++ LL + L E L HL G + VQ L +
Sbjct: 72 HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH 245
I RGL ++H++D +I+RD K SN+ ++ KI DFGLA+ +
Sbjct: 128 QI--------LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 177
Query: 246 VTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTG 286
V TR Y APE + H D++ G ++ E+LTG
Sbjct: 178 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 51/172 (29%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
A+G+ FL + ++ I+RD A NILL + KI DFGLA+
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
+ APE + ++SDV+ FGV+L EI + L + G + E+
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVK---------IDEEFCR 293
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL-ERLQAS 366
R R++ P ++ Q L C EP RP+ E+VE L LQA+
Sbjct: 294 RLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 50/289 (17%)
Query: 86 LGEGGFGKVFKGWL----DEKAPGKSGSGTV-IAVKKLNSE----SLQGFEEWQSEVNFL 136
LG G +++ G L D++ G S + + +K L+ SL FE + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET----ASMM 58
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
++SH ++V L G C D E ++V EF++ G L+ LF S L + K+A A
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKS-DVLTTPWKFKVAKQLA 115
Query: 197 RGLAFLHTSDKQVIYRDFKASNILL-----DGSYTA--KISDFGLAKLGPSASQSHVTTR 249
L++L DK +++ + NILL DG K+SD G+ S+ R
Sbjct: 116 SALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI--TVLSRQECVER 171
Query: 250 VMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ + APE V + +L + +D + FG L EI +G+ L D
Sbjct: 172 I----PWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KT 214
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
L+EK +F + + P + ++A L C+ +P RP R ++
Sbjct: 215 LAEKERF---YEGQCMLVTP--SCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/229 (26%), Positives = 112/229 (48%), Gaps = 39/229 (17%)
Query: 74 RAATRNFKSDTVLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSE 132
R+ +++K ++G G FG V++ +D + +A+KK+ LQ + E
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICID--------TSEKVAIKKV----LQDPQYKNRE 109
Query: 133 VNFLGRLSHPNLVRLLGY----CWEDKE----LLLVYEFMQKGSLENHL--FGRGASVQP 182
+ + L+H N++ L Y C++ E L +V EF+ + ++ ++ + R P
Sbjct: 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALP 168
Query: 183 LAWNIRLKI-AIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDFGLAK--LG 238
L +K+ + R LA++H+ K + +RD K N+L+D ++T K+ DFG AK L
Sbjct: 169 L---FLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223
Query: 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
S S++ +R Y APE + Y D++ G ++ E++ G
Sbjct: 224 GQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 48/227 (21%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEV---- 133
+ S +G G +G V +D++ +G +A+KKL+ +QSE+
Sbjct: 15 ERYTSLKQVGSGAYGSVCSA-IDKR------TGEKVAIKKLS-------RPFQSEIFAKR 60
Query: 134 -----NFLGRLSHPNLVRLL--------GYCWEDKELLLVYEFMQKGSLENHLFGRGASV 180
L + H N++ LL G ++D L++ Y + H V
Sbjct: 61 AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSE-DKV 119
Query: 181 QPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240
Q L + + GL ++H++ +I+RD K N+ ++ KI DFGLA+ +
Sbjct: 120 QYLVYQM--------LCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169
Query: 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+V TR Y APE + Y ++ D++ G ++ E+LTG
Sbjct: 170 EMTGYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 43/221 (19%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR------L 139
+G G FGKV L E + V+ K N+ S + + FL + L
Sbjct: 3 IGNGWFGKVL---LSEIYTDTGVARVVVKELKANASS-------KEQNEFLQQGDPYRIL 52
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL------FGRGASVQPLAWNIRLKIAI 193
HPN+++ LG C E LLV+E+ + G L+++L + ++A
Sbjct: 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL------LQRMAC 106
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA-SQSHVTT--RV 250
A G+ +H + ++ D N L T K+ D+G +GPS + ++ T
Sbjct: 107 EIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDK 161
Query: 251 MGTYGYAAPEYVATGHLYV-------KSDVYGFGVVLVEIL 284
+ APE V H + S+V+ GV L E+
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS--ESLQGFEEWQSEVNFLG 137
+K V+G+G +G V + + +G +A+KK+N E + E+ L
Sbjct: 2 YKIQEVIGKGSYGVVC-------SAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR 54
Query: 138 RLSHPNLVRLLGYCW-----EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
L HP++V + E K++ +V+E M+ S + + + P L
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHHQFFLYQL 112
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT-TRVM 251
+ R L ++HT++ V +RD K NIL + KI DFGLA++ + + + + T +
Sbjct: 113 L---RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 252 GTYGYAAPEYVATGHLYVKS----DVYGFGVVLVEILTG 286
T Y APE G + K D++ G + E+LTG
Sbjct: 168 ATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK---LGPSASQSHVTTRVMGT 253
GL ++H+++ V++RD K N+L++ KI DFGLA+ P + +T V T
Sbjct: 116 CGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172
Query: 254 YGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
Y APE + + Y K+ DV+ G +L E+L
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ------SE 132
++ +GEG +GKV+K +K GK ++A+KK E +E E
Sbjct: 2 AYEKLEKIGEGTYGKVYKA--RDKNTGK-----LVALKKTRLEM----DEEGIPPTALRE 50
Query: 133 VNFLGRLSH-PNLVRLLGYCWEDKE-------LLLVYEFMQ---KGSLENHLFGRGASVQ 181
++ L LS +VRLL E E L LV+E++ K ++++ GRG +
Sbjct: 51 ISLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN--GRGPG-R 105
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA-KISDFGLAKLG-- 238
PL +G+A H V++RD K N+L+D KI+D GL +
Sbjct: 106 PLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
P S +H T Y APE + Y D++ G + E+
Sbjct: 164 PVKSYTHEIV----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
RGL +LH++ +++RD K N+L++ + KI DFGLA++ H+T V+ Y Y
Sbjct: 114 RGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 257 AAPEYVATG--HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302
APE + G H D++ G + E+L P Q +L+
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
RGL ++H+++ V++RD K SN+LL+ + KI DFGLA+ S +T V+ T Y
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGDFMTEYVV-TRWY 174
Query: 257 AAPEYVATGHLYVKS-DVYGFGVVLVEILT 285
APE + Y + DV+ G + E+L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 39/236 (16%)
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
+ + ++SH +L + G C E ++V EF++ G L+ L V P+AW I +A
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKI--TVAQ 124
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILL------DGSYT-AKISDFGLAKLGPSASQSHV 246
A L++L DK +++ + A NILL +G+ K+SD G++ + S+
Sbjct: 125 QLASALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF--TALSREER 180
Query: 247 TTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEI-LTGLRALDTNRPSGQHNLVDW 304
R+ + APE V G L +D + FG L+EI G L PS
Sbjct: 181 VERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-------- 228
Query: 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
EK +F + + P + ++A L +CL EP RPS R ++ L
Sbjct: 229 ------EKERFY-----EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 65/231 (28%), Positives = 97/231 (41%), Gaps = 40/231 (17%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ- 130
+LR +F V+G G FG+V + S V A+K L+ FE +
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEV-------QLVRHKSSKQVYAMKLLSK-----FEMIKR 84
Query: 131 SEVNFLGR----LSHPN---LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPL 183
S+ F ++H N +V+L +DK L +V E+M G L N + P
Sbjct: 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPE 141
Query: 184 AWNI----RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239
W + +A+ A + F+H RD K N+LLD S K++DFG
Sbjct: 142 KWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMD 193
Query: 240 SASQSHVTTRVMGTYGYAAPEYVAT--GHLYV--KSDVYGFGVVLVEILTG 286
+ T V GT Y +PE + + G Y + D + GV L E+L G
Sbjct: 194 ANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 80/327 (24%), Positives = 125/327 (38%), Gaps = 84/327 (25%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE----EWQSEVNFLGRLSH 141
+G+GG G+V+ + D + +A+KK+ E L + E L H
Sbjct: 10 IGKGGMGEVYLAY-DPVCSRR------VALKKIR-EDLSENPLLKKRFLREAKIAADLIH 61
Query: 142 PNLVRLLGYCWEDKELLLVYEFM----------------QKGSLENHLFGRGASVQPLAW 185
P +V + C D + VY M QK SL L SV
Sbjct: 62 PGIVPVYSIC-SDGDP--VYYTMPYIEGYTLKSLLKSVWQKESLSKEL-AEKTSVGAF-- 115
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL-------- 237
L I + ++H+ K V++RD K NILL I D+G A
Sbjct: 116 ---LSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 238 --------GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRA 289
S + +++GT Y APE + +D+Y GV+L ++LT L
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSF 229
Query: 290 LDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAA-YQ-----IAQLSLKCL 343
PY ++K R I R P + A Y+ ++Q+++K L
Sbjct: 230 -----------------PY--RRKKGRKISY-RDVILSPIEVAPYREIPPFLSQIAMKAL 269
Query: 344 EAEPKHR-PSMREVVETLER-LQASDQ 368
+P R S++E+ + LE LQ S +
Sbjct: 270 AVDPAERYSSVQELKQDLEPHLQGSPE 296
|
Length = 932 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 38/226 (16%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE---WQSEVN 134
++F +++G G FG+V + EKA +G + A+K + L E ++ E +
Sbjct: 1 KDFDVKSLVGRGHFGEV--QVVREKA-----TGDIYAMKVMKKSVLLAQETVSFFEEERD 53
Query: 135 FLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHL------FGRGASVQPLAWNI 187
L + P + +L Y ++DK+ L LV E+ G L + L F + LA
Sbjct: 54 ILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA--- 109
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG-LAKLGPSASQSHV 246
L +AI + + ++H RD K N+L+D + K++DFG A+L +A++
Sbjct: 110 ELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSAARL--TANKMVN 159
Query: 247 TTRVMGTYGYAAPEYVATGHLYVKS------DVYGFGVVLVEILTG 286
+ +GT Y APE + T + K D + GV+ E++ G
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 131 SEVNFLGRLSHPNLVRLL-GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL 189
E++ L +SH ++ L+ Y W+ V M K + LF PL +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKS----TVCMVMPKYKCD--LFTYVDRSGPLPLEQAI 188
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTT 248
I LA+LH + +I+RD K NI LD A + DFG A KL
Sbjct: 189 TIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEIL 284
GT +PE +A K+D++ G+VL E+
Sbjct: 247 WS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 24/222 (10%)
Query: 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSE 132
L+ ++ V+G G FG+V + K+ K + +++ ++ S F W+ E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEV--QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF-WE-E 93
Query: 133 VNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAW----NIR 188
+ + + P +V+L +DK L +V E+M G L N + P W
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV---PEKWAKFYTAE 150
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
+ +A+ A + +H RD K N+LLD K++DFG T
Sbjct: 151 VVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 249 RVMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLVEILTG 286
V GT Y +PE + + G+ + D + GV L E+L G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS 131
+LR +++ V+G G FG+V + K+ K + +++ ++ S F W+
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF-WE- 92
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAW----NI 187
E + + + P +V+L +D+ L +V E+M G L N + P W
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV---PEKWARFYTA 149
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT 247
+ +A+ A + F+H RD K N+LLD S K++DFG
Sbjct: 150 EVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201
Query: 248 TRVMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLVEILTG 286
T V GT Y +PE + + G+ + D + GV L E+L G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 66/250 (26%), Positives = 97/250 (38%), Gaps = 63/250 (25%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE-----EWQSE 132
++FK +LG+G G+VF L G+G + A+K L+ + + + E
Sbjct: 1 KHFKKIKLLGKGDVGRVF---LVRL----KGTGKLFALKVLDKKEMIKRNKVKRVLTEQE 53
Query: 133 VNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
+ L L HP L L + L LV ++ G L L R QP L
Sbjct: 54 I--LATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR----QPGK---CLSEE 103
Query: 193 IGAAR--------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL------- 237
+ AR L +LH ++YRD K NILL S +SDF L+K
Sbjct: 104 V--ARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
Query: 238 ----------GPSASQSHVTTRV----------MGTYGYAAPEYVATGHLYVKS-DVYGF 276
S + T +GT Y APE V +G + + D +
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTL 218
Query: 277 GVVLVEILTG 286
G++L E+L G
Sbjct: 219 GILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 41/241 (17%)
Query: 130 QSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSL--------ENHLFGRGASVQ 181
+SE++ L H +V+ D +LLL+ E+ G L + HL + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241
L + I L A +++++RD K++NI L + K+ DFG +K +
Sbjct: 173 LLFYQIVL----------ALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301
V + GT Y APE K+D++ GV+L E+LT R PS
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG--PSQ---- 276
Query: 302 VDWIKPYLSEKRKFRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
R I+ L G+Y P + + L L P RP+ ++++
Sbjct: 277 --------------REIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322
Query: 359 T 359
T
Sbjct: 323 T 323
|
Length = 478 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS--ESLQGFEEWQSEVNFLGRLSH 141
T +G G +G V + D + K +AVKKL+ +SL E+ L + H
Sbjct: 21 TPVGSGAYGSVCSAY-DTRLRQK------VAVKKLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 142 PNLVRLL-----GYCWED-KELLLVYEFMQKGSLENHLFGRGAS---VQPLAWNIRLKIA 192
N++ LL E+ E+ LV M L N + + S VQ L + +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQL----- 127
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
RGL ++H++ +I+RD K SN+ ++ +I DFGLA+ +V TR
Sbjct: 128 ---LRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR--- 179
Query: 253 TYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
Y APE + Y ++ D++ G ++ E+L G
Sbjct: 180 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 17/168 (10%)
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
A G+ FL + K ++RD A N+L+ KI DFGLA+ S
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
+ APE + SDV+ FG++L EI T L P L +F
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFT---------------LGGTPYPELPMNEQF 351
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ I + P A+ +I ++ KC E + + RP ++V + L
Sbjct: 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 23/172 (13%)
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQPLAWNIRLKIAIGAARGL 199
PN+V L Y + + LV + + G L +H+ F W + +A+ A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG-LAKLGPSASQSHVTTRVMGTYGYAA 258
LH + ++ RD +NILLD +++ F +++ S V Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG-----QHNLVDWI 305
PE D + G +L E+LTG + L PSG N+ +W+
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
G+ LH++ +I+RD K SNI++ T KI DFGLA+ +A + + T + T Y
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTG 286
APE + D++ G ++ E++ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 66/256 (25%), Positives = 104/256 (40%), Gaps = 70/256 (27%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ-----SEV 133
+F+S V+G G FG+V + K +G + A+KKL + E+ Q +E
Sbjct: 2 DFESIKVIGRGAFGEV-------RLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAER 52
Query: 134 NFLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHL-----FGRGASVQPLAWNI 187
+ L +P +V+L Y ++D+ L L+ E++ G + L F + +A I
Sbjct: 53 DILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI 111
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL------------- 234
+AI + L ++H RD K N+LLD K+SDFGL
Sbjct: 112 ---LAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160
Query: 235 ---AKLGPSASQSHVTT---------------RVM-----GTYGYAAPEYVATGHLYVKS 271
+ PS ++ R + GT Y APE V Y K
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKE 219
Query: 272 -DVYGFGVVLVEILTG 286
D + GV++ E+L G
Sbjct: 220 CDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQ-SEVNFLGRLSHP 142
V+GEG +G V K E + ++A+KK +SE + +E E+ L L
Sbjct: 8 VVGEGAYGVVLKCRHKE-------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLEN-HLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
N+V L +L LV+E+++K LE G + + I I + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI-----KAIHW 115
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
H +D +++RD K N+L+ + K+ DFG A+ S ++ T V T Y +PE
Sbjct: 116 CHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPEL 172
Query: 262 VATGHLYVKS-DVYGFGVVLVEILTG 286
+ G Y K+ D++ G +L E+ G
Sbjct: 173 L-LGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 86 LGEGGFGKVFK-----GWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS 140
+G G +G V+K G D K GT I++ E+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR------------EIALLRELK 56
Query: 141 HPNLVRL--LGYCWEDKELLLVYEFMQKGSLENHLFGRG--ASVQP--LAWNIRLKIAIG 194
HPN++ L + D+++ L++++ + F R A+ +P L + +
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYT----AKISDFGLAKLGPSASQSHVTTR- 249
G+ +LH + V++RD K +NIL+ G KI+D G A+L S +
Sbjct: 117 ILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILT 285
V+ T+ Y APE + Y K+ D++ G + E+LT
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 32/246 (13%)
Query: 131 SEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK 190
+E + L ++HP++++L G +K L+ + L+ A+ + +A L
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNIAICDILA 186
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
I R + +LH + ++I+RD KA NI ++ + DFG A + +
Sbjct: 187 IERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRA------LDTN----------- 293
GT APE +A D++ G+VL E+ T + LD +
Sbjct: 245 -GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIID--ARLQGQYP-----YKAAYQIAQLSLKCLEAE 346
R SG H I + + + +R G P Y+ + L K L +
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363
Query: 347 PKHRPS 352
HRPS
Sbjct: 364 AHHRPS 369
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
G+ LH++ +I+RD K SNI++ T KI DFGLA+ +A S + T + T Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTG 286
APE + D++ G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 86 LGEGGFGKVFKGWL----DEKAPG-KSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS 140
+G G +G V+K DEK K GT I++ E+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR------------EIALLRELK 56
Query: 141 HPNLVRL--LGYCWEDKELLLVYEFMQKGSLENHLFGRG--ASVQP--LAWNIRLKIAIG 194
HPN++ L + D+++ L++++ + F R A+ +P L ++ +
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYT----AKISDFGLAKLGPSASQSHVTTR- 249
G+ +LH + V++RD K +NIL+ G KI+D G A+L S +
Sbjct: 117 ILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILT 285
V+ T+ Y APE + Y K+ D++ G + E+LT
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 37/161 (22%)
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
G+ LH++ +I+RD K SNI++ T KI DFGLA+ +A S + T + T Y
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
APE + D++ G ++ E++ +H ++ + Y+ + K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV-------------RHKILFPGRDYIDQWNKV-- 230
Query: 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
I QL C E K +P++R VE
Sbjct: 231 -----------------IEQLGTPCPEFMKKLQPTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
G+ LH++ +I+RD K SNI++ T KI DFGLA+ +A S + T + T Y
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 258 APEYVATGHLYVKS-DVYGFGVVLVEILTG 286
APE V G Y ++ D++ G ++ E++ G
Sbjct: 185 APE-VILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 57/248 (22%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE---WQSEVNF 135
+F+S V+G G FG+V + K +G + A+K L + E+ ++E +
Sbjct: 2 DFESLKVIGRGAFGEV-------RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI 54
Query: 136 LGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGA-SVQPLAWNIRLKI-A 192
L +V++ Y ++DK L L+ EF+ G + L + S + + I + A
Sbjct: 55 LVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA 113
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS-------- 244
I A L F+H RD K N+LLD K+SDFGL A ++
Sbjct: 114 IDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 245 -------------------------HVTTRVMGTYGYAAPE-YVATGHLYVKSDVYGFGV 278
+ +GT Y APE ++ TG+ + D + GV
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGV 224
Query: 279 VLVEILTG 286
++ E+L G
Sbjct: 225 IMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 32/194 (16%)
Query: 114 AVKKLNSESL-------QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQK 166
A+KK+N ++L Q F E + L +P +V + + L +V E+++
Sbjct: 30 AMKKINKQNLILRNQIQQVF----VERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85
Query: 167 GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226
G L GA +A R+ A L +LH +++RD K N+L+
Sbjct: 86 GDCATLLKNIGALPVDMA---RMYFA-ETVLALEYLHNYG--IVHRDLKPDNLLITSMGH 139
Query: 227 AKISDFGLAKLG-------------PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-D 272
K++DFGL+K+G ++ + +V GT Y APE V Y K D
Sbjct: 140 IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE-VILRQGYGKPVD 198
Query: 273 VYGFGVVLVEILTG 286
+ G++L E L G
Sbjct: 199 WWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 63/274 (22%), Positives = 105/274 (38%), Gaps = 66/274 (24%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFL 136
F +G G FG+V L K + + A+K L + ++E + L
Sbjct: 3 FVKIKTIGIGAFGEV---CLVRKVDTNA----LYAMKTLRKADVLMRNQAAHVKAERDIL 55
Query: 137 GRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLA--WNIRLKIAI 193
+ +V+L Y ++DK+ L V +++ G + + L G + LA + L AI
Sbjct: 56 AEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAI 114
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA------------------ 235
+ + F+H RD K NIL+D K++DFGL
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 236 ---KLGPSASQSHVTTRVM--------------------GTYGYAAPEYVA-TGHLYVKS 271
+ PS S + + GT Y APE + TG+ +
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-C 225
Query: 272 DVYGFGVVLVEILTGLRALDTNRPSG-QHNLVDW 304
D + GV+L E+L G + P+ Q +++W
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 50/229 (21%)
Query: 86 LGEGGFGKVF-------------KGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSE 132
L G FGK+F + ++ GK +IA + E +E
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE--NE 213
Query: 133 VNFLGRLSHPNLVRL---LGYCWEDKELLL-------VYEFMQKGSLENHLFGRGASVQP 182
+ LGRL+H N++++ L E ++ +Y FM + + +P
Sbjct: 214 ILALGRLNHENILKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFD-------WKDRP 264
Query: 183 LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242
L R I + ++H DK++I+RD K NI L+ + DFG A
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTA------- 314
Query: 243 QSHVTTRVMGTYGYA------APEYVATGHLYVKSDVYGFGVVLVEILT 285
R YG+ +PE +A +D++ G++L+++L+
Sbjct: 315 MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 62/267 (23%), Positives = 107/267 (40%), Gaps = 58/267 (21%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE---WQSEVNF 135
+F+S V+G G FG+V + K +G V A+K L + E+ ++E +
Sbjct: 2 DFESLKVIGRGAFGEV-------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI 54
Query: 136 LGRLSHPNLVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGASVQPLA--WNIRLKIA 192
L +V++ Y ++DK L L+ EF+ G + L + + + +A
Sbjct: 55 LVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA 113
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS-------- 244
I + L F+H RD K N+LLD K+SDFGL A ++
Sbjct: 114 IDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165
Query: 245 -------------------------HVTTRVMGTYGYAAPE-YVATGHLYVKSDVYGFGV 278
+ +GT Y APE ++ TG+ + D + GV
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGV 224
Query: 279 VLVEILTGLRALDTNRPSGQH-NLVDW 304
++ E+L G + P + +++W
Sbjct: 225 IMYEMLIGYPPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 32/168 (19%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ-----SEV 133
+F + V+G+G FG+V + K +G + A+K L + F++ Q +E
Sbjct: 2 DFHTVKVIGKGAFGEV-------RLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAER 52
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELL-LVYEFMQKGSLENHL-----FGRGASVQPLAWNI 187
+ L P +V L Y ++D + L L+ EF+ G L L F + +A +
Sbjct: 53 DVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235
+AI A L F+H RD K NIL+D K+SDFGL+
Sbjct: 112 ---LAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 4/97 (4%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLG 137
N + LG G FGKV + GK + +AVK L + + E SE+ L
Sbjct: 39 NLQFGKTLGAGAFGKVVEA--TAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS 96
Query: 138 RL-SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL 173
L H N+V LLG C +L++ E+ G L N L
Sbjct: 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 29/181 (16%)
Query: 132 EVNFLGRLSHPNLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL 189
EVN + L H N+VR + +++L ++ EF G L ++ + + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 190 KIAIGAARGLAFLHT-----SDKQVIYRDFKASNILL-----------------DGSYTA 227
I LA+ H + ++V++RD K NI L +G A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV--ATGHLYVKSDVYGFGVVLVEILT 285
KI DFGL+K S +H +GT Y +PE + T KSD++ G ++ E+ +
Sbjct: 182 KIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 286 G 286
G
Sbjct: 239 G 239
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 16/152 (10%)
Query: 89 GGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLV 145
G FGKV+ G K + + AVK + + + Q+E + L P +V
Sbjct: 15 GAFGKVYLGR-------KKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205
L + LV E++ G +++ L G + +A +K A L +LH
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLHRH 123
Query: 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237
+I+RD K N+L+ K++DFGL+K+
Sbjct: 124 G--IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLS-HP 142
LG G FGKV + KS S +AVK L + ++ +E+ L + H
Sbjct: 14 PLGRGAFGKVIQA--SAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHL 71
Query: 143 NLVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGR 176
N+V LLG C + L+++ E+ + G+L N+L +
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 27/194 (13%)
Query: 109 SGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQK 166
+GT++ V+ + E+ + + Q+EV HPN++ L ++ FM
Sbjct: 24 TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 167 GSLENHL----FGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222
GS N L F G S + L NI GA RGL +LH + I+R+ KAS+IL+
Sbjct: 84 GS-ANSLLKTYFPEGMS-EALIGNI----LFGALRGLNYLHQNG--YIHRNIKASHILIS 135
Query: 223 GSYTAKISD----FGLAKLGPSASQSH----VTTRVMGTYGYAAPEYVATG-HLY-VKSD 272
G +S + L + G A + +T V+ + +PE + + Y VKSD
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGYNVKSD 192
Query: 273 VYGFGVVLVEILTG 286
+Y G+ E+ TG
Sbjct: 193 IYSVGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 58/255 (22%), Positives = 101/255 (39%), Gaps = 62/255 (24%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS 131
++ +T+ FK ++LGEG FGKV + W D K V V K ++ +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAW-DRKRKEYCAVKIVRNVPKYTRDA-------KI 174
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGASVQP------LA 184
E+ F+ ++ + D+ L+ + + Q + G V P L
Sbjct: 175 EIQFMEKVRQADP--------ADRFPLMKIQRYFQNET------GHMCIVMPKYGPCLLD 220
Query: 185 WNIR---------LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA-------- 227
W ++ +I L + HT + +++ D K NIL++ S T
Sbjct: 221 WIMKHGPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDTVVDPVTNRA 279
Query: 228 --------KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV-ATGHLYVKSDVYGFGV 278
+I D LG + H T ++ T Y +PE V G +Y +D++ G
Sbjct: 280 LPPDPCRVRICD-----LGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMY-STDMWSMGC 333
Query: 279 VLVEILTGLRALDTN 293
++ E+ TG DT+
Sbjct: 334 IIYELYTGKLLYDTH 348
|
Length = 467 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 35/93 (37%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 85 VLGEGGFGKVFKGWLDEKAPG--KSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLGRL-S 140
LG G FGKV ++ A G KS + +AVK L S L E SE+ L L +
Sbjct: 42 TLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 97
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL 173
H N+V LLG C L++ E+ G L N L
Sbjct: 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFL 136
F LG G FG+V K + + A+K L + + ++E + L
Sbjct: 3 FVKIKTLGIGAFGEVC-------LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL 55
Query: 137 GRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLA--WNIRLKIAI 193
+ +VRL Y ++DK+ L V +++ G + + L G + LA + L A+
Sbjct: 56 AEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
+ + F+H RD K NIL+D K++DFGL
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
E L RLSHP ++ LL LV + L +L GA ++PL ++
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYL---GARLRPLG---LAQV 262
Query: 192 AIGAARGL--AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
AR L A + + +I+RD K N+L++G + DFG A + +
Sbjct: 263 T-AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVE 282
+ GT APE +A G Y S D++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 413 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.39 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.0 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.49 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.45 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.16 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.07 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.01 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.9 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.78 | |
| PLN02236 | 344 | choline kinase | 97.67 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.63 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.49 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.48 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.16 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.99 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.96 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.88 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.8 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.78 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.49 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.42 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.23 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.19 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.11 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-54 Score=386.03 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=216.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
.+.+.++.||+|..|+||++.+.. +++.+|+|++... .....+++.+|+++++..+||+||.+|+.|..+.
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~-------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP-------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 345667899999999999997654 7899999999554 3345678999999999999999999999999998
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.++|+||||+||+|++++...+ .+++.....++.+|++||.|||. .++||||||||+|||++..|+|||||||.+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEecccccc
Confidence 5999999999999999996553 79999999999999999999995 367999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+.. ... -..+
T Consensus 227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~----------~~Ll 291 (364)
T KOG0581|consen 227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDI----------FELL 291 (364)
T ss_pred HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCH----------HHHH
Confidence 864333 5567899999999999999999999999999999999999999998752111 001 1112
Q ss_pred hHhHHhhhcCCCchH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYK-AAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
..+++.. ...+|.. +++++++||..||++||.+||++.|+++|-.-..
T Consensus 292 ~~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 292 CAIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred HHHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 2222211 2234454 8999999999999999999999999999877544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=404.65 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=217.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.+|...+.||+|+|+.||.++... +++.||+|++.+. .....+++.+||+|.+.|+|||||+++++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence 579999999999999999996533 7899999999764 234567899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+++|||+|+|..++|..++..++ ++++..++.+++||+.||.|||+ .+|+|||||..|+|++++.+|||+|||+
T Consensus 91 ~nVYivLELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred CceEEEEEecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccce
Confidence 99999999999999999996443 89999999999999999999997 5599999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
|..... ..+...+.||||.|.|||++....++..+||||+||+||.||+|++||+..+
T Consensus 165 At~le~--~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------------------- 222 (592)
T KOG0575|consen 165 ATQLEY--DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------------------- 222 (592)
T ss_pred eeeecC--cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------------------
Confidence 997543 3344566899999999999999999999999999999999999999998752
Q ss_pred hhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
++........ ..+|..++.++.+||.++|+.||.+|||+++|+.+-..
T Consensus 223 vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 223 VKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 2222222222 24567889999999999999999999999999987554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=385.60 Aligned_cols=251 Identities=29% Similarity=0.463 Sum_probs=209.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..+|.+.+.||.|+||+||+|++.. ++..||||.+.+. ..+..+.+..|+.+|+.++|||||.++++++.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~-------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK-------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc-------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 3578999999999999999997765 5689999999877 556677789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC------CCeE
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS------YTAK 228 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~------~~~k 228 (413)
+.+|||||||.||+|.+|++.++ .+++..++.++.||+.||++||+ ++||||||||+||||+.. -.+|
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEE
Confidence 99999999999999999998776 78999999999999999999996 779999999999999754 4689
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|+|||+|+... ........+|++.|||||+++.+.|+.|+|+||+|+|+|+|++|+.||+...+.+.....
T Consensus 156 IADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~------ 226 (429)
T KOG0595|consen 156 IADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI------ 226 (429)
T ss_pred ecccchhhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------
Confidence 99999999744 444566789999999999999999999999999999999999999999876543211100
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
.. ........+...+..+.+|+...|..++.+|.+..+.+.
T Consensus 227 -~k--------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 227 -KK--------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred -hc--------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 00 011112233445556778888888888888887766654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-54 Score=387.86 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=209.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-------hHHHHHHHHHHHhhccCCCccceE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-------GFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
....|.+.+.||+|+||.|-+|+... +++.||||++++.... ....+.+|++||++|+|||||+++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~-------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK-------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc-------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 45679999999999999999996544 7999999999765321 122367999999999999999999
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---C
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS---Y 225 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~---~ 225 (413)
++|+..+..||||||++||+|.+.+...+ .+.+..-..+++|++.||.|||+ +||+||||||+|||+..+ .
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcce
Confidence 99999999999999999999999996554 56777778899999999999997 679999999999999765 7
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCc---cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL---YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
.+||+|||+|+... .......+|||+.|.|||++.+..+ ..++|||||||+||-+++|.+||........
T Consensus 317 llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---- 389 (475)
T KOG0615|consen 317 LLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---- 389 (475)
T ss_pred EEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----
Confidence 89999999999743 4556677999999999999977543 3588999999999999999999976532210
Q ss_pred HhhhhhhhhhhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
-.+.+....+. ......++.+..+||.+||..||++|||+.|+|+|-|.-
T Consensus 390 -----------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 390 -----------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred -----------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 00111111111 122346788999999999999999999999999998853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=373.29 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=212.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEe-EEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLG-YCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~ 153 (413)
...|++++.||+|+||.||++.+.. +++.||.|.++-... ...+.+..|+.+|++|+|||||++++ .|.+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~-------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLL-------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeecc-------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 3468899999999999999996543 789999999875533 44567889999999999999999998 4555
Q ss_pred CCe-eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhc--CCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 154 DKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT--SDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 154 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
+.. ++||||||.+|+|..++.......+.+++..+|+++.|++.||..||+ ...-|+||||||.||+++.+|.+||+
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 554 999999999999999998777777789999999999999999999997 33448999999999999999999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||+++.... .......++|||.||+||.+.+..|+.++|||||||++|||+.-.+||.+.+-
T Consensus 171 DfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------------- 233 (375)
T KOG0591|consen 171 DFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------------- 233 (375)
T ss_pred cchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---------------
Confidence 9999997533 33345568999999999999999999999999999999999999999987621
Q ss_pred hhhhhhHhHHhhhcCCC---c-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQY---P-YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~---~-~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+..+.-++++ | ...+.++..||..|+..||..||+.-.++..+.
T Consensus 234 -----~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 234 -----LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 112222222333 3 678999999999999999999998554444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=388.85 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=219.4
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEe
Q 015094 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLG 149 (413)
Q Consensus 74 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~ 149 (413)
.....+|.+++.||+|+|++|++|+... +++.||||++.+.- ....+.+.+|-.+|.+| .||.|++|+.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~-------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~ 141 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA-------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF 141 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC-------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE
Confidence 3455789999999999999999996443 78999999987652 22344577888999999 6999999999
Q ss_pred EEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 150 YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
.|.++..+|+|+||+++|+|.++|.+.+ .+.+..++.++.+|+.||+|||+ +|||||||||+|||++.++.++|
T Consensus 142 TFQD~~sLYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 142 TFQDEESLYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred EeecccceEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEE
Confidence 9999999999999999999999998776 78999999999999999999996 67999999999999999999999
Q ss_pred ccCCCcccCCCCCCc---------ce--eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 015094 230 SDFGLAKLGPSASQS---------HV--TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ 298 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~ 298 (413)
+|||-|+........ .. ...++||..|.+||++.....++.+||||||||||+|+.|.+||...++.
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-- 293 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-- 293 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--
Confidence 999999875432222 11 24589999999999999999999999999999999999999999987432
Q ss_pred chhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 299 HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..|+.++. +...++..+++.+.+||+++|..||.+|+|+++|.+|.
T Consensus 294 --------------liFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 --------------LIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred --------------HHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 23444443 34467788889999999999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=377.47 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=211.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|+++++||+|+||+||.++.. .+++.||+|++++... ...+....|..||..++||+||+++..|++
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~-------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKK-------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEc-------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 357999999999999999999543 4889999999987643 345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+|+||+.||.|...|++.+ .+++..+..++..|+.||.|||+ +|||||||||+|||++.+|.++|+|||
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccc
Confidence 999999999999999999997665 78999999999999999999997 679999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+++... ..+..+..++||+.|||||++.+..|+..+|+|||||++|+|++|.+||...+...
T Consensus 171 L~k~~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~---------------- 232 (357)
T KOG0598|consen 171 LCKEDL--KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK---------------- 232 (357)
T ss_pred cchhcc--cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH----------------
Confidence 998532 23334556899999999999999999999999999999999999999998764221
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP----SMREVVE 358 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp----t~~e~l~ 358 (413)
....+.... ....+...+.+.++|++++|..||++|. ++.+|.+
T Consensus 233 ~~~~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 233 MYDKILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 111222211 2234555889999999999999999996 5555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=364.20 Aligned_cols=266 Identities=25% Similarity=0.358 Sum_probs=209.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|+.+..+|+|+||+||+|+++ .+|+.||||++.... ....+-..|||++|++|+|+|+|.++++|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 46888889999999999999544 489999999986442 233445789999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++|+|||+. ++.+-+... ...++...+.++++|++.|+.|||+ +++|||||||+||||+.+|.+||||||+|
T Consensus 75 klhLVFE~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 75 KLHLVFEYCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred eeEEEeeecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhh
Confidence 99999999987 555555433 3468899999999999999999997 55999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-h------
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK-P------ 307 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~-~------ 307 (413)
+.... .+...+.++.|.||+|||++.+ ..|+..+||||+||++.||++|.+.|++....++...+.... .
T Consensus 149 R~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 149 RTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred HhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 97543 3344566889999999999988 789999999999999999999999999987766654432221 1
Q ss_pred -hhhhhhhhhHhHHhh------hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 308 -YLSEKRKFRHIIDAR------LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 308 -~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+..+..|..+.-+. +...+| ..+.-+.+|+++||..||.+|++.++++.|
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111111000 011111 445678999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=371.93 Aligned_cols=258 Identities=35% Similarity=0.570 Sum_probs=216.6
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeE-EEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTV-IAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~-vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
..+.+.||.|+||+||+|.|.. +. ||||++..... ...+.|.+|+.+|.+|+|||||++++++.+..
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g---------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRG---------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCC---------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4455669999999999998863 45 99999976532 22568999999999999999999999999887
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCCCcEEEcCCC-CeEEccCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQ-VIYRDFKASNILLDGSY-TAKISDFG 233 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~-ivHrDlkp~Nil~~~~~-~~kl~DfG 233 (413)
.+++||||+++|+|.+++... ....++...++.++.||++||.|||+ ++ ||||||||+|||++.++ .+||+|||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 799999999999999999764 34589999999999999999999997 55 99999999999999997 99999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccc--cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVA--TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
+++...... ...+...||..|||||++. ...|+.++||||||+++|||+||..||.......
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-------------- 253 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-------------- 253 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--------------
Confidence 998633221 2233468999999999998 5699999999999999999999999998865411
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
....+.....+..++..++..+..|+.+||..||..||++.+++..|+.+.....
T Consensus 254 --~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 254 --VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred --HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1122333444556666789999999999999999999999999999999877543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=369.48 Aligned_cols=290 Identities=57% Similarity=0.987 Sum_probs=247.0
Q ss_pred CcccccHHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC
Q 015094 64 NLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN 143 (413)
Q Consensus 64 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 143 (413)
....+++.++..++++|.-..+||+|+||.||+|.... ++.||||++.........+|.+|+.+|.+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~--------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~N 132 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD--------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPN 132 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC--------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcC
Confidence 57789999999999999999999999999999997653 4889999887765431345999999999999999
Q ss_pred ccceEeEEEeCC-eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC-CCCeeeCCCCCCcEEE
Q 015094 144 LVRLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS-DKQVIYRDFKASNILL 221 (413)
Q Consensus 144 i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~ivHrDlkp~Nil~ 221 (413)
+|+++|||.+.+ ..+||+||+..|+|.+++...... +++|..+++|+.++++||+|||.. ...|||||||+.|||+
T Consensus 133 lv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 133 LVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred cccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 999999999998 599999999999999999765443 889999999999999999999973 2369999999999999
Q ss_pred cCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 222 DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
|++.+.||+|||+|+..... .........||.+|+|||++..+..+.++||||||++|.||++|+.+.+...+......
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999999764331 11111111799999999999999999999999999999999999999987766666667
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhc-CCCch-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQ-GQYPY-KAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
.+|..+.+.+. .+..+++..+. ..++. .....+..+..+|++.+|.+||++.+|++.|+.+..
T Consensus 290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88887766655 77888888876 56654 566779999999999999999999999999866553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=377.57 Aligned_cols=268 Identities=25% Similarity=0.357 Sum_probs=213.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHH--HHHHHHHHhhcc-CCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--WQSEVNFLGRLS-HPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~E~~~l~~l~-h~~i~~~~~~~~ 152 (413)
..++|.+++.||.|+||.||+|+-.+ +++.||||.++..-.. .++ -.||++.|++|+ |||||++.+++.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~-------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE-------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC-------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 44689999999999999999996544 6788999998765322 222 358999999999 999999999999
Q ss_pred eCC-eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 153 EDK-ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 153 ~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
+.+ .+|+|||||+. +|.+++..+ ...+++..+..|+.||++||+|+|. +|+.||||||+|||+.....+||+|
T Consensus 80 d~~~~L~fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 80 DNDRILYFVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred ccCceEeeeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecc
Confidence 887 99999999955 999999766 4589999999999999999999996 6699999999999999888999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh-
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL- 309 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~- 309 (413)
||+|+.. ......+.++.|.||+|||++.. ..|+.++||||+|||++|+.+-++.|.+.++.++...+-.+....
T Consensus 154 FGLARev---~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 154 FGLAREV---RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred ccccccc---ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 9999963 33334567899999999998854 678899999999999999999999999988776654432221110
Q ss_pred ----hhhhhhhHhHHhhhc--------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 310 ----SEKRKFRHIIDARLQ--------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 310 ----~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+...+...+.-.+. ..++ .++.++.+||.+||.+||.+||||.+++++--
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 111111111111111 1122 47889999999999999999999999998643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=348.46 Aligned_cols=238 Identities=29% Similarity=0.446 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++++.||.|+||+|.+++.+. ++..||+|++++... ...+...+|..+|+.+.||+++++++.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~-------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH-------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc-------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 3578999999999999999996554 689999999987744 345567789999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+||||||+.||.|..++++.+ ++++..++.++.||+.||+|||+ ++|++|||||+|||+|.+|.+||+|||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEecc
Confidence 999999999999999999997665 78999999999999999999997 559999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+|+.... .+...|||+.|+|||++....|+.++|+|||||++|||+.|.+||...++. .
T Consensus 190 FAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~ 248 (355)
T KOG0616|consen 190 FAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------Q 248 (355)
T ss_pred ceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------H
Confidence 9986322 255689999999999999999999999999999999999999999887542 1
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~R 350 (413)
.+..|+...+ .+|..++.++++||.++|+.|-.+|
T Consensus 249 iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 IYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2333333322 4788899999999999999999999
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=342.81 Aligned_cols=268 Identities=25% Similarity=0.338 Sum_probs=213.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh--HHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.+|...+.||+|.||.||+|++.+ +++.||||+++.....+ -....|||+.|+.++|+||+.++++|.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~-------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE-------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC-------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence 478889999999999999997654 78999999998664332 245789999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+.||+||++. +|+..+.... ..++...+..++.++++||+|||+ +.|+||||||+|+|++.+|.+||+|||+|
T Consensus 75 ~l~lVfEfm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 75 NLSLVFEFMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred ceEEEEEeccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccch
Confidence 99999999965 9999996543 478999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------h
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--------K 306 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~--------~ 306 (413)
+.+....... +..+-|.+|+|||++.| ..|+..+||||.|||+.||+.|.+.|.+....++...+-.. +
T Consensus 149 r~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 9865443332 23378999999999877 57899999999999999999999999988776655443221 1
Q ss_pred hhhhhhhhhhHh---HHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 PYLSEKRKFRHI---IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
|-+..-.++..+ ....... +-..++.++.+|+.+||..||.+|+++.|++++-.
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred ccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 111111111111 1111111 22356677899999999999999999999998644
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=379.07 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=221.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
+-|++++.||.|+-|.|-+|++.. +|+.+|||++.+.. ......+.+||-||+.+.||||+++|+++++.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~-------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~ 84 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE-------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK 84 (786)
T ss_pred cceeccccccCCCCceehhhhccc-------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC
Confidence 358999999999999999996544 89999999997662 22345689999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
.++|+|+||++||.|++++..++ ++++..+..+++||+.|+.|||.. +|+||||||+|+|++..+++||+|||+
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~--~icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF--NICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh--cceeccCCchhhhhhcccCEeeeccce
Confidence 99999999999999999997776 899999999999999999999984 499999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCcc-chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
|.. ...+....+.||++.|.|||++.|..|+ .++||||.|||||.||+|..||+..
T Consensus 159 AsL---e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------------------- 215 (786)
T KOG0588|consen 159 ASL---EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------------------- 215 (786)
T ss_pred eec---ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------------------
Confidence 986 4444555667999999999999999996 8999999999999999999999864
Q ss_pred hhhHhHHhhhcCC--CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 314 KFRHIIDARLQGQ--YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 314 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
+++.++.+..++. .|..++.++.+||.+||..||++|.|++||++|.+....
T Consensus 216 Nir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 216 NIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred cHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 2344455555544 467899999999999999999999999999999887553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=369.65 Aligned_cols=268 Identities=25% Similarity=0.339 Sum_probs=211.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
...|+.+++||+|+||.||+|+.. .+++.||+|++..+. .....-..|||.||++|+||||+++.+...+.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~-------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDL-------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeec-------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 356888899999999999999644 489999999987665 34455678999999999999999999988876
Q ss_pred --CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 155 --KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 155 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
..+|||+|||+. +|.-++...+ -.+++.++..+++||+.||+|||+ +||+|||||..||||+.+|.+||+||
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccc
Confidence 689999999977 9988885433 379999999999999999999996 77999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
|+|+++...... ..+..+-|.||+|||++.|. .|+.++|+||+||||.||++|++.|.+..+..+...+-.+-....+
T Consensus 263 GLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 263 GLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred cceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 999976544332 24556789999999999884 7899999999999999999999999998776655443221100000
Q ss_pred ----hhhhhHh--H------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 ----KRKFRHI--I------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 ----~~~~~~~--~------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..++... + ...+... -..++....+|+..||..||.+|.||.++|+.
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0011100 0 0000000 12456678899999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=371.27 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=214.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc----Ch-hhHHHHHHHHHHHhhcc-CCCccceEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE----SL-QGFEEWQSEVNFLGRLS-HPNLVRLLG 149 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~ 149 (413)
..++|++.+.||+|+||+|++|++.. ++..||+|+++.. .. ...+.+.+|+.+++.+. ||||+++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~-------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e 87 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL-------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE 87 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc-------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence 45689999999999999999996654 6799999987664 11 23456779999999999 999999999
Q ss_pred EEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeE
Q 015094 150 YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAK 228 (413)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~k 228 (413)
++.....+|+||||+.||+|.+++..++ ++.+..+..+++||+.|++|||+ +||+||||||+|||++.+ +++|
T Consensus 88 v~~t~~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 88 VFATPTKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEecCCeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999999999999997644 78889999999999999999997 669999999999999999 9999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCC-cc-chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH-LY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
|+|||++.... .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+..+...
T Consensus 162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--------- 230 (370)
T KOG0583|consen 162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--------- 230 (370)
T ss_pred EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---------
Confidence 99999998743 2334456689999999999999877 86 88999999999999999999998743211
Q ss_pred hhhhhhhhhhHhHHhhhcCCCchHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYPYKA-AYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.+..+... .-.+|..+ +.++.+|+.+||..||.+|+|+.+++++-+...
T Consensus 231 -------l~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 231 -------LYRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------HHHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11111111 12345556 899999999999999999999999997777543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=365.91 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=211.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|+++++||+|+||.||+|+ +..+|..+|+|++++... ...+.++.|-.+|...++|.||+++..|++.
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLar-------Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLAR-------KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred ccchhheeeccccceeEEEEE-------EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 589999999999999999994 555899999999987744 3456678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+++||||||++||++..+|...+ .+++..++.++.+++.|++.||. .|+|||||||+|+|||..|.+||+||||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999999997665 89999999999999999999997 5599999999999999999999999999
Q ss_pred cccCCCC----------------------CCc-----------------------ceeecccccccccCccccccCCccc
Q 015094 235 AKLGPSA----------------------SQS-----------------------HVTTRVMGTYGYAAPEYVATGHLYV 269 (413)
Q Consensus 235 a~~~~~~----------------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 269 (413)
+...... ... ......+|||.|+|||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 8532110 000 0011357999999999999999999
Q ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh--hcCCCchHHHHHHHHHHHHccccCC
Q 015094 270 KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEP 347 (413)
Q Consensus 270 ~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp 347 (413)
.+|+||||||+||||.|.+||...++.. .+.+++.-. +.......+++++.|||.+||. ||
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~----------------T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQE----------------TYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 9999999999999999999999876543 333333333 2222233567899999999999 99
Q ss_pred CCCC---CHHHHHHHHH
Q 015094 348 KHRP---SMREVVETLE 361 (413)
Q Consensus 348 ~~Rp---t~~e~l~~L~ 361 (413)
.+|. .++||.+|-.
T Consensus 431 ~~RLG~~G~~EIK~HPf 447 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHPF 447 (550)
T ss_pred HHhcCcccHHHHhcCCc
Confidence 9996 5777776543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=351.79 Aligned_cols=256 Identities=27% Similarity=0.333 Sum_probs=215.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.+.|++++.||.|.-|+||+|.... ++..+|+|++.++... .+.++..|-+||+.++||+++.||..|+.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~-------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG-------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC-------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 3568889999999999999996543 6699999999887543 34456679999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+...|+|||||.||+|..+++++. .+.+++..++.++..++-||+|||. .|||.|||||+||||.++|.|.|+||.
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeecc
Confidence 999999999999999999987654 4589999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCC---------------------------------CCC---------------------cceeecccccccccCc
Q 015094 234 LAKLGPS---------------------------------ASQ---------------------SHVTTRVMGTYGYAAP 259 (413)
Q Consensus 234 ~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aP 259 (413)
++..... ... ......++||..|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8754210 000 0112347899999999
Q ss_pred cccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHH
Q 015094 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLS 339 (413)
Q Consensus 260 E~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 339 (413)
|++.|...+.++|+|+|||++||||.|..||.+.+ .+.++.+++.+.+.-.....++..++|||
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~----------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN----------------NKETLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC----------------chhhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 99999999999999999999999999999999874 33456666666555444447789999999
Q ss_pred HHccccCCCCCCC----HHHHHHH
Q 015094 340 LKCLEAEPKHRPS----MREVVET 359 (413)
Q Consensus 340 ~~~L~~dp~~Rpt----~~e~l~~ 359 (413)
+++|.+||.+|.. |.||.+|
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHhccChhhhhccccchHHhhcC
Confidence 9999999999987 8888765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=356.32 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=217.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..+|++.+.||+|.||+|-+|+.+. .++.||||.+.++.. +++-.+++||+||..|+||||+.++++|+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~-------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN 124 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHK-------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN 124 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhcc-------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence 4689999999999999999996443 789999999977643 445568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+.|||||..+|.|.+|+..++ .+++..++.+++||+.|+.|||. ++++|||||.+|||++.++++||+|||
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccc
Confidence 999999999999999999997766 79999999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCcc-chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++..+. .......+||++.|.+||++.|.+|. +.+|-||||++||.|+.|..||++.+
T Consensus 199 LSNly~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------------------ 257 (668)
T KOG0611|consen 199 LSNLYA---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------------------ 257 (668)
T ss_pred hhhhhc---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------------------
Confidence 998743 33445678999999999999999985 99999999999999999999999863
Q ss_pred hhhhHhHHhhhcCCC-chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQY-PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...++.+...+.| .+..+.+..-||++||..||++|.|+.+|..|.|--
T Consensus 258 --hk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 258 --HKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --HHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 2233333344433 234566788999999999999999999999998853
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=367.76 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=213.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|-+.+.||+|+||.||+| +.+.+.+.||+|.+.+.. .++++.+.+|++|++.|+||||+.++++|+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg-------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG-------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeec-------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 46888899999999999999 455688999999997764 345678999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
++|+|.||+.| +|..++...+ .++++.+..++.+++.||.|||+ .+|+|||+||.|||++.+|.+|+||||+|
T Consensus 75 ~~~vVte~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred eEEEEehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhh
Confidence 99999999977 9999996655 79999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
+.... .....+...||+.|||||++.+.+|+..+|+||||||+|||++|++||.... +
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------------------i 205 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------------------I 205 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------------------H
Confidence 97432 4445667889999999999999999999999999999999999999996531 1
Q ss_pred hHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 316 RHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 316 ~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..++..... -.+|...+..+.+|+..+|.+||.+|.+..+++.|-
T Consensus 206 ~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 206 TQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred HHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 111111111 234568889999999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=357.60 Aligned_cols=262 Identities=30% Similarity=0.437 Sum_probs=210.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK-- 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 155 (413)
.+|...+.||+|+||.||++...+ +++..|||..........+.+.+|+.+|.+|+|||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~-------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK-------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREND 89 (313)
T ss_pred chhhhhccccCccceEEEEEEecC-------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence 357788999999999999997654 47899999987764444677899999999999999999999744443
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeEEccCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGL 234 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~ 234 (413)
.++++|||+.+|+|.+++...+. .+++..++.+.+||++||.|||+ +|||||||||+|||++. ++.+||+|||+
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCcc
Confidence 69999999999999999976553 69999999999999999999996 66999999999999999 79999999999
Q ss_pred cccCCC-CCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 235 AKLGPS-ASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 235 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
+..... ...........||+.|||||++.++ ...+++|||||||++.||+||.+||.... ...
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~---------- 229 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEA---------- 229 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chH----------
Confidence 986442 1112223457899999999999853 33469999999999999999999997630 000
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
..+..+........+|..++.++.+||.+|+..||++||||.++|+|....+..
T Consensus 230 ~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 230 EALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 011111111122356778899999999999999999999999999988765433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=370.38 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=216.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
...|...+.||+|+.|.||.|.. ..+++.||||.+........+-+.+|+.+|+.++|+|||.+++.|..++.
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~-------~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARK-------ISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeee-------ccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 45788889999999999999954 34678899999987766666778999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||++||+|.+.+... .+++.++..|+++++.||+|||. +||+|||||.+|||++.+|.+||+|||++.
T Consensus 345 LWVVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred eEEEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeee
Confidence 99999999999999998543 58999999999999999999996 779999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
....... .....+||++|||||++....|++++||||||++++||+-|.+||-..++.....
T Consensus 418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly---------------- 479 (550)
T KOG0578|consen 418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---------------- 479 (550)
T ss_pred ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH----------------
Confidence 7543332 4556789999999999999999999999999999999999999998755432111
Q ss_pred HhH-HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 317 HII-DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 317 ~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+. +.......+..++..+++|+.+||..|+.+|++|.|+|+|--
T Consensus 480 LIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 480 LIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred HHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 111 112223456688999999999999999999999999998644
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=348.10 Aligned_cols=272 Identities=27% Similarity=0.335 Sum_probs=217.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecC--CcChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN--SESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
...+|...+.||+|+||.|+.|.+.. +++.||||++. -...-..++..+|+++|+.++|+||+.+++++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~-------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR-------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC-------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 44567778999999999999997654 67999999987 4455567888999999999999999999999875
Q ss_pred -----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 154 -----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 154 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
-..+|+|+|+| +-+|...+.. ++.++...+..+++||++||.|+|+.+ |+||||||.|+|++.+..+|
T Consensus 93 ~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred ccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEE
Confidence 25799999999 5599999943 346999999999999999999999855 99999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccc-cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|||||+|+...........+.++.|.+|+|||++. ...|+.++||||+|||+.||++|++.|.+.+...+........+
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999999754433344457788999999999874 46899999999999999999999999999887766655433322
Q ss_pred hhhhh-------hhhhHhHHhhh-------cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 YLSEK-------RKFRHIIDARL-------QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 ~~~~~-------~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+. ......+.... ...++ +.++.+.+|+.+||..||.+|+|++|+|+|.-.
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 21110 01111111111 11122 667889999999999999999999999987543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=363.22 Aligned_cols=267 Identities=27% Similarity=0.442 Sum_probs=220.0
Q ss_pred HHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceE
Q 015094 71 VELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 71 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
.++....+...+.+.||+|+||+||+|.|+. .||||+++.. ..+.++.|++|+.++++-+|.||+-+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG----------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG----------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc----------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeee
Confidence 5666677788999999999999999998873 5999998765 345778899999999999999999999
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
+++..... .||+.+|+|-+|+.+++... ..+.....+.|++||++|+.|||. ++|||||||..|||+.++++||
T Consensus 455 G~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 455 GACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred hhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEE
Confidence 99988776 99999999999999996544 478999999999999999999997 7799999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
|+|||++................|...|||||+++. .+|++.+|||||||++|||++|..||...........+.
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-- 606 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-- 606 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec--
Confidence 999999987555544444555678999999999854 478899999999999999999999998443322111110
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
..++.. ........++.++++|+..||..++++||.+.+|+..|+.+...
T Consensus 607 rG~l~p-----------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 RGYLMP-----------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccccCc-----------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 000000 00012246788999999999999999999999999999988764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=340.89 Aligned_cols=269 Identities=24% Similarity=0.292 Sum_probs=213.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--hHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
+.|+.+..|++|+||.||+|+ ++.+++.||+|+++.+... .--...|||.+|.+++|||||.+.++..-.
T Consensus 76 ~efe~lnrI~EGtyGiVYRak-------dk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAK-------DKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHhhcccCcceeEEEec-------cCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 357888899999999999995 4458999999999876432 123457899999999999999999987644
Q ss_pred -CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 155 -KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+.+|||||||+. +|..++.... +++...++..++.|++.||+|||. +.|+|||||++|+|++..|.+||+|||
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccc
Confidence 679999999976 9999996544 589999999999999999999996 779999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh------
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK------ 306 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~------ 306 (413)
+|+.+.... ...+..+-|.+|+|||++.+ ..|+.++|+||+|||+.||+++++.|.+....++...+-...
T Consensus 223 LAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 223 LAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred hhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 999765442 23455778999999999988 468899999999999999999999999987776655432221
Q ss_pred --hhhhh-----hhhhhHhHHhhhcCCCchH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 --PYLSE-----KRKFRHIIDARLQGQYPYK-AAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 --~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
|-+.+ ...+.......++..++.. .+..-.+|+..+|.+||.+|.||.|.|++=.
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 11111 1112222222333334333 5678899999999999999999999997643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=363.13 Aligned_cols=259 Identities=31% Similarity=0.467 Sum_probs=219.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+.+++++.||+|-||.||+|+|.. ...||+|.++.... ..+.|.+|+++|++|+|+|||++++++..++.
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~--------~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG--------STKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC--------CCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 3456678899999999999999874 34799998876543 33678899999999999999999999999889
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+||||||++.|+|.++|... ....+...+.+.++.||++|++||++ +++|||||...||||+++..+||+|||+|+
T Consensus 276 iyIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred eEEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEccccccc
Confidence 99999999999999999763 23478889999999999999999997 669999999999999999999999999999
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
.. ............-...|.|||.+....++.+||||||||+||||+| |+.|+..... ..+
T Consensus 352 ~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev 413 (468)
T KOG0197|consen 352 LI-GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEV 413 (468)
T ss_pred cc-CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHH
Confidence 42 2222222333334567999999999999999999999999999999 8888776532 234
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
-..+....+...|..|+.++.+|+..||+.+|++|||++.+...|+++...
T Consensus 414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 455667777788899999999999999999999999999999999987754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=364.18 Aligned_cols=251 Identities=28% Similarity=0.435 Sum_probs=213.6
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhcc-CCCccceEeE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLS-HPNLVRLLGY 150 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 150 (413)
...++|+++++||+|+||+|++|..+. +++.||||++++.. ..+.+..+.|-+|+.... ||+++.++..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~-------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKG-------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcC-------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence 345789999999999999999996554 67899999998873 356778889999998886 9999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
|+..+++|+||||+.||++..+.+ ...+++..+..++..|+.||+|||. +|||+||||.+|||+|.+|.+||+
T Consensus 438 fQT~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred cccCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEec
Confidence 999999999999999999554442 2379999999999999999999996 669999999999999999999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||+++.. ......+.+++||+.|||||++.+..|+.++|+|||||+|||||.|..||.+.++.
T Consensus 511 DFGlcKe~--m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------- 574 (694)
T KOG0694|consen 511 DFGLCKEG--MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------- 574 (694)
T ss_pred cccccccc--CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------
Confidence 99999863 33445677899999999999999999999999999999999999999999987432
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVET 359 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~ 359 (413)
+.+..|+.. ...+|..++.+..++++++|.++|++|.. +.+|.+|
T Consensus 575 --e~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 575 --EVFDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred --HHHHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 223333322 23477889999999999999999999974 4566543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=359.97 Aligned_cols=270 Identities=30% Similarity=0.426 Sum_probs=210.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+... .....++.||||++.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGI--DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEecc--CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 346899999999999999999975321 223356789999987543 23446788999999999 79999999998876
Q ss_pred C-CeeEEEEeeCCCCCHHHhhhhcCCC-----------------------------------------------------
Q 015094 154 D-KELLLVYEFMQKGSLENHLFGRGAS----------------------------------------------------- 179 (413)
Q Consensus 154 ~-~~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------------------------- 179 (413)
. ..+++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4689999999999999998653211
Q ss_pred -----CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccc
Q 015094 180 -----VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254 (413)
Q Consensus 180 -----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~ 254 (413)
..++++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...............++.
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2357788889999999999999997 679999999999999999999999999997543222212222344667
Q ss_pred cccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHH
Q 015094 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAY 333 (413)
Q Consensus 255 ~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (413)
.|+|||++.+..++.++|||||||++|||++ |..||....... .+...+........+..++.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 304 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----------------EFCQRLKDGTRMRAPENATP 304 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----------------HHHHHHhcCCCCCCCCCCCH
Confidence 8999999999999999999999999999997 999997643211 00011111111223445677
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 334 QIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 334 ~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=350.22 Aligned_cols=263 Identities=27% Similarity=0.371 Sum_probs=212.1
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------------hhHHHHHHHHHHHhh
Q 015094 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------------QGFEEWQSEVNFLGR 138 (413)
Q Consensus 73 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~E~~~l~~ 138 (413)
-....++|++.+.||+|.||+|-+|+.. .+++.||||++.+... ...++.++||.||++
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~-------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk 164 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDE-------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK 164 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeec-------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh
Confidence 3445689999999999999999999644 4789999999865422 123578899999999
Q ss_pred ccCCCccceEeEEEeC--CeeEEEEeeCCCCCHHHhhhhcCCCCCC-CcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 139 LSHPNLVRLLGYCWED--KELLLVYEFMQKGSLENHLFGRGASVQP-LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 139 l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
|.|||||+|+++..+. +.+|||+|||..|.+...- ...+ +.+.++++++++++.||+|||. +||||||||
T Consensus 165 l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIK 237 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIK 237 (576)
T ss_pred cCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccc
Confidence 9999999999988765 6899999999988775432 2224 8999999999999999999998 569999999
Q ss_pred CCcEEEcCCCCeEEccCCCcccCCCC---CCcceeecccccccccCccccccCC---c-cchhhhHHHHHHHHHHHhCCC
Q 015094 216 ASNILLDGSYTAKISDFGLAKLGPSA---SQSHVTTRVMGTYGYAAPEYVATGH---L-YVKSDVYGFGVVLVEILTGLR 288 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DiwslG~il~~lltG~~ 288 (413)
|.|+||+.+|++||+|||.+...... .........+||+.|+|||...++. + +.+.|||||||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 99999999999999999998754221 1111223368999999999987732 3 477899999999999999999
Q ss_pred CCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 289 ALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 289 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
||..... ...+..|++..+.-.....+..++.+||++||.+||++|.++.+|..|.+..+.
T Consensus 318 PF~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 318 PFFDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9987532 224455555555444444678899999999999999999999999999987654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=354.81 Aligned_cols=250 Identities=25% Similarity=0.389 Sum_probs=212.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..|+..+.||+|+||.||+|.+.. +++.||+|++..+.. ...+.+.+|+.+|..++++||.++|+.|..+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~-------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK-------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccchhccccccceeeeeeecc-------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 467888999999999999997654 789999999987643 456788999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
++++||||.||++.+.+.... .+.+..+..++++++.||.|||. .+.+|||||+.|||+..+|.+||+|||.+.
T Consensus 86 LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceee
Confidence 999999999999999995433 45778888899999999999997 559999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .....++||+.|||||++.+..|+.++||||||++.+||.+|.+|+....+.....
T Consensus 160 ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf---------------- 221 (467)
T KOG0201|consen 160 QLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF---------------- 221 (467)
T ss_pred eeechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------
Confidence 643322 23366899999999999998899999999999999999999999998776532111
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
++.+.....+...+++.+++||..||.+||+.||+|.++++|
T Consensus 222 -lIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 222 -LIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -eccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 122222233344778889999999999999999999999974
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=343.99 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
...|++.+.||.|..++||+|++.. .++.||||+++.+... .++.+.+|+..|..++||||++++..|..+.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p-------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP-------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc-------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 3579999999999999999997765 5799999999876443 3588999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||.||.+|++.+++..... ..+.+..+..|++++++||.|||. +|.||||||+.||||+.+|.|||+|||.+
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceee
Confidence 99999999999999999976543 358999999999999999999996 67999999999999999999999999987
Q ss_pred ccCCCCCCcc-ee-ecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 236 KLGPSASQSH-VT-TRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 236 ~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
.......... .. ..++||++|||||+++. ..|+.|+|||||||+..||.+|..||....+.......-...+.
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp--- 250 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP--- 250 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC---
Confidence 6544332221 11 56789999999999654 57999999999999999999999999876543211100000000
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
......+..+-...++..++++|..||+.||.+|||+.+++++-.
T Consensus 251 -----~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 251 -----TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred -----CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 000000111112245668999999999999999999999997544
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.61 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=217.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeE-EEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGY-CWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~~ 154 (413)
..+++|.+.|.+|+|+.||+|.... .+..||+|++-..+...++.+++||++|++|+ |+|||.+++. ....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~-------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK-------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC-------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 4578889999999999999996554 34889999987778888899999999999998 9999999993 2221
Q ss_pred ------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 ------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
-.++|+||||.||.|.+++..+... .|++.++++|+.++++|+++||.....|||||||-|||||+.+|.+|
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 2578999999999999999876543 59999999999999999999999888899999999999999999999
Q ss_pred EccCCCcccCCCCCCcce-------eecccccccccCcccc---ccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 015094 229 ISDFGLAKLGPSASQSHV-------TTRVMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ 298 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~ 298 (413)
|||||-|........... .-....|+.|+|||++ .+..++.|+|||||||+||-||....||+.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 999999875333221111 1123579999999987 5788999999999999999999999999876332
Q ss_pred chhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 299 HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.|++..+........+..+.+||..||+.||.+||++.+++.++-++....
T Consensus 265 ------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 233333333333578899999999999999999999999999999887643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=322.12 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=217.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++++.||+|-||.||+|+.++ ++-.||+|++.+... ....++.+|++|-..|+||||+++|++|.+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekk-------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKK-------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred hhhccccccccCCccccEeEeeecc-------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 3579999999999999999996554 678999999876532 234578999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
...+||++||..+|.|...+.... ...+.+.....++.|++.||.|+|. ++++||||||+|+|++..|.+||+|||
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCC
Confidence 999999999999999999996433 2368888889999999999999995 779999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
.+.... .......|||..|.+||++.+..++..+|+|++|++.||++.|.+||+.... .+
T Consensus 170 wsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----------------~e 229 (281)
T KOG0580|consen 170 WSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH----------------SE 229 (281)
T ss_pred ceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh----------------HH
Confidence 998532 3334567999999999999999999999999999999999999999987532 12
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.++.+.. .+..+|..++.++.|||.+||.++|.+|.+..|++++.+-.
T Consensus 230 tYkrI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 230 TYKRIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred HHHHHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 2223322 22346678899999999999999999999999999988753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=348.16 Aligned_cols=253 Identities=27% Similarity=0.372 Sum_probs=215.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.+|..++++|+|+||.+++++++ ..++.|++|.+..... ...+...+|+.+++++.|||||.+++.|.+++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk-------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK-------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc-------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 57899999999999999998544 4677999999876543 33446889999999999999999999999998
Q ss_pred e-eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 156 E-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 156 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
. +||||+||+||+|.+.+.+.. ...++++.++.|+.|++.|+.|||+ ++|+|||||+.|||++.++.|||+|||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhh
Confidence 8 999999999999999997655 4578999999999999999999995 6799999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
|+...... .....++||+.||.||++.+.+|+.++|||||||++|||++-+++|...+...
T Consensus 153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------- 213 (426)
T KOG0589|consen 153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------- 213 (426)
T ss_pred hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----------------
Confidence 99754332 24566899999999999999999999999999999999999999998764321
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
+..-+........+...+.++..||..||..+|..||++.++|.+.
T Consensus 214 Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 214 LILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred HHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1111122223456778999999999999999999999999999863
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=320.01 Aligned_cols=268 Identities=24% Similarity=0.345 Sum_probs=217.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
..+||++.+.||+|+|+-||++. ...+++.||+|++.....++.+...+|++..++++||||++++++...+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~-------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVK-------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cCceEEEeeeecCCCceeeeeec-------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 45799999999999999999984 4557899999999888878888999999999999999999999875543
Q ss_pred ----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 155 ----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 155 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
...||+++|+..|+|.+.+......+..+++.+++.|+.+|++||++||.....++||||||.|||+++++.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 3599999999999999999887777778999999999999999999999755569999999999999999999999
Q ss_pred cCCCcccCCCCCCcce-------eecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 015094 231 DFGLAKLGPSASQSHV-------TTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~ 300 (413)
|||.++.......+.. ......|..|+|||++. +...+.++|||||||+||.|+.|..||+..-..+...
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 9999876332211111 12245789999999884 4567899999999999999999999997643322111
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.. .+........-...++..+.+||+.||+.||.+||++.+++..++.+.
T Consensus 252 aL--------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 AL--------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EE--------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 10 011111111122347888999999999999999999999999988764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=325.14 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=211.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.+.|.+-++||+|.|+.||++.+. .+++.+|+|+++.. .....+++.+|+.|.+.|+||||+++.+.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~-------~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc-------cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence 356888899999999999998543 37888999987644 334678899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCCeEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYTAKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~---~~~~~kl~D 231 (413)
...|||+|++.|++|..-|-++. ..++..+-.+++||+++|.|+|. ++|||||+||+|+|+. ...-+||+|
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecc
Confidence 99999999999999987765542 67888899999999999999996 7799999999999993 455799999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||+|.... .......+.|||.|||||++...+|+..+|||+.|++||-||.|.+||.+.+..
T Consensus 157 FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------------- 218 (355)
T KOG0033|consen 157 FGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------------- 218 (355)
T ss_pred cceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---------------
Confidence 99998644 444556788999999999999999999999999999999999999999874321
Q ss_pred hhhhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 312 KRKFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 312 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.-++.++.... .......++++.++||++||..||.+|.|+.|.|+|-|-
T Consensus 219 -rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 219 -RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred -HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 11222222221 222345788999999999999999999999999987664
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=346.67 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=205.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.+|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG-------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 468999999999999999997653 57899999986542 23345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999996543 67888899999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 165 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~ 223 (329)
T PTZ00263 165 AKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----------------I 223 (329)
T ss_pred ceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----------------H
Confidence 9854221 223579999999999999999999999999999999999999997543210 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~ 361 (413)
...+... ...++..++..+.+||.+||+.||.+|++ ++++++|-+
T Consensus 224 ~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 224 YEKILAG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred HHHHhcC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 1111111 11234456778999999999999999986 688887744
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.62 Aligned_cols=270 Identities=25% Similarity=0.344 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|+++|+.++||||+++++++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP-------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC-------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 4689999999999999999997553 67889999987653 234567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 9999999999999999996543 57889999999999999999996 235999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-----------
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW----------- 304 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~----------- 304 (413)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 152 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 152 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred cccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 753221 22345789999999999999999999999999999999999999975432110000000
Q ss_pred -h------------------hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 305 -I------------------KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 305 -~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
. .+.......+..+............++.++.+||.+||..||++|||+.+++++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0 000000000000111111111122457789999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=337.63 Aligned_cols=264 Identities=25% Similarity=0.321 Sum_probs=207.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC--C-
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED--K- 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~- 155 (413)
.|...+++|.|+||.||.|...+ +++.||||+.-.+.. .-.+|+++|+.++|||||++.-+|... +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e-------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE-------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC-------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 57788999999999999998765 478999998765532 225799999999999999999888643 2
Q ss_pred --eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeEEccC
Q 015094 156 --ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDF 232 (413)
Q Consensus 156 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~kl~Df 232 (413)
.+.+||||++. +|.++++.....++.++.-.+.-+..||++||.|||+ .+|+||||||.|||+|.+ |.+|||||
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccC
Confidence 56799999965 9999997655556678888889999999999999997 569999999999999865 99999999
Q ss_pred CCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
|.|+.... +.....+..|..|+|||++.| ..|+.+.||||.||++.||+-|++.|.+....++...+-.+......
T Consensus 171 GSAK~L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 171 GSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred Ccceeecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99997433 333456788999999999987 57899999999999999999999999997665544332211111000
Q ss_pred -----------hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 -----------KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...+..+....+...+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111222222222223445678899999999999999999999999965
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=334.48 Aligned_cols=269 Identities=26% Similarity=0.333 Sum_probs=205.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--hHHHHHHHHHHHhhccCCC-ccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEEWQSEVNFLGRLSHPN-LVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~ 155 (413)
.|..++.||+|+||+||+|+... +++.||+|++..+..+ .-....+|+.+|+.|+|+| |+.+++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~-------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKR-------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEec-------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence 46667789999999999997554 6799999998766432 3355789999999999999 999999998877
Q ss_pred ------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 156 ------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 156 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
.+++||||++. +|..++.........++...+..+++||+.||+|||+ ++|+||||||.||||+.+|.+||
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEee
Confidence 89999999955 9999997765433467778999999999999999997 56999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||+|+....... ..+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+....++...+-.+...
T Consensus 162 aDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 162 ADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred eccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 99999996443222 23456789999999999886 7889999999999999999999999987664333222111000
Q ss_pred --------hhh----hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 309 --------LSE----KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 309 --------~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
... +..+..+...............+..+++.+||+.+|.+|.|++.++.|
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 000000000000000001122478999999999999999999999987
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.84 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=217.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhH--HHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF--EEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..-|.+.+.||+|.|++|-+| ++..+|+.||||++.+...... ..+.+|++.|+.++|||||++|++....
T Consensus 17 AGLYDLekTlG~GHFAVVKLA-------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLA-------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ 89 (864)
T ss_pred eeeehhhhhhcCCceehhhhh-------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence 345888899999999999998 4566899999999988765443 4578999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-cCCCCeEEccCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL-DGSYTAKISDFG 233 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~-~~~~~~kl~DfG 233 (413)
..+|||+|+-++|+|.+||.++.. .+.+..+.+++.||+.|+.|||. .++|||||||+||++ ..-|-|||+|||
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeecc
Confidence 999999999999999999987653 78999999999999999999996 569999999999876 677999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCcc-chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++..+.. +...+..||+..|-|||++.|..|+ +++||||||+|||-|++|++||...+..
T Consensus 165 FSNkf~P---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------- 225 (864)
T KOG4717|consen 165 FSNKFQP---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------- 225 (864)
T ss_pred ccccCCC---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------
Confidence 9986443 3345567999999999999999997 8899999999999999999999877543
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+.+..+++-.. ..|..++.++++||..||..||++|.+.++|..+-|
T Consensus 226 ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 226 ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 23444444332 467899999999999999999999999999987655
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=351.14 Aligned_cols=268 Identities=30% Similarity=0.418 Sum_probs=210.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|++... +...+...||||++.... ....+.+.+|+.+++.+ +|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGL--GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecC--CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45799999999999999999976432 223356789999997543 33456688999999999 799999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC--------------------------------------------------------
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA-------------------------------------------------------- 178 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 178 (413)
..+|+||||+.+|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999854321
Q ss_pred ----------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceee
Q 015094 179 ----------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248 (413)
Q Consensus 179 ----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 248 (413)
...++++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 11347788899999999999999997 669999999999999999999999999997543222211222
Q ss_pred cccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCC
Q 015094 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQY 327 (413)
Q Consensus 249 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (413)
...++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+............
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~~~~~ 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGYQMSR 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHcccCccC
Confidence 2345667999999988899999999999999999997 999997643211 11111122222223
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 328 PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 328 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
+...+.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3345688999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=342.56 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI-------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC
Confidence 368999999999999999996543 57899999986542 23345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCc
Confidence 99999999999999999996543 68889999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----------------~ 206 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----------------I 206 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 8753221 223569999999999998899999999999999999999999997643211 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~~ 362 (413)
...+... ...++...+..+.+||.+||..||.+|++ +.++++|.+.
T Consensus 207 ~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 207 YEKILAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred HHHHHhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 1111111 12344456778999999999999999995 9999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=345.86 Aligned_cols=244 Identities=28% Similarity=0.367 Sum_probs=200.5
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 160 (413)
+.||+|+||.||+|.... +++.||||++.... ......+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEE
Confidence 479999999999996543 67899999987542 23345678899999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
|||+.+++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 74 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 99999999999986543 68899999999999999999997 6699999999999999999999999999875321
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+..
T Consensus 148 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----------------~~~~~~~ 209 (323)
T cd05571 148 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILM 209 (323)
T ss_pred C--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----------------HHHHHHc
Confidence 1 122334679999999999999999999999999999999999999997542110 0011111
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETL 360 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L 360 (413)
....++..++.++.+||.+||..||++|| ++.++++|-
T Consensus 210 --~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 210 --EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 11234556788999999999999999999 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=348.45 Aligned_cols=266 Identities=30% Similarity=0.406 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+... ....++..||||+++... ....+.+.+|+.+|+.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~--~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL--FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc--ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45799999999999999999965321 123356789999987542 23446788999999999 799999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC--------------------------------------------------------
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA-------------------------------------------------------- 178 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 178 (413)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999865321
Q ss_pred ---------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCC
Q 015094 179 ---------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ 243 (413)
Q Consensus 179 ---------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 243 (413)
....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 01246788899999999999999997 6699999999999999999999999999986433222
Q ss_pred cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 244 SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
........++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+...+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----------------~~~~~~~~~ 333 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----------------KFYKMIKEG 333 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----------------HHHHHHHhC
Confidence 112222345667999999999999999999999999999998 888886542211 111112222
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.....+...+.++.+|+.+||+.||++||++.++++.|+.
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 2222333456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.02 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=205.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.|++.+.||+|+||.||+|.+.. +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec-------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC
Confidence 37788999999999999997654 678999998865432 22345778999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999998875432 2368889999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... .......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ..
T Consensus 150 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~-------------~~ 213 (285)
T cd05631 150 VQIPEG---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE-------------EV 213 (285)
T ss_pred EEcCCC---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH-------------HH
Confidence 863221 12234578999999999999999999999999999999999999998654321100 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLE 361 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~ 361 (413)
...+ ......++..++.++.+|+.+||+.||.+||+ +++++++-+
T Consensus 214 ~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 214 DRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred HHHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 0000 11112344567788999999999999999997 889988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=349.39 Aligned_cols=268 Identities=25% Similarity=0.354 Sum_probs=211.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-C-----CCccceEeEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-H-----PNLVRLLGYC 151 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~ 151 (413)
.+|.+.++||+|+||.|.+|++.. +++.||||+++... ....+...|+.+|..|+ | -|||+++++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~-------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHK-------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEEecccccceeEEEEecC-------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 378899999999999999997665 78999999998764 34566788999999997 4 3899999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--CCCeEE
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG--SYTAKI 229 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~--~~~~kl 229 (413)
...+++|||+|.+ ..+|.+++....- ..++...++.++.||+.+|.+||. .+|||+||||+||||.+ ...|||
T Consensus 258 ~fr~HlciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 258 YFRNHLCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ccccceeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeE
Confidence 9999999999999 5599999976543 468999999999999999999996 66999999999999953 348999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh----
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI---- 305 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~---- 305 (413)
+|||.+... ......++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.++.++...+..+
T Consensus 333 IDFGSSc~~-----~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 333 IDFGSSCFE-----SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred Eeccccccc-----CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 999999852 22223678999999999999999999999999999999999999999998877665444211
Q ss_pred -----------hhhhhh-hhhh-----------------hH-hHHhhhcCCCc-----------hHHHHHHHHHHHHccc
Q 015094 306 -----------KPYLSE-KRKF-----------------RH-IIDARLQGQYP-----------YKAAYQIAQLSLKCLE 344 (413)
Q Consensus 306 -----------~~~~~~-~~~~-----------------~~-~~~~~~~~~~~-----------~~~~~~l~~li~~~L~ 344 (413)
..++.. .... .. +.........| ......+.+||++||.
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 011111 0000 00 00001111111 1334568999999999
Q ss_pred cCCCCCCCHHHHHHHHHHH
Q 015094 345 AEPKHRPSMREVVETLERL 363 (413)
Q Consensus 345 ~dp~~Rpt~~e~l~~L~~i 363 (413)
.||.+|+|..++++|-.--
T Consensus 488 ~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 488 WDPAERITPAQALNHPFLT 506 (586)
T ss_pred cCchhcCCHHHHhcCcccc
Confidence 9999999999999987653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=336.24 Aligned_cols=273 Identities=25% Similarity=0.414 Sum_probs=206.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCC---------CCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKA---------PGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVR 146 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---------~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~ 146 (413)
.++|++.+.||+|+||.||+|.+.... ......+..||+|.+.... ......+.+|+.+|+.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 467999999999999999999764321 0123355689999987653 234457889999999999999999
Q ss_pred eEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCC---------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 015094 147 LLGYCWEDKELLLVYEFMQKGSLENHLFGRGA---------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIY 211 (413)
Q Consensus 147 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivH 211 (413)
+++++.+.+..|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||+ .+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCccc
Confidence 99999999999999999999999999865321 11246778889999999999999997 66999
Q ss_pred CCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh--CCCC
Q 015094 212 RDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT--GLRA 289 (413)
Q Consensus 212 rDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--G~~p 289 (413)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975432222222233456788999999988899999999999999999987 4566
Q ss_pred CCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 290 LDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 290 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
|....... ........... . ........+..++..+.+|+.+||..||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRD------Q-GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhh------c-cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66532211 11100000000 0 000011123456778999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=357.87 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=209.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
..|.+.+.||+|+||.||+|.... ..++.||+|.+..........+.+|+.+|+.++||||+++++++..++.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~------~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGS------DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcC------CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 348999999999999999996432 12577889987666555556788899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||++|++|.+++........++++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 99999999999999886544444578899999999999999999997 6699999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+..
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----------------~~~~~ 282 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----------------EIMQQ 282 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 44332222334567999999999999999999999999999999999999999754211 01111
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
+... ....++..++.++.+||.+||..||++||++.+++.+
T Consensus 283 ~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 283 VLYG-KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHhC-CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111 1112344567889999999999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.56 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=198.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+++.
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP-------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC-------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 356778999999999999997553 578999999865432 334678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+.+++|.+.. ...+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 147 ~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999986543 35667788999999999999996 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCcccccc-----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
...... .......||..|+|||++.. ...+.++|||||||++|+|++|..||..........
T Consensus 217 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~----------- 283 (353)
T PLN00034 217 ILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS----------- 283 (353)
T ss_pred eccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-----------
Confidence 543211 11233579999999998743 234568999999999999999999997432211000
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
+...+........+..++.++.+||.+||..||++|||+.|++++-+..
T Consensus 284 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 284 ---LMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred ---HHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 0000011111223446678899999999999999999999999875543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=345.21 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD-------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC
Confidence 368999999999999999997653 57899999987542 22345678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||++|++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcC
Confidence 99999999999999999996443 68889999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ . .
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~-------~ 212 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---K-------Y 212 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---H-------h
Confidence 975332 233457999999999999999999999999999999999999999765332110000 0 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+...........++.++.+||.+||..+|.+||++.+++++..
T Consensus 213 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 213 WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 00000000000001245788999999999999999999999998744
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=342.35 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=215.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHHHHHHHHHHhhcc-CCCccceEeEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFLGRLS-HPNLVRLLGYC 151 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 151 (413)
....|++.+.||+|.||.||+|.... +++.+|+|++.+.... ..+.+.+|+.+|+++. ||||+.++++|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~-------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS-------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC-------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34679999999999999999996543 6899999999776543 3468899999999999 99999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC----CCCe
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG----SYTA 227 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~----~~~~ 227 (413)
++...+++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+.. ++.+
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcE
Confidence 9999999999999999999999765 28999999999999999999997 66999999999999943 3589
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||........
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------- 246 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------- 246 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH---------
Confidence 9999999997543 4456678999999999999889999999999999999999999999987653321
Q ss_pred hhhhhhhhhHhHHhh--hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..+.... +.......++..+.++|.+||..||..|+|+.++|+|.|
T Consensus 247 -------~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 247 -------FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -------HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11222222 223334567889999999999999999999999999866
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=315.54 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=212.3
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--------hhhHHHHHHHHHHHhhcc-CCCc
Q 015094 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--------LQGFEEWQSEVNFLGRLS-HPNL 144 (413)
Q Consensus 74 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~-h~~i 144 (413)
......|...++||.|..++|.+|.+.. +++.+|+|++.... ....+.-.+|+.||+++. ||+|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~-------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKE-------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcc-------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 3455678889999999999999986544 67888999875321 123345668999999986 9999
Q ss_pred cceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 145 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
+++.++|+.+..+++|+|.|+.|.|.|++.... .+++.....|++||++|++|||. ++||||||||+|||++++
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn 159 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDN 159 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccc
Confidence 999999999999999999999999999996554 79999999999999999999997 669999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCccccc------cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA------TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ 298 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~ 298 (413)
.++||+|||++.... .+......|||++|+|||.+. ...|+..+|+||+|+|+|.|+.|.+||.....
T Consensus 160 ~~i~isDFGFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--- 233 (411)
T KOG0599|consen 160 MNIKISDFGFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--- 233 (411)
T ss_pred cceEEeccceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---
Confidence 999999999998743 334456689999999999873 35688899999999999999999999864311
Q ss_pred chhhHhhhhhhhhhhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 299 HNLVDWIKPYLSEKRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
. --++.++..... ..-..+++...++||.+||+.||.+|.|++|+|.|-..++-.
T Consensus 234 ---------m----lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 234 ---------M----LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred ---------H----HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 0 012222222221 222346788899999999999999999999999988876543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.22 Aligned_cols=247 Identities=21% Similarity=0.368 Sum_probs=201.7
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHHHHHHHHHHhhccCCCccceEeEEEe----CCe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFLGRLSHPNLVRLLGYCWE----DKE 156 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~ 156 (413)
..||+|++|.||+|.+. ++.||||.+...... ..+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 26 ~~i~~g~~~~v~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN---------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred eEEeeCCceEEEEEEEC---------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 57999999999999763 688999998765332 24678899999999999999999999877 357
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++||||+.+|+|.+++... ..+++...+.++.+++.||.|||.. .+++||||||+|||++.++.+||+|||++.
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 89999999999999999654 3678888999999999999999962 358899999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
..... .....|+..|+|||++.+ ..++.++|||||||++|||++|..||....... .
T Consensus 172 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----------------~ 230 (283)
T PHA02988 172 ILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----------------I 230 (283)
T ss_pred hhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----------------H
Confidence 53221 123468899999999876 688999999999999999999999997643210 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
+..+.........+..++..+.+|+.+||+.||++|||+.++++.|+.++.
T Consensus 231 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 231 YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111212222233444678899999999999999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=335.61 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||.||+|++.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE-------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC-------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 479999999999999999997653 57889999986542 233466789999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.++.+..+... ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred EEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999988766655422 2368889999999999999999996 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hhhhh----
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI-KPYLS---- 310 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~-~~~~~---- 310 (413)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|.+||............... .+...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 148 RNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred cccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 86432211 1223356899999999998889999999999999999999999999865432211111000 00000
Q ss_pred ---hhhhhhHhHHhh------hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 311 ---EKRKFRHIIDAR------LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 311 ---~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
....+....... ....+...++.++.+||.+||+.||++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 0001112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=334.24 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||.|+||.||+|+... +++.||+|++..... .....+.+|+.+++.++||||+++++++..++.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL-------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC-------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 579999999999999999996543 578999999865432 233467789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCccee
Confidence 9999999975 9999886543 257888999999999999999997 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------hh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--------KP 307 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~--------~~ 307 (413)
...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||............... .+
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 532211 11233468999999998865 56889999999999999999999999765432211111000 00
Q ss_pred hhhhhhhhhHhHHhhhcC----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQG----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.......+.......... ......+.++.+||.+||..||.+|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000111110000000 0011346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=338.53 Aligned_cols=270 Identities=24% Similarity=0.352 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++++.+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP-------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC-------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 4689999999999999999996543 57889999887542 234467889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 9999999999999999996543 57888999999999999999995 235999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH------------
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD------------ 303 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~------------ 303 (413)
...... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||.............
T Consensus 152 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 152 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred hhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 753221 2233568999999999988889999999999999999999999997543211100000
Q ss_pred ------------hhhhhhhhhhhhhHhHHhhhcC---CC-chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 304 ------------WIKPYLSEKRKFRHIIDARLQG---QY-PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 304 ------------~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+..........+....... .. ....+.++.+||.+||+.||++|||+.|++++-..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 0000000000000011111111 11 11246789999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.29 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=200.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|.+++.||+|+||.||+|.... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD-------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC-------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 368999999999999999996543 67899999886532 23446688899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||++|++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999998643 368889999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCc---------------------------------------------ceeecccccccccCccccccCCccc
Q 015094 235 AKLGPSASQS---------------------------------------------HVTTRVMGTYGYAAPEYVATGHLYV 269 (413)
Q Consensus 235 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 269 (413)
++........ ......+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 8632110000 0001246999999999999999999
Q ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCC
Q 015094 270 KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEP 347 (413)
Q Consensus 270 ~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp 347 (413)
++|||||||++|+|++|..||....... .+..+........++ ..++.++.+||.+||. +|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHE----------------TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHH----------------HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 9999999999999999999997643211 011111100011112 2456789999999998 67
Q ss_pred CCC---CCHHHHHHHHH
Q 015094 348 KHR---PSMREVVETLE 361 (413)
Q Consensus 348 ~~R---pt~~e~l~~L~ 361 (413)
.+| +++.+++++.+
T Consensus 291 ~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 291 ENRLGRGGAHEIKSHPF 307 (377)
T ss_pred hhcCCCCCHHHHhcCCC
Confidence 665 59999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=339.36 Aligned_cols=244 Identities=28% Similarity=0.369 Sum_probs=199.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 160 (413)
+.||+|+||.||+|.... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEE
Confidence 479999999999996543 67899999987542 23445677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
|||+.+++|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 74 ~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 74 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 99999999998885443 68899999999999999999997 6699999999999999999999999999874221
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+..
T Consensus 148 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~~~~~ 209 (323)
T cd05595 148 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILM 209 (323)
T ss_pred C--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhc
Confidence 1 112234579999999999999999999999999999999999999997543210 0111111
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETL 360 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L 360 (413)
....++..++.++.+||.+||..||.+|+ ++.+++++-
T Consensus 210 --~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 210 --EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 11234556778899999999999999998 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=357.08 Aligned_cols=269 Identities=31% Similarity=0.481 Sum_probs=223.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+.+..+.||+|+||+||+|...... .......||||.++..... ..++|++|+++|..|+|||||+++|++.+++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~--p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLL--PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCC--CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 345667789999999999999765432 2346788999999887655 6788999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC------C----CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA------S----VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~------~----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~ 225 (413)
.+|+|+|||..|||.++|..+.. . ..+++..+.+.|+.||+.|++||-+ +.+|||||...|+||.++.
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceeccce
Confidence 99999999999999999975432 2 2338899999999999999999996 5699999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~ 304 (413)
.|||+|||+++.....+.......-.-...||+||.+..+.|+.+|||||+||+|||+++ |+.||.+....
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------- 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------- 712 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--------
Confidence 999999999997544444333333345678999999999999999999999999999998 88888765321
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+.+. .+........|..++.++.+|+..||+.+|++||+++||-..|......
T Consensus 713 --------EVIe-~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 713 --------EVIE-CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------HHHH-HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1222 2222223567889999999999999999999999999999999987654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=328.89 Aligned_cols=264 Identities=30% Similarity=0.486 Sum_probs=211.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||.||+|.+.... .......|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPN--ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCC--CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 46899999999999999999765421 12345789999987543 2344568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCC------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGAS------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
.|++|||+++++|.+++...... ...+++..++.++.||+.||.|||. ++|+|+||||+||+++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcCC
Confidence 99999999999999999654211 1357888999999999999999996 669999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVD 303 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~ 303 (413)
+.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------- 233 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------- 233 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 9999999999975433222222334456888999999988899999999999999999998 99998764321
Q ss_pred hhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 304 WIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.....+........+..++.++.+|+.+||+.||.+||++.+|+++|..
T Consensus 234 ----------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 ----------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111222223455678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=350.15 Aligned_cols=270 Identities=21% Similarity=0.316 Sum_probs=197.5
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC------CCccceE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH------PNLVRLL 148 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~ 148 (413)
...++|++.+.||+|+||+||+|++.. +++.||||+++... .....+..|+.+++.+.| .+|++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRK-------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcC-------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 345789999999999999999997643 57899999986532 223445678888877754 4588888
Q ss_pred eEEEeC-CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC--
Q 015094 149 GYCWED-KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-- 225 (413)
Q Consensus 149 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-- 225 (413)
+++..+ .++|+|||++ |++|.+++.+.+ .+.+..+..++.||+.||+|||+ ..|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCCcc
Confidence 888765 5789999998 779999886543 68899999999999999999996 24699999999999998665
Q ss_pred --------------CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCC
Q 015094 226 --------------TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 226 --------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~ 291 (413)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 49999999876321 12334679999999999999999999999999999999999999998
Q ss_pred CCCCCCcchhhHhhhh-h---hhh---hhhhhHhHHh---------------hhcCC-C-chHHHHHHHHHHHHccccCC
Q 015094 292 TNRPSGQHNLVDWIKP-Y---LSE---KRKFRHIIDA---------------RLQGQ-Y-PYKAAYQIAQLSLKCLEAEP 347 (413)
Q Consensus 292 ~~~~~~~~~~~~~~~~-~---~~~---~~~~~~~~~~---------------~~~~~-~-~~~~~~~l~~li~~~L~~dp 347 (413)
................ . +.. ......+... ..... . .......+.+||.+||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 7654322111111000 0 000 0000000000 00000 0 00124568899999999999
Q ss_pred CCCCCHHHHHHHHHHH
Q 015094 348 KHRPSMREVVETLERL 363 (413)
Q Consensus 348 ~~Rpt~~e~l~~L~~i 363 (413)
.+|||++|+++|-+..
T Consensus 427 ~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 427 QKRLNARQMTTHPYVL 442 (467)
T ss_pred hhCCCHHHHhcCcccc
Confidence 9999999999987653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=356.58 Aligned_cols=259 Identities=24% Similarity=0.315 Sum_probs=210.4
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
...++|++.+.||+|+||+||+|.+.. +++.||||++.... ......+.+|+.++..++|+||+++++.+.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS-------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC-------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 345799999999999999999996543 57899999986542 344566889999999999999999988765
Q ss_pred eCC--------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 153 EDK--------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 153 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
... .+++||||+.+|+|.+++..+......+++..+..++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSN 179 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCC
Confidence 432 3789999999999999997665555678999999999999999999997 669999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~- 252 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------E- 252 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------H-
Confidence 999999999998644332233334567999999999999999999999999999999999999999754211 0
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+..+.. ......+..++.++.+|+.+||+.||.+||++.+++++
T Consensus 253 ---------~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 ---------VMHKTLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---------HHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0111111 11123455677899999999999999999999999876
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.48 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=205.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.+... .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 4699999999999999999975431 24689999886432 23345678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 99999999999999999996543 68899999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+.. .
T Consensus 178 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----------------~ 236 (340)
T PTZ00426 178 AKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----------------I 236 (340)
T ss_pred CeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----------------H
Confidence 975322 1234579999999999998889999999999999999999999997643210 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
...+... ...++..++..+.++|.+||+.||.+|+ ++++++++.+
T Consensus 237 ~~~i~~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 237 YQKILEG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred HHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 1111111 1124556678899999999999999995 8999988743
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=339.34 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=200.0
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 160 (413)
+.||+|+||.||+|.... +++.||+|++.... ......+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEE
Confidence 469999999999996543 67899999987542 23445678899999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
|||+.+++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 74 ~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 74 MEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999999999888543 368899999999999999999997 6699999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+..
T Consensus 148 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----------------~~~~~~~ 209 (328)
T cd05593 148 D--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILM 209 (328)
T ss_pred c--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----------------HHHHhcc
Confidence 1 112234579999999999999999999999999999999999999997543210 0000100
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETL 360 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L 360 (413)
....++..++.++.+||.+||..||++|+ ++.+++++.
T Consensus 210 --~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 210 --EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred --CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 11234556778899999999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.81 Aligned_cols=269 Identities=29% Similarity=0.423 Sum_probs=210.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~- 153 (413)
.++|++.+.||+|+||.||+|++... ....+++.||+|++.... ....+.+.+|+.+++.+ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGI--EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEecccccc--ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 45899999999999999999965321 233467899999987543 23345678899999999 79999999998764
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCC------------------------------------------------------
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGAS------------------------------------------------------ 179 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------ 179 (413)
+..++++|||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46789999999999999998543211
Q ss_pred ---CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccc
Q 015094 180 ---VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256 (413)
Q Consensus 180 ---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y 256 (413)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++................++..|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1267888999999999999999996 67999999999999999999999999999864332222222234567789
Q ss_pred cCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHH
Q 015094 257 AAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQI 335 (413)
Q Consensus 257 ~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 335 (413)
+|||++.+..++.++|||||||++|+|++ |..||....... .+...+........+...+.++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----------------EFCRRLKEGTRMRAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCHHH
Confidence 99999999999999999999999999998 999997643211 0111111111222334566789
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 336 AQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 336 ~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
.+++.+||+.+|++||++.+++++|..+..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=342.62 Aligned_cols=240 Identities=30% Similarity=0.463 Sum_probs=204.6
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
++-||.|+.|.||+|+++ ++.||||+++.-. +-+|+-|++|+||||+.+.++|...-.+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl~---------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH---------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeecc---------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 466999999999999776 4789999875432 347888999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
||..|-|.++|... .++.......|..+|+.|+.|||.+. |||||||.-||||..+..|||+|||-++.....
T Consensus 193 fCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred ccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 99999999999544 47888899999999999999999855 999999999999999999999999999853222
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
...-.++||..|||||++.+.+.+.|+|||||||+|||||||..||...+...... .+-...
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----------------GVGsNs 327 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----------------GVGSNS 327 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE----------------eccCCc
Confidence 33445899999999999999999999999999999999999999998754322110 111233
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
+....|..+++.+.-||+.||+-.|..||++++++.||+..
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 44567889999999999999999999999999999999853
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=343.36 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=199.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||+||+|.... +++.||||++.... ......+.+|+.++..++|+||+++++.+.++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD-------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC-------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 368999999999999999996543 67899999987542 22345678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccC
Confidence 99999999999999999996543 68999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCC---------------------------------cceeecccccccccCccccccCCccchhhhHHHHHHHH
Q 015094 235 AKLGPSASQ---------------------------------SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLV 281 (413)
Q Consensus 235 a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 281 (413)
++....... .......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 875321100 00112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCC---CCCCHHHH
Q 015094 282 EILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPK---HRPSMREV 356 (413)
Q Consensus 282 ~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~---~Rpt~~e~ 356 (413)
+|++|..||....... .+..+........++ ..++.++.+||.+|+. +|. .||++.|+
T Consensus 228 ell~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei 290 (363)
T cd05628 228 EMLIGYPPFCSETPQE----------------TYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEI 290 (363)
T ss_pred HHHhCCCCCCCCCHHH----------------HHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 9999999997653211 111111100011122 2356788999998775 444 45899999
Q ss_pred HHH
Q 015094 357 VET 359 (413)
Q Consensus 357 l~~ 359 (413)
++|
T Consensus 291 ~~h 293 (363)
T cd05628 291 KTN 293 (363)
T ss_pred hCC
Confidence 987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=342.52 Aligned_cols=268 Identities=28% Similarity=0.386 Sum_probs=210.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
.++|+++++||+|+||.||+|.+... ........||||++.... ....+.+.+|+.+|+.+. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~--~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGL--SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEccc--CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56899999999999999999975421 222345679999997543 233467889999999996 99999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC--------------------------------------------------------
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA-------------------------------------------------------- 178 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 178 (413)
..+|+|||||++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998865321
Q ss_pred ------------------------------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 179 ------------------------------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 179 ------------------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
....+++..++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nill~ 271 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEEEe
Confidence 01246778889999999999999996 6699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 999999999999976433222222233456788999999988899999999999999999997 888887542110
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.+...+........+..++.++.+++.+||+.||++||++.+|.+.|+.+.
T Consensus 348 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 ------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011111111222334466788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=346.00 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=202.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||+||+|.+.. +++.||||++.... ......+.+|+.+|+.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD-------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence 368999999999999999997553 57899999987542 23345678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+.|++|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeeccc
Confidence 99999999999999999986543 68999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCc------------------------------------ceeecccccccccCccccccCCccchhhhHHHHH
Q 015094 235 AKLGPSASQS------------------------------------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGV 278 (413)
Q Consensus 235 a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 278 (413)
+......... ......+||+.|+|||++.+..++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 8753211100 0011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh--hcCCCchHHHHHHHHHHHHccccCCCCCCC---H
Q 015094 279 VLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEPKHRPS---M 353 (413)
Q Consensus 279 il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt---~ 353 (413)
++|+|++|..||....... ....+.... +.......++.++.+||.+||. +|.+|++ +
T Consensus 228 il~el~~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQE----------------TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred HHHHhhcCCCCCCCCCHHH----------------HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 9999999999997653211 001111100 1111112457789999999997 9999997 9
Q ss_pred HHHHHHHH
Q 015094 354 REVVETLE 361 (413)
Q Consensus 354 ~e~l~~L~ 361 (413)
.+++++-+
T Consensus 291 ~~ll~h~~ 298 (364)
T cd05599 291 NEIKSHPF 298 (364)
T ss_pred HHHhcCCC
Confidence 99988643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.60 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=200.6
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.|++++.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|+.+++.++|+||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD-------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence 58899999999999999996543 67899999986542 234567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||. .+|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 9999999999999999986543 68889999999999999999996 66999999999999999999999999997
Q ss_pred ccCCCCCC---------------------------------------------cceeecccccccccCccccccCCccch
Q 015094 236 KLGPSASQ---------------------------------------------SHVTTRVMGTYGYAAPEYVATGHLYVK 270 (413)
Q Consensus 236 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 270 (413)
........ .......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 53210000 001123579999999999998899999
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH--hhhcCCCchHHHHHHHHHHHHcc--ccC
Q 015094 271 SDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID--ARLQGQYPYKAAYQIAQLSLKCL--EAE 346 (413)
Q Consensus 271 ~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L--~~d 346 (413)
+|||||||++|||++|..||........ ...+.. ..........++.++.+||.+|| ..+
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTET----------------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHH----------------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCccc
Confidence 9999999999999999999976532110 001111 00111112246788999999955 445
Q ss_pred CCCCCCHHHHHHHHH
Q 015094 347 PKHRPSMREVVETLE 361 (413)
Q Consensus 347 p~~Rpt~~e~l~~L~ 361 (413)
+..|+++.++++|-.
T Consensus 293 ~~~R~~~~~~l~hp~ 307 (381)
T cd05626 293 RLGRNGADDIKAHPF 307 (381)
T ss_pred ccCCCCHHHHhcCcc
Confidence 556999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=327.61 Aligned_cols=269 Identities=28% Similarity=0.423 Sum_probs=213.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|.+.+.||+|+||.||++..... ....+...+|+|.+........+.+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNL--CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccC--CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35789999999999999999965321 1233567799999877665566779999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcC---------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 157 LLLVYEFMQKGSLENHLFGRG---------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
+++||||+.+++|.+++...+ .....+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcE
Confidence 999999999999999986543 122358999999999999999999996 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~ 306 (413)
+|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------- 230 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------- 230 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence 9999999975432221112223345778999999988899999999999999999998 898886543210
Q ss_pred hhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 307 PYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+.. ......+..++.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 231 -------~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 -------VIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------HHHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0001111 111112334567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=334.05 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=198.7
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHH---hhccCCCccceEeEEEe
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFL---GRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~ 153 (413)
|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.++ +.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~ 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK-------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc
Confidence 6788999999999999996553 67899999987542 22345566676655 56679999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.+++|..++.. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCccc
Confidence 9999999999999999988743 268999999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++...... ........|++.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 147 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---------------- 208 (324)
T cd05589 147 LCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---------------- 208 (324)
T ss_pred CCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----------------
Confidence 98742211 122334679999999999999999999999999999999999999997643210
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETL 360 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L 360 (413)
.+..+... ...++..++..+.+||.+||+.||.+|| ++.+++++.
T Consensus 209 ~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 209 VFDSIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 11111111 1234556778899999999999999999 677887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=324.80 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=207.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.+.||+|+||.||+|++.. ....+..||+|.++... ....+.+.+|+.+++.++||||+++++++..++.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~----~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKL----PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEec----CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 568999999999999999997653 22356789999987653 2334568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+++|.+++.... ..+++..++.++.||+.||+|||. .+++||||||+|||++.++.++++|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999999986532 368899999999999999999996 679999999999999999999999999876
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......++..|+|||++.+..++.++|||||||++|++++ |..||....... +
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----------------~ 217 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----------------V 217 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------H
Confidence 4321111 11112345678999999999999999999999999999775 999997643211 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...+........+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011111122233456778899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=336.33 Aligned_cols=242 Identities=28% Similarity=0.379 Sum_probs=197.6
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
||+|+||.||+|.+.. +++.||+|++... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEc
Confidence 7999999999997543 5788999998643 22344567889999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++...+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 74 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~- 146 (312)
T cd05585 74 FINGGELFHHLQREG----RFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD- 146 (312)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-
Confidence 999999999996543 68889999999999999999997 66999999999999999999999999998753221
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...... . .+..+...
T Consensus 147 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~----------~~~~~~~~- 208 (312)
T cd05585 147 -DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------E----------MYRKILQE- 208 (312)
T ss_pred -CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------H----------HHHHHHcC-
Confidence 12233467999999999999999999999999999999999999999754211 0 11111111
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCC---CHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRP---SMREVVETL 360 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rp---t~~e~l~~L 360 (413)
...++..++.++.+||.+||..||.+|| ++.++++|-
T Consensus 209 -~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 209 -PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 1234556778899999999999999997 467777653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=326.75 Aligned_cols=263 Identities=27% Similarity=0.445 Sum_probs=209.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|.+.+.||+|+||.||+|.+... ......+.||||.+...... ..+.+.+|+++|+.++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL--EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc--cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 4688999999999999999976432 12245688999998765443 45678999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCC----------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGA----------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
.++||||+++++|.+++...+. ....+.+..+..++.||+.+|.|||+ ++++||||||+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCe
Confidence 9999999999999999976432 23357888999999999999999996 66999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~ 305 (413)
++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------- 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------- 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------
Confidence 99999999875322222112223346788999999999999999999999999999998 999986543211
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.. ..+........+..++..+.+++.+||..||++||++.|+++.|.
T Consensus 233 --------~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 --------VI-ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --------HH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 111111112234456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=330.98 Aligned_cols=268 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.... +++.||||++..... .....+.+|+.+++.++||||+++++++..+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV-------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC-------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 3679999999999999999996543 578999999875432 22345678999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+. ++|.+++.... ..+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 9999999995 58888875432 357888999999999999999997 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh--h
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE--K 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~--~ 312 (413)
....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......... .......+.. .
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~ 226 (303)
T cd07869 151 RAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNE 226 (303)
T ss_pred eeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCCh
Confidence 7532211 12233568999999998865 45788999999999999999999999864321100 0000000000 0
Q ss_pred hhh------hHhHHhhhcCCCc---------hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 313 RKF------RHIIDARLQGQYP---------YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 313 ~~~------~~~~~~~~~~~~~---------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+ ............+ ...+.++.+|+.+||+.||++|||+.++++|-.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 000 0000000000000 012357889999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.40 Aligned_cols=248 Identities=28% Similarity=0.387 Sum_probs=200.5
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
++.||+|+||.||+|+... ....++.||||++.... ......+.+|+.+|+.++||||+++++++..++.+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~ 76 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVT----GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLY 76 (323)
T ss_pred CceeeecCCeEEEEEEEcc----cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEE
Confidence 3689999999999996532 22467899999986532 223455778999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+||||+.+++|.+++...+ .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999999999986543 57888889999999999999997 66999999999999999999999999998743
Q ss_pred CCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
... ........|++.|+|||++.+..++.++|||||||++|+|++|..||....... ....+
T Consensus 151 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------------~~~~~ 212 (323)
T cd05584 151 IHE--GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------------TIDKI 212 (323)
T ss_pred ccC--CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------------HHHHH
Confidence 211 122234579999999999998889999999999999999999999997643210 11111
Q ss_pred HHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 015094 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETL 360 (413)
Q Consensus 319 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L 360 (413)
... ...++..++.++.+||.+||+.||++|| ++.+++++-
T Consensus 213 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 213 LKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 111 1234456678899999999999999999 899988864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=326.69 Aligned_cols=268 Identities=27% Similarity=0.445 Sum_probs=214.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.+|.+.+.||+|+||.||+|.+... ....+...+++|.+........+.+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL--SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc--CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4688899999999999999965431 12345677999998877666667789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 015094 158 LLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~ 225 (413)
++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCC
Confidence 999999999999999975432 12347889999999999999999996 6799999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~ 304 (413)
.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------- 233 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 999999999975433222222233456788999999998999999999999999999998 999986543211
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++..+.+++.+||..||++||++.++++.|..+...
T Consensus 234 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 ----------VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----------HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0001111111122334567899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=344.00 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|.+.+.||+|+||+||+|.+.. +++.||||++..... .....+.+|+.++..++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD-------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC-------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence 368999999999999999997553 678999999875421 3445688899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCC
Confidence 9999999999999999999655 368899999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCC---------------------------CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCC
Q 015094 235 AKLGPSAS---------------------------QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL 287 (413)
Q Consensus 235 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~ 287 (413)
+....... .........||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 97643322 001123457999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH--hhhcCCCchHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHH
Q 015094 288 RALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID--ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-MREVVETLE 361 (413)
Q Consensus 288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-~~e~l~~L~ 361 (413)
.||....... ....+.. ..........++.++.+||.+||. ||.+|++ +.+++++..
T Consensus 228 ~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 228 PPFYSDTLQE----------------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCCCCCCHHH----------------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 9998654211 0111111 111111112257889999999997 9999999 999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=344.10 Aligned_cols=254 Identities=21% Similarity=0.275 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++++.||+|+||.||+|.... +++.||||++.... ....+.+.+|+.+|+.++|+||+++++.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD-------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 368999999999999999996543 57899999986542 12345678999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+++++|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999999999996543 67888899999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCC-----------------------------------------CcceeecccccccccCccccccCCccchhhh
Q 015094 235 AKLGPSAS-----------------------------------------QSHVTTRVMGTYGYAAPEYVATGHLYVKSDV 273 (413)
Q Consensus 235 a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 273 (413)
+....... ........+||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 75221000 0000123579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH--hhhcCCCchHHHHHHHHHHHHccccCCCCCC
Q 015094 274 YGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID--ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP 351 (413)
Q Consensus 274 wslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp 351 (413)
|||||++|+|++|..||....+.... ..+.. ..........++.++.++|.+|+ .+|.+|+
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQ----------------LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHH----------------HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 99999999999999999865432100 00000 00111112246778899999976 5999999
Q ss_pred ---CHHHHHHHHH
Q 015094 352 ---SMREVVETLE 361 (413)
Q Consensus 352 ---t~~e~l~~L~ 361 (413)
++.++++|-+
T Consensus 291 ~~~t~~ell~h~~ 303 (376)
T cd05598 291 GKNGADEIKAHPF 303 (376)
T ss_pred CCCCHHHHhCCCC
Confidence 8999998744
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=349.90 Aligned_cols=269 Identities=21% Similarity=0.324 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC--
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-- 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 154 (413)
..+|++.+.||+|+||.||+|.+.. +++.||||++.... ....+|+.+|+.++|+||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICID-------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECC-------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 4679999999999999999997543 57899999885442 2345799999999999999999876432
Q ss_pred ------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-Ce
Q 015094 155 ------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TA 227 (413)
Q Consensus 155 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~ 227 (413)
..+++||||+.+ +|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCce
Confidence 247799999965 7887775544444578999999999999999999997 6699999999999998654 79
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
||+|||+++..... .......||+.|+|||++.+. .|+.++|||||||++|+|++|.+||................
T Consensus 211 kL~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 211 KLCDFGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred eeeccccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999999854322 122345789999999988664 68999999999999999999999998754332111110000
Q ss_pred --hhhhhh----h-----hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 307 --PYLSEK----R-----KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 307 --~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+..... . .+..+....+...++...+.++.+||.+||..||.+|||+.|+++|-+.
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 000000 0 0000000111122333456789999999999999999999999988663
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=329.13 Aligned_cols=271 Identities=28% Similarity=0.406 Sum_probs=213.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
++|.+.+.||+|+||.||+|.+.............||+|.+.... ......+.+|+.+++.+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999997654222222345679999987642 33456788899999999 6999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
..|+||||+.+++|.+++..+.. ....+++..++.++.|++.||+|||+ ++++||||||+|||++.
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTE 175 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheEEcC
Confidence 99999999999999999976432 12357888999999999999999996 67999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~ 302 (413)
++.+||+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||......
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~------ 249 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ 249 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH------
Confidence 99999999999875432221111222234568999999988889999999999999999998 88888653211
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.+...+........+..++.++.+|+.+||..+|.+||++.++++.|..+....
T Consensus 250 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 -----------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -----------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111111112222344566789999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=341.13 Aligned_cols=265 Identities=21% Similarity=0.253 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|++.+.||+|+||.||+|++.. +++.||||.... ..+.+|+++|+.|+||||++++++|..+..
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~-------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK-------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC-------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 4679999999999999999997654 678999997532 346789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+|||++. ++|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 999999995 68988885432 67889999999999999999997 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc-h----hhHhhhhh---
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH-N----LVDWIKPY--- 308 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~-~----~~~~~~~~--- 308 (413)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... . ....+...
T Consensus 231 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 231 FPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred cccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 432211 11223457999999999999999999999999999999999999877543322110 0 00000000
Q ss_pred -----hhhhhhhhHhHHhh----hc--CCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 309 -----LSEKRKFRHIIDAR----LQ--GQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 309 -----~~~~~~~~~~~~~~----~~--~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
......+....... .. ... ....+.++.+||.+||+.||.+|||+.|++++-+.
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 00000011111000 00 000 01346689999999999999999999999987653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=337.55 Aligned_cols=246 Identities=27% Similarity=0.361 Sum_probs=199.7
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 160 (413)
+.||+|+||.||+|.... +++.||+|++.... ......+.+|+++++.++||||+++++++...+.+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEE
Confidence 479999999999996543 67899999987542 23345677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+ .++|+||||||+|||++.++.+||+|||++.....
T Consensus 74 ~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9999999999988543 268899999999999999999995 25699999999999999999999999999874321
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+..+..
T Consensus 149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~----------------~~~~i~~ 210 (325)
T cd05594 149 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILM 210 (325)
T ss_pred C--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH----------------HHHHHhc
Confidence 1 112234579999999999999999999999999999999999999997543210 0001111
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
....++..++.++.+||.+||+.||++|+ ++.++++|.+
T Consensus 211 --~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 211 --EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 11234456778899999999999999997 8999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=332.69 Aligned_cols=258 Identities=27% Similarity=0.351 Sum_probs=203.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhcc-CCCccceEeEEEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 153 (413)
+|++.+.||+|+||.||+|+... ...+++.||+|++.... ....+.+.+|+.+++.+. |+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc----cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 48889999999999999986532 23467899999986432 223456788999999995 9999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++.+|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCc
Confidence 999999999999999999986543 68899999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++........ .......||..|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 151 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------------ 217 (332)
T cd05614 151 LSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS------------ 217 (332)
T ss_pred CCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH------------
Confidence 9875322211 122345799999999998765 47889999999999999999999997543221110
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
.+...+. .....++..++..+.+|+.+||..||++|| ++++++++-+
T Consensus 218 -~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 218 -EVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred -HHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 0000000 111234456778899999999999999999 7889987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=344.84 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=199.9
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
+|++++.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++.+.+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD-------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC-------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC
Confidence 58899999999999999996543 67899999987542 233456889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCC
Confidence 9999999999999999986543 67888999999999999999997 66999999999999999999999999997
Q ss_pred ccCCCCC---------------------------------------------CcceeecccccccccCccccccCCccch
Q 015094 236 KLGPSAS---------------------------------------------QSHVTTRVMGTYGYAAPEYVATGHLYVK 270 (413)
Q Consensus 236 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 270 (413)
....... ........+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0000123579999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh--hcCCCchHHHHHHHHHHHHccccCCC
Q 015094 271 SDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEPK 348 (413)
Q Consensus 271 ~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp~ 348 (413)
+|||||||++|+|++|..||....+.. ....+.... .........++++.++|.+|+ .+|.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLE----------------TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHH----------------HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 999999999999999999997653211 001111100 111112346778999999976 5999
Q ss_pred CCCC---HHHHHHHH
Q 015094 349 HRPS---MREVVETL 360 (413)
Q Consensus 349 ~Rpt---~~e~l~~L 360 (413)
+|++ +.++++|-
T Consensus 292 ~R~~~~~~~ei~~hp 306 (382)
T cd05625 292 DRLGKNGADEIKAHP 306 (382)
T ss_pred HcCCCCCHHHHhcCC
Confidence 9987 88888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=330.10 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=208.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.+.||+|+||.||+|.+.. ........||+|++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~---~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEec---CCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 579999999999999999997653 122234569999987543 34456788999999999999999999988764 5
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++|+||+.+|+|.+++.... ..++...++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccccccc
Confidence 789999999999999996543 257888899999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...............++..|+|||++.+..++.++|||||||++|+|++ |..||...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----------------~~ 220 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 220 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HH
Confidence 6443222222222334678999999999999999999999999999998 99998754211 01
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
..++........+..++.++.+++.+||..||.+||++.+++..|..+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 111222222223345667899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=325.12 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=206.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..++|++.+.||+|+||.||+|.+... .....+..||||++.... ......+.+|+.+++.++|+||+++++++.++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~--~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV--VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC--CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 356799999999999999999976532 122356789999886432 23445688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCC------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGAS------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
...++||||+.+++|.+++...... ...+.+..++.++.|++.||.|||+ .+++||||||+||+++.++.++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999998653221 1245778889999999999999996 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---------- 229 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---------- 229 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------
Confidence 999999875332222111122345778999999988899999999999999999999 688886542210
Q ss_pred hhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+... .....+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 230 ------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 ------VLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ------HHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00011111 111233456678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=335.10 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=203.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|.+.+.||+|+||.||+|.... +++.||||++..... ...+.+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA-------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 368999999999999999996543 678999999875422 2445678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCC
Confidence 99999999999999999996542 368999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc------cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA------TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+........ .......||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------- 216 (330)
T cd05601 149 AARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----------- 216 (330)
T ss_pred CeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----------
Confidence 976432221 1223357899999999986 4567899999999999999999999997643211
Q ss_pred hhhhhhhhHhHHhhhcCCC--chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQY--PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+........+ ...++.++.+||.+||. +|.+|||+.++++|-.
T Consensus 217 -----~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 217 -----TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred -----HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 11111111111111 12467889999999998 9999999999997643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=333.91 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=199.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
++||+|+||.||+|.+.. +++.||||+++... ....+.+.+|+.+++.+ +||||+++++++.+...+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEE
Confidence 479999999999997654 57899999987542 23345678899999998 69999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 99999999999988544 368999999999999999999997 669999999999999999999999999987421
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCc--chhhHhhhhhhhhhhhhhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ--HNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 317 (413)
. .........||..|+|||++.+..++.++|+|||||++|+|++|..||+....... .....+ ....
T Consensus 148 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~---------~~~~ 216 (329)
T cd05588 148 R--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY---------LFQV 216 (329)
T ss_pred c--CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH---------HHHH
Confidence 1 11223346799999999999999999999999999999999999999974322110 000000 0111
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS------MREVVETLE 361 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt------~~e~l~~L~ 361 (413)
+... ...++..++.++.+||.+||+.||.+|++ +.++++|-+
T Consensus 217 ~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 217 ILEK--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 1111 12345566788999999999999999997 678877633
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=333.18 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=200.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCC-CccceEeEEEeC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHP-NLVRLLGYCWED 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~ 154 (413)
+|++.+.||+|+||.||+|.... +++.||||++.... ....+.+..|+.++..+.|+ +|+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG-------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Confidence 48889999999999999997553 57889999987542 23456678899999999865 688899999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 99999999999999999986543 57888999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 148 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----------------~ 209 (324)
T cd05587 148 CKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------L 209 (324)
T ss_pred ceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 8742211 112334679999999999999999999999999999999999999997643210 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVET 359 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~ 359 (413)
+..+.. ....++...+.++.+|+.+||..||.+|++. ++++++
T Consensus 210 ~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 210 FQSIME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111 1123455677889999999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.55 Aligned_cols=272 Identities=26% Similarity=0.403 Sum_probs=213.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
..+|.+.+.||+|+||.||+|.+..........+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 4578999999999999999997543222223345689999987542 34456788999999999 799999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
...|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nili~ 171 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVLVT 171 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEEEc
Confidence 999999999999999999976432 12357788899999999999999996 6799999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---- 247 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 247 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----
Confidence 999999999999986433222222223345678999999988889999999999999999998 777875432110
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+...+........+..++..+.+|+.+||..+|.+||++.++++.|..+....
T Consensus 248 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 -------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred -------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 00111111122234466788999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.46 Aligned_cols=260 Identities=25% Similarity=0.450 Sum_probs=208.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||+||+|.+... ......||||.+.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLP----GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccC----CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 5789999999999999999987531 1235689999887543 2334568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+|+||||+|||++.++.++|+|||++.
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 999999999999999986543 268899999999999999999996 679999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----------------~~ 217 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----------------DV 217 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----------------HH
Confidence 7542222222222345678999999988899999999999999999998 99888643211 01
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...+........+..++..+.+|+.+||+.+|++||++.+++++|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 218 IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111112223445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=335.88 Aligned_cols=269 Identities=21% Similarity=0.247 Sum_probs=204.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|++++.||+|+||.||+|.... ...++.|++|.+.... ...+|+.+|+.++||||+++++++.....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~-----~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHG-----DEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcC-----CccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 4679999999999999999996432 2356789999876542 34689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+|||++. ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 999999995 5888888433 368999999999999999999996 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh------
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS------ 310 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~------ 310 (413)
...............||+.|+|||++.+..++.++|||||||++|+|++|..||..............+...+.
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 64433332233356799999999999999999999999999999999999999977554321111100000000
Q ss_pred ---hhhhhhHhHHh---hhcCC--Cc-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 311 ---EKRKFRHIIDA---RLQGQ--YP-----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 311 ---~~~~~~~~~~~---~~~~~--~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+...+.. ..... .+ ...+.++.+||.+||..||++|||+.+++.+-..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 00000000000 00000 01 1235678899999999999999999999988554
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=331.04 Aligned_cols=243 Identities=28% Similarity=0.414 Sum_probs=194.5
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||.||+|.+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++..+..+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 469999999999997653 57899999987542 22334556677777654 79999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.|++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999999999999986543 68889999999999999999997 669999999999999999999999999997532
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+... .+..+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----------------~~~~i~ 209 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----------------LFDSIL 209 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 211 22344679999999999999999999999999999999999999997643210 001111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR-EVVET 359 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~-e~l~~ 359 (413)
. ....++..++.++.+||.+||+.||.+||++. +++++
T Consensus 210 ~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 210 N--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred c--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1 12234556778899999999999999999875 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=332.76 Aligned_cols=244 Identities=29% Similarity=0.408 Sum_probs=196.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||.||+|++.. +++.||||++.... ....+.+..|+.++..+ +||||+++++++...+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEE
Confidence 469999999999997553 57899999987542 23445677888888876 59999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~Ey~~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 74 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEcCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 999999999999886543 68899999999999999999997 669999999999999999999999999987522
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+.
T Consensus 148 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------------~~~~i~ 209 (320)
T cd05590 148 F--NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD----------------LFEAIL 209 (320)
T ss_pred c--CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----------------HHHHHh
Confidence 1 1122334579999999999998999999999999999999999999997643211 011111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM------REVVETL 360 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~------~e~l~~L 360 (413)
.. ...++...+.++.+||.+||+.||.+|+++ +++++|-
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~ 254 (320)
T cd05590 210 ND--EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP 254 (320)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence 11 112344567889999999999999999998 6676653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=334.97 Aligned_cols=270 Identities=24% Similarity=0.370 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC--
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-- 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 154 (413)
+|++.+.||+|+||.||+|+... +++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC-------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 58899999999999999997543 6789999988643 223345688999999999999999999987643
Q ss_pred ---CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 155 ---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 155 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 74 REFKDIYVVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEcc
Confidence 35899999995 68999885432 68899999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCc-ceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--
Q 015094 232 FGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK-- 306 (413)
Q Consensus 232 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~-- 306 (413)
||+++........ .......|++.|+|||++.+ ..++.++|||||||++|+|++|++||................
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999753222111 11234579999999998865 678899999999999999999999997654321111100000
Q ss_pred hhhh-----hhhhhhHhHHhhhc---CCCc---hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 307 PYLS-----EKRKFRHIIDARLQ---GQYP---YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 307 ~~~~-----~~~~~~~~~~~~~~---~~~~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+... ........+..... ..+. ...+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 0000 00000011111000 0000 1245678999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=339.94 Aligned_cols=254 Identities=24% Similarity=0.274 Sum_probs=203.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..+|++.+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKS-------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4579999999999999999996553 67899999986432 2233457789999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+..+|+||||++||+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEecc
Confidence 99999999999999999998532 47888889999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccC----CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATG----HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------------ 254 (370)
T cd05596 188 TCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------ 254 (370)
T ss_pred ceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------------
Confidence 9975322111 122345799999999988653 47899999999999999999999997653211
Q ss_pred hhhhhhhHhHHhhhcCCCch--HHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYPY--KAAYQIAQLSLKCLEAEPKH--RPSMREVVETLE 361 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L~ 361 (413)
.+..+........++. .++.++.+||.+||..+|.+ |+++.++++|.+
T Consensus 255 ----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 255 ----TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred ----HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 1112222111112222 46789999999999999988 999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=322.54 Aligned_cols=266 Identities=28% Similarity=0.422 Sum_probs=210.1
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+|++.+.||+|+||.||+|+.... ........+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL--KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecC--CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 478899999999999999976432 112244679999887553 23456788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCC--------------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 015094 158 LLVYEFMQKGSLENHLFGRGA--------------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKAS 217 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~ 217 (413)
++||||+.+++|.+++..... ....+++..++.++.|++.||.|||+ .+|+||||||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~ 156 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAAR 156 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhh
Confidence 999999999999999864221 12357888999999999999999996 66999999999
Q ss_pred cEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 015094 218 NILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPS 296 (413)
Q Consensus 218 Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~ 296 (413)
|||+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999875332222111222345678999999988889999999999999999998 99999754321
Q ss_pred CcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 297 GQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
. +............+..++.++.+++.+||+.+|++||++.++++.|+.+..
T Consensus 237 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 R-----------------LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-----------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 111122222223344567789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=323.99 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=200.3
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
||+|+||+||+|.+.. +++.||+|.+..... ...+.+..|+.+++.++|+||+++.+++..+..+|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRA-------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEcc-------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEe
Confidence 6999999999996543 678999999865422 234567789999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+++++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 151 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence 999999998886544444578999999999999999999997 669999999999999999999999999987533221
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||......... ......+...
T Consensus 152 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~------------~~~~~~~~~~- 216 (280)
T cd05608 152 --SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN------------KELKQRILND- 216 (280)
T ss_pred --ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH------------HHHHHhhccc-
Confidence 1223457899999999999999999999999999999999999999764321100 0000001110
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
...++..++..+.+|+.+||+.||++|| ++++++++-+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 217 -SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 1123445778899999999999999999 7788887644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=325.56 Aligned_cols=268 Identities=28% Similarity=0.421 Sum_probs=211.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+.... .......+|+|.+.... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~--~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLD--NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCC--CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3467999999999999999999765321 12345789999887542 23445688999999999 79999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcC------------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRG------------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~ 221 (413)
++.+++||||+.+++|.+++.... .....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLV 165 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEEE
Confidence 999999999999999999986532 233468899999999999999999996 669999999999999
Q ss_pred cCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 015094 222 DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHN 300 (413)
Q Consensus 222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~ 300 (413)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 9999999999999986433222111222335677999999988899999999999999999997 888886543211
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
....+........+..++..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 243 --------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 --------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 01111111122334456778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=332.35 Aligned_cols=244 Identities=27% Similarity=0.371 Sum_probs=197.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||.||+|.+.. +++.||||++.... ....+.+..|++++..+ +||||+++++++..++.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECC-------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEE
Confidence 469999999999997543 57899999987542 23345677888888876 69999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+++++|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 74 VMEYVNGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999886543 68888999999999999999997 669999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|..||....... .+..+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----------------~~~~i~ 209 (321)
T cd05591 148 LN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----------------LFESIL 209 (321)
T ss_pred cC--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----------------HHHHHH
Confidence 21 122334579999999999998899999999999999999999999997653211 111111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCC-------CHHHHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-------SMREVVETL 360 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-------t~~e~l~~L 360 (413)
.. ...++..++.++.+||.+||..||++|+ ++.+++++.
T Consensus 210 ~~--~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 210 HD--DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 11 1123445678899999999999999999 888888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=322.42 Aligned_cols=263 Identities=27% Similarity=0.449 Sum_probs=207.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..|++.+.||+|+||+||+|.+.. .....+..|++|.+.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL---PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec---CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 468889999999999999997532 122356789999987533 3344678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGA-------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
.|+||||+.+++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~ 159 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGE 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcC
Confidence 9999999999999999853321 12357888899999999999999996 67999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~ 302 (413)
++.+||+|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999976433222222333446678999999988889999999999999999998 88888654211
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.....+........+..++..+.+++.+||+.||.+||++.+++++|..
T Consensus 234 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -----------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0011111111112344567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=329.97 Aligned_cols=243 Identities=29% Similarity=0.403 Sum_probs=195.0
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||.||+|.+.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEE
Confidence 479999999999997553 67899999987542 12345567788888754 79999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 74 VMEFLNGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EECCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 999999999999986543 67888999999999999999996 669999999999999999999999999987422
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+..+.
T Consensus 148 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~----------------~~~~~~ 209 (316)
T cd05620 148 F--GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE----------------LFESIR 209 (316)
T ss_pred c--CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 1 1122344679999999999999999999999999999999999999997543210 001111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR-EVVET 359 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~-e~l~~ 359 (413)
. ....++..++.++.+||.+||+.||++|+++. ++++|
T Consensus 210 ~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 210 V--DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred h--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0 11233445678899999999999999999984 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=339.06 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKS-------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 4689999999999999999997653 67899999986431 2234457889999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+..+|+||||+.+++|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999999998532 47888999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccC----CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATG----HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 188 ~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------------- 253 (370)
T cd05621 188 TCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------------- 253 (370)
T ss_pred cceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------------
Confidence 998643211 1122346799999999998654 3778999999999999999999999765321
Q ss_pred hhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKH--RPSMREVVETLER 362 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L~~ 362 (413)
..+..+........++ ..++..+.+++.+||..++.+ |+++.++++|-+.
T Consensus 254 ---~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 254 ---GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred ---HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 1112222211111222 245788999999999865544 8899999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=326.34 Aligned_cols=272 Identities=25% Similarity=0.403 Sum_probs=212.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
..+|.+.+.||+|+||.||+|.+.............||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3578999999999999999997543222223456789999887542 33456788999999999 599999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
..+|+||||+.+++|.+++..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~ 168 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVT 168 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEEEc
Confidence 999999999999999999965421 12357888999999999999999996 6799999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999985432221111122234567999999988899999999999999999999 888886542211
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+...+........+..++.++.+|+.+||..||++||++.++++.|..+....
T Consensus 245 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 -------------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 00111111112334566778999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=317.54 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=208.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|++.. +++.||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL-------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC-------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence 479999999999999999997653 5789999987542 223345688899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..++||||+++++|.+++.........+++..+..++.||+.||.|||+ ++|+|+||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~ 152 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECcccc
Confidence 99999999999999999886544334468889999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+....... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~----------- 215 (267)
T cd08228 153 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FS----------- 215 (267)
T ss_pred ceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HH-----------
Confidence 87643221 11223468889999999988889999999999999999999999986542210 00
Q ss_pred hhHhHHh-hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 315 FRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 315 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
+...+.. ..........+..+.+++.+||..+|++||++.++++.|+.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 216 LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0001111 1111122345678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=315.01 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=197.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|+||.||+|.+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.....+|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEec-------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 469999999999997643 57889999876543 2344678899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 74 LVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCccccccc
Confidence 999999999986432 257889999999999999999996 669999999999999999999999999987533211
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (413)
..........+..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....+..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~ 211 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQ 211 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHc
Confidence 1111111123456999999988899999999999999999998 88888643211 11111112
Q ss_pred hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 322 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
......+..++..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2222344456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=329.14 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=195.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
...+|++.+.||+|+||.||+|.+.. +++.||+|+..... ...|+.+++.++|+||+++++++....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG-------QPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC-------CCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 44679999999999999999997543 56789999754432 346899999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+|||++. ++|.+++.... ..+++..++.++.||+.||.|||. ++|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred eeEEEEEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccc
Confidence 9999999995 58888885433 368899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH----hhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD----WIKPYLSE 311 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~----~~~~~~~~ 311 (413)
..... ........||..|+|||++.+..++.++|||||||++|+|+++..++....+........ .+......
T Consensus 205 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~ 281 (357)
T PHA03209 205 QFPVV---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281 (357)
T ss_pred ccccc---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence 75221 112234569999999999999999999999999999999998665543332222111000 00000000
Q ss_pred ----h---------hhhhHhHHhhhcC--CC-------chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 312 ----K---------RKFRHIIDARLQG--QY-------PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 312 ----~---------~~~~~~~~~~~~~--~~-------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
. ......+...... .+ ...++.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 0 0000000000000 00 0133456778999999999999999999998743
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=331.17 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=200.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
+|.+.+.||+|+||.||+|++.. +++.||||++.... ....+.+..|..++..+. |++|+++++++...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG-------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC
Confidence 47889999999999999996543 57899999987542 223345667888888774 89999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCC
Confidence 99999999999999999986543 68889999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 148 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----------------~ 209 (323)
T cd05616 148 CKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------L 209 (323)
T ss_pred ceecCC--CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 874221 1112334679999999999999999999999999999999999999997643210 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVET 359 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~ 359 (413)
+..+... ...++...+.++.+|+.+||+.||.+|+++ .+++++
T Consensus 210 ~~~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 210 FQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1111111 123455677889999999999999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=324.05 Aligned_cols=267 Identities=25% Similarity=0.357 Sum_probs=196.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhc---cCCCccceEeEEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRL---SHPNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~ 152 (413)
++|++.+.||+|+||+||+|.+.. ..++.||||.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 479999999999999999997532 1367899998864321 2234556777777766 6999999999875
Q ss_pred -----eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 153 -----EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 153 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
....+++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCE
Confidence 2456899999996 59999886543 2357889999999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||+|||++...... .......|+..|+|||++.+..++.++|||||||++|+|++|.+||.................
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 99999999753322 223345789999999999888999999999999999999999999987543221111100000
Q ss_pred hhhhhhhhhH---hHHhhhc---C----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 308 YLSEKRKFRH---IIDARLQ---G----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 308 ~~~~~~~~~~---~~~~~~~---~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
. .....+.. +....+. . .....++..+.+|+.+||+.||++|||+.+++++
T Consensus 227 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 227 L-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred C-CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00000000 0000000 0 0112346678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=329.50 Aligned_cols=243 Identities=29% Similarity=0.421 Sum_probs=197.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||+||+|.+.. +++.||||++.... ......+.+|+.+++.+ +||||+++++++...+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 469999999999997653 57889999987542 23445677899999888 59999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.|++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 999999999999886543 68999999999999999999996 669999999999999999999999999987422
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. .......+|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+.
T Consensus 148 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----------------~~~~i~ 209 (318)
T cd05570 148 LG--GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----------------LFQSIL 209 (318)
T ss_pred cC--CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----------------HHHHHH
Confidence 11 112234578999999999999999999999999999999999999997543110 001111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVET 359 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~ 359 (413)
.. ...++..++..+.+||.+||..||.+||++ .+++++
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 210 ED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11 122344567889999999999999999999 888875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=322.46 Aligned_cols=266 Identities=29% Similarity=0.416 Sum_probs=210.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
..++|.+.+.||+|+||.||+|.+... .....+..||||.+.... ....+.+.+|+.+++++ +|+||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGL--SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecC--CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345799999999999999999975321 223456789999887553 23446788999999999 79999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.+++|.+++..... ..+++..+..++.|++.||.|||+ ++|+|+||||+|||++.++.++|+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999864332 247899999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------------- 251 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------------- 251 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------
Confidence 9875433222112223346778999999989999999999999999999998 999987543210
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+...+........+...+.++.+|+.+||..+|++|||+.++++.|.++
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 -KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111222222223334567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=319.64 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=212.9
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEE
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
|.+++.||+|+||.||+|.+.+ +|..+|||.+..+. +++.+..|+.||++.+.+++|++|+.|.....+|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E-------sG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE-------SGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc-------cCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 5567789999999999997665 79999999987765 67889999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
|||||..|++.++++.+. +++.+..+..+++..+.||+|||.. .-||||||..|||++.+|..||+|||.|....
T Consensus 106 VMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~--~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL--KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred ehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH--HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 999999999999997654 4899999999999999999999964 47999999999999999999999999997532
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
+ .-.....++||+.|||||++..-.|+.++||||||++..||..|++||....+......+..
T Consensus 181 D--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT--------------- 243 (502)
T KOG0574|consen 181 D--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT--------------- 243 (502)
T ss_pred h--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---------------
Confidence 2 22234567899999999999999999999999999999999999999987765543322111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.....-..|..++.++.+||++||.+.|++|.|+.++++|-
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 01111234567899999999999999999999999998763
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.37 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=197.5
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.++..+ +||||+++++++..++.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEE
Confidence 479999999999997554 5789999998754 223445677899888776 79999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99999999999888543 368899999999999999999997 669999999999999999999999999987422
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhhhhhhhhhhhhhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH--NLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 317 (413)
.. ........||..|+|||++.+..++.++|||||||++|+|++|..||......... ....+. ...
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~ 216 (329)
T cd05618 148 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQV 216 (329)
T ss_pred CC--CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH---------HHH
Confidence 11 11223467999999999999999999999999999999999999999642211100 000000 001
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM------REVVET 359 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~------~e~l~~ 359 (413)
+.. ....+|...+..+.+||.+||+.||++|+++ .++++|
T Consensus 217 i~~--~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 217 ILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred Hhc--CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111 1123556677889999999999999999984 677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.93 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=207.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.+|.+.+.||+|+||.||+|.+.. .++.||+|.+.... .....+.+|+++++.++|+||+++++++..+..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec-------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 458888999999999999997654 57889999987553 3356788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+++++|.+++.... ...+++..++.++.|++.+|+|||+ ++++||||||+||+++.++.+||+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999986543 2357888999999999999999996 6799999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----------------~~ 215 (263)
T cd05052 154 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VY 215 (263)
T ss_pred ccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HH
Confidence 432211 11112234567999999988999999999999999999998 899987542210 00
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
..+........+..++.++.++|.+||..||++||++.++++.|+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112222334556778999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=317.41 Aligned_cols=261 Identities=29% Similarity=0.455 Sum_probs=205.1
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe-
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE- 156 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 156 (413)
|++.+.||+|+||.||+|.+.. ....+..||+|++.... ....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ----DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEec----CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 6788999999999999997653 22345789999987542 3345678999999999999999999998766544
Q ss_pred -----eEEEEeeCCCCCHHHhhhhcC--CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 157 -----LLLVYEFMQKGSLENHLFGRG--ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 157 -----~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
.++||||+.+++|..++.... .....+++..++.++.|++.||.|||+ .+|+||||||+||++++++.+||
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEE
Confidence 799999999999999985432 223468889999999999999999996 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----------- 223 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----------- 223 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence 99999986433222111222335678999999988889999999999999999999 888886543210
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+ ..+........+..++.++.+++.+||+.||++||++.++++.|+.+
T Consensus 224 -----~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 -----IY-DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----HH-HHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 11111111223456778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=323.40 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=204.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.|++.+.||+|+||.||++.+.. +++.||||++..... .....+.+|+.+++.++|+||+++++.+..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC-------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC
Confidence 47889999999999999996543 578999999865422 22345678999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999998885432 2368899999999999999999997 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||......... ..+
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~ 213 (285)
T cd05605 150 VEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEV 213 (285)
T ss_pred eecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHH
Confidence 7632211 123357899999999998889999999999999999999999999764321100 001
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
...+. .....++..++..+.+||.+||..||++|| ++.+++++-+
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 214 ERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred HHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 11111 111234456778899999999999999999 8889887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=319.71 Aligned_cols=263 Identities=28% Similarity=0.435 Sum_probs=209.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|.+.+.||+|+||.||+|..... ....++..+++|.+........+.+.+|+++++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNL--LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecC--CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 4688899999999999999965321 23345678999998876666667899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCC-----------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 158 LLVYEFMQKGSLENHLFGRGA-----------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCC
Confidence 999999999999999865432 11347889999999999999999996 66999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~ 305 (413)
+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |.+||.......
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------- 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------- 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------
Confidence 99999999875332221111222345678999999999999999999999999999998 899986532211
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
... ..........+..++..+.+|+.+||+.||.+||++.++++.|+
T Consensus 233 --------~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 --------AIE-CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --------HHH-HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 011 11111112233456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=326.95 Aligned_cols=243 Identities=29% Similarity=0.408 Sum_probs=194.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhh-ccCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGR-LSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||+||+|.+.. +++.||||++.... ....+....|..++.. ++||||+++++++.+.+.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEE
Confidence 469999999999997553 57889999987542 1234456678888876 489999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~ey~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 74 VMEYLNGGDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 999999999999986532 67888899999999999999996 669999999999999999999999999987422
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. ........||..|+|||++.+..++.++|||||||++|+|++|..||....... .+..+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~i~ 209 (316)
T cd05619 148 LG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----------------LFQSIR 209 (316)
T ss_pred CC--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHH
Confidence 11 112334579999999999999999999999999999999999999997643210 000110
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR-EVVET 359 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~-e~l~~ 359 (413)
.....++..++.++.+||.+||+.||++|+++. +++++
T Consensus 210 --~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 210 --MDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred --hCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 011223445677899999999999999999997 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=326.25 Aligned_cols=243 Identities=28% Similarity=0.384 Sum_probs=192.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHH-HHhhccCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVN-FLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||+||+|.+.. +++.||||++..... .....+..|.. +++.++||||+++++++...+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEE
Confidence 479999999999997653 678999999865421 22234445544 5678999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 74 VLDYVNGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEcCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 999999999999986533 68889999999999999999996 669999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+... .+..+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~ 209 (323)
T cd05575 148 EH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----------------MYDNIL 209 (323)
T ss_pred cC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHH
Confidence 21 122334579999999999999999999999999999999999999997642110 111111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH----HHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR----EVVET 359 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~----e~l~~ 359 (413)
... ...+...+..+.+||.+||+.||.+||++. +++++
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 210 NKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 111 123345678899999999999999999884 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=317.73 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.+.||+|+||+||+|.+... .......|++|.+.... ......+..|+.+++.+.||||+++++++. +..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~---~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPE---GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCC---CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 4788999999999999999976531 11122358888876443 233466788898999999999999999865 456
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++++||+.+++|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 889999999999999996543 268899999999999999999996 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...............++..|+|||.+.+..++.++|||||||++|||++ |..||....+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----------------~ 220 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----------------V 220 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------H
Confidence 6433222222233457778999999988899999999999999999998 999987643211 1
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
..++........+..++.++.+++.+||..||++|||+.++++.|..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 221 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11112111112233456678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=332.82 Aligned_cols=247 Identities=28% Similarity=0.357 Sum_probs=198.2
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 160 (413)
++.||+|+||.||+++... ...+++.||+|++..... .....+.+|+++|++++||||+++++++..++.+|+|
T Consensus 1 l~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 76 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKIT----GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLI 76 (318)
T ss_pred CceeeeCCCEEEEEEEEec----cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEE
Confidence 3679999999999986431 223678999999875432 2334567899999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999999999998543 268999999999999999999997 6699999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
. ........|++.|+|||++.+..++.++|||||||++|+|++|..||....... ....+..
T Consensus 151 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----------------~~~~i~~ 212 (318)
T cd05582 151 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE----------------TMTMILK 212 (318)
T ss_pred C--CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH----------------HHHHHHc
Confidence 2 122334679999999999988889999999999999999999999997643210 0111111
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVET 359 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~ 359 (413)
. ...++..++.++.+||.+||+.||.+||++ .+++++
T Consensus 213 ~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 213 A--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1 122445567889999999999999999994 556544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=333.34 Aligned_cols=269 Identities=27% Similarity=0.370 Sum_probs=210.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhcc-CCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 153 (413)
..++|.+.+.||+|+||.||+|++... .....++.||||++.... ....+.+.+|+.+|..+. ||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGL--SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCC--CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 345688999999999999999986531 123356789999997653 233456889999999998 9999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCC-------------------------------------------------------
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGA------------------------------------------------------- 178 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 178 (413)
.+.+|+||||+.+|+|.+++.....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999965321
Q ss_pred ---------------------------------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 015094 179 ---------------------------------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNI 219 (413)
Q Consensus 179 ---------------------------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Ni 219 (413)
....+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~Ni 270 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARNV 270 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcceE
Confidence 11235677788999999999999996 6799999999999
Q ss_pred EEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 015094 220 LLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQ 298 (413)
Q Consensus 220 l~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~ 298 (413)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 999999999999999975332221111223456788999999988889999999999999999998 888886542211
Q ss_pred chhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 299 HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.....+........+..++.++.+|+.+||..+|.+||++++|++.|+.+.
T Consensus 350 ---------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011111122222344566789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=315.74 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=205.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-----hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
+.|++.+.||+|++|.||+|.... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 74 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD-------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR 74 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC-------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence 468999999999999999996543 57889999876432 123456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
++..+++||||+++++|.+++.... .+++..+..++.|++.||.|||. .+|+|+||+|+||+++.++.++|+||
T Consensus 75 ~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 75 DDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred cCCeEEEEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 9999999999999999999986543 67888999999999999999996 66999999999999999999999999
Q ss_pred CCcccCCCCCCcce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 233 GLAKLGPSASQSHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 233 G~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
|++........... .....++..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------------- 214 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-------------- 214 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------------
Confidence 99875432211111 123567889999999999889999999999999999999999986542110
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.............++..++..+.++|.+||..+|.+|||+.+++++.
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 215 --AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred --HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 01111111122344556778899999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=326.63 Aligned_cols=272 Identities=27% Similarity=0.399 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
..+|++.+.||+|+||.||+|++.............||+|.+.... ....+.+.+|+.+++++ +|+||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3579999999999999999997653221222334579999887542 33456788999999999 799999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+.++++|||+.+++|.+++..... ....+.+..++.++.||+.||.|||. ++|+||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nill~ 168 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVLVT 168 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEc
Confidence 999999999999999999975421 22357888899999999999999996 6799999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999976433221111222334567999999999999999999999999999998 888886542110
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+...+........+..++.++.+|+.+||+.+|.+||++.++++.|+.+....
T Consensus 245 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -------------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111111222334456778999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=338.12 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.... +++.||||++.... ......+.+|+.++..++|+||+++++.+.++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD-------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 368899999999999999996553 67899999986432 23345678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||++|++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999986543 68899999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCc---------------------------------ceeecccccccccCccccccCCccchhhhHHHHHHHH
Q 015094 235 AKLGPSASQS---------------------------------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLV 281 (413)
Q Consensus 235 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 281 (413)
+......... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8743211100 0112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 015094 282 EILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKHRPS---MREV 356 (413)
Q Consensus 282 ~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt---~~e~ 356 (413)
+|++|..||....+.. .+..+........++ ..++.++.+||.+|+ .||.+|++ +.++
T Consensus 228 el~tG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 228 EMLIGYPPFCSETPQE----------------TYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred ecccCCCCCCCCCHHH----------------HHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 9999999997654321 011111101111112 135678999999977 49999984 6788
Q ss_pred HHHH
Q 015094 357 VETL 360 (413)
Q Consensus 357 l~~L 360 (413)
++|-
T Consensus 291 ~~hp 294 (360)
T cd05627 291 KSHP 294 (360)
T ss_pred hcCC
Confidence 8764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.82 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+.++.++ .||||+++++++...+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEE
Confidence 479999999999997554 57899999997642 23445678899999888 59999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+++++|..++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 999999999999885433 68999999999999999999997 669999999999999999999999999987422
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||............... ...+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~---------~~~~~ 216 (327)
T cd05617 148 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL---------FQVIL 216 (327)
T ss_pred CC--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH---------HHHHH
Confidence 11 12233467999999999999999999999999999999999999999754322111111110 11111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM------REVVET 359 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~------~e~l~~ 359 (413)
. ....++...+..+.++|.+||..||++|+++ .++++|
T Consensus 217 ~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 217 E--KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred h--CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1 1123455677889999999999999999985 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=317.58 Aligned_cols=255 Identities=34% Similarity=0.544 Sum_probs=200.3
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEE
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 160 (413)
+.+.||.|+||.||+|.+.. .....+..|+||.++... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~---~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ---KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES---TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEc---ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccc
Confidence 45789999999999998873 234467889999996543 33467899999999999999999999999988889999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
|||+.+|+|.+++... ....+++..+..|+.||+.||.|||+ ++|+|+||++.|||++.++.+||+|||++.....
T Consensus 80 ~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 9999999999999776 22378999999999999999999997 5699999999999999999999999999986522
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
...............|+|||.+.+..++.++||||||+++|||++ |..||...... .+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----------------~~~~~~ 218 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----------------EIIEKL 218 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----------------HHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------cccccc
Confidence 222222333457788999999988999999999999999999999 67887654211 111112
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
........+..++..+.++|..||..||.+||++.++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22233344556788899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=320.92 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=209.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.... .......||+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVV--KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccC--CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 467999999999999999999765321 12356889999986543 334456889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCC------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGAS------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
..|+||||+.+++|.+++...... ...+.+..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEE
Confidence 999999999999999999654321 1246788899999999999999996 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----------- 229 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----------- 229 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-----------
Confidence 99999875433222222233456788999999988889999999999999999998 888886542211
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+...+........+..++..+.+|+.+||+.+|++|||+.++++.|+
T Consensus 230 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 ------VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 01111111122334556788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=318.21 Aligned_cols=256 Identities=32% Similarity=0.511 Sum_probs=210.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
...+|++.+.||.|+||.||+|.+.. ++.+++|.+..........+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN--------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC--------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 34579999999999999999996542 5789999998776656678899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||+++++|.+++.... ...+.+..+..++.||+.||.|||. ++|+|+||||+||++++++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccch
Confidence 9999999999999999996533 2367889999999999999999996 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----------------~ 213 (261)
T cd05148 152 RLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----------------V 213 (261)
T ss_pred hhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----------------H
Confidence 76432211 1123345678999999988889999999999999999998 899996543110 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+..+ ........+..++..+.+++.+||..||.+|||+.++++.|+.
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 214 YDQI-TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHH-HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111 1122223345677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=316.57 Aligned_cols=264 Identities=24% Similarity=0.391 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+|++.+.||+|+||+||+|.+... .......||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPD---GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecC---CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45789999999999999999976532 11123468999986543 2345678899999999999999999998865 4
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..+++|||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCce
Confidence 5789999999999999986532 368899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~ 219 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----------------E 219 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------H
Confidence 86433222111222335678999999988899999999999999999998 88888653211 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++.++.+++.+||..||++||++.++++.|..+...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 220 IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1111222222223345677899999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=352.85 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=202.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
...+|++++.||+|+||+||+|.+.. ++..||+|++.... ......+..|+.+|+.|+||||++++++|..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~-------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKR-------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECC-------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34689999999999999999997653 67899999886542 2345678899999999999999999998865
Q ss_pred C--CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC-----CCeeeCCCCCCcEEEcC---
Q 015094 154 D--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD-----KQVIYRDFKASNILLDG--- 223 (413)
Q Consensus 154 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----~~ivHrDlkp~Nil~~~--- 223 (413)
. ..+||||||+.+++|.++|.........+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4 5799999999999999999764444457999999999999999999999743 46999999999999954
Q ss_pred --------------CCCeEEccCCCcccCCCCCCcceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCC
Q 015094 224 --------------SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGL 287 (413)
Q Consensus 224 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~ 287 (413)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 345899999999753221 12234579999999999854 45889999999999999999999
Q ss_pred CCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 288 RALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.||....... .+...+.... .......+.++.+||..||..+|.+||++.++|.+-.
T Consensus 241 ~PF~~~~~~~----------------qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 241 TPFHKANNFS----------------QLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CCCCcCCcHH----------------HHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 9997543211 0000011100 0111234678999999999999999999999997543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=335.92 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=203.4
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceE
Q 015094 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 72 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
++....++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++||||++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECC-------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 344455799999999999999999996554 67899999986432 22334577899999999999999999
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
+++..+..+|+||||++|++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999998542 47888889999999999999997 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccC----CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG----HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
|+|||++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus 183 L~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------- 253 (371)
T cd05622 183 LADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------- 253 (371)
T ss_pred EEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------
Confidence 99999997643221 1122346799999999998653 3788999999999999999999999764321
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCC--chHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQY--PYKAAYQIAQLSLKCLEAEPKH--RPSMREVVETLE 361 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L~ 361 (413)
..+..+........+ ...++..+.+||.+||..++.+ |+++.+++++.+
T Consensus 254 --------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 254 --------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred --------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 111122211111111 2356788999999999844443 789999998865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=332.72 Aligned_cols=262 Identities=32% Similarity=0.490 Sum_probs=216.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
+-.+.+.||+|+||.||+|.+.... ......||||..+.. .......+.+|.++|++++|||||++||++....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~---~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKN---GFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecC---CceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 4455689999999999999887531 111223999998853 3556778999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++|||+|.||+|.++|.+... .++..+...++.+.+.||+|||+ +++|||||-..|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999976543 58899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceee-cccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTT-RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.... .
T Consensus 310 ~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----------------~ 370 (474)
T KOG0194|consen 310 RAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----------------E 370 (474)
T ss_pred cCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------------H
Confidence 8643 111111 2235678999999999999999999999999999999 88898875322 1
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
....+.....+...+...+.++..++.+|+..||++||++.++.+.|+.+....
T Consensus 371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 222233455566677788899999999999999999999999999999987654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=314.46 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=205.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+. .++.||||.+..... ..+.+.+|+.++++++|+||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN--------NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec--------CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence 457999999999999999999653 246799999876532 34678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||. ++|+||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred eeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 999999999999999996543 3468899999999999999999996 679999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
........ .......+..|+|||++.+..++.++|+||||+++|+|++ |..||....... .
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~ 213 (261)
T cd05068 152 VIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-----------------V 213 (261)
T ss_pred EccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------H
Confidence 64322111 1111223457999999988899999999999999999999 999986542110 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+........+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 214 LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01111111222344567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=326.87 Aligned_cols=269 Identities=28% Similarity=0.399 Sum_probs=206.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+... ....+++.||||++.... ......+.+|+.++..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccC--CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999975421 233467899999987543 23345688999999999 589999999977654
Q ss_pred -CeeEEEEeeCCCCCHHHhhhhcCCC------------------------------------------------------
Q 015094 155 -KELLLVYEFMQKGSLENHLFGRGAS------------------------------------------------------ 179 (413)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------ 179 (413)
..+++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 5689999999999999998653210
Q ss_pred ---------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecc
Q 015094 180 ---------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250 (413)
Q Consensus 180 ---------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 250 (413)
...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 1236777888999999999999997 67999999999999999999999999998754322211112223
Q ss_pred cccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCch
Q 015094 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPY 329 (413)
Q Consensus 251 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (413)
.++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+...+........+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLKEGTRMRAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----------------HHHHHHhccCCCCCCC
Confidence 45677999999988899999999999999999997 888886542210 0001111111112233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 330 KAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 330 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
..+.++.+++.+||+.||++|||+.+++++|+.+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 456689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=318.00 Aligned_cols=273 Identities=31% Similarity=0.458 Sum_probs=206.9
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeC--Ce
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED--KE 156 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 156 (413)
|++.+.||+|+||+||++.+.. ....++..||+|.+..... .....+.+|+++|+.++||||+++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP---ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc---ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 4899999999999999876542 2334677899999876532 3446788999999999999999999987653 46
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++||||+.+++|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeeccccc
Confidence 89999999999999998542 58999999999999999999996 669999999999999999999999999998
Q ss_pred cCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
......... ......++..|+|||++.+..++.++|||||||++|+|++|..||........ ........ ......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQG-QMTVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccc-ccchhhh
Confidence 643322111 11223456679999999888899999999999999999999999865432110 00000000 0000111
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
............+..++..+.+++.+||..||++|||++++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1112222222334566789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=320.68 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=206.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+|++.+.||+|+||.||+|.+... .....++.||||++..... ...+.+.+|+.++..++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGT--APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecC--CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 477888999999999999976532 1223467899999975533 2345688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcC------------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 015094 158 LLVYEFMQKGSLENHLFGRG------------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~ 225 (413)
++++||+.+++|.+++.... .....++...++.++.|++.||.|||+ ++|+||||||+|||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCCC
Confidence 99999999999999985321 112357888899999999999999996 6699999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~ 304 (413)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------- 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999875433222222233456788999999988889999999999999999998 88888653211
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.....+........+..++..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus 234 ---------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 ---------DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0111111111223445677889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=318.63 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=194.2
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
||+|+||.||++.... +++.||+|.+..... .....+..|+++++.++||||+++++++..+..+|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEcc-------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEe
Confidence 7999999999996543 688999998864322 122345679999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.|++|.+++..... ..+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++......
T Consensus 74 ~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~- 148 (277)
T cd05607 74 LMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG- 148 (277)
T ss_pred cCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-
Confidence 9999999988854432 357888889999999999999996 66999999999999999999999999998764321
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||......... .. .........
T Consensus 149 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~----------~~~~~~~~~ 214 (277)
T cd05607 149 --KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EE----------LKRRTLEDE 214 (277)
T ss_pred --ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HH----------HHHHhhccc
Confidence 2223456899999999998888999999999999999999999999754321100 00 000111100
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.. .....++.++.+|+.+||+.||++||+++|+++.+.
T Consensus 215 ~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 215 VK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 10 111246778999999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=315.42 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=205.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN--------NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec--------CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 457999999999999999999654 246799998765432 35678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccce
Confidence 999999999999999986542 2357888889999999999999996 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----------------~ 213 (261)
T cd05072 152 VIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----------------V 213 (261)
T ss_pred ecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----------------H
Confidence 6432211 11222345678999999988889999999999999999998 999986542211 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...+...........++.++.+++.+||..+|++||+++++++.|+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 214 MSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 001111111122234667899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=315.30 Aligned_cols=262 Identities=22% Similarity=0.371 Sum_probs=209.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.+|++.+.||+|+||.||+|.+.. +++.|+||.+... .....+.+.+|+.+++.++|+||+++++++..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL-------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC-------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC
Confidence 468899999999999999996543 5788999987543 223345788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..+++|||+.+++|.+++.........+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~ 152 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchh
Confidence 99999999999999999986544444578999999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~---------- 216 (267)
T cd08229 153 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SL---------- 216 (267)
T ss_pred hhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HH----------
Confidence 875432211 12234688999999999888899999999999999999999999865422100 00
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
...+.........+...+..+.+++.+||..||++|||+.+|++.+.++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 217 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00011111111122356778999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=318.16 Aligned_cols=255 Identities=21% Similarity=0.375 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||.||+|.+.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL-------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC-------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 368889999999999999996543 5788999988654 23344568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 74 ISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred EEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 99999999999997653 56788889999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||............ .....
T Consensus 144 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~ 210 (279)
T cd06619 144 QLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQ 210 (279)
T ss_pred ecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHH
Confidence 53221 223457899999999999889999999999999999999999999753322111000 00000
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+.............+.++.+|+.+||+.||++||++++++++.+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 211 CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 1111111111122356789999999999999999999999987553
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.41 Aligned_cols=269 Identities=25% Similarity=0.341 Sum_probs=202.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
+|++.+.||+|+||.||+|.... +++.||||++... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 47889999999999999996543 5789999988653 2234567889999999999999999999998776
Q ss_pred ----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 156 ----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 156 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 74 DPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred cccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEecc
Confidence 7999999996 5888887433 368999999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK--PY 308 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~--~~ 308 (413)
||++....... ........++..|+|||++.+. .++.++|||||||++|+|++|+.||....+........... +.
T Consensus 147 fg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~ 225 (372)
T cd07853 147 FGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225 (372)
T ss_pred ccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99998543221 1122334688999999998774 57899999999999999999999998765433221111000 00
Q ss_pred hhh----hhhhhHhHHh-hhcC-------CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 309 LSE----KRKFRHIIDA-RLQG-------QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 309 ~~~----~~~~~~~~~~-~~~~-------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
... .......+.. .... ......+.++.+||.+||+.||++|||+.+++++-+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 000 0000000000 0000 1122346789999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=326.81 Aligned_cols=248 Identities=28% Similarity=0.395 Sum_probs=199.1
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
+|++.+.||+|+||.||+|.... +++.||||++.... ....+.+..|+.+++.+. |++|+++++++...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG-------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC
Confidence 37788999999999999996543 67899999987542 223456778899998886 57788899999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||++|++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEecccc
Confidence 99999999999999999986543 68899999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 148 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------------~~ 209 (323)
T cd05615 148 CKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----------------EL 209 (323)
T ss_pred ccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 8742211 11223456999999999999899999999999999999999999999764321 01
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVET 359 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~ 359 (413)
...+... ...++..++.++.+|+.+||+.||.+|++. ++++++
T Consensus 210 ~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 210 FQSIMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHHHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1111111 123455677889999999999999999974 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.93 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=205.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||.||+|+.... .....+++|.++.. .....+.+.+|+.+++++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD-----GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC-----CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 4789999999999999999976431 12345788887643 233456788999999999 6999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
.+|+||||+++++|.+++..... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGE 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECC
Confidence 99999999999999999965331 12357889999999999999999996 67999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~ 302 (413)
++.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 155 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----- 226 (297)
T cd05089 155 NLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----- 226 (297)
T ss_pred CCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 999999999998642111 11111223457999999988889999999999999999997 999997543211
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+ ..+........+..++..+.+|+.+||..+|.+||++.++++.|..+...
T Consensus 227 -----------~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 227 -----------LY-EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -----------HH-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 01111122233445678899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=318.36 Aligned_cols=268 Identities=25% Similarity=0.367 Sum_probs=206.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..++|++.+.||+|+||.||+|.+.... ....+..||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDII--KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccC--CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3568999999999999999999765321 12245689999886543 23344678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCC------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGAS------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
...|+||||+.+++|.+++...... ...+....+..++.||+.||.|||+ ++|+||||||+||+++.++.++
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999653211 2345667888999999999999996 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---------- 229 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---------- 229 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------
Confidence 999999875332222111222345678999999988899999999999999999998 788886532110
Q ss_pred hhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
....+........+..++..+.+++.+||+.||++|||+.++++.|.+..
T Consensus 230 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 -------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00111111111223345678999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=319.50 Aligned_cols=273 Identities=29% Similarity=0.433 Sum_probs=208.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCC---------CCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKA---------PGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVR 146 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---------~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~ 146 (413)
..+|++.+.||+|+||.||+|.+.... .........||+|.+.... ....+.+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999765421 1223345779999987653 334567889999999999999999
Q ss_pred eEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCC-------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 015094 147 LLGYCWEDKELLLVYEFMQKGSLENHLFGRGA-------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNI 219 (413)
Q Consensus 147 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Ni 219 (413)
+++++..+...++||||+.+++|.+++..... ....+++..++.++.|++.||.|||+ .+|+||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence 99999999999999999999999999865431 12358899999999999999999997 6699999999999
Q ss_pred EEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 015094 220 LLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT--GLRALDTNRPSG 297 (413)
Q Consensus 220 l~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--G~~pf~~~~~~~ 297 (413)
+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999875433322222334456778999999988889999999999999999998 666775432111
Q ss_pred cchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 298 QHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
........... .........+..++.++.+|+.+||+.||.+|||+.++++.|.
T Consensus 242 ---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ---VIENAGHFFRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHhcccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 00000000000 0001111223345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.39 Aligned_cols=266 Identities=22% Similarity=0.253 Sum_probs=197.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
...|.+.+.||+|+||.||+|.+.. .++.||||.... ..+.+|+++|++|+|+||+++++++..++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 4579999999999999999997654 578899996432 245689999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+|||++. ++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 999999995 68888885432 268999999999999999999997 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCC-CcchhhHhhhhhhhh----
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPS-GQHNLVDWIKPYLSE---- 311 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~~~~~~~~~~~---- 311 (413)
...............||..|+|||++.+..++.++|||||||++|||++|..++...... ........+...+..
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 643322222223457999999999999999999999999999999999987655432211 111000000000000
Q ss_pred ---------hhhhhHhHHh---hhcCCCc-------hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 312 ---------KRKFRHIIDA---RLQGQYP-------YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 312 ---------~~~~~~~~~~---~~~~~~~-------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.......... ....... ...+.++.+||.+||+.||.+|||+.|+|++-+
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 0000000000 0000000 123457899999999999999999999998743
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.34 Aligned_cols=239 Identities=27% Similarity=0.351 Sum_probs=189.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHH-HHHhhccCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEV-NFLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||+||+|++.. +++.||+|++..... .....+..|. .+++.++|+||+++++++...+.+|+
T Consensus 1 ~~lg~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEE
Confidence 479999999999997553 578899999865421 1223344444 35678899999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++.... .+.+..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 74 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999999999986533 57788888999999999999997 669999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+..+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~ 209 (325)
T cd05602 148 EH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNIL 209 (325)
T ss_pred cC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----------------HHHHHH
Confidence 21 112334679999999999999999999999999999999999999997543210 111111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e 355 (413)
.. ...++..++..+.++|.+||+.||.+|+++.+
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 210 NK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred hC--CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11 11234467788999999999999999998774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=322.19 Aligned_cols=270 Identities=25% Similarity=0.350 Sum_probs=206.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||.||+|.+.. ++..||+|.+... .......+.+|+++++.++||||+++++++..++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP-------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC-------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 368999999999999999996543 5788999988754 23344568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+ ..+++|+||||+|||++.++.++|+|||++.
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred EEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 99999999999999999654 368899999999999999999996 2469999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh-----
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE----- 311 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~----- 311 (413)
..... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.................
T Consensus 149 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 149 QLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred ccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 53221 123457899999999998888999999999999999999999999754322111000000000000
Q ss_pred -----------hhhhhHhHHhhhc---CCCc-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 312 -----------KRKFRHIIDARLQ---GQYP-YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 312 -----------~~~~~~~~~~~~~---~~~~-~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
............. ...+ ..++.++.+|+.+||..||++|||+.+++++.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0000001111111 0111 13567899999999999999999999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=316.76 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=202.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|++.+.||+|+||.||+|.... +++.||+|++..........+.+|+.+++.++||||+++++++..+..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH-------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC-------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence 4579999999999999999996543 578999999876544455678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999985432 67899999999999999999996 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
...... .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||....+....... ...
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~ 224 (267)
T cd06646 155 KITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKS 224 (267)
T ss_pred eecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecC
Confidence 542211 1122346889999999874 345778999999999999999999998654322110000 000
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+ ... .......++..+.+||.+||..||++||++++++++|
T Consensus 225 ~~---~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 NF---QPP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC---CCC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 000 0011124567899999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=318.17 Aligned_cols=273 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCC---------CCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAP---------GKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVR 146 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~ 146 (413)
.++|++.+.||+|+||.||+|.+..... ........||+|.+.... ....+.+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986442110 122245679999987543 334567889999999999999999
Q ss_pred eEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCC-------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 015094 147 LLGYCWEDKELLLVYEFMQKGSLENHLFGRGAS-------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNI 219 (413)
Q Consensus 147 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Ni 219 (413)
+++++...+..|+||||+.+++|.+++...... ...+++..++.++.||+.||+|||+ .+|+|+||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheE
Confidence 999999999999999999999999998764321 1246778899999999999999996 6699999999999
Q ss_pred EEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 015094 220 LLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT--GLRALDTNRPSG 297 (413)
Q Consensus 220 l~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--G~~pf~~~~~~~ 297 (413)
|++.++.++|+|||++................++..|++||...++.++.++|+|||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875432221112222345678999999888889999999999999999998 667776533211
Q ss_pred cchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 298 QHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
. ......+... . ........+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 242 ~---~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRD------Q-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhh------c-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0000000000 0 000011123356688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=321.24 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=205.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||.||+|.+.. ......+++|.+... .......+.+|+.++.++ +|+||+++++++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEcc-----CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 468899999999999999997643 112345688877643 223446788999999999 7999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
.+|+||||+++++|.+++..... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGE 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecC
Confidence 99999999999999999965432 12357889999999999999999996 67999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~ 302 (413)
++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----- 231 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 231 (303)
T ss_pred CCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----
Confidence 999999999998632111 11111234567999999988889999999999999999998 999986543211
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
....+........+..++.++.+|+.+||+.+|++||++.++++.|..+....
T Consensus 232 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 232 ------------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred ------------HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00011111122233446678999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=312.45 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=200.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.....+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~--------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA--------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc--------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 458889999999999999997642 35799998765432 345788899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccc
Confidence 99999999999999986432 257889999999999999999996 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|+|||++.+..++.++|+||||+++|+|++ |..||....... ...
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~----------------~~~ 212 (256)
T cd05114 150 VLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE----------------VVE 212 (256)
T ss_pred cCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHH
Confidence 322111 11122335568999999988889999999999999999999 899987543211 000
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+ ........+...+..+.+|+.+||..+|.+||++.++++.|
T Consensus 213 ~i-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 213 MI-SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HH-HCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 11111122334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.26 Aligned_cols=264 Identities=26% Similarity=0.383 Sum_probs=205.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|.+.+.||+|+||.||+|.+... ........|++|.+.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGR--DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecC--CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 35789999999999999999976531 112256789999886543 223456888999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC---CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---CeEE
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA---SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY---TAKI 229 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~---~~kl 229 (413)
..++||||+.|++|.+++..... ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++ .+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999866432 12358889999999999999999997 6699999999999998654 6999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----------- 229 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------- 229 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------
Confidence 99999986422111111112233567999999988999999999999999999997 999987643211
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+........+..++..+.+++.+||+.+|++||++.+++++|.
T Consensus 230 ------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 ------VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111222344566788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.27 Aligned_cols=273 Identities=25% Similarity=0.418 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCC-------CCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKA-------PGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
.++|++.+.||+|+||.||+|+..... .........||+|.+.... ....+.+.+|+++++.++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 458999999999999999998654310 0112344569999987652 23445788999999999999999999
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCC--------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGA--------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNIL 220 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil 220 (413)
+++......++||||+.+++|.+++..... ....+.+..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEE
Confidence 999999999999999999999999865321 11246788889999999999999996 66999999999999
Q ss_pred EcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh--CCCCCCCCCCCCc
Q 015094 221 LDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT--GLRALDTNRPSGQ 298 (413)
Q Consensus 221 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--G~~pf~~~~~~~~ 298 (413)
++.++.+||+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999875432222112223345678999999988899999999999999999998 556765432211
Q ss_pred chhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 299 HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.......+.. ..........+...+..+.+|+.+||..||++||++.+|++.|.
T Consensus 241 --~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFR-------NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhh-------hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0000000000 00000111223345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=312.99 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=199.7
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC---
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED--- 154 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 154 (413)
|.+.+.||+|+||.||+|.+... .....||+|.++.. .....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-----DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred CccccccCcccCceEEEeEEccC-----CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 35778999999999999976531 12246999988654 234456788999999999999999999976432
Q ss_pred ---CeeEEEEeeCCCCCHHHhhhhcC--CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 155 ---KELLLVYEFMQKGSLENHLFGRG--ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 155 ---~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
...++||||+.+++|.+++.... .....+++..+..++.||+.||+|||. ++|+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEE
Confidence 25789999999999999874322 223458899999999999999999996 67999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||++................++..|++||.+.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~------ 224 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY------ 224 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH------
Confidence 99999986432221111122346678999999988899999999999999999999 78888653211 000
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
..+........+..++..+.++|.+||+.||++|||+.++++.|+.+
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 --------DYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111111123345667899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.63 Aligned_cols=261 Identities=23% Similarity=0.400 Sum_probs=210.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 479999999999999999997653 5788999987532 223356788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..++||||+++++|.+++.........+++..++.++.+|+.||.|||+ .+|+||||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~ 152 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccce
Confidence 99999999999999999986544444568999999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ....
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~---------- 216 (267)
T cd08224 153 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL---------- 216 (267)
T ss_pred eeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH----------
Confidence 875332211 122346888999999998888999999999999999999999998654311 0000
Q ss_pred hhHhHHhhhcCCCch-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPY-KAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
. ..+........+. .++..+.++|.+||..+|++|||+.++++.|..++
T Consensus 217 ~-~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 217 C-KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred H-hhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 0001111111222 56678999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.93 Aligned_cols=277 Identities=27% Similarity=0.391 Sum_probs=206.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe--CC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE--DK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 155 (413)
.+|++.+.||+|+||.||+|.+.. ....+++.||+|.+........+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP---LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC---CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 478999999999999999996532 1234678999999887766666788999999999999999999997653 35
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||. ++|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCccc
Confidence 6899999999999999986432 257889999999999999999996 66999999999999999999999999999
Q ss_pred ccCCCCCCcce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........... .....++..|+|||++.+..++.++|||||||++|||++|..++.............. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIVYH 234 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccchHH
Confidence 86433222111 1112234569999999888999999999999999999998776543221100000000 000000001
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
+...+........+..++.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111221112223345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=329.91 Aligned_cols=266 Identities=24% Similarity=0.295 Sum_probs=200.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV-------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC-------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 35789999999999999999996543 6789999998654 22345667899999999999999999998865
Q ss_pred CC------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 DK------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
.. .+|+||||+.+ +|.+.+.. .++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 92 QKSLEEFQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred CCCccccceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCE
Confidence 43 57999999965 67666521 47788889999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ....
T Consensus 163 kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~--~~~~ 237 (359)
T cd07876 163 KILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK--VIEQ 237 (359)
T ss_pred EEecCCCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHh
Confidence 9999999975321 2223345789999999999999999999999999999999999999986543211110 0000
Q ss_pred hhhhh--------hhhhHhHHhhhc------------------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 308 YLSEK--------RKFRHIIDARLQ------------------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 308 ~~~~~--------~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..... ............ .......+..+.+||.+||..||++|||+.|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000 000000000000 0011123567899999999999999999999999866
Q ss_pred H
Q 015094 362 R 362 (413)
Q Consensus 362 ~ 362 (413)
.
T Consensus 318 ~ 318 (359)
T cd07876 318 I 318 (359)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.23 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=203.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..|.-++.||.|+||.||-|++.. +.+.||||++..... +..+.+..|+..|++|.|||+|.+.++|..+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~-------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre 98 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVR-------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE 98 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccC-------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence 346667789999999999996554 679999999875533 4456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...|||||||-| +-.|++.-+. +++.+..+..|+.+.+.||.|||+++ .||||||..|||+++.|.|||+|||.
T Consensus 99 ~TaWLVMEYClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 99 HTAWLVMEYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred chHHHHHHHHhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccc
Confidence 999999999954 8888886544 48999999999999999999999865 99999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
|.... ....++|||+|||||++. .+.|+-++|||||||+..||...++|+...+....
T Consensus 173 Asi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------------- 233 (948)
T KOG0577|consen 173 ASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------------- 233 (948)
T ss_pred hhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------------
Confidence 87532 244589999999999984 57899999999999999999999999877643211
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
+..|...-....-...++..+.+||..||++-|.+|||..+++.|
T Consensus 234 ---LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 234 ---LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111111111111235788999999999999999999999999864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.30 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||++.+.. +++.||+|++.... ......+.+|+.++..++|+||+++++.+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 368999999999999999997654 57889999986432 12334578899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+.+|+|.+++.+.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecch
Confidence 99999999999999999996532 268888999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
+...... .........||+.|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 149 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------------ 215 (332)
T cd05623 149 CLKLMED-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------------ 215 (332)
T ss_pred heecccC-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------------
Confidence 8743221 111223457999999999885 3467899999999999999999999997643211
Q ss_pred hhhhhhhHhHHhhhcCCCc---hHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYP---YKAAYQIAQLSLKCLEAEPKH--RPSMREVVETL 360 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L 360 (413)
.+..+........++ ..++.++.+|+.+||..++.+ |+++.++++|-
T Consensus 216 ----~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 216 ----TYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred ----HHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 111111111111122 245788999999999765555 68999999883
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.37 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=210.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
-|.|+..||.|+||+||+|...+ ++-..|-|++.....+.++.+.-||+||..++||+||++++.|..++.+|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nke-------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKE-------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhccc-------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 46677889999999999996443 56677889998888888999999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
|+.|||.||-+..++..-+ ..+.+.++..+++|++.||.|||+ ++|||||||..|||++-+|.++|+|||.+...
T Consensus 106 iliEFC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred EEEeecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccccc
Confidence 9999999999998886544 389999999999999999999997 66999999999999999999999999998642
Q ss_pred CCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
.........++||++|||||+++ ..+|++++|||||||+|.||..+.+|-..-++..
T Consensus 181 --~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---------------- 242 (1187)
T KOG0579|consen 181 --KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------------- 242 (1187)
T ss_pred --hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH----------------
Confidence 22333456789999999999874 5789999999999999999999998876543321
Q ss_pred hhhHhHH-hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 314 KFRHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+.. ......-|..++..+.||+++||.+||..||++.++++|-.
T Consensus 243 VllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 243 VLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred HHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 0001100 01112346788999999999999999999999999997644
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=326.07 Aligned_cols=255 Identities=20% Similarity=0.248 Sum_probs=199.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|+... +++.||||++... .....+.+.+|+.+++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN-------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 478999999999999999997654 5789999998642 122345678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.|++|.+++.+.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCc
Confidence 99999999999999999996532 368889999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc-----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
+........ .......||+.|+|||++.. ..++.++|||||||++|+|++|..||.......
T Consensus 149 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------------ 215 (331)
T cd05597 149 CLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------------ 215 (331)
T ss_pred eeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------------
Confidence 875332211 11223469999999999863 457889999999999999999999997543211
Q ss_pred hhhhhhhHhHHhhhcCCC---chHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKH--RPSMREVVETLE 361 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L~ 361 (413)
....+........+ ...++..+.+||.+||..++++ |+++.+++++-+
T Consensus 216 ----~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 216 ----TYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred ----HHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 01111111000111 1236778999999988765444 789999998854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=314.43 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=210.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEe-C
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-D 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 154 (413)
.++|++.+.||+|+||.||+|.+... ....+..|++|.+... .....+.+.+|+.+++.++|+||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~---~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDE---KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecC---CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46899999999999999999977641 1224678999988654 33445678899999999999999999998766 4
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCC----CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGAS----VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
...++++||+.+++|.+++...... ...+++..++.++.||+.||+|||. .+++||||||+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEEC
Confidence 7789999999999999998654322 1468899999999999999999996 669999999999999999999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
|||+++...............++..|+|||++.+..++.++|||||||++|++++ |..||...++..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------------ 227 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------------ 227 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------------
Confidence 9999975432222112223346778999999988889999999999999999999 999997643211
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
....+........+..++.++.+++.+||..||++|||+.++++.|..+..
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 228 -----MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -----HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011111111112233456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.89 Aligned_cols=238 Identities=29% Similarity=0.402 Sum_probs=189.2
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHH-HHhhccCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVN-FLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
++||+|+||.||+|++.. +++.||+|++..... .....+.+|.. +++.++||||+++++++.+.+.+|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEE
Confidence 479999999999997543 578999999865422 22334555554 6788999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+++++|..++... ..+.+..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 74 VLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 99999999999888543 367888899999999999999996 669999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~ 209 (321)
T cd05603 148 EP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----------------MYDNIL 209 (321)
T ss_pred CC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHh
Confidence 11 112334579999999999998899999999999999999999999997643110 011111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 354 (413)
.. ...++...+..+.++|.+||+.||.+|+++.
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 HK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 1233445677899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=318.12 Aligned_cols=256 Identities=29% Similarity=0.414 Sum_probs=204.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.|++.+.||+|+||.||+|.+.. +++.||+|.+..... .....+.+|+.+++.++|++|+.+++.+.+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC-------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC
Confidence 37788999999999999996654 678999998865422 22345678999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.|++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 99999999999999998854332 358889999999999999999996 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ..
T Consensus 150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-------------~~ 213 (285)
T cd05630 150 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-------------EV 213 (285)
T ss_pred eecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-------------HH
Confidence 7532211 1223468999999999999999999999999999999999999997643211000 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLER 362 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~~ 362 (413)
..... .....++..++.++.+|+.+||+.||++||| +.+++++-+.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 214 ERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred Hhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 00100 0111234456778999999999999999999 8899987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=309.83 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=210.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|..+++||+|.||+|.+|+ .+.+++.||+|+++++.. .....-..|-++|+..+||++..+.-.|+.
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~r-------EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCR-------EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cchhhHHHHhcCCccceEEEEe-------ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 4568888999999999999994 445899999999988743 233445568899999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+++|+||||..||.|.-.+... ..+++...+.+-..|+.||.|||+ ++||.||||.+|+|++.+|.+||+|||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred CceEEEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecc
Confidence 99999999999999999888543 378888999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+++.. .........+|||+.|+|||++....|+.++|+|.+|+++|||++|+.||...+...
T Consensus 314 LCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---------------- 375 (516)
T KOG0690|consen 314 LCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---------------- 375 (516)
T ss_pred cchhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------
Confidence 99863 334445677999999999999999999999999999999999999999998754321
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVET 359 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~ 359 (413)
.|..++.. ...+|..+++++..|+..+|.+||.+|. ++.||.++
T Consensus 376 LFeLIl~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 376 LFELILME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHhh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 12222221 2357888999999999999999999996 45666554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=321.61 Aligned_cols=270 Identities=24% Similarity=0.346 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|.+.+.||+|+||.||+|+... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++..++.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL-------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS 78 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC-------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe
Confidence 579999999999999999996543 578899999875432 223457789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+ +|.+++.... ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccce
Confidence 9999999975 8888875443 257888899999999999999997 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------h
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK--------P 307 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~--------~ 307 (413)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+......... +
T Consensus 153 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 532221 11223467899999998865 467899999999999999999999997764432211110000 0
Q ss_pred hhhhhhhhhHhHHhhhcC----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQG----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.......+.......... .....++.++.+||.+||..||.+|||+.|++++-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 000000000000000000 0112356788999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=309.54 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=198.7
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
.||+|+||.||+|.+.. ..++..||+|++.... ....+.+.+|+.+++.++|+||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-----KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEec-----CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEe
Confidence 58999999999997643 2256889999986543 234567889999999999999999999875 457899999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||.|||++.++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 999999999985432 68889999999999999999996 669999999999999999999999999997643222
Q ss_pred Ccce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 243 QSHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 243 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
.... .....++..|+|||.+....++.++|+|||||++|||++ |..||....... ....+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~~~~i~ 212 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----------------VTQMIE 212 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHH
Confidence 2111 112234578999999988889999999999999999998 999997542210 111122
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.......+..++.++.+||.+||+.||++||++.+|.+.|+..
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2222334556788999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=329.48 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=200.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|+... +++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV-------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC-------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence 45789999999999999999996543 5788999998754 22344667889999999999999999998864
Q ss_pred C------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 D------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
. ..+|+||||+.+ +|.+.+.. .++...+..++.|++.||.|||+ +||+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 88 QKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCE
Confidence 4 357999999965 67776632 47788889999999999999996 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh-
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV-DWI- 305 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~-~~~- 305 (413)
||+|||+++.... ........||..|+|||++.+..++.++|||||||++|+|++|..||............ ...
T Consensus 159 kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999985322 22233457899999999999999999999999999999999999999765422111000 000
Q ss_pred hh---hhhh-hhhhhHhHHhhh------------------cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 306 KP---YLSE-KRKFRHIIDARL------------------QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 306 ~~---~~~~-~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+ +... ......+..... ....+...+.++.+||.+||..||++|||+.|++++-+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 00 0000 000000100000 001112235678999999999999999999999988553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.82 Aligned_cols=238 Identities=29% Similarity=0.371 Sum_probs=189.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHH-HHhhccCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVN-FLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||+||+|.... +++.||+|++.... ......+..|.. +++.++||||+++++++..++.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEE
Confidence 469999999999996543 67899999986542 122344555554 4677999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|..++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 74 VLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 99999999999888543 368899999999999999999997 669999999999999999999999999987432
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|..||...+... .+..+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~~~ 209 (325)
T cd05604 148 AQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----------------MYDNIL 209 (325)
T ss_pred CC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----------------HHHHHH
Confidence 11 112334679999999999999999999999999999999999999997643210 111111
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 354 (413)
... ...+...+..+.++|.+||..||.+||+++
T Consensus 210 ~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 210 HKP--LVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred cCC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 111 122334677899999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.28 Aligned_cols=254 Identities=19% Similarity=0.251 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||++++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH-------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 478999999999999999996553 57889999986532 22334578899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..|+||||+.||+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccc
Confidence 99999999999999999996532 267888999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc-----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
+........ .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------------ 215 (331)
T cd05624 149 CLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------------ 215 (331)
T ss_pred eeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------------
Confidence 875432211 12233579999999998865 467889999999999999999999997543211
Q ss_pred hhhhhhhHhHHhhhcCCCc---hHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYP---YKAAYQIAQLSLKCLEAEPKH--RPSMREVVETL 360 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L 360 (413)
.+..+........++ ..++.++.+||.+||..++.+ |+++++++++.
T Consensus 216 ----~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 216 ----TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred ----HHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 111111111111112 235678999999999976655 46899998774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.31 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=204.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhcc-CCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 152 (413)
....|++++.||.|+.+.||++... ..+.||+|++... ....+.-+.+|+.+|.+|+ |.+||++++|-.
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s--------~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS--------DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC--------CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 3467999999999999999998533 3467888866433 4456778999999999998 999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
.++.+||||||- ..+|..+|.++... +..-.+..+..|++.++.++|. .||||.||||.|+|+- .|.+||+||
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~---~~~~~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSI---DPDWFLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCC---CchHHHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEE-eeeEEeeee
Confidence 999999999986 55999999776542 3323778899999999999997 5599999999999996 459999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCC-----------ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH-----------LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
|+|.........-.....+||..||+||.+.... .++++||||||||||+|+.|++||...
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------- 575 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------- 575 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------
Confidence 9999877666666777889999999999884322 457899999999999999999999642
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHH-HHHHHHHccccCCCCCCCHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQ-IAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.....++..+.+.....+|+..-... +.++++.||..||++||++.++|++
T Consensus 576 -------~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 -------INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12223444555554444555433333 9999999999999999999999975
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=312.65 Aligned_cols=252 Identities=32% Similarity=0.501 Sum_probs=201.5
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHH--HHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE--EWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
|++++.||+|+||+||+|.... +++.||+|++......... ...+|+.+++.++|+||+++++++.+....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC-------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccc
Confidence 6788999999999999997654 6789999999877543322 345699999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+.+++|.+++... ..++...++.++.||++||.+||+ .+|+|+||||+||+++.++.++|+|||.+..
T Consensus 74 ~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccc----cccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc
Confidence 9999999999999999733 378999999999999999999997 5699999999999999999999999999975
Q ss_pred CCCCCCcceeecccccccccCccccc-cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
. ...........++..|+|||++. +..++.++|+||||+++|+|++|..||......... ..+.
T Consensus 148 ~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-------------~~~~ 212 (260)
T PF00069_consen 148 L--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-------------EIIE 212 (260)
T ss_dssp S--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-------------HHHH
T ss_pred c--cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhh-------------hhhh
Confidence 3 12222344567899999999998 788999999999999999999999999865111000 0011
Q ss_pred HhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
........ ..........+.++|.+||+.||++||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110000 00111223789999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.13 Aligned_cols=267 Identities=23% Similarity=0.288 Sum_probs=199.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|+... +++.||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~ 94 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI-------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC-------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecc
Confidence 35689999999999999999997543 5788999998754 22344567889999999999999999998754
Q ss_pred C------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 D------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
. ..+|+||||+.+ +|.+++.. .++...+..++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 95 QKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcE
Confidence 3 357999999965 77777632 46788889999999999999996 679999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW-IK 306 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~-~~ 306 (413)
||+|||+++.... ........||..|+|||++.+..++.++|||||||++|+|++|..||...+.......... ..
T Consensus 166 kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 166 KILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred EEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999975322 1223345789999999999999999999999999999999999999976543221111000 00
Q ss_pred -h---hhhhh-hhhhHhHHhh-----------h-------cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 -P---YLSEK-RKFRHIIDAR-----------L-------QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 -~---~~~~~-~~~~~~~~~~-----------~-------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+ +.... .......... . ........+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0 00000 0000000000 0 00011123457899999999999999999999998755
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=302.46 Aligned_cols=257 Identities=25% Similarity=0.286 Sum_probs=205.7
Q ss_pred HhcCCCCC-CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEe
Q 015094 76 ATRNFKSD-TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 153 (413)
..++|.+. ++||-|-.|+|..|+++. +++.+|+|++... .+.++|+++.-... |||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~-------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR-------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc-------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 45677775 579999999999996554 7899999988644 46688999876665 9999999998865
Q ss_pred C----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCC
Q 015094 154 D----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYT 226 (413)
Q Consensus 154 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~---~~~~ 226 (413)
. ..+.+|||+++||.|...++.++. +.+++.++.+|++||..|+.|||+ .+|.||||||+|+|.. .+..
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcc
Confidence 3 578899999999999999988764 479999999999999999999998 4599999999999995 4568
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||+|+.... .......+-|++|.|||++....|+...|+||||+++|-||+|.+||..........
T Consensus 203 lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp------ 273 (400)
T KOG0604|consen 203 LKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------ 273 (400)
T ss_pred eEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh------
Confidence 99999999986332 233445688999999999988999999999999999999999999997754321110
Q ss_pred hhhhhhhhhhHhHHhh-h--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDAR-L--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.++.-+... . ...-...++...+++|+++|..+|.+|.|+.+++++-+-.+
T Consensus 274 -------gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 274 -------GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred -------hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 111111111 0 11112367889999999999999999999999999887544
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.88 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=214.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..|.+.+.||+|.|++|.+|++.. ++..||||++++... ...+.+.+|+++|+.|+|||||+++.+.....
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~-------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHIL-------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecC-------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 468999999999999999997654 689999999987643 33456889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+|.+++++.+++ .+.+..+..++.|++.|++|||+ ++|||||||.+|||++.+.++||+|||++
T Consensus 129 ~lylV~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccccc
Confidence 9999999999999999997776 55668889999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCcc-chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
..+. .......++|++.|.|||++.+..|+ +++|+|+||+++|.|+.|..||++........
T Consensus 203 ~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-------------- 265 (596)
T KOG0586|consen 203 TFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-------------- 265 (596)
T ss_pred eeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc--------------
Confidence 8743 44455678999999999999998885 89999999999999999999999864322110
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
..+.. ....+...+.++.+||+++|.++|.+|++++++.++-|.-
T Consensus 266 --rvl~g--k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 266 --RVLRG--KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred --hheee--eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 01111 1234556778899999999999999999999999887754
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.70 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=200.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.+|++.+.||+|+||.||+|.+. .+..+|+|++..... ....+.+|+.+++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR--------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec--------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 35889999999999999999653 245799998865432 235678899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCccccee
Confidence 99999999999999986543 267899999999999999999997 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------~- 211 (256)
T cd05059 150 VLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----------------V- 211 (256)
T ss_pred cccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH----------------H-
Confidence 322111 11111223457999999988999999999999999999999 7889875432110 0
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..+........+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01111112233445678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=309.42 Aligned_cols=255 Identities=34% Similarity=0.509 Sum_probs=207.0
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|+||.||+|.+... ...+..|++|.+...... ..+.+.+|+.+++.++|+||+++++++.....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK----DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecC----CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 4699999999999976531 134788999998766433 36788999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCC-----CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 163 FMQKGSLENHLFGRGAS-----VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+++++|.+++...... ...+++..++.++.||+.||+|||+ ++|+|+||||+||+++.++.++|+|||.+..
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99999999999765211 3578999999999999999999996 6799999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..............++..|+|||.+.+..++.++|||||||++|+|++ |..||....... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~ 217 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----------------VL 217 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HH
Confidence 544332222334567889999999988889999999999999999999 699997652210 01
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+........+..++.++.+++.+||..+|.+||++.+++++|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 218 EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111112223345566889999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=328.66 Aligned_cols=246 Identities=27% Similarity=0.415 Sum_probs=205.8
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEeeC
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFM 164 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 164 (413)
+||+|.||+||-|++. .+...+|||.+.....+..+.+..||.+.+.|+|.|||++++.+.+++++-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~-------~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-------DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccc-------cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 6999999999999544 467889999998777677788999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhcCCCCCCC--cHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEccCCCcccCCCC
Q 015094 165 QKGSLENHLFGRGASVQPL--AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDFGLAKLGPSA 241 (413)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~DfG~a~~~~~~ 241 (413)
+||+|.+++..+.+ ++ .+..+-.+.+||++||.|||. +.|||||||-+||||+ -.|.+||.|||-+++. .
T Consensus 655 PGGSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL--A 727 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL--A 727 (1226)
T ss_pred CCCcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhh--c
Confidence 99999999976543 45 788889999999999999995 6699999999999995 6799999999998863 3
Q ss_pred CCcceeecccccccccCccccccC--CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 242 SQSHVTTRVMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 242 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
..+..+..+.||..|||||++..+ .|+.++|||||||++.||.||++||-....... +.+ ..-
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMF------------kVG 792 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMF------------KVG 792 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhh------------hhc
Confidence 334456678899999999999764 688999999999999999999999965322110 000 000
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
--......|...+.+++.||.+|+.+||.+||+|.++|+.
T Consensus 793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 0112345678899999999999999999999999999864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=346.40 Aligned_cols=265 Identities=21% Similarity=0.309 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|++.. +++.||||++.... ....+++.+|+++++.++||||+++++++.++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~-------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV-------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC-------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence 579999999999999999997543 57899999986542 22345788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC-------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA-------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
+..|+||||++|++|.+++..... ....++...++.++.||+.||+|||+ ++|+||||||+|||++.++.+
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~v 152 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEV 152 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCE
Confidence 999999999999999999864211 12245667788999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCC----------------cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCC
Q 015094 228 KISDFGLAKLGPSASQ----------------SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~ 291 (413)
+|+|||++........ .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 9999999976421110 001123569999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhc
Q 015094 292 TNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQAS 366 (413)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-t~~e~l~~L~~i~~~ 366 (413)
......... ...+...........++..+.+++.+||..||++|+ +++++++.|+.+...
T Consensus 233 ~~~~~ki~~---------------~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 233 RKKGRKISY---------------RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred Ccchhhhhh---------------hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 632211000 000000000001124567789999999999999996 677888888876543
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=310.82 Aligned_cols=260 Identities=26% Similarity=0.462 Sum_probs=204.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..|++.+.||+|+||.||+|.+... ...+..||||.+... .....+.+..|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLP----GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 3588999999999999999976532 123457999998765 33445678999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 80 VMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCcccc
Confidence 999999999999999986543 257888999999999999999996 679999999999999999999999999987
Q ss_pred cCCCCCCcceeec-cc--ccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 237 LGPSASQSHVTTR-VM--GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 237 ~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
............. .. .+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---------------- 218 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------------- 218 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----------------
Confidence 5432221111111 11 2457999999988999999999999999999886 99998654221
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+...+........+..++..+.+++.+||..+|.+||++.+++..|+.+
T Consensus 219 -~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 -DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111111112223345677899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=315.69 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=194.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhc---cCCCccceEeEEEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRL---SHPNLVRLLGYCWE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~ 153 (413)
+|++.+.||+|+||+||+|.+.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH-------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 58899999999999999996553 678999998865321 1223456777777665 69999999998764
Q ss_pred -----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 154 -----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 154 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
...+++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 74 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 74 SRTDRETKVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred ccCCCCceEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEE
Confidence 3468999999975 8988886433 2358899999999999999999997 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|+|||++...... .......|+..|+|||++.+..++.++|||||||++|+|++|.+||............ ...
T Consensus 149 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~---~~~ 222 (288)
T cd07863 149 LADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI---FDL 222 (288)
T ss_pred ECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH---HHH
Confidence 9999999754321 1223356899999999998889999999999999999999999999765332111100 000
Q ss_pred hh--hhhhhhHhH---Hhhhc-------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 309 LS--EKRKFRHII---DARLQ-------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 309 ~~--~~~~~~~~~---~~~~~-------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. ....+.... ..... ......++..+.+||.+||+.||++|||+.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000 00000 00112356678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=309.71 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.+.||+|+||.||+|.+... ......+|+|.+.... ....+.+.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLP----GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecC----CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 5789999999999999999976431 1234579999887543 2345678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 999999999999999996543 357888999999999999999996 669999999999999999999999999998
Q ss_pred cCCCCCCcce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 237 LGPSASQSHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 237 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
.......... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||....... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~------------- 218 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V------------- 218 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H-------------
Confidence 6433221111 111223567999999988899999999999999999886 999987543211 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
. ..+........+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 219 ~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 219 I-KAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred H-HHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00111111122345677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=309.48 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+|++.+.||+|+||.||++.+.. +++.||+|.+... .....+.+.+|+.+++.++|+||+++++.+..++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN-------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC-------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 47889999999999999996543 5788999988543 234456788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+++++|.+++.... ...+++..++.++.||+.||.|||+ ++|+|+||||+||+++.++.++|+|||++..
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred EEEEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCccee
Confidence 99999999999999885432 2357889999999999999999996 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
..... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ....
T Consensus 150 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------------~~~~ 211 (255)
T cd08219 150 LTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----------------LILK 211 (255)
T ss_pred ecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----------------HHHH
Confidence 43221 12234568899999999988889999999999999999999999997542110 0000
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
+ ........+..++..+.+||.+||..||++||++.+++..
T Consensus 212 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 212 V-CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred H-hcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1 1111112344567789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=313.26 Aligned_cols=273 Identities=29% Similarity=0.448 Sum_probs=206.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC--C
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED--K 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 155 (413)
-|++++.||+|+||.||+|.+.. ....++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDP---EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEcc---CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 47899999999999999997643 234467899999987553 33456789999999999999999999988775 5
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||++|++|.+++.+.. ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCccc
Confidence 7899999999999999985442 257889999999999999999996 67999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh--h
Q 015094 236 KLGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE--K 312 (413)
Q Consensus 236 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~--~ 312 (413)
......... .......++..|+|||++.+..++.++|||||||++|+|+++..|+....... .....+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~----~~~~~~~~~~~~~ 232 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF----LKMIGPTHGQMTV 232 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh----hhhcccccccccH
Confidence 864332221 11223456778999999988889999999999999999999876543211100 0000000000 0
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
......+........+..++..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000011111111223345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.24 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=200.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.+|++.+.||+|+||.||+|.+.. ...||||.+..... ..+.+.+|+.+++.++||||+++++++.....+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~--------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG--------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC--------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 468899999999999999996542 34599998875432 345788999999999999999999999988999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++..... .+++..++.++.||+.||.|||+ .+++|+||||.||+++.++.+||+|||++..
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999999865332 67899999999999999999996 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|++||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~ 212 (256)
T cd05113 150 VLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----------------TVE 212 (256)
T ss_pred cCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHH
Confidence 432211 11112335678999999988889999999999999999998 999986543210 000
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+. .......+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 213 ~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 213 KVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111 11111223345678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=316.62 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|++.+.||+|+||.||+|+... +++.|++|.+........+.+.+|+.+++.+.|+||+++++.+..+..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA-------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC-------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence 4589999999999999999996543 578899999876655556778899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++... .+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccch
Confidence 99999999999999998432 57888999999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+..... .
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---------------~ 227 (296)
T cd06654 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---------------L 227 (296)
T ss_pred hccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH---------------H
Confidence 532211 11223468899999999988889999999999999999999999997654321100 0
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
...........+...+..+.+|+.+||..||++||++.+++++-.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 000000111223456678999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=344.75 Aligned_cols=268 Identities=29% Similarity=0.473 Sum_probs=218.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
....+.+.||+|+||.||.|...... ... ....||||.+... +.+....|.+|..+|+.++|||||++++++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~-~~~-~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVP-GSV-SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCC-CCc-cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 34566789999999999999776432 111 1567999998765 45667889999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcC---CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRG---ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+|++|||.||+|..+|++.. .....++....+.++.+|++|+.||++ +++|||||...|+|++....+||+|||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999997642 123468899999999999999999997 779999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
+|+...............-...|||||.+..+.++.++|||||||++||+++ |..||...+..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---------------- 911 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---------------- 911 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------------
Confidence 9995333322222222233468999999999999999999999999999999 88898775332
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+.+..+.... +.+.|..|+..+.+++..||+.+|++||++..|++.+..+...
T Consensus 912 ~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 912 EVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1111222333 5677889999999999999999999999999999988887654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=308.57 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=201.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+.. ...||+|++..... ..+.+.+|+.+++.++|+||+++++.+. +..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC--------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCC
Confidence 3579999999999999999996542 24599999876432 3457889999999999999999999774 456
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCcee
Confidence 899999999999999996532 2357888999999999999999996 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----------------~~ 213 (262)
T cd05071 151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VL 213 (262)
T ss_pred ecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----------------HH
Confidence 5432221 11122346678999999988899999999999999999999 888886543210 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
. .+........+..++..+.+|+.+||+.||++||++.++++.|+..
T Consensus 214 ~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 214 D-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred H-HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0111111123345678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=314.55 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=201.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.|+..+.||+|+||+||+|.+.. +++.||+|.+..... .....+.+|+.+|+.++|+||+.+.+.+..++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA-------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC-------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC
Confidence 36778899999999999997654 578999999865432 22345678999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999998886433 2368999999999999999999996 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......... ..
T Consensus 150 ~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~-------------~~ 213 (285)
T cd05632 150 VKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE-------------EV 213 (285)
T ss_pred eecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HH
Confidence 753221 11233578999999999988899999999999999999999999997643211000 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETL 360 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L 360 (413)
...+. .....++..++..+.+|+.+||+.||++||+ +.+++++-
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05632 214 DRRVL-ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHP 262 (285)
T ss_pred HHhhh-ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcCh
Confidence 00000 0011234456778899999999999999999 67777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=314.38 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=205.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+.|++++.||.|+||.||+|.+.. +++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+.
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKE-------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECC-------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 34679999999999999999996543 57899999998776666778899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++++|..++.+.. ..+++..+..++.||+.+|.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999999988875432 258889999999999999999996 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
....... .......++..|+|||++. ...++.++|+|||||++|+|++|..||.......
T Consensus 158 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------------- 222 (292)
T cd06644 158 AKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------------- 222 (292)
T ss_pred eeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------------
Confidence 7532211 1123356888999999884 3456789999999999999999999986543210
Q ss_pred hhhhhhHhHHhhh-cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 311 EKRKFRHIIDARL-QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+..... ....+..++.++.+||.+||..||++||++.+++++-.
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 223 ---VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred ---HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000000000 11123355678999999999999999999999987533
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=308.46 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=201.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++|+||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN--------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec--------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence 357999999999999999999654 245699998876433 3457889999999999999999999875 456
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|++|||+.+++|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeee
Confidence 899999999999999986532 2357889999999999999999997 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----------------~ 212 (260)
T cd05070 151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-----------------V 212 (260)
T ss_pred eccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----------------H
Confidence 5432211 11122335667999999988889999999999999999999 888986542110 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+........+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 213 LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111112223344567789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=308.29 Aligned_cols=260 Identities=26% Similarity=0.461 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|...+.||+|+||.||+|..... ......+++|.+... .....+.+..|+++++.++|+||+++.+++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMP----GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecC----CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 4688889999999999999976531 123458999998755 23345678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccce
Confidence 999999999999999986532 367888999999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCccee-ecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 237 LGPSASQSHVT-TRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 237 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........... .....+..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----------------~ 218 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----------------E 218 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----------------H
Confidence 64332221111 11223457999999988889999999999999999997 99998654221 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
....+........+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus 219 ~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111112223345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.11 Aligned_cols=251 Identities=29% Similarity=0.415 Sum_probs=204.6
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|.+.+.||+|+||.||+|.+.. +++.|++|.+... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA-------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC-------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence 47788999999999999997654 5788999988643 23445678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+++|.+++.... ...++...++.++.||+.||.|||. .+|+|+||||+||+++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 999999999999999997542 2468889999999999999999996 679999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ...
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~ 211 (256)
T cd08529 150 LLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----------------LIL 211 (256)
T ss_pred eccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 543221 12233568899999999999999999999999999999999999997543110 000
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+. .......+..++.++.+++.+||+.+|++||++.+++++
T Consensus 212 ~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 KII-RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHH-cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111 111122333567789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=317.21 Aligned_cols=267 Identities=21% Similarity=0.315 Sum_probs=190.0
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe--CCeeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE--DKELLLV 160 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 160 (413)
.+.||+|+||+||+|.+.. ..+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.. +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-----~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-----GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEcc-----CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 4689999999999997542 22567899999875532 2457789999999999999999998864 4578999
Q ss_pred EeeCCCCCHHHhhhhcC-----CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeEEcc
Q 015094 161 YEFMQKGSLENHLFGRG-----ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL----DGSYTAKISD 231 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~----~~~~~~kl~D 231 (413)
|||+. ++|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99985 58888875322 122358889999999999999999997 669999999999999 4567999999
Q ss_pred CCCcccCCCCCCc-ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch------hhH
Q 015094 232 FGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN------LVD 303 (413)
Q Consensus 232 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~------~~~ 303 (413)
||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... ...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 9999864322111 12234578999999999877 458899999999999999999999997544321100 000
Q ss_pred hhhhhhh-----hhhhhh------HhHHhhhcCC------------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 304 WIKPYLS-----EKRKFR------HIIDARLQGQ------------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 304 ~~~~~~~-----~~~~~~------~~~~~~~~~~------------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+...+. ...... .......... .....+..+.+||.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 000000 0000000000 000123468899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=298.38 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=199.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 156 (413)
+.+.+..||.|+.|.|+++.+.. ++..+|||.+... +.+..+++...+.++.... +|+||+.+++|..+..
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs-------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRS-------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcc-------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 34566789999999999996654 7899999998654 4555667777777766654 9999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++.||.| +..++.++..- ..++++..+-++...++.||.||.. ..+|+|||+||+|||+++.|++||||||++.
T Consensus 166 V~IcMelM-s~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccc
Confidence 99999998 44666666433 2479999999999999999999975 5679999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+..+ ....+...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+.. -+
T Consensus 241 rlvd---SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe 302 (391)
T KOG0983|consen 241 RLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------------FE 302 (391)
T ss_pred eeec---ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------------HH
Confidence 7443 334455679999999998853 47889999999999999999999999875321 11
Q ss_pred hhhHhHHhhhc-CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 314 KFRHIIDARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+++.... ......+++++.+|+..||.+|+.+||...++++|--
T Consensus 303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 11122221110 0111247899999999999999999999999997643
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=313.22 Aligned_cols=265 Identities=28% Similarity=0.426 Sum_probs=205.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.... ...++..||+|.+.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLL--PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccC--CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 357999999999999999999754211 12356789999987553 234466889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC------------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA------------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKAS 217 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~ 217 (413)
..|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||. ++++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHh
Confidence 99999999999999999964321 12246788899999999999999996 67999999999
Q ss_pred cEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 015094 218 NILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPS 296 (413)
Q Consensus 218 Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~ 296 (413)
|||++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875322211111222334667999999988899999999999999999997 88888643211
Q ss_pred CcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 297 GQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
. ....+.. ......+..++.++.+|+.+||+.||.+|||+.|+++.|++
T Consensus 240 ~----------------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E----------------VIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H----------------HHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 0001111 11112234567789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=306.22 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=198.8
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEee
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEF 163 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 163 (413)
.||+|+||.||+|.+... ..+..||+|++..... ...+.+.+|+.+++.++|+||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-----KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecC-----CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence 389999999999976531 2456799999876532 33466889999999999999999999875 4578999999
Q ss_pred CCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCC
Q 015094 164 MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ 243 (413)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 243 (413)
+++++|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 99999999986432 368899999999999999999996 6699999999999999999999999999875332221
Q ss_pred cce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHh
Q 015094 244 SHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321 (413)
Q Consensus 244 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (413)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~ 213 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----------------EVMSFIEQ 213 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHC
Confidence 111 111223568999999988889999999999999999996 99998754321 11112222
Q ss_pred hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 322 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
......+..++.++.+++.+||..||++||++.+|++.|+.+
T Consensus 214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223344556788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=309.04 Aligned_cols=251 Identities=26% Similarity=0.432 Sum_probs=202.6
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---------hhHHHHHHHHHHHhhccCCCccceEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---------QGFEEWQSEVNFLGRLSHPNLVRLLG 149 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~ 149 (413)
+|.+.+.||+|+||.||+|.... .++.||+|.+..... ...+.+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS-------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG 73 (267)
T ss_pred CccccceeecCCCeEEEEEEecC-------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 58889999999999999996543 568899998764322 12356889999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 150 YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
++......++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 74 SSLDADHLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEeCCccEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEe
Confidence 9999999999999999999999996543 67888899999999999999996 66999999999999999999999
Q ss_pred ccCCCcccCCCCCC----cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 230 SDFGLAKLGPSASQ----SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 230 ~DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
+|||++........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------- 219 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------- 219 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--------
Confidence 99999876432111 111123468889999999988889999999999999999999999997542110
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
....+.. ......+...+..+.++|.+||+.||.+||++.+++++
T Consensus 220 --------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 220 --------AIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --------HHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0001111 12223445677889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=306.63 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=202.0
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|++|.||+|.+... ......||||.+..... ...+.+.+|+.++++++|+||+++++++.. ..+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS----GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecC----CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 4689999999999977531 22345799999987765 566789999999999999999999999888 89999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+++++|.+++..... ..+++..++.++.|++.||+|||. ++++|+||||+||+++.++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 76 LAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred ecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 9999999999976432 368899999999999999999996 679999999999999999999999999998643322
Q ss_pred Ccc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 243 QSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 243 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+..
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~ 215 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----------------ILKKIDK 215 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHh
Confidence 111 1123456788999999988899999999999999999998 999986542211 0011111
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.......+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11111223345678999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=306.82 Aligned_cols=250 Identities=30% Similarity=0.486 Sum_probs=205.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~---------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR---------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec---------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence 357899999999999999999643 57899999977654 45778999999999999999999999998999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++..... ..+++..++.++.|++.||.|||. .+|+|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEccccccc
Confidence 9999999999999999965432 268899999999999999999996 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... +
T Consensus 151 ~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~ 208 (256)
T cd05039 151 EASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------V 208 (256)
T ss_pred cccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------H
Confidence 642111 12334567999999988889999999999999999997 999986542110 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+........+..++..+.++|.+||..+|++||++.++++.|..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11111111222344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.59 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=207.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.+.||+|+||.||+|.+... .......||+|.+.... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~---~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPE---GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecC---CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 5789999999999999999976531 12234579999887654 3345678899999999999999999998877 78
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999999986543 258899999999999999999996 679999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...............++..|+|||.+....++.++|+|||||++|+|++ |..||....... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~ 220 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----------------I 220 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------H
Confidence 6443222111122224567999999988889999999999999999998 999997643211 1
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
...+........+..++..+.+++.+||..||++||++.++++.|..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111111222334456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=309.39 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=203.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|... .++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN--------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QE 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC--------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cC
Confidence 3467999999999999999999643 357799998876543 3467889999999999999999999864 56
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..+++|||+.+++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcce
Confidence 7899999999999999986543 2367888999999999999999996 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------- 211 (260)
T cd05067 150 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----------------- 211 (260)
T ss_pred eecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----------------
Confidence 76432111 11223345678999999988889999999999999999999 999997543210
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+........+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 212 VIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001111111222334566789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=306.79 Aligned_cols=253 Identities=32% Similarity=0.473 Sum_probs=199.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|+||.||+|.+.. .......||+|.+..... ...+.+.+|+.+++.++|+||+++++++. ....++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM----KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeec----cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 469999999999997653 222447899999876543 24467889999999999999999999765 557899999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++.... .+++..++.++.|++.+|.|||. .+++|+||||+|||++.++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 76 LAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred eCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 999999999996543 67899999999999999999996 669999999999999999999999999988543222
Q ss_pred Ccce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 243 QSHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 243 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... +...+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-----------------~~~~~~ 212 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----------------VIAMLE 212 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-----------------HHHHHH
Confidence 1111 111223467999999988899999999999999999998 999986543210 111111
Q ss_pred hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 321 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.......+..++..+.++|.+||..+|++||++.++++.|+.+.
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11122334456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=307.65 Aligned_cols=249 Identities=29% Similarity=0.442 Sum_probs=200.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEE-eCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCW-EDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 156 (413)
.+|++.+.||+|+||.||+|... +..|++|.+.... ..+.+.+|+.+++.++|+||+++++++. .+..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc---------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 47899999999999999998543 5679999886553 3457889999999999999999999754 4567
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccce
Confidence 9999999999999999865432 257888999999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 151 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----------------~ 208 (256)
T cd05082 151 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------V 208 (256)
T ss_pred eccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----------------H
Confidence 532211 12334567999999988889999999999999999997 998886532110 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 209 VPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011111122233445678899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=312.28 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||.||+|.... +++.||+|.++.........+.+|+.+++.++||||+++++++...+.+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN-------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC-------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 468888999999999999996543 5788999998766555556788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++...+ .+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999999999986543 68899999999999999999996 5699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
.... ........|+..|+|||++. ...++.++|+|||||++|+|++|..||....+....... ....
T Consensus 156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--------~~~~ 225 (267)
T cd06645 156 ITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------TKSN 225 (267)
T ss_pred ccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--------hccC
Confidence 3221 11223457899999999874 456889999999999999999999998654322110000 0000
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
+ ..... .....++..+.++|.+||..+|++||++.+++++
T Consensus 226 ~---~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 226 F---QPPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred C---CCCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 00000 0011345678999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=310.23 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.+.||+|+||.||+|+.... ......+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI--EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC--CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 5789999999999999999976542 22345678999988765433 45678999999999999999999999999899
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCC-----CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGAS-----VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.|+||||+++++|.+++...... ...+++..+..++.||+.+|+|||+ .+|+||||||+||+++.++.++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999654321 1258899999999999999999996 6699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------------- 226 (275)
T cd05046 161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------------- 226 (275)
T ss_pred cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------------
Confidence 99987432111 111223356778999999988888999999999999999998 788886432110
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+............+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 ---VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001111111112233456778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.81 Aligned_cols=279 Identities=23% Similarity=0.307 Sum_probs=205.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEe-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 153 (413)
...|+++..||+|.||.||+|.-.+. .....+.+|||+++.+.. ..-....+|+.+++.|+||||+.+..+|..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~---n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNT---NDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccC---CcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 45799999999999999999954431 222256899999976632 123467899999999999999999998877
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCC-CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC----CCeE
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGA-SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS----YTAK 228 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~----~~~k 228 (413)
+..+++++||.+. +|+.+|.-+.. ....++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.||
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeE
Confidence 7899999999976 99998865332 23468889999999999999999997 679999999999999777 8999
Q ss_pred EccCCCcccCCCCCCcc-eeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch---hhH
Q 015094 229 ISDFGLAKLGPSASQSH-VTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN---LVD 303 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~---~~~ 303 (413)
|+|||+++.+...-... ....++-|.+|+|||++.|. .|+.+.|+||+|||+.||+|-.+.|.+........ ..+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999865544332 23446789999999999885 68899999999999999999999997654321110 001
Q ss_pred hh--------------hhhhhhhhhhhHhHHhhhcCCCch-----------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 304 WI--------------KPYLSEKRKFRHIIDARLQGQYPY-----------KAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 304 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
.+ .|.+.........+.......+.. .-++...+|+.+||..||-+|.|++++++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 11 111111111111111110000000 11334789999999999999999999998
Q ss_pred HHH
Q 015094 359 TLE 361 (413)
Q Consensus 359 ~L~ 361 (413)
+.-
T Consensus 337 h~y 339 (438)
T KOG0666|consen 337 HPY 339 (438)
T ss_pred ccc
Confidence 754
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.66 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=197.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 161 (413)
+.||+|+||.||+|.+.+. .....+++|.+.... ....+.+.+|+.++.++ +||||+++++++...+.+|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKD-----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCC-----CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 4689999999999976531 122457889887532 33456788999999999 7999999999999999999999
Q ss_pred eeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 162 EFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEE
Confidence 99999999999865431 12347889999999999999999996 67999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 154 ~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----------- 219 (270)
T cd05047 154 ADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------- 219 (270)
T ss_pred CCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----------
Confidence 999998632111 11111234567999999988889999999999999999997 999986542110
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
....+........+..++.++.+|+.+||..||.+|||+.++++.|..+.
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 220 ------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------HHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00011111122233456678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=307.19 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||.|+||.||+|.+.. +++.+++|++........+.+.+|+.+++.++||||+++++++..+..+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA-------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC-------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence 578999999999999999996543 5678999998876555667899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|++|||+.+++|.+++.... ..+++..+..++.|++.||.|||. .+|+|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchh
Confidence 99999999999999986542 368899999999999999999996 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccC---CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
..... .......++..|+|||++.+. .++.++|+|||||++|+|++|..||....+...... . ....
T Consensus 151 ~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~--~~~~ 220 (262)
T cd06613 151 LTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------I--SKSN 220 (262)
T ss_pred hhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H--Hhcc
Confidence 33211 122335688899999998776 788999999999999999999999976432110000 0 0000
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
+ ...........+.++.+|+.+||..+|.+|||+.+++.+
T Consensus 221 ~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 221 F-----PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred C-----CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000111233567789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.48 Aligned_cols=266 Identities=25% Similarity=0.299 Sum_probs=198.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.... +++.||||++..... ...+.+.+|+.+|+.++|+||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR-------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC-------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence 45789999999999999999996543 578999999875422 234567789999999999999999998754
Q ss_pred C------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 D------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
. ...|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 86 ATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCE
Confidence 3 4579999998 7799888742 268899999999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 158 kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 158 RILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred EEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999985332 1234578999999999876 568899999999999999999999997654321110000000
Q ss_pred --h---hhhh--hhhhhHhHHhhhcCC-------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 307 --P---YLSE--KRKFRHIIDARLQGQ-------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 307 --~---~~~~--~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+ .... .......+.. +... .....++.+.+||.+||..||.+|||+.++++|-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 0000 0000000000 0000 001234567899999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=310.71 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=202.9
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEE
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
|++.+.||+|+||.||+|.+.. ++..+++|.+........+.+.+|+++++.++|+||+++++++..+...|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE-------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC-------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 6788999999999999996543 578899999877665666788899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|..++.... .++++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 80 v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999999999998875422 368999999999999999999997 669999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
.. ........++..|+|||++. +..++.++|+|||||++|+|++|.+||....... .
T Consensus 155 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----------------~ 216 (282)
T cd06643 155 RT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR----------------V 216 (282)
T ss_pred cc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH----------------H
Confidence 21 11223356899999999873 4567789999999999999999999987543211 0
Q ss_pred hhHhHHh-hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
...+... ......+..++.++.+||.+||+.||.+||++.+++++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 0001000 0011223456778999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.88 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=207.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+|.+.+.||+|+||.||+|.+... ......|+||...... ....+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSP----ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecC----CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 35688999999999999999976531 1234579999887654 4455678999999999999999999998865 5
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCcee
Confidence 6789999999999999996533 257899999999999999999996 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........ .......++..|+|||.+....++.++|||||||++|+|++ |..||........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---------------- 217 (270)
T cd05056 155 RYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---------------- 217 (270)
T ss_pred eecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------
Confidence 75433211 11122234567999999988889999999999999999986 9999975432110
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
. ..+........+..++..+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus 218 ~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 218 I-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred H-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00111111223456678899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=310.77 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=199.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
+.+.|++.+.||+|+||.||+|.+.. +++.||+|.+.... .....+.+|+.+++.+ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK-------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC-------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 45678899999999999999996543 57899999986543 2345678899999998 699999999988753
Q ss_pred ------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 ------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
..+|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||+ ++|+|+||||+||++++++.++
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEE
Confidence 46899999999999999986532 2368889999999999999999997 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD 303 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~ 303 (413)
|+|||++....... .......|+..|+|||++. +..++.++|+|||||++|+|++|..||.........
T Consensus 152 l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---- 225 (272)
T cd06637 152 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---- 225 (272)
T ss_pred EccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----
Confidence 99999987532211 1223456899999999885 346788999999999999999999999653221100
Q ss_pred hhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 304 WIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
............+..++.++.+|+.+||..||.+|||+.+++++
T Consensus 226 ------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 226 ------------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ------------HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000111111223456789999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=313.44 Aligned_cols=264 Identities=27% Similarity=0.350 Sum_probs=203.7
Q ss_pred HHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEe
Q 015094 71 VELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLG 149 (413)
Q Consensus 71 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~ 149 (413)
..+....++|++.+.||+|+||.||+|.... +++.||+|++..... ....+.+|+.+++.+ +|+||+++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKK-------NGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECC-------CCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 4444566799999999999999999996543 578899998765332 235678899999999 6999999999
Q ss_pred EEE-----eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 150 YCW-----EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 150 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
++. .+..+++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+|+||||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEECCC
Confidence 874 3457999999999999999886543344568889999999999999999997 569999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCcccccc-----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
+.++|+|||++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||.........
T Consensus 161 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~ 238 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238 (286)
T ss_pred CCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence 999999999987543221 12233468999999998753 45788999999999999999999998754321100
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
. ..... .......+..++.++.+|+.+||+.||++|||+.++++++.
T Consensus 239 ~-------------~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 239 F-------------KIPRN--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred h-------------hcccc--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0 00000 00011122334567999999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=315.61 Aligned_cols=269 Identities=23% Similarity=0.325 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||.|+||.||+|.+.. +++.||+|.+..... .....+.+|+.+++.++|+||+++++++..+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL-------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 78 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC-------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCe
Confidence 579999999999999999996543 578899998864432 223457789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++.
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 999999996 58988886543 257888999999999999999997 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|.+||................... ....+
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~-~~~~~ 229 (301)
T cd07873 153 AKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP-TEETW 229 (301)
T ss_pred ccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-Chhhc
Confidence 5322211 12234578899999988654 57889999999999999999999997654322111100000000 00000
Q ss_pred hHhHHh---------hhcC----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 316 RHIIDA---------RLQG----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 316 ~~~~~~---------~~~~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+... .... .....++..+.+||.+||+.||.+|||+.+++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 000000 0000 0112356688999999999999999999999986554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=324.60 Aligned_cols=243 Identities=26% Similarity=0.373 Sum_probs=189.3
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhc---cCCCccceEeEEEeCCeeEE
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRL---SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~l 159 (413)
||+|+||+||+|++.. +++.||||++..... .....+..|..++..+ .||||+++++++.+...+|+
T Consensus 1 lG~G~~g~Vy~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECC-------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEE
Confidence 7999999999996543 678999999865321 2233445666777655 69999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 74 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 74 VTDYMSGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEcCCCCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 999999999999886543 68899999999999999999997 669999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
.. .......+||..|+|||++.+. .++.++|||||||++|+|++|..||....... .+..+
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----------------~~~~i 209 (330)
T cd05586 148 TD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----------------MYRNI 209 (330)
T ss_pred CC--CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----------------HHHHH
Confidence 21 1223346799999999998764 57899999999999999999999997643210 00111
Q ss_pred HHhhhcCCCc-hHHHHHHHHHHHHccccCCCCCC----CHHHHHHHHH
Q 015094 319 IDARLQGQYP-YKAAYQIAQLSLKCLEAEPKHRP----SMREVVETLE 361 (413)
Q Consensus 319 ~~~~~~~~~~-~~~~~~l~~li~~~L~~dp~~Rp----t~~e~l~~L~ 361 (413)
.... ..++ ..++.++.+||.+||+.||.+|| ++.+++++-+
T Consensus 210 ~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 210 AFGK--VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred HcCC--CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 1100 1111 23567899999999999999998 5777776543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=314.19 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=206.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
...+|++.+.||+|+||.||+|.... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA-------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC-------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34689999999999999999996543 57899999987655555567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+++++|.+++.+. .+++..+..++.|++.+|.|||+ .+|+||||||+|||++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred EEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999999998532 57888999999999999999997 56999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+.......
T Consensus 163 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------------- 227 (297)
T cd06656 163 AQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------- 227 (297)
T ss_pred eEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------------
Confidence 7532221 1122346888999999998888999999999999999999999999765432111000
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..........+...+..+.+|+.+||..||++||++.+++++-+
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 228 --ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred --ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 00000011123355677899999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=309.19 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=206.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||.|+||.||+|.+.. +++.|++|.+.... ......+.+|+.+++.++|+||+++++++.++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR-------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC-------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 368899999999999999997543 67899999987553 3445678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+|+||+.+++|.+++... ++++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccce
Confidence 99999999999999998542 68899999999999999999996 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|+|||++.+..++.++|+|||||++|+|++|..||....+....
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~----------------- 207 (274)
T cd06609 147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL----------------- 207 (274)
T ss_pred eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-----------------
Confidence 643321 1223456888999999998888999999999999999999999999764321100
Q ss_pred HhHHhhhcCCCchH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYK-AAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+........+.. ++.++.+++.+||..||++|||+++++++-.-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 208 FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 00111111122222 66789999999999999999999999986443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=306.58 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=204.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +..||||.+..... ..+.+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~--------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG--------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC--------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 35689999999999999999996542 46799998876543 3467889999999999999999999999889
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||+++++|.+++.... ...+++..+..++.||+.||.|||. ++++|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccc
Confidence 9999999999999999996543 2367889999999999999999996 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
....... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .
T Consensus 151 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----------------~ 213 (261)
T cd05034 151 RLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----------------V 213 (261)
T ss_pred eeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------H
Confidence 7543211 111112234568999999988889999999999999999998 999986542110 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
... +........+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 214 LEQ-VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHH-HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001 11111222334457789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=311.09 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=205.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||.||+|.+.. +++.||+|.+... .......+.+|+.+++.++|+||+++++.+...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP-------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC-------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 368899999999999999997653 5789999988654 33345678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+++++|..++.... ....+++..+..++.||+.||.|||. ..+|+|+||||+||+++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999999999999885431 23368999999999999999999995 2469999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccC------CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
..... ......++..|+|||++.+. .++.++|+|||||++|+|++|..||.........
T Consensus 152 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----------- 216 (286)
T cd06622 152 NLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF----------- 216 (286)
T ss_pred cccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-----------
Confidence 53221 12234688899999988543 3578999999999999999999999654221100
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+..+.. ......+..++.++.+||.+||..+|++||++.+++++-+.
T Consensus 217 --~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 217 --AQLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred --HHHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 00111111 11123445678899999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.89 Aligned_cols=276 Identities=28% Similarity=0.388 Sum_probs=209.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEe--C
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWE--D 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 154 (413)
+.|++.+.||+|+||.||+|.+... ...+++.||||.+...... ..+.+.+|+++++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPL---GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCC---CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 4688889999999999999976531 2346789999998766543 46779999999999999999999998877 5
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+ ++|+|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 68999999999999999996543 258889999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+........... .....++..|++||.+.+..++.++|||||||++|+|++|..||............. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHH
Confidence 986542222111 112334567999999988889999999999999999999998886532211000000 00000001
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+...+........+..++.++.+|+.+||..+|.+|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111222222222345567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.33 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=205.1
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||.|+||.||.+.... +++.+++|.+... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE-------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC-------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence 58899999999999999986543 5788999987654 23445678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
++++|||+.+++|.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.+||+|||++.
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred EEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceE
Confidence 999999999999999996542 2367899999999999999999997 569999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
....... ......++..|+|||++.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~ 211 (256)
T cd08221 150 ILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----------------LVV 211 (256)
T ss_pred Ecccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHH
Confidence 6433221 2234568999999999988889999999999999999999999997543211 011
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+..... ...+..++.++.+++.+||..+|.+||++.++++++
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 KIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111111 112235677899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=312.70 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=206.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.+|++.+.||.|+||.||+|.... +++.|+||.+........+.+.+|+.+++.++|+||+++++++..+..+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA-------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC-------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 469999999999999999996543 6789999998766555567788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++... .+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 9999999999999988432 57899999999999999999997 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
...... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+... ...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----------------~~~ 226 (296)
T cd06655 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----------------LYL 226 (296)
T ss_pred cccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHH
Confidence 322211 12234688899999999888899999999999999999999999976532110 000
Q ss_pred hHH-hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 318 IID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 318 ~~~-~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+.. .......+..++..+.+||.+||..||.+||++.+++++-+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 000 001112334567789999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.54 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=200.7
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|+||.||+|.+.... .....++.|+||.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL-GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccc-cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 36899999999999765421 112345789999876543 2345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCC---CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-----CeEEccCCC
Q 015094 163 FMQKGSLENHLFGRGA---SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-----TAKISDFGL 234 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-----~~kl~DfG~ 234 (413)
|+++++|.+++..... ....+++..++.++.||+.||.|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999965332 12347888999999999999999996 6699999999999998877 899999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---------------- 221 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---------------- 221 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----------------
Confidence 875432221111222345678999999999999999999999999999998 999986542110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+........+...+..+.+||.+||..+|.+||++.++++.|.
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 222 -VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111111122334466788999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=302.91 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=195.4
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEE-eCCeeEEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCW-EDKELLLVY 161 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~ 161 (413)
+.||+|+||.||+|.+.. .......||||.+... .....+.+.+|+.+++.++||||+++++++. .++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID----SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEec----CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 468999999999997643 1234578999988543 3344567889999999999999999999765 456789999
Q ss_pred eeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCC
Q 015094 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 241 (413)
||+.+++|.+++..... ......+..++.||+.||.|||. .+|+||||||+|||++.++.+||+|||++......
T Consensus 77 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999865432 45667788899999999999996 67999999999999999999999999998753221
Q ss_pred CCcc--eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 242 SQSH--VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG-LRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 242 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
.... ......++..|+|||.+.+..++.++|||||||++|+|++| .+||....... . ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~--------------~~~ 214 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---I--------------TVY 214 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H--------------HHH
Confidence 1100 11123456789999999888999999999999999999995 55665432110 0 000
Q ss_pred HHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 319 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
+........+..++..+.+++.+||..+|++||++.++++.|+.+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11111112233456789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.80 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=201.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC------hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES------LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
+|++.+.||.|+||.||+|... +++.+|+|.+.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN--------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL 72 (265)
T ss_pred CccccceEeccCCeEEEEEEEc--------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee
Confidence 5889999999999999999542 46789999876432 223456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+...+|+||||+.+++|.+++.+.. .+++..+..++.|++.+|+|||+ .+|+|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccc
Confidence 9999999999999999999996543 57888999999999999999996 66999999999999999999999999
Q ss_pred CCcccCCCCC----CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 233 GLAKLGPSAS----QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 233 G~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|++....... .........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---------- 216 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---------- 216 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----------
Confidence 9987532111 11112235688999999999888899999999999999999999999975432110
Q ss_pred hhhhhhhhHhHHh-hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 309 LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 309 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...+... ......+..++.++.++|.+||..+|.+||++.+++++
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 217 ------MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ------HHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 11122344567889999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=311.19 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=206.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||.|+||.||+|.+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+..+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKE-------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcC-------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 568999999999999999997543 5788999998776666667889999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+++++|.+++.... ..+++..++.++.|++.+|.|||+ .+|+|+||||+||+++.++.++|+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchh
Confidence 99999999999999986543 368999999999999999999996 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
..... .......++..|+|||++. +..++.++|+|||||++|+|++|..||.......
T Consensus 153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------------- 215 (280)
T cd06611 153 NKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------------- 215 (280)
T ss_pred hcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---------------
Confidence 33221 1223456899999999874 3456789999999999999999999997643211
Q ss_pred hhhhHhHHhh-hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 313 RKFRHIIDAR-LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 313 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+.... .....+..++.++.++|.+||..+|.+||++.+++++-+.
T Consensus 216 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 216 -VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred -HHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 000010000 0111233566789999999999999999999999987553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=312.05 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||+||+|.+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP-------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC-------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 578899999999999999997543 57889999876543 3345678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+++++|.+++...+ .+++..+..++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 999999999999999886533 68899999999999999999995 2469999999999999999999999999986
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||............. ... ...+.
T Consensus 153 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--~~~---~~~~~ 223 (284)
T cd06620 153 ELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP--MGI---LDLLQ 223 (284)
T ss_pred chhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh--hHH---HHHHH
Confidence 43211 1223568999999999988899999999999999999999999998654321110000 000 00011
Q ss_pred HhHHhhhcCCCc-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 317 HIIDARLQGQYP-YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 317 ~~~~~~~~~~~~-~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.+.... ...++ ..++.++.+|+.+||..||.+|||+.|++++..-++
T Consensus 224 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 224 QIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111111 11111 236678999999999999999999999998766544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.26 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=201.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe-CC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-DK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 155 (413)
.|++.+.||+|++|.||++.... +++.||+|++.... ....+.+.+|+++++.++|+||+++++.+.. +.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC
Confidence 48899999999999999996543 56789999986542 2345568899999999999999999998764 44
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++++|.+++.... ...+++..++.++.+++.+|.+||+ ++|+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccce
Confidence 6899999999999999986532 2368899999999999999999996 67999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......+++.|+|||++.+..++.++|+|||||++|+|++|..||...+... ..
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----------------~~ 211 (257)
T cd08223 150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS----------------LV 211 (257)
T ss_pred EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------------HH
Confidence 7643221 12234568899999999999999999999999999999999999987542110 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+.. ......+...+..+.+|+.+||+.||++||++.+++++
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 212 YRIIE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01111 11122344677889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.05 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||.||+|.+.. ...+|+|.+..... ..+.+.+|+.+++.++|+||+++++++. ....
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~--------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG--------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI 75 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC--------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence 568999999999999999996542 24589998765432 3456889999999999999999998775 4678
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||+ .+|+|+||||+||++++++.++|+|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 99999999999999996532 2357888899999999999999996 6699999999999999999999999999975
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~- 213 (260)
T cd05069 152 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----------------VL- 213 (260)
T ss_pred ccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HH-
Confidence 422211 11122345678999999988889999999999999999999 888987543210 00
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+........+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111111222344567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.03 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+|++.+.||+|+||.||+|.+... .......||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPE---GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecC---CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 35788999999999999999976531 111234689998875532 2334678999999999999999999988654
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccc
Confidence 5789999999999999986543 257888999999999999999996 67999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----------------- 219 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----------------- 219 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence 86432222112223345678999999988999999999999999999997 888886542110
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...++........+..++.++.+++.+||..+|++||++.++++.|..+...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 220 IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111111122334567899999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.87 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=193.4
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEee
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEF 163 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 163 (413)
+.||+|+||.||+|...............|++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999765321111224456889988766555566788999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--------eEEccCCCc
Q 015094 164 MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT--------AKISDFGLA 235 (413)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~--------~kl~DfG~a 235 (413)
+.+++|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999965432 57888999999999999999996 67999999999999977665 699999998
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCC-CCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGL-RALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|. .||.......
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------------- 213 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------------- 213 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----------------
Confidence 64321 223467889999999876 45789999999999999999995 5554322110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
...... ....++.....++.+|+.+||+.||++|||++++++.|
T Consensus 214 -~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 214 -KLQFYE--DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -HHHHHH--ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000111 11233444557899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.12 Aligned_cols=268 Identities=24% Similarity=0.329 Sum_probs=199.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|+||.||+|++.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK-------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECC-------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence 47889999999999999997543 578899998865422 234567889999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+. ++|.+++..... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 149 (285)
T cd07861 74 LYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149 (285)
T ss_pred EEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECccccee
Confidence 999999997 589888754332 3468999999999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhh-------h
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV-DWIK-------P 307 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~-~~~~-------~ 307 (413)
...... .......++..|+|||++.+. .++.++|+|||||++|+|++|.+||............ .... +
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 150 AFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227 (285)
T ss_pred ecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 532221 112234578899999988654 5788999999999999999999999765332110000 0000 0
Q ss_pred hhhhhhhhhHhHHhhhc---CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQ---GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.......+......... ......++.++.+||.+||..||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000000 00112356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=330.98 Aligned_cols=282 Identities=18% Similarity=0.240 Sum_probs=192.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCC--------CCCCeE----EEEEecCCcChhhHHHHHHHHHHHhhccCCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGK--------SGSGTV----IAVKKLNSESLQGFEEWQSEVNFLGRLSHPN 143 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--------~~~~~~----vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 143 (413)
...+|++++.||+|+||+||+|.+....... ...+.. ++.|.+.. .......+.+|+.+|+.++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 4578999999999999999998654311000 000011 11122211 1223456889999999999999
Q ss_pred ccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCC-CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGA-SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 144 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
|+++++++...+..|+|+|++. ++|.+++..... .........++.++.||+.||.|||+ ++||||||||+|||++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEC
Confidence 9999999999999999999995 577777643321 11223456678899999999999997 6699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCC-CCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRA-LDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~~~~~~~~~ 301 (413)
.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||++|..+ |...........
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999986432211 122346799999999999999999999999999999999998754 433222111111
Q ss_pred hHhhhh-------hhhhhhhhhHhHHhhhcC----CCc-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 302 VDWIKP-------YLSEKRKFRHIIDARLQG----QYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 302 ~~~~~~-------~~~~~~~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+.. +......+..++...... .++ ...+.++.++|.+||+.||.+|||+.|++++-..
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 111110 000000111111100000 000 1234568889999999999999999999987553
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=314.38 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.... +++.||||.+...... ..+.+.+|+++++.++|+||+++++.+..+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG-------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC-------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC
Confidence 368899999999999999996543 5789999998765322 445688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...|+||||+.+++|.+++.... ...+++..+..++.||+.+|+|||+ .+++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecch
Confidence 99999999999999999986432 2468899999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCc---------------------------ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCC
Q 015094 235 AKLGPSASQS---------------------------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL 287 (413)
Q Consensus 235 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~ 287 (413)
+......... .......|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 8753221100 0111346889999999998888999999999999999999999
Q ss_pred CCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC----HHHHHHHH
Q 015094 288 RALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS----MREVVETL 360 (413)
Q Consensus 288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt----~~e~l~~L 360 (413)
.||....... .+..+.............+..+.++|.+||..||++||+ +.+++++-
T Consensus 230 ~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 230 TPFKGSNRDE----------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred CCCCCCchHH----------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 9997653211 111111111111111225788999999999999999999 88887753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=302.00 Aligned_cols=248 Identities=29% Similarity=0.461 Sum_probs=197.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
++||+|+||.||+|.+. .++.|++|.+...... ..+.+.+|+++++.++|+||+++++++......++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~--------~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK--------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEe--------CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 46999999999999643 2688999988765433 45678999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++.... ..++...+..++.+++.+|.|||+ ++++||||||+|||++.++.++|+|||++.......
T Consensus 73 ~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 73 LVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 999999999986532 257888899999999999999996 679999999999999999999999999987533211
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (413)
.........++..|+|||.+.+..++.++|+|||||++|+|++ |..||....... ....+..
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----------------~~~~~~~ 210 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----------------TRERIES 210 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----------------HHHHHhc
Confidence 1111111233567999999988899999999999999999999 788886543211 1111111
Q ss_pred hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 322 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
......+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1122234456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=304.59 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=206.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe--C
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE--D 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 154 (413)
+|++.+.||.|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++.. +
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 48889999999999999996543 57889999886442 3345678889999999999999999997764 4
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC---CCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS---DKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..+|++|||+.+++|.+++........++++..++.++.||+.||.|||.. ..+|+|+||||+||+++.++.+||+|
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence 568999999999999999976544455789999999999999999999932 36699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||++........ ......++..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 154 ~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------- 216 (265)
T cd08217 154 FGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------------- 216 (265)
T ss_pred ccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---------------
Confidence 999986433221 123356899999999998888999999999999999999999999764311
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+...+........+...+..+.+++.+||..+|++||++.+|+++
T Consensus 217 --~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 217 --QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111111122223455677899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=304.77 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=198.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-----hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
..|++.+.||+|+||.||+|.... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD-------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLR 74 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC-------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEE
Confidence 368999999999999999996543 57899999875432 233456889999999999999999999887
Q ss_pred eC--CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 153 ED--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 153 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
+. ..++++|||+.+++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+
T Consensus 75 ~~~~~~~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 75 DRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred cCCCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEc
Confidence 53 67899999999999999986433 57888889999999999999996 669999999999999999999999
Q ss_pred cCCCcccCCCCCC-cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 231 DFGLAKLGPSASQ-SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 231 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
|||++........ ........++..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------------ 216 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------------ 216 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------------
Confidence 9999875322111 111223458889999999988889999999999999999999999997542110
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.............++...+..+.+++ +||..+|++||+++++++|
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 217 ----AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01111111112334555677788888 6888899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=304.38 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=199.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-----hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
.+|++.+.||+|+||.||+|+... +++.|+||.+.... ....+.+.+|+.+++.+.|+||+++++++.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~-------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 74 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD-------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR 74 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC-------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence 468999999999999999996543 57899999875321 233567889999999999999999999887
Q ss_pred eC--CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 153 ED--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 153 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
+. ..+++||||+++++|.+++.... .+++..++.++.|++.+|.|||+ .+|+|+||||+||+++.++.++|+
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 75 DPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred cCCCceEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEEC
Confidence 64 56889999999999999986543 57888889999999999999997 669999999999999999999999
Q ss_pred cCCCcccCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 231 DFGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 231 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
|||++......... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------------ 216 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------------ 216 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------------
Confidence 99998753321111 11223468889999999988889999999999999999999999986532110
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..............+...+..+.++|.+||. +|++||++++++++
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 217 ----AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111111112233455677789999999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=305.33 Aligned_cols=258 Identities=25% Similarity=0.301 Sum_probs=191.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|+||.||+|.+.. ..+...+++|.+..... .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-----GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcC-----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 468999999999997542 22457799998875532 233468889999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCC-CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCC
Q 015094 163 FMQKGSLENHLFGRGA-SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 241 (413)
|+++++|.+++..... .........+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999999999965432 22245667788899999999999996 66999999999999999999999999998753222
Q ss_pred CCcceeecccccccccCccccccC-------CccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 242 SQSHVTTRVMGTYGYAAPEYVATG-------HLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 242 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
..........++..|+|||++.+. .++.++|||||||++|+|++ |..||.......... ....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~-- 224 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-------YTVR-- 224 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-------HHhh--
Confidence 211112234577889999988542 35789999999999999996 999997543211000 0000
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
...............+..+.+++..|+ .+|++|||+++|+..|+
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 ---EQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---cccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000011112234567889999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=314.77 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=212.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh-HHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
......+.+.||+|.||.|.+|... .+..||+|.++...... ...|.+|+++|.+|+||||++++++|..+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve--------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE--------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec--------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 3456788999999999999999654 26899999998775443 47899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+|+||++.|+|.+++.++.... +.......|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccc
Confidence 99999999999999999998775432 455566779999999999999855 99999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh--CCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT--GLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--G~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++..............+-...|||+|.+..+.++.++|+|+||+++||+++ ...||....... ..+
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vve--------- 751 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVE--------- 751 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHH---------
Confidence 996555555555555677889999999999999999999999999999876 456665432211 000
Q ss_pred hhhhHhHHhh---hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 313 RKFRHIIDAR---LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 313 ~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.....+... .-...|..++..+.+|+.+||..|-.+||+++++..+|...
T Consensus 752 -n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 752 -NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 011111111 11234567889999999999999999999999999888753
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=306.05 Aligned_cols=246 Identities=25% Similarity=0.390 Sum_probs=190.9
Q ss_pred eeeecCCceEEEEEecCCC-----------------CCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccce
Q 015094 85 VLGEGGFGKVFKGWLDEKA-----------------PGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRL 147 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~-----------------~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 147 (413)
.||+|+||.||+|.+.... .........|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999753211 11223445689999876655455678889999999999999999
Q ss_pred EeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC--
Q 015094 148 LGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-- 225 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-- 225 (413)
++++..+...++||||+++++|..++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999885432 367888999999999999999996 6799999999999997543
Q ss_pred -----CeEEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHH-hCCCCCCCCCCCCc
Q 015094 226 -----TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEIL-TGLRALDTNRPSGQ 298 (413)
Q Consensus 226 -----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll-tG~~pf~~~~~~~~ 298 (413)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||....+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 4899999987642211 12357788999998865 56889999999999999995 68888875432210
Q ss_pred chhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 299 HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
...... ....+......+.++|.+||+.+|++|||+.++++.|
T Consensus 231 -----------------~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 -----------------ERFYEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -----------------HHHHHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 001111 1112223445789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.63 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence 368899999999999999997654 57889999886532 23446688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||+|.|||++.++.+||+|||+
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999998654 368899999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~ 206 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----------------QI 206 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 8864322 23456889999999998888899999999999999999999999764311 00
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
...+.. ....++...+..+.++|.+||..||.+|+ ++++++++-.
T Consensus 207 ~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 207 YEKILE--GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred HHHHhc--CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 111111 11233445678899999999999999999 7788876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=305.08 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=204.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC------hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES------LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
+|+..+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 73 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK-------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC 73 (268)
T ss_pred CccccceecCcCceEEEEEEEcC-------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec
Confidence 48889999999999999996433 57889999886432 123567889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEcc
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISD 231 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~D 231 (413)
+.+.+++||||+.+++|.+++.... ++++..++.++.||+.||.|||+ ++++|+||+|+||+++.++ .++|+|
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 9999999999999999999986543 67889999999999999999996 6799999999999998765 699999
Q ss_pred CCCcccCCCCCC--cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 232 FGLAKLGPSASQ--SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 232 fG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
||++........ ........++..|+|||++.+..++.++|+|||||++|+|++|..||..........
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--------- 218 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA--------- 218 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---------
Confidence 999876433211 111223468889999999988889999999999999999999999996543221110
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..............+...+.++.+++.+||..+|.+||++.+++++
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 219 ----LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0001111112234555677889999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=302.37 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=202.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-----hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
+|+..+.||+|+||+||+|.... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD-------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE 73 (258)
T ss_pred CccccceeeecCCceEEEEEEcC-------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence 57888999999999999997653 56889999875432 2345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+..+|+||||+++++|.+++.... .+++..++.++.||+.+|.|||+ .+|+|+||+|+||+++.++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 74 EDNLYIFLELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred CCeEEEEEEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCc
Confidence 999999999999999999986432 57889999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCC-ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++....... ......|+..|++||.+.... ++.++|+|||||++|+|++|..||.......
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--------------- 209 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--------------- 209 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---------------
Confidence 987633222 233456889999999987766 8899999999999999999999997643110
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
....+.........+..++..+.+++.+||..+|.+||++.+++.+
T Consensus 210 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 210 -AVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -HHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000111011123344567889999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=300.24 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=196.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
++||+|+||.||+|... .+..||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEec--------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 46899999999999643 357899999876543 233468899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+++++|.+++.... ..+.+..+..++.|++.+|.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 73 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 73 LVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred CCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 999999999985432 257889999999999999999996 669999999999999999999999999987532211
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (413)
. .......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+..
T Consensus 148 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----------------~~~~~~~ 209 (250)
T cd05085 148 Y-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----------------AREQVEK 209 (250)
T ss_pred c-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HHHHHHc
Confidence 1 11112234567999999988889999999999999999998 999986542210 0011111
Q ss_pred hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 322 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
......+..++..+.+|+.+||..+|++||++.++++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1222334456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=305.50 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..|+..+.||.|+||.||+|.+.. ++..||||.+.... ....+.+.+|+.+++.+.|+||+++++++.++..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR-------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc-------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 457888999999999999996553 57899999887543 3445678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+++|.+++.. .++++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccce
Confidence 9999999999999999853 257888899999999999999996 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|+|||++.+..++.++|+|||||++|+|++|..||....+....
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------- 210 (277)
T cd06640 150 QLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------- 210 (277)
T ss_pred eccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------
Confidence 543221 1223346788999999998888999999999999999999999998754322100
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+........+..++..+.+++.+||..+|++||++.+++++-..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 0011111223444677889999999999999999999999988654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.39 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=191.7
Q ss_pred CeeeecCCceEEEEEecCCCCC-----CCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPG-----KSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
+.||+|+||.||+|++..+... .......|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999976432110 11234568999887665555567888999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-------eEEcc
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT-------AKISD 231 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~-------~kl~D 231 (413)
+||||+.+++|..++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998885432 368889999999999999999996 67999999999999976654 89999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccc-cCCccchhhhHHHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEIL-TGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll-tG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
||++..... .....++..|+|||++. +..++.++|||||||++|+|+ .|..||........
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----------- 218 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----------- 218 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----------
Confidence 999864321 12345788899999886 467889999999999999998 57777765322110
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
........ ........++.+||.+||+.||.+||++.+|++++
T Consensus 219 ------~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ------ERFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ------HHHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00001001 11123456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.61 Aligned_cols=268 Identities=20% Similarity=0.254 Sum_probs=196.7
Q ss_pred CCCeeeec--CCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 82 SDTVLGEG--GFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 82 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++++||+| +|++||++.... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP-------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeecc-------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence 56789999 678999996543 68999999987652 23345678899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.++++||+.+..
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred EEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 999999999999999865422 258889999999999999999997 6699999999999999999999999986543
Q ss_pred CCCCCCc-----ceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh---h
Q 015094 238 GPSASQS-----HVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK---P 307 (413)
Q Consensus 238 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~---~ 307 (413)
....... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..... +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~ 228 (327)
T cd08227 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVP 228 (327)
T ss_pred cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCcc
Confidence 2111110 01122356778999999876 46889999999999999999999999753321100 00000 0
Q ss_pred hhhhh-----hh-------------hhH---------hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 308 YLSEK-----RK-------------FRH---------IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 308 ~~~~~-----~~-------------~~~---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
...+. .. ... .........+...+++.+.+||.+||+.||++|||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 00000 00 000 0000000012224567899999999999999999999999876
Q ss_pred HH
Q 015094 361 ER 362 (413)
Q Consensus 361 ~~ 362 (413)
..
T Consensus 309 ~f 310 (327)
T cd08227 309 FF 310 (327)
T ss_pred hh
Confidence 54
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=303.14 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=204.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||.||+|.+.. +++.|++|.+..... .+.+.+|+++++.++|+||+++++++..+..+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE-------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC-------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence 579999999999999999997653 468899999876532 67889999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+++||+.+++|.+++.... ..+++..+..++.|++.||.|||. .+|+|+||+|+||+++.++.++|+|||++..
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred EEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchh
Confidence 99999999999999986433 368899999999999999999996 6699999999999999999999999999886
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
...... ......++..|+|||++.+..++.++||||||+++|+|++|..||....+...... ...
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~ 213 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPN 213 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hcc
Confidence 432221 22334578899999999888999999999999999999999999976433211000 000
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
........+..++.++.++|.+||+.||++|||+.+++++
T Consensus 214 --~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 --KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000111233456789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=316.18 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=219.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
....+.+.||.|.||.||+|.+... +++..-.||||..+.+ .....+.|..|..+|+.++||||+++++++.+ ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~---~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDP---EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEeccc---ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3455678899999999999988752 2445567999999874 45667889999999999999999999999875 47
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|||||+++.|.|..|++.... .++......++.||+.||+|||+ +.+|||||...|||+.....|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccchhh
Confidence 8999999999999999976543 68888899999999999999998 669999999999999999999999999999
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...+....... ...-...|||||.+.-..++.++|+|.||+.+||++. |..||.+....+ +
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------------V 601 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------------V 601 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------e
Confidence 76554433322 3345678999999999999999999999999999886 899998754332 1
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
-..+...-+...|..|++.+..|+.+||..||.+||++.++...|..+..+
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 222344455667889999999999999999999999999999999887663
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=303.15 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=202.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
...+|++.+.||+|+||.||+|.+. .+..+++|.+.... ...+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~--------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec--------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence 3568999999999999999999643 24569999887543 234678899999999999999999998877 7
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..+++|||+.+++|.+++.... ...+++..+..++.||+.||.|||. .+++|+||||+||+++.++.+||+|||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcce
Confidence 8899999999999999996543 2357888889999999999999996 67999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........ .......++..|+|||++....++.++|+|||||++|++++ |..||.......
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----------------- 211 (260)
T cd05073 150 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------------- 211 (260)
T ss_pred eeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----------------
Confidence 75432211 11222345677999999988889999999999999999999 899987542210
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+........+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 212 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011111111122334566789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=300.29 Aligned_cols=256 Identities=32% Similarity=0.510 Sum_probs=203.4
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
+++.+.||.|+||.||+|.+... ....+..||+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL---SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCC---CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 46788999999999999976542 1134588999999766433 5678899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
++|||+++++|.+++..... ..+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999865432 128999999999999999999996 66999999999999999999999999999864
Q ss_pred CCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...... .+..
T Consensus 154 ~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-----------------~~~~ 215 (258)
T smart00219 154 YDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-----------------EVLE 215 (258)
T ss_pred ccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHH
Confidence 4331111 112236788999999988889999999999999999998 78888653211 0001
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+........+...+.++.+++.+||..||++|||+.++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111112233445678899999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.91 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=198.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHH-HhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNF-LGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||.||+|.+.. +++.||||.+..... .....+..|+.+ ++.++||||+++++++..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP-------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC-------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 368899999999999999996553 689999999875432 223345556665 66678999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||++ ++|.+++.........+++..++.++.||+.||+|||+. .+++||||||+|||++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999996 588888865444445789999999999999999999962 26999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCcccccc----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
...... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.......
T Consensus 152 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------------- 214 (283)
T cd06617 152 GYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------------- 214 (283)
T ss_pred cccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--------------
Confidence 753221 12233468889999998854 456889999999999999999999986432110
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..................++.++.++|.+||..+|.+||++.+++++-..
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 215 -QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred -HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 00111111111111122456789999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=303.46 Aligned_cols=257 Identities=27% Similarity=0.326 Sum_probs=189.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|+||.||+|..... .....+++|.+.... ......+.+|+.+++.++|+||+++++++.....+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecC-----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence 3689999999999965321 245678999876543 2334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCC-CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCC
Q 015094 163 FMQKGSLENHLFGRGAS-VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 241 (413)
|+.+++|.+++...... .....+..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccccc
Confidence 99999999999664322 2234677788999999999999997 66999999999999999999999999998643221
Q ss_pred CCcceeecccccccccCccccc-------cCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 242 SQSHVTTRVMGTYGYAAPEYVA-------TGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 242 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
..........++..|+|||++. ...++.++|||||||++|+|++ |..||........ .......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~-- 225 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVRE-- 225 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhc--
Confidence 1111112234567799999874 2456789999999999999999 7788865422110 0000000
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..........+..++..+.+++..|+ .||++|||+++|++.|
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 ----QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ----cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00000111223356677888999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.68 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=203.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.|+..+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+...
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR-------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC-------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence 46677889999999999997543 56889999987543 33456788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+++++|.+++.. ..+.+..+..++.||+.||.|||+ ++++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEcccccccc
Confidence 999999999999998843 267889999999999999999996 6799999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
..... .......++..|+|||++.+..++.++|+|||||++|+|++|..||....+.... .
T Consensus 151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~ 211 (277)
T cd06642 151 LTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-----------------F 211 (277)
T ss_pred ccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-----------------h
Confidence 33211 1122346888999999998888999999999999999999999998654321100 0
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+........+..++.++.++|.+||..+|++||++.+++++-..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 212 LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 011111122333566789999999999999999999999987653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=301.53 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|+||.||+|.... +++.+|||.+.... ....+.+.+|+.+++.++||||+++++.+..++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA-------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC-------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence 58889999999999999996543 57889999886542 2345678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeEEccCCCc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFGLA 235 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~a 235 (413)
+++||||+++++|.+++.... ...+++..+..++.+++.+|.|||+ ++|+|+||+|+||+++.+ +.++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 999999999999999996543 2357889999999999999999996 679999999999999754 46899999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+... ..
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----------------~~ 210 (256)
T cd08220 150 KILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----------------LV 210 (256)
T ss_pred eecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----------------HH
Confidence 8643221 1223568889999999988888999999999999999999999987643211 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+.. ......+..++.++.+++.+||..||.+|||+.+++++
T Consensus 211 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 211 LKIMS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01111 11122344567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=302.74 Aligned_cols=261 Identities=27% Similarity=0.411 Sum_probs=201.4
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC--
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK-- 155 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 155 (413)
|++.+.||+|+||.||+|.+.. ...+++.||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS----EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec----cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 6778899999999999997652 23467899999886542 334567889999999999999999999886542
Q ss_pred ----eeEEEEeeCCCCCHHHhhhhcC--CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 156 ----ELLLVYEFMQKGSLENHLFGRG--ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 156 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
..++++||+.+++|.+++.... .....++...++.++.||+.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEE
Confidence 2478999999999998874322 122357888899999999999999996 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||+++...............++..|++||.+.+..++.++|||||||++|+|++ |.+||....... .
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~------- 224 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I------- 224 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H-------
Confidence 99999886432221112223345678999999988889999999999999999999 888886543210 0
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...+........+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 225 -------~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 -------YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000011112234567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=304.72 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh----------hhHHHHHHHHHHHhhccCCCccceE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----------QGFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
+|.+.+.||.|+||.||+|.... +++.||+|.+..... ...+.+.+|+.+++.++|+||++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 74 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74 (272)
T ss_pred ceeecceecccCceEEEEEeecC-------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 58889999999999999996432 578899998753211 1234678899999999999999999
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
+++......++||||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+++||||+|+||+++.++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEE
Confidence 9999999999999999999999998654 368888999999999999999996 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCC--ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
|+|||++................|+..|+|||.+.... ++.++|+||||+++|+|++|..||........ . .
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~-~ 222 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----M-F 222 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----H-H
Confidence 99999997643322222233456889999999887654 78999999999999999999999864321100 0 0
Q ss_pred hhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.... ..............++..+.++|.+||..+|.+||++.+++++
T Consensus 223 ~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 223 KLGN------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Hhhc------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000 0000001111222457889999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=311.77 Aligned_cols=267 Identities=21% Similarity=0.320 Sum_probs=189.5
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe--CCeeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE--DKELLLV 160 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 160 (413)
...||+|+||.||+|.... ..++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~-----~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKD-----GKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecC-----CCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 3579999999999997542 22567899998875532 2457889999999999999999998854 4678999
Q ss_pred EeeCCCCCHHHhhhhcC-----CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeEEcc
Q 015094 161 YEFMQKGSLENHLFGRG-----ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL----DGSYTAKISD 231 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~----~~~~~~kl~D 231 (413)
|||+.+ +|.+++.... .....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 999865 8888774321 122357888999999999999999997 669999999999999 5667999999
Q ss_pred CCCcccCCCCCCc-ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh---hHhhh
Q 015094 232 FGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL---VDWIK 306 (413)
Q Consensus 232 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~---~~~~~ 306 (413)
||+++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|.+||........... .....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 9999864322211 11234568999999999876 4578999999999999999999999975433211000 00000
Q ss_pred hhhh-----hhhh---------hhHhHHhhhc------------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 307 PYLS-----EKRK---------FRHIIDARLQ------------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 307 ~~~~-----~~~~---------~~~~~~~~~~------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.... .... +......... ..........+.+|+.+||..||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0000 0000000000 00011234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=308.24 Aligned_cols=258 Identities=27% Similarity=0.366 Sum_probs=200.8
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeE
Q 015094 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGY 150 (413)
Q Consensus 72 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 150 (413)
++....+.|++.+.||+|+||.||+|.+.. +++.||+|++..... ....+..|+.+++++ +|+||++++++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVK-------TGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcC-------CCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 334456789999999999999999997653 578899998865532 345678899999998 69999999998
Q ss_pred EEe------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 151 CWE------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 151 ~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
+.. ...+|++|||+.+++|.+++.... ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCC
Confidence 853 467899999999999999986533 2357888899999999999999997 669999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
+.++|+|||++....... .......|+..|+|||++. +..++.++|+|||||++|+|++|..||....+....
T Consensus 158 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred CCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 999999999987532211 1123356889999999875 356788999999999999999999999654321100
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+............++.++.+||.+||+.||.+|||+.+++++
T Consensus 236 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 ----------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00001111111123466789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=302.68 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=202.9
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc----------ChhhHHHHHHHHHHHhh-ccCCCccce
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE----------SLQGFEEWQSEVNFLGR-LSHPNLVRL 147 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~~i~~~ 147 (413)
.|++.+.||+|+||.||+|.+.. ..++.+|+|.+... .......+.+|+.++.+ ++|+||+++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~ 74 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRY 74 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeE
Confidence 47888999999999999997643 14678999987532 22234557788888865 789999999
Q ss_pred EeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 148 LGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
++++..++..|+||||+.+++|.+++.........+++..++.++.|++.+|.|||+ ..+++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred EeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCCcE
Confidence 999999999999999999999999886533334578999999999999999999995 3569999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
+|+|||++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---------- 220 (269)
T cd08528 154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---------- 220 (269)
T ss_pred EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH----------
Confidence 999999998633221 2344568899999999988889999999999999999999999986542110
Q ss_pred hhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+............++..+.++|.+||+.||++||++.|+..++.
T Consensus 221 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 ------LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000111111111112245678999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=300.95 Aligned_cols=247 Identities=31% Similarity=0.523 Sum_probs=199.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.+|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY---------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc---------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence 5689999999999999999842 45779999986543 335788999999999999999999988654 57
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 999999999999999965432 357888999999999999999996 6799999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
.... ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||....... ..
T Consensus 150 ~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~ 207 (254)
T cd05083 150 GSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------VK 207 (254)
T ss_pred cccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HH
Confidence 3221 112234567999999988899999999999999999997 999987543211 11
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+........+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 208 ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111222223344567889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.00 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=199.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~--------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL--------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe--------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 36888999999999999999654 246799998875432 235688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++.... ..+++..++.++.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceee
Confidence 99999999999999986433 257888999999999999999996 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... +.
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~ 211 (256)
T cd05112 150 VLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----------------VV 211 (256)
T ss_pred cccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----------------HH
Confidence 322111 11112235678999999988899999999999999999998 899986542110 00
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..+........+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 212 ETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00111111122334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=302.09 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=199.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
.+.....||+|+||.||+|.+.. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLS-------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cCCceEEEecCCceEEEEeEecC-------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34445689999999999996543 57889999988776666778999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCC--cHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeEEccCCCc
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPL--AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGLA 235 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~a 235 (413)
+||||+.+++|.+++..... .+ ....+..++.||+.||.|||+ ++|+||||||+||+++. ++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999865421 34 777888999999999999996 67999999999999976 679999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCC--ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
....... .......|+..|+|||++.+.. ++.++|+||||+++|+|++|..||......... .+
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~--------- 222 (268)
T cd06624 157 KRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MF--------- 222 (268)
T ss_pred eecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hh---------
Confidence 7532211 1122345889999999886543 788999999999999999999998653221100 00
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..........++..++.++.+|+.+||..+|++|||+.+++.+
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 223 ---KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000011223455677889999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.78 Aligned_cols=264 Identities=23% Similarity=0.308 Sum_probs=196.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|+||.||+|.+.. +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~-------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE-------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC-------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence 58889999999999999997654 578899998865422 223457789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+|+||+.+ +|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 74 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 74 LTLVFEYCDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred eEEEEecCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 9999999964 8888775432 368999999999999999999997 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh--hhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS--EKR 313 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 313 (413)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ....+..... ...
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 223 (284)
T cd07839 148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEE 223 (284)
T ss_pred ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChH
Confidence 5322211 12234578899999988764 478999999999999999999888644322110 0000000000 000
Q ss_pred hhh---HhHHhhhc---------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 KFR---HIIDARLQ---------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~~~---~~~~~~~~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
... ........ ......++.++.+||.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 00000000 01112456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.50 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=190.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.||+|+||.||+|.+... .....+++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTD-----TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcC-----CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEe
Confidence 3599999999999964321 123557778766443 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++.+............+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence 999999999997654334456777888999999999999996 669999999999999999999999999986422111
Q ss_pred CcceeecccccccccCcccccc-------CCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVAT-------GHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
.........++..|+|||++.. ..++.++|||||||++|+|++ |..||....... ........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~--- 224 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKD--- 224 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhh---
Confidence 1112234567889999998743 245678999999999999997 566775432210 00000000
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..............+..+.+++..|| .+|++||+++++++.|.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 ---QQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---cccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 00001112223346678889999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=303.50 Aligned_cols=255 Identities=29% Similarity=0.405 Sum_probs=201.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.|++|++..... ..+.+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK-------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC-------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 4689999999999999999997543 567899999876543 346788999999999 6999999999987644
Q ss_pred ------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 156 ------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 156 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
.+|+||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEE
Confidence 5899999999999999986544334578999999999999999999997 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCcccccc-----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
+|||++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||........
T Consensus 155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------ 226 (275)
T cd06608 155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------ 226 (275)
T ss_pred CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------
Confidence 9999987532211 12233568899999998753 3467889999999999999999999965322110
Q ss_pred hhhhhhhhhhhhHhHHhh-hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDAR-LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...+.... .....+..++.++.+||.+||..||++|||+.+++++
T Consensus 227 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 227 ----------LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ----------HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00011100 0111223466789999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=308.78 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=200.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
.|.....||+|+||.||++.... +++.||||.+........+.+.+|+.+++.++|+||+++++.+..++..|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKH-------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECC-------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 34455779999999999996543 57889999987665555677889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 99999999999998742 257888999999999999999997 56999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
.... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... . .+...
T Consensus 169 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~-------~~~~~ 233 (292)
T cd06658 169 SKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------R-------RIRDN 233 (292)
T ss_pred cccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-------HHHhc
Confidence 2221 1122356889999999998888999999999999999999999999754321100 0 00000
Q ss_pred HHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 319 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..... ......+..+.+++.+||..||.+|||+++++++-.
T Consensus 234 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 234 LPPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred CCCcc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 00000 111245667899999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=306.55 Aligned_cols=243 Identities=30% Similarity=0.443 Sum_probs=205.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhcc-CCCccceEeEEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLS-HPNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 152 (413)
..+|..+.+||+|+||+|.+| +..++.+.||||+++++.. .+.+--..|-++|.... -|.++++...|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLa-------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLA-------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred ecccceEEEeccCccceeeee-------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 457889999999999999999 4556889999999987632 23444456777777765 679999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
.-+.+|+||||+.||+|...|++.+ .+.+..+..++..|+.||-|||+ +|||.||||.+|||++.+|.+||+||
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeec
Confidence 9999999999999999999998877 45666778899999999999996 77999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|+++... .....+..++||+.|+|||++...+|+.++|+||+|++||||+.|++||++.+. .
T Consensus 495 GmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----------------~ 556 (683)
T KOG0696|consen 495 GMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------D 556 (683)
T ss_pred ccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----------------H
Confidence 9998533 334455678999999999999999999999999999999999999999998743 3
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt 352 (413)
+.++.+.+... .+|...+.++.++.+.+|.+.|.+|..
T Consensus 557 elF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 557 ELFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 34555554433 478889999999999999999999963
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=307.35 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=198.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.+.. +++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE-------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC-------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC
Confidence 368899999999999999996543 578899998875532 3345678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||++|++|.+++...+ .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCC
Confidence 99999999999999999996543 68889999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCC-------------cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 235 AKLGPSASQ-------------SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 235 a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
++....... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---- 223 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---- 223 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 864211100 001112457889999999988889999999999999999999999997542210
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhc-CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+......... ......++.++.+||.+||+.||++||++.++++.|
T Consensus 224 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 224 ------------LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ------------HHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 00011111000 011124567899999999999999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=304.33 Aligned_cols=268 Identities=25% Similarity=0.311 Sum_probs=201.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|+||.||+|.+.. +++.|++|++.... ....+.+.+|+.+++.++|+||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE-------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC-------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 58899999999999999997543 57889999987553 2334678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+ +++|.+++.... ..+++..++.++.||+.+|.|||+ .+|+|+||||+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 74 FVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred eEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 99999999 999999986543 468999999999999999999997 569999999999999999999999999988
Q ss_pred cCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-h-------hh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW-I-------KP 307 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~-~-------~~ 307 (413)
....... .......++..|+|||++.+. .++.++|||||||++|+|++|.++|.............. . .+
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 6433221 112334689999999988654 468999999999999999999888865432211100000 0 00
Q ss_pred hhhhhhhhhHhHHhhhc----CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQ----GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..........+...... .......+..+.+||.+||..||.+||++++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000000000000000 001113457899999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=304.21 Aligned_cols=267 Identities=25% Similarity=0.356 Sum_probs=199.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE-------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC-------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 468999999999999999997543 57899999886432 123355788999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++||||++++.|..++... ..+++..++.++.||+.+|.|||+ .+|+|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred EEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999998887776432 258899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD-WIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 313 (413)
........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||............. ..........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 86433221 1223457889999998866 567899999999999999999999997654322111000 0000000000
Q ss_pred h-------hhHhHHhhhcCC-----CchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 K-------FRHIIDARLQGQ-----YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~-------~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
. +........... .....+..+.+|+.+||+.||++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000000000000 001346778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=299.84 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=203.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|+||.||++.... .++.|++|.+... .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence 58899999999999999996543 5788999988643 22344578899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+++|.+++.... ...+++..++.++.|++.+|.|||+ ++++|+||+|+|||++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred EEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 999999999999999886532 2257888999999999999999996 669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ...
T Consensus 150 ~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~ 211 (256)
T cd08218 150 VLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----------------LVL 211 (256)
T ss_pred ecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----------------HHH
Confidence 543221 11223468889999999988889999999999999999999999986542110 011
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+.. ......+...+.++.++|.+||+.+|.+||++.+++++
T Consensus 212 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 212 KIIR-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHhc-CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 11112344567789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.32 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=207.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+|++.+.||+|++|.||+|.+.. +++.|+||++..... ...+.+.+|+.++..++|+||+++++++.....+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~-------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKP-------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence 68899999999999999996553 678999999876643 3456789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+++++|.+++... ..+++..++.++.||+.+|.|||+ ..+++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~-~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhc-cCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999999999999999654 378999999999999999999995 15699999999999999999999999999886
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ....
T Consensus 150 ~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~-------------~~~~ 214 (264)
T cd06623 150 LENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE-------------LMQA 214 (264)
T ss_pred cccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH-------------HHHH
Confidence 432222 1123467889999999988889999999999999999999999997654311000 0111
Q ss_pred hHHhhhcCCCchH-HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 318 IIDARLQGQYPYK-AAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 318 ~~~~~~~~~~~~~-~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
+. .......+.. ++..+.++|.+||..+|++||++.+++++-
T Consensus 215 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~ 257 (264)
T cd06623 215 IC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257 (264)
T ss_pred Hh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence 11 1111223334 678899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=300.66 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||.|+||+||+|.+.. ++..+++|++.... ....+.+.+|+.+++.++|+||+++++.+..+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 368999999999999999996543 56789999986543 2355678999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+|||++.+++|.+++..... ...+++..+..++.||+.||.|||+ .+|+|+||+|+||++++++.++|+|||++.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 9999999999999999965432 2368899999999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCcc--eeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 237 LGPSASQSH--VTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 237 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
......... ......|+..|+|||++... .++.++|+|||||++|+|++|..||.......... . .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~----~~~~~- 223 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--L----TLQND- 223 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--H----HhcCC-
Confidence 654433221 22345689999999998776 78899999999999999999999997653321000 0 00000
Q ss_pred hhhHhHHhhhcCC-CchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 KFRHIIDARLQGQ-YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
....... ....++..+.+++.+||..||++||++.+++++
T Consensus 224 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 ------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 012456789999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.37 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeC--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-- 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 154 (413)
++|...+.||.|++|.||+|.+.. +++.||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 367888999999999999997643 578999998875432 3456788999999999999999999988654
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+++++|.+++.........++...+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 151 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGV 151 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeeccc
Confidence 47899999999999999876543344568889999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+....... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......... ..+... ......
T Consensus 152 ~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~-~~~~~~- 224 (287)
T cd06621 152 SGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELLS-YIVNMP- 224 (287)
T ss_pred cccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHHH-HHhcCC-
Confidence 87532211 12345788999999998899999999999999999999999999865321100 000000 000000
Q ss_pred hhHhHHhhhcCCC--chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQY--PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
........ ....+..+.+||.+||..+|.+|||+.|++++-+.
T Consensus 225 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 225 -----NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred -----chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 00000011 12356789999999999999999999999987664
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.06 Aligned_cols=243 Identities=28% Similarity=0.432 Sum_probs=196.4
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEE---EEecC-CcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIA---VKKLN-SESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~va---iK~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+..++||+|+|-+||+|.+.. +|..|| ||+-+ ......+++|..|+.+|+.|+|+||+++|++|.+...
T Consensus 43 k~~evLGrGafKtVYka~De~-------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE-------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred ehhhhcccccceeeeeccccc-------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 455689999999999996543 566565 33222 1234566889999999999999999999999987754
Q ss_pred --eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEccCC
Q 015094 157 --LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDFG 233 (413)
Q Consensus 157 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~DfG 233 (413)
+.+|+|++..|+|..|+.+.+ .+....+..|++||++||.|||+++.+|||||||.+||||+ ..|.|||+|+|
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 889999999999999997765 67888999999999999999999999999999999999996 56899999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+|+... .......+|||.|||||+. ...|+..+||||||+.++||+|+.+||..-...
T Consensus 192 LAtl~r----~s~aksvIGTPEFMAPEmY-EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----------------- 249 (632)
T KOG0584|consen 192 LATLLR----KSHAKSVIGTPEFMAPEMY-EENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----------------- 249 (632)
T ss_pred HHHHhh----ccccceeccCccccChHHH-hhhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----------------
Confidence 999632 2223447999999999966 699999999999999999999999999653221
Q ss_pred hhhHhHHhhhcCCCchH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYK----AAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..|..+...+..|.. -.+++++||.+||.. .++|+|+.|+|++
T Consensus 250 --AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 250 --AQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --HHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 112222222332322 246899999999999 9999999999975
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=307.21 Aligned_cols=268 Identities=25% Similarity=0.364 Sum_probs=201.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||.||+|.+.. +++.|++|+++... ....+.+.+|+++++.++|+||+++++++..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA-------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC-------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 368999999999999999997553 57899999886532 233467889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++||||+.++.+..+.... ..+++..+..++.||+.||.|||. .+++|+||+|+||+++.++.+||+|||++
T Consensus 74 ~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 74 RLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred EEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 999999999886666555322 358899999999999999999996 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhhhhh---
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW-IKPYLS--- 310 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~-~~~~~~--- 310 (413)
........ .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||......+....... ......
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 86443322 122345688999999999887 888999999999999999999999976432211100000 000000
Q ss_pred ----hhhhhh-----HhH-HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 311 ----EKRKFR-----HII-DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 311 ----~~~~~~-----~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
....+. ... .......++..++.++.+||.+||..+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 000 0000111233447889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=298.09 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|+||.||+|.... +++.|++|.+..... ...+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD-------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC-------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence 58899999999999999996543 578899999876544 356788999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++|+||+.+++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccccccc
Confidence 999999999999999986432 57888899999999999999996 669999999999999999999999999988
Q ss_pred cCCCCCCcce--eecccccccccCccccccCC---ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 237 LGPSASQSHV--TTRVMGTYGYAAPEYVATGH---LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 237 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
.......... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~------------ 215 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI------------ 215 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH------------
Confidence 6433222111 12346788999999987766 889999999999999999999999754311000
Q ss_pred hhhhhHhHHhhhcCCCch--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPY--KAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...+.......++. .++..+.++|.+||+.+|.+||++.+++.+
T Consensus 216 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 216 ----MFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ----HHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000011112222 236788999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=305.71 Aligned_cols=260 Identities=29% Similarity=0.368 Sum_probs=201.7
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeE
Q 015094 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGY 150 (413)
Q Consensus 72 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 150 (413)
++....++|.+.+.||+|+||.||+|.... +++.+|+|.+..... ....+.+|+.+++++ +||||++++++
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~-------~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKK-------DGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECC-------CCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 333456789999999999999999996543 578999999865432 235677899999999 79999999998
Q ss_pred EEeC-----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 015094 151 CWED-----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 151 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~ 225 (413)
+... ..+|+||||+.+++|.+++.........+++..++.++.|++.||.|||+ .+|+||||||+||+++.++
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCC
Confidence 8754 36899999999999999886543344578899999999999999999996 6699999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccC-----CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-----HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~ 300 (413)
.+||+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|..||....+....
T Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~- 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL- 242 (291)
T ss_pred CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-
Confidence 999999999875332211 12234688899999987543 3678999999999999999999999764321100
Q ss_pred hhHhhhhhhhhhhhhhHhHHh-hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 301 LVDWIKPYLSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+... ......+......+.+||.+||+.+|++||++.+++++
T Consensus 243 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 ---------------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---------------HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000 00111223455679999999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=301.84 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=204.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+|++.+.||.|+||.||+|.+.. +++.|++|.+.... ....+.+.+|+++++.++||||+++++++..+..+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRP-------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcC-------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence 57888999999999999997653 57889999887653 23456788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++|+||+.+++|.+++.... ..+++..+..++.|++.+|.|||+ ..+++|+||||+||+++.++.++|+|||.+..
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 99999999999999986543 478889999999999999999996 25699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ... .+..
T Consensus 151 ~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~----------~~~~ 215 (265)
T cd06605 151 LVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFE----------LLQY 215 (265)
T ss_pred hHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHH----------HHHH
Confidence 32211 11256888999999998889999999999999999999999999754321100 000 0111
Q ss_pred hHHhhhcCCCchH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 318 IIDARLQGQYPYK-AAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 318 ~~~~~~~~~~~~~-~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+... .....+.. ++.++.++|.+||..||++|||+.+++.+-+
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 216 IVNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred HhcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 1111 11112222 6778999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=307.74 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=206.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
..+.|+.-++||+|+||.||-|... .+|+.||+|.+.+.... ...-..+|-.||.+++.++||.+-..|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvr-------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVR-------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred cccceeeeEEEecccccceeEEEEe-------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 3467888999999999999998544 38999999988765332 2234678999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
..+.+|+||..|.||+|.-+|.+.+. ..+++..++.++.+|+.||++||. .+||.|||||+|||+|+.|.++|+|+
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999999977664 479999999999999999999996 66999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|+|... .........+||.+|||||++.++.|+...|+|||||+||||+.|..||.........
T Consensus 332 GLAvei---~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------- 395 (591)
T KOG0986|consen 332 GLAVEI---PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------- 395 (591)
T ss_pred ceEEec---CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------
Confidence 999863 3344455568999999999999999999999999999999999999999754221110
Q ss_pred hhhhHhHHhh---hcCCCchHHHHHHHHHHHHccccCCCCCCCH
Q 015094 313 RKFRHIIDAR---LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353 (413)
Q Consensus 313 ~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~ 353 (413)
.-++.+ ....++..+++++++|...+|.+||++|...
T Consensus 396 ----eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 396 ----EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ----HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 011221 1235677899999999999999999999744
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=302.48 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=204.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
+|++.+.||.|+||.||+|.+.. +++.||+|++..... ...+.+.+|++++++++||||+++++.+..+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD-------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc-------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC
Confidence 48889999999999999996543 578899999875432 34567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+.|++|.+++... ..+.+..+..++.||+++|.|||. .+++|+||+|+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccc
Confidence 999999999999999999654 368899999999999999999996 56999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .. +
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~----------~ 210 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQ----------I 210 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HH----------H
Confidence 8643321 22335688899999999888899999999999999999999999986543210 00 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM--REVVE 358 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~--~e~l~ 358 (413)
...... .....+...+..+.++|.+||..||.+||++ +|+++
T Consensus 211 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 211 RAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 001110 2234455677899999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=307.13 Aligned_cols=273 Identities=23% Similarity=0.336 Sum_probs=200.6
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
+|++.+.||+|+||.||+|..... ..++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 588899999999999999975431 257899999987632 23345678899999999999999999999988
Q ss_pred -CeeEEEEeeCCCCCHHHhhhhcCCCC-CCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC----CCCeE
Q 015094 155 -KELLLVYEFMQKGSLENHLFGRGASV-QPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG----SYTAK 228 (413)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~----~~~~k 228 (413)
..+|+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+|
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceEE
Confidence 889999999965 7877775433322 378899999999999999999997 66999999999999998 99999
Q ss_pred EccCCCcccCCCCCCc-ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch------
Q 015094 229 ISDFGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN------ 300 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~------ 300 (413)
|+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||..........
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence 9999998864332221 11233567889999998866 457899999999999999999999998655432100
Q ss_pred -hhHhhhhh----------hhhhhhhhHhHHhhhcCCCc-----------hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 301 -LVDWIKPY----------LSEKRKFRHIIDARLQGQYP-----------YKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 301 -~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
........ ......+...........++ ...+.++.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 00000000000000011111 034457899999999999999999999987
Q ss_pred H
Q 015094 359 T 359 (413)
Q Consensus 359 ~ 359 (413)
+
T Consensus 313 ~ 313 (316)
T cd07842 313 H 313 (316)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=301.20 Aligned_cols=268 Identities=24% Similarity=0.316 Sum_probs=204.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC--C----CccceEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH--P----NLVRLLG 149 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~----~i~~~~~ 149 (413)
..++|.+.+.||+|.||.|..+++.+ ++..||||+++.-. ...+..+-|+++|+++.+ | -++++.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~-------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRE-------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecC-------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 47899999999999999999998664 47899999987543 234556779999999952 2 3788889
Q ss_pred EEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC------
Q 015094 150 YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG------ 223 (413)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~------ 223 (413)
+|...++.|||+|.+ |.++.+++.... -.+++...++.+++||+++++|||+ .+++|-||||+|||+..
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEE
Confidence 999999999999998 779999996543 3478999999999999999999997 55999999999999921
Q ss_pred --------------CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCC
Q 015094 224 --------------SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRA 289 (413)
Q Consensus 224 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~p 289 (413)
+..|+|+|||-|+.. .......+.|..|+|||++.+-.++..+||||+||||+|+++|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 335899999999852 2223557889999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhh-hhh---hhhhhhHhHHhh----------------hcCC--------CchHHHHHHHHHHHH
Q 015094 290 LDTNRPSGQHNLVDWIKP-YLS---EKRKFRHIIDAR----------------LQGQ--------YPYKAAYQIAQLSLK 341 (413)
Q Consensus 290 f~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~----------------~~~~--------~~~~~~~~l~~li~~ 341 (413)
|.+.+..+...+++.+.. +.. ........+... ++.. .......++.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 988764443333322211 100 000000000000 0000 112334579999999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 015094 342 CLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 342 ~L~~dp~~Rpt~~e~l~~L~ 361 (413)
||..||.+|+|+.|++.|-.
T Consensus 389 mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPF 408 (415)
T ss_pred HHccCccccccHHHHhcCHH
Confidence 99999999999999997643
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=307.52 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=201.3
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEE
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
|.....||+|+||.||+|.... +++.||+|.+........+.+.+|+.+++.+.||||+++++++..++..|+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH-------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC-------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 4455679999999999996543 578899999876544455678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 96 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 96 LMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 9999999999988743 257889999999999999999996 669999999999999999999999999987432
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||......... .... ..
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~----------~~- 232 (297)
T cd06659 169 KDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLR----------DS- 232 (297)
T ss_pred ccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHh----------cc-
Confidence 211 1223356899999999998888999999999999999999999999754321100 0000 00
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...........+..+.++|.+||+.+|++||++.+++++-...
T Consensus 233 -~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 233 -PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred -CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 0000111224566789999999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=295.60 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=208.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|.+.+.||.|+||.||++.+.. ++..|++|++..... ...+.+.+|+++++.++|+|++++.+.+..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence 58889999999999999997653 578899999876533 455678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++|+||+++++|.+++.........+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~ 151 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISK 151 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCcccee
Confidence 999999999999999997654334578999999999999999999997 579999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~ 213 (258)
T cd08215 152 VLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----------------LAL 213 (258)
T ss_pred ecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----------------HHH
Confidence 643322 22334568899999999988889999999999999999999999987543210 000
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. ........+..++..+.+++.+||..+|++|||+.+++++
T Consensus 214 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 KI-LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 1111223344667889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=295.60 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=190.3
Q ss_pred CeeeecCCceEEEEEecCCCCC---CCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPG---KSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 160 (413)
+.||+|+||.||+|.+...... .......|++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999987642100 0122346888887655433 5678899999999999999999999888 778999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-------CeEEccCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-------TAKISDFG 233 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-------~~kl~DfG 233 (413)
|||+.+++|.+++..... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999965432 67888899999999999999996 6799999999999998887 79999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccC--CccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||......... .
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~------~---- 217 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE------R---- 217 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH------H----
Confidence 9885322 2234567789999998776 78899999999999999999 56777654321100 0
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
... .....+......+.+++.+||..+|.+|||+.++++.|
T Consensus 218 -------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 218 -------FYQ--DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------HHh--cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 00111112227889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=305.47 Aligned_cols=267 Identities=25% Similarity=0.366 Sum_probs=199.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE-------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC-------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 368899999999999999997643 578899998764422 23456788999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+++++|.++.... ..+.+..++.++.||+.+|.|||+ .+|+|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred eEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeee
Confidence 999999999998888876432 257899999999999999999997 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD-WIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 313 (413)
....... .......++..|+|||++.+ ..++.++||||||+++|+|++|.+||............. ....+.....
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 7533222 12233568899999998865 457789999999999999999999997543211100000 0000000000
Q ss_pred h-h--hHhHHhhhcC---------CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 K-F--RHIIDARLQG---------QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~-~--~~~~~~~~~~---------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
. + ..+....... .....++..+.+|+.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0 0000000000 0112456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=302.90 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=195.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||.||+|+... +++.||||.+..... .....+.+|+++++.++|+||+++++++.+++.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL-------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT 77 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC-------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCe
Confidence 579999999999999999996543 568899999865432 122346789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+ +|.+++.... ..+.+..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECcccccc
Confidence 9999999975 9999886543 267889999999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh--hh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE--KR 313 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 313 (413)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .......+.. ..
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 227 (291)
T cd07844 152 AKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEE 227 (291)
T ss_pred ccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChh
Confidence 5322111 1122346788999998865 45789999999999999999999999755421100 0000000000 00
Q ss_pred hhhHhHH--------------hhhcCCCchHH--HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 KFRHIID--------------ARLQGQYPYKA--AYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~~~~~~~--------------~~~~~~~~~~~--~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+..+.. ....... ... ..++.+++.+||+.+|.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 0000000 012 2678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.52 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=205.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|.+.+.||+|+||.||+|.... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA-------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC-------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 3689999999999999999996433 467899999876544455678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 99999999999999998542 46788899999999999999996 669999999999999999999999999887
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
....... ......++..|++||.+.+..++.++|+|||||++|+|++|..||.............
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------------- 228 (293)
T cd06647 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------- 228 (293)
T ss_pred ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------------
Confidence 5332211 2233468889999999988889999999999999999999999997654322110000
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.........+...+..+.++|.+||..+|++||++.+++.+-..
T Consensus 229 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 229 --TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred --cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 00000111223456679999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=303.22 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=198.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-----hHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-----GFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
+|.+.+.||+|+||.||+|.+.. +++.|+||.+...... ....+..|+.+++.++|+||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence 48888999999999999997543 5789999998755322 23456789999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
...+|+||||+ +++|.+++.... ..+++..++.++.||++||.|||+ ++|+|+||||+|||++.++.++|+|||
T Consensus 74 ~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 74 KSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred CCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccce
Confidence 99999999999 889999995432 268999999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh-
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE- 311 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~- 311 (413)
++........ ......++..|+|||++.+ ..++.++|+|||||++|+|++|.++|........... ........
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~--~~~~~~~~~ 223 (298)
T cd07841 148 LARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK--IFEALGTPT 223 (298)
T ss_pred eeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH--HHHHcCCCc
Confidence 9986433221 1222356788999998855 4678999999999999999999888876443211100 00000000
Q ss_pred hh------hhhHhHHhhhcC-----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 KR------KFRHIIDARLQG-----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 ~~------~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. ............ ......+..+.+||.+||..||++|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 000000000000 0112346789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=312.52 Aligned_cols=268 Identities=23% Similarity=0.318 Sum_probs=200.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.... +++.||||.+... .......+.+|+.+++.++|+||+++++++..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV-------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP 86 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC-------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence 45789999999999999999996543 6789999998643 23344567789999999999999999998864
Q ss_pred C------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 D------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
. ...|+||||+.+ +|.+.+.. .++...+..++.||+.||+|||+ .+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 87 QKSLEEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred CCCccccCcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCE
Confidence 4 357999999965 88887732 27888889999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH----
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD---- 303 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~---- 303 (413)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|..||...+.........
T Consensus 158 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999999864322 11233468889999999999999999999999999999999999997654321110000
Q ss_pred -----h---h----hhhhhhh-----hhhhHhHHhhh----cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 304 -----W---I----KPYLSEK-----RKFRHIIDARL----QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 304 -----~---~----~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+ . ..+.... ..+........ ....+...+..+.+||.+||+.||++|||+.|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 0 0 0000000 00000000000 000112346678999999999999999999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.59 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=204.3
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 161 (413)
.++||+|+|+.|-.|.... ++..||||++.+...-...++.+|++++...+ |+||++++++|+++..+||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~-------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQ-------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHHhcCccceeeeeeeeec-------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4689999999999885443 78999999999886666778999999999997 999999999999999999999
Q ss_pred eeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---CeEEccCCCcccC
Q 015094 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY---TAKISDFGLAKLG 238 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~---~~kl~DfG~a~~~ 238 (413)
|-+.||+|...|.++. -+++..+..++++|+.||.|||. +||.||||||+|||-.... -||||||.++...
T Consensus 156 EKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred ecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 9999999999997765 68999999999999999999995 8899999999999996543 5799999987642
Q ss_pred CCCCC-----cceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh-
Q 015094 239 PSASQ-----SHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP- 307 (413)
Q Consensus 239 ~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~- 307 (413)
..... .......+|+..|||||++. -..|+.+.|.||||+|+|-||.|.+||-+.-..+=. .+.-.+
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG--WdrGe~C 307 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG--WDRGEVC 307 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC--ccCCCcc
Confidence 21111 11123468999999999862 246789999999999999999999999764332100 000000
Q ss_pred hhhhhhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+..|..|.+.... ..-..+++.+..+||..+|..|+.+|.++.+++++.+.
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 00111222222222211 11123778999999999999999999999999986553
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=297.64 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=202.9
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
-|++.+.||.|+||.||+|.+.. +++.||||.+.... ....+.+.+|+.+++.++|+||+++++++..+...
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR-------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC-------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence 47888999999999999996543 57899999876443 23446788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++.. ..+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 999999999999999843 257889999999999999999996 6799999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
..... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||........ . .
T Consensus 151 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----------------~-~ 211 (277)
T cd06641 151 LTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV----------------L-F 211 (277)
T ss_pred cccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH----------------H-H
Confidence 33211 112234688899999999888889999999999999999999999865322100 0 0
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+........+..++.++.+++.+||..+|.+||++.+++++-..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 256 (277)
T cd06641 212 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256 (277)
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 011111122334566789999999999999999999999997544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=295.33 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=201.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-----ChhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-----SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
.+|++.+.||+|+||.||+|.... +++.|++|.+... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 74 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD-------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR 74 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC-------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEE
Confidence 468999999999999999996543 6789999987432 2234567889999999999999999999887
Q ss_pred eC--CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 153 ED--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 153 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
+. ..++++|||+++++|.+++.... .+.+..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 75 DPEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEC
Confidence 64 56899999999999999986443 57888899999999999999996 669999999999999999999999
Q ss_pred cCCCcccCCCCCC-cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 231 DFGLAKLGPSASQ-SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 231 DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
|||++........ ........++..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------- 215 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------------- 215 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------------
Confidence 9999985432111 11122356889999999998888999999999999999999999999653211
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.....+........++...+..+.++|.+||. +|..||++.+++.|
T Consensus 216 ---~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 ---AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 01111122222334566788899999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=298.99 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhcc---CCCccceEeEEEeC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLS---HPNLVRLLGYCWED 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~ 154 (413)
.|++.+.||+|+||.||+|.+.. +++.|++|.+... .....+.+.+|+.+++.+. ||||+++++++..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP-------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC-------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 47888999999999999997543 5789999988654 2334567889999999997 99999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...|+||||+.+++|.+++... .+++..++.++.|++.+|.|||. .+|+|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCc
Confidence 9999999999999999998432 68899999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+....... .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------------- 212 (277)
T cd06917 148 AALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------------- 212 (277)
T ss_pred eeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------------
Confidence 88643322 12233468899999998865 456889999999999999999999997643221100
Q ss_pred hhhHhHHhhhcCCCch-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPY-KAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+........+. ..+.++.+++.+||..||++||++.+++++-+.
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 213 ----LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred ----ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 000000011111 256789999999999999999999999986443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=301.51 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=195.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+|++.+.||+|+||.||+|.... +++.|++|.+...... ....+.+|+.+++.++|+||+++++++..+.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI-------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC-------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 3679999999999999999996543 5788999998654322 2235678999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+. ++|.+++.... ..+.+..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccc
Confidence 9999999995 67877764332 256778888999999999999997 56999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--h-hhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--K-PYLSE 311 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~--~-~~~~~ 311 (413)
........ ......++..|+|||++.+. .++.++|||||||++|+|++|..||.............+. . +....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 151 RAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred cccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 75322211 12234578899999988764 5788999999999999999999999765431100000000 0 00000
Q ss_pred ---hhhhhHhHHhhhcCCCc---------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 ---KRKFRHIIDARLQGQYP---------YKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 ---~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...+............+ ...+..+.+++.+||..||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000 0124678899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=296.03 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|+||.||++.+.. +++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS-------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC-------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence 48889999999999999996543 57889999986542 2334567789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~ 151 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISK 151 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchh
Confidence 999999999999999987644444578999999999999999999996 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... ......++..|++||.+.+..++.++|+||||+++|+|++|..||...... .+.
T Consensus 152 ~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~ 210 (256)
T cd08530 152 VLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----------------DLR 210 (256)
T ss_pred hhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHH
Confidence 64332 222345888999999998888999999999999999999999999764321 011
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...........+...+.++.+++.+||..+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111111223344677889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=301.62 Aligned_cols=251 Identities=29% Similarity=0.401 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..+|++.+.||+|+||.||+|.... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVR-------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcC-------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 3569999999999999999996543 57899999886432 2344568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++..|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecC
Confidence 999999999996 47777775432 368899999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||...+....
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------------ 222 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------------ 222 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------------
Confidence 98753221 2346788999999874 45688999999999999999999999865432110
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+.........+..++..+.+||.+||..||++||++.+++.+.+.
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 223 ----LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred ----HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 000000000111123466789999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=311.20 Aligned_cols=264 Identities=27% Similarity=0.438 Sum_probs=224.4
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEE
Q 015094 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYC 151 (413)
Q Consensus 72 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 151 (413)
++..-..+......||-|.||.||.|+|++ ..-.||||.++.+.. .+++|..|..+|+.++|||+|+++++|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKk-------yslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeec-------cceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 344444556677889999999999999986 356799999987754 568899999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..+-.+|||+|||..|+|.+||++.... .++....+.++.||..|++||.. +++|||||...|+|+.++..|||+|
T Consensus 333 T~EpPFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 333 THEPPFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred ccCCCeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeec
Confidence 9999999999999999999999876543 56777888999999999999996 7799999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
||+++........ ......-...|.|||-+....++.++|||+||++|||+.| |..||.+.+.
T Consensus 409 FGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------------- 472 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------- 472 (1157)
T ss_pred cchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------------
Confidence 9999975433221 1222334567999999999999999999999999999998 8889887532
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
..+..++...++..-|..|++.+.+|++.||+++|.+||++.|+-+.++.+..
T Consensus 473 --SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 473 --SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 23445667777788889999999999999999999999999999999987654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=298.92 Aligned_cols=246 Identities=26% Similarity=0.364 Sum_probs=190.0
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhh---ccCCCccceEeEEEeCCeeE
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGR---LSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~---l~h~~i~~~~~~~~~~~~~~ 158 (413)
+||+|+||.||+|.... +++.||+|.+..... .....+.+|..+++. ..|+||+.+++++..++..|
T Consensus 1 ~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECC-------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEE
Confidence 48999999999996543 578999998865421 111223444444443 46999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+||||+.+++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++...
T Consensus 74 lv~e~~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 9999999999999886543 68999999999999999999997 66999999999999999999999999998743
Q ss_pred CCCCCcceeecccccccccCccccc-cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
... ......|+..|+|||.+. +..++.++|||||||++|+|++|..||.......... ...
T Consensus 148 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------------~~~ 209 (279)
T cd05633 148 SKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDR 209 (279)
T ss_pred ccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--------------HHH
Confidence 221 122346899999999886 4568899999999999999999999997643221100 000
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLER 362 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~~ 362 (413)
. ........+..++.++.++|.+||..||++|+ +++++++|...
T Consensus 210 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 210 M-TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred H-hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 0 01112234556778999999999999999999 69999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.85 Aligned_cols=287 Identities=26% Similarity=0.439 Sum_probs=232.6
Q ss_pred CCCCCCCCCCCcccccHHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHH
Q 015094 54 YPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSE 132 (413)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E 132 (413)
+.+......|+.....|.... ......|.++||.|.||.||+|+++.. ......||||.++... ......|..|
T Consensus 606 YiDP~TYEDPnqAvreFakEI-d~s~i~Ie~VIGaGEFGEVc~GrLk~p----gkre~~VAIKTLK~GytekqrrdFL~E 680 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEI-DPSCVKIEKVIGAGEFGEVCSGRLKLP----GKREITVAIKTLKAGYTEKQRRDFLSE 680 (996)
T ss_pred ecCCccccCccHHHHHhhhhc-ChhheEEEEEEecccccceecccccCC----CCcceeEEEeeeccCccHHHHhhhhhh
Confidence 333344444554444443322 234567889999999999999987642 2356789999998764 3455679999
Q ss_pred HHHHhhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 015094 133 VNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYR 212 (413)
Q Consensus 133 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHr 212 (413)
+.||-+++||||++|.++......+.||.|||+.|+|+.+|+.+.. .+..-+...+++.|+.|+.||-. .++|||
T Consensus 681 AsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsd--m~YVHR 755 (996)
T KOG0196|consen 681 ASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSD--MNYVHR 755 (996)
T ss_pred hhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhh--cCchhh
Confidence 9999999999999999999999999999999999999999976653 58888889999999999999995 669999
Q ss_pred CCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceee-cccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCC
Q 015094 213 DFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT-RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRAL 290 (413)
Q Consensus 213 Dlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf 290 (413)
||...|||++.+...|++|||+++..++......++ .-.=...|.|||.+....++.++|+||+||+|||.++ |..||
T Consensus 756 DLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 756 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 999999999999999999999999765544222111 1122468999999999999999999999999999887 88887
Q ss_pred CCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 291 DTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.... +.++-+-++..++...|.+|+..|.+|+..||++|-.+||.+.+|+..|+++....
T Consensus 836 WdmS-----------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 836 WDMS-----------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred cccc-----------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 6542 22344455666777888999999999999999999999999999999999987553
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.13 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..|...+.||+|+||.||+|.+.. ++..||+|.+... .....+.+.+|+.+++.++|+|++++++++..+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR-------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC-------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 347788999999999999997543 5788999988643 223445788899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...++||||+.| +|.+++.... .++++..+..++.||+.||.|||. ++|+||||+|+||+++.++.++|+|||+
T Consensus 98 ~~~~lv~e~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 98 HTAWLVMEYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred CeEEEEEeCCCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCC
Confidence 999999999975 7877775432 368899999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
+..... .....|+..|+|||++. ++.++.++|+|||||++|+|++|..||.......
T Consensus 172 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------------- 231 (317)
T cd06635 172 ASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------------- 231 (317)
T ss_pred ccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------------
Confidence 875322 12346888999999873 4568899999999999999999999986532110
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
....+............++..+.+|+.+||+.+|.+||++.++++++..+..
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 232 --ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred --HHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0111111111112223566789999999999999999999999998876553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.90 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=200.2
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
||.|+||.||+|.... +++.|++|++..... ...+.+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKS-------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECC-------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEe
Confidence 6999999999997643 578999999865422 234678899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+++++|.+++.... .++...+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 74 YCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 999999999996542 57889999999999999999997 669999999999999999999999999998643321
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
......++..|++||.+.+..++.++|+||||+++|+|++|..||....... ......+....
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~ 210 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--------------MEIYNDILKGN 210 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--------------HHHHHHHhccC
Confidence 2233568899999999988889999999999999999999999997654210 00111112112
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLE 361 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~ 361 (413)
....++...+.++.++|.+||..||++||+ ++|++++-+
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 233445556789999999999999999999 888887544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=298.44 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=199.9
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
.|...+.||+|++|.||+|.... +++.|++|++........+.+.+|+.+++.++|+||+++++++...+..|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~ 92 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS-------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELW 92 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC-------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEE
Confidence 45556799999999999996543 56889999887555445567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+|+||+.+++|.+++.. ..++...+..++.||+.+|.|||+ .+|+||||+|+||+++.++.++|+|||++...
T Consensus 93 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 93 VVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 99999999999999854 257888999999999999999997 66999999999999999999999999988753
Q ss_pred CCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
.... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...++... .. .+
T Consensus 166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~----------~~ 227 (285)
T cd06648 166 SKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MK----------RI 227 (285)
T ss_pred ccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HH----------HH
Confidence 2211 112235688999999999888899999999999999999999999875432110 00 00
Q ss_pred HHh-hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 319 IDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 319 ~~~-~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
... ......+..++..+.+|+.+||..+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 228 RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000 00001122356789999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.34 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=197.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||.|+||.||+|.+.. +++.||||.+.... ......+.+|++++++++||||+++++++.+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL-------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC-------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 48889999999999999996543 57899999886542 2233568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+. ++|.+++.... ...+++..++.++.|++.||+|||. .+++|+||+|+||+++.++.+||+|||++.
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 999999996 58988885433 2368899999999999999999996 669999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCC-ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhh-------h
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL-VDWIK-------P 307 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~-~~~~~-------~ 307 (413)
....... ......++..|+|||++.+.. ++.++|||||||++|+|+||..||........... ..... +
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 149 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 5322211 122235688899999886644 58899999999999999999999976532211000 00000 0
Q ss_pred hhhh----hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 308 YLSE----KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 308 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.... ...+..+...... .....++.++.++|.+||+.||.+|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 0000000000000 0012345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=291.93 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=207.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeC--
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-- 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 154 (413)
+|.+.+.||+|++|.||+|.... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 47888999999999999997553 578899999876542 4567789999999999999999999999988
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+++|+||+.+++|.+++.... .+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccccc
Confidence 89999999999999999996543 78999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+................++..|++||.+.+..++.++|+||||+++|+|++|..||....... . .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~----------~ 212 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----A----------A 212 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----H----------H
Confidence 986443322111334568899999999988889999999999999999999999997654100 0 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...+.........+...+..+.++|.+||..||.+||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 001111112223445567889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=290.82 Aligned_cols=249 Identities=28% Similarity=0.447 Sum_probs=204.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
.|.+.+.||+|++|.||+|.+.. +++.|++|++........+.+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 47788999999999999997653 57889999998765555678899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+++||+.+++|.+++.... ..+++..+..++.|++.+|.+||. .+++|+||+|+||+++.++.++|+|||.+...
T Consensus 74 l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 9999999999999986543 368999999999999999999996 67999999999999999999999999998764
Q ss_pred CCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
..... .....++..|++||++.+..++.++|+||||+++|+|++|..||......... ...
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~ 209 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL----------------FKI 209 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH----------------HHH
Confidence 33221 23456889999999998888899999999999999999999998754321100 000
Q ss_pred HHhhhcCCC--chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 319 IDARLQGQY--PYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 319 ~~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. ...... ...++..+.++|.+||..||++|||+.+++++
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 210 AT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Hh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 011111 11236789999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=302.40 Aligned_cols=267 Identities=25% Similarity=0.346 Sum_probs=199.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
++|++.+.||.|+||.||+|.+.. +++.|++|.++.... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK-------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC-------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 468899999999999999997653 578899998865432 2233567899999999999999999998877
Q ss_pred -CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 155 -KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
..+|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+ .+|+|+||||+|||++.++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 78 LDKIYMVMEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred CCcEEEEehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecC
Confidence 899999999975 9998886543 268999999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhh-h---
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD-WIK-P--- 307 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~-~~~-~--- 307 (413)
++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|.+||............. ... +
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9886433211 12234578899999988654 46889999999999999999999997654321110000 000 0
Q ss_pred ---hhhh-----hhhhhHhHHhhhcCCCchH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 308 ---YLSE-----KRKFRHIIDARLQGQYPYK-AAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 308 ---~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.... ...........+...++.. .+..+.+||.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0000000001111222222 47789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=342.20 Aligned_cols=253 Identities=27% Similarity=0.368 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
-+|+-.-.||.|.||.||.|.... +|+..|+|.+... .......+.+|+.+|..|+|||+|+++++=.+.+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~-------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLD-------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCC-------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 467777899999999999996543 7899999987644 2345567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.++|.||||+||+|.+.+...+ ..++.....+..|++.|+.|||. .|||||||||+||+++.+|.+|++|||.|
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccce
Confidence 9999999999999999985432 56677778889999999999997 55999999999999999999999999999
Q ss_pred ccCCCCCCcc--eeecccccccccCccccccC---CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 236 KLGPSASQSH--VTTRVMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 236 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
.........- ......||+-|||||++.+. ....+.|||||||++.||+||+.||...+...+
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a------------ 1449 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA------------ 1449 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH------------
Confidence 8754432111 12356899999999999764 456889999999999999999999976543211
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..--+...-..++|...+.+-++||.+||..||+.|+++.|++++
T Consensus 1450 ----IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 ----IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111122333456777899999999999999999999999999875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.98 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=207.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+.|++.+.||+|+||.||+|.+.. ++..|++|++..... ..+.+.+|+++++.++|+||+++++++..+.
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA-------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc-------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence 44568888999999999999997653 568899999876543 4567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+|+||+.+++|.+++.... ..++...+..++.|++.+|.|||+ .||+|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchh
Confidence 9999999999999999997654 368899999999999999999996 67999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
........ ......++..|++||++.+..++.++|+||||+++|+|++|..||....+.. ..
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----------------~~ 225 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----------------AL 225 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----------------HH
Confidence 75332211 1223457889999999988889999999999999999999999986543210 00
Q ss_pred hHhHHhhhc-CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 316 RHIIDARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 316 ~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+...... ...+..++..+.++|.+||+.+|.+||++.+++++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 001111111 11122366789999999999999999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=300.06 Aligned_cols=268 Identities=23% Similarity=0.285 Sum_probs=197.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.+.. +++.||||.+..... .....+.+|+.+++.+. |+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~-------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN-------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC-------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 368999999999999999997653 578999998765432 23356788999999996 69999999988876
Q ss_pred Ce-----eEEEEeeCCCCCHHHhhhhcCCC-CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCe
Q 015094 155 KE-----LLLVYEFMQKGSLENHLFGRGAS-VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTA 227 (413)
Q Consensus 155 ~~-----~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-~~~~ 227 (413)
.. .|+||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+
T Consensus 74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~ 150 (295)
T cd07837 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLL 150 (295)
T ss_pred CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeE
Confidence 65 8999999976 898888654332 3468999999999999999999996 66999999999999998 8899
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
||+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........... ...
T Consensus 151 kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~--~~~ 226 (295)
T cd07837 151 KIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH--IFK 226 (295)
T ss_pred EEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHH
Confidence 9999999875422211 1122356888999998865 4578999999999999999999999976533211100 000
Q ss_pred hhhh-hhhhhhHhHHhh-----------hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 307 PYLS-EKRKFRHIIDAR-----------LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 307 ~~~~-~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.... ....+....... .........+.++.+||.+||..||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000000000000 0000112356789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=297.01 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=196.4
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
||+|+||+||+|.... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++...+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKA-------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcC-------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEe
Confidence 6899999999996543 578999998865422 233456789999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 74 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-- 147 (277)
T cd05577 74 LMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-- 147 (277)
T ss_pred cCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--
Confidence 9999999999865432 368899999999999999999997 6699999999999999999999999999875332
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
........++..|+|||++.+..++.++|+|||||++|+|++|..||.......... .+..... .
T Consensus 148 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~-~ 212 (277)
T cd05577 148 -GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRTL-E 212 (277)
T ss_pred -CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhccc-c
Confidence 112233467889999999988889999999999999999999999997654311100 0000000 0
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
....++..++..+.++|.+||+.||.+|| ++.+++++-+
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChh
Confidence 11223445678899999999999999999 7777876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=301.83 Aligned_cols=259 Identities=26% Similarity=0.355 Sum_probs=196.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 156 (413)
+|...+.||+|+||.||++.+.. +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+..
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP-------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC-------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 45667889999999999996543 57899999887543 234456889999999996 9999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhc-CCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 157 LLLVYEFMQKGSLENHLFGR-GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++|||+.. +|.++.... ......+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred EEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 9999999854 665543211 1122468999999999999999999995 246999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccC---CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
....... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||..... ...........
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~- 226 (288)
T cd06616 156 GQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG- 226 (288)
T ss_pred HHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC-
Confidence 7533221 12234688899999998765 688999999999999999999999975421 00000000000
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.........+..++.++.+||.+||+.||++|||+.+++++-.
T Consensus 227 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 227 ------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred ------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0001111122346778999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=297.21 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=199.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+|++.+.||.|++|.||+|.+.. +++.||||.+..... ...+.+.+|+.+++.++|+||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT-------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC-------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 48889999999999999997543 578999999875532 2345677899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+.+ +|.+++..... ...+++..+..++.||+.||.|||+ .+|+||||||+||++++++.++|+|||++..
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 999999975 89888865442 3368999999999999999999996 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... ......++..|++||++.+. .++.++|+|||||++|+|++|..||.................. .....+.
T Consensus 150 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (284)
T cd07836 150 FGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT-PTESTWP 226 (284)
T ss_pred hcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-CChhhHH
Confidence 322111 11234578899999988664 5688999999999999999999999865432211100000000 0000000
Q ss_pred HhHH-hhhc-----------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIID-ARLQ-----------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~-~~~~-----------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+.. ..+. .......+..+.++|.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 0000 01112346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=315.87 Aligned_cols=273 Identities=26% Similarity=0.379 Sum_probs=202.0
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC----
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED---- 154 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 154 (413)
|...+.||+|+||.||+++++ .+|+.||||.++.. .....+.+.+|+++|++|+|+|||+++++=++.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnk-------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNK-------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred eeehhhhcCCccceeeeeccc-------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence 455678999999999999544 38999999999765 334567889999999999999999999974433
Q ss_pred --CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE--cCCC--CeE
Q 015094 155 --KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL--DGSY--TAK 228 (413)
Q Consensus 155 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~--~~~~--~~k 228 (413)
....+|||||.||+|...+.+-. +...+++..++.++.++..||.|||. +||+||||||.||++ ..+| ..|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEe
Confidence 35689999999999999997643 34479999999999999999999995 779999999999998 3333 579
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccc-cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI-- 305 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~-- 305 (413)
|+|||.|+.. .++.....++||..|++||++. .+.|+..+|.|||||++|+++||..||..........-..|.
T Consensus 165 LtDfG~Arel---~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~ 241 (732)
T KOG4250|consen 165 LTDFGAAREL---DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII 241 (732)
T ss_pred eecccccccC---CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence 9999999964 3444677889999999999887 488889999999999999999999999654333211111110
Q ss_pred -hhh------h--hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHHh
Q 015094 306 -KPY------L--SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP--SMREVVETLERLQA 365 (413)
Q Consensus 306 -~~~------~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp--t~~e~l~~L~~i~~ 365 (413)
++. . .++..+..-..-.............+..++..+|..+|.+|. ...+....+..|..
T Consensus 242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 000 0 000000000000000111123344566788899999999998 77777777776654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=300.94 Aligned_cols=271 Identities=25% Similarity=0.286 Sum_probs=198.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..+|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+|+.++++++|+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT-------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC-------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 3579999999999999999997543 578999998864422 1223456899999999999999999998765
Q ss_pred --CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 155 --KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 155 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+.+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 79 HLDSIFLVMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred CCCeEEEEEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcc
Confidence 568999999965 8888886432 368999999999999999999997 66999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-hh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY-LS 310 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~-~~ 310 (413)
|++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.................. ..
T Consensus 153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 153 GLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99986433221 1222345788999998865 56789999999999999999999999765432211111000000 00
Q ss_pred h-hhhhhHhH---Hhhhc-CC------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 311 E-KRKFRHII---DARLQ-GQ------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 311 ~-~~~~~~~~---~~~~~-~~------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
. ...+.... ..... .. .....+..+.+||.+||+.||++|||+.+++.+-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0 00000000 00000 00 001246778999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=307.88 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=197.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP-------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC-------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 4689999999999999999996543 57899999986432 23445678899999999999999999986644
Q ss_pred ----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 155 ----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 155 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
..+|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccceEEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEC
Confidence 358999999965 88887743 268899999999999999999997 669999999999999999999999
Q ss_pred cCCCcccCCCCCCc-ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 231 DFGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 231 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....... ....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~~ 225 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILGV 225 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHH
Confidence 99998764322111 11233568999999998754 5688999999999999999999999976532111000 0000
Q ss_pred hh--hhhhhhHhHHhh-------hc--CC-----CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 LS--EKRKFRHIIDAR-------LQ--GQ-----YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 ~~--~~~~~~~~~~~~-------~~--~~-----~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+. ....+..+.... .. .. .....+.++.+||.+||+.||++|||+.+++++-.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00 000111111000 00 00 01134567999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=297.12 Aligned_cols=260 Identities=26% Similarity=0.323 Sum_probs=193.2
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhcc-CCCccceEeEEEeC--C
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED--K 155 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~ 155 (413)
|++.+.||+|+||.||+|.... +++.||+|++..... .......+|+.+++++. |+||+++++++.++ +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~-------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK-------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcC-------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 6788999999999999996543 578899998865421 12223457888999886 99999999999987 8
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||. .+++||||+|+||+++. +.+||+|||++
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 74 RLALVFELMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred cEEEEEecCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccc
Confidence 99999999965 8888875432 368999999999999999999996 66999999999999999 99999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh-hh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE-KR 313 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 313 (413)
....... ......++..|+|||++.. ..++.++|||||||++|+|++|..||...+..+... ........ ..
T Consensus 147 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~---~~~~~~~~~~~ 220 (282)
T cd07831 147 RGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA---KIHDVLGTPDA 220 (282)
T ss_pred cccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHH---HHHHHcCCCCH
Confidence 7543221 1223467899999997644 557889999999999999999999997754322111 11000000 00
Q ss_pred hhhHhHHhh--hcCC-----------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 KFRHIIDAR--LQGQ-----------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~~~~~~~~~--~~~~-----------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
......... .... .....+..+.+||.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0000 012457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=332.82 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=214.4
Q ss_pred HHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccce
Q 015094 71 VELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRL 147 (413)
Q Consensus 71 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~ 147 (413)
.+++....+|.|+++||+|+||.|.++++.. +++.||+|++++.. .....-|..|-.+|-.-+.+=|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~-------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~L 140 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKS-------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQL 140 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeec-------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence 3455566899999999999999999996554 78999999998753 2344568889999998889999999
Q ss_pred EeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 148 LGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
.-.|.++.++|+||||++||+|..++.+.. ++++..++.++..|+-||..||+ .|+|||||||+||||+..|.+
T Consensus 141 hyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 141 HYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred HHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCcE
Confidence 999999999999999999999999996543 79999999999999999999997 569999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccc----c-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA----T-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
||+|||-+-.... ...-.....+|||.|.+||++. + +.|++..|+|||||++|||+.|..||.....
T Consensus 215 kLADFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------- 286 (1317)
T KOG0612|consen 215 KLADFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------- 286 (1317)
T ss_pred eeccchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-------
Confidence 9999998865332 2222344578999999999983 3 6789999999999999999999999976422
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHH
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKHRPS---MREVVETLE 361 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~~L~ 361 (413)
..++..|++..-.-.|| ..++.++.+||.+++. +|+.|.. ++++..|..
T Consensus 287 ---------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 287 ---------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred ---------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 22444455443333455 5688999999999886 5888987 888887754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=290.38 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=204.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|++.+.||+|++|.||+|.... .++.|++|.+..... ...+.+.+|++++++++|+||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE-------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC-------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence 58889999999999999996543 568899999876644 456778999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+++|.+++... ..+++..++.++.|++.+|.|||+ .+|+||||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccce
Confidence 99999999999999998654 368999999999999999999996 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
....... ......++..|+|||.+.+..++.++|+|+||+++|+|++|..||........ ..
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----------------~~ 209 (254)
T cd06627 148 KLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----------------LF 209 (254)
T ss_pred ecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----------------HH
Confidence 6433222 12335688899999998888888999999999999999999999875431100 00
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. ........+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 210 RI-VQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HH-hccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 00 0111223444567889999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=293.55 Aligned_cols=251 Identities=22% Similarity=0.383 Sum_probs=200.6
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|.+.+.||.|+||.||+|.... ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence 57888999999999999997643 57789999986542 1234567899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEccCCCc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFGLA 235 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~a 235 (413)
.|+|+||+.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .++|+|||.+
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred EEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 9999999999999999865332 257889999999999999999996 6699999999999998875 4699999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... . .
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~----------~ 211 (257)
T cd08225 150 RQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------L----------V 211 (257)
T ss_pred hhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------H----------H
Confidence 7643221 12223468899999999988889999999999999999999999986542110 0 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
........ .......+.++.++|.+||..+|++|||+.+++++
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 212 LKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111111 11223456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=307.29 Aligned_cols=255 Identities=25% Similarity=0.310 Sum_probs=216.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..+++++..||-|+||.|-++..+. ....+|+|++++... ...+.+..|-+||.....|+||++|..|.+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~-------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNS-------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecc-------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 3466778889999999999986653 223588888876532 344567889999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+.++|++||-|-||.|+..+..++ .+....+..++..+++|++|||+ +|||.|||||+|+|++.+|.+||.|||
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehh
Confidence 999999999999999999998776 67778888999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+|+... .+..+-.++||+.|.|||++.+...+.++|.||||+++||||+|.+||.+.++..
T Consensus 566 FAKki~---~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---------------- 626 (732)
T KOG0614|consen 566 FAKKIG---SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---------------- 626 (732)
T ss_pred hHHHhc---cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH----------------
Confidence 999743 3344556899999999999999999999999999999999999999999886543
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLERL 363 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~~i 363 (413)
.+..++...-...+|..++....+||+++...+|.+|.. +.+|.+|-|..
T Consensus 627 tYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 627 TYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 333344444445678888999999999999999999974 78888887753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=312.57 Aligned_cols=258 Identities=29% Similarity=0.419 Sum_probs=214.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+.++.++||+|.||+|++|.|.. ..+....||||.+...... ....|.+|+.+|.+|+|+|+++||++..+ ...
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~----psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQ----PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccC----CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 45667899999999999999886 2334567999999877554 67789999999999999999999998877 778
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
.+|||++..|+|.+.|.+ .....+.......++.||+.||.||.+ +++|||||...|||+-....|||+|||+.+.
T Consensus 186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceec
Confidence 999999999999999976 334478888899999999999999997 7799999999999999899999999999997
Q ss_pred CCCCCCcceeec-ccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTR-VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 238 ~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
.......+.... ..-...|.|||.+....++.++|+|++||+||||++ |..||.+.... .+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------qI 324 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------QI 324 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------HH
Confidence 665554443322 334557999999999999999999999999999998 77888876432 12
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+.++..-+..-|..|+.++.++++.||..+|++|||+..|.+.+-.
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 23334444455678999999999999999999999999999855443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=300.82 Aligned_cols=270 Identities=24% Similarity=0.333 Sum_probs=194.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.... +++.||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK-------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC-------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 3579999999999999999996543 67899999875432 12233567899999999999999999987755
Q ss_pred C--------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 155 K--------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 155 ~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
. ..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGI 157 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCc
Confidence 3 45999999964 8888875432 368899999999999999999996 56999999999999999999
Q ss_pred eEEccCCCcccCCCCCCc--ceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 015094 227 AKISDFGLAKLGPSASQS--HVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD 303 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~ 303 (413)
+||+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.............
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999764332211 112234578899999988664 46889999999999999999999997654322111111
Q ss_pred hhhhh-----hhhhhhhhHhHH--------hhhcCC-CchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 304 WIKPY-----LSEKRKFRHIID--------ARLQGQ-YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 304 ~~~~~-----~~~~~~~~~~~~--------~~~~~~-~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+... ......+...-. ...... .+...+..+.+||.+||..||.+|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 10000 000000000000 000000 011124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=293.88 Aligned_cols=242 Identities=26% Similarity=0.456 Sum_probs=194.7
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
||.|+||.||+|++.. +++.|++|.+..... ...+.+.+|+++++.++|+||+++++.+..+...|+|||
T Consensus 1 lg~g~~~~vy~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECC-------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEe
Confidence 6899999999997553 578999999876543 345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++.... .+++..+..++.||+.+|.|||. .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 74 YLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 999999999996543 68999999999999999999996 669999999999999999999999999987643321
Q ss_pred C------cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 243 Q------SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 243 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
. ........++..|++||.+.+..++.++|+||||+++|+|++|..||....... .+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~ 211 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----------------IFQ 211 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 1 112234567889999999988888999999999999999999999997553211 011
Q ss_pred HhHHhhhcCCCchH--HHHHHHHHHHHccccCCCCCCCH---HHHHH
Q 015094 317 HIIDARLQGQYPYK--AAYQIAQLSLKCLEAEPKHRPSM---REVVE 358 (413)
Q Consensus 317 ~~~~~~~~~~~~~~--~~~~l~~li~~~L~~dp~~Rpt~---~e~l~ 358 (413)
.+.... ...+.. .+..+.+++.+||+.+|.+|||+ .++++
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 212 NILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111111 112222 37889999999999999999999 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=296.55 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=205.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhcc-CCCccceEeEEEe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWE 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 153 (413)
++|.+.+.||+|+||.||+|.... +++.|++|++.... ....+.+.+|+.+++.+. |+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC
Confidence 468999999999999999996543 67899999986532 233456888999999999 9999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCc
Confidence 999999999999999999996543 68999999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCc------------------ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCC
Q 015094 234 LAKLGPSASQS------------------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRP 295 (413)
Q Consensus 234 ~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~ 295 (413)
++......... .......++..|+|||++.+..++.++|+||||+++++|++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98764332211 122334678899999999888899999999999999999999999986531
Q ss_pred CCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 015094 296 SGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM----REVVET 359 (413)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~----~e~l~~ 359 (413)
. ..+..+. .....++..++..+.+||.+||..+|.+||++ ++++++
T Consensus 228 ~----------------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 Y----------------LTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H----------------HHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 0111111 12223455667889999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=295.37 Aligned_cols=262 Identities=15% Similarity=0.143 Sum_probs=186.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhH-----------HHHHHHHHHHhhccCCCcc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-----------EEWQSEVNFLGRLSHPNLV 145 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~~i~ 145 (413)
.++|++.++||+|+||+||+|.+... ......+++|+......... .....++..+..+.|++|+
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASD----HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCC----cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 46899999999999999999976531 11245677776443321110 1122334455667899999
Q ss_pred ceEeEEEeCC----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 015094 146 RLLGYCWEDK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221 (413)
Q Consensus 146 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~ 221 (413)
++++.+.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill 159 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMV 159 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE
Confidence 9998765443 4578888874 47777664322 35677889999999999999997 669999999999999
Q ss_pred cCCCCeEEccCCCcccCCCCCCc-----ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCC
Q 015094 222 DGSYTAKISDFGLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPS 296 (413)
Q Consensus 222 ~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~ 296 (413)
+.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999764321110 1122346999999999999999999999999999999999999999865322
Q ss_pred CcchhhHhhhhhhhhhhhh-hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 297 GQHNLVDWIKPYLSEKRKF-RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
....... ...+ ..+.... .....++..+.+++..|+..+|++||++.++++.+
T Consensus 240 ~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GNLIHAA--------KCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHh--------HHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1110000 0000 0111110 11224568899999999999999999999998865
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.48 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=195.9
Q ss_pred Ceeeec--CCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEG--GFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
..||+| +||+||+|++.. +++.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP-------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HHhCCcccCceeEEEEEEcC-------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEE
Confidence 456666 899999996543 68999999987542 2345678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.++++||+.+....
T Consensus 77 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 9999999999999865432 358888999999999999999996 679999999999999999999999998654321
Q ss_pred CCCCcc-----eeecccccccccCccccccC--CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hh--
Q 015094 240 SASQSH-----VTTRVMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK--PY-- 308 (413)
Q Consensus 240 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~--~~-- 308 (413)
...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||......... ..... ++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~ 230 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSP 230 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCC
Confidence 111000 01112345679999998763 4789999999999999999999999764321100 00000 00
Q ss_pred -----hh--------hhhhh-----h---------HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 -----LS--------EKRKF-----R---------HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 -----~~--------~~~~~-----~---------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.. ....+ . ......+....+..++..+.+|+.+||..||++|||+.+++++-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00 00000 0 000001111223456788999999999999999999999998877
Q ss_pred HHH
Q 015094 362 RLQ 364 (413)
Q Consensus 362 ~i~ 364 (413)
.-.
T Consensus 311 ~~~ 313 (328)
T cd08226 311 FKQ 313 (328)
T ss_pred HHH
Confidence 543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=305.16 Aligned_cols=268 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|.... +++.||||.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 76 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE-------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP 76 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC-------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence 4579999999999999999996543 6789999988653 222345677899999999999999999987644
Q ss_pred -----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 155 -----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 155 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 77 HREAFNDVYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccccCcEEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEE
Confidence 35899999995 6898888543 368999999999999999999997 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh-
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW-IK- 306 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~-~~- 306 (413)
+|||++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......... ..
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998643221 22234568889999998765 4688999999999999999999999976532111100000 00
Q ss_pred ------hhhhhhhhhhHhHHhhhcC------CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 ------PYLSEKRKFRHIIDARLQG------QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ------~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+.. .......+...... .....++.++.+||.+||+.||++|||+++++++-+
T Consensus 228 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 228 PSEEDLGFIR-NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred CChHHhhhcC-chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 0000 00000011000000 011245678999999999999999999999999844
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=295.02 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=197.3
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
|++.+.||.|++|.||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence 6788999999999999997653 57899999886543 22335678899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+. ++|.+++..... ..+++..++.++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++..
T Consensus 74 ~iv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 74 YLVFEFLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred EEEEeccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 99999995 589998865432 368899999999999999999997 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhh-------h
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV-DWIKP-------Y 308 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~-~~~~~-------~ 308 (413)
...... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||............ ..... .
T Consensus 149 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 149 FGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred cCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 322211 11223568899999987664 5788999999999999999999999765332110000 00000 0
Q ss_pred hhhhhhhhHhHHhh---hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 309 LSEKRKFRHIIDAR---LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 309 ~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
......+....... .........+..+.++|.+||+.||.+|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000000 0001122345789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=290.21 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=195.1
Q ss_pred HHHHHHhcCCCCCCee--eecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccce
Q 015094 71 VELRAATRNFKSDTVL--GEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRL 147 (413)
Q Consensus 71 ~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 147 (413)
.+.....+.|.+.+.+ |+|+||.||++.... +++.+|+|.+........ |+.+...+ +|+||+++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~ 74 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKP-------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKL 74 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcC-------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEE
Confidence 4444555678888877 999999999996543 578899999865432211 23333323 69999999
Q ss_pred EeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-C
Q 015094 148 LGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-T 226 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~ 226 (413)
++++...+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+ .+++||||||+||+++.++ .
T Consensus 75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 75 YYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred EEEEecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCe
Confidence 999999999999999999999999996543 78999999999999999999997 5699999999999999888 9
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
++|+|||++...... ....++..|+|||++.+..++.++|+||||+++|+|++|..||....... .....
T Consensus 149 ~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~--- 218 (267)
T PHA03390 149 IYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES--- 218 (267)
T ss_pred EEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH---
Confidence 999999998753221 22468899999999988899999999999999999999999997543221 00000
Q ss_pred hhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-MREVVET 359 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-~~e~l~~ 359 (413)
+.... ......+...+..+.+||.+||+.||.+|++ +++++++
T Consensus 219 --------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 219 --------LLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --------HHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00000 0111233357788999999999999999996 6999865
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=293.37 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=189.4
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHHHHHHH---HHHhhccCCCccceEeEEEeCCeeE
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEV---NFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~---~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
+||+|+||.||+|.... +++.||+|.+...... ....+..|. .+++...||+|+++++++...+.+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 73 (278)
T ss_pred CcccCCCeEEEEEEEec-------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEE
Confidence 48999999999996543 5789999988654221 111233343 3444457999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+||||+.|++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 74 ~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 74 FILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 999999999999988543 368999999999999999999997 66999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
... ......|+..|+|||++.++ .++.++|||||||++|+|++|..||.......... ...
T Consensus 148 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--------------~~~ 209 (278)
T cd05606 148 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDR 209 (278)
T ss_pred Ccc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--------------HHH
Confidence 221 12234689999999998754 68899999999999999999999997653221110 000
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
. ........+...+.++.+++.+||..+|.+|| ++.+++++-+
T Consensus 210 ~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 210 M-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred H-hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 0 01112234445678999999999999999999 9999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=302.35 Aligned_cols=273 Identities=22% Similarity=0.310 Sum_probs=202.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 153 (413)
.++|++.+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 76 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR-------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP 76 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC-------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc
Confidence 3689999999999999999996553 57899999987542 2345667889999999999999999998763
Q ss_pred ---CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 154 ---DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 154 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||. ++|+||||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 77 GADFKDVYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred CCCCceEEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEec
Confidence 357899999995 5899888543 358999999999999999999996 669999999999999999999999
Q ss_pred cCCCcccCCCCCCc--ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--
Q 015094 231 DFGLAKLGPSASQS--HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI-- 305 (413)
Q Consensus 231 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~-- 305 (413)
|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...............
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 99998754322211 11233578999999998765 46889999999999999999999999765432211110000
Q ss_pred hh---hhh--hhhhhhHhHHhhh-cCCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 306 KP---YLS--EKRKFRHIIDARL-QGQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 306 ~~---~~~--~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+ ... ............. .... ....+.++.++|.+||+.+|.+||++.+++.+.+.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 00 000 0000011111000 0011 123567899999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=294.39 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=197.8
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
...||+|+||.||++.... +++.||||++..........+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKS-------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred HHHcCCCCCeEEEEEEEcC-------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 4679999999999996553 678999999865554455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+++++|.+++.. ..+++..+..++.|++.+|+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 98 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 9999999998743 257888899999999999999997 669999999999999999999999999987533211
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ . ..+...
T Consensus 171 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~----------------~-~~~~~~ 231 (292)
T cd06657 171 --PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----------------M-KMIRDN 231 (292)
T ss_pred --ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------H-HHHHhh
Confidence 112335688999999999888889999999999999999999999875422110 0 000111
Q ss_pred hcCC--CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 323 LQGQ--YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 323 ~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.... .....+..+.+++.+||..||.+||++.+++++-.
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred CCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 1111 11245667899999999999999999999998633
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=327.24 Aligned_cols=250 Identities=30% Similarity=0.415 Sum_probs=189.9
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
+...+|+.+++||+|+||.||+++. .-+|+.||||++... ......++.+|+.+|.+|+|||||+++..|.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRN-------KlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE 548 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRN-------KLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE 548 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEee-------cccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence 3456788899999999999999954 447899999998765 34456778999999999999999999876531
Q ss_pred C-------------------------------------------------------------------------------
Q 015094 154 D------------------------------------------------------------------------------- 154 (413)
Q Consensus 154 ~------------------------------------------------------------------------------- 154 (413)
.
T Consensus 549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~ 628 (1351)
T KOG1035|consen 549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR 628 (1351)
T ss_pred cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence 0
Q ss_pred ----------------------------------------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHH
Q 015094 155 ----------------------------------------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194 (413)
Q Consensus 155 ----------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~q 194 (413)
..+||-||||+..+|.+++..... .. .....+.++++
T Consensus 629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~--~~d~~wrLFre 705 (1351)
T KOG1035|consen 629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NS--QRDEAWRLFRE 705 (1351)
T ss_pred ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-ch--hhHHHHHHHHH
Confidence 116899999988666666644321 11 46778999999
Q ss_pred HHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC----------------CCCCcceeecccccccccC
Q 015094 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP----------------SASQSHVTTRVMGTYGYAA 258 (413)
Q Consensus 195 i~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~----------------~~~~~~~~~~~~gt~~y~a 258 (413)
|++||.|+|. +|||||||||.|||++.++.|||+|||+|+... ........+..+||.-|+|
T Consensus 706 IlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 706 ILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 9999999996 679999999999999999999999999998611 0111123456789999999
Q ss_pred ccccccC---CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc------h
Q 015094 259 PEYVATG---HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP------Y 329 (413)
Q Consensus 259 PE~~~~~---~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 329 (413)
||++.+. .|+.|+|+||||||++||+. ||...- ++. .++.....+.+| .
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM------------------ERa-~iL~~LR~g~iP~~~~f~~ 841 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM------------------ERA-SILTNLRKGSIPEPADFFD 841 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH------------------HHH-HHHHhcccCCCCCCccccc
Confidence 9998664 49999999999999999985 454431 010 111111122222 2
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 330 KAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 330 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
...+.-..+|.+||+.||.+||||.|+|+
T Consensus 842 ~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 842 PEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 23345678999999999999999999985
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=293.83 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=196.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|++|.||+|.+.. +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++..+.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC-------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 478999999999999999996543 578899998865422 23356788999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeEEccCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGL 234 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~ 234 (413)
..|+||||+. ++|.+++..... ..+.+..+..++.||+.||+|||+ ++|+|+||+|+||+++. ++.+||+|||+
T Consensus 75 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 75 RLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred eEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEccccc
Confidence 9999999996 488888754332 245788888999999999999996 67999999999999985 56799999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--hh---h
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--KP---Y 308 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~--~~---~ 308 (413)
+........ ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+........ .+ .
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 150 ARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227 (294)
T ss_pred ccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 975332211 1123457889999998866 45789999999999999999999999765432111000000 00 0
Q ss_pred hhhhhhhhHhHHh--hhcC----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 309 LSEKRKFRHIIDA--RLQG----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 309 ~~~~~~~~~~~~~--~~~~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
+............ .... ......+..+.+++.+||+.+|++||++.+++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0000000000000 0000 01123467789999999999999999999999764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=294.83 Aligned_cols=246 Identities=28% Similarity=0.404 Sum_probs=195.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.|...+.||+|+||+||+|.... +++.|++|++.... ....+.+.+|+.+++.++|+||+++++++.+..
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSH-------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH 94 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECC-------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 47778889999999999996543 57899999986432 233456888999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+. ++|.+++.... .++++..+..++.||+.+|.|||+ .+|+|+||+|+||+++.++.++|+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999999996 47877775432 368889999999999999999996 66999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
..... .....|+..|+|||++. +..++.++|+|||||++|+|++|..||.........
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------------- 229 (313)
T cd06633 169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------- 229 (313)
T ss_pred cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-------------
Confidence 64211 22356888999999874 456888999999999999999999998765321100
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+............++..+.+|+.+||+.+|.+||++.+++.+
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 230 ---YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00110111111122445679999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=303.94 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=203.2
Q ss_pred cCCCC--CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 78 RNFKS--DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 78 ~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.-|+| .++||.|.||+||-|.+.+ +|+.||||++.+... .....+++|+.||+.+.||.||.+..-|+.
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRk-------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET 634 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRK-------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET 634 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecc-------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC
Confidence 34555 4799999999999996544 799999999976532 233678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeEEc
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS---YTAKIS 230 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~---~~~kl~ 230 (413)
.+.+|+|||-+.| ++.++|-... ..++++.....++.||+.||.|||. ++|+|+||||+|||+... .++|||
T Consensus 635 ~ervFVVMEKl~G-DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 635 PERVFVVMEKLHG-DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred CceEEEEehhhcc-hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeec
Confidence 9999999999955 7766664432 2378999999999999999999996 779999999999999543 479999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||+|+.... .......+||+.|+|||+++.+.|...-|+||+|+|+|.-|.|..||.......+
T Consensus 710 DFGfARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd------------ 774 (888)
T KOG4236|consen 710 DFGFARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND------------ 774 (888)
T ss_pred cccceeecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH------------
Confidence 9999998443 3345567899999999999999999999999999999999999999976532210
Q ss_pred hhhhhhHhHHh--hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 311 EKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+.++ +.......+++..+.+||..+|+..-.+|.+....+.+.|
T Consensus 775 ------QIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 775 ------QIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred ------HhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 01111 1112223467888999999999999999999998887655
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.96 Aligned_cols=270 Identities=25% Similarity=0.313 Sum_probs=203.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
+|++.+.||.|+||.||+|.... +++.|+||.+.... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR-------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC-------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 58899999999999999997543 57899999887643 334567889999999999999999999988775
Q ss_pred ----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 156 ----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 156 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++|+|
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 74 EDFNDVYIVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred ccccceEEEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcc
Confidence 7899999997 48988885432 78999999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCc-ceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 232 FGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 232 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
||++......... .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||...................
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999864433210 112335678999999999887 78999999999999999999999997764321111000000000
Q ss_pred h-------hhhhhhHhHHhhhc------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 310 S-------EKRKFRHIIDARLQ------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 310 ~-------~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
. ........+..... .......+.++.+||.+||+.+|.+||++.+++++-+-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 0 00000001110000 00112356789999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=292.59 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=198.4
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC--C
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED--K 155 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 155 (413)
|++.+.||.|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++... +
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK-------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC-------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCC
Confidence 6788999999999999997653 57899999987653 33345678899999999999999999999888 8
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||. .+++|+||+|+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 74 SIYMVFEYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred cEEEEeccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccce
Confidence 99999999975 8988885442 368899999999999999999996 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh--hhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEK 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~--~~~~ 312 (413)
........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.................. ....
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 148 RPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred eeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 86443321 11223456888999997765 46789999999999999999999999765432111100000000 0000
Q ss_pred hhhhH-----------hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 313 RKFRH-----------IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 313 ~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+.. .....+...+...++..+.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 000000001111136789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=263.00 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=200.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
+|.-.+.||+|.||+||+|+.. .+.+.||+|.+..+. ...-....+||.+|+.|+|.|||+++++...+..
T Consensus 3 ~ydkmekigegtygtvfkarn~-------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccC-------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 4555678999999999999543 478999999876542 2334568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+-+|+|||. .+|..+...... .+....+..++.|+++||.|+|++ ++.||||||.|+||+.+|++||+|||+++
T Consensus 76 ltlvfe~cd-qdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh--nvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 76 LTLVFEFCD-QDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH--NVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred eEEeHHHhh-HHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh--hhhhccCCcceEEeccCCcEEecccchhh
Confidence 999999995 489888865443 688899999999999999999984 49999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhh--
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEK-- 312 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~-- 312 (413)
....... .....+-|.+|++|.++.+. -|+.+.|+||.|||+.|+.. |++.|++.+-.++...+-+......+.
T Consensus 150 afgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 6543322 22234678999999999885 57788999999999999986 777787766544433322221111110
Q ss_pred hhhhHhHHhhhcCCCc---------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYP---------YKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+..+.+-.....++ +.....-++|+.++|..+|.+|.++++.+++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0111111111111111 1334456799999999999999999999875
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=288.23 Aligned_cols=242 Identities=23% Similarity=0.340 Sum_probs=188.4
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHH-hhccCCCccceEeEEEeCCeeEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFL-GRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
+.||+|+||.||+|.... +++.||+|.+..... .....+..|..++ ..++|+||+++++++..++.+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecC-------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEE
Confidence 579999999999996543 578999999865432 1222344455444 44579999999999999999999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
||||+.+++|.+++.... .+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 75 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 75 VMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999999999986443 68899999999999999999997 569999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... . +..+.
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~----------~~~~~ 206 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------V----------FDNIL 206 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------H----------HHHHH
Confidence 2 223468889999999988888999999999999999999999997543210 0 00011
Q ss_pred Hhh--hcCCCchHHHHHHHHHHHHccccCCCCCCCH---HHHHHHH
Q 015094 320 DAR--LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM---REVVETL 360 (413)
Q Consensus 320 ~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~---~e~l~~L 360 (413)
... ........++..+.+++.+||..||++||++ .|++++-
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred hcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 111 1111223467889999999999999999966 5665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=301.83 Aligned_cols=270 Identities=27% Similarity=0.342 Sum_probs=198.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhc-cCCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 152 (413)
..++|.+.+.||+|+||.||+|.+.. +++.||+|++... .......+.+|+.+++.+ +|+||+++++++.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR-------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC-------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence 35689999999999999999997543 5788999987542 223345677899999999 9999999999886
Q ss_pred eC--CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 153 ED--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 153 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
.. ..+|+||||+.+ +|.+++... .+.+..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 78 AENDKDIYLVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred cCCCceEEEEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEe
Confidence 54 468999999974 999888432 56788888999999999999996 669999999999999999999999
Q ss_pred cCCCcccCCCCCCc---ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 231 DFGLAKLGPSASQS---HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 231 DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
|||++......... .......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||................
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999864332221 12234568999999998755 557889999999999999999999997643321111000000
Q ss_pred hhhhh-------hhhhhHhHHhhhc------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 307 PYLSE-------KRKFRHIIDARLQ------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 307 ~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..... ......++..... ......++.++.++|.+||+.||++|||+.+++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 00000 0000000100000 001112567899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.44 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=200.2
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--hHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
|++.+.||.|++|.||+|.... +++.+++|.+...... ....+.+|+.+++.++|+||+++++++..+..+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence 6778899999999999996543 5788999988755332 346788899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+.+ +|.+++.... ..+++..+..++.||+.+|.|||. .+|+|+||||+||+++.++.++|+|||.+..
T Consensus 74 ~~v~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 74 YLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred EEEEeccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 999999975 8888886543 378899999999999999999996 6699999999999999999999999999876
Q ss_pred CCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-h-hhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW-I-KPYLSEKRK 314 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~-~-~~~~~~~~~ 314 (413)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......... . .+.......
T Consensus 148 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 148 FGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred cCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 43322 112234578899999998776 788999999999999999999999976543221110000 0 000000000
Q ss_pred hhHhHH---hhhc-------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 315 FRHIID---ARLQ-------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 315 ~~~~~~---~~~~-------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
+..... .... .......+.++.++|.+||..||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 0000 01122457789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=288.92 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=196.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCC---c--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS---E--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
+|.+.+.||+|+||.||++.+.. .+..+++|+++. . .......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE 73 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence 58899999999999999997543 233344444432 1 11223456789999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
....++||||+.+++|.+++.........+++..++.++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccC
Confidence 999999999999999999987644445578999999999999999999996 66999999999999975 579999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++....... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~---------- 212 (260)
T cd08222 151 VSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------S---------- 212 (260)
T ss_pred ceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------H----------
Confidence 987643221 1223356888999999998888899999999999999999999998643210 0
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
....+. .......+..++.++.++|.+||..||++||++.+++++
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 213 VVLRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000011 111122345677889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=298.09 Aligned_cols=268 Identities=22% Similarity=0.289 Sum_probs=197.4
Q ss_pred hcCCC-CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh--------------HHHHHHHHHHHhhccC
Q 015094 77 TRNFK-SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--------------FEEWQSEVNFLGRLSH 141 (413)
Q Consensus 77 ~~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~h 141 (413)
.++|. +.+.||.|+||+||+|.... .++.||||++....... ...+.+|+++++.++|
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 79 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTL-------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECC-------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC
Confidence 35665 45789999999999996543 57889999886542211 1246789999999999
Q ss_pred CCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 015094 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221 (413)
Q Consensus 142 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~ 221 (413)
+||+++++++..++..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||+|+||++
T Consensus 80 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill 152 (335)
T PTZ00024 80 ENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFI 152 (335)
T ss_pred cceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEE
Confidence 999999999999999999999996 5999988543 368899999999999999999996 669999999999999
Q ss_pred cCCCCeEEccCCCcccCCCCC------------CcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCC
Q 015094 222 DGSYTAKISDFGLAKLGPSAS------------QSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLR 288 (413)
Q Consensus 222 ~~~~~~kl~DfG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~ 288 (413)
+.++.++|+|||++....... .........++..|+|||++.+. .++.++|+|||||++|+|++|.+
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999987543110 01111223568889999988764 46899999999999999999999
Q ss_pred CCCCCCCCCcchhhHhhhhhhhhh--hhhhHhH------------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH
Q 015094 289 ALDTNRPSGQHNLVDWIKPYLSEK--RKFRHII------------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354 (413)
Q Consensus 289 pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 354 (413)
||...+........ ....... ..+.... ..... ......+.++.++|.+||+.+|++||++.
T Consensus 233 p~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 233 LFPGENEIDQLGRI---FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCHHHHHHHH---HHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 99866432211100 0000000 0000000 00000 00123456789999999999999999999
Q ss_pred HHHHHHHH
Q 015094 355 EVVETLER 362 (413)
Q Consensus 355 e~l~~L~~ 362 (413)
+++.+.+.
T Consensus 309 ~~l~~~~~ 316 (335)
T PTZ00024 309 EALKHEYF 316 (335)
T ss_pred HHhcCccc
Confidence 99986554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.66 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=198.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..|...+.||+|+||.||+|+... +++.|++|.+... .....+.+.+|+++++.++|+|++++++++...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 87 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR-------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC-------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence 457778899999999999997543 5688999987642 223445678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...++||||+. ++|.+++.... ..+.+..+..++.|++.+|.|||+ .+++||||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCccc
Confidence 99999999996 58887775432 357889999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
+..... .....++..|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 162 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------------- 221 (308)
T cd06634 162 ASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------------- 221 (308)
T ss_pred ceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------------
Confidence 875322 12346888999999874 3567889999999999999999999986532110
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
....+............++..+.+||.+||..+|++||++.+++++.+.+.
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 222 --ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000011111111122356678999999999999999999999998766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.21 Aligned_cols=270 Identities=21% Similarity=0.294 Sum_probs=196.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC--
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-- 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 154 (413)
..+|++.+.||.|+||.||+|.... +++.||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~-------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD-------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC-------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 3689999999999999999996543 6789999998766555667788999999999999999999766543
Q ss_pred ------------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 ------------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||. .+|+||||||+||+++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~ 148 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEc
Confidence 35799999996 589888742 257889999999999999999996 6699999999999997
Q ss_pred -CCCCeEEccCCCcccCCCCCCcc-eeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 223 -GSYTAKISDFGLAKLGPSASQSH-VTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 223 -~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
.++.++|+|||++.......... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||....+....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 45678999999987532211111 1122357889999997754 56788999999999999999999999765432211
Q ss_pred hhhHhhhhhhh--hhhhhhHhHHh-----hhcCC-----CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 300 NLVDWIKPYLS--EKRKFRHIIDA-----RLQGQ-----YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 300 ~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~-----~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.......+... ....+...... ..... .....+.++.+||.+||..||.+|||+.+++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 11000000000 00000000000 00000 11235578899999999999999999999997633
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.85 Aligned_cols=256 Identities=27% Similarity=0.375 Sum_probs=198.3
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh----hhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----QGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
.|++.+.||+|+||.||+|+... ...+++.||+|++..... ...+.+.+|+.+++.+ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS----GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc----CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 47889999999999999996532 223578899999865322 2345678899999999 49999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+..+|+||||+++++|.+++.... .+.+..+..++.||+.||.|||+ .+++||||+|+|||++.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCc
Confidence 999999999999999999986543 67888999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccC--CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||......... .....
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~----- 222 (290)
T cd05613 151 LSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISR----- 222 (290)
T ss_pred cceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHH-----
Confidence 9875332211 112235688999999988653 4678999999999999999999999643221100 00000
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVET 359 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~ 359 (413)
.+.. ....++..++..+.+++.+||..||++|| ++.+++++
T Consensus 223 -----~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 -----RILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----Hhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 11223445677899999999999999997 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.75 Aligned_cols=266 Identities=25% Similarity=0.328 Sum_probs=196.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKD-------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECC-------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 45689999999999999999997653 56889999986542 2233467789999999999999999998876
Q ss_pred CC----------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 154 DK----------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 154 ~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
.. .+|+||||+.+ +|..++... ...+++..++.++.||+.||+|||. .+|+|+||||+||++++
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~ 151 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNN 151 (302)
T ss_pred cchhhhccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECC
Confidence 54 79999999976 777777543 2368999999999999999999996 66999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
++.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|++||............
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 152 KGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred CCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999876433221 11122346778999998765 45789999999999999999999999754322111000
Q ss_pred Hhhhhhhhh--hhhhhHhHH--------------hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 303 DWIKPYLSE--KRKFRHIID--------------ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 303 ~~~~~~~~~--~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...... ...+..+.. ..... ....++..+.+++.+||..||.+||++.+++.+
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 231 ---SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ---HHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 000000000 00000 011346789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=291.53 Aligned_cols=259 Identities=27% Similarity=0.369 Sum_probs=199.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
+|++.+.||+|+||.||+|.... ....++.||||.+.... ....+.+.+|+.++..+ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~----~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG----GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec----cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 47888999999999999986542 22356889999886432 12345678899999999 49999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+..+|+||||+.+++|.+++... ..+.+..+..++.|++.+|.|||. .+++||||+|.||+++.++.++|+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECc
Confidence 99999999999999999998543 267888999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCC--ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
++....... ........|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......... ...
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~------- 220 (288)
T cd05583 151 LSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEI------- 220 (288)
T ss_pred ccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHH-------
Confidence 987533221 11122346889999999987654 778999999999999999999999643221100 000
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...... .....+..++..+.+++.+||+.||++|||+.++.+.|..
T Consensus 221 ---~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 ---SRRILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---HHHHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000111 1123344567789999999999999999997776655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.90 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=196.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||.+.... ......+.+|+.++..+. |+||+++++++..+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK-------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC-------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 4578999999999999999997653 57899999987543 223345667777666665 99999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ ..+|+||||+|+||+++.++.+||+|||+
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 99999999985 47877775432 278889999999999999999996 24699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCC----ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGH----LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
+....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||....... .
T Consensus 162 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~------- 226 (296)
T cd06618 162 SGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----E------- 226 (296)
T ss_pred chhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----H-------
Confidence 87532211 122335788899999986553 7889999999999999999999996532110 0
Q ss_pred hhhhhhHhHHhhh-cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARL-QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 311 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+..... .......++.++.+|+.+||..||.+||++.+++++.+.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 227 ---VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred ---HHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 0001111100 001111356789999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=287.92 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=194.8
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhc---cCCCccceEeEEEeC
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRL---SHPNLVRLLGYCWED 154 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~ 154 (413)
|++.+.||+|+||.||+|.+.. +++.||+|.+..... .....+.+|+.+++.+ +|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 6788999999999999997653 578899999864322 1234566788877766 599999999999887
Q ss_pred Ce-----eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 155 KE-----LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 155 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
.. ++++|||+.+ +|.+++..... ..+++..++.++.||+.||.|||+ .+++|+||+|+||+++.++.+||
T Consensus 74 ~~~~~~~~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 74 RTDRELKLTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred cCCCCceeEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEE
Confidence 76 9999999965 89888865432 258899999999999999999997 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
+|||++....... ......++..|+|||++.+..++.++|+|||||++|+|++|.+||.......... .......
T Consensus 149 ~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~ 223 (287)
T cd07838 149 ADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIG 223 (287)
T ss_pred eccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcC
Confidence 9999987643221 1223357889999999998899999999999999999999999987644321110 0000000
Q ss_pred hh-hhhh-------hHhHHhhhc---CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 310 SE-KRKF-------RHIIDARLQ---GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 310 ~~-~~~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. ...+ ......... .......+..+.++|.+||+.||.+||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0000 000000000 01112446788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=292.76 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=194.3
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
.+.+.+|.|+++.||++ . .+++.||||++... .....+.+.+|+.+++.++|+||+++++++.+.+..|
T Consensus 5 ~i~~~~~~~~~v~~~~~--~-------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (314)
T cd08216 5 LIGKCFEDLMIVHLAKH--K-------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELY 75 (314)
T ss_pred hhhHhhcCCceEEEEEe--c-------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEE
Confidence 34444455544444443 2 26789999998654 3345678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
++|||+.+++|.+++..... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||.+...
T Consensus 76 ~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 76 VVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred EEEeccCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceee
Confidence 99999999999999965432 357888999999999999999996 66999999999999999999999999988653
Q ss_pred CCCCC-----cceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh----
Q 015094 239 PSASQ-----SHVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP---- 307 (413)
Q Consensus 239 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~---- 307 (413)
..... ........++..|+|||++.. ..++.++|+|||||++|+|++|..||........ .......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 229 (314)
T cd08216 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPC 229 (314)
T ss_pred ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCcc
Confidence 22111 111123457788999999865 4588999999999999999999999976432210 0000000
Q ss_pred hhh------hhhhhh--------HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 YLS------EKRKFR--------HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 ~~~------~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+. ...... ..............++.++.+|+.+||..||++|||+.+++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 000 000000 0000111112334566789999999999999999999999987764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.53 Aligned_cols=146 Identities=27% Similarity=0.388 Sum_probs=129.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|.+.+.||+|+||.||+|++.. +++.||||++.... ......+..|+.+++.++|+||+++++++...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN-------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC-------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 579999999999999999997654 57899999986542 23346788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+.|++|.+++...+ .+.+..++.++.||+.||.|||. .+|+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 99999999999999999986543 57888899999999999999997 5699999999999999999999999998
Q ss_pred cc
Q 015094 235 AK 236 (413)
Q Consensus 235 a~ 236 (413)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=282.55 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=193.3
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEE
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 159 (413)
-+..||.|+||+|++-.++. +++..|||.+..... ...+++..|.+...+- ++||||++|+....++..|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~-------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKP-------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred HHHHhcCCcchhhhhhhcCc-------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 34679999999999985544 799999999987654 4556788888865554 59999999999999999999
Q ss_pred EEeeCCCCCHHHhhhh-cCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 160 VYEFMQKGSLENHLFG-RGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
.||+|+ .+|..+... .......++++.+-.|....+.||.||.. +.+|||||+||+|||++..|.+||||||++...
T Consensus 141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999994 477665432 11223468888888999999999999986 466999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
. .+...+.-.|-..|||||.+.. ..|+.++|+||||++|||+.||..|+..++.. .+ .+.
T Consensus 219 v---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----fe----------ql~ 280 (361)
T KOG1006|consen 219 V---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FE----------QLC 280 (361)
T ss_pred H---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HH----------HHH
Confidence 2 2233445678899999998843 46899999999999999999999999765321 11 111
Q ss_pred HhHHhh---h-cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 317 HIIDAR---L-QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 317 ~~~~~~---~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.++..- + ...-..+.+..+..+|.-||.+|...||...+++++-
T Consensus 281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 111100 0 0011124678899999999999999999999998653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.89 Aligned_cols=270 Identities=23% Similarity=0.312 Sum_probs=200.3
Q ss_pred HHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceE
Q 015094 71 VELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 71 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
.++....++|.+.+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+.+++.++|+||++++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~ 82 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK-------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcC-------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence 3445567899999999999999999996543 57899999987542 22345678899999999999999999
Q ss_pred eEEEeC------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 149 GYCWED------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 149 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+++... ...|++++++ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~ 154 (345)
T cd07877 83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVN 154 (345)
T ss_pred eeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEc
Confidence 987643 3478888887 7799888743 257889999999999999999997 6699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 155 ~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 155 EDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred CCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999875322 1233568899999998866 5678999999999999999999999976443211110
Q ss_pred hHhh--------hhhhhhhhhhhHhHHh---hhcCCC---chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 302 VDWI--------KPYLSEKRKFRHIIDA---RLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 302 ~~~~--------~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.... ...+.. ......+.. .....+ ....+.++.+||.+||+.||.+||++.+++++-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 230 ILRLVGTPGAELLKKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHHhCCCCHHHHhhccc-HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0000 000000 000000000 000000 1124567899999999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.23 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=197.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.... +++.||||++.... ....+.+.+|+.+|+.++|+||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR-------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC-------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 46789999999999999999996543 57889999886432 2234567899999999999999999998876
Q ss_pred CC------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 DK------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
+. .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCE
Confidence 53 469999999 7799888743 268899999999999999999996 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+|+|||++...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||................
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999753221 223467889999998865 457899999999999999999999997654221100000000
Q ss_pred -----hhhhh--hhhhhHhHHhhhc------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 -----PYLSE--KRKFRHIIDARLQ------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 -----~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+... ............. ......++..+.++|.+||+.||++|||+.+++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00000 0000000000000 0011245667899999999999999999999997644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=280.34 Aligned_cols=272 Identities=25% Similarity=0.351 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
+.|.-...||+|.||.||+|+.. .+++.||+|+.-.++ ...-....+|+++|..|+|+|++.+++++..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~-------n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSK-------NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhc-------CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 35666678999999999999544 367889998754332 2233567899999999999999999887642
Q ss_pred ------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 ------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
...+|+||++|+. +|..++... ...++...+..++.++..||.|+|+ +.|+|||+|++|+||+.+|.+
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGIL 163 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceE
Confidence 2358999999976 999988543 3478999999999999999999998 459999999999999999999
Q ss_pred EEccCCCcccCCCCCCcc--eeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 228 KISDFGLAKLGPSASQSH--VTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
||+|||+++......... ..+..+-|.+|++||.+.| ..|+++.|||+.|||+.||+++.+.|.+.....+...+..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 999999997644332221 1234566999999998877 5789999999999999999999999988766544433322
Q ss_pred h--------hhhhhhhhhhhHhHHh-hhcCC--------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 305 I--------KPYLSEKRKFRHIIDA-RLQGQ--------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 305 ~--------~~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+ +|-.....-+..+-.. ...+. .|..-.++..+|+.++|..||.+|+++.++++|-..
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 1 1111111111111000 00000 112224578899999999999999999999987554
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=294.68 Aligned_cols=265 Identities=26% Similarity=0.351 Sum_probs=197.8
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
...++|++.+.||.|+||.||+|+... +++.||||++.... ....+.+.+|+.+++.++||||+++.+++.
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 79 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL-------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI 79 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC-------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence 456789999999999999999996543 67899999875432 223466788999999999999999999887
Q ss_pred e-CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 153 E-DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 153 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
. ....|+||||+ +++|.+++.. ..++...+..++.||+.||.|||+ .+|+||||+|.|||++.++.++|+|
T Consensus 80 ~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 80 SPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred cCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCc
Confidence 6 56789999998 5689888742 257788888999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hh-----
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV-DW----- 304 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~-~~----- 304 (413)
||++..... ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||............ ..
T Consensus 152 fg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 152 FGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999875321 1123467889999998765 57889999999999999999999999765431111000 00
Q ss_pred ---hhhhhhhhhhhhHhHHhhhcCCCc-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 305 ---IKPYLSEKRKFRHIIDARLQGQYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 305 ---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
....... .....+.........+ ..++..+.++|.+||+.+|++||++.+++.+-
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 227 DDVINTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHHHHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 0000000 0000000000011111 13467899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.85 Aligned_cols=269 Identities=24% Similarity=0.262 Sum_probs=194.1
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC-
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED- 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~- 154 (413)
+|++.+.||+|+||.||+|.+... ..+..||+|.+... .....+.+.+|+.+++.+. |+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-----SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-----CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence 478889999999999999975431 12678999988643 2223456788999999995 99999999864432
Q ss_pred ---CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 155 ---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 155 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..+|+++||+. ++|.+++... ..+++..++.++.||+.||.|||. .+|+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 76 GNFNELYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccCCcEEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCc
Confidence 46789999985 6899888543 368899999999999999999996 6699999999999999999999999
Q ss_pred CCCcccCCCCCC--cceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-----
Q 015094 232 FGLAKLGPSASQ--SHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD----- 303 (413)
Q Consensus 232 fG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~----- 303 (413)
||++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.............
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 999975432211 111233578999999998765 568899999999999999999999997654221110000
Q ss_pred ----hhhhhhhhhhhhhHhHHhh---hcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 304 ----WIKPYLSEKRKFRHIIDAR---LQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 304 ----~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
........ ......... .... .....+..+.+|+.+||+.||.+|||+.+++++-+
T Consensus 229 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 229 PDEETLSRIGSP--KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred CCHHHHHhhhhh--hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00000000 000000000 0000 01123568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=329.79 Aligned_cols=264 Identities=31% Similarity=0.540 Sum_probs=203.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
....|...++||+|+||.||+|++.. +++.||||++...... ...|++++++++||||+++++++.+..
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIK-------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECC-------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 34567888999999999999997543 5789999998654321 235688999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC-CCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS-DKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..|+||||+++++|.+++. .+++..+..++.||+.||+|||.. ..+|+||||||+||+++.++..++. ||.
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 9999999999999999983 378888999999999999999953 4679999999999999998888775 665
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||+..... ......|...... ...
T Consensus 829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~ 900 (968)
T PLN00113 829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCH 900 (968)
T ss_pred cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccc
Confidence 442111 12236889999999999999999999999999999999999999643222 1222233222111 111
Q ss_pred hhHhHHhhhcC--CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQG--QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...+++..... ..+.....++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 22233332222 22345556788999999999999999999999999987653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=291.70 Aligned_cols=270 Identities=26% Similarity=0.332 Sum_probs=193.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--hHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK-------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC-------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecc
Confidence 3689999999999999999997543 5788999987543221 224567899999999999999999987543
Q ss_pred --------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 155 --------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 155 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
..+++||||+.+ +|...+... ...+++..+..++.||++||.|||+ ++|+|+||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccCceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence 347999999965 777776543 2368999999999999999999997 66999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcc---------eeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCC
Q 015094 227 AKISDFGLAKLGPSASQSH---------VTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPS 296 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~ 296 (413)
++|+|||++.......... ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||......
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999997543222111 11234578889999987654 5789999999999999999999999765432
Q ss_pred CcchhhHhh-hhh----hhhhhhhhHhHHhhhcCCCc-------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 297 GQHNLVDWI-KPY----LSEKRKFRHIIDARLQGQYP-------YKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 297 ~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
......... ... ...................+ ......+.++|.+||..||.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 211110000 000 00000000000000000000 1233678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=281.19 Aligned_cols=241 Identities=30% Similarity=0.418 Sum_probs=196.0
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
||.|+||.||++.+.. +++.|++|.+..... .....+.+|+.+++.++|+||+++++.+..+...|+|||
T Consensus 1 lg~G~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECC-------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEe
Confidence 6999999999996543 578899998875532 244578899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
|+.+++|.+++.... .+++..+..++.|++.+|.|||. .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 74 YAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 999999999996543 68899999999999999999997 669999999999999999999999999987643221
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
.......++..|++||.+.+..++.++|+||||+++|+|++|..||...... .....+..
T Consensus 148 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~-- 207 (250)
T cd05123 148 --SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----------------EIYEKILK-- 207 (250)
T ss_pred --CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHhc--
Confidence 1233456888999999998888899999999999999999999999754320 00111111
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCCCH---HHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM---REVVET 359 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~---~e~l~~ 359 (413)
....++...+..+.+++.+||..||++||++ .+++++
T Consensus 208 ~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 208 DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 1223445557889999999999999999999 566543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=287.23 Aligned_cols=265 Identities=27% Similarity=0.360 Sum_probs=195.8
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 157 (413)
|.+.+.||+|+||+||+|.... +++.|+||.+..... .......+|+..++.+. |+||+++++++..++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 6788999999999999997643 468899998865432 12223457999999999 99999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+ +++|.+++.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++..
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred EEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 9999999 779999886543 2367999999999999999999996 6699999999999999999999999999975
Q ss_pred CCCCCCcceeecccccccccCccccc-cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhhhhhh----h
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD-WIKPYLS----E 311 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~-~~~~~~~----~ 311 (413)
..... ......++..|+|||++. +..++.++|+||||+++++|++|.+||............. ....... +
T Consensus 149 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 149 IRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred ccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 43221 122356888999999874 4557899999999999999999999997654322111000 0000000 0
Q ss_pred hh----hhhHhHHhhhc---CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 312 KR----KFRHIIDARLQ---GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 312 ~~----~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. .....+..... .......+.++.+||.+||..||++|||++|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00 00000000000 00011225679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=278.45 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=204.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhc-cCCCccceEeEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRL-SHPNLVRLLGYC 151 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 151 (413)
..++|.++++||+|+|++|.++.+.. +.+.||+|+++++.. ++..-.+.|-.+.... +||++|.+...|
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~-------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKK-------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcc-------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 45789999999999999999986544 789999999987632 3444556677777766 499999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..+..+++|.||+.||+|.-.+++.. .++++.++.+...|.-||.|||+ +|||.||||.+|+|++..|.+||+|
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecc
Confidence 99999999999999999988775543 79999999999999999999996 7799999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCC-CcchhhHhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPS-GQHNLVDWIKPYLS 310 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~~~~~~~~~~ 310 (413)
+|+++... .....+..++||+.|.|||++.+..|..++|+|+||++++||+.|+.||+-.... ...+..
T Consensus 395 ygmcke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte-------- 464 (593)
T KOG0695|consen 395 YGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE-------- 464 (593)
T ss_pred cchhhcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh--------
Confidence 99998643 3344567789999999999999999999999999999999999999999753211 111111
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt 352 (413)
.-.|+-++.+.. ..|...+-....+++..|++||.+|..
T Consensus 465 -dylfqvilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 465 -DYLFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -HHHHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 112333333332 345556667788999999999999963
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=287.25 Aligned_cols=264 Identities=28% Similarity=0.398 Sum_probs=198.7
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
|++.+.||+|.||.||+|.... +++.|++|++.... ....+.+.+|+.+++.++|+||+++++++.....+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK-------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeecC-------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence 5677889999999999996543 57899999987653 23345678899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+. ++|.+++.... ..+++..+..++.|++.+|.|||. .+|+||||+|+||+++.++.++|+|||++..
T Consensus 74 ~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 74 YLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred EEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 99999997 59999996543 368899999999999999999997 6699999999999999999999999999875
Q ss_pred CCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h-------hh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI-K-------PY 308 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~-~-------~~ 308 (413)
...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||............... . +.
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 432221 12234567789999998766 7889999999999999999999999765432111100000 0 00
Q ss_pred hhh----hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 309 LSE----KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 309 ~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
... ...+...........+ ...+..+.++|.+||..||++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000 0000000000000011 1236789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.86 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=193.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..+|.+.+.||+|+||.||+|++.. +++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 86 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR-------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA 86 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC-------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence 4789999999999999999996543 57899999886532 22335678999999999999999999988754
Q ss_pred ------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 ------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
..+|+||||+.. +|..++. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ccCCCCceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEE
Confidence 346999999954 7776651 257888999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK- 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~- 306 (413)
|+|||++...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+............
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998753221 123467889999998866 468899999999999999999999998654321111000000
Q ss_pred ---hhhhh---hhhhhHhHHhh---hcCCC---chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 307 ---PYLSE---KRKFRHIIDAR---LQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 307 ---~~~~~---~~~~~~~~~~~---~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
+.+.. ........... ..... ....+..+.+||.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000000000 00000 01345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=301.39 Aligned_cols=244 Identities=23% Similarity=0.261 Sum_probs=201.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
...|.+...||.|+|+.|-.+.+. .+++..++|++.+... ...+|+.++... +||||+++.+++.++.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~-------~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESS-------PTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeecc-------ccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCc
Confidence 467888889999999999998544 3678899999977622 234577666555 5999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-cCCCCeEEccCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL-DGSYTAKISDFGL 234 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~-~~~~~~kl~DfG~ 234 (413)
+.|+|||.+.|+-|.+.+.... .....+..|+.+|+.|+.|||+ +|+|||||||+|||+ +..+.++|+|||.
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred eeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEech
Confidence 9999999999999888875432 2336777899999999999997 779999999999999 6899999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... ....+-|..|.|||++....|+.++||||||++||+||+|+.||......
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------ 519 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------ 519 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------
Confidence 9863332 22346788999999999999999999999999999999999999875432
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+......+.+...++..+++||.+||+.||.+|+++.+++.+-+.
T Consensus 520 -~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 520 -IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 12333333444557889999999999999999999999999988776
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=280.37 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=198.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-----C---CCccceEe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-----H---PNLVRLLG 149 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~i~~~~~ 149 (413)
.+|-+.+.||.|-|++||+|++.+ ..+.||+|+.+... ...+....||++|+++. | .+||+|++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq-------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ-------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc-------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 689999999999999999998776 57899999987663 23466789999999984 2 36999999
Q ss_pred EEEe----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-
Q 015094 150 YCWE----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS- 224 (413)
Q Consensus 150 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~- 224 (413)
.|.. +.++|||+|++ |.+|..+|...... .++...+.+|++||+.||.|||+ ..||||-||||+|||+..+
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e 225 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTE 225 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccc
Confidence 9975 46899999999 88999999765543 67888999999999999999998 6789999999999999211
Q ss_pred ----------C--C------------------------------------------------------------------
Q 015094 225 ----------Y--T------------------------------------------------------------------ 226 (413)
Q Consensus 225 ----------~--~------------------------------------------------------------------ 226 (413)
+ .
T Consensus 226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~ 305 (590)
T KOG1290|consen 226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN 305 (590)
T ss_pred cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------------------------------------------------------------
Q 015094 227 -------------------------------------------------------------------------------- 226 (413)
Q Consensus 227 -------------------------------------------------------------------------------- 226 (413)
T Consensus 306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~ 385 (590)
T KOG1290|consen 306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP 385 (590)
T ss_pred ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence
Q ss_pred -------eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 227 -------AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 227 -------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
+||+|||-|.. .....+.-+.|..|+|||++.+..|+..+||||++|++|||+||...|+........
T Consensus 386 ~~~~di~vKIaDlGNACW-----~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~ 460 (590)
T KOG1290|consen 386 LPECDIRVKIADLGNACW-----VHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS 460 (590)
T ss_pred CCccceeEEEeeccchhh-----hhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence 12222222211 011122335688999999999999999999999999999999999999765433221
Q ss_pred hhhHhh---------------------hhhhhhhhhhhHhHH-------hhh--cCCCchHHHHHHHHHHHHccccCCCC
Q 015094 300 NLVDWI---------------------KPYLSEKRKFRHIID-------ARL--QGQYPYKAAYQIAQLSLKCLEAEPKH 349 (413)
Q Consensus 300 ~~~~~~---------------------~~~~~~~~~~~~~~~-------~~~--~~~~~~~~~~~l~~li~~~L~~dp~~ 349 (413)
.-.+.+ +.|+.....++.|-. ..+ ...++.....++.+|+.-||+.+|++
T Consensus 461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeK 540 (590)
T KOG1290|consen 461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEK 540 (590)
T ss_pred ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccc
Confidence 111111 122222222222211 111 12355677788999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 015094 350 RPSMREVVETLER 362 (413)
Q Consensus 350 Rpt~~e~l~~L~~ 362 (413)
||||.++++|-+.
T Consensus 541 R~tA~~cl~hPwL 553 (590)
T KOG1290|consen 541 RPTAAQCLKHPWL 553 (590)
T ss_pred cccHHHHhcCccc
Confidence 9999999988764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=295.61 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=198.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|++.. +++.||||++... .....+.+.+|+.+++.+.|+||+++.+++..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK-------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC-------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 35689999999999999999997653 5788999988653 22334567789999999999999999998766
Q ss_pred CCe------eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 DKE------LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
.+. +|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 86 ASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCE
Confidence 554 89999999 6699998853 368999999999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||................
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999999853221 233467889999998765 467899999999999999999999997654321111000000
Q ss_pred h-----hhhh--hhhhhHhHHhh---hcCCC---chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 P-----YLSE--KRKFRHIIDAR---LQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ~-----~~~~--~~~~~~~~~~~---~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
. +... .......+... ....+ ....+..+.+||.+||..||++|||+.+++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 0 0000 00000000000 00001 1124678999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=290.58 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=203.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-h------hhHHHHHHHHHHHhhccCCCccceEeE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-L------QGFEEWQSEVNFLGRLSHPNLVRLLGY 150 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 150 (413)
.+|-++.+||+|+|+.||+|.+.. ..+.||||+-.... + ...+...+|..|.+.|+||.||++|++
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~-------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLT-------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccc-------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 578888999999999999997554 56899999864321 1 123446789999999999999999999
Q ss_pred EEeC-CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCC
Q 015094 151 CWED-KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYT 226 (413)
Q Consensus 151 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~---~~~~ 226 (413)
|.-+ +.+|-|+|||+|.+|.-|+..+. .+++..++.|+.||+.||.||.....+|||-||||.|||+. .-|.
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence 8755 67999999999999999996554 78999999999999999999998778899999999999994 4589
Q ss_pred eEEccCCCcccCCCCCCc-----ceeecccccccccCcccccc----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 015094 227 AKISDFGLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~ 297 (413)
+||+|||+++........ ..+....||.||++||++.- ...+.++||||+|||+|+.+.|+.||.......
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 999999999987655443 24456789999999998743 346789999999999999999999997653211
Q ss_pred cchhhHhhhhhhhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 298 QHNLVDWIKPYLSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+.++ .++.. ..-.|| +.++.+..+||++||++--++|.+..++..+
T Consensus 692 ---------dILqeN----TIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 692 ---------DILQEN----TILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ---------HHHhhh----chhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111111 11111 111232 3578899999999999999999998887643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=303.53 Aligned_cols=255 Identities=28% Similarity=0.384 Sum_probs=207.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEe-
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWE- 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 153 (413)
....|++.+.||.|.+|.||++.... +++.+|+|+....... -++++.|+++|+.+. |||++.++++|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~-------~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVK-------TGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeee-------cCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34568899999999999999996443 6788888887766432 356788999999986 9999999998863
Q ss_pred ----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 154 ----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 154 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
++++|||||||.||+..|++..-. ...+.+..+..|++.++.||.+||. +.++|||||-.|||++.++.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEEE
Confidence 478999999999999999996654 6689999999999999999999995 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
+|||++.... .........+||+.|||||++. ...|+.++|+||||++..||--|.+|+....+.....
T Consensus 165 vDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---- 238 (953)
T KOG0587|consen 165 VDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---- 238 (953)
T ss_pred eeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc----
Confidence 9999987532 2223345678999999999984 3467789999999999999999999998765532111
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...-++.....-+..++.++.++|..||.+|..+||++.++++|
T Consensus 239 -----------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 -----------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111222223356888999999999999999999999998864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=277.06 Aligned_cols=220 Identities=20% Similarity=0.209 Sum_probs=177.2
Q ss_pred cCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEeeCCCCC
Q 015094 89 GGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGS 168 (413)
Q Consensus 89 G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 168 (413)
|.||.||+|++.. +++.||+|.+..... ..+|...+....||||+++++++.+....|+||||+.|++
T Consensus 4 g~~~~v~~~~~~~-------~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR-------TQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc-------CCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCC
Confidence 8999999996543 678999999876532 2345555556679999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceee
Q 015094 169 LENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248 (413)
Q Consensus 169 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 248 (413)
|.+++.... .+++..+..++.|++.||.|||. ++|+||||||+||+++.++.++|+|||.+...... ..
T Consensus 72 L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 72 LWSHISKFL----NIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred HHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence 999986543 58899999999999999999996 67999999999999999999999999987643221 12
Q ss_pred cccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc
Q 015094 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP 328 (413)
Q Consensus 249 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (413)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||....... ........+
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~ 198 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIP 198 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCc
Confidence 2346778999999988889999999999999999999998875431110 000111234
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCH
Q 015094 329 YKAAYQIAQLSLKCLEAEPKHRPSM 353 (413)
Q Consensus 329 ~~~~~~l~~li~~~L~~dp~~Rpt~ 353 (413)
..++..+.+||.+||+.||++|+++
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 4567789999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=278.31 Aligned_cols=269 Identities=29% Similarity=0.402 Sum_probs=202.2
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc--cCCCccceEeEEEeCC-
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL--SHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~- 155 (413)
..++.++||+|.||.||+|.+. ++.||||++... ..+.|..|-+|.... +|+||++++++-....
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~---------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD---------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred chhhHHHhhcCccceeehhhcc---------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 4566788999999999999765 489999999765 456777787777664 6999999998766555
Q ss_pred ---eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhc-------CCCCeeeCCCCCCcEEEcCCC
Q 015094 156 ---ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT-------SDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 156 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-------~~~~ivHrDlkp~Nil~~~~~ 225 (413)
.++||+||.+.|+|.+||..+ .+++.....++..+++||+|||. +...|+|||||..||||.+|+
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 799999999999999999654 68999999999999999999996 235799999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCC-c-----cchhhhHHHHHHHHHHHhCCCCCCC-CCCCCc
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH-L-----YVKSDVYGFGVVLVEILTGLRALDT-NRPSGQ 298 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DiwslG~il~~lltG~~pf~~-~~~~~~ 298 (413)
+..|+|||+|...............+||..|||||++.+.. + -.+.||||+|.+||||++....+.. ..+.-+
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999998866444443444578999999999985532 1 1468999999999999998765542 222111
Q ss_pred chhhHh--hhhhhhhhhhhhH-hHHhhhcCCCch-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 299 HNLVDW--IKPYLSEKRKFRH-IIDARLQGQYPY-----KAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 299 ~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
..+... ..|.+. .++. .+..+.+..++. ....-+++.+..||..|++-|.|+.=+.+.+..+....
T Consensus 434 lpfe~evG~hPt~e---~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLE---EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CchhHHhcCCCCHH---HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111100 011111 1111 122223333333 23456889999999999999999999988888776554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=261.97 Aligned_cols=265 Identities=16% Similarity=0.261 Sum_probs=203.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
..++|++.+.+|+|-|+.||.|... .+++.++||+++.- ..+.+.+|+.||+.|. ||||++++++..+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~-------~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINI-------TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccccc-------CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3467999999999999999999533 36788999999765 3467899999999998 99999999998765
Q ss_pred --CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEcc
Q 015094 155 --KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISD 231 (413)
Q Consensus 155 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~D 231 (413)
....||+||+...+...+. +.++...+..++.+|+.||.|||+ +||+|||+||.|+||+ +...++|+|
T Consensus 106 ~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred cccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeee
Confidence 5688999999998887766 267888899999999999999998 6699999999999997 456899999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCC-Ccchhh-------
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPS-GQHNLV------- 302 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~~------- 302 (413)
+|+|.++..... -...+.+..|.-||++.. ..|+.+-|+|||||++..|+..+.||...... ++...+
T Consensus 177 WGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 177 WGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred cchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 999998654443 233567889999998855 67889999999999999999999888655433 222211
Q ss_pred ---Hhhhhh-hhhhhhhhHhHHhhhcCC--------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 303 ---DWIKPY-LSEKRKFRHIIDARLQGQ--------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 303 ---~~~~~~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.++..+ +.....+..++....+.. -....++++.+|+.++|..|..+|+|++|++.|-..
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 111111 111223333332222211 112345889999999999999999999999987543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=292.23 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=198.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
-|..++.||-|+||.|+++. +..+...||+|.+.+... ......+.|-.||...+.+-||+||-.|.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~-------KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVR-------KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred ceEEEeeecccccceeEEEe-------ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 45667889999999999983 344678999999876643 33445778999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||++||++..+|.+.+ -+.+..++.++..|..|+++.|. .|+|||||||+|||||.+|.|||+||||+
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCceeeeecccc
Confidence 9999999999999999997766 68899999999999999999996 66999999999999999999999999998
Q ss_pred ccCC---------CCC---Cc----------------------------ceeecccccccccCccccccCCccchhhhHH
Q 015094 236 KLGP---------SAS---QS----------------------------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYG 275 (413)
Q Consensus 236 ~~~~---------~~~---~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 275 (413)
+-+. ... .. ...-..+||+.|+|||++....|+...|+||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 6311 000 00 0011367999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC---C
Q 015094 276 FGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP---S 352 (413)
Q Consensus 276 lG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp---t 352 (413)
.|+|||||+.|+.||....+.+....+..+. ..+...+-..++.++.+||.++. .+++.|. .
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~--------------~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng 921 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVINWR--------------NFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNG 921 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeeehh--------------hccccccccccCHHHHHHHHHHh-cChhhhhcccc
Confidence 9999999999999998877765332211111 11222233466778888888755 4577775 3
Q ss_pred HHHHHHH
Q 015094 353 MREVVET 359 (413)
Q Consensus 353 ~~e~l~~ 359 (413)
+++|..|
T Consensus 922 ~d~vKaH 928 (1034)
T KOG0608|consen 922 ADQVKAH 928 (1034)
T ss_pred hhhhhcC
Confidence 4445443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=274.78 Aligned_cols=267 Identities=30% Similarity=0.453 Sum_probs=204.7
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhh--ccCCCccceEeE
Q 015094 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR--LSHPNLVRLLGY 150 (413)
Q Consensus 73 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~ 150 (413)
-+...++..+.+.||+|.||.||+|.|. |+.||||++.... .+.+.+|.+|.+. |+|+||+.+++.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr---------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR---------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc---------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 3456778899999999999999999886 6889999997653 3568888888876 589999999986
Q ss_pred EEeC----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCcEE
Q 015094 151 CWED----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------DKQVIYRDFKASNIL 220 (413)
Q Consensus 151 ~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------~~~ivHrDlkp~Nil 220 (413)
-..+ .++|||.+|.+.|+|.|||... .++.+..++++..++.||++||.. ...|.|||||..|||
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 4333 4799999999999999999653 788999999999999999999941 235899999999999
Q ss_pred EcCCCCeEEccCCCcccCCCCCC--cceeecccccccccCccccccC----Cc--cchhhhHHHHHHHHHHHhC------
Q 015094 221 LDGSYTAKISDFGLAKLGPSASQ--SHVTTRVMGTYGYAAPEYVATG----HL--YVKSDVYGFGVVLVEILTG------ 286 (413)
Q Consensus 221 ~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~DiwslG~il~~lltG------ 286 (413)
+..+|...|+|+|+|........ ....+..+||..|||||++... .+ ...+||||||.++||+...
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 99999999999999987544322 1223457899999999998553 22 2568999999999999753
Q ss_pred ----CCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh-HHhhhcCCCc-----hHHHHHHHHHHHHccccCCCCCCCHHHH
Q 015094 287 ----LRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI-IDARLQGQYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREV 356 (413)
Q Consensus 287 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~ 356 (413)
++||...-+.+-.. +.+... ....++...| ......+.+|++.||..+|.-|.|+-.+
T Consensus 429 ~eey~~Pyyd~Vp~DPs~------------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSF------------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ehhhcCCcccCCCCCCCH------------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 44665543332111 011111 1122222222 2456678899999999999999999999
Q ss_pred HHHHHHHHhcCC
Q 015094 357 VETLERLQASDQ 368 (413)
Q Consensus 357 l~~L~~i~~~~~ 368 (413)
.+.|.++.+...
T Consensus 497 KKtl~~l~~~~e 508 (513)
T KOG2052|consen 497 KKTLAKLSNSDE 508 (513)
T ss_pred HHHHHHHhcChh
Confidence 999999886543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=297.18 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=219.1
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
.+-.++||.|+||+||+|.|..+ .+.-.-+||||++... ..+..+++.+|+-+|.+|+|||++++++++.... +-
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pe---ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPE---GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecC---CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 44567999999999999988753 2334567999988654 4445678999999999999999999999988765 88
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
||++|+++|.|.++++.+.. .+.....+.|+.||++||.|||. +.+|||||-..|||+..-..+||.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 99999999999999987543 78888999999999999999995 66999999999999999999999999999986
Q ss_pred CCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
.............-.+.|||-|.+....|+.++|||||||++||++| |..|+++.... .+..
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~d 911 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPD 911 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhH
Confidence 66555554444455678999999999999999999999999999998 88888775322 3344
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
++....+...|..++.++..++.+||..|+..||+++++...+.++..
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 455555556788999999999999999999999999999998887654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.89 Aligned_cols=269 Identities=30% Similarity=0.438 Sum_probs=216.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
.++..+.+.||+|+||.|++|...............||||.++... ..+.+.+..|+++|+.+. |+||+.+++++...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3445677799999999999997664332222236789999987553 245678999999999996 99999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcC---C-------CC--CCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRG---A-------SV--QPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~---~-------~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+.+++|+||+..|+|.+++.... . .. ..+.....+.++.||+.|++||++ .++|||||-..|||+.
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARNVLIT 452 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhhEEec
Confidence 99999999999999999997765 0 11 238889999999999999999996 6699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccc--cccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMG--TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQH 299 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~ 299 (413)
.+..+||+|||+|+.......... ..-.+ ...|||||.+....|+.++||||||++|||+++ |..|+.+....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--- 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--- 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH---
Confidence 999999999999996433332221 11122 345999999999999999999999999999998 77888763211
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
..+...+....+...|..++.++.++++.||+.+|++||++.++.+.++...
T Consensus 529 -------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 -------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1222345556666778899999999999999999999999999999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.82 Aligned_cols=291 Identities=23% Similarity=0.308 Sum_probs=231.8
Q ss_pred CCCCCCCCCCCcccccHHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCC-CCeEEEEEecCCc-ChhhHHHHHH
Q 015094 54 YPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSG-SGTVIAVKKLNSE-SLQGFEEWQS 131 (413)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~ 131 (413)
.++......|..-.....++.....++++.-++-+|.||.||.|.|.+. ++. ..+.|.+|.++.. +.-....+..
T Consensus 260 ~~ns~~~~~p~e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE---dt~n~~q~v~vKTvk~~AS~iQv~~~L~ 336 (563)
T KOG1024|consen 260 SPNSEYEHEPEEFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE---DTYNDCQEVLVKTVKQHASQIQVNLLLQ 336 (563)
T ss_pred CCCccccCChHHHhhhHHhhhhhhhheechhhhhcCchhheeeeeeccc---CCcchHHHHHHHHHHhcccHHHHHHHHH
Confidence 3444333344333444556666677899999999999999999988753 222 3456777877654 3334567888
Q ss_pred HHHHHhhccCCCccceEeEEEeC-CeeEEEEeeCCCCCHHHhhhhcC----CCCCCCcHHHHHHHHHHHHHHHHHhhcCC
Q 015094 132 EVNFLGRLSHPNLVRLLGYCWED-KELLLVYEFMQKGSLENHLFGRG----ASVQPLAWNIRLKIAIGAARGLAFLHTSD 206 (413)
Q Consensus 132 E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 206 (413)
|-.++..+.|||+..+.++..++ ...++++.++.-|+|..++.... ...+.+...+...++.|++.|++|||+
T Consensus 337 es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-- 414 (563)
T KOG1024|consen 337 ESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-- 414 (563)
T ss_pred HHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--
Confidence 99999999999999999987654 67889999999999999997322 233456777888899999999999997
Q ss_pred CCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-
Q 015094 207 KQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT- 285 (413)
Q Consensus 207 ~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt- 285 (413)
.++||.||...|.+|++.-.+||+|=.+++..-..+.............||+||.+.+..|+.++|+||||++||||+|
T Consensus 415 ~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 415 HGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred cCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 5599999999999999999999999999987655555444444456678999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 286 GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 286 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
|+.|+...+|. .+...+....+..-|.+|++++..++..||..+|++||+++|+...|..+..
T Consensus 495 g~~PyaeIDPf-----------------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 495 GKLPYAEIDPF-----------------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred CCCCccccCHH-----------------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 88888765443 3445566666667788999999999999999999999999999999998765
Q ss_pred c
Q 015094 366 S 366 (413)
Q Consensus 366 ~ 366 (413)
.
T Consensus 558 q 558 (563)
T KOG1024|consen 558 Q 558 (563)
T ss_pred H
Confidence 4
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.70 Aligned_cols=268 Identities=26% Similarity=0.358 Sum_probs=204.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC--
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-- 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 154 (413)
+.+-.+.||.|+||+||.+.+ ..+++.|++|++..- +....+.+.+|+++|..++|.|++..+++..-.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTD-------PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTD-------PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred cCCCCCcccccceeEEEeccC-------CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 345567899999999999843 447899999988643 334557788999999999999999999976644
Q ss_pred ---CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 155 ---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 155 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..+|+|+|++.. +|..+| .+.+.++...+.-+++||++||.|||+ .+|.||||||.|+|++.+..+||||
T Consensus 127 dfFqEiYV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 127 SFFQELYVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred hHHHHHHHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEecc
Confidence 357889999854 888887 566789999999999999999999998 4599999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK--PY 308 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~--~~ 308 (413)
||+++.-. .......+..+-|.+|+|||+++|. .|+.++||||+|||+.||+-.+..|....+..+...+..+. |.
T Consensus 200 FGLARvee-~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 200 FGLARTWD-QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS 278 (449)
T ss_pred cccccccc-hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence 99998632 2333344556678999999999885 68899999999999999999999999888876665543321 11
Q ss_pred hhhhhh-----hhHhHHhhhcC-C--------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 LSEKRK-----FRHIIDARLQG-Q--------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 ~~~~~~-----~~~~~~~~~~~-~--------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..... -..++...... . -+.....+..+++.++|..||..|.+..+.+.++.
T Consensus 279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111110 01111111110 0 11233456788999999999999999999987765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=292.94 Aligned_cols=269 Identities=20% Similarity=0.208 Sum_probs=170.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeE-----
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGY----- 150 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~----- 150 (413)
..++|.+.+.||+|+||.||+|++.... ...+..||||++...... +.+..| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~---~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ---SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCc---cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4568999999999999999999776421 123788999987644321 111111 1122222222222211
Q ss_pred -EEeCCeeEEEEeeCCCCCHHHhhhhcCCC----------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 015094 151 -CWEDKELLLVYEFMQKGSLENHLFGRGAS----------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRD 213 (413)
Q Consensus 151 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrD 213 (413)
...+..+++||||+.+++|.+++...... ........+..++.||+.||.|||+ ++|+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEeCc
Confidence 23557899999999999999998643210 0011234466899999999999997 6699999
Q ss_pred CCCCcEEEcC-CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccC----------------------Cccch
Q 015094 214 FKASNILLDG-SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG----------------------HLYVK 270 (413)
Q Consensus 214 lkp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 270 (413)
|||+|||++. ++.+||+|||+++..... .........+++.|+|||++... .++.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999985 679999999999753222 12223456789999999966322 23456
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh---HhHHhhhcCC------CchHHHHHHHHHHHH
Q 015094 271 SDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR---HIIDARLQGQ------YPYKAAYQIAQLSLK 341 (413)
Q Consensus 271 ~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~l~~li~~ 341 (413)
+|||||||++|||+++..+++... ..+...+......+. .......... ..........+||.+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 799999999999999765543210 000000000000000 1111100000 000112345689999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 015094 342 CLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 342 ~L~~dp~~Rpt~~e~l~~L~ 361 (413)
||+.||++|||+.++++|-.
T Consensus 433 mL~~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 433 MMRFKGRQRISAKAALAHPY 452 (566)
T ss_pred HccCCcccCCCHHHHhCCcC
Confidence 99999999999999998754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=248.30 Aligned_cols=204 Identities=27% Similarity=0.358 Sum_probs=169.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 156 (413)
...-+..||+|+||.|-+-++. .+|...|+|.+... +.+..+++.+|+.+..+. .+|++|.+|+.+..+..
T Consensus 47 ~L~~i~elGrGayG~vekmrh~-------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHI-------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred hhhhhhhhcCCccchhhheeec-------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3445677999999999776444 48999999998654 234456677888876655 59999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++.||.|. .+|..+..+.-..+..+++..+-+|+..++.||.|||+ ...++|||+||.||||+.+|++|+||||++-
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999995 49988887766667789999999999999999999997 5669999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCcccccc----CCccchhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
...+.. ..+...|-..|||||.+.. ..|+.++||||||++++||.+++.||+.+.
T Consensus 198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 643322 2333568889999998743 478999999999999999999999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=259.34 Aligned_cols=238 Identities=30% Similarity=0.416 Sum_probs=192.2
Q ss_pred CCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh-HHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEeeCCCCC
Q 015094 90 GFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGS 168 (413)
Q Consensus 90 ~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 168 (413)
+||.||+|.+.. +++.+++|++....... .+.+.+|++++++++|+||+++++++......+++|||+.+++
T Consensus 1 ~~g~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKK-------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 589999997653 57889999998765444 6789999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceee
Q 015094 169 LENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248 (413)
Q Consensus 169 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 248 (413)
|.+++.... .++...++.++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||.+....... ...
T Consensus 74 L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 74 LFDLLKKRG----RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred HHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 999986533 37889999999999999999997 569999999999999999999999999998643321 233
Q ss_pred cccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc
Q 015094 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP 328 (413)
Q Consensus 249 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (413)
...++..|++||.+.+..++.++|||+||+++++|++|..||....... .....+.........
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~ 208 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL----------------ELFKKIGKPKPPFPP 208 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----------------HHHHHHhccCCCCcc
Confidence 4568889999999988889999999999999999999999987631110 000011111110011
Q ss_pred hH--HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 329 YK--AAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 329 ~~--~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.. ++.++.+++.+||..+|++||++.+++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 11 66789999999999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=280.19 Aligned_cols=279 Identities=19% Similarity=0.203 Sum_probs=185.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCC---------CCCCCCCeEEEEEecCCcChhhHHH--------------HHHH
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKA---------PGKSGSGTVIAVKKLNSESLQGFEE--------------WQSE 132 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---------~~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~E 132 (413)
..++|.+.++||+|+||+||+|.+.... ......++.||||++........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999753211 1122345789999986543322222 3346
Q ss_pred HHHHhhccCCCc-----cceEeEEEe--------CCeeEEEEeeCCCCCHHHhhhhcCC--------------------C
Q 015094 133 VNFLGRLSHPNL-----VRLLGYCWE--------DKELLLVYEFMQKGSLENHLFGRGA--------------------S 179 (413)
Q Consensus 133 ~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~ 179 (413)
+.++.+++|.++ ++++++|.. .+..++||||+.+++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776544 566666543 3568999999999999999864321 1
Q ss_pred CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCc
Q 015094 180 VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259 (413)
Q Consensus 180 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP 259 (413)
...+.+..++.++.|++.+|.|||+ .+|+||||||+|||++.++.+||+|||++........ .......+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 1234567788999999999999996 6699999999999999999999999999975322111 111122357899999
Q ss_pred cccccCC--------------------cc--chhhhHHHHHHHHHHHhCCC-CCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 260 EYVATGH--------------------LY--VKSDVYGFGVVLVEILTGLR-ALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 260 E~~~~~~--------------------~~--~~~DiwslG~il~~lltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
|++.... |. .+.||||+||++|+|++|.. ||......... ...+......+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-----~~~~~~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-----LRQYDNDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-----HhhccchHHHHH
Confidence 9875322 12 24699999999999999875 66432111100 000000000111
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEP---KHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp---~~Rpt~~e~l~~L~~ 362 (413)
.+......-......+....+|+.+||..+| .+|+|+.|+|+|-+.
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 1111111111223467889999999999876 689999999987553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.73 Aligned_cols=270 Identities=21% Similarity=0.224 Sum_probs=204.0
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc------CCCccceE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS------HPNLVRLL 148 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~ 148 (413)
....+|.+....|+|-|++|..|.+.. .+..||||++..... ..+.=.+|++||++|+ --|+++++
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~-------r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQA-------RGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccC-------CCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 345688888899999999999995443 466999999976643 3344568999999996 24899999
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCe
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTA 227 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~ 227 (413)
..|.+.+++|||+|-+ ..+|.+++.+.+. +..+....+..+++||+.||..|-. .||+|.||||+|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCccee
Confidence 9999999999999998 5699999987664 4468889999999999999999996 559999999999999765 578
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||||||.|.... .+. .+.+.-+..|.|||++.|..|+...|+||+||+||||+||+..|++........+...++.
T Consensus 577 KLCDfGSA~~~~---ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFAS---ENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccc---ccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999999998632 222 2345567889999999999999999999999999999999999988765432222211100
Q ss_pred -h----------------------------------------hhhhhhhhHhHHhhh-cCCCchHHHHHHHHHHHHcccc
Q 015094 308 -Y----------------------------------------LSEKRKFRHIIDARL-QGQYPYKAAYQIAQLSLKCLEA 345 (413)
Q Consensus 308 -~----------------------------------------~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~ 345 (413)
+ +.....+...+.... ...-....-..+.+|+.+||.+
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 0 000001111111100 0011123455789999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 015094 346 EPKHRPSMREVVETL 360 (413)
Q Consensus 346 dp~~Rpt~~e~l~~L 360 (413)
||++|.|+.++|+|.
T Consensus 733 dP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 733 DPEKRITVNQALKHP 747 (752)
T ss_pred ChhhcCCHHHHhcCC
Confidence 999999999999763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=288.29 Aligned_cols=245 Identities=29% Similarity=0.409 Sum_probs=186.9
Q ss_pred CCCCCeeeecCCce-EEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGK-VFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 157 (413)
|.-.+++|.|+.|+ ||+|.+. ++.||||.+-.+. ..-..+||..|+.-+ |||||++++.-.+.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye---------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~ 578 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE---------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL 578 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC---------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence 44456789999985 9999765 5899999886553 345689999999986 99999999988888999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---C--CCeEEccC
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---S--YTAKISDF 232 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~--~~~kl~Df 232 (413)
||..|.|.. +|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+||
T Consensus 579 YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 579 YIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred EEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence 999999955 999999764211111121345788999999999999855 999999999999965 3 46899999
Q ss_pred CCcccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhh
Q 015094 233 GLAKLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG-LRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 233 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|+++......... ......||-+|+|||++....-..++|||||||++|+.++| .+||...-.-
T Consensus 656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-------------- 721 (903)
T KOG1027|consen 656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-------------- 721 (903)
T ss_pred ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--------------
Confidence 9998754433222 23457799999999999988888899999999999999996 8999754211
Q ss_pred hhhhhhHhHHhhhc---CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 311 EKRKFRHIIDARLQ---GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 311 ~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
-.+++..... .....++ ++.+||.+||+++|..||+|.+|+.|
T Consensus 722 ----~~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 722 ----QANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----hhhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0111111110 0111122 88999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=257.69 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..+|.-++.+|.|+- .|..|. +...++.||+|+.... .....++..+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~-------D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAF-------DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ 87 (369)
T ss_pred eeeeeeecccCCCCc-eEEecc-------hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence 357888889999988 676663 3346789999987654 233456788999999999999999999998644
Q ss_pred ------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 ------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
..+|+|||++.. +|...+. ..+.-..+..++.|++.|+.|||+ .+|+||||||+||++..++.+|
T Consensus 88 ~~l~~~~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 88 KTLEEFQEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred ccHHHHHhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhhee
Confidence 468999999955 9988875 256778889999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh---
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--- 305 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~--- 305 (413)
|.|||+|+.. ...-..+.++.|..|.|||++.+..|...+||||+||++.||++|.-.|.+.+..++.......
T Consensus 159 i~dfg~ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 159 ILDFGLARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred eccchhhccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 9999999852 2223556788999999999999988999999999999999999999999877655544332111
Q ss_pred ---------hh----hhhhhhhh-----hHhH-HhhhcC--CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 306 ---------KP----YLSEKRKF-----RHII-DARLQG--QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 306 ---------~~----~~~~~~~~-----~~~~-~~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+ +....... ...+ +..+.. +.+..-...+++|+.+||..||++|.+++++|.|-
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 00 00000000 0000 000000 01112345688999999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=267.54 Aligned_cols=197 Identities=24% Similarity=0.346 Sum_probs=168.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--------hHHHHHHHHHHHhhcc---CCCccc
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--------GFEEWQSEVNFLGRLS---HPNLVR 146 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~~i~~ 146 (413)
..|..++.||+|+||.|++|.+++ ....|+||.+.++..- .+-.+-.||.||..|+ |+||++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~-------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE-------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred ccceeeeeccccccceEEEeeecc-------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 468999999999999999998775 4688999998776421 1112345999999998 999999
Q ss_pred eEeEEEeCCeeEEEEeeC-CCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 015094 147 LLGYCWEDKELLLVYEFM-QKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 147 ~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~ 225 (413)
++++|++++++||+||-- +|.+|.++|..+ ..+.+..+..|++|++-|+++||+ .||||||||-+|+.++.+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCC
Confidence 999999999999999964 466899999544 378999999999999999999996 6699999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCcc-chhhhHHHHHHHHHHHhCCCCCC
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltG~~pf~ 291 (413)
.+||+|||.+... .......++||..|.|||++.|..|- ..-||||||++||.++....||.
T Consensus 708 ~~klidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 FVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eEEEeeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999998753 33345668999999999999988884 77899999999999998877764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=242.13 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=187.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeE-EEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGY-CWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~ 153 (413)
..+.|.|.+.||+|.||.+-+|.+. .+.+.+++|.+.... ...+.|.+|...--.|. |.||+.-|++ |+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr-------~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHR-------QSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeecc-------CCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 3457999999999999999999554 478999999887764 35578999998776676 9999998875 667
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE--cCCCCeEEcc
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISD 231 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~--~~~~~~kl~D 231 (413)
.+.++++|||++.|+|.+-+... .+.+.....++.|++.||.|+|+ +++||||||.+|||| .+.-.|||||
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeee
Confidence 78899999999999999988442 57888889999999999999997 669999999999999 3344899999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc---CC--ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT---GH--LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~--~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
||+.+.... .......+..|.+||+... +. ..+.+|+|.||+++|.+|||..||..... ....+..|..
T Consensus 167 FG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~ 240 (378)
T KOG1345|consen 167 FGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQ 240 (378)
T ss_pred cccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHH
Confidence 999985221 1222335667999997643 22 35788999999999999999999984322 2222222211
Q ss_pred hhhhhhhhhhHhHHhhhcCCCc---hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYP---YKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
+. .+.....| ..+++.+..++++-|..++++|.-..++.+
T Consensus 241 -----------w~-~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 241 -----------WL-KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred -----------Hh-cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 11 01111111 245678999999999999999954444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=272.69 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|.++..+|.|+||.||+|++ ..+++..|+|+++.+...++.-+.+|+-+++..+||||+.+++.+...+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd-------~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARD-------KRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred ccchhheeeecCCcccchhhhcc-------cccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 45799999999999999999954 44789999999998877788889999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++.||||.||+|.+..+-.+ ++++.++...++..+++|+|||+ .+=+|||||-.||++++.|.+||+|||.+.
T Consensus 87 lwicMEycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cEEEEEecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCchh
Confidence 999999999999999885544 89999999999999999999996 568999999999999999999999999986
Q ss_pred cCCCCCCcceeecccccccccCcccc---ccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
.+... -.....++||++|||||+. ..+.|...+|||++|++..|+-.-++|.....+.... ++..+.
T Consensus 161 qitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l--------~LmTkS 230 (829)
T KOG0576|consen 161 QITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL--------FLMTKS 230 (829)
T ss_pred hhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH--------HHhhcc
Confidence 53221 1123457899999999976 4578999999999999999998877765443322111 111111
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
.++ .....-...++..+.+|++.+|.++|++||+++.+|.
T Consensus 231 ~~q-----pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQ-----PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCC-----CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 100 0011122356778999999999999999999988775
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-31 Score=231.85 Aligned_cols=212 Identities=37% Similarity=0.605 Sum_probs=181.3
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEeeC
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFM 164 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 164 (413)
||+|++|.||++.... +++.+++|++...... ..+.+.+|+.+++.++|++|+++++++......+++|||+
T Consensus 1 l~~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKK-------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecC-------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 6899999999996543 5788999999876542 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeEEccCCCcccCCCCCC
Q 015094 165 QKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGLAKLGPSASQ 243 (413)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~a~~~~~~~~ 243 (413)
.+++|.+++.... ..++...++.++.+++.+|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 74 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 74 EGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 9899999986542 367889999999999999999997 57999999999999998 89999999999986433221
Q ss_pred cceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh
Q 015094 244 SHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322 (413)
Q Consensus 244 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (413)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence 12234578889999988776 788999999999999998
Q ss_pred hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 323 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..+.+++.+||..||++||++.++++++
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3477899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=243.40 Aligned_cols=272 Identities=20% Similarity=0.276 Sum_probs=200.2
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEE
Q 015094 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCW 152 (413)
Q Consensus 74 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 152 (413)
....+.|..+..||+|+|++||+|.+.. .....+.||+|.+...+ ...++.+|+++|..+. +.||+++.+.+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~----~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIE----QDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhh----hccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 3456789999999999999999997654 13457899999987654 3457889999999997 999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEcc
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISD 231 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~D 231 (413)
.++..++||||++.....+++. .++...+..+++.++.||.++|. +|||||||||.|+|.+ ..+.-.|+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEe
Confidence 9999999999999999999883 56788899999999999999997 7799999999999996 457789999
Q ss_pred CCCcccCCCCC--------------------------------Cc----------ceeecccccccccCcccccc-CCcc
Q 015094 232 FGLAKLGPSAS--------------------------------QS----------HVTTRVMGTYGYAAPEYVAT-GHLY 268 (413)
Q Consensus 232 fG~a~~~~~~~--------------------------------~~----------~~~~~~~gt~~y~aPE~~~~-~~~~ 268 (413)
||+|....... .+ .......||++|+|||++.. ..-+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99997211000 00 01123569999999999866 4557
Q ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh-H---------hhh----h--hhh---------hhhhhhHh-HHhh
Q 015094 269 VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV-D---------WIK----P--YLS---------EKRKFRHI-IDAR 322 (413)
Q Consensus 269 ~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~-~---------~~~----~--~~~---------~~~~~~~~-~~~~ 322 (413)
.++||||.|+|+.-++++..||......-..-.. . ... . .+. ....+..+ ....
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 8999999999999999999998654332111000 0 000 0 000 00011111 0111
Q ss_pred hc--------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 323 LQ--------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 323 ~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.. .......+..+.+|+.+||..||.+|.|++++|+|-
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 11 011123345789999999999999999999999753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=227.47 Aligned_cols=200 Identities=32% Similarity=0.467 Sum_probs=171.3
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
|.+.+.||.|++|.||+|.... +++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 5678899999999999997653 4688999999876554 5678899999999999999999999999989999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+++|++.+++|.+++..... .+++..+..++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||.+...
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred EEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 99999999999999865431 17888999999999999999996 57999999999999999999999999998864
Q ss_pred CCCCCcceeecccccccccCcccc-ccCCccchhhhHHHHHHHHHHHhCCCCCCC
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLVEILTGLRALDT 292 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~lltG~~pf~~ 292 (413)
...... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 433211 22335678889999988 667778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=216.29 Aligned_cols=257 Identities=19% Similarity=0.238 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 157 (413)
.|++++.||+|+||+++.|. +..+++.||||.-...+ ...++..|.+..+.|. .++|..++-+..++.+-
T Consensus 29 hyrVGkKIGeGsFG~lf~G~-------Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGK-------NLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred cceeccccccCcceeeeccc-------ccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 69999999999999999994 44578999999876554 3357888999999987 79999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-----CCCeEEccC
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-----SYTAKISDF 232 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-----~~~~kl~Df 232 (413)
.||||++ |.+|+|++.-++ ..++..+++.++.|++.-++|+|+ +.+|.|||||+|+||.. ...|.|+||
T Consensus 100 iLVidLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEec
Confidence 9999998 889999986555 379999999999999999999997 55999999999999953 346899999
Q ss_pred CCcccCCCCCCcce-----eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 233 GLAKLGPSASQSHV-----TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 233 G~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|+.+.+...... .....||..||+.....|..-+.+.|+-|||-+++++|-|..||.+-....
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t---------- 243 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT---------- 243 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc----------
Confidence 99998766543322 245789999999999999999999999999999999999999998753321
Q ss_pred hhhhhhhhhHhHHhhhcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+.+++.|-+...... +-..++.++..-+...=..+-.+-|+.+-+...+..+
T Consensus 244 ---nK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 244 ---NKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred ---hHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1222222222211111 1123556677777777777777778776665555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=266.91 Aligned_cols=199 Identities=21% Similarity=0.221 Sum_probs=140.5
Q ss_pred hccC-CCccceEeEE-------EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCe
Q 015094 138 RLSH-PNLVRLLGYC-------WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQV 209 (413)
Q Consensus 138 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i 209 (413)
.++| .||++++++| .+...++++|||+ +++|.+++... ...+++..++.++.||+.||.|||+ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~--~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHS--QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHh--CCe
Confidence 4445 5777777776 3335678889988 66999999643 2368999999999999999999996 679
Q ss_pred eeCCCCCCcEEEcC-------------------CCCeEEccCCCcccCCCCCC--------------cceeecccccccc
Q 015094 210 IYRDFKASNILLDG-------------------SYTAKISDFGLAKLGPSASQ--------------SHVTTRVMGTYGY 256 (413)
Q Consensus 210 vHrDlkp~Nil~~~-------------------~~~~kl~DfG~a~~~~~~~~--------------~~~~~~~~gt~~y 256 (413)
+||||||+||||+. ++.+||+|||+++....... ........||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666776653211000 0001124689999
Q ss_pred cCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHH
Q 015094 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIA 336 (413)
Q Consensus 257 ~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 336 (413)
||||++.+..|+.++|||||||+||||++|.+|+..... . +..+......... ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--------~----------~~~~~~~~~~~~~-~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--------T----------MSSLRHRVLPPQI-LLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--------H----------HHHHHHhhcChhh-hhcCHHHH
Confidence 999999999999999999999999999998877643210 0 0000000000000 11233467
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHH
Q 015094 337 QLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 337 ~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+++.+||+.||.+||++.|++++..
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchh
Confidence 8899999999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=206.62 Aligned_cols=165 Identities=21% Similarity=0.232 Sum_probs=127.3
Q ss_pred CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcce
Q 015094 167 GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHV 246 (413)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 246 (413)
|+|.+++..++ ..+++..++.++.||+.||.|||+ .+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccc-----
Confidence 68999996543 369999999999999999999996 33 999999999999999 9998763321
Q ss_pred eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcC-
Q 015094 247 TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQG- 325 (413)
Q Consensus 247 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 325 (413)
...|++.|+|||++.+..++.++|||||||++|||++|..||........ .+..+.......
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~---------------~~~~~~~~~~~~~ 125 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA---------------ILEILLNGMPADD 125 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH---------------HHHHHHHHhccCC
Confidence 12689999999999999999999999999999999999999965432110 000111111100
Q ss_pred ----CCchHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 326 ----QYPYKAAY--QIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 326 ----~~~~~~~~--~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
..+..... ++.+++.+||..||.+||++.++++++..+...
T Consensus 126 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 126 PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 11223333 699999999999999999999999999887543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=220.30 Aligned_cols=265 Identities=22% Similarity=0.217 Sum_probs=201.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC----CCccceEeEE-Ee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH----PNLVRLLGYC-WE 153 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h----~~i~~~~~~~-~~ 153 (413)
+|++.+.||+|+||.||+|..... ..+.+|+|............+..|+.++..+.. .++..+++.+ ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSE------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCC------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 799999999999999999965431 146789998766533222267889999999873 6899999998 57
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-----CCeE
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-----YTAK 228 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-----~~~k 228 (413)
+...|+||+.+ |.+|.++..... ...++...++.++.|++.+|++||+ .|++||||||+|+++... ..+.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEE
Confidence 78899999988 889999885554 4589999999999999999999996 669999999999999754 4699
Q ss_pred EccCCCcccCC--CCCCc----c-e-eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 015094 229 ISDFGLAKLGP--SASQS----H-V-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300 (413)
Q Consensus 229 l~DfG~a~~~~--~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~ 300 (413)
|.|||+++... ..... . . ...+.||..|+++.+..+...+.+.|+||++.++.+|+.|..||.........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~- 246 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK- 246 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-
Confidence 99999998322 11111 0 1 23456999999999999999999999999999999999999999664432111
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
..+...........+....+..+.++...+-..+...+|....+...|.......
T Consensus 247 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 ------------SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ------------HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111111111111122334567777777788899999999999999988766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=217.97 Aligned_cols=167 Identities=23% Similarity=0.197 Sum_probs=127.7
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-----ChhhHHHHHHHHHHHhhccCCCccc-eE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-----SLQGFEEWQSEVNFLGRLSHPNLVR-LL 148 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~-~~ 148 (413)
....+|.+.+.||+|+||+||+|++... +++.||||++... .....+.+.+|+++|+.|+|+||+. ++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 3456899999999999999999976531 3567899986533 1223456899999999999999985 44
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCcEEEcCCCCe
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDF-KASNILLDGSYTA 227 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDl-kp~Nil~~~~~~~ 227 (413)
+ .+..|+||||++|++|.... ... ...++.+++++|.|||+ +||+|||| ||+|||++.++.+
T Consensus 89 ~----~~~~~LVmE~~~G~~L~~~~--------~~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 89 A----TGKDGLVRGWTEGVPLHLAR--------PHG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred E----cCCcEEEEEccCCCCHHHhC--------ccc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCE
Confidence 3 24689999999999996321 111 14678899999999997 67999999 9999999999999
Q ss_pred EEccCCCcccCCCCCCcce------eecccccccccCcccccc
Q 015094 228 KISDFGLAKLGPSASQSHV------TTRVMGTYGYAAPEYVAT 264 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 264 (413)
||+|||+++.......... -....+++.|+|||.+..
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999986543321111 134568888999998854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=196.14 Aligned_cols=261 Identities=19% Similarity=0.212 Sum_probs=202.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 154 (413)
...+|++++.||.|+||.+|+|... .+++.||||+-..... ..++..|..+.+.|+ ...|..+..++.+.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i-------~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISI-------TSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred eccceEEEEeecCCchhheeeeeec-------cCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 4578999999999999999999654 3789999998765532 235677899999998 57888888889999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTAKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~kl~D 231 (413)
.+-.+||+.+ |.+|++++.-.. ..++..+++-++-|++.-++|+|. +++|||||||+|+|..- ...+.|+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEe
Confidence 9999999998 899999986554 378999999999999999999996 77999999999999953 35789999
Q ss_pred CCCcccCCCCCCcce-----eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 232 FGLAKLGPSASQSHV-----TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 232 fG~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
||+|+.+.+...... .....||..|.+-....+..-+.+.|+-|+|.+|.++.-|..||.+-......
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~------- 230 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK------- 230 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-------
Confidence 999997655443321 23467999999998888888889999999999999999999999886544322
Q ss_pred hhhhhhhhhhHhHHhhhcCCC---chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.+.+.+.+....... -..++.++.-.+..|=..--++-|+..-+.+.+..+.
T Consensus 231 ------QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 231 ------QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred ------HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 223333333222211 1234567777888888777788888766665555443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=239.98 Aligned_cols=263 Identities=21% Similarity=0.227 Sum_probs=192.3
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhH-HHHHHHHHHHhhccCCCccceEeEEEeCCeeEE
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 159 (413)
....++|.|++|.|+.+..... ......+.+++|.......... ..+..|+.+-..|.|+|++..+..+.+....+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~--~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD--LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCC--CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 4567899999998877643321 1112223333331022222222 226678888888999999888887777666666
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
+||||++ +|..++... ..+....+..+++||+.||.|+|+ .||.|||||++|+++..+|.+||+|||.+..+.
T Consensus 399 ~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 6999999 999998654 267888889999999999999997 669999999999999999999999999998765
Q ss_pred CCCCc--ceeecccccccccCccccccCCccc-hhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 240 SASQS--HVTTRVMGTYGYAAPEYVATGHLYV-KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 240 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... ......+|+..|+|||++.+..|++ .+||||.|++++.|++|+.||......++................
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~-- 549 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG-- 549 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC--
Confidence 55544 5556789999999999999999984 579999999999999999999876655433200000000000000
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
........+...+.+|.+||++||.+|.|+++|++.=|
T Consensus 550 -------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 550 -------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred -------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 00122355677889999999999999999999998655
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-24 Score=204.17 Aligned_cols=257 Identities=32% Similarity=0.471 Sum_probs=194.8
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHHHHHHHHHHhhccCC-CccceEeEEEeCC
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEEWQSEVNFLGRLSHP-NLVRLLGYCWEDK 155 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~ 155 (413)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +|+++++.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC
Confidence 677889999999999999643 67899988765332 366789999999999988 7999999998777
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEccCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFGL 234 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~ 234 (413)
..+++++++.++++.+++...... ..+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||+
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 889999999999999777443211 368888999999999999999997 5599999999999999888 799999999
Q ss_pred cccCCCCCCcc----eeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCC-CcchhhHhhh
Q 015094 235 AKLGPSASQSH----VTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPS-GQHNLVDWIK 306 (413)
Q Consensus 235 a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~-~~~~~~~~~~ 306 (413)
+.......... ......|+..|++||.+.+ ..+....|+|++|++++++++|..||...... ........+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 97533322221 2456789999999999977 57889999999999999999999997665431 0000000000
Q ss_pred hhhhhhhhhhHhHHhhhcCCCc----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..... ....... ......+.+++..++..+|..|.+..+....
T Consensus 229 ---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ---ELPTP-------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---hcCCc-------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000 0000111 1223578899999999999999988877765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=190.55 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=195.8
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
..++..|.+...|..|+|+|.. ..++.|+++-.. ...-+.|..|.-.|+.+.||||+.+++.+....++
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg---------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG---------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred hhhhhhhccCCCcccccccccC---------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 3456678899999999998874 446677765432 23335688899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc--cCCCc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS--DFGLA 235 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~--DfG~a 235 (413)
.+|..|++.|+|+..+.... .-.....++..++.++++|++|||+.+.-|----|....++|+++.+.+|. |--++
T Consensus 263 v~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence 99999999999999996543 335677888999999999999999977655555789999999999887764 21111
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCcc---chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY---VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
. ......-.+.||+||.+...+-+ .++|+|||++++|||.|..-||....+.+-.
T Consensus 341 f---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------------- 398 (448)
T KOG0195|consen 341 F---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------------- 398 (448)
T ss_pred e---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------------
Confidence 1 11223457889999999776544 6789999999999999999999876543211
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.++....++-..|+.++..+..|+.-|+..||.+||.+..++-.|+++.
T Consensus 399 ---mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 ---MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1233345566778899999999999999999999999999999888764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=190.66 Aligned_cols=172 Identities=12% Similarity=0.103 Sum_probs=132.3
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh---hHHH------HHHHHHHHhhccCCCcc
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ---GFEE------WQSEVNFLGRLSHPNLV 145 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~------~~~E~~~l~~l~h~~i~ 145 (413)
...++|++.++||.|+||.||++.. .+..+|||++...... ..+. +.+|+..+.++.|++|.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~---------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~ 98 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT---------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA 98 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec---------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence 3568999999999999999999632 2456999999754322 2222 67899999999999999
Q ss_pred ceEeEEEeC--------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 015094 146 RLLGYCWED--------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKAS 217 (413)
Q Consensus 146 ~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~ 217 (413)
.+.+++... ...++||||++|.+|.++. .+++ ....+++.+|..||. .|++|||+||.
T Consensus 99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~ 164 (232)
T PRK10359 99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ--HGMVSGDPHKG 164 (232)
T ss_pred cceEeeeecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH--cCCccCCCChH
Confidence 999986643 3589999999999998874 2232 245689999999996 66999999999
Q ss_pred cEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHH
Q 015094 218 NILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEIL 284 (413)
Q Consensus 218 Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 284 (413)
||+++.+| ++|+|||.......... ...++....|..++|+|+||+++..+.
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999988 99999999875321110 011345666778999999999886654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=186.87 Aligned_cols=235 Identities=20% Similarity=0.278 Sum_probs=151.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccC----------CCcc
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSH----------PNLV 145 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~~i~ 145 (413)
.+...+.||.|+++.||.+.+.+ +++.+|||++... .....+.+++|.-....+.+ -.++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~-------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l 85 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE-------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFL 85 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred EEEEccccccCCceEEEEEEEcc-------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence 34556789999999999997655 7899999987433 23456777777765555322 2233
Q ss_pred ceEeEEE---------eC---C-----eeEEEEeeCCCCCHHHhhh---hcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC
Q 015094 146 RLLGYCW---------ED---K-----ELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIAIGAARGLAFLHTS 205 (413)
Q Consensus 146 ~~~~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 205 (413)
..++... .. . ..+++|+-+. ++|.+++. ........+.....+.+..|+++.+++||+
T Consensus 86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~- 163 (288)
T PF14531_consen 86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS- 163 (288)
T ss_dssp --SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred eeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-
Confidence 3333322 11 1 2478888884 48887753 222222234555567777999999999997
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCcccccc--------CCccchhhhHHHH
Q 015094 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT--------GHLYVKSDVYGFG 277 (413)
Q Consensus 206 ~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG 277 (413)
.||+|+||+|+|+|++.+|.++|+||+....... .......+..|.+||.... -.++.+.|.|+||
T Consensus 164 -~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 164 -YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp -TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred -cceEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 5699999999999999999999999998875221 1111344577999997633 2577899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCC
Q 015094 278 VVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350 (413)
Q Consensus 278 ~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~R 350 (413)
+++|.|++|..||....+...... .+. ... +.+..+.+||..+|+.||.+|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHccCCCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999999987533221110 111 233 788899999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=179.39 Aligned_cols=138 Identities=17% Similarity=0.153 Sum_probs=106.1
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--h------------------------HHHHHHHHHHH
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--G------------------------FEEWQSEVNFL 136 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~~~l 136 (413)
...||+|+||.||+|... +++.||||+++..... . .....+|+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 73 (190)
T cd05147 2 NGCISTGKEANVYHATTA--------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNL 73 (190)
T ss_pred CCccccccceEEEEEECC--------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHH
Confidence 468999999999999642 5789999998654211 0 01234599999
Q ss_pred hhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHh-hcCCCCeeeCCCC
Q 015094 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL-HTSDKQVIYRDFK 215 (413)
Q Consensus 137 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~~~ivHrDlk 215 (413)
..+.++++.....+.. ...+|||||+.|+++...+... ..++...+..++.|++.+|.++ |+ .||+|||||
T Consensus 74 ~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlk 145 (190)
T cd05147 74 KRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD--CRLVHADLS 145 (190)
T ss_pred HHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCC
Confidence 9999888754443322 2238999999987776543222 2678889999999999999999 65 569999999
Q ss_pred CCcEEEcCCCCeEEccCCCccc
Q 015094 216 ASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+|||++ ++.++|+|||++..
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred HHHEEEE-CCcEEEEEcccccc
Confidence 9999998 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-24 Score=206.15 Aligned_cols=229 Identities=28% Similarity=0.380 Sum_probs=183.0
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh--HHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEE
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 161 (413)
.+|+|+||.|+++.-. .....+..+|+|++++..... ......|..++...+ ||.++++...++.+..+++++
T Consensus 1 vlg~g~~gkvfLvrk~----~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA----GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHh----ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhh
Confidence 3799999999987311 233467889999887653321 124456888888888 999999999999999999999
Q ss_pred eeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCC
Q 015094 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 241 (413)
+++.||.|...+.+.. .+.+.....+...++-+++++|. .+|+|||+|++||+++.+|.+++.|||+++.....
T Consensus 77 d~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9999999998874433 56777778888899999999997 66999999999999999999999999999863322
Q ss_pred CCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHh
Q 015094 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321 (413)
Q Consensus 242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (413)
.. .+||..|||||++. ....++|.||||+++++|++|..||... .+..++.
T Consensus 151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~- 201 (612)
T KOG0603|consen 151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILK- 201 (612)
T ss_pred hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhh-
Confidence 22 18999999999987 6778899999999999999999998751 1112222
Q ss_pred hhcCCCchHHHHHHHHHHHHccccCCCCCCCH
Q 015094 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353 (413)
Q Consensus 322 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~ 353 (413)
.....|...+..+.+++..++..+|..|...
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1234577888899999999999999999754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=171.66 Aligned_cols=188 Identities=17% Similarity=0.126 Sum_probs=138.4
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh----hHHHHHHHHHHHhhcc-CCCccceEeEEEeCC
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ----GFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDK 155 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 155 (413)
.+...|++|+||+||++.. .+..++.+.+...... ....+.+|+++|++|. |++|++++++ .
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~ 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D 71 (218)
T ss_pred ccceeecCCCcceEEEeec---------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c
Confidence 3567899999999998632 4577887777655431 1225789999999996 5889999886 4
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCcEEEcCCCCeEEccCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDF-KASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDl-kp~Nil~~~~~~~kl~DfG~ 234 (413)
..|++|||+.|.+|.+.+. .. ...++.|++.+|.++|+ .||+|||| ||+|||++.++.++|+|||+
T Consensus 72 ~~~lvmeyI~G~~L~~~~~--------~~---~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 72 GRHLDRSYLAGAAMYQRPP--------RG---DLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred CEEEEEeeecCccHHhhhh--------hh---hHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 5799999999999875431 01 13577899999999997 66999999 79999999999999999999
Q ss_pred cccCCCCCCc----c-------eeecccccccccCcccccc-CCcc-chhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 235 AKLGPSASQS----H-------VTTRVMGTYGYAAPEYVAT-GHLY-VKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 235 a~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~-~~~~-~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
+......... . .......++.|++|+...- ...+ ...++++.|+-+|.++|+..++....
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 9854322210 0 0112235777788875422 1233 67799999999999999988765543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=171.89 Aligned_cols=141 Identities=18% Similarity=0.149 Sum_probs=108.5
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--------------------------hHHHHHHHHHH
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--------------------------GFEEWQSEVNF 135 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~E~~~ 135 (413)
+.+.||+|+||.||+|... +++.||||++...... ....+.+|+..
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~--------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 72 (190)
T cd05145 1 INGCISTGKEANVYHARTG--------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRN 72 (190)
T ss_pred CCceeecCCCcEEEEEEcC--------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHH
Confidence 4578999999999999532 5789999998754210 01224679999
Q ss_pred HhhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 136 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
+.++.|++|.....+... ..|+||||+.|+++....... ..++...+..++.|++.+|.++|+ ..||+|||||
T Consensus 73 l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDlk 145 (190)
T cd05145 73 LKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDLS 145 (190)
T ss_pred HHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCC
Confidence 999999988655544333 248999999987654432222 256778889999999999999996 2569999999
Q ss_pred CCcEEEcCCCCeEEccCCCcccC
Q 015094 216 ASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
|+|||++ ++.++|+|||++...
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceec
Confidence 9999999 789999999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=208.24 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=175.7
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
+|...+.||.+.|=+|.+|.+.+ |. |+||++-+.. ...+.+...|++ ...+++||++.+.-+.+.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e--------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~ 93 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE--------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD 93 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC--------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh
Confidence 57778899999999999996553 44 8899885543 223334444555 5566899999998887788
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...|||-+|+.. +|.|.+.-+. -+...+...|+.||+.||.-+|. .||+|||||.+||||+.=+-+.|+||.-
T Consensus 94 kAAylvRqyvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 94 KAAYLVRQYVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHHHHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccc
Confidence 888999999965 9999884332 46667778899999999999996 6699999999999999988999999976
Q ss_pred cccCCCCCCc-c----eeecccccccccCcccccc----------CC-ccchhhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 015094 235 AKLGPSASQS-H----VTTRVMGTYGYAAPEYVAT----------GH-LYVKSDVYGFGVVLVEILT-GLRALDTNRPSG 297 (413)
Q Consensus 235 a~~~~~~~~~-~----~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DiwslG~il~~llt-G~~pf~~~~~~~ 297 (413)
-+......++ . ....-..-.+|.|||-+.. .. .+++.||||+||+++||++ |.++|.....
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-- 244 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-- 244 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH--
Confidence 6532211111 1 1112223457999997743 12 5678999999999999998 6888864310
Q ss_pred cchhhHhhhhhhhh-hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 298 QHNLVDWIKPYLSE-KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 298 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+-.. .......+.. -....+++||..|++.||..|.+|++.|+.
T Consensus 245 --------~aYr~~~~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 --------LAYRSGNADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --------HhHhccCccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 001000 0011111111 112368899999999999999999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=182.63 Aligned_cols=198 Identities=23% Similarity=0.296 Sum_probs=141.1
Q ss_pred cCCCccceEeEEEe---------------------------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHH
Q 015094 140 SHPNLVRLLGYCWE---------------------------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192 (413)
Q Consensus 140 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 192 (413)
+|||||++..+|.+ +..+|+||..++. +|.+++..+ ..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 59999999987753 2458999999865 999999544 34556667789
Q ss_pred HHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--CC--CCeEEccCCCcccCCCCC----CcceeecccccccccCcccccc
Q 015094 193 IGAARGLAFLHTSDKQVIYRDFKASNILLD--GS--YTAKISDFGLAKLGPSAS----QSHVTTRVMGTYGYAAPEYVAT 264 (413)
Q Consensus 193 ~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~--~~--~~~kl~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 264 (413)
.|+++|+.|||. .||.|||+|.+|||+. ++ ..++|+|||++-...... .....-..-|....||||+...
T Consensus 348 aQlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999997 5599999999999993 33 367999999876422110 0011122457778999998743
Q ss_pred C--C----ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHH
Q 015094 265 G--H----LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQL 338 (413)
Q Consensus 265 ~--~----~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 338 (413)
. + ...++|.|+.|.+.||++....||......- -+...+ ........+..+++.+.+|
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~------------L~~r~Y----qe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML------------LDTRTY----QESQLPALPSRVPPVARQL 489 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe------------echhhh----hhhhCCCCcccCChHHHHH
Confidence 2 1 2368999999999999999999997632110 000011 1111123566788899999
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 015094 339 SLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 339 i~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..+|+.||++|++..-..+.|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999998765555443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=203.55 Aligned_cols=197 Identities=19% Similarity=0.218 Sum_probs=157.8
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc---CCCccceEeEE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS---HPNLVRLLGYC 151 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~ 151 (413)
.....|.|.+.||+|+||+||+|... .++.||||+-+......+ .--.+++.+|+ -+.|..+...+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~--------~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHS--------NGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecC--------CCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHH
Confidence 34567889999999999999999543 289999999876654321 11223444444 34566666666
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-------CC
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-------GS 224 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-------~~ 224 (413)
...+..+||+||.+.|+|.++++ ..+.+++..+..+..|++..++.||. .+|||+||||+|+||. +.
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred ccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCcc
Confidence 66778899999999999999996 34478888899999999999999997 5599999999999993 34
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCC
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLR 288 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~ 288 (413)
--++|+|||.+.....-.........++|-.+-.+|+..|..|++.+|.|.|+.+++-||+|++
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 4689999999876554445555666788999999999999999999999999999999999964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-22 Score=201.13 Aligned_cols=209 Identities=24% Similarity=0.370 Sum_probs=146.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
..|..+|+|..|+||.||++++.. +.+.+|+| +++++.-. ++ ++.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~-------trqrfa~k-iNkq~lil----Rn---ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKE-------TRQRFAMK-INKQNLIL----RN---ILTFAGNPFVV------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccc-------cccchhhc-ccccchhh----hc---cccccCCccee------------
Confidence 468899999999999999996553 66889985 44443110 01 22222334333
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+-...+..-+ +++... +.+++|||+ .+|+|||+||+|.+|..-|.+|++|||+++.
T Consensus 136 ---------gDc~tllk~~g----~lPvdm--------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIG----PLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ---------chhhhhcccCC----CCcchh--------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhh
Confidence 33334442212 333222 678999996 7799999999999999999999999999876
Q ss_pred CCCCCCc-------------ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 238 GPSASQS-------------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 238 ~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
+...... ......+||+.|.|||++....|+..+|+|++|+|+|+++-|+.||.+..+....
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf----- 267 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF----- 267 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-----
Confidence 3221111 0112468999999999999999999999999999999999999999988654321
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP 351 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp 351 (413)
..++.+...+ .+-......++.++|.++|+.+|..|.
T Consensus 268 -g~visd~i~w---------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 -GQVISDDIEW---------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -hhhhhhhccc---------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111111111 111335667899999999999999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=166.24 Aligned_cols=136 Identities=16% Similarity=0.191 Sum_probs=103.9
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-----cCCCccceEeEEEeCC-
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-----SHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~- 155 (413)
-.+.||+|+||.||. +.. +... +||++........+.+.+|+.+++.+ +||||++++++++++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~-------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE-------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CcceecCCCceEEEE--CCC-------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 457899999999995 332 2333 68988765444556789999999999 5799999999998873
Q ss_pred --eeE-EEEee--CCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHH-HHhhcCCCCeeeCCCCCCcEEEcC----CC
Q 015094 156 --ELL-LVYEF--MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL-AFLHTSDKQVIYRDFKASNILLDG----SY 225 (413)
Q Consensus 156 --~~~-lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l-~~lH~~~~~ivHrDlkp~Nil~~~----~~ 225 (413)
.++ +|||| +.+++|.+++.+. .+.+. ..++.+++.++ +|||+ .+|+||||||+|||++. ++
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEV 146 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCC
Confidence 434 78999 5579999999542 24444 35677888777 99997 56999999999999963 34
Q ss_pred CeEEccCCCcc
Q 015094 226 TAKISDFGLAK 236 (413)
Q Consensus 226 ~~kl~DfG~a~ 236 (413)
.++|+||+.+.
T Consensus 147 ~~~LiDg~G~~ 157 (210)
T PRK10345 147 IPVVCDNIGES 157 (210)
T ss_pred cEEEEECCCCc
Confidence 89999955443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.9e-22 Score=185.93 Aligned_cols=245 Identities=24% Similarity=0.262 Sum_probs=161.0
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEe-------EE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLG-------YC 151 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-------~~ 151 (413)
.+.+.+..+..+++.++...... .....+.++-+..+.+.........+++-.+....|-+..-+.+ .+
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~----~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKN----NSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred cccccccccccccCCchhhhhcc----cchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 34555666666666665542111 11123444445444444333344445555555555433332222 11
Q ss_pred Ee-----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 152 WE-----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 152 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
.. ..++||.|++|...+|.++|..+.. ....+....+.++.|++.+++| ++.+|+|+||.||++..+..
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchh
Confidence 11 2358999999999999999965432 2356777889999999999999 55999999999999999999
Q ss_pred eEEccCCCcccCCCCC----CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhC-CCCCCCCCCCCcchh
Q 015094 227 AKISDFGLAKLGPSAS----QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG-LRALDTNRPSGQHNL 301 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~ 301 (413)
+||.|||+........ .....+...||.+||+||++.+..|+.++||||||++|+||+.- ...|+..
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------- 466 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------- 466 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------
Confidence 9999999988644333 12234567899999999999999999999999999999999982 2222110
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHH---HHHHHHHHHHccccCCCCCCCHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKA---AYQIAQLSLKCLEAEPKHRPSMREV 356 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~ 356 (413)
..+ .....+.+|+.. .+.-..|+.++|.+.|.+||++.+.
T Consensus 467 -----------~t~----~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 -----------ATL----TDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -----------Hhh----hhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 011 111122333211 1234589999999999999954433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=166.35 Aligned_cols=143 Identities=17% Similarity=0.128 Sum_probs=109.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh------------------------hHHHHHHHH
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ------------------------GFEEWQSEV 133 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~E~ 133 (413)
.-|.+.+.||+|+||.||+|++. ..+++.||||++...... ....+.+|+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~------~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDF------DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred chHHhCCeeccCcceeEEEEEec------CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 35889999999999999999621 125789999988643210 112356899
Q ss_pred HHHhhccCCC--ccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCC-ee
Q 015094 134 NFLGRLSHPN--LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQ-VI 210 (413)
Q Consensus 134 ~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~-iv 210 (413)
.+++++.+.+ +++++++ ...++||||+.|.+|...+... ..+....+..++.||+.+|.+||. .| |+
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~g~ii 171 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYK--EGELV 171 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHh--cCCEE
Confidence 9999998533 4444432 2358999999998887654222 245556678899999999999996 77 99
Q ss_pred eCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 211 YRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 211 HrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
||||||+||+++ ++.++|+|||.+..
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 999999999999 88999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-19 Score=159.91 Aligned_cols=134 Identities=19% Similarity=0.316 Sum_probs=110.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--------hHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--------GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
+.||+|++|.||+|.+ .+..|++|+....... ....+.+|+.++..+.|++|+....++....
T Consensus 2 ~~l~~G~~~~vy~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEee---------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence 6799999999999965 2466888876543211 1235778999999999999888777777788
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||++|++|.+++.... . ....++.+++.+|.++|. .+++|+|++|.|||++ ++.++|+|||++
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 8999999999999999984321 1 678899999999999996 6699999999999999 789999999998
Q ss_pred cc
Q 015094 236 KL 237 (413)
Q Consensus 236 ~~ 237 (413)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 73
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=175.09 Aligned_cols=217 Identities=24% Similarity=0.406 Sum_probs=162.2
Q ss_pred HhhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 136 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... ...+++.....++++|+.||.|||...-+ .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeec
Confidence 46789999999999999999999999999999999999653 34788889999999999999999974422 999999
Q ss_pred CCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCC-------ccchhhhHHHHHHHHHHHhCCC
Q 015094 216 ASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH-------LYVKSDVYGFGVVLVEILTGLR 288 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~lltG~~ 288 (413)
..|.+++....+||+|||+.................-..-|.|||++.+.. .+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988654311111122223455799999886631 3567899999999999999999
Q ss_pred CCCCCCCCCcc-hhhHhhhhhhhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 289 ALDTNRPSGQH-NLVDWIKPYLSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 289 pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
||+........ ..+..++. .....++.... ....+++..++..||..+|..||+++++-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~----------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK----------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh----------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99875443321 11111110 00000111110 1344479999999999999999999999988877654
Q ss_pred c
Q 015094 366 S 366 (413)
Q Consensus 366 ~ 366 (413)
.
T Consensus 227 ~ 227 (484)
T KOG1023|consen 227 G 227 (484)
T ss_pred c
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=155.94 Aligned_cols=130 Identities=19% Similarity=0.277 Sum_probs=104.4
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.||+|+||.||+|.+ .+..|++|....... ...+++.+|+++++.+.|+++.....++.....
T Consensus 1 ~ig~G~~~~vy~~~~---------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEeec---------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence 489999999999964 246788887543211 123567789999999998876665555666777
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||++|++|.+++.... . .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++.
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEGN----D-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CEEEEEEECCccHHHHHhhcH----H-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 899999999999998874321 1 788999999999997 6699999999999999 7899999999987
Q ss_pred c
Q 015094 237 L 237 (413)
Q Consensus 237 ~ 237 (413)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 5
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=151.53 Aligned_cols=141 Identities=16% Similarity=0.042 Sum_probs=108.0
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh----------------------hhHHHHH
Q 015094 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----------------------QGFEEWQ 130 (413)
Q Consensus 73 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~ 130 (413)
+......|.+.+.||+|+||.||+|... +++.||||++..... .......
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP--------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQ 81 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC--------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHH
Confidence 3333445888999999999999999542 578999998654320 0012356
Q ss_pred HHHHHHhhccCCC--ccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCC
Q 015094 131 SEVNFLGRLSHPN--LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQ 208 (413)
Q Consensus 131 ~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ 208 (413)
+|+.++..+.|.+ ++.+++ ....++||||++|++|..+... .....++.+++.++.++|. .+
T Consensus 82 ~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~--~g 145 (198)
T cd05144 82 KEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK--HG 145 (198)
T ss_pred HHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH--CC
Confidence 7999999998774 445543 2456999999999998765420 2345788899999999997 66
Q ss_pred eeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 209 VIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 209 ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||||+||+++.++.++|+|||++..
T Consensus 146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 146 IIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 99999999999999999999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=175.40 Aligned_cols=137 Identities=20% Similarity=0.222 Sum_probs=109.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEec-CCc-C------hhhHHHHHHHHHHHhhccCCCccceE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSE-S------LQGFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
...|...+.||+|+||+||+|.+.. ..+++|+. ... . ....+.+.+|+++++.++|++|+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG---------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC---------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 4456778999999999999986543 22333322 111 1 11235678999999999999999888
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
.++......++||||++|++|.+++. ....++.+++.+|.+||+ .+|+||||||+|||+ .++.++
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEE
Confidence 77777778899999999999999883 346789999999999996 669999999999999 577999
Q ss_pred EccCCCccc
Q 015094 229 ISDFGLAKL 237 (413)
Q Consensus 229 l~DfG~a~~ 237 (413)
|+|||+++.
T Consensus 468 liDFGla~~ 476 (535)
T PRK09605 468 LIDFGLGKY 476 (535)
T ss_pred EEeCccccc
Confidence 999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-19 Score=180.94 Aligned_cols=261 Identities=24% Similarity=0.257 Sum_probs=196.9
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 155 (413)
.|.+.+.||+|+|+.|-++... ......+|+|.+.... ....+....|..+-+.+. |.|++.+++...+.+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNS------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccchhhhhhhc------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc
Confidence 5778888999999999876422 2244567777765443 233445566888888887 999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhh-hcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEccCC
Q 015094 156 ELLLVYEFMQKGSLENHLF-GRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFG 233 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~DfG 233 (413)
..+++++|..|+++.+.+. ... .......+..++.|+..++.|+|. +.++.|+||||+|.+++..+ .+++.|||
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred ccccccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCch
Confidence 9999999999999998883 221 134455567789999999999993 36699999999999999999 99999999
Q ss_pred CcccCCC-CCCcceeecccc-cccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 234 LAKLGPS-ASQSHVTTRVMG-TYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 234 ~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
+|..+.. ..........+| ++.|+|||...+..| .+..|+||.|+++..+++|..||..........
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---------- 240 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---------- 240 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----------
Confidence 9997665 344444455678 999999999888544 588899999999999999999998765443111
Q ss_pred hhhhhhHhHHh--hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 311 EKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 311 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
..+... ...............+++.++|..+|..|.+.+++...-+...
T Consensus 241 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 241 -----SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----eeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 011111 1112233456677889999999999999999988876544433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-16 Score=133.31 Aligned_cols=134 Identities=22% Similarity=0.151 Sum_probs=110.9
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC--CCccceEeEEEeCCeeEE
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH--PNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~l 159 (413)
+.+.||.|.++.||++... +..+++|....... ...+.+|+.+++.+.| .++++++.++...+..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~---------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK---------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec---------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence 4578999999999999643 25789998866543 4568899999999986 589999998887788999
Q ss_pred EEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD-KQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
+|||+.|..+..+ +......++.+++.+|.++|... .+++|+||+|+||+++..+.++++|||.+..
T Consensus 71 v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999988777543 34455678899999999999632 4699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-16 Score=141.85 Aligned_cols=135 Identities=21% Similarity=0.155 Sum_probs=101.2
Q ss_pred CCeee-ecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-------------hhhHHHHHHHHHHHhhccCCCc--cc
Q 015094 83 DTVLG-EGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-------------LQGFEEWQSEVNFLGRLSHPNL--VR 146 (413)
Q Consensus 83 ~~~lg-~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i--~~ 146 (413)
...|| .|+.|+||.+... +..++||.+.... ......+.+|+.++..|.|++| +.
T Consensus 36 ~~~lg~~~g~gtv~~v~~~---------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~ 106 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP---------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPR 106 (239)
T ss_pred CceeecCCCCccEEEEEeC---------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCce
Confidence 35677 7888888887532 4678888774321 0122457889999999998875 67
Q ss_pred eEeEEEeCC-e---eEEEEeeCCC-CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 015094 147 LLGYCWEDK-E---LLLVYEFMQK-GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221 (413)
Q Consensus 147 ~~~~~~~~~-~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~ 221 (413)
.+++..... . .++|||+++| .+|.+++... .++.. .+.+|+.+|.+||. .||+||||||+|||+
T Consensus 107 pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv 175 (239)
T PRK01723 107 PIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILL 175 (239)
T ss_pred eEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEE
Confidence 777644332 2 3599999997 6898887432 34433 36789999999996 669999999999999
Q ss_pred cCCCCeEEccCCCccc
Q 015094 222 DGSYTAKISDFGLAKL 237 (413)
Q Consensus 222 ~~~~~~kl~DfG~a~~ 237 (413)
+.++.++|+|||.+..
T Consensus 176 ~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCEEEEECCCccc
Confidence 9889999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=138.75 Aligned_cols=137 Identities=18% Similarity=0.139 Sum_probs=96.1
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--hHH----------------------HHHHHHHHHh
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFE----------------------EWQSEVNFLG 137 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~----------------------~~~~E~~~l~ 137 (413)
+.+.||+|+||+||+|... +++.||||++...... ... ....|...+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~--------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 72 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG--------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLK 72 (187)
T ss_pred CCcccccccceeEEEEECC--------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHH
Confidence 3578999999999999543 4688999987653211 111 1135666777
Q ss_pred hccCCC--ccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 138 RLSHPN--LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 138 ~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
.+.+.. +.++++. ...++||||+.++.+........ ... ..+..++.+++.++.++|. ..+|+|+|||
T Consensus 73 ~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl~ 142 (187)
T cd05119 73 RLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR-EAGLVHGDLS 142 (187)
T ss_pred HHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh-ccCcCcCCCC
Confidence 765443 4555543 34699999999854332110000 001 5567899999999999996 2569999999
Q ss_pred CCcEEEcCCCCeEEccCCCccc
Q 015094 216 ASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||+++ ++.++|+|||.+..
T Consensus 143 p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred hhhEEEE-CCcEEEEECccccc
Confidence 9999999 88999999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-16 Score=149.07 Aligned_cols=252 Identities=22% Similarity=0.249 Sum_probs=185.1
Q ss_pred cCCCCCCeeee--cCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhcc-CCCccceEeEEE
Q 015094 78 RNFKSDTVLGE--GGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLS-HPNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 152 (413)
..|.+.+.+|. |.+|.||.+.... ..+...+|+|.-+... ......-.+|+...+.++ |++.++.+..++
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN-----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc-----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 46888999999 9999999985522 3467889999743322 223333456777777776 999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHH----HHHHhhcCCCCeeeCCCCCCcEEEcCC-CCe
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR----GLAFLHTSDKQVIYRDFKASNILLDGS-YTA 227 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~ 227 (413)
..+.+|+-+|+| +.+|.++...... -++...++..+.+... ||.++|+ .+|+|-|+||+||+...+ ...
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheeccccccee
Confidence 999999999999 5788888865442 4677777888888888 9999997 669999999999999988 899
Q ss_pred EEccCCCcccCCCCCCcc---eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 228 KISDFGLAKLGPSASQSH---VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
+++|||+........... ......|...|++||.. .+-++...|||+||.++.+..+|..+........-.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~----- 336 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS----- 336 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----
Confidence 999999988754433221 11223578889999965 778899999999999999999997765543111000
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
.++... +..++-...+.++...+..|++.+|..|++++.+.+
T Consensus 337 ---------~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 ---------QLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---------cccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000 112222334456666999999999999999887764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.7e-15 Score=145.10 Aligned_cols=144 Identities=19% Similarity=0.197 Sum_probs=95.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh--------------------------------
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-------------------------------- 125 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------- 125 (413)
..|.. +.||.|++|.||+|+++. +|+.||||+........
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~-------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~ 191 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD-------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA 191 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC-------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence 45666 789999999999997653 47899999987542110
Q ss_pred --HHH------HHHHHHHHhhcc----CCCccceEeEEEe-CCeeEEEEeeCCCCCHHHh--hhhcCCCCCCCcHHHHHH
Q 015094 126 --FEE------WQSEVNFLGRLS----HPNLVRLLGYCWE-DKELLLVYEFMQKGSLENH--LFGRGASVQPLAWNIRLK 190 (413)
Q Consensus 126 --~~~------~~~E~~~l~~l~----h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~ 190 (413)
.+. +.+|+..+.++. +...+.+-.++.+ ....+|||||+.|+.+.++ +...+.....+....+..
T Consensus 192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 111 233443444432 3333333333332 4567899999999999874 323322222355555555
Q ss_pred HHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----CeEEccCCCcccC
Q 015094 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY----TAKISDFGLAKLG 238 (413)
Q Consensus 191 i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~----~~kl~DfG~a~~~ 238 (413)
++.|++. .|++|+|+||.||+++.+| .++++|||++...
T Consensus 272 ~~~Qif~---------~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 272 FFTQVFR---------DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHh---------CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 6666543 4599999999999999888 9999999998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.6e-15 Score=133.30 Aligned_cols=207 Identities=23% Similarity=0.298 Sum_probs=143.7
Q ss_pred HHhhccCCCccceEeEEEeC-----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCe
Q 015094 135 FLGRLSHPNLVRLLGYCWED-----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQV 209 (413)
Q Consensus 135 ~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i 209 (413)
-|-.+.|.||+++..|+.+. ....++.||+..|+|..+|++..+....+......+|+-||+.||.|||+....|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34455699999999987654 3578999999999999999887777778888899999999999999999999999
Q ss_pred eeCCCCCCcEEEcCCCCeEEccCCCcccCCC--CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCC
Q 015094 210 IYRDFKASNILLDGSYTAKISDFGLAKLGPS--ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL 287 (413)
Q Consensus 210 vHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~ 287 (413)
+|+++..+.|++..+|-+|+.----...... ...........+-++|.+||.=...+.+-++|||+||....+|..|.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999999988742211111000 00001111234677899999765566778899999999999998875
Q ss_pred CCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 288 RALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 288 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.--...... + .........+ .+ .....-+.++.+||...|..||++++++-|..
T Consensus 280 iq~tnseS~-----------~-~~ee~ia~~i----~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 280 IQSTNSESK-----------V-EVEENIANVI----IG----LENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred eccCCCcce-----------e-ehhhhhhhhe----ee----ccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 321111000 0 0000000000 00 00111346888999999999999999986543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.1e-14 Score=138.30 Aligned_cols=138 Identities=20% Similarity=0.187 Sum_probs=94.1
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHH-----------------------------------
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE----------------------------------- 127 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----------------------------------- 127 (413)
.+.||.|++|.||+|+.. +|+.||||+..........
T Consensus 122 ~~plasaSigQVh~A~l~--------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 193 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV--------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKT 193 (437)
T ss_pred CcceeeeehhheEEEEec--------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHH
Confidence 367999999999999764 4789999998654211100
Q ss_pred -----HHHHHHHHHhhcc-----CCC--ccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHH
Q 015094 128 -----EWQSEVNFLGRLS-----HPN--LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195 (413)
Q Consensus 128 -----~~~~E~~~l~~l~-----h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi 195 (413)
.+.+|...+.++. +++ |.+++. ...+..+|||||++|++|.++...... ... ...++..+
T Consensus 194 l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~ 265 (437)
T TIGR01982 194 LRRELDLRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENL 265 (437)
T ss_pred HHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHH
Confidence 1334555555552 233 233332 223557999999999999887643211 111 23455555
Q ss_pred HH-HHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 196 AR-GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 196 ~~-~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
+. .+..+|. .|++|+|+||.||+++.++.++|+|||++...
T Consensus 266 ~~~~l~ql~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 266 ARSFLNQVLR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHHHh--CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 55 3667785 66999999999999999999999999999753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.4e-13 Score=132.80 Aligned_cols=164 Identities=20% Similarity=0.239 Sum_probs=126.1
Q ss_pred CCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHH
Q 015094 109 SGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR 188 (413)
Q Consensus 109 ~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 188 (413)
.+..|.|...+.......+..++-++.|+.|+||||+++++.++.++.+|||+|-+. .|..++.+ +....+
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~v 106 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEEV 106 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHHH
Confidence 567788887776654445667888899999999999999999999999999999885 77777753 335667
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCcc
Q 015094 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY 268 (413)
Q Consensus 189 ~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 268 (413)
...+.||+.||.|||. +.+++|++|.-..|+++..|..||++|-++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 7788999999999985 57799999999999999999999999988764221111 111112223456666543222
Q ss_pred chhhhHHHHHHHHHHHhC
Q 015094 269 VKSDVYGFGVVLVEILTG 286 (413)
Q Consensus 269 ~~~DiwslG~il~~lltG 286 (413)
-..|.|-|||++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.1e-13 Score=115.48 Aligned_cols=130 Identities=17% Similarity=0.086 Sum_probs=95.0
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCc-cceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL-VRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 161 (413)
++.|+.|.++.||++... ++.|++|....... ....+.+|+.+++.+.+.++ ++++.+. ....++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~---------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA---------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC---------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEE
Confidence 356899999999998542 57799998765432 12346789999999875554 4555543 33458999
Q ss_pred eeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC---CCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD---KQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
||++|.++.... .. ...++.+++++|..||..+ .+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 71 e~i~G~~l~~~~--------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 71 EFIEGSELLTED--------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EecCCCcccccc--------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 999998876430 11 1345678999999999743 1259999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.9e-14 Score=144.79 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=173.9
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.+.+.+-+-.|+++.++.+ ....++-..++|+..... ..+.+....+-.++-...+|.++.....+....
T Consensus 805 ~~~i~~p~qS~sp~ss~p~-------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPA-------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred cceecccccCCCCcccccC-------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC
Confidence 4556677888999999886 333445445555443321 122333444444444445566666655556678
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..+|+++|+.+++|...++..+ ..+.+.+......+..++++||+ ..+.|+|++|.|+++..+|..++.|||..
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCccccc
Confidence 8999999999999999986654 45555556677788899999997 33899999999999999999999999843
Q ss_pred ccCCCC----------------------CCc-------ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhC
Q 015094 236 KLGPSA----------------------SQS-------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG 286 (413)
Q Consensus 236 ~~~~~~----------------------~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG 286 (413)
...... ... .......||+.|.+||.+.+......+|+|++|+++++.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 321100 000 011235689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhc-CCCchHHHHHHHHHHHHccccCCCCCCCHH
Q 015094 287 LRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354 (413)
Q Consensus 287 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 354 (413)
.+||....+.. .|+++...... ..-+...++...+++..+|..+|.+|..+.
T Consensus 1032 ~pp~na~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99998765432 22222222211 122446677899999999999999997765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.2e-14 Score=135.08 Aligned_cols=251 Identities=21% Similarity=0.197 Sum_probs=177.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHH--HHHHHHHHhhcc-CCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--WQSEVNFLGRLS-HPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~E~~~l~~l~-h~~i~~~~~~~~ 152 (413)
...+|..+..||.|.|+.|+.+... ...+..|++|.+.........+ -..|+.+...+. |.+++..+..|.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 3457888999999999999987421 1256789999876554333333 245777777775 999999988888
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeEEcc
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISD 231 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~kl~D 231 (413)
...+.|+-.|||.++++...+ .....+.+...+.+..|++.++.++|+ +.++|+|+||.||++..+ +..++.|
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhccc
Confidence 888889999999999887766 222356777788999999999999997 569999999999999875 7889999
Q ss_pred CCCcccCCCCCCcceeeccccccccc--CccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYA--APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
||........ .....+.-+++ +++......+..+.|+++||..+.+.++|...-......
T Consensus 411 ~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~------------- 472 (524)
T KOG0601|consen 411 FGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS------------- 472 (524)
T ss_pred ccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------------
Confidence 9998641111 11122333344 444445567789999999999999999986432221110
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
..+ ........+ ....++..+.+.++..++..||.+.++..+...+.
T Consensus 473 ------~~i-~~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ------LTI-RSGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------eee-ecccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 000 000011111 23367888999999999999999988877666544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.9e-12 Score=108.64 Aligned_cols=142 Identities=13% Similarity=0.056 Sum_probs=97.7
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh----------------------hhHHH----HHHHHHHH
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----------------------QGFEE----WQSEVNFL 136 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~----~~~E~~~l 136 (413)
...||.|--+.||.|...... ..+..+..+|||+.+.... ...+. .++|+..|
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~-~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE-TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CCccccCcceEEEEEecCccc-ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 356899999999999532100 0112457899998632110 00112 33799999
Q ss_pred hhccC--CCccceEeEEEeCCeeEEEEeeCCCCCHHH-hhhhcCCCCCCCcHHHHHHHHHHHHHHHHHh-hcCCCCeeeC
Q 015094 137 GRLSH--PNLVRLLGYCWEDKELLLVYEFMQKGSLEN-HLFGRGASVQPLAWNIRLKIAIGAARGLAFL-HTSDKQVIYR 212 (413)
Q Consensus 137 ~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~~~ivHr 212 (413)
+++.. -++++++++ ...+|||||+.+..+.. .+.. ..++......++.+++.+|..| |. .||||+
T Consensus 81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHG 149 (197)
T cd05146 81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHA 149 (197)
T ss_pred HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence 99973 467777764 46789999997654422 1211 1344455677889999999988 75 569999
Q ss_pred CCCCCcEEEcCCCCeEEccCCCccc
Q 015094 213 DFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 213 Dlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
||++.|||+. ++.++|+|||.+..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCcee
Confidence 9999999997 46899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.7e-12 Score=104.31 Aligned_cols=131 Identities=21% Similarity=0.277 Sum_probs=98.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---h-----hHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---Q-----GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+++|+-+.+|.+.+. +..+++|.-..... + ..++-.+|+.++.++.--.|.-.+=++.+..
T Consensus 2 ~~i~~GAEa~i~~~~~~---------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL---------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD 72 (204)
T ss_pred chhhCCcceeEEeeecc---------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence 45789999999998553 34466775433211 1 1234668999999998666655555566777
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
...|+|||++|..|.+++... ...++..+-..+.-||. .||+|+||.++||++..++ +.++|||++
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcc
Confidence 888999999999999888543 14577777788899996 6699999999999998774 999999999
Q ss_pred cc
Q 015094 236 KL 237 (413)
Q Consensus 236 ~~ 237 (413)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 74
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-11 Score=108.01 Aligned_cols=141 Identities=20% Similarity=0.256 Sum_probs=104.7
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccC--CCccceEeEEEeC---Cee
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSH--PNLVRLLGYCWED---KEL 157 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~---~~~ 157 (413)
+.|+.|.++.||++... .++.+++|+...... .....+.+|+.+++.+.+ ..+++++.+.... +..
T Consensus 4 ~~l~~G~~n~~~~v~~~--------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred eecCCCccceEEEEEec--------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 56899999999998542 246799998765432 134567899999999975 3467787766553 267
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS-------------------------------- 205 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-------------------------------- 205 (413)
++||||++|.++.+.+.. ..++......++.++++.|..||+.
T Consensus 76 ~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred eEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 899999999888775521 1355666666777777777777741
Q ss_pred ----------------------CCCeeeCCCCCCcEEEcC--CCCeEEccCCCccc
Q 015094 206 ----------------------DKQVIYRDFKASNILLDG--SYTAKISDFGLAKL 237 (413)
Q Consensus 206 ----------------------~~~ivHrDlkp~Nil~~~--~~~~kl~DfG~a~~ 237 (413)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999988 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-10 Score=111.15 Aligned_cols=216 Identities=16% Similarity=0.209 Sum_probs=148.2
Q ss_pred ceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe----CCeeEEEEeeCCC-
Q 015094 92 GKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE----DKELLLVYEFMQK- 166 (413)
Q Consensus 92 g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~- 166 (413)
.+.|+|+.. .+|..|++|+++............-+++++++.|+|||++.++|.. +..+++|++|+++
T Consensus 290 ~Ttyk~~s~-------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 290 ITTYKATSN-------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ceeEeeeec-------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 468888644 3788999999954433333233456788999999999999998873 3578999999885
Q ss_pred CCHHHhhhhcC-----------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 167 GSLENHLFGRG-----------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 167 ~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
++|.++..... ..+...++..+|.++.||..||.++|+ .|+..+-|.|.+|+++.+..++|...|+.
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecccce
Confidence 57777653221 223457889999999999999999998 45999999999999999989999877776
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... . |.+.+ -.+-|.=.||.+++.|.||..--... .. .
T Consensus 441 Dvl~~d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~-d~------------------~ 482 (655)
T KOG3741|consen 441 DVLQEDP--------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRT-DS------------------T 482 (655)
T ss_pred eeecCCC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccc-cc------------------h
Confidence 5432211 0 11111 13568899999999999995310000 00 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
... -........+.+++++|..+...++++ -++.+++.+
T Consensus 483 ~~s----~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 483 QSS----HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHH----HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 000 001122356677888888888888876 567777654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.1e-11 Score=97.80 Aligned_cols=143 Identities=18% Similarity=0.200 Sum_probs=105.4
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.+.+|-+|+-+.|+++.+. |+..+||.-..... -...+.++|+++|.++.--.|.-..-+|.+
T Consensus 11 ~l~likQGAEArv~~~~~~---------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS---------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeeccC---------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence 5678999999999998654 67777775432211 123457789999999876566555556777
Q ss_pred CCeeEEEEeeCCC-CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---CeEE
Q 015094 154 DKELLLVYEFMQK-GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY---TAKI 229 (413)
Q Consensus 154 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~---~~kl 229 (413)
...-+|+|||++| .++.+++...... .........++..|-+.+.-||. ++|+|+||..+||++..++ .+.|
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEE
Confidence 7778899999977 4778887654322 22333336788899999999996 6699999999999995444 3489
Q ss_pred ccCCCccc
Q 015094 230 SDFGLAKL 237 (413)
Q Consensus 230 ~DfG~a~~ 237 (413)
+|||++..
T Consensus 158 Idfgls~~ 165 (229)
T KOG3087|consen 158 IDFGLSSV 165 (229)
T ss_pred Eeecchhc
Confidence 99999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-09 Score=101.36 Aligned_cols=270 Identities=15% Similarity=0.143 Sum_probs=165.5
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhh-ccCCCccceEeE------EEe
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR-LSHPNLVRLLGY------CWE 153 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~------~~~ 153 (413)
...+.||+|+-+.+|-.- .-...+-|++.........+. +..|.. -.||-+-.-+.+ .-+
T Consensus 14 ~~gr~LgqGgea~ly~l~----------e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG----------EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred CCCccccCCccceeeecc----------hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 356789999999999741 112234577765543222221 222222 346643321111 112
Q ss_pred -CCeeEEEEeeCCCCCH-HHhhhh--cCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 154 -DKELLLVYEFMQKGSL-ENHLFG--RGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 154 -~~~~~lv~e~~~~~~L-~~~l~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
+..+.++|..+.|.-- ..++.- +..+-....+...+..++.|+.+.+.||. .|.+-+|+.++|+|+++++.++|
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~~V~L 158 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDSKVVL 158 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCceEEE
Confidence 2337889998887532 222221 22233457888999999999999999996 55899999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhC-CCCCCCCCCCCcchh-h
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTG-LRALDTNRPSGQHNL-V 302 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~-~ 302 (413)
.|-.--.. ........-.+|...|.+||.-. +..-+...|.|.||++||+++.| ++||.+......... .
T Consensus 159 VdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 159 VDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred Ecccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 98654333 22333344467999999999653 34456778999999999999997 899977432211100 0
Q ss_pred H-hhh--hhhhhhhhhhHhHHhhhcCCCc-hHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHHhcCCCC
Q 015094 303 D-WIK--PYLSEKRKFRHIIDARLQGQYP-YKAAYQIAQLSLKCLEAE--PKHRPSMREVVETLERLQASDQKP 370 (413)
Q Consensus 303 ~-~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~L~~d--p~~Rpt~~e~l~~L~~i~~~~~~~ 370 (413)
+ .+. .|...... ..-........| ...++++..|+.+|+... +.-|||++.++..|..+..+..+.
T Consensus 236 E~~Ia~g~f~ya~~~--~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 236 ETDIAHGRFAYASDQ--RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred hhhhhcceeeechhc--cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 0 000 00000000 000000011122 245678888999998764 568999999999999887765443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.4e-10 Score=99.48 Aligned_cols=134 Identities=17% Similarity=0.102 Sum_probs=95.3
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh----------------------hhHHHHHHHHHHHh
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----------------------QGFEEWQSEVNFLG 137 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~E~~~l~ 137 (413)
+.++..||-|--+.||.|... .+..+|||.-..... ......++|.++|.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~--------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~ 164 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP--------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ 164 (304)
T ss_pred HhhccccccCccceEEEEECC--------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence 567889999999999999644 478899996422110 11234678999999
Q ss_pred hccCC--CccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 138 RLSHP--NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 138 ~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
.|.-. .+++.+++ +..++|||+++|-.|...- +.......++..|++-+.-+-. .||||+|+.
T Consensus 165 ~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~--~GiVHGDlS 229 (304)
T COG0478 165 RLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYR--RGIVHGDLS 229 (304)
T ss_pred HhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHH--cCccccCCc
Confidence 99754 78888775 5678999999996665432 1122223334444444433332 669999999
Q ss_pred CCcEEEcCCCCeEEccCCCcc
Q 015094 216 ASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~ 236 (413)
+-||+++++|.+.++||--+.
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred hheEEEecCCCEEEEeCcccc
Confidence 999999999999999996654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.5e-09 Score=97.49 Aligned_cols=141 Identities=16% Similarity=0.114 Sum_probs=99.1
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHH----------HHHHHHHHHhhccCCCc--cceEeE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFE----------EWQSEVNFLGRLSHPNL--VRLLGY 150 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~~i--~~~~~~ 150 (413)
+.+-......|+++.+ .|+.|.||........ ..+ .+.+|+..+..|..-+| +.++.+
T Consensus 28 e~v~~~~~rrvvr~~~---------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~ 98 (268)
T PRK15123 28 EVFRELEGRRTLRFEL---------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAF 98 (268)
T ss_pred cEEecCCCceEEEEEE---------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEE
Confidence 4444444445666543 3578999976543321 111 37789999998864443 445555
Q ss_pred EEe-----CCeeEEEEeeCCCC-CHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-
Q 015094 151 CWE-----DKELLLVYEFMQKG-SLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG- 223 (413)
Q Consensus 151 ~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~- 223 (413)
++. ...-+||||++++. +|.+++..... .+........++.+++..+.-||. .||+|+|+++.|||++.
T Consensus 99 ~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 99 GERGSNPATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLP 174 (268)
T ss_pred EEecCCCccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEecc
Confidence 543 23578999999886 79988853321 244566777899999999999996 66999999999999975
Q ss_pred ------CCCeEEccCCCccc
Q 015094 224 ------SYTAKISDFGLAKL 237 (413)
Q Consensus 224 ------~~~~kl~DfG~a~~ 237 (413)
+..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 46899999998863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=93.12 Aligned_cols=97 Identities=22% Similarity=0.186 Sum_probs=63.6
Q ss_pred HHHHHHHHHhhccCC--CccceEeEEEeCCeeEEEEeeCC--CCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHH-h
Q 015094 128 EWQSEVNFLGRLSHP--NLVRLLGYCWEDKELLLVYEFMQ--KGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF-L 202 (413)
Q Consensus 128 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~-l 202 (413)
..++|++.|.++..- ++++++++. ..+|||||+. |..+..+.... +.......++.+++..+.. +
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHH
Confidence 467899999999855 577777542 3579999998 65554433211 1122335567777775544 5
Q ss_pred hcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 203 H~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|. .||+|+||.+.|||++++ .+.|+|||.+..
T Consensus 124 ~~--~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 124 HK--AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HC--TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred Hh--cCceecCCChhhEEeecc-eEEEEecCccee
Confidence 75 669999999999999987 999999999874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-10 Score=114.73 Aligned_cols=149 Identities=19% Similarity=0.285 Sum_probs=105.5
Q ss_pred HHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcc-------eeecccccccccCccccccCC
Q 015094 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH-------VTTRVMGTYGYAAPEYVATGH 266 (413)
Q Consensus 194 qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~ 266 (413)
+++.||.|+|. ..++||++|.|++|.++.++.+||+.|+++.......... ......-...|.|||++.+..
T Consensus 107 ~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 45589999997 4679999999999999999999999999876533311110 001122456799999999988
Q ss_pred ccchhhhHHHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHcccc
Q 015094 267 LYVKSDVYGFGVVLVEIL-TGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEA 345 (413)
Q Consensus 267 ~~~~~DiwslG~il~~ll-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 345 (413)
.+.++|+||||+++|.+. .|+..+......... .+.......-...+...++.++.+-+.++|..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 889999999999999998 555555443221110 01111111122234467888999999999999
Q ss_pred CCCCCCCHHHHH
Q 015094 346 EPKHRPSMREVV 357 (413)
Q Consensus 346 dp~~Rpt~~e~l 357 (413)
+..-||++.+++
T Consensus 252 ~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 252 DSAVRPTLDLLL 263 (700)
T ss_pred CcccCcchhhhh
Confidence 999999776665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-09 Score=107.48 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=90.7
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhH----------------------------------H--
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF----------------------------------E-- 127 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------~-- 127 (413)
+.|+.++-|.||+|+++ +|+.||||+......... +
T Consensus 131 ~PiAsASIaQVH~A~L~--------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 131 EPIASASIAQVHRAVLK--------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred CchhhhhHhhheeEEec--------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 67899999999999876 489999999765422110 0
Q ss_pred ----HHHHHHHHHhhcc-----CCCccceEeEEEeCCeeEEEEeeCCCCCHHHhh--hhcCCCCCCCcHHHHHHHHHHHH
Q 015094 128 ----EWQSEVNFLGRLS-----HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL--FGRGASVQPLAWNIRLKIAIGAA 196 (413)
Q Consensus 128 ----~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~qi~ 196 (413)
.+.+|...+.++. .++|.-..=+++..+.-.|+|||++|-.+.+.. ...+...+.+....+..++.|++
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL 282 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1334555555553 233221111233346678999999999998874 33332222333333334444332
Q ss_pred HHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccC
Q 015094 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238 (413)
Q Consensus 197 ~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~ 238 (413)
. .|++|.|.+|.||++..+|.+.+.|||+....
T Consensus 283 ~---------dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 R---------DGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred h---------cCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 2 45999999999999999999999999998753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.9e-08 Score=88.65 Aligned_cols=139 Identities=17% Similarity=0.189 Sum_probs=86.4
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC--ccceEeEEEeCCeeEEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN--LVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~ 161 (413)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+++++....+...+||
T Consensus 7 ~~i~~G~t~~~y~~-----------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe-----------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence 57899999999984 13457789876533 3345788999999997433 578888887888889999
Q ss_pred eeCCCCC-HHHhh---------------------hhcCCCCCCCcHHHHHHHHH----------HHHH-HHHHh--hcCC
Q 015094 162 EFMQKGS-LENHL---------------------FGRGASVQPLAWNIRLKIAI----------GAAR-GLAFL--HTSD 206 (413)
Q Consensus 162 e~~~~~~-L~~~l---------------------~~~~~~~~~~~~~~~~~i~~----------qi~~-~l~~l--H~~~ 206 (413)
|+++|.+ +...+ +........+... ...+.. .+.. ...+| +...
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 9999963 21111 1100011111100 000000 0000 11111 1223
Q ss_pred CCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 207 KQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 207 ~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
..++|+|+.|.||++++++ +.|+||+.+..
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 4578999999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.4e-08 Score=86.32 Aligned_cols=105 Identities=23% Similarity=0.197 Sum_probs=82.9
Q ss_pred HHHHHHHHHHhhccCC--CccceEeEEEeCC----eeEEEEeeCCCC-CHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHH
Q 015094 127 EEWQSEVNFLGRLSHP--NLVRLLGYCWEDK----ELLLVYEFMQKG-SLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199 (413)
Q Consensus 127 ~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l 199 (413)
....+|...+..|..- .+++++++.+... ..+||+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 4577899988888643 3566677666532 458999999884 7999886533 245566788999999999
Q ss_pred HHhhcCCCCeeeCCCCCCcEEEcCCC---CeEEccCCCccc
Q 015094 200 AFLHTSDKQVIYRDFKASNILLDGSY---TAKISDFGLAKL 237 (413)
Q Consensus 200 ~~lH~~~~~ivHrDlkp~Nil~~~~~---~~kl~DfG~a~~ 237 (413)
.-||. .||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 132 ~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99996 6699999999999998887 899999998774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=2e-07 Score=80.81 Aligned_cols=137 Identities=16% Similarity=0.116 Sum_probs=98.1
Q ss_pred eecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC------hhhHHHHHHHHHHHhhccCCC--ccceEeEEEeC----
Q 015094 87 GEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES------LQGFEEWQSEVNFLGRLSHPN--LVRLLGYCWED---- 154 (413)
Q Consensus 87 g~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~---- 154 (413)
|+|+.+.|+...+. ++.+-+|.-.... ......|.+|+..|+.|..-+ ++++. ++...
T Consensus 27 ~rgG~SgV~r~~~~---------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~ 96 (216)
T PRK09902 27 RRNGMSGVQCVERN---------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG 96 (216)
T ss_pred CCCCcceEEEEEeC---------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence 66899999986443 3457788654211 123457899999999997433 44554 33211
Q ss_pred -CeeEEEEeeCCC-CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--eEEc
Q 015094 155 -KELLLVYEFMQK-GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT--AKIS 230 (413)
Q Consensus 155 -~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~--~kl~ 230 (413)
-.-+||+|-+.| .+|.+++..... .+.+......++.+++..+.-||. .|+.|+|+.+.|||++.+|. ++++
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEE
Confidence 246899997753 588888754322 245667778899999999999996 66999999999999986667 9999
Q ss_pred cCCCccc
Q 015094 231 DFGLAKL 237 (413)
Q Consensus 231 DfG~a~~ 237 (413)
||--++.
T Consensus 173 DlEk~r~ 179 (216)
T PRK09902 173 DLEKSRR 179 (216)
T ss_pred Ehhccch
Confidence 9976653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.8e-07 Score=79.38 Aligned_cols=137 Identities=14% Similarity=0.095 Sum_probs=91.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHH---------HHHHHHHHhhccCC---C
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE---------WQSEVNFLGRLSHP---N 143 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~E~~~l~~l~h~---~ 143 (413)
...+|.+.+++-......|.+... .++.+++|..........+. ..+++..+..+... .
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei---------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~ 99 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI---------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE 99 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE---------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence 457888889998888777877643 36889999876654322111 23444444444322 2
Q ss_pred ccceEeEEE-----eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 015094 144 LVRLLGYCW-----EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASN 218 (413)
Q Consensus 144 i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~N 218 (413)
+..++.+.+ .....++||||++|..|.++. .+.+ .+...|.+++.-||. .|++|+|++|.|
T Consensus 100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgN 165 (229)
T PF06176_consen 100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGN 165 (229)
T ss_pred cccceeeeeeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH--cCCccCCCCcCc
Confidence 333222222 224567899999998887654 2232 244566778899997 559999999999
Q ss_pred EEEcCCCCeEEccCCCcc
Q 015094 219 ILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 219 il~~~~~~~kl~DfG~a~ 236 (413)
++++++ .++++||+..+
T Consensus 166 Flv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEECC-cEEEEECcccc
Confidence 999865 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.6e-07 Score=77.76 Aligned_cols=150 Identities=19% Similarity=0.151 Sum_probs=97.6
Q ss_pred HHHHHHHhcCCCCCCeee---ecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhH--------------------
Q 015094 70 FVELRAATRNFKSDTVLG---EGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-------------------- 126 (413)
Q Consensus 70 ~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-------------------- 126 (413)
...+....++..+....| +|--+.||+|.. ..+..+|+|++........
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~--------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr 108 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAET--------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR 108 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeecc--------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence 344555667777766655 455667999842 2478899999754321100
Q ss_pred ----HHHHHHHHHHhhcc--CCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHH
Q 015094 127 ----EEWQSEVNFLGRLS--HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200 (413)
Q Consensus 127 ----~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~ 200 (413)
.-..+|+.-|+++. +-.+++.+.+. ...|||||+....+. .-.-...++....+..+..++++.+.
T Consensus 109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~p----AP~LkDv~~e~~e~~~~~~~~v~~~~ 180 (268)
T COG1718 109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLP----APRLKDVPLELEEAEGLYEDVVEYMR 180 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCC----CCCcccCCcCchhHHHHHHHHHHHHH
Confidence 11346888888886 44566666643 457999999543110 00011112233356667777888777
Q ss_pred HhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 201 ~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
-|-. ..++||+||..-|||+. ++.+.|+|||-|..
T Consensus 181 ~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 181 RLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHHH-hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 7764 35699999999999999 78999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.8e-07 Score=81.05 Aligned_cols=140 Identities=18% Similarity=0.083 Sum_probs=84.4
Q ss_pred eeeecCC-ceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEEe
Q 015094 85 VLGEGGF-GKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 85 ~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 162 (413)
.|-.|.. ..||+... .+..+.||+..... ...+.+|+.+++.+. +--+.+++++...++..++|||
T Consensus 5 ~~~~g~~~~~v~~~~~---------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDG---------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcC---------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence 3455555 68999732 12468888876543 235678999998885 4456678887776677899999
Q ss_pred eCCCCCHHHhh-------------------hhcCCCCCCCcHH--HHHHH-----------------------HHHHHHH
Q 015094 163 FMQKGSLENHL-------------------FGRGASVQPLAWN--IRLKI-----------------------AIGAARG 198 (413)
Q Consensus 163 ~~~~~~L~~~l-------------------~~~~~~~~~~~~~--~~~~i-----------------------~~qi~~~ 198 (413)
+++|.+|.... +.......++... ..... +.++...
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T cd05150 73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE 152 (244)
T ss_pred eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence 99998776432 0000000011100 00000 1111111
Q ss_pred HHHhh--cCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 199 LAFLH--TSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 199 l~~lH--~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
|.... .....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 11110 012458999999999999998778899998876
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.6e-07 Score=79.86 Aligned_cols=143 Identities=20% Similarity=0.152 Sum_probs=83.2
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCC--CccceEeEEEe---CCee
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHP--NLVRLLGYCWE---DKEL 157 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~---~~~~ 157 (413)
++.|+.|..+.||+.... +..+++|..... .....+.+|+.+++.|... -+.+++..... ....
T Consensus 2 i~~l~~G~~n~~~~v~~~---------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~ 70 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD---------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP 70 (239)
T ss_dssp EEEEEESSSSEEEEEEET---------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred CccCCCCCeeeEEEEEEC---------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence 357899999999998543 248899987665 3456788899999998633 35677764432 2457
Q ss_pred EEEEeeCCCCCHHH----------------hhh---hcCCCCCCCcHHH---------HHHH------------HHHHHH
Q 015094 158 LLVYEFMQKGSLEN----------------HLF---GRGASVQPLAWNI---------RLKI------------AIGAAR 197 (413)
Q Consensus 158 ~lv~e~~~~~~L~~----------------~l~---~~~~~~~~~~~~~---------~~~i------------~~qi~~ 197 (413)
+++|++++|..+.. .+. ............. .... ...+..
T Consensus 71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (239)
T PF01636_consen 71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE 150 (239)
T ss_dssp EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence 99999999988877 111 1100000111000 0000 111111
Q ss_pred -HHHHhhc-----CCCCeeeCCCCCCcEEEc-CCCCeEEccCCCcc
Q 015094 198 -GLAFLHT-----SDKQVIYRDFKASNILLD-GSYTAKISDFGLAK 236 (413)
Q Consensus 198 -~l~~lH~-----~~~~ivHrDlkp~Nil~~-~~~~~kl~DfG~a~ 236 (413)
.+..++. ....++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2233321 345699999999999999 66666899998876
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.9e-08 Score=97.09 Aligned_cols=184 Identities=20% Similarity=0.168 Sum_probs=131.3
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC-ccceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-LVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 161 (413)
..-+++|+++++++.+.. .+ +....+++... ....-++++|.+++||| .+..++-+..+...+++|
T Consensus 247 fh~fvK~altknpKkRpt-------ae-klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPT-------AE-KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred HHHHHHHHhcCCCccCCC-------hh-hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 345789999999997432 12 22335554433 33456888999999999 677777777778999999
Q ss_pred eeCCCC-CHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 162 EFMQKG-SLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 162 e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
+++.++ +....+ ......+..-+...+++.-+++|+++|+.. =+|+| ||+..+ +..+..||+.......
T Consensus 314 ~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 314 RICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCc
Confidence 999877 222222 111123444455667777888999999732 48998 777765 6899999999875433
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCC
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDT 292 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~ 292 (413)
.. ......+++.++|||+.....+....|.|++|.-..+|--|.+|-..
T Consensus 384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 22 34557899999999999999999999999999877778777766543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1e-06 Score=87.00 Aligned_cols=135 Identities=17% Similarity=0.195 Sum_probs=85.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh----H---------------------------H-----
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG----F---------------------------E----- 127 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~---------------------------~----- 127 (413)
+.||.-+.|.||+|+.+ .|+.||||+-+..-... . +
T Consensus 167 ~piaaASlaQVhrA~L~--------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred chhhhcchhheEEEEec--------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 67999999999999766 38999999865542210 0 0
Q ss_pred -HHHHHHHHHhhc----cCCC------ccceEeEEEeCCeeEEEEeeCCCCCHHHh--hhhcCCCCCCCcHHHHHHHHHH
Q 015094 128 -EWQSEVNFLGRL----SHPN------LVRLLGYCWEDKELLLVYEFMQKGSLENH--LFGRGASVQPLAWNIRLKIAIG 194 (413)
Q Consensus 128 -~~~~E~~~l~~l----~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~i~~q 194 (413)
+|.+|.+-..++ .|-+ |++++- .....-.|+||||+|..+.+. |.+.+ ++...+..-+.+
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~i~~~l~~ 311 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPHDILNKLVE 311 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-----CCHHHHHHHHHH
Confidence 133444433333 3444 444432 223567899999999877665 33333 333333333333
Q ss_pred HHHHHHHhhcCCCCeeeCCCCCCcEEEc----CCCCeEEccCCCccc
Q 015094 195 AARGLAFLHTSDKQVIYRDFKASNILLD----GSYTAKISDFGLAKL 237 (413)
Q Consensus 195 i~~~l~~lH~~~~~ivHrDlkp~Nil~~----~~~~~kl~DfG~a~~ 237 (413)
..--+-+. .|++|+|-+|.||++. .++.+.+.|||+...
T Consensus 312 ~~~~qIf~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 312 AYLEQIFK----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred HHHHHHHh----cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 22222222 4499999999999998 467899999999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-06 Score=77.68 Aligned_cols=74 Identities=18% Similarity=0.184 Sum_probs=47.9
Q ss_pred CCeeeecCCc-eEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCC---CccceEeEEEeC---C
Q 015094 83 DTVLGEGGFG-KVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHP---NLVRLLGYCWED---K 155 (413)
Q Consensus 83 ~~~lg~G~~g-~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~---~ 155 (413)
++.|+.|+.. .||+. +..+++|+..... ....+.+|+++|+.|... -+.++++..... .
T Consensus 2 ~~~~~~gG~~n~vy~~------------~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~ 67 (235)
T cd05155 2 IEPVDSGGTDNATFRL------------GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYP 67 (235)
T ss_pred ceeccCCCcccceEEc------------CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCC
Confidence 3567777766 59975 1347788765432 234788999999888632 345555543332 2
Q ss_pred eeEEEEeeCCCCCHH
Q 015094 156 ELLLVYEFMQKGSLE 170 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~ 170 (413)
..|+||++++|.++.
T Consensus 68 ~~~~l~~~i~G~~l~ 82 (235)
T cd05155 68 WPWSVYRWLEGETAT 82 (235)
T ss_pred cceEEEEeecCCCCC
Confidence 358999999997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2e-06 Score=71.67 Aligned_cols=130 Identities=18% Similarity=0.172 Sum_probs=88.9
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCc-cceEeEEEeCCeeE
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL-VRLLGYCWEDKELL 158 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~ 158 (413)
-+..+.|++|.+|.||+|.|. +..+|+|+-..++ ....+..|+++|..+.-.++ .+++.+. ..+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~---------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~ 88 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR---------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDF 88 (201)
T ss_pred hhhhhhhhcccccEEEEeecc---------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhh
Confidence 345678999999999999775 4689999887765 34678899999999986655 4555543 234
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC-CCcEEEcCCCCeEEccCCCccc
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK-ASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk-p~Nil~~~~~~~kl~DfG~a~~ 237 (413)
+.|||+.|..|.+.-.. ... +-+..+++.---|-. .||-|+.|. |..+++..++.+.|+||.-|+.
T Consensus 89 i~me~i~G~~L~~~~~~-------~~r----k~l~~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIG-------GDR----KHLLRVLEKAYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhc-------ccH----HHHHHHHHHHHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 56999999888776521 121 222333444223332 558888875 4555555555999999988874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-05 Score=70.04 Aligned_cols=128 Identities=18% Similarity=0.301 Sum_probs=89.1
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----------------hhhHHHHHHHHHHHhhcc------
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----------------LQGFEEWQSEVNFLGRLS------ 140 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------ 140 (413)
...||+|+.-.||.- . .+...+||+..... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H--P--------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~ 75 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P--------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVD 75 (199)
T ss_pred CcccccCCCceEEEC--C--------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCc
Confidence 457999999999973 1 23457789887665 122455667777766665
Q ss_pred CCCccceEeEEEeCCeeEEEEeeCCC------CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 015094 141 HPNLVRLLGYCWEDKELLLVYEFMQK------GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDF 214 (413)
Q Consensus 141 h~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDl 214 (413)
+.+|.+++|+.+.+..+.+|+|.+.. .+|.+++... .++. ...+.+.++.+ ||-. .+|+.+||
T Consensus 76 ~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f~~---~l~~--~~Iv~~dl 144 (199)
T PF10707_consen 76 WSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEFKR---YLLD--HHIVIRDL 144 (199)
T ss_pred ccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHHHH---HHHH--cCCeecCC
Confidence 78999999999999999999998653 3678887432 3444 44444444444 4443 44999999
Q ss_pred CCCcEEEcCC--C--CeEEcc
Q 015094 215 KASNILLDGS--Y--TAKISD 231 (413)
Q Consensus 215 kp~Nil~~~~--~--~~kl~D 231 (413)
+|.||++... + .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 9999999432 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.3e-05 Score=85.20 Aligned_cols=82 Identities=17% Similarity=0.265 Sum_probs=56.6
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhcc-CCCc--cceEeEEEeC---C
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HPNL--VRLLGYCWED---K 155 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~ 155 (413)
++.|+.|.+..+|+..+.. ......+++|+..... ......+.+|+++|+.|. |.+| ++++.++.+. +
T Consensus 43 v~~l~gG~sn~ty~l~~~~-----~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G 117 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGN-----GGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG 117 (822)
T ss_pred EEEeCCCCcCceEEEEECC-----CCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence 5678999999999875432 1112357777765432 123346889999999996 6665 7777777654 4
Q ss_pred eeEEEEeeCCCCCH
Q 015094 156 ELLLVYEFMQKGSL 169 (413)
Q Consensus 156 ~~~lv~e~~~~~~L 169 (413)
..|+||||++|..+
T Consensus 118 ~~flVME~v~G~~~ 131 (822)
T PLN02876 118 TAFYIMEYLEGRIF 131 (822)
T ss_pred CceEEEEecCCccc
Confidence 68999999998653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-05 Score=83.91 Aligned_cols=199 Identities=20% Similarity=0.216 Sum_probs=133.8
Q ss_pred HHHHHHHHHHhhccCCCccceEeEEEeCCe----eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHh
Q 015094 127 EEWQSEVNFLGRLSHPNLVRLLGYCWEDKE----LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202 (413)
Q Consensus 127 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 202 (413)
.....|+..+.++.|+|++.++.|..+... ..+..++|...++...+...+ .++....+.+..+++.||.|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHH
Confidence 334557777888899999999998765533 335567888888888885544 678888999999999999999
Q ss_pred hcCCCCeeeCCCCCC---cEEEcCCCCeEEc--cCCCcccCCCCCCcceeecccccccccCccccccCCccch--hhhHH
Q 015094 203 HTSDKQVIYRDFKAS---NILLDGSYTAKIS--DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVK--SDVYG 275 (413)
Q Consensus 203 H~~~~~ivHrDlkp~---Nil~~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Diws 275 (413)
|++. +.|.-|... +.-.+..+.+.+. ||+.......... ......+..+.++|......+..+ .|+|.
T Consensus 303 h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HHhc--cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHH
Confidence 9742 444433333 2333455566666 8888775433322 222334556778887766655544 69999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHH
Q 015094 276 FGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355 (413)
Q Consensus 276 lG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e 355 (413)
+|.....+..|..+-.... ....++ +........+++.+|+..+.++|+++.+
T Consensus 378 lgll~~~~~~~~~i~~~~~-------------------~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA-------------------VPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHhhhhhcCccccccc-------------------chhhhh--------ccccchhhhhhhhhhcchhhhhccchhh
Confidence 9999999998854322110 000111 1111125778899999999999999999
Q ss_pred HHHHHH
Q 015094 356 VVETLE 361 (413)
Q Consensus 356 ~l~~L~ 361 (413)
++.+.-
T Consensus 431 ll~~~f 436 (1351)
T KOG1035|consen 431 LLTHPF 436 (1351)
T ss_pred hhhchh
Confidence 987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=1e-05 Score=69.89 Aligned_cols=103 Identities=22% Similarity=0.224 Sum_probs=78.4
Q ss_pred HHHHHHHhhccC-CCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC-C
Q 015094 130 QSEVNFLGRLSH-PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD-K 207 (413)
Q Consensus 130 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~ 207 (413)
..|.-+|+.+++ +++++++|++ .-++|.||+..+++...... -......++..+.+|+.++++.+.+++... .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999985 6999999987 23678999987655421000 000115689999999999999999998521 2
Q ss_pred CeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 208 QVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 208 ~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
.+.-.|++++|+-++++|.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 377889999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.3e-05 Score=73.24 Aligned_cols=143 Identities=19% Similarity=0.116 Sum_probs=83.2
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC--ccceEe------EEEeC
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN--LVRLLG------YCWED 154 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~------~~~~~ 154 (413)
.+.|..|....+|+.... +..+++|+.... ....+..|+.+++.|.+.+ +.+++. +...+
T Consensus 19 i~~i~~G~~n~~y~v~~~---------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 19 FEGISAGIENTNYFVTTD---------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred eecccCccccceEEEEeC---------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 456777877889987422 246888987652 3356777888888886433 444443 12334
Q ss_pred CeeEEEEeeCCCCCHHH----hh----------hhc--CCCC-----CCCcHHHH----------HHHHHHHHHHHHHhh
Q 015094 155 KELLLVYEFMQKGSLEN----HL----------FGR--GASV-----QPLAWNIR----------LKIAIGAARGLAFLH 203 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~----~l----------~~~--~~~~-----~~~~~~~~----------~~i~~qi~~~l~~lH 203 (413)
+..++|++|++|..+.. .+ +.. .... ....+... ......+..++.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 56789999999876532 01 000 0000 00010000 001111222333333
Q ss_pred c-----CCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 204 T-----SDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 204 ~-----~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
. ...+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1 235699999999999999887778999988763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.2e-05 Score=65.41 Aligned_cols=125 Identities=27% Similarity=0.380 Sum_probs=86.9
Q ss_pred cCCCCCCeeeecCC-ceEEEEEecCCCCCCCCCCeEEEEEecCC---cCh------------------hhHHHHHHHHHH
Q 015094 78 RNFKSDTVLGEGGF-GKVFKGWLDEKAPGKSGSGTVIAVKKLNS---ESL------------------QGFEEWQSEVNF 135 (413)
Q Consensus 78 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~E~~~ 135 (413)
..++.++.||.|.- |.||++... ++.||||++.. ... .....|..|.+.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~---------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRA 107 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID---------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRA 107 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC---------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHh
Confidence 67889999999999 999999764 67999999321 110 112346778877
Q ss_pred Hhhcc---CCCc--cceEeEEEeC------------------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHH
Q 015094 136 LGRLS---HPNL--VRLLGYCWED------------------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192 (413)
Q Consensus 136 l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 192 (413)
..+|+ +.++ +++++|..-. ....||.||+.... .+.. .-+
T Consensus 108 fgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~ 170 (207)
T PF13095_consen 108 FGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDI 170 (207)
T ss_pred hHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHH
Confidence 77665 5566 8888886422 12467778775422 1222 334
Q ss_pred HHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 193 ~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|.+-|..+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 171 ~~~~~dl~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence 567777889997 55999999999986 4578999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.4e-05 Score=69.73 Aligned_cols=77 Identities=14% Similarity=0.014 Sum_probs=54.9
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC---CCccceEeEEEeC---C
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH---PNLVRLLGYCWED---K 155 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~~---~ 155 (413)
-.+.||.|..+.||..... +..+++|..+... ....+..|...|+.|.- -.++++++++..+ +
T Consensus 18 ~~~~i~~G~~~~vy~~~~~---------~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 18 RVECISEQPYAALWALYDS---------QGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred eeeecCCccceeEEEEEcC---------CCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 3567999999999997322 1246677754321 22467889999999863 3688888877543 6
Q ss_pred eeEEEEeeCCCCCH
Q 015094 156 ELLLVYEFMQKGSL 169 (413)
Q Consensus 156 ~~~lv~e~~~~~~L 169 (413)
..+||||+++|.++
T Consensus 87 ~~~LVmE~i~G~~~ 100 (297)
T PRK10593 87 PDVLLLERLRGVSV 100 (297)
T ss_pred CeEEEEeccCCEec
Confidence 68999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.9e-05 Score=67.41 Aligned_cols=75 Identities=19% Similarity=0.172 Sum_probs=47.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC-CCccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH-PNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 162 (413)
+.|..|-...||++.... ..++.|++|+....... .....+|+.+++.+.. .-.++++..+. + .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~------~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKE------DNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCC------CCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 567778888999974221 02467889977654222 2234579999999863 33455554332 2 48999
Q ss_pred eCCCCCH
Q 015094 163 FMQKGSL 169 (413)
Q Consensus 163 ~~~~~~L 169 (413)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9999776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.3e-05 Score=69.22 Aligned_cols=138 Identities=15% Similarity=0.072 Sum_probs=77.9
Q ss_pred eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCc-cceEeEEEeCCeeEEEEeeC
Q 015094 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL-VRLLGYCWEDKELLLVYEFM 164 (413)
Q Consensus 86 lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 164 (413)
+..|-...+|+... .++.+++|..........-...+|..+++.+....+ .+++... . -++||||+
T Consensus 4 ~~~G~tn~~y~~~~---------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i 70 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWL 70 (256)
T ss_pred CCCcCcCCeEEEEe---------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEec
Confidence 45677788998741 346788887654432211235779999999974333 4555433 2 36899999
Q ss_pred CCCCHHHh--------------h---hhcCCCCCCCcHH-HHHHHHHHH---------HHHHHHhhc------CCCCeee
Q 015094 165 QKGSLENH--------------L---FGRGASVQPLAWN-IRLKIAIGA---------ARGLAFLHT------SDKQVIY 211 (413)
Q Consensus 165 ~~~~L~~~--------------l---~~~~~~~~~~~~~-~~~~i~~qi---------~~~l~~lH~------~~~~ivH 211 (413)
+|..+... + +.......++... .+..+..++ ...+..+-. ....++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 98765421 1 1111111122211 111111111 111111111 1235899
Q ss_pred CCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 212 RDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 212 rDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
+|+.|.||++++++ +.|+||..+..
T Consensus 151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 151 MDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCCcCcEEEeCCC-CEEEeccccCc
Confidence 99999999999876 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00012 Score=68.87 Aligned_cols=156 Identities=18% Similarity=0.142 Sum_probs=86.9
Q ss_pred HHHHHHhcCCCC-----CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC--
Q 015094 71 VELRAATRNFKS-----DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-- 143 (413)
Q Consensus 71 ~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-- 143 (413)
.++.....+|.+ .+.++.|....||++... +..+++|+..... ..+.+..|++++..|...+
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~---------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~p 78 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD---------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLP 78 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeC---------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCC
Confidence 344444445544 456777777889987421 2357788875532 1234566778887775322
Q ss_pred ccceEeE------EEeCCeeEEEEeeCCCCCHHH-----------hh---hh--cCC-CC--C--CC-cHHHHH------
Q 015094 144 LVRLLGY------CWEDKELLLVYEFMQKGSLEN-----------HL---FG--RGA-SV--Q--PL-AWNIRL------ 189 (413)
Q Consensus 144 i~~~~~~------~~~~~~~~lv~e~~~~~~L~~-----------~l---~~--~~~-~~--~--~~-~~~~~~------ 189 (413)
+++++.. ....+..++||||++|..+.. .+ +. .+. .. . .. .+....
T Consensus 79 vp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (307)
T TIGR00938 79 VPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEA 158 (307)
T ss_pred CCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhc
Confidence 3444431 122456789999999865421 11 11 000 00 0 00 000000
Q ss_pred ------HHHHHHHHHHHHhhc-----CCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 190 ------KIAIGAARGLAFLHT-----SDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 190 ------~i~~qi~~~l~~lH~-----~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
.....+...++++.. ...+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 159 ~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 159 APQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred ccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 011122334444431 246799999999999999887778999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00017 Score=68.15 Aligned_cols=155 Identities=18% Similarity=0.115 Sum_probs=83.1
Q ss_pred HHHHHHhcCCCC-----CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC--
Q 015094 71 VELRAATRNFKS-----DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-- 143 (413)
Q Consensus 71 ~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-- 143 (413)
.++......|.+ .+.|+.|....+|+.... +..+++|++... ..+.+..|+.+++.|...+
T Consensus 10 ~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~---------~g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glp 77 (319)
T PRK05231 10 DELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT---------QGEYVLTLFERL---TAEDLPFFLGLMQHLAARGVP 77 (319)
T ss_pred HHHHHHHHhcCCchhhccchhccccccceEEEEeC---------CCcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCC
Confidence 444444455655 345667777789987422 235888987622 2234455666776664222
Q ss_pred ccceEe------EEEeCCeeEEEEeeCCCCCHH-----------Hhhh---hcCC-C------CCCCcH-HHH-------
Q 015094 144 LVRLLG------YCWEDKELLLVYEFMQKGSLE-----------NHLF---GRGA-S------VQPLAW-NIR------- 188 (413)
Q Consensus 144 i~~~~~------~~~~~~~~~lv~e~~~~~~L~-----------~~l~---~~~~-~------~~~~~~-~~~------- 188 (413)
+.+++. +....+..++++||++|..+. +.+. .... . ...+.+ ...
T Consensus 78 vP~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~ 157 (319)
T PRK05231 78 VPAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPF 157 (319)
T ss_pred CCcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhc
Confidence 334432 123356689999999987542 1111 0000 0 000100 000
Q ss_pred -----HHHHHH-HHHHHHHhhc-----CCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 189 -----LKIAIG-AARGLAFLHT-----SDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 189 -----~~i~~q-i~~~l~~lH~-----~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
...+.+ +...+..+.. ...+++|+|++|.||+++++...-|+||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 158 LADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 001111 1111222221 235799999999999999776668999998863
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.0002 Score=68.94 Aligned_cols=77 Identities=18% Similarity=0.207 Sum_probs=53.4
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc------C-hhhHHHHHHHHHHHhhcc---CCCccceEeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE------S-LQGFEEWQSEVNFLGRLS---HPNLVRLLGYCW 152 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~ 152 (413)
.+.||.|.+..||++.... .++.|+||.-... . ....++...|.+.|+.+. -.++++++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~-------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-- 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE-------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-- 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCC-------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--
Confidence 3578999999999986431 1257999974311 1 124566778888888874 2467788775
Q ss_pred eCCeeEEEEeeCCCCC
Q 015094 153 EDKELLLVYEFMQKGS 168 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~ 168 (413)
+.+..++||||+++..
T Consensus 102 D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 DEELAVTVMEDLSDHK 117 (401)
T ss_pred CCCCCEEEEecCCCcc
Confidence 4466889999998644
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00022 Score=66.75 Aligned_cols=81 Identities=19% Similarity=0.186 Sum_probs=50.1
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC-ccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-LVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 162 (413)
+.|..|-...||+....... .....++.|++|+...... ......+|+.+++.+...+ ..+++.++. + .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~-~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED-ALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcc-cccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence 34566666789988533210 1223457899998765432 2345678999999886333 445665543 2 36899
Q ss_pred eCCCCCHH
Q 015094 163 FMQKGSLE 170 (413)
Q Consensus 163 ~~~~~~L~ 170 (413)
|++|..+.
T Consensus 78 ~i~G~~l~ 85 (302)
T cd05156 78 FIPSRTLT 85 (302)
T ss_pred eeCCCcCC
Confidence 99987764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=3.5e-06 Score=90.19 Aligned_cols=159 Identities=12% Similarity=-0.035 Sum_probs=117.4
Q ss_pred HHHHHHHhhccCCCccceEeEEEe--CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC--
Q 015094 130 QSEVNFLGRLSHPNLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS-- 205 (413)
Q Consensus 130 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-- 205 (413)
..|...++...|+++.....-... ....|..++|+.+|.+.+.|.+.-....++....+.....+.+.+..-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 345555666789988776654432 3467899999999999999976555555555555554444446666666652
Q ss_pred -CCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHH
Q 015094 206 -DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEIL 284 (413)
Q Consensus 206 -~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 284 (413)
+.--+|++||+-|.+|..+-.+|+.++|+.+.. ...........+++.|+.+++...-.++.++|+|..|+.+|.+.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 233689999999999999999999999999831 11122233456888999999988888998899999999999999
Q ss_pred hCCCCC
Q 015094 285 TGLRAL 290 (413)
Q Consensus 285 tG~~pf 290 (413)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887655
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00041 Score=66.18 Aligned_cols=145 Identities=19% Similarity=0.207 Sum_probs=82.5
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCc-cceEeEEEeCCeeEEEEee
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL-VRLLGYCWEDKELLLVYEF 163 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~ 163 (413)
.|..|-.-.+|++.+.. .....++.|++|+.......... -.+|+.+++.+..-++ .++++.+..+ .|.||
T Consensus 43 ~l~gGlTN~~y~v~~~~---~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef 114 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPT---KEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF 114 (344)
T ss_pred EcCCcccceeEEEEeCC---CCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence 45456777899985432 11123468899988665432322 3679999999874443 4666655332 58999
Q ss_pred CCCCCHHHh-----------------hhhcCCC--CCCCcHHHHHHHHHHH-----------------HHHHHH----hh
Q 015094 164 MQKGSLENH-----------------LFGRGAS--VQPLAWNIRLKIAIGA-----------------ARGLAF----LH 203 (413)
Q Consensus 164 ~~~~~L~~~-----------------l~~~~~~--~~~~~~~~~~~i~~qi-----------------~~~l~~----lH 203 (413)
+++.+|... ++..... ........+..++.++ ...+.. +.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 988776421 0111100 0011122222332211 111111 11
Q ss_pred --cCCCCeeeCCCCCCcEEEcC-CCCeEEccCCCccc
Q 015094 204 --TSDKQVIYRDFKASNILLDG-SYTAKISDFGLAKL 237 (413)
Q Consensus 204 --~~~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~a~~ 237 (413)
.....++|+|+++.|||+++ ++.++|+||..+..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11235899999999999976 47899999988763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=5.6e-05 Score=69.16 Aligned_cols=145 Identities=13% Similarity=0.110 Sum_probs=94.9
Q ss_pred ccHHHHHHHhcC---CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--------------------hh
Q 015094 68 FTFVELRAATRN---FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--------------------LQ 124 (413)
Q Consensus 68 ~~~~~~~~~~~~---y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------------------~~ 124 (413)
+++..+....++ +.++..||-|--+-||.+.+. .|...++|+-.... +.
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~--------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWl 150 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE--------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWL 150 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecC--------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchh
Confidence 444444444333 567889999999999998544 36778888532110 11
Q ss_pred hH--HHHHHHHHHHhhcc-CC-CccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHH
Q 015094 125 GF--EEWQSEVNFLGRLS-HP-NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200 (413)
Q Consensus 125 ~~--~~~~~E~~~l~~l~-h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~ 200 (413)
.+ -...+|+..|+.|. |- -+++.+++ ...|+|||++.|..|...-. ...... +...+..-+.
T Consensus 151 yLSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv 216 (465)
T KOG2268|consen 151 YLSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIV 216 (465)
T ss_pred hhHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHH
Confidence 11 12457999999986 32 35556553 56799999999988865531 112222 2333333344
Q ss_pred HhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 201 ~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
-|.. .|+||+|..-=||++.+++.++++||--..
T Consensus 217 ~la~--~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 217 RLAN--HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred HHHH--cCceecccchheeEEecCCCEEEeechHhh
Confidence 4443 669999999999999999999999996543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0016 Score=60.59 Aligned_cols=121 Identities=21% Similarity=0.317 Sum_probs=73.8
Q ss_pred CeEEEEEecC-CcChhhHHHHHHHHHHHhhccCCC--ccceEeEEEeCC--eeEEEEeeCCCCCHHHhhhhcCCCCCCCc
Q 015094 110 GTVIAVKKLN-SESLQGFEEWQSEVNFLGRLSHPN--LVRLLGYCWEDK--ELLLVYEFMQKGSLENHLFGRGASVQPLA 184 (413)
Q Consensus 110 ~~~vaiK~~~-~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 184 (413)
++.+++..-. ...........+|+.+++.+.--- +...++++.++. ..|.||+|++|..+...+... ...
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~-----~~~ 122 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE-----SLG 122 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-----cch
Confidence 5677777221 122344566788999988875323 334444455444 669999999985443322100 000
Q ss_pred HHHHHHHH-HHHHHHHHHhh--------------------------------------------------c------CCC
Q 015094 185 WNIRLKIA-IGAARGLAFLH--------------------------------------------------T------SDK 207 (413)
Q Consensus 185 ~~~~~~i~-~qi~~~l~~lH--------------------------------------------------~------~~~ 207 (413)
.+++ ..+++.|.-|| . ...
T Consensus 123 ----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 123 ----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 1111 13444444444 1 112
Q ss_pred CeeeCCCCCCcEEEcCCCCeEEccCCCcccCC
Q 015094 208 QVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239 (413)
Q Consensus 208 ~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~ 239 (413)
.++|+|+.+.||+++.++.+=|.||+++..+.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 47999999999999999889999999998643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0014 Score=60.52 Aligned_cols=31 Identities=23% Similarity=0.373 Sum_probs=25.8
Q ss_pred CCeeeCCCCCCcEEEcCCCC-eEEccCCCccc
Q 015094 207 KQVIYRDFKASNILLDGSYT-AKISDFGLAKL 237 (413)
Q Consensus 207 ~~ivHrDlkp~Nil~~~~~~-~kl~DfG~a~~ 237 (413)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987555 46999999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0017 Score=60.82 Aligned_cols=139 Identities=17% Similarity=0.148 Sum_probs=91.1
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-------------------------hhHH-HHHHHHHHH
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-------------------------QGFE-EWQSEVNFL 136 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------------------~~~~-~~~~E~~~l 136 (413)
.-.|..|--+.||.|.-. .|..+|||+++.... ...+ -...|++-|
T Consensus 149 nGCiSTGKEANVYHat~~--------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL 220 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE--------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL 220 (520)
T ss_pred ccccccCccceeEeeecC--------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence 346788999999998432 467799998754311 0111 245789999
Q ss_pred hhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 015094 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKA 216 (413)
Q Consensus 137 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp 216 (413)
++|....|.-..-+.. ....|||+|+.+.....= ....-.++...+..+-.+++.-+.-|-. ..++||.||.-
T Consensus 221 kRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aP----kLKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSE 293 (520)
T KOG2270|consen 221 KRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAP----KLKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSE 293 (520)
T ss_pred HHHHhcCCCCCCceee--ecceEeeeeccCCCCcCc----ccccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhh
Confidence 9998666654433332 245799999953222111 1112246666677777777777766643 35699999999
Q ss_pred CcEEEcCCCCeEEccCCCccc
Q 015094 217 SNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 217 ~Nil~~~~~~~kl~DfG~a~~ 237 (413)
-|+|+-+ |.+.|+|.+-+..
T Consensus 294 fN~Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 294 FNLLYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred hhheEEC-CEEEEEEcccccc
Confidence 9999964 5899999887753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.005 Score=58.30 Aligned_cols=73 Identities=21% Similarity=0.253 Sum_probs=47.6
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCC------cC-hhhHHHHHHHHHHHhhcc--CC-CccceEeEEEeC
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS------ES-LQGFEEWQSEVNFLGRLS--HP-NLVRLLGYCWED 154 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~------~~-~~~~~~~~~E~~~l~~l~--h~-~i~~~~~~~~~~ 154 (413)
.||.|....||++... ..++.|+||.-.. +. .-..++...|...|+... .| .+++++. .+.
T Consensus 2 EigdGnlN~VfrV~~~-------~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~ 72 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ-------EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDT 72 (370)
T ss_pred cCCCCceEEEEEEEcC-------CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ecc
Confidence 5799999999999632 1235789996321 11 223456667888887764 34 5666654 355
Q ss_pred CeeEEEEeeCCC
Q 015094 155 KELLLVYEFMQK 166 (413)
Q Consensus 155 ~~~~lv~e~~~~ 166 (413)
....+|||+++.
T Consensus 73 e~~~~vMEdL~~ 84 (370)
T TIGR01767 73 EMAVTVMEDLSH 84 (370)
T ss_pred ccceehHhhCcc
Confidence 667799999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0031 Score=59.86 Aligned_cols=77 Identities=17% Similarity=0.274 Sum_probs=47.2
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCc-cceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL-VRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 162 (413)
+.|..|=.-.+|+...... ...+..|++|+....... .-.-.+|..+++.+..-++ +++++++. ++ +|.+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~----~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEE----NGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEeCCcccceEEEEEecCC----CCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 3444466667898754321 112347889987654332 2233679999999975544 46666553 22 5899
Q ss_pred eCCCCCH
Q 015094 163 FMQKGSL 169 (413)
Q Consensus 163 ~~~~~~L 169 (413)
|++|..|
T Consensus 91 fi~g~~l 97 (330)
T PLN02421 91 FINARTL 97 (330)
T ss_pred hhcCCCC
Confidence 9988765
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0065 Score=57.11 Aligned_cols=32 Identities=16% Similarity=0.217 Sum_probs=28.6
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 206 ~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
..+++|+|+.++|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 35799999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0013 Score=58.15 Aligned_cols=122 Identities=21% Similarity=0.214 Sum_probs=59.6
Q ss_pred CeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC-ccceEeEEEeCCeeEEEEeeCCCCCHHHh-------h--------
Q 015094 110 GTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-LVRLLGYCWEDKELLLVYEFMQKGSLENH-------L-------- 173 (413)
Q Consensus 110 ~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-------l-------- 173 (413)
++.|+|++..... ...-.-..|..+++.+..-+ -.++++.+.. .+|.+|+.|..|..- +
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 3568888887663 23445678999999987444 4566665432 257799977665320 0
Q ss_pred --hh--c-CCCCCCCcHHHHHHH----------------------HHHHHHHH----HHhhc--CCCCeeeCCCCCCcEE
Q 015094 174 --FG--R-GASVQPLAWNIRLKI----------------------AIGAARGL----AFLHT--SDKQVIYRDFKASNIL 220 (413)
Q Consensus 174 --~~--~-~~~~~~~~~~~~~~i----------------------~~qi~~~l----~~lH~--~~~~ivHrDlkp~Nil 220 (413)
+. . ........+..+..+ +..+..-+ ..+-. ...-++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0 001111111111111 01111111 22211 1234789999999999
Q ss_pred E-cCCCCeEEccCCCcc
Q 015094 221 L-DGSYTAKISDFGLAK 236 (413)
Q Consensus 221 ~-~~~~~~kl~DfG~a~ 236 (413)
+ +.++.++|+||..|.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999998876
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0027 Score=61.88 Aligned_cols=48 Identities=25% Similarity=0.372 Sum_probs=37.7
Q ss_pred HHHHHHHHHhhccCCCccceEeEEEeC-CeeEEEEeeCCCCCHHHhhhhc
Q 015094 128 EWQSEVNFLGRLSHPNLVRLLGYCWED-KELLLVYEFMQKGSLENHLFGR 176 (413)
Q Consensus 128 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~ 176 (413)
++.-...+++.+.|+|....+++.... ....+|||++ +.+|++++..+
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 455667789999999999999876543 4588999999 66999988543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0083 Score=56.37 Aligned_cols=30 Identities=23% Similarity=0.333 Sum_probs=26.2
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 206 ~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367999999999999987 678999998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0024 Score=55.59 Aligned_cols=88 Identities=15% Similarity=0.123 Sum_probs=62.1
Q ss_pred HHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC
Q 015094 127 EEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD 206 (413)
Q Consensus 127 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 206 (413)
.-+..+..++.++. .|+++..- ..-.+.+|+|+|.... .... .++..=+.+|.-.|+..
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~~----N~i~agi~~L~~fH~~~ 161 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------INFS----NFITAGIKDLMDFHSEN 161 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cchh----HHHHHhHHHHHHhhccC
Confidence 34677888888774 57777631 3345779999984311 1111 12222246788889878
Q ss_pred CCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 207 KQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 207 ~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+.+|+|-.|+|||-+..|.+||.|=+..
T Consensus 162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 162 QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CCeecCCCChhheeecCCCCEEecChhhh
Confidence 89999999999999999999999996543
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.017 Score=55.69 Aligned_cols=73 Identities=11% Similarity=0.055 Sum_probs=49.1
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-------hhHHHHHHHHHHHhhcc---CCCccceEeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-------QGFEEWQSEVNFLGRLS---HPNLVRLLGYCW 152 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~ 152 (413)
.+.||.|....||+.... +..|+||.-..... -...+...|+..|+.+. -.++++++.+..
T Consensus 37 ~~eiggGn~N~VyrV~~~---------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de 107 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS---------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR 107 (418)
T ss_pred EEEcCCCceeeEEEEEcC---------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC
Confidence 467899999999997431 24588987541111 13445566777777664 247888887665
Q ss_pred eCCeeEEEEeeCCC
Q 015094 153 EDKELLLVYEFMQK 166 (413)
Q Consensus 153 ~~~~~~lv~e~~~~ 166 (413)
+..+++||++++
T Consensus 108 --d~~vlvME~L~~ 119 (418)
T PLN02756 108 --TMALIGMRYLEP 119 (418)
T ss_pred --CCCEEEEeecCC
Confidence 556889999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.008 Score=57.65 Aligned_cols=75 Identities=16% Similarity=0.243 Sum_probs=50.5
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCC-----cC-hhhHHHHHHHHHHHhhcc--CC-CccceEeEEEe
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS-----ES-LQGFEEWQSEVNFLGRLS--HP-NLVRLLGYCWE 153 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~-----~~-~~~~~~~~~E~~~l~~l~--h~-~i~~~~~~~~~ 153 (413)
.+.||.|.-.-||++.... .++.|+||.-.. +. .-..++..-|.++|+.+. .| ++++++. .+
T Consensus 34 ~~eigdGnlN~VfrV~~~~-------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D 104 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FD 104 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--EC
Confidence 4578999999999996421 235688885321 11 234567777888888775 44 5666754 45
Q ss_pred CCeeEEEEeeCCC
Q 015094 154 DKELLLVYEFMQK 166 (413)
Q Consensus 154 ~~~~~lv~e~~~~ 166 (413)
.....+|||+++.
T Consensus 105 ~e~~~~vMEdL~~ 117 (409)
T PRK12396 105 SVMNCCVMEDLSD 117 (409)
T ss_pred cHHhhHHHHhCcc
Confidence 6677899999854
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0037 Score=59.33 Aligned_cols=60 Identities=17% Similarity=0.150 Sum_probs=38.6
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
..++=+|..|.++..++... ..++.....++.--++||.-+--. .+++|.|++|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-----~~pe~l~kkva~lg~~AllkMl~v-DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-----SQPEALVKKVAKLGVNALLKMLIV-DNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc-----cChHHHHHHHHHHHHHHHHHHHHh-hcceecccCCCcEEEE
Confidence 45666788898998888433 234444444544444444333221 3499999999999994
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.012 Score=54.38 Aligned_cols=73 Identities=18% Similarity=0.268 Sum_probs=46.3
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc---CCCccceEeEEEeCCeeEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS---HPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~l 159 (413)
.+.|+-|....+|+.. ..++.+.||+-... ....+..|..-|+.|. --.+++++.+....+..||
T Consensus 22 ~~~v~GG~i~~a~~~~---------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL 89 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD---------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL 89 (288)
T ss_dssp EEEE--SSSSEEEEEE---------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred eEecCCCChhheEEEE---------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence 4568888899999874 24678999987633 2235677888888884 4468899999888878899
Q ss_pred EEeeCCCC
Q 015094 160 VYEFMQKG 167 (413)
Q Consensus 160 v~e~~~~~ 167 (413)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0036 Score=58.52 Aligned_cols=73 Identities=19% Similarity=0.150 Sum_probs=56.5
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
..+.|++|++- |++|.-.- .....++..++.+.+..++-+.. +-..-|||+...||||+ +|+|.|+||-
T Consensus 298 ~~y~yl~~kdh-gt~is~ik--------~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPISIIK--------ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceeeeee--------cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEee
Confidence 34677888875 55554321 34567778899888887777765 55688999999999999 9999999999
Q ss_pred Cccc
Q 015094 234 LAKL 237 (413)
Q Consensus 234 ~a~~ 237 (413)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.031 Score=52.69 Aligned_cols=140 Identities=20% Similarity=0.208 Sum_probs=78.9
Q ss_pred eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC------ccceEeE--EEeCC-
Q 015094 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN------LVRLLGY--CWEDK- 155 (413)
Q Consensus 85 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~--~~~~~- 155 (413)
.|.+ .-..||+.... +..+++|+.... .....+..|+..|..|.-.. |..+-+- ..-..
T Consensus 33 ~l~s-~eN~~f~~~~~---------~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~ 100 (331)
T COG2334 33 GLNS-EENSNFRVQTE---------DGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG 100 (331)
T ss_pred cccc-ccCceEEEEec---------CCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence 3444 44568887433 233489988876 23456777888888885222 2222221 11223
Q ss_pred -eeEEEEeeCCCCCHHH-hh--------------hh--cC------CCCCCCcHHH-------------HHHHHHHHHHH
Q 015094 156 -ELLLVYEFMQKGSLEN-HL--------------FG--RG------ASVQPLAWNI-------------RLKIAIGAARG 198 (413)
Q Consensus 156 -~~~lv~e~~~~~~L~~-~l--------------~~--~~------~~~~~~~~~~-------------~~~i~~qi~~~ 198 (413)
..+-|++|++|..+.. .. +. ++ .......+.. -.....++...
T Consensus 101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~ 180 (331)
T COG2334 101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA 180 (331)
T ss_pred ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence 7889999999988872 11 00 00 0000111110 01122333334
Q ss_pred HHHhhc------CCCC--eeeCCCCCCcEEEcCCCC-eEEccCCCcc
Q 015094 199 LAFLHT------SDKQ--VIYRDFKASNILLDGSYT-AKISDFGLAK 236 (413)
Q Consensus 199 l~~lH~------~~~~--ivHrDlkp~Nil~~~~~~-~kl~DfG~a~ 236 (413)
+..+.+ ...+ +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 444432 1122 999999999999998874 8899999876
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.033 Score=53.76 Aligned_cols=81 Identities=11% Similarity=0.083 Sum_probs=46.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCC-CccceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHP-NLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 162 (413)
+.|..|-...+|++...... ......+.|.++....... ..-.-.+|+.+++.|... .-.++++.+. -++|.|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~-~~~~~~k~Vl~R~~g~~~~-l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGD-KDRYPIKSVCIKKSSTYNS-LVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCC-CCccccceEEEEeccCCCc-eEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 45555777889998643210 0111123355555432221 122236799999999754 4456666653 269999
Q ss_pred eCCCCCHH
Q 015094 163 FMQKGSLE 170 (413)
Q Consensus 163 ~~~~~~L~ 170 (413)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99997764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.061 Score=50.06 Aligned_cols=79 Identities=11% Similarity=0.109 Sum_probs=46.9
Q ss_pred eecCCceEEEEEecCC-CCCCCCCCeEEEEEecCCcCh-----hhHHHHHHHHHHHhhcc---------C----CCccce
Q 015094 87 GEGGFGKVFKGWLDEK-APGKSGSGTVIAVKKLNSESL-----QGFEEWQSEVNFLGRLS---------H----PNLVRL 147 (413)
Q Consensus 87 g~G~~g~Vy~~~~~~~-~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~---------h----~~i~~~ 147 (413)
|.|-.|.+|++...-. ..........++||....... .....+.+|+.+.+.+- . ..+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 6778889998865431 112233456788998762211 12345778888776551 1 234566
Q ss_pred EeEEEeCCeeEEEEeeCC
Q 015094 148 LGYCWEDKELLLVYEFMQ 165 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~ 165 (413)
+....+....+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 655544456789998653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.067 Score=58.48 Aligned_cols=34 Identities=35% Similarity=0.357 Sum_probs=27.8
Q ss_pred cCCCCeeeCCCCCCcEEEcCCC--CeE-EccCCCccc
Q 015094 204 TSDKQVIYRDFKASNILLDGSY--TAK-ISDFGLAKL 237 (413)
Q Consensus 204 ~~~~~ivHrDlkp~Nil~~~~~--~~k-l~DfG~a~~ 237 (413)
....++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 200 ~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 200 ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3346799999999999998775 555 999999864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.15 Score=48.25 Aligned_cols=71 Identities=14% Similarity=0.039 Sum_probs=42.9
Q ss_pred CCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC--ccceE---e--EEEeCCeeEEEEe
Q 015094 90 GFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN--LVRLL---G--YCWEDKELLLVYE 162 (413)
Q Consensus 90 ~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~---~--~~~~~~~~~lv~e 162 (413)
.-..||+.... .+..+++|+..... .....+..|+..+..|.... ++... + +...++..+.|++
T Consensus 37 ~eN~vy~v~~~--------~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~ 107 (325)
T PRK11768 37 YENRVYQFGDE--------DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFP 107 (325)
T ss_pred ccceEEEEecC--------CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEe
Confidence 34568887432 34679999876432 23456777888888775222 22211 1 2233567889999
Q ss_pred eCCCCCH
Q 015094 163 FMQKGSL 169 (413)
Q Consensus 163 ~~~~~~L 169 (413)
++.|..+
T Consensus 108 ~~~G~~~ 114 (325)
T PRK11768 108 RRGGRAP 114 (325)
T ss_pred eeCCCCC
Confidence 9988643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 413 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-62 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-53 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-24 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-24 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-24 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-24 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-24 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-24 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-24 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-24 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-23 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-23 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-22 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-20 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-17 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-16 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 510 bits (1316), Expect = 0.0
Identities = 112/317 (35%), Positives = 178/317 (56%), Gaps = 26/317 (8%)
Query: 60 LPTPNLRIFTFVELRAATRNFKSDT------VLGEGGFGKVFKGWLDEKAPGKSGSGTVI 113
+ F+F EL+ T NF +GEGGFG V+KG+++ T +
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---------NTTV 57
Query: 114 AVKKLNS----ESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSL 169
AVKKL + + + +++ E+ + + H NLV LLG+ + +L LVY +M GSL
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 170 ENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229
+ L + PL+W++R KIA GAA G+ FLH + I+RD K++NILLD ++TAKI
Sbjct: 118 LDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKI 174
Query: 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRA 289
SDFGLA+ +Q+ +T+R++GT Y APE + G + KSD+Y FGVVL+EI+TGL A
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 290 LDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKH 349
+D +R L+D + E++ ID ++ + + ++ +CL +
Sbjct: 234 VDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 350 RPSMREVVETLERLQAS 366
RP +++V + L+ + AS
Sbjct: 291 RPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 500 bits (1290), Expect = e-179
Identities = 119/321 (37%), Positives = 178/321 (55%), Gaps = 11/321 (3%)
Query: 41 GNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLD 100
G+ A++ + L V+L AT NF ++G G FGKV+KG L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 101 EKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLV 160
+ G +A+K+ ES QG EE+++E+ L HP+LV L+G+C E E++L+
Sbjct: 62 D--------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113
Query: 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNIL 220
Y++M+ G+L+ HL+G ++W RL+I IGAARGL +LHT + +I+RD K+ NIL
Sbjct: 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINIL 171
Query: 221 LDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVL 280
LD ++ KI+DFG++K G Q+H++T V GT GY PEY G L KSDVY FGVVL
Sbjct: 172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231
Query: 281 VEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSL 340
E+L A+ + P NL +W + I+D L + ++ + ++
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAV 290
Query: 341 KCLEAEPKHRPSMREVVETLE 361
KCL + RPSM +V+ LE
Sbjct: 291 KCLALSSEDRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-152
Identities = 134/302 (44%), Positives = 188/302 (62%), Gaps = 14/302 (4%)
Query: 64 NLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL 123
L+ F+ EL+ A+ NF + +LG GGFGKV+KG L GT++AVK+L E
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--------DGTLVAVKRLKEERT 67
Query: 124 QGFE-EWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQP 182
QG E ++Q+EV + H NL+RL G+C E LLVY +M GS+ + L R S P
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 183 LAWNIRLKIAIGAARGLAFLH-TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241
L W R +IA+G+ARGLA+LH D ++I+RD KA+NILLD + A + DFGLAKL
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY- 186
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH-- 299
+HVTT V GT G+ APEY++TG K+DV+G+GV+L+E++TG RA D R +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359
L+DW+K L +++K ++D LQG Y + Q+ Q++L C ++ P RP M EVV
Sbjct: 247 MLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 360 LE 361
LE
Sbjct: 306 LE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-86
Identities = 77/325 (23%), Positives = 129/325 (39%), Gaps = 43/325 (13%)
Query: 68 FTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE 127
L + + V G FG V+K L +AVK + Q ++
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---------NEYVAVKIFPIQDKQSWQ 64
Query: 128 EWQSEVNFLGRLSHPNLVRLLGYCWED----KELLLVYEFMQKGSLENHLFGRGASVQPL 183
+ EV L + H N+++ +G +L L+ F +KGSL + L +
Sbjct: 65 N-EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVV 118
Query: 184 AWNIRLKIAIGAARGLAFLHTSDKQ--------VIYRDFKASNILLDGSYTAKISDFGLA 235
+WN IA ARGLA+LH + +RD K+ N+LL + TA I+DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-----YVKSDVYGFGVVLVEILTGLRAL 290
+ + T +GT Y APE + +++ D+Y G+VL E+ + A
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 291 DTNRPSGQHNLVDWIKPYLSE--------KRKFRHIIDARLQGQYPYKAAYQIAQLSLKC 342
D + I + S +K R ++ Q + + + +C
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEEC 295
Query: 343 LEAEPKHRPSMREVVETLERLQASD 367
+ + + R S V E + ++Q
Sbjct: 296 WDHDAEARLSAGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-73
Identities = 73/354 (20%), Positives = 121/354 (34%), Gaps = 58/354 (16%)
Query: 68 FTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE 127
E N K ++G G +G V+KG LD +AVK + + Q F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD---------ERPVAVKVFSFANRQNFI 53
Query: 128 EWQSEVNFLGRLSHPNLVRLLGYCWED-----KELLLVYEFMQKGSLENHLFGRGASVQP 182
+ + + + H N+ R + E LLV E+ GSL +L
Sbjct: 54 N-EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HT 107
Query: 183 LAWNIRLKIAIGAARGLAFLHT-------SDKQVIYRDFKASNILLDGSYTAKISDFGLA 235
W ++A RGLA+LHT + +RD + N+L+ T ISDFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 236 K------LGPSASQSHVTTRVMGTYGYAAPEY-------VATGHLYVKSDVYGFGVVLVE 282
L + + +GT Y APE + D+Y G++ E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 283 ILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR----LQGQYP---------Y 329
I L ++ + + +E D + + Q P
Sbjct: 228 IFMRCTDLFPGESVPEYQM-----AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 330 KAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRPTHSMAH 383
A + + C + + + R + + E + L ++ K H H
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 83/289 (28%), Positives = 126/289 (43%), Gaps = 40/289 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHP 142
+G G FG V + G+ +AVK L + E+ EV + RL HP
Sbjct: 44 KIGAGSFGTVHRAEWH---------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N+V +G + L +V E++ +GSL L GA + L RL +A A+G+ +L
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYL 153
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H + +++R+ K+ N+L+D YT K+ DFGL++L AS + GT + APE V
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPE-V 210
Query: 263 ATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
KSDVY FGV+L E+ T +P+ ++ A
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQ------------------QPW--GNLNPAQVVAA 250
Query: 322 RLQGQY----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
P Q+A + C EP RPS +++ L L S
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-65
Identities = 72/312 (23%), Positives = 128/312 (41%), Gaps = 45/312 (14%)
Query: 85 VLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN 143
VLG+G FG+ K +G V+ +K+L + + EV + L HPN
Sbjct: 17 VLGKGCFGQAIKVTHR--------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+++ +G ++DK L + E+++ G+L + W+ R+ A A G+A+LH
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLH 125
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL------------GPSASQSHVTTRVM 251
+I+RD + N L+ + ++DFGLA+L V+
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 252 GTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
G + APE + G Y K DV+ FG+VL EI+ + A P ++
Sbjct: 184 GNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-- 240
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS--DQ 368
++ P ++++C + +P+ RPS ++ LE L+
Sbjct: 241 --DRYC-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 369 KPKQPRVRPTHS 380
P P++
Sbjct: 288 LPLGPQLEQLDR 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-65
Identities = 83/307 (27%), Positives = 126/307 (41%), Gaps = 44/307 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
V+G G FG V K +A+K++ SES + + + E+ L R++HPN+
Sbjct: 15 VVGRGAFGVVCKAKWR---------AKDVAIKQIESESER--KAFIVELRQLSRVNHPNI 63
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L G C + LV E+ + GSL N L G + + + ++G+A+LH+
Sbjct: 64 VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 205 SD-KQVIYRDFKASNILLDGSYT-AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
K +I+RD K N+LL T KI DFG A T G+ + APE V
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE-V 174
Query: 263 ATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
G Y K DV+ +G++L E++T KP+ I+ A
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRR------------------KPFDEIGGPAFRIMWA 216
Query: 322 RLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRPT 378
G I L +C +P RPSM E+V+ + L +P P
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276
Query: 379 HSMAHRQ 385
Sbjct: 277 QHSLPPG 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 5e-64
Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-------FEEWQSEVNFLG 137
+G+GGFG V KG L +V+A+K L +G F+E+Q EV +
Sbjct: 26 QIGKGGFGLVHKGRL-------VKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
L+HPN+V+L G +V EF+ G L + L + P+ W+++L++ + A
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIAL 133
Query: 198 GLAFLHTSDKQVIYRDFKASNILLD-----GSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
G+ ++ + +++RD ++ NI L AK++DFGL++ H + ++G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188
Query: 253 TYGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
+ + APE + K+D Y F ++L ILTG P +++ +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG------EGPFDEYSYGKIKFINMI 242
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ R I P ++ + C +PK RP +V+ L L
Sbjct: 243 REEGLRPTI--------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-62
Identities = 65/307 (21%), Positives = 107/307 (34%), Gaps = 79/307 (25%)
Query: 84 TVLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLS 140
T L E G+++KG W G I VK L ++ E L S
Sbjct: 16 TKLNENHSGELWKGRW----------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 141 HPNLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
HPN++ +LG C L+ +M GSL N L + + + +K A+ ARG
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARG 123
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+AFLHT + + + ++++D TA+IS + S + M + A
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVA 176
Query: 259 PEYVATGHLYV----KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
PE +D++ F V+L E++T P+
Sbjct: 177 PE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------VPF------ 211
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSL-----------------KCLEAEPKHRPSMREVV 357
+ ++A L C+ +P RP +V
Sbjct: 212 ---------ADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIV 262
Query: 358 ETLERLQ 364
LE++Q
Sbjct: 263 PILEKMQ 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-61
Identities = 76/296 (25%), Positives = 121/296 (40%), Gaps = 55/296 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ----GFEEWQSEVNFLGRLS 140
++G GGFGKV++ + G +AVK + + E + E L
Sbjct: 14 IIGIGGFGKVYRAFWI---------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
HPN++ L G C ++ L LV EF + G L L G+ + +I + A+ ARG+
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMN 119
Query: 201 FLHTSD-KQVIYRDFKASNILLDGSY--------TAKISDFGLAKLGPSASQSHVTTRVM 251
+LH +I+RD K+SNIL+ KI+DFGLA+ ++ +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA- 175
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
G Y + APE + SDV+ +GV+L E+LTG P+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------------------VPF--R 215
Query: 312 KRKFRHIIDARLQGQY----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + P A+L C +P RPS +++ L +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-59
Identities = 83/292 (28%), Positives = 128/292 (43%), Gaps = 49/292 (16%)
Query: 86 LGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHP 142
+G G FG V+KG W G V AVK LN + + +++EV L + H
Sbjct: 32 IGSGSFGTVYKGKW----------HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N++ +GY + L +V ++ + SL +HL + IA ARG+ +L
Sbjct: 81 NILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYL 136
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE-- 260
H K +I+RD K++NI L T KI DFGLA S SH ++ G+ + APE
Sbjct: 137 HA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 261 -YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319
+ +SDVY FG+VL E++TG PY S II
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQL------------------PY-SNINNRDQII 235
Query: 320 DARLQG-------QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364
+ +G + ++ +L +CL+ + RPS ++ +E L
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-59
Identities = 61/308 (19%), Positives = 118/308 (38%), Gaps = 56/308 (18%)
Query: 85 VLGEGGFGKVFKG-WLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSH 141
++G+G FG+V+ G W G V A++ ++ E + ++ EV + H
Sbjct: 40 LIGKGRFGQVYHGRW----------HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
N+V +G C L ++ + +L + + L N +IA +G+ +
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGY 145
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL---GPSASQSHVTTRVMGTYGYAA 258
LH K ++++D K+ N+ D + I+DFGL + + + G + A
Sbjct: 146 LHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 259 PEYVATGHLYV---------KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309
PE + SDV+ G + E+ P+
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------------------WPF- 243
Query: 310 SEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365
+ + II G P +I+ + L C E + RP+ ++++ LE+L
Sbjct: 244 -KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
Query: 366 SDQKPKQP 373
+++ P
Sbjct: 303 RNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-58
Identities = 68/317 (21%), Positives = 124/317 (39%), Gaps = 47/317 (14%)
Query: 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEV 133
R R+ +G+G +G+V++G G +AVK +S + + ++E+
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQ---------GENVAVKIFSSRDEKSWFR-ETEL 53
Query: 134 NFLGRLSHPNLVRLLGYCWEDK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL 189
L H N++ + + +L L+ + + GSL ++L + L L
Sbjct: 54 YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCL 108
Query: 190 KIAIGAARGLAFLHTSDKQ------VIYRDFKASNILLDGSYTAKISDFGLAKL---GPS 240
+I + A GLA LH + +RD K+ NIL+ + I+D GLA + +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 241 ASQSHVTTRVMGTYGYAAPE------YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
RV GT Y APE V Y + D++ FG+VL E+ + +
Sbjct: 169 QLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 295 P--------SGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAE 346
+ ++ + ++ R I R +A+L +C
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQ-RPNIPNRWF---SDPTLTSLAKLMKECWYQN 283
Query: 347 PKHRPSMREVVETLERL 363
P R + + +TL ++
Sbjct: 284 PSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 8e-57
Identities = 66/308 (21%), Positives = 116/308 (37%), Gaps = 41/308 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSE--VNFLGRLSHP 142
+G+G +G+V+ G G +AVK + W E + + H
Sbjct: 44 QIGKGRYGEVWMGKWR---------GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHE 91
Query: 143 NLVRLLGYCWEDK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
N++ + + +L L+ ++ + GSL ++L L LK+A + G
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSG 146
Query: 199 LAFLHTSDKQ------VIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH--VTTRV 250
L LHT + +RD K+ NIL+ + T I+D GLA S +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 251 MGTYGYAAPE------YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ-HNLVD 303
+GT Y PE Y+ +D+Y FG++L E+ + ++ +
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 304 WIKPYLSEKRKFRHIIDARL---QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
P + R+ I R + Q+ +L +C P R + V +TL
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 361 ERLQASDQ 368
++ S
Sbjct: 327 AKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 73/310 (23%), Positives = 131/310 (42%), Gaps = 47/310 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G+G FG+V++G G +AVK +S + + ++E+ L H N+
Sbjct: 49 SIGKGRFGEVWRGKWR---------GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 98
Query: 145 VRLLGYCWEDK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
+ + +D +L LV ++ + GSL ++L + + +K+A+ A GLA
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLA 153
Query: 201 FLHTSDKQ------VIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS---HVTTRVM 251
LH + +RD K+ NIL+ + T I+D GLA SA+ + RV
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV- 212
Query: 252 GTYGYAAPE----YVATGHL--YVKSDVYGFGVVLVEILTGLRALDTNRP--------SG 297
GT Y APE + H + ++D+Y G+V EI +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 298 QHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
V+ ++ + E++ R I R Q + +A++ +C A R + +
Sbjct: 273 SDPSVEEMRKVVCEQKL-RPNIPNRWQSCEALRV---MAKIMRECWYANGAARLTALRIK 328
Query: 358 ETLERLQASD 367
+TL +L +
Sbjct: 329 KTLSQLSQQE 338
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-48
Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 28/300 (9%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
R+ K LG+G FG V D P + +G V+AVKKL + + +++ E+ L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYD---PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 138 RLSHPNLVRLLGYCWEDKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L H N+V+ G C+ L L+ E++ GSL ++L + L+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQI 123
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG--- 252
+G+ +L K+ I+RD NIL++ KI DFGL K+ P + + G
Sbjct: 124 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESP 180
Query: 253 ---TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309
APE + V SDV+ FGVVL E+ T + P + +
Sbjct: 181 IFWY----APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQ- 233
Query: 310 SEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
+ H+I+ P +I + +C RPS R++ +++++ +
Sbjct: 234 -GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 79/332 (23%), Positives = 133/332 (40%), Gaps = 36/332 (10%)
Query: 54 YPNGQILPTPNLRIFTFVELRAAT--------RNFKSDTVLGEGGFGKVFKGWLDEKAPG 105
+ + I T NL + R+ K LG+G FG V D P
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYD---PL 65
Query: 106 KSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE--LLLVYEF 163
+ +G V+AVKKL + + +++ E+ L L H N+V+ G C+ L L+ E+
Sbjct: 66 QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 164 MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223
+ GSL ++L + L+ +G+ +L K+ I+RD NIL++
Sbjct: 126 LPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVEN 180
Query: 224 SYTAKISDFGLAKLGPSASQSHVTTRVMG------TYGYAAPEYVATGHLYVKSDVYGFG 277
KI DFGL K+ P + + + G APE + V SDV+ FG
Sbjct: 181 ENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWY----APESLTESKFSVASDVWSFG 235
Query: 278 VVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQ---YPYKAAYQ 334
VVL E+ T + P + + + H+I+ P +
Sbjct: 236 VVLYELFT--YIEKSKSPPAEFMRMIGNDKQ--GQMIVFHLIELLKNNGRLPRPDGCPDE 291
Query: 335 IAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
I + +C RPS R++ +++++
Sbjct: 292 IYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 32/299 (10%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFL 136
R K LGEG FGKV D P +G +AVK L ES + + E+ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77
Query: 137 GRLSHPNLVRLLGYCWEDKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L H N+V+ G C ED + L+ EF+ GSL+ +L + +LK A+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQ 134
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG-- 252
+G+ +L +Q ++RD A N+L++ + KI DFGL K + + + T +
Sbjct: 135 ICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDRDS 191
Query: 253 ----TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKP 307
APE + Y+ SDV+ FGV L E+LT D++ L
Sbjct: 192 PVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYC----DSDSSPMALFLKMIGPT 243
Query: 308 YLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + +++ +G+ P ++ QL KC E +P +R S + ++E E L
Sbjct: 244 H--GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 31/309 (10%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
R+ K + LG+G FG V D P +G ++AVK+L ++Q E+ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYD---PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 138 RLSHPNLVRLLGYCWEDKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L +V+ G + L LV E++ G L + L A + + L +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQI 136
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG--- 252
+G+ +L ++ ++RD A NIL++ KI+DFGLAKL P + + R G
Sbjct: 137 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSP 193
Query: 253 ---TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308
APE ++ +SDV+ FGVVL E+ T ++ +
Sbjct: 194 IFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYC------DKSCSPSAEFLRMMGC 243
Query: 309 LSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365
+ +++ +GQ P ++ +L C P+ RPS + L+ L +
Sbjct: 244 ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303
Query: 366 SDQKPKQPR 374
+ +
Sbjct: 304 GSRGCETHA 312
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 80/313 (25%), Positives = 123/313 (39%), Gaps = 56/313 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G F K+FKG E T + +K L+ E + + + +LSH +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V G C E +LV EF++ GSL+ +L + L +L++A A + FL
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL---WKLEVAKQLAAAMHFL-- 129
Query: 205 SDKQVIYRDFKASNILLDGSYT--------AKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
+ +I+ + A NILL K+SD G++ V+
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 257 ------AAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY- 308
PE + + +D + FG L EI +G G KP
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG----------GD-------KPLS 220
Query: 309 -LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
L +RK + D +L P A ++A L C++ EP HRPS R ++ L L
Sbjct: 221 ALDSQRKLQFYEDRHQL--PAPKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
Query: 367 DQKPKQPRVRPTH 379
D P+ H
Sbjct: 277 DLVPRGSHHHHHH 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-46
Identities = 85/297 (28%), Positives = 127/297 (42%), Gaps = 34/297 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LGEG FGKV D P G+G ++AVK L ++ Q W+ E++ L L H +
Sbjct: 38 DLGEGHFGKVSLYCYD---PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 144 LVRLLGYCWEDKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
+++ G C + L LV E++ GSL ++L + L L A G+A+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAY 149
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG------TYG 255
LH + I+RD A N+LLD KI DFGLAK P + R G
Sbjct: 150 LH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWY-- 204
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
APE + Y SDV+ FGV L E+LT D+++ L +
Sbjct: 205 --APECLKEYKFYYASDVWSFGVTLYELLTHC----DSSQSPPTKFLELIGIAQ--GQMT 256
Query: 315 FRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368
+ + +G+ P K ++ L C E E RP+ ++ L+ + Q
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-46
Identities = 77/295 (26%), Positives = 122/295 (41%), Gaps = 46/295 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
+G G FG+VF G L T++AVK ++ E L + SHPN
Sbjct: 121 QIGRGNFGEVFSGRL-------RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+VRL+G C + + + +V E +Q G L GA ++ L++ AA G+ +L
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLE 230
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY----AAP 259
K I+RD A N L+ KISDFG+++ V G AP
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE----ADGVYAASGGLRQVPVKWTAP 284
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRH 317
E + G +SDV+ FG++L E + G PY LS ++
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSL----------GA-------SPYPNLSNQQTREF 327
Query: 318 IIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPK 371
+ RL P + +L +C EP RPS + + L+ ++ ++ +
Sbjct: 328 VEKGGRLPC--PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR---KRHR 377
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 91/347 (26%), Positives = 135/347 (38%), Gaps = 54/347 (15%)
Query: 39 VSGNSRFSASSGDESYPNGQILPTPNLRIFTFV-ELRAATRNFKSDTVLGEGGFGKVFKG 97
+ S S + G S G I+ P V ++ K LGEG FGKVF
Sbjct: 3 MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLK--WELGEGAFGKVFLA 60
Query: 98 WLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157
P + ++AVK L S +++Q E L L H ++VR G C E + L
Sbjct: 61 ECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 158 LLVYEFMQKGSLENHL-----------FGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD 206
L+V+E+M+ G L L G + PL L +A A G+ +L +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AG 176
Query: 207 KQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV------MGTYGYAAPE 260
++RD N L+ KI DFG+++ S V R M PE
Sbjct: 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPE 230
Query: 261 YVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRH 317
+ +SDV+ FGVVL EI T G + P+ LS
Sbjct: 231 SILYRKFTTESDVWSFGVVLWEIFTYGKQ------------------PWYQLSNTEAIDC 272
Query: 318 IIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
I L + P ++ + C + EP+ R S+++V L+ L
Sbjct: 273 ITQGREL--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPN 143
VLG G FG V+KG G+ V A+K+L + +E E + + +P+
Sbjct: 22 VLGSGAFGTVYKGLW--IPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+ RLLG C + L+ + M G L +++ ++ L + A+G+ +L
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYL- 133
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
D+++++RD A N+L+ KI+DFGLAKL + + + + A E +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
+SDV+ +GV + E++T G KPY + I
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTF----------GS-------KPY--DGIPASEISSILE 233
Query: 324 QGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+G+ P + + KC + RP RE++ ++
Sbjct: 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 80/313 (25%), Positives = 125/313 (39%), Gaps = 78/313 (24%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
LGEG FGKVF +P K ++AVK L +L +++Q E L L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------LKIAI 193
+ G C + L++V+E+M+ G L L G L L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
A G+ +L + + ++RD N L+ + KI DFG++ R +
Sbjct: 141 QIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDV-- 183
Query: 254 YGYAAPEYVATGH-------------LY----VKSDVYGFGVVLVEILT-GLRALDTNRP 295
Y+ Y GH +Y +SDV+ FGV+L EI T G +
Sbjct: 184 --YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ------- 234
Query: 296 SGQHNLVDWIKPY--LSEKRKFRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHR 350
P+ LS I QG+ P ++ + L C + EP+ R
Sbjct: 235 -----------PWFQLSNTEVIECIT----QGRVLERPRVCPKEVYDVMLGCWQREPQQR 279
Query: 351 PSMREVVETLERL 363
+++E+ + L L
Sbjct: 280 LNIKEIYKILHAL 292
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 8e-42
Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 39/284 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G +G+V++G +AVK L ++++ EE+ E + + HPNL
Sbjct: 227 KLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 278
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+LLG C + ++ EFM G+L ++L R + Q ++ + L +A + + +L
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL-- 334
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS-QSHVTTRVMGTYGYAAPEYVA 263
K I+R+ A N L+ ++ K++DFGL++L + +H + + APE +A
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 392
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
+KSDV+ FGV+L EI T PY + +
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGM-----------------SPY--PGIDLSQVYELLE 433
Query: 324 QGQY----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ Y P ++ +L C + P RPS E+ + E +
Sbjct: 434 KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-42
Identities = 81/313 (25%), Positives = 135/313 (43%), Gaps = 63/313 (20%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G +G+V++G +AVK L ++++ EE+ E + + HPNL
Sbjct: 20 KLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 71
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+LLG C + ++ EFM G+L ++L R + Q ++ + L +A + + +L
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL-- 127
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA------- 257
K I+RD A N L+ ++ K++DFGL+ R+M Y
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKF 174
Query: 258 -----APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LS 310
APE +A +KSDV+ FGV+L EI T G PY +
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY----------GM-------SPYPGID 217
Query: 311 EKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL----QA 365
+ + + R++ P ++ +L C + P RPS E+ + E +
Sbjct: 218 LSQVYELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
Query: 366 SDQKPKQPRVRPT 378
SD+ K+ R T
Sbjct: 276 SDEVEKELGKRGT 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 49/302 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHP 142
+LGEG FG V +G + G+ +AVK + + S + EE+ SE + SHP
Sbjct: 41 ILGEGEFGSVMEG----NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 143 NLVRLLGYCWEDK-----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR--LKIAIGA 195
N++RLLG C E + +++ FM+ G L +L P ++ LK +
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV----- 250
A G+ +L S++ ++RD A N +L T ++DFGL+K S
Sbjct: 157 ALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 251 -MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY- 308
+ A E +A KSDV+ FGV + EI T G PY
Sbjct: 215 WI------AIESLADRVYTSKSDVWAFGVTMWEIAT----------RGM-------TPYP 251
Query: 309 -LSEKRKFRHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
+ + +++ RL + P ++ ++ C +P RP+ + LE+L S
Sbjct: 252 GVQNHEMYDYLLHGHRL--KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
Query: 367 DQ 368
Sbjct: 310 LP 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 43/290 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V G + +AVK + S+ +E+ E + +LSHP L
Sbjct: 15 ELGSGQFGVVKLGKWKGQYD--------VAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKL 65
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+ G C ++ + +V E++ G L N+L G ++P + L++ G+AFL
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFL-- 120
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPEY 261
Q I+RD A N L+D K+SDFG+ + +GT ++APE
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----VLDDQYVSSVGTKFPVKWSAPEV 176
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHII 319
KSDV+ FG+++ E+ + G+ PY + +
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSL----------GK-------MPYDLYTNSEVVLKVS 219
Query: 320 DA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368
RL P+ A+ I Q+ C P+ RP+ ++++ ++E L+ D+
Sbjct: 220 QGHRLYR--PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 76/301 (25%), Positives = 119/301 (39%), Gaps = 41/301 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+ + LG+G FG V +G D SG +AVK L + L + +++ EVN
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWD----APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
+ L H NL+RL G + +V E GSL + L + A+
Sbjct: 75 MHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQV 130
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT-- 253
A G+ +L K+ I+RD A N+LL KI DFGL + P +V
Sbjct: 131 AEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKV 186
Query: 254 -YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312
+ + APE + T SD + FGV L E+ T GQ +P+
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY----------GQ-------EPW--IG 227
Query: 313 RKFRHIIDARLQGQY----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368
I+ + P I + ++C +P+ RP+ + + L Q +D
Sbjct: 228 LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
Query: 369 K 369
+
Sbjct: 288 R 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 74/320 (23%), Positives = 126/320 (39%), Gaps = 72/320 (22%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHP 142
LGEG FG+V K +AVK L + + + + SE+ + + H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------LK 190
N++ LLG C +D L ++ E+ KG+L +L R +++I +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
ARG+ +L + ++ I+RD A N+L+ + KI+DFGLA R
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 206
Query: 251 MGTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLVEILTGLRALDTN 293
+ Y T +Y +SDV+ FGV++ EI T
Sbjct: 207 I----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL------- 255
Query: 294 RPSGQHNLVDWIKPY--LSEKRKFRHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
G PY + + F+ + + R+ P ++ + C A P R
Sbjct: 256 ---GGS-------PYPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAVPSQR 303
Query: 351 PSMREVVETLERLQASDQKP 370
P+ +++VE L+R+
Sbjct: 304 PTFKQLVEDLDRILTLTTNE 323
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-41
Identities = 74/307 (24%), Positives = 131/307 (42%), Gaps = 61/307 (19%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LG+G FG V++G K K T +A+K +N S++ E+ +E + + + +
Sbjct: 32 ELGQGSFGMVYEGVA--KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHL------FGRGASVQPLAWNIRLKIAIGAAR 197
+VRLLG + + L++ E M +G L+++L + P + + +++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
G+A+L + + ++RD A N ++ +T KI DFG+ R + Y
Sbjct: 150 GMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMT-------------RDIYETDYY 194
Query: 258 -------------APEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVD 303
+PE + G SDV+ FGVVL EI T
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------- 238
Query: 304 WIKPY--LSEKRKFRHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360
+PY LS ++ R +++ L P + +L C + PK RPS E++ ++
Sbjct: 239 --QPYQGLSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
Query: 361 ERLQASD 367
+
Sbjct: 295 KEEMEPG 301
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 49/290 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G+G FG V G G +AVK + +++ + + +E + + +L H NL
Sbjct: 200 TIGKGEFGDVMLGDY---------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 248
Query: 145 VRLLGYCWEDKELL-LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
V+LLG E+K L +V E+M KGSL ++L R L + LK ++ + +L
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL- 305
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPE 260
++RD A N+L+ AK+SDFGL K ++ + APE
Sbjct: 306 -EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPE 356
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHI 318
+ KSDV+ FG++L EI + G+ PY + K +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSF----------GR-------VPYPRIPLKDVVPRV 399
Query: 319 IDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367
++ P + + C + RP+ ++ E LE ++ +
Sbjct: 400 EKGYKMDA--PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-41
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPN 143
VLG G FG V+KG G+ V A+K+L + +E E + + +P+
Sbjct: 22 VLGSGAFGTVYKGLW--IPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+ RLLG C + L+ + M G L +++ ++ L + A+G+ +L
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYL- 133
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
D+++++RD A N+L+ KI+DFGLAKL + + + + A E +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
+SDV+ +GV + E++T G KPY + I
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTF----------GS-------KPY--DGIPASEISSILE 233
Query: 324 QGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQK 369
+G+ P + + +KC + RP RE++ ++ Q+
Sbjct: 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-41
Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 51/291 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G+G FG V G G +AVK + +++ + + +E + + +L H NL
Sbjct: 28 TIGKGEFGDVMLGDYR---------GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 76
Query: 145 VRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
V+LLG E+K L +V E+M KGSL ++L R L + LK ++ + +L
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL- 133
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV----MGTYGYAAP 259
++RD A N+L+ AK+SDFGL K AS + T ++ AP
Sbjct: 134 -EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------AP 183
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319
E + KSDV+ FG++L EI + G+ PY + + ++
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSF----------GR-------VPY--PRIPLKDVV 224
Query: 320 DARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367
+G P + ++ C + RPS ++ E LE ++ +
Sbjct: 225 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 32/283 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPN 143
VLG G FG V KG G+S V +K + +S Q F+ + +G L H +
Sbjct: 20 VLGSGVFGTVHKGVW--IPEGESIKIPV-CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+VRLLG C L LV +++ GSL +H+ ++ P + L + A+G+ +L
Sbjct: 77 IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP---QLLLNWGVQIAKGMYYL- 131
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
+ +++R+ A N+LL +++DFG+A L P + + + + A E +
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
G +SDV+ +GV + E++T G +PY + + D
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTF----------GA-------EPY--AGLRLAEVPDLLE 231
Query: 324 QGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+G+ P + + +KC + RP+ +E+ R+
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 45/286 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G G FG V G+ K +A+K + ++ E++ E + +LSHP L
Sbjct: 15 EIGSGQFGLVHLGYWLNKDK--------VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKL 65
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L G C E + LV EFM+ G L ++L + L + + G+A+L
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYL-- 120
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPEY 261
+ VI+RD A N L+ + K+SDFG+ + T GT +A+PE
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEV 176
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
+ KSDV+ FGV++ E+ + G+ PY E R +++
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSE----------GK-------IPY--ENRSNSEVVED 217
Query: 322 RLQGQY----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
G + P A+ + Q+ C P+ RP+ ++ L +
Sbjct: 218 ISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 79/307 (25%), Positives = 126/307 (41%), Gaps = 45/307 (14%)
Query: 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSH 141
D LG G FG V +G + K +A+K L + EE E + +L +
Sbjct: 15 DIELGCGNFGSVRQGVY--RMRKKQ---IDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
P +VRL+G C + + L+LV E G L L G+ + + ++ + G+ +
Sbjct: 70 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKY 125
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG------TYG 255
L +K ++RD A N+LL + AKISDFGL+K + S+ T R G
Sbjct: 126 L--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWY-- 180
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
APE + +SDV+ +GV + E L+ GQ KPY +K K
Sbjct: 181 --APECINFRKFSSRSDVWSYGVTMWEALSY----------GQ-------KPY--KKMKG 219
Query: 316 RHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQ 372
++ QG+ P + ++ L C + + RP V + + S +
Sbjct: 220 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
Query: 373 PRVRPTH 379
H
Sbjct: 280 GHHHHHH 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 74/314 (23%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHP 142
LGEG FG+V K +AVK L + + + + SE+ + + H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------LK 190
N++ LLG C +D L ++ E+ KG+L +L R +++I +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
ARG+ +L + ++ I+RD A N+L+ + KI+DFGLA R
Sbjct: 208 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 252
Query: 251 MGTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLVEILT-GLRALDT 292
+ Y T +Y +SDV+ FGV++ EI T G
Sbjct: 253 I----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG----- 303
Query: 293 NRPSGQHNLVDWIKPY--LSEKRKFRHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKH 349
PY + + F+ + + R+ P ++ + C A P
Sbjct: 304 -------------SPYPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAVPSQ 348
Query: 350 RPSMREVVETLERL 363
RP+ +++VE L+R+
Sbjct: 349 RPTFKQLVEDLDRI 362
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 74/349 (21%), Positives = 124/349 (35%), Gaps = 61/349 (17%)
Query: 46 SASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPG 105
+S + Y G ++ + + + F++ LGEGGF V G
Sbjct: 10 HSSGRENLYFQGHMV-IIDNKHYLFIQ------------KLGEGGFSYVDL------VEG 50
Query: 106 KSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK----ELLLVY 161
G A+K++ Q EE Q E + +HPN++RL+ YC ++ E L+
Sbjct: 51 LH-DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109
Query: 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221
F ++G+L N + L + L + +G RGL +H K +RD K +NILL
Sbjct: 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILL 167
Query: 222 DGSYTAKISDFGLAKLGPSASQSHVTTRVM-------GTYGYAAPE------YVATGHLY 268
+ D G + + T Y APE +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE-- 225
Query: 269 VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP 328
++DV+ G VL ++ G D G + +L P
Sbjct: 226 -RTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---------------VALAVQNQL--SIP 267
Query: 329 YKAAY--QIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRV 375
+ + QL + +P RP + ++ LE LQ ++
Sbjct: 268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQI 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 43/289 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V G + +A+K + S+ +E+ E + LSH L
Sbjct: 31 ELGTGQFGVVKYGKWRGQYD--------VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKL 81
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L G C + + + ++ E+M G L N+L Q L++ + +L
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYL-- 136
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPEY 261
KQ ++RD A N L++ K+SDFGL++ T +G+ ++ PE
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY----VLDDEYTSSVGSKFPVRWSPPEV 192
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
+ KSD++ FGV++ EI + G+ PY E+ +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSL----------GK-------MPY--ERFTNSETAEH 233
Query: 322 RLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367
QG P+ A+ ++ + C + RP+ + ++ + + +
Sbjct: 234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 50/298 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHP 142
+LG+G FG V + + + GS +AVK L ++ + EE+ E + HP
Sbjct: 30 MLGKGEFGSVREA----QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 143 NLVRLLGYCWED------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR--LKIAIG 194
++ +L+G +++ FM+ G L L P ++ ++ +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS--QSHVTTRV-- 250
A G+ +L S + I+RD A N +L T ++DFGL++ S + +++
Sbjct: 146 IACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 251 --MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ A E +A V SDV+ FGV + EI+T GQ PY
Sbjct: 204 KWL------ALESLADNLYTVHSDVWAFGVTMWEIMTR----------GQ-------TPY 240
Query: 309 --LSEKRKFRHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + ++I RL + P + ++ L +C A+PK RPS + LE +
Sbjct: 241 AGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 72/293 (24%), Positives = 114/293 (38%), Gaps = 35/293 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LG G FG+V++G + S +AVK L S Q ++ E + + +H N
Sbjct: 37 GLGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASV---QPLAWNIRLKIAIGAARGLA 200
+VR +G + ++ E M G L++ L LA L +A A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 201 FLHTSDKQVIYRDFKASNILLDGS---YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
+L + I+RD A N LL AKI DFG+A+ AS M +
Sbjct: 155 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY--LSEKRK 314
PE G K+D + FGV+L EI + G PY S +
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------------------PYPSKSNQEV 254
Query: 315 FRHIID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
+ R+ P + ++ +C + +P+ RP+ ++E +E
Sbjct: 255 LEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 53/295 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
V+G G FG V+ G G AVK LN + ++ +E + SHPN
Sbjct: 32 VIGRGHFGCVYHG----TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 144 LVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGA--SVQPLAWNIRLKIAIGAARGLA 200
++ LLG C + L+V +M+ G L N + +V+ L + + A+G+
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMK 142
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL----GPSASQSHVTTRV----MG 252
+L + K+ ++RD A N +LD +T K++DFGLA+ + + ++ M
Sbjct: 143 YL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM- 199
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY--L 309
A E + T KSDV+ FGV+L E++T G PY +
Sbjct: 200 -----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP------------------PYPDV 236
Query: 310 SEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ +++ RL P + ++ LKC + + RPS E+V + +
Sbjct: 237 NTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 49/302 (16%)
Query: 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFEEWQSEVNFLGRLS 140
D LG G FG V KG+ K TV AVK K + +E +E N + +L
Sbjct: 22 DKELGSGNFGTVKKGYY----QMKKVVKTV-AVKILKNEANDPALKDELLAEANVMQQLD 76
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL-FGRGASVQPLAWNIRLKIAIGAARGL 199
+P +VR++G C E + +LV E + G L +L R + + +++ + G+
Sbjct: 77 NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGM 130
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG------T 253
+L + ++RD A N+LL + AKISDFGL+K + +++ + G
Sbjct: 131 KYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWY 187
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
APE + KSDV+ FGV++ E + GQ KPY
Sbjct: 188 ----APECINYYKFSSKSDVWSFGVLMWEAFSY----------GQ-------KPY--RGM 224
Query: 314 KFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKP 370
K + +G+ P ++ L C + ++RP V L
Sbjct: 225 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
Query: 371 KQ 372
Sbjct: 285 GH 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-40
Identities = 85/327 (25%), Positives = 149/327 (45%), Gaps = 40/327 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLG 137
N D V+G G FG+V G L K P K +A+K L + + ++ E + +G
Sbjct: 46 NISIDKVVGAGEFGEVCSGRL--KLPSKKE--ISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
+ HPN++RL G + K +++V E+M+ GSL++ L A + + G A
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIAS 158
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---Y 254
G+ +L SD ++RD A NIL++ + K+SDFGL ++ ++ TTR G
Sbjct: 159 GMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPI 214
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ +PE +A SDV+ +G+VL E+++ G+ +PY +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY----------GE-------RPY--WEMS 255
Query: 315 FRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPK 371
+ +I A +G P + QL L C + + +RP ++V L++L + K
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLK 315
Query: 372 ---QPRVRPTHSMAHRQGQQPLHHRSP 395
RP++ + + R+
Sbjct: 316 IITSAAARPSNLLLDQSNVDITTFRTT 342
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-40
Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 57/305 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LGE FGKV+KG L APG+ +A+K L + EE++ E RL HPN
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQT--QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------LKI 191
+V LLG +D+ L +++ + G L L R + + + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
A G+ +L S V+++D N+L+ KISD GL + + +++
Sbjct: 134 VAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE----VYAADYYKLL 187
Query: 252 G--------TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLV 302
G APE + G + SD++ +GVVL E+ + GL+
Sbjct: 188 GNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-------------- 229
Query: 303 DWIKPY--LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359
PY S + I + L P + L ++C P RP +++
Sbjct: 230 ----PYCGYSNQDVVEMIRNRQVL--PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 360 LERLQ 364
L
Sbjct: 284 LRAWG 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-40
Identities = 72/295 (24%), Positives = 115/295 (38%), Gaps = 45/295 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
LG G FG+V++G + S +AVK L S Q ++ E + + +H N
Sbjct: 78 GLGHGAFGEVYEGQV--SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFG-RGASVQPLAWNIR--LKIAIGAARGLA 200
+VR +G + ++ E M G L++ L R QP + + L +A A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 201 FLHTSDKQVIYRDFKASNILLDGS---YTAKISDFGLAKLGPSASQSHVTTRVMGTYGY- 256
+L + I+RD A N LL AKI DFG+A+ A G
Sbjct: 196 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAML 248
Query: 257 ----AAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY--L 309
PE G K+D + FGV+L EI + G PY
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------------------PYPSK 290
Query: 310 SEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
S + + R+ P + ++ +C + +P+ RP+ ++E +E
Sbjct: 291 SNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 83/295 (28%), Positives = 139/295 (47%), Gaps = 43/295 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG+V+ G+ +G V AVK L S+ + + +E N + +L H L
Sbjct: 20 RLGAGQFGEVWMGYY-------NGHTKV-AVKSLKQGSMSP-DAFLAEANLMKQLQHQRL 70
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
VRL ++ + ++ E+M+ GSL + L + S L N L +A A G+AF+
Sbjct: 71 VRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI-- 125
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPEY 261
++ I+RD +A+NIL+ + + KI+DFGLA+L + + T G + APE
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWTAPEA 181
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHII 319
+ G +KSDV+ FG++L EI+T G+ PY ++ +++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTH----------GR-------IPYPGMTNPEVIQNLE 224
Query: 320 DA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQP 373
R+ P ++ QL C + P+ RP+ + LE + + QP
Sbjct: 225 RGYRMVR--PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 83/321 (25%), Positives = 125/321 (38%), Gaps = 79/321 (24%)
Query: 85 VLGEGGFGKVFKGWLDEKAPG--KSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-S 140
LG G FGKV + A G K + +AVK L S E SE+ + L
Sbjct: 53 TLGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL----------FGRGASVQPLAWNIRLK 190
H N+V LLG C +L++ E+ G L N L + + L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
+ A+G+AFL + K I+RD A N+LL + AKI DFGLA R
Sbjct: 169 FSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------------RD 213
Query: 251 MGTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLVEILT-GLRALDT 292
+ Y+ G +Y V+SDV+ +G++L EI + GL
Sbjct: 214 I----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN---- 265
Query: 293 NRPSGQHNLVDWIKPY---LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPK 348
PY L + ++ + D ++ P A I + C EP
Sbjct: 266 --------------PYPGILVNSKFYKLVKDGYQM--AQPAFAPKNIYSIMQACWALEPT 309
Query: 349 HRPSMREVVETLERLQASDQK 369
HRP+ +++ L+ D++
Sbjct: 310 HRPTFQQICSFLQEQAQEDRR 330
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 88/377 (23%), Positives = 145/377 (38%), Gaps = 58/377 (15%)
Query: 9 PHDTIGHLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIF 68
H + GI G+ +S S + + + Y G +L
Sbjct: 13 HHGRRRASVAAGILVPRGSPGLDGICSIEELST-SLYKKAGSENLYFQGANTVHIDLSAL 71
Query: 69 TFVELRAATRNFKSD---------TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN 119
EL A ++ V+G G FG V+ G G AVK LN
Sbjct: 72 N-PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG----TLLDNDGKKIHCAVKSLN 126
Query: 120 SE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRG 177
+ ++ +E + SHPN++ LLG C + L+V +M+ G L N +
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 186
Query: 178 A--SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235
+V+ L + + A+G+ FL + K+ ++RD A N +LD +T K++DFGLA
Sbjct: 187 HNPTVKDL-----IGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
Query: 236 KLGPSASQSHVTTRVMG------TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRA 289
+ V + A E + T KSDV+ FGV+L E++T
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTR--- 292
Query: 290 LDTNRPSGQHNLVDWIKPY--LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAE 346
G PY ++ +++ RL P + ++ LKC +
Sbjct: 293 -------GA-------PPYPDVNTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPK 336
Query: 347 PKHRPSMREVVETLERL 363
+ RPS E+V + +
Sbjct: 337 AEMRPSFSELVSRISAI 353
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 37/292 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G FG+V+ G +G+ V A+K L ++ E + E + +L H L
Sbjct: 191 KLGQGCFGEVWMGTW-------NGTTRV-AIKTLKPGTMSP-EAFLQEAQVMKKLRHEKL 241
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L E+ + +V E+M KGSL + L +G + + L + +A A G+A++
Sbjct: 242 VQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV-- 296
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
++RD +A+NIL+ + K++DFGLA+L ++ + APE
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALY 355
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHIIDA- 321
G +KSDV+ FG++L E+ T R PY + + +
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNREVLDQVERGY 398
Query: 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQP 373
R+ P + + L +C EP+ RP+ + LE S + QP
Sbjct: 399 RMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 84/346 (24%), Positives = 152/346 (43%), Gaps = 53/346 (15%)
Query: 54 YPNGQILPTPNLRIFTFV-ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTV 112
Y G + PN + F E+ + V+G G FG+V+KG L K V
Sbjct: 21 YFQGAMGSDPNQAVLKFTTEIHPS--CVTRQKVIGAGEFGEVYKGML--KTSSGKKEVPV 76
Query: 113 IAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLEN 171
A+K L + + + ++ E +G+ SH N++RL G + K ++++ E+M+ G+L+
Sbjct: 77 -AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 172 HLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231
L + + + + G A G+ +L ++ ++RD A NIL++ + K+SD
Sbjct: 136 FLREKDGE---FSVLQLVGMLRGIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSD 190
Query: 232 FGLAKLGPSASQSHVTTRVMGTYG------YAAPEYVATGHLYVKSDVYGFGVVLVEILT 285
FGL+++ ++ TT G + APE ++ SDV+ FG+V+ E++T
Sbjct: 191 FGLSRVLEDDPEATYTTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
Query: 286 GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQY---PYKAAYQIAQLSLKC 342
G+ +PY + ++ A G P I QL ++C
Sbjct: 246 Y----------GE-------RPY--WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQC 286
Query: 343 LEAEPKHRPSMREVVETLERL--------QASDQKPKQPRVRPTHS 380
+ E RP ++V L++L +D P+ P+ S
Sbjct: 287 WQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTS 332
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 51/298 (17%)
Query: 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL 139
SD V+G+G FG V+ G + ++ + A+K L+ +Q E + E + L
Sbjct: 24 HSDRVIGKGHFGVVYHG----EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 140 SHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGA--SVQPLAWNIRLKIAIGAA 196
+HPN++ L+G + ++ +M G L + +V+ L + + A
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVA 134
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL----GPSASQSHVTTRV-- 250
RG+ +L ++++ ++RD A N +LD S+T K++DFGLA+ + Q H R+
Sbjct: 135 RGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 251 --MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
A E + T KSDV+ FGV+L E+LT G PY
Sbjct: 193 KWT------ALESLQTYRFTTKSDVWSFGVLLWELLTR----------GA-------PPY 229
Query: 309 --LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + RL P + Q+ +C EA+P RP+ R +V +E++
Sbjct: 230 RHIDPFDLTHFLAQGRRL--PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 80/309 (25%), Positives = 128/309 (41%), Gaps = 64/309 (20%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHP 142
LGEG FG+V K T +AVK L S+ + + + SE+ + + H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------LK 190
N++ LLG C +D L ++ E+ KG+L +L R ++N +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
A ARG+ +L + K+ I+RD A N+L+ KI+DFGLA R
Sbjct: 196 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------------RD 240
Query: 251 MGTYGY-------------AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297
+ Y APE + +SDV+ FGV+L EI T G
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL----------G 290
Query: 298 QHNLVDWIKPY--LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
PY + + F+ + + R+ P ++ + C A P RP+ +
Sbjct: 291 GS-------PYPGVPVEELFKLLKEGHRM--DKPSNCTNELYMMMRDCWHAVPSQRPTFK 341
Query: 355 EVVETLERL 363
++VE L+R+
Sbjct: 342 QLVEDLDRI 350
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 81/300 (27%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHP 142
V+GEG FG+V K + K G A+K++ S ++ E+ L +L HP
Sbjct: 32 VIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------LK 190
N++ LLG C L L E+ G+L + L A+ I L
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT--- 247
A ARG+ +L S KQ I+RD A NIL+ +Y AKI+DFGL++ + +
Sbjct: 147 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 248 TRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIK 306
R M A E + SDV+ +GV+L EI++ G
Sbjct: 205 VRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------------------ 240
Query: 307 PY--LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
PY ++ + + RL+ P ++ L +C +P RPS +++ +L R+
Sbjct: 241 PYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-39
Identities = 65/295 (22%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
+LGEG FG+V++G G +AVK + +L E++ SE + L HP+
Sbjct: 19 ILGEGFFGEVYEG----VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+L+G E++ ++ E G L ++L S++ L + ++ + +A+L
Sbjct: 75 IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYL- 129
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPE 260
++RD NIL+ K+ DFGL++ + + T + +PE
Sbjct: 130 -ESINCVHRDIAVRNILVASPECVKLGDFGLSRY----IEDEDYYKASVTRLPIKWMSPE 184
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
+ SDV+ F V + EIL+ G+ +P+ + + +I
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSF----------GK-------QPF--FWLENKDVIG 225
Query: 321 ARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQ 372
+G P + L +C + +P RP E+V +L + ++
Sbjct: 226 VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 83/323 (25%), Positives = 132/323 (40%), Gaps = 87/323 (26%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSG--TVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSH 141
LGEG FGKV K A G T +AVK L S + SE N L +++H
Sbjct: 30 TLGEGEFGKVVKA----TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------- 188
P++++L G C +D LLL+ E+ + GSL L +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 189 -------LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241
+ A ++G+ +L ++ ++++RD A NIL+ KISDFGL+
Sbjct: 146 ALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLS------ 197
Query: 242 SQSHVTTRVMGTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLVEIL 284
R + Y YV H+Y +SDV+ FGV+L EI+
Sbjct: 198 -------RDV----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 285 T-GLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHIIDA-RLQGQYPYKAAYQIAQLSL 340
T G PY + +R F + R+ + P + ++ +L L
Sbjct: 247 TLGG------------------NPYPGIPPERLFNLLKTGHRM--ERPDNCSEEMYRLML 286
Query: 341 KCLEAEPKHRPSMREVVETLERL 363
+C + EP RP ++ + LE++
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKM 309
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 33/292 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
++G G G+V G L +A+K L + + + ++ SE + +G+ HPN
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRD----VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++RL G + ++V E+M+ GSL+ L + + G G+ +L
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---MQLVGMLRGVGAGMRYL- 167
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAAPEYV 262
SD ++RD A N+L+D + K+SDFGL++ L ++ TT + APE +
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
A SDV+ FGVV+ E+L G+ +PY R +I +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAY----------GE-------RPY--WNMTNRDVISSV 267
Query: 323 LQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPK 371
+G P + + QL L C + RP ++V L+ L S + +
Sbjct: 268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR 319
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 83/317 (26%), Positives = 123/317 (38%), Gaps = 73/317 (23%)
Query: 85 VLGEGGFGKVFKGWLDEKAPG--KSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-S 140
LG G FGKV + A G KS + +AVK L L E SE+ L L +
Sbjct: 30 TLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------ 188
H N+V LLG C L++ E+ G L N L + S +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 189 --LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHV 246
L + A+G+AFL + K I+RD A NILL KI DFGLA
Sbjct: 146 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLA----------- 192
Query: 247 TTRVMGTYGY-------------AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTN 293
R + APE + +SDV+ +G+ L E+ +
Sbjct: 193 --RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL------- 243
Query: 294 RPSGQHNLVDWIKPY--LSEKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLKCLEAEPKH 349
G PY + KF +I R+ P A ++ + C +A+P
Sbjct: 244 ---GSS-------PYPGMPVDSKFYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLK 291
Query: 350 RPSMREVVETLERLQAS 366
RP+ +++V+ +E+ +
Sbjct: 292 RPTFKQIVQLIEKQISE 308
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-38
Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 40/291 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
+GEG FG V +G +A+K + S E++ E + + HP+
Sbjct: 22 CIGEGQFGDVHQG----IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+L+G + + ++ E G L + L R S+ + A + LA+L
Sbjct: 78 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL---ASLILYAYQLSTALAYL- 132
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPE 260
K+ ++RD A N+L+ + K+ DFGL++ + + + APE
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY----MEDSTYYKASKGKLPIKWMAPE 187
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
+ SDV+ FGV + EIL G KP+ + K +I
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMH----------GV-------KPF--QGVKNNDVIG 228
Query: 321 ARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368
G+ P + L KC +P RP E+ L + ++
Sbjct: 229 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 6e-38
Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 37/292 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G FG+V+ G +G+ V A+K L ++ E + E + +L H L
Sbjct: 274 KLGQGCFGEVWMGTW-------NGTTRV-AIKTLKPGTMSP-EAFLQEAQVMKKLRHEKL 324
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L E+ + +V E+M KGSL + L +G + + L + +A A G+A++
Sbjct: 325 VQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV-- 379
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
++RD +A+NIL+ + K++DFGLA+L ++ + APE
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALY 438
Query: 265 GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHIIDA- 321
G +KSDV+ FG++L E+ T R PY + + +
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNREVLDQVERGY 481
Query: 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQP 373
R+ P + + L +C EP+ RP+ + LE S + QP
Sbjct: 482 RMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 78/312 (25%), Positives = 118/312 (37%), Gaps = 70/312 (22%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHP 142
LG G FG+V + K+ + +AVK L + SE+ L + H
Sbjct: 34 PLGRGAFGQVIEADA--FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 143 NLVRLLGYC-WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------------L 189
N+V LLG C L+++ EF + G+L +L + P +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
+ A+G+ FL + ++ I+RD A NILL KI DFGLA R
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLA-------------R 196
Query: 250 VMGTYGY-------------AAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRP 295
+ APE + ++SDV+ FGV+L EI + G
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-------- 248
Query: 296 SGQHNLVDWIKPY--LSEKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLKCLEAEPKHRP 351
PY + +F + R+ + P ++ Q L C EP RP
Sbjct: 249 ----------SPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRP 296
Query: 352 SMREVVETLERL 363
+ E+VE L L
Sbjct: 297 TFSELVEHLGNL 308
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 82/321 (25%), Positives = 129/321 (40%), Gaps = 83/321 (25%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
+GEG FG+VF+ P + T++AVK L E S ++Q E + +PN
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPF--TMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHL--------------------FGRGASVQPL 183
+V+LLG C K + L++E+M G L L PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 184 AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ 243
+ +L IA A G+A+L S+++ ++RD N L+ + KI+DFGL+
Sbjct: 172 SCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLS-------- 221
Query: 244 SHVTTRVMGTYGYAAPEYVATGH-------------LY----VKSDVYGFGVVLVEILT- 285
R + Y+A Y A G+ Y +SDV+ +GVVL EI +
Sbjct: 222 -----RNI----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 286 GLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHIID-ARLQGQYPYKAAYQIAQLSLKC 342
GL+ PY ++ + ++ D L P ++ L C
Sbjct: 273 GLQ------------------PYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLC 312
Query: 343 LEAEPKHRPSMREVVETLERL 363
P RPS + L+R+
Sbjct: 313 WSKLPADRPSFCSIHRILQRM 333
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 68/348 (19%), Positives = 123/348 (35%), Gaps = 51/348 (14%)
Query: 40 SGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWL 99
G + L F + +G G F +V++
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEK------------KIGRGQFSEVYRAA- 52
Query: 100 DEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSHPNLVRLLGYCWEDKE 156
G +A+KK+ L + E++ L +L+HPN+++ ED E
Sbjct: 53 ------CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106
Query: 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKA 216
L +V E G L + + + K + L +H ++V++RD K
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKP 164
Query: 217 SNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYG 275
+N+ + + K+ D GL + S+ + + V GT Y +PE + Y KSD++
Sbjct: 165 ANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPE-RIHENGYNFKSDIWS 221
Query: 276 FGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP--YKAAY 333
G +L E+ + P+ +K + Q YP Y
Sbjct: 222 LGCLLYEMAAL-------QS-----------PFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 334 --QIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRPTH 379
++ QL C+ +P+ RP + V + +R+ A H
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA-CTASSLEHHHHHH 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 72/299 (24%), Positives = 117/299 (39%), Gaps = 50/299 (16%)
Query: 70 FVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFE 127
V + R K D +G G F V+KG LD + + +A + + +
Sbjct: 18 AVGMSNDGRFLKFDIEIGRGSFKTVYKG-LDTE------TTVEVAWCELQDRKLTKSERQ 70
Query: 128 EWQSEVNFLGRLSHPNLVRLLGYCWED-----KELLLVYEFMQKGSLENHL--FGRGASV 180
++ E L L HPN+VR WE K ++LV E M G+L+ +L F
Sbjct: 71 RFKEEAEMLKGLQHPNIVRFYD-SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----- 124
Query: 181 QPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFGLAKLGP 239
+ + +GL FLHT +I+RD K NI + G + KI D GLA L
Sbjct: 125 -VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-- 181
Query: 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299
++ V+GT + APE + DVY FG+ ++E+ T
Sbjct: 182 --KRASFAKAVIGTPEFMAPEMYEEKYDE-SVDVYAFGMCMLEMATS-------EY---- 227
Query: 300 NLVDWIKPYLSEKRK---FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
PY + +R + + A ++ ++ C+ R S+++
Sbjct: 228 -------PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 67/310 (21%), Positives = 114/310 (36%), Gaps = 63/310 (20%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL 136
+F+ VLG+G FG+V K + A+KK+ + SEV L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKAR--NALDSR-----YYAIKKIRHTEEK-LSTILSEVMLL 56
Query: 137 GRLSHPNLVRLLGYCWEDKE--------------LLLVYEFMQKGSLENHLFGRGASVQP 182
L+H +VR W ++ L + E+ + G+L + + + Q
Sbjct: 57 ASLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 183 -LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL---- 237
W + +I L+++H + +I+RD K NI +D S KI DFGLAK
Sbjct: 116 DEYWRLFRQIL----EALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 238 ---------GPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGL 287
S ++T+ + GT Y A E + Y K D+Y G++ E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP- 227
Query: 288 RALDTNRPSGQHNLVDWIKPYLSEK-RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAE 346
S V+ + +K R ++ ++ +
Sbjct: 228 -------FSTGMERVN-----ILKKLRSVSIEFPPDFDDNKMKVE----KKIIRLLIDHD 271
Query: 347 PKHRPSMREV 356
P RP R +
Sbjct: 272 PNKRPGARTL 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 64/315 (20%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
+FK ++G GGFG+VFK + G +K++ + E+ + EV L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAK--HRI-----DGKTYVIKRVKYNN----EKAEREVKALA 59
Query: 138 RLSHPNLVRLLGYCWEDKE-----------------LLLVYEFMQKGSLENHLFGRGASV 180
+L H N+V G CW+ + L + EF KG+LE + R
Sbjct: 60 KLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 181 QP--LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238
LA + +I +G+ ++H K++I RD K SNI L + KI DFGL
Sbjct: 119 LDKVLALELFEQIT----KGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT-- 170
Query: 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSG 297
S TR GT Y +PE + Y + D+Y G++L E+L
Sbjct: 171 -SLKNDGKRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCD-----TAFE 223
Query: 298 QHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357
++ G + L K L +P+ RP+ E++
Sbjct: 224 TSKFFTDLR-----------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266
Query: 358 ETLERLQASDQKPKQ 372
TL + S +K ++
Sbjct: 267 RTLTVWKKSPEKNER 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 77/322 (23%), Positives = 116/322 (36%), Gaps = 84/322 (26%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHP 142
VLG G FGKV K+G +AVK L + E SE+ + +L SH
Sbjct: 52 VLGSGAFGKVMNATA--YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR-------------- 188
N+V LLG C + L++E+ G L N+L +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 189 -----LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ 243
L A A+G+ FL K ++RD A N+L+ KI DFGLA
Sbjct: 170 TFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLA-------- 219
Query: 244 SHVTTRVMGTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLVEILT- 285
R + + YV G +Y +KSDV+ +G++L EI +
Sbjct: 220 -----RDI----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 286 GLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLK 341
G+ PY + F +I ++ P+ A +I +
Sbjct: 271 GVN------------------PYPGIPVDANFYKLIQNGFKM--DQPFYATEEIYIIMQS 310
Query: 342 CLEAEPKHRPSMREVVETLERL 363
C + + RPS + L
Sbjct: 311 CWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-37
Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 37/297 (12%)
Query: 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSH 141
D LG G FG V +G + K +A+K L EE E + +L +
Sbjct: 341 DIELGCGNFGSVRQGVY--RMRKKQ---IDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
P +VRL+G C + + L+LV E G L L G+ + + ++ + G+ +
Sbjct: 396 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKY 451
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA--AP 259
L +K ++R+ A N+LL + AKISDFGL+K A S+ T R G + AP
Sbjct: 452 L--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAP 508
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319
E + +SDV+ +GV + E L+ GQ KPY +K K ++
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSY----------GQ-------KPY--KKMKGPEVM 549
Query: 320 DARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQP 373
QG+ P + ++ L C + + RP V + + S +
Sbjct: 550 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 79/286 (27%), Positives = 129/286 (45%), Gaps = 45/286 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG+V+ + V AVK + S+ E + +E N + L H L
Sbjct: 195 KLGAGQFGEVWMATYN-------KHTKV-AVKTMKPGSMSV-EAFLAEANVMKTLQHDKL 245
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+L ++ + ++ EFM KGSL + L S QPL + + A G+AF+
Sbjct: 246 VKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFI-- 300
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPEY 261
+ I+RD +A+NIL+ S KI+DFGLA++ + + T G + APE
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARV----IEDNEYTAREGAKFPIKWTAPEA 356
Query: 262 VATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
+ G +KSDV+ FG++L+EI+T G+ PY +I A
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTY----------GR-------IPY--PGMSNPEVIRA 397
Query: 322 RLQGQY----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+G Y P ++ + ++C + P+ RP+ + L+
Sbjct: 398 LERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 40/291 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPN 143
+GEG FG V +G +A+K + S E++ E + + HP+
Sbjct: 397 CIGEGQFGDVHQG----IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+L+G + + ++ E G L + L R S+ + + A + LA+L
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQLSTALAYL- 507
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT---YGYAAPE 260
K+ ++RD A N+L+ + K+ DFGL++ + + + APE
Sbjct: 508 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY----MEDSTYYKASKGKLPIKWMAPE 562
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--LSEKRKFRHI 318
+ SDV+ FGV + EIL G KP+ + I
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMH----------GV-------KPFQGVKNNDVIGRI 605
Query: 319 IDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368
+ RL P + L KC +P RP E+ L + ++
Sbjct: 606 ENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 70/325 (21%), Positives = 127/325 (39%), Gaps = 36/325 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHP 142
+GEG FGK + G +K++N + + EE + EV L + HP
Sbjct: 31 KIGEGSFGKAILVK-------STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N+V+ E+ L +V ++ + G L + + L + L +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H D+++++RD K+ NI L T ++ DFG+A++ +++ + GT Y +PE +
Sbjct: 142 H--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPE-I 196
Query: 263 ATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321
Y KSD++ G VL E+ T A + NLV I F +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKII-----SGSFPPV--- 245
Query: 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET--LERLQASDQKPKQPRVRPTH 379
+Y + L + + P+ RPS+ ++E + + P+
Sbjct: 246 ------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCL 299
Query: 380 SMAHRQGQQPLHHRSPLHTNLDRNR 404
+ G QP+ + P +
Sbjct: 300 KTFSKFGSQPIPAKRPASGQNSISV 324
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 65/285 (22%), Positives = 109/285 (38%), Gaps = 43/285 (15%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFL 136
+F+ + LG G +G+VFK G + AVK+ S + + EV
Sbjct: 58 SFQRLSRLGHGSYGEVFKVR-------SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 137 GRL-SHPNLVRLLGYCWEDKELL-LVYEFMQKGSLENHLFGRGASVQ-PLAWNIRLKIAI 193
++ HP VRL WE+ +L L E SL+ H GAS+ W
Sbjct: 111 EKVGQHPCCVRLEQ-AWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTL- 167
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
LA LH + +++ D K +NI L K+ DFGL +A V G
Sbjct: 168 ---LALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGD 219
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
Y APE + + +DV+ G+ ++E+ + P G
Sbjct: 220 PRYMAPELLQGSYGT-AADVFSLGLTILEVACNMEL-----PHGGEGW------------ 261
Query: 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ + L ++ + ++ + + LE +PK R + ++
Sbjct: 262 --QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 76/329 (23%), Positives = 127/329 (38%), Gaps = 66/329 (20%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLG 137
+F+ LG GGFG VF+ A+K++ E+ EV L
Sbjct: 6 DFEPIQCLGRGGFGVVFEAK-------NKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58
Query: 138 RLSHPNLVRLLGYCWEDKE-------------LLLVYEFMQKGSLENHLFGRGASVQPLA 184
+L HP +VR W +K L + + +K +L++ + GR +++
Sbjct: 59 KLEHPGIVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERE 116
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-------- 236
++ L I + A + FLH K +++RD K SNI K+ DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 237 ---LGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDT 292
L P + + T +V GT Y +PE G+ Y K D++ G++L E+L
Sbjct: 175 QTVLTPMPAYARHTGQV-GTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY------- 225
Query: 293 NRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP---YKAAYQIAQLSLKCLEAEPKH 349
P+ ++ + R + D R ++P + + L P
Sbjct: 226 --------------PFSTQMERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPME 270
Query: 350 RPSMREVVET--LERLQASDQKPKQPRVR 376
RP ++E E L + + R R
Sbjct: 271 RPEAINIIENAVFEDLDFPGKTVLRQRSR 299
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 39/248 (15%), Positives = 82/248 (33%), Gaps = 18/248 (7%)
Query: 52 ESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGT 111
SYPN I E + ++ +LGEG F +V++ + + +
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA--TQGDLNDAKNKQ 96
Query: 112 VIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLEN 171
+K + F + L ++ +LV E G+L N
Sbjct: 97 KFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLN 156
Query: 172 HL-FGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA--- 227
+ + + + + + A+ + +H D ++I+ D K N +L +
Sbjct: 157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDD 214
Query: 228 --------KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGV 278
+ D G + + + T T G+ E + + + + D +G
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAA 273
Query: 279 VLVEILTG 286
+ +L G
Sbjct: 274 TVYCMLFG 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 78/359 (21%), Positives = 121/359 (33%), Gaps = 76/359 (21%)
Query: 20 GISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRN 79
G +S + S S S G E+ N +L T L+ + E R
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHW 59
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL 139
+G G FG+V + D +G AVKK+ E + E+ L
Sbjct: 60 MTHQPRVGRGSFGEVHRM-KD------KQTGFQCAVKKVRLEVFR-----VEELVACAGL 107
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
S P +V L G E + + E ++ GSL + G + A + GL
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA----LEGL 163
Query: 200 AFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFGLAK-LGPSASQSHVTTR--VMGTYG 255
+LH +++++ D KA N+LL A + DFG A L P + T + GT
Sbjct: 164 EYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 256 YAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ APE V G K D++ +++ +L G P+
Sbjct: 222 HMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGCH------------------PWTQY--- 259
Query: 315 FRHIIDARLQGQYPYKAAYQIAQ-----------LS-------LKCLEAEPKHRPSMRE 355
+ +IA + + L EP HR S E
Sbjct: 260 ------------FRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAME 306
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 63/363 (17%), Positives = 129/363 (35%), Gaps = 70/363 (19%)
Query: 15 HLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELR 74
H SS + + + + + D++ + + RI++ ++
Sbjct: 5 HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ- 63
Query: 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK-----KLNSESLQGFEEW 129
+G GG KVF+ + + A+K + ++++L +
Sbjct: 64 -----------IGSGGSSKVFQV--------LNEKKQIYAIKYVNLEEADNQTLDSY--- 101
Query: 130 QSEVNFLGRLSHPNL--VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNI 187
++E+ +L +L + +RL Y D+ + +V E L + L + +
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK----SIDPWE 156
Query: 188 RLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT 247
R + +H +++ D K +N L+ K+ DFG+A + S V
Sbjct: 157 RKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 213
Query: 248 TRVMGTYGYAAPE---------YVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRPS 296
+G Y PE + KSDV+ G +L + G +
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-------KT- 265
Query: 297 GQHNLVDWIKPY---LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353
P+ +++ K IID + ++P + + CL+ +PK R S+
Sbjct: 266 ----------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315
Query: 354 REV 356
E+
Sbjct: 316 PEL 318
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-33
Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 41/285 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHP 142
+G G +G+ K + G ++ K+L+ S+ + SEVN L L HP
Sbjct: 13 TIGTGSYGRCQKIR-------RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 143 NLVRLLG--YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
N+VR + L +V E+ + G L + + Q L L++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 201 FLH---TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
H V++RD K +N+ LDG K+ DFGLA++ + S T V GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYM 183
Query: 258 APEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
+PE Y KSD++ G +L E+ + Q L I+
Sbjct: 184 SPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIR---------- 229
Query: 317 HIIDARLQGQY-PYKAAY--QIAQLSLKCLEAEPKHRPSMREVVE 358
+G++ Y ++ ++ + L + HRPS+ E++E
Sbjct: 230 -------EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 58/293 (19%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK-----KLNSESLQGFEEWQSEVNFLGRL 139
+G GG KVF+ + + A+K + ++++L + ++E+ +L +L
Sbjct: 35 QIGSGGSSKVFQV--------LNEKKQIYAIKYVNLEEADNQTLDSY---RNEIAYLNKL 83
Query: 140 SHPNL--VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
+ +RL Y D+ + +V E L + L + + R
Sbjct: 84 QQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK----SIDPWERKSYWKNMLE 138
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
+ +H +++ D K +N L+ K+ DFG+A + S V +GT Y
Sbjct: 139 AVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 258 APE---------YVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306
PE + KSDV+ G +L + G +
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-------KT----------- 237
Query: 307 PY---LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
P+ +++ K IID + ++P + + CL+ +PK R S+ E+
Sbjct: 238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 58/294 (19%), Positives = 110/294 (37%), Gaps = 60/294 (20%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK-----KLNSESLQGFEEWQSEVNFLGRL 139
+G GG KVF+ + + A+K + ++++L + ++E+ +L +L
Sbjct: 16 QIGSGGSSKVFQV--------LNEKKQIYAIKYVNLEEADNQTLDSY---RNEIAYLNKL 64
Query: 140 SHPNL--VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
+ +RL Y D+ + +V E L + L + + R
Sbjct: 65 QQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK----SIDPWERKSYWKNMLE 119
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
+ +H +++ D K +N L+ K+ DFG+A + S V +GT Y
Sbjct: 120 AVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 258 APEYVATGHLYV------------KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305
PE KSDV+ G +L + G +
Sbjct: 177 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-------KT---------- 218
Query: 306 KPY---LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
P+ +++ K IID + ++P + + CL+ +PK R S+ E+
Sbjct: 219 -PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 69/295 (23%), Positives = 113/295 (38%), Gaps = 72/295 (24%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
VLG+G +G V+ G D + IA+K++ + + E+ L H N+
Sbjct: 29 VLGKGTYGIVYAG-RD------LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLEN---HLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
V+ LG E+ + + E + GSL +G + +I GL +
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI----LEGLKY 137
Query: 202 LHTSDKQVIYRDFKASNILLD-GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
LH D Q+++RD K N+L++ S KISDFG +K A + T GT Y APE
Sbjct: 138 LH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPE 193
Query: 261 YV---ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
+ G+ +D++ G ++E+ TG P + L +
Sbjct: 194 IIDKGPRGYGK-AADIWSLGCTIIEMATG------KPP--FYELGE-------------- 230
Query: 318 IIDARLQGQYPYKAAYQIA----------QLS-------LKCLEAEPKHRPSMRE 355
P A +++ +S LKC E +P R +
Sbjct: 231 ----------PQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACAND 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 54/312 (17%), Positives = 112/312 (35%), Gaps = 53/312 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS------- 131
+++ L +G F K+ L EK A+KK L+ ++
Sbjct: 32 DYRIIRTLNQGKFNKII---LCEK------DNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 132 ----------EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQ 181
E+ + + + + G E+ ++YE+M+ S+ +
Sbjct: 83 IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 182 PLAWNIRLKIAIGAAR----GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237
I +++ + +++H ++K + +RD K SNIL+D + K+SDFG ++
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRP 295
+ GTY + PE+ + Y K D++ G+ L +
Sbjct: 202 MVD---KKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN-------VV 250
Query: 296 --SGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLS-------LKCLEAE 346
S + +LV+ ++ ++ + L K+ LS L
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310
Query: 347 PKHRPSMREVVE 358
P R + + ++
Sbjct: 311 PAERITSEDALK 322
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 81/360 (22%), Positives = 135/360 (37%), Gaps = 67/360 (18%)
Query: 79 NFKSDTVLGEGGFGK-VFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
+F VLG G G V++G D +AVK++ E + EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD---------NRDVAVKRILPECFSFAD---REVQLLR 72
Query: 138 RLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGAS-VQPLAWNIRLKIAIGA 195
HPN++R + + + E +L+ ++ + + + + +
Sbjct: 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTT--- 128
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILL-----DGSYTAKISDFGLAK-LGPSASQSHVTTR 249
GLA LH +++RD K NIL+ G A ISDFGL K L +
Sbjct: 129 -SGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 250 VMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306
V GT G+ APE + + D++ G V +++ G H
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE----------GSH------- 228
Query: 307 PY--LSEKRKFRHIIDARLQGQYPYKAAYQIAQ-LSLKCLEAEPKHRPSMREV------V 357
P+ +++ + L +P K IA+ L K + +P+ RPS + V
Sbjct: 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
Query: 358 ETLERLQ----ASDQKPKQPRVRP------THSMAHRQGQQPLHHRSPLHTNLDRNRGYQ 407
++LQ SD+ K+ P A + + PL T+L + R Y+
Sbjct: 289 SLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYK 348
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 60/305 (19%), Positives = 103/305 (33%), Gaps = 41/305 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFLG 137
+ +LG+G VF+G K +G + A+K N+ S + E L
Sbjct: 10 LWLLSDILGQGATANVFRGR--HKK-----TGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 138 RLSHPNLVRLLGYCWED---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
+L+H N+V+L E+ + +L+ EF GSL L + L + L +
Sbjct: 63 KLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILL----DGSYTAKISDFGLAKLGPSASQSHVTTRV 250
G+ L + +++R+ K NI+ DG K++DFG A+ +
Sbjct: 121 VVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY 176
Query: 251 MGTYGYAAPEYVATGHLYV--------KSDVYGFGVVLVEILTG-LRALDTNRPSGQHNL 301
GT Y P+ L D++ GV TG L P +
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 302 VDWIK----------PYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP 351
+ I +E D + + + LEA+ +
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
Query: 352 SMREV 356
+
Sbjct: 296 GFDQF 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 60/313 (19%), Positives = 104/313 (33%), Gaps = 41/313 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFLG 137
+ +LG+G VF+G K +G + A+K N+ S + E L
Sbjct: 10 LWLLSDILGQGATANVFRGR--HKK-----TGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 138 RLSHPNLVRLLGYCWED---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
+L+H N+V+L E+ + +L+ EF GSL L + L + L +
Sbjct: 63 KLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILL----DGSYTAKISDFGLAKLGPSASQSHVTTRV 250
G+ L + +++R+ K NI+ DG K++DFG A+ +
Sbjct: 121 VVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY 176
Query: 251 MGTYGYAAPEYVATGHLYV--------KSDVYGFGVVLVEILTG-LRALDTNRPSGQHNL 301
GT Y P+ L D++ GV TG L P +
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 302 VDWIK----------PYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP 351
+ I +E D + + + LEA+ +
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
Query: 352 SMREVVETLERLQ 364
+ +
Sbjct: 296 GFDQFFAETSDIL 308
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEE-WQSEVNFLGRLSH 141
LG+G FG V+ EK S ++A+K L L+ G E + EV L H
Sbjct: 16 PLGKGKFGNVYLA--REKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
PN++RL GY + + L+ E+ G++ L + ++A L++
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSY 124
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
H+ K+VI+RD K N+LL + KI+DFG + P S GT Y PE
Sbjct: 125 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPE- 177
Query: 262 VATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
+ G ++ K D++ GV+ E L G + N + + ++ I
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISR 221
Query: 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+P L + L+ P RP +REV+E
Sbjct: 222 VEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 78/315 (24%), Positives = 123/315 (39%), Gaps = 58/315 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN 143
VL EGGF V++ GSG A+K+L S + EV F+ +LS HPN
Sbjct: 35 VLAEGGFAFVYEA-------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 144 LVRLLGYCWEDKE-------LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
+V+ KE L+ + KG L L + PL+ + LKI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTC 146
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA---KLGPSASQSHVTTRVM-- 251
R + +H +I+RD K N+LL T K+ DFG A P S S ++
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 252 -----GTYGYAAPEYV-ATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRP----SGQH 299
T Y PE + + + K D++ G +L + + +G++
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY 266
Query: 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359
+ I P+ ++ F +I L+ P+ R S+ EVV
Sbjct: 267 S----IPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQ 302
Query: 360 LERLQAS-DQKPKQP 373
L+ + A+ + PK P
Sbjct: 303 LQEIAAARNVNPKSP 317
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 56/336 (16%), Positives = 106/336 (31%), Gaps = 53/336 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFLGRLSHPN 143
+ GG G ++ LD G+ + +K L + +E FL + HP+
Sbjct: 87 CIAHGGLGWIYLA-LDRNVNGR-----PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 144 LVRLLGY-----CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
+V++ + D +V E++ SL+ L + +
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPA 194
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
L++LH ++Y D K NI+L K+ D G + + GT G+ A
Sbjct: 195 LSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS---RINS---FGYLYGTPGFQA 245
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318
PE + V +D+Y G L + L + G P L + +
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTYDSYGRL 300
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQASDQKPKQPRVRP 377
+ + ++ +P+ R + E+ L + RP
Sbjct: 301 L--------------------RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRP 340
Query: 378 THSMAHRQGQQPLHHRSPLHTNLDRNRGYQHSPRVR 413
S + + G H+ ++
Sbjct: 341 GLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLT 376
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 31/295 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFLG 137
++ LG GGFG V + + +G +A+K+ E E W E+ +
Sbjct: 15 PWEMKERLGTGGFGYVLRWI--HQD-----TGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 138 RLSHPNLVRLL------GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
+L+HPN+V + LL E+ + G L +L + L +
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTL 126
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYTAKISDFGLAKLGPSASQSHVTT 248
+ L +LH + ++I+RD K NI+L KI D G AK T
Sbjct: 127 LSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTE 182
Query: 249 RVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLR-ALDTNRPSGQHNLV---- 302
V GT Y APE + Y V D + FG + E +TG R L +P H V
Sbjct: 183 FV-GTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 303 -DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREV 356
+ I Y + A ++ + L + R + +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEE-WQSEVNFLGRLSH 141
LG+G FG V+ EK + ++A+K L L+ G E + E+ L H
Sbjct: 21 PLGKGKFGNVYLA--REKQ-----NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
PN++R+ Y + K + L+ EF +G L L G + + ++A L +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA----DALHY 129
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
H ++VI+RD K N+L+ KI+DFG + PS + T GT Y PE
Sbjct: 130 CHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TM--CGTLDYLPPE- 182
Query: 262 VATGHLY-VKSDVYGFGVVLVEILTG 286
+ G + K D++ GV+ E L G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-29
Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 43/280 (15%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEE-WQSEVNFLGRLSHP 142
LG+G F V++ + +G +A+K ++ +++ G + Q+EV +L HP
Sbjct: 19 LGKGSFAGVYRA--ESIH-----TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQ-PLAWNIRLKIAIGAARGLAF 201
+++ L Y + + LV E G + +L R A + +I G+ +
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLY 127
Query: 202 LHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
LH+ +++RD SN+LL + KI+DFGLA + H T GT Y +PE
Sbjct: 128 LHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPE- 182
Query: 262 VATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK--FRHI 318
+AT + ++SDV+ G + +L G RP P+ ++ K +
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIG-------RP-----------PFDTDTVKNTLNKV 224
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ A + P + + L + L P R S+ V++
Sbjct: 225 VLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 69/287 (24%), Positives = 113/287 (39%), Gaps = 42/287 (14%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF---EEWQSEVN 134
R + LG+GGF K F+ + + V A K + L E+ E++
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDAD-------TKEVFAGKIVPKSLLLKPHQREKMSMEIS 67
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L+H ++V G+ ++ + +V E ++ SL R A +P A +I
Sbjct: 68 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV-- 125
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
G +LH +VI+RD K N+ L+ KI DFGLA + GT
Sbjct: 126 --LGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTP 179
Query: 255 GYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
Y APE V + + + DV+ G ++ +L G +P P+ +
Sbjct: 180 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVG-------KP-----------PFETSCL 220
Query: 314 K--FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
K + I P A L K L+ +P RP++ E++
Sbjct: 221 KETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 72/301 (23%), Positives = 109/301 (36%), Gaps = 49/301 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPN 143
LG G G VFK SG V+A K ++ E + E+ L + P
Sbjct: 40 ELGAGNGGVVFKVSHKP-------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHL-FGRGASVQPLAWNIRLKIAIGAARGLAFL 202
+V G + D E+ + E M GSL+ L Q L K++I +GL +L
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLA-KLGPSASQSHVTTRVMGTYGYAAPEY 261
++++RD K SNIL++ K+ DFG++ +L S + S V GT Y +PE
Sbjct: 148 R-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPE- 200
Query: 262 VATGHLY-VKSDVYGFGVVLVEILTG---LRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
G Y V+SD++ G+ LVE+ G + D + R
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 318 IIDARLQGQYPYKAAYQIAQLSL-----------------------KCLEAEPKHRPSMR 354
G L KCL P R ++
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 355 E 355
+
Sbjct: 321 Q 321
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 60/319 (18%), Positives = 106/319 (33%), Gaps = 65/319 (20%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVN 134
T F +G G FG VFK K G + A+K+ +E + EV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV-------KRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 135 FLGRLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
L H ++VR ED +L+ E+ GSL + + + + +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLD-------------------GSYTAKISDFGL 234
RGL ++H +++ D K SNI + KI D G
Sbjct: 123 QVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTN 293
S G + A E + + + K+D++ + +V
Sbjct: 181 VT-----RISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA------- 227
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPY---KAAYQIAQLSLKCLEAEPKHR 350
+P ++ I QG+ P + + +L + +P+ R
Sbjct: 228 ------------EPLPRNGDQWHEIR----QGRLPRIPQVLSQEFTELLKVMIHPDPERR 271
Query: 351 PSMREVVETLERLQASDQK 369
PS +V+ L ++ +K
Sbjct: 272 PSAMALVK-HSVLLSASRK 289
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 68/309 (22%), Positives = 125/309 (40%), Gaps = 58/309 (18%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEE-WQSEVNFLGRLSHP 142
LG GG V+ D +A+K + + + ++ EV+ +LSH
Sbjct: 19 LGGGGMSTVYLA-EDTIL------NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N+V ++ ED LV E+++ +L ++ G PL+ + + G+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHA 127
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H D ++++RD K NIL+D + T KI DFG+AK S + T V+GT Y +PE
Sbjct: 128 H--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQA 184
Query: 263 ATGHLYVKSDVYGFGVVLVEILTG-------------LRALDTNRPSGQHNLVDWIKPYL 309
+D+Y G+VL E+L G ++ + + P+ ++ I L
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244
Query: 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQASDQ 368
S +I L+ E + +R +++E+ + L + +
Sbjct: 245 SN------VI--------------------LRATEKDKANRYKTIQEMKDDLSSV-LHEN 277
Query: 369 KPKQPRVRP 377
+ +
Sbjct: 278 RANEDVYEL 286
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 36/321 (11%), Positives = 65/321 (20%), Gaps = 56/321 (17%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS 131
L R K L G VF A+K + E +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVR-------DVERLEDFALKVFTMGAENSRSELER 108
Query: 132 ---EVNFLGRLSHPNLVRLLGYC--------------------------WEDKELLLVYE 162
RL + + LL+
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 163 FMQ--KGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNIL 220
L + L + R A L K +++ F N+
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLF 226
Query: 221 LDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYV--KSDVYGFGV 278
+ + D YA E++ + + G+
Sbjct: 227 IMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 279 VLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQL 338
+ + P + ++ R L + L
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTL 332
Query: 339 SLKCLEAEPKHRPSMREVVET 359
+ L + + R E +ET
Sbjct: 333 IGRFLNFDRRRRLLPLEAMET 353
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 69/287 (24%), Positives = 113/287 (39%), Gaps = 42/287 (14%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF---EEWQSEVN 134
R + LG+GGF K F+ + + V A K + L E+ E++
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDAD-------TKEVFAGKIVPKSLLLKPHQREKMSMEIS 93
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L+H ++V G+ ++ + +V E ++ SL R A +P A +I
Sbjct: 94 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV-- 151
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
G +LH +VI+RD K N+ L+ KI DFGLA + GT
Sbjct: 152 --LGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTP 205
Query: 255 GYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
Y APE V + + + DV+ G ++ +L G +P P+ +
Sbjct: 206 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVG-------KP-----------PFETSCL 246
Query: 314 K--FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
K + I P A L K L+ +P RP++ E++
Sbjct: 247 KETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 75/303 (24%), Positives = 123/303 (40%), Gaps = 79/303 (26%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL 136
+ + +G+G G V+ +G +A++++N + E +E+ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM-------DVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK---IAI 193
+PN+V L EL +V E++ GSL + + + IA
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAA 120
Query: 194 ---GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTR 249
+ L FLH+ QVI+RD K+ NILL + K++DFG A++ + QS +T
Sbjct: 121 VCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTM 176
Query: 250 VMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTG---------LRAL---DTNRPS 296
V GT + APE V T Y K D++ G++ +E++ G LRAL TN
Sbjct: 177 V-GTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT- 233
Query: 297 GQHNLVDWIKPYLSEKRK----FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352
P L K FR ++ +CLE + + R S
Sbjct: 234 ----------PELQNPEKLSAIFRDFLN--------------------RCLEMDVEKRGS 263
Query: 353 MRE 355
+E
Sbjct: 264 AKE 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 71/303 (23%), Positives = 120/303 (39%), Gaps = 79/303 (26%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL 136
S +GEG G V + SG +AVK ++ Q E +EV +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAR-------EKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 96
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK---IAI 193
H N+V + +EL ++ EF+Q G+L + + +RL IA
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-----------IVSQVRLNEEQIAT 145
Query: 194 ---GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTR 249
+ LA+LH + VI+RD K+ +ILL K+SDFG A++ S +
Sbjct: 146 VCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSL 201
Query: 250 VMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTG---------LRAL---DTNRPS 296
V GT + APE V + LY + D++ G++++E++ G ++A+ + P
Sbjct: 202 V-GTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP- 258
Query: 297 GQHNLVDWIKPYLSEKRK----FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352
P L K R ++ + L +P+ R +
Sbjct: 259 ----------PKLKNSHKVSPVLRDFLE--------------------RMLVRDPQERAT 288
Query: 353 MRE 355
+E
Sbjct: 289 AQE 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 50/298 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLG 137
+++ V+G G V +A+K++N E Q +E E+ +
Sbjct: 16 DYELQEVIGSGATAVVQAA-YCAP------KKEKVAIKRINLEKCQTSMDELLKEIQAMS 68
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR-LKIAI--- 193
+ HPN+V EL LV + + GS+ + + A + + + IA
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTR--V 250
GL +LH I+RD KA NILL + +I+DFG+ A L + R
Sbjct: 129 EVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 251 MGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTG---------LRAL---DTNRPSG 297
+GT + APE + Y K+D++ FG+ +E+ TG ++ L N P
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 298 QHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
V + + FR +I CL+ +P+ RP+ E
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMIS--------------------LCLQKDPEKRPTAAE 284
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 78/379 (20%), Positives = 136/379 (35%), Gaps = 83/379 (21%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL 139
S+ +LG G G V G G +AVK++ + E+ L
Sbjct: 17 VVSEKILGYGSSGTVVFQ-------GSF-QGRPVAVKRMLIDFCDIA---LMEIKLLTES 65
Query: 140 S-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI---GA 195
HPN++R D+ L + E +L++ + + S + L
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLD-------------GSYTAKISDFGLAKL---GP 239
A G+A LH ++I+RD K NIL+ + ISDFGL K G
Sbjct: 125 ASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 240 SASQSHVTTRVMGTYGYAAPE------YVATGHLYVKS-DVYGFGVVLVEILTGLRALDT 292
S+ ++++ GT G+ APE + T +S D++ G V IL+
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------ 235
Query: 293 NRPSGQHNLVDWIKPYLSEKRKFRHIIDAR-----LQGQYPYKAAYQIAQLSLKCLEAEP 347
G+H P+ + + +II ++ + + L + ++ +P
Sbjct: 236 ----GKH-------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284
Query: 348 KHRPSMREV------VETLERLQ----ASDQKPKQPRVRPTHSMAH---------RQGQQ 388
RP+ +V ++L+ SD+ + R P+ + G
Sbjct: 285 LKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDW 344
Query: 389 PLHHRSPLHTNLDRNRGYQ 407
+ NL+R R Y
Sbjct: 345 TVKFDKTFMDNLERYRKYH 363
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 66/234 (28%), Positives = 96/234 (41%), Gaps = 35/234 (14%)
Query: 68 FTFVELRAATRN-FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--- 123
+ ++E + + F VLG GGFG+VF + +G + A KKLN + L
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVF---ACQMK----ATGKLYACKKLNKKRLKKR 226
Query: 124 QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQP 182
+G++ E L ++ +V L Y +E K L LV M G + H++
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP- 284
Query: 183 LAWNIRLKIAIGAAR--------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234
A GL LH + +IYRD K N+LLD +ISD GL
Sbjct: 285 -------GFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
A + GT G+ APE + G Y S D + GV L E++
Sbjct: 336 AVELKAGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 74/301 (24%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL 139
++ LG+G FGKV+K +++ +G + A K + ++S + E++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA-KNKE------TGALAAAKVIETKSEEELEDYIVEIEILATC 73
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI---GAA 196
HP +V+LLG + D +L ++ EF G+++ + + +I +
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT------EPQIQVVCRQML 127
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYG 255
L FLH+ K++I+RD KA N+L+ +++DFG+ AK + + +GT
Sbjct: 128 EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDS-FIGTPY 182
Query: 256 YAAPEYVATGHL----Y-VKSDVYGFGVVLVEILTG---------LRAL---DTNRPSGQ 298
+ APE V + Y K+D++ G+ L+E+ +R L + P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP--- 239
Query: 299 HNLVDWIKPYLSEKRK----FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
P L K FR + L+ P+ RPS
Sbjct: 240 --------PTLLTPSKWSVEFRDFLK--------------------IALDKNPETRPSAA 271
Query: 355 E 355
+
Sbjct: 272 Q 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 49/285 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HP 142
LG G +G V K SG ++AVK++ + Q + +++ R P
Sbjct: 14 ELGRGAYGVVEKMRHVP-------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
V G + + ++ + E M SL+ Q + +I KIA+ + L L
Sbjct: 67 FTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYAAPE- 260
H S VI+RD K SN+L++ K+ DFG+ L ++ G Y APE
Sbjct: 126 H-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMAPER 180
Query: 261 --YVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR- 316
Y VKSD++ G+ ++E+ R PY S F+
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAIL-------RF-----------PYDSWGTPFQQ 222
Query: 317 --HIIDA---RL-QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
+++ +L ++ + +Q CL+ K RP+ E
Sbjct: 223 LKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 263
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 66/293 (22%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGR 138
F +G+G FG+VFKG +D + + V+A+K ++ E + E+ Q E+ L +
Sbjct: 24 FTKLEKIGKGSFGEVFKG-IDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 76
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
P + + G +D +L ++ E++ GS + L +A +R +G
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKG 131
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYA 257
L +LH+ ++ I+RD KA+N+LL K++DFG+ +L + +Q T +GT +
Sbjct: 132 LDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNT-FVGTPFWM 186
Query: 258 APEYVATGHLY-VKSDVYGFGVVLVEILTG---------LRAL---DTNRPSGQHNLVDW 304
APE V Y K+D++ G+ +E+ G ++ L N P
Sbjct: 187 APE-VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--------- 236
Query: 305 IKPYLSEK--RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
P L + + ++ CL EP RP+ +E
Sbjct: 237 --PTLEGNYSKPLKEFVE--------------------ACLNKEPSFRPTAKE 267
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 65/287 (22%), Positives = 115/287 (40%), Gaps = 54/287 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HP 142
+G G G+V+K + +G VIAVK++ + + +++ + + P
Sbjct: 32 EMGSGTCGQVWKMRFRK-------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
+V+ G + ++ + E M + + +G P+ I K+ + + L +L
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTVAIVKALYYL 140
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYAAPE- 260
VI+RD K SNILLD K+ DFG+ +L ++ R G Y APE
Sbjct: 141 K-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMAPER 195
Query: 261 ---YVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
T Y +++DV+ G+ LVE+ TG + PY + K F
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATG-------QF-----------PYKNCKTDFE 237
Query: 317 ---HIIDA---RLQGQYPYKAAYQ--IAQLSLKCLEAEPKHRPSMRE 355
++ L G + +Q + CL + + RP +
Sbjct: 238 VLTKVLQEEPPLLPGHMGFSGDFQSFVKD----CLTKDHRKRPKYNK 280
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 68/284 (23%), Positives = 116/284 (40%), Gaps = 43/284 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLS-HP 142
+G G +G V K + + SG ++AVK++ S + ++ +++ + R S P
Sbjct: 29 EIGRGAYGSVNKM-VHKP------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
+V+ G + + + + E M + + + + I KI + + L L
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMGTYGYAAPE- 260
+ ++I+RD K SNILLD S K+ DFG+ +L S ++ TR G Y APE
Sbjct: 142 K-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPER 196
Query: 261 --YVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR- 316
A+ Y V+SDV+ G+ L E+ TG R PY F
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATG-------RF-----------PYPKWNSVFDQ 238
Query: 317 --HIIDA---RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
++ +L + + CL + RP +E
Sbjct: 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+F ++G GGFG+V+ K+ +G + A+K L+ + + QG +E
Sbjct: 190 DFSVHRIIGRGGFGEVY-------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 136 LGRLS---HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
L +S P +V + Y + + L + + M G L HL G + R
Sbjct: 243 LSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM---RFYA 298
Query: 192 A-IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
A I GL +H ++ V+YRD K +NILLD +ISD GLA V
Sbjct: 299 AEI--ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV 351
Query: 251 MGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
GT+GY APE + G Y S D + G +L ++L G
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 42/330 (12%), Positives = 85/330 (25%), Gaps = 88/330 (26%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG---FEEWQSEV 133
R TVLG+ + +G V ++ + EV
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEAT-------DQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 134 NFLGRL-------------------------SHPNLVRLLGYC--WEDKELLLVYEFMQK 166
L L ++R+ +Y MQ
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 167 --GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224
+ L ++ + L + RL++ + R LA LH +++ + +I+LD
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQR 242
Query: 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYV-----------KSDV 273
++ F + + G+ PE A D
Sbjct: 243 GGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 274 YGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF----RHIIDARLQGQYPY 329
+ G+V+ I + P + + + + R +++
Sbjct: 297 WALGLVIYWIWCA------DLPITKDAALGGSEWIFRSCKNIPQPVRALLE--------- 341
Query: 330 KAAYQIAQLSLKCLEAEPKHRPSMREVVET 359
L + R + +ET
Sbjct: 342 -----------GFLRYPKEDRLLPLQAMET 360
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 68/326 (20%), Positives = 121/326 (37%), Gaps = 58/326 (17%)
Query: 46 SASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSD----TVLGEGGFGKVFKGWLDE 101
+S + Y G + TP + I + + LG G +G+V +
Sbjct: 7 HSSGRENLYFQGDLQATPGMFI------TSKKGHLSEMYQRVKKLGSGAYGEVLLCR--D 58
Query: 102 KAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLL 159
K + A+K + S+ + EV L L HPN+++L + + + L
Sbjct: 59 KV-----THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113
Query: 160 VYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNI 219
V E + G L + + R + A I ++ G+ +LH +++RD K N+
Sbjct: 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQV----LSGVTYLH--KHNIVHRDLKPENL 167
Query: 220 LL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGF 276
LL + KI DFGL+ + +GT Y APE V K DV+
Sbjct: 168 LLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 277 GVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAY--- 333
GV+L +L G +++ R + +G+Y + +
Sbjct: 224 GVILFILLAGYPPFGGQ----------------TDQEILRKV----EKGKYTFDSPEWKN 263
Query: 334 ---QIAQLSLKCLEAEPKHRPSMREV 356
L + L+ + + R S ++
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 67/300 (22%), Positives = 123/300 (41%), Gaps = 73/300 (24%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL 136
F LGEG +G V+K +G ++A+K++ E +E E++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAI-------HKETGQIVAIKQVPVE--SDLQEIIKEISIM 78
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI--- 193
+ P++V+ G +++ +L +V E+ GS+ + + R ++ +IA
Sbjct: 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT------EDEIATILQ 132
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTRVMG 252
+GL +LH + I+RD KA NILL+ AK++DFG+ +L + + + T + G
Sbjct: 133 STLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVI-G 187
Query: 253 TYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTG---------LRAL---DTNRPSGQH 299
T + APE V Y +D++ G+ +E+ G +RA+ TN P
Sbjct: 188 TPFWMAPE-VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP---- 242
Query: 300 NLVDWIKPYLSEKRK----FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
P + F + +CL P+ R + +
Sbjct: 243 -------PTFRKPELWSDNFTDFVK--------------------QCLVKSPEQRATATQ 275
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 73/229 (31%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 68 FTFVELRAATRN-FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--- 123
+ ++E + T+N F+ VLG+GGFG+V + +G + A KKL + +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVC---ACQVR----ATGKMYACKKLEKKRIKKR 225
Query: 124 QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASV-- 180
+G +E L +++ +V L Y +E K+ L LV M G L+ H++ G +
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 181 QPLAWNIRLKIA-IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGP 239
+ A A I GL LH ++++YRD K NILLD +ISD GLA P
Sbjct: 285 EARA---VFYAAEI--CCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 240 SASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
RV GT GY APE V Y S D + G +L E++ G
Sbjct: 338 EGQTIK--GRV-GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ--SEVNFLGRLSHP 142
VLG+G FGKVF L +K G + + A+K L +L+ + + E + L ++HP
Sbjct: 31 VLGQGSFGKVF---LVKKISGS-DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 143 NLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARGLA 200
+V+L Y ++ + L L+ +F++ G L L + + +A + A L
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV---KFYLAELALA--LD 140
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GTYGYAAP 259
LH +IYRD K NILLD K++DFGL+K + GT Y AP
Sbjct: 141 HLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAP 195
Query: 260 EYVATGHLYVKS-DVYGFGVVLVEILTGL 287
E V + +S D + FGV++ E+LTG
Sbjct: 196 E-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEW---QSEVN 134
F+ VLG+GG+GKVF K G +G + A+K L + + ++ ++E N
Sbjct: 18 CFELLRVLGKGGYGKVF---QVRKVTGA-NTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 135 FLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA- 192
L + HP +V L+ Y ++ L L+ E++ G L L G ++ A +A
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA---CFYLAE 129
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM- 251
I A L LH K +IYRD K NI+L+ K++DFGL K T
Sbjct: 130 ISMA--LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFC 182
Query: 252 GTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
GT Y APE + + ++ D + G ++ ++LTG
Sbjct: 183 GTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 81/326 (24%), Positives = 125/326 (38%), Gaps = 80/326 (24%)
Query: 61 PTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNS 120
P +L LR F+ ++G G +G+V+KG K +G + A+K ++
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVK------TGQLAAIKVMDV 59
Query: 121 ESLQGFEEWQSEVNFLGRLS-HPNLVRLLG------YCWEDKELLLVYEFMQKGSLENHL 173
EE + E+N L + S H N+ G D +L LV EF GS+ + +
Sbjct: 60 TG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 174 FGRGASVQPLAWNIRLKIAI---GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230
+ L IA RGL+ LH +VI+RD K N+LL + K+
Sbjct: 119 --KNTKGNTLK---EEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLV 171
Query: 231 DFGL-AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-----VKSDVYGFGVVLVEIL 284
DFG+ A+L + T +GT + APE +A KSD++ G+ +E+
Sbjct: 172 DFGVSAQL--DRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 285 TG---------LRAL---DTNRPSGQHNLVDWIKPYLSEKR---KFRHIIDARLQGQYPY 329
G +RAL N P L K+ KF+ I+
Sbjct: 229 EGAPPLCDMHPMRALFLIPRNPA-----------PRLKSKKWSKKFQSFIE--------- 268
Query: 330 KAAYQIAQLSLKCLEAEPKHRPSMRE 355
CL RP+ +
Sbjct: 269 -----------SCLVKNHSQRPATEQ 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 27/210 (12%)
Query: 85 VLGEGGFGKVFKGW---LDEKAPGKSGSGTVIAVKKLNSE--SLQGFEE-WQSEVNFLGR 138
++G GG G V++ + ++A+K ++ S F Q E GR
Sbjct: 41 LVGRGGMGDVYEAEDTVRER----------IVALKLMSETLSSDPVFRTRMQREARTAGR 90
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L P++V + + D +L + + L L +G PLA + I
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSA 146
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT--RVMGTYGY 256
L H +RD K NIL+ A + DFG+A + + +T +GT Y
Sbjct: 147 LDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYY 201
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
APE + H ++D+Y VL E LTG
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTG 231
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 71/311 (22%), Positives = 123/311 (39%), Gaps = 57/311 (18%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR------- 138
LG GG +V D + +AVK L ++ + +F R
Sbjct: 20 LGFGGMSEVHLA-RDLRD------HRDVAVKVLRAD-------LARDPSFYLRFRREAQN 65
Query: 139 ---LSHPNLVRLLGYCWEDKELL----LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
L+HP +V + + +V E++ +L + + G P+ +++
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEV 121
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRV 250
A + L F H +I+RD K +NI++ + K+ DFG+A+ + S + T V
Sbjct: 122 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG---QHNLVDWIKP 307
+GT Y +PE + +SDVY G VL E+LTG + P QH V
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPI 237
Query: 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQAS 366
S + + + + + LK L P++R + E+ L R+
Sbjct: 238 PPSARHE---------------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282
Query: 367 DQKPKQPRVRP 377
+ P+ P+V
Sbjct: 283 -EPPEAPKVLT 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 54/355 (15%), Positives = 99/355 (27%), Gaps = 79/355 (22%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG---FEEWQSEV 133
R TVLG+ + D++ +G V ++ + EV
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEAT-DQE------TGESFEVHVPYFTERPPSNAIKQMKEEV 129
Query: 134 NFLGRL-------------------------SHPNLVRLL--GYCWEDKELLLVYEFMQK 166
L L ++R+ +Y MQ
Sbjct: 130 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 189
Query: 167 --GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224
+ L ++ + L + RL++ + R LA LH +++ + +I+LD
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQR 247
Query: 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA----------TGHLYVKSDVY 274
++ F + + G+A PE A + D +
Sbjct: 248 GGVFLTGFEHLVRDGA------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 275 GFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQ 334
G+ + I + G +WI FR + P
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALG---GSEWI---------FRSCKN------IP----QP 339
Query: 335 IAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRPTHSMAHRQGQQP 389
+ L L + R + +ET E Q + + T R+G P
Sbjct: 340 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAP 394
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 72/300 (24%), Positives = 118/300 (39%), Gaps = 53/300 (17%)
Query: 73 LRAATRNFKSD----TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE 128
++ +T F VLG+G FG+V +K +G AVK ++ ++ +
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCK--DKI-----TGQECAVKVISKRQVKQKTD 69
Query: 129 WQS---EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAW 185
+S EV L +L HPN+++L + + LV E G L + + R + A
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSAS 242
I ++ G+ ++H ++++RD K N+LL +I DFGL+
Sbjct: 130 RIIRQV----LSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FE 180
Query: 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302
S +GT Y APE V G K DV+ GV+L +L+G
Sbjct: 181 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP-------------- 225
Query: 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAY------QIAQLSLKCLEAEPKHRPSMREV 356
P+ I+ +G+Y ++ L K L P R S R+
Sbjct: 226 ----PFNGANEY--DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 36/218 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----EVNFLGRLS 140
+LGEG +GKV + S + AVK L + L+ ++ E+ L RL
Sbjct: 12 LLGEGSYGKVKEVL-------DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 141 HPNLVRLLG--YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR- 197
H N+++L+ Y E +++ +V E+ G E + R + A
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP-------EKRFPVC--QAHG 113
Query: 198 -------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
GL +LH+ + ++++D K N+LL T KIS G+A+ +
Sbjct: 114 YFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 251 MGTYGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTG 286
G+ + PE + K D++ GV L I TG
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW-QSEVNFLGRLSHPNL 144
LGEG +G+V + + +AVK ++ + E + E+ L+H N+
Sbjct: 15 LGEGAYGEV-------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR------- 197
V+ G+ E L E+ G L + + + A+
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP--DAQRFFHQLM 115
Query: 198 -GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
G+ +LH + +RD K N+LLD KISDFGLA + ++ + ++ GT Y
Sbjct: 116 AGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 257 AAPEYVATGHLYV--KSDVYGFGVVLVEILTG 286
APE + + DV+ G+VL +L G
Sbjct: 174 VAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVN 134
+FK +LGEG F V + + A+K L + + E +
Sbjct: 30 EDFKFGKILGEGSFSTVVLA-------RELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 135 FLGRLSHPNLVRLLGYCWEDKELL-LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA- 192
+ RL HP V+L + ++D E L + + G L ++ G+ + R A
Sbjct: 83 VMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RFYTAE 138
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
I +A L +LH K +I+RD K NILL+ +I+DFG AK+ S+ +G
Sbjct: 139 IVSA--LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 253 TYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
T Y +PE + T KS D++ G ++ +++ GL
Sbjct: 195 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 80/281 (28%), Positives = 120/281 (42%), Gaps = 47/281 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS---EVNF 135
F+ +LG+G FGKV L ++ +G A+K L E + +E E
Sbjct: 149 EFEYLKLLGKGTFGKVI---LVKEK----ATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 136 LGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-I 193
L HP L L Y ++ + L V E+ G L HL + A R A I
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---RFYGAEI 257
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-G 252
+A L +LH S+K V+YRD K N++LD KI+DFGL K G T + G
Sbjct: 258 VSA--LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCG 311
Query: 253 TYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
T Y APE V + Y ++ D +G GVV+ E++ G P+ ++
Sbjct: 312 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR------------------LPFYNQ 352
Query: 312 KRK--FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
+ F I+ + ++P + L L+ +PK R
Sbjct: 353 DHEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 57/318 (17%), Positives = 102/318 (32%), Gaps = 56/318 (17%)
Query: 80 FKSDTVLGEG--GFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEEWQSEVNF 135
++ TV+G+G V + +G + V+++N E+ Q E++
Sbjct: 27 YELLTVIGKGFEDLMTVNLA-RYKP------TGEYVTVRRINLEACSNEMVTFLQGELHV 79
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI-- 193
+HPN+V D EL +V FM GS ++ + + + L IA
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMN---ELAIAYIL 134
Query: 194 -GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG-LAKLGPSASQSHVTTRVM 251
G + L ++H ++R KAS+IL+ +S + + V
Sbjct: 135 QGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 252 ----GTYGYAAPEYVA-TGHLY-VKSDVYGFGVVLVEILTG---------LRAL------ 290
+ +PE + Y KSD+Y G+ E+ G + L
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 291 -------------DTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQ 337
+ S ++ + R Y +
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 338 LSLKCLEAEPKHRPSMRE 355
+CL+ P RPS
Sbjct: 313 FVEQCLQRNPDARPSAST 330
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW-QSEVNFLGRLSHPNL 144
LGEG +G+V + + +AVK ++ + E + E+ L+H N+
Sbjct: 15 LGEGAYGEV-------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR------- 197
V+ G+ E L E+ G L + + + A+
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP--DAQRFFHQLM 115
Query: 198 -GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
G+ +LH + +RD K N+LLD KISDFGLA + ++ + ++ GT Y
Sbjct: 116 AGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 257 AAPEYVATGHLYV--KSDVYGFGVVLVEILTG 286
APE + + DV+ G+VL +L G
Sbjct: 174 VAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 59/308 (19%), Positives = 103/308 (33%), Gaps = 50/308 (16%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGT----VIAVKKLNSESLQGFE 127
R K+ L G + F WL+ S +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 128 EWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQP---LA 184
++ + S N V L L + + +K +L++ + R + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS 244
+I ++IA + FLH K +++RD K SNI K+ DFGL +
Sbjct: 167 LHIFIQIA----EAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 245 HVT----------TRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTN 293
T +GT Y +PE G+ Y K D++ G++L E+L
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELLY-------- 271
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP---YKAAYQIAQLSLKCLEAEPKHR 350
+ ++ + R I D R ++P + Q + L P R
Sbjct: 272 -------------SFSTQMERVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317
Query: 351 PSMREVVE 358
P +++E
Sbjct: 318 PEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 20/80 (25%), Positives = 31/80 (38%), Gaps = 9/80 (11%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFL 136
+F+ +G GGFG VF+ A+K++ E+ EV L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAK-------NKVDDCNYAIKRIRLPNRELAREKVMREVKAL 58
Query: 137 GRLSHPNLVRLLGYCWEDKE 156
+L HP +VR W +
Sbjct: 59 AKLEHPGIVRYFN-AWLETP 77
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 70/216 (32%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS---EVNF 135
+F +LG+G FGKV L + +G A+K L E + +E E
Sbjct: 6 DFDYLKLLGKGTFGKVI---LVRE----KATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 136 LGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-I 193
L HP L L Y ++ + L V E+ G L HL + A R A I
Sbjct: 59 LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA---RFYGAEI 114
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-G 252
+A L +LH + V+YRD K N++LD KI+DFGL K G S T + G
Sbjct: 115 VSA--LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCG 167
Query: 253 TYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
T Y APE V + Y ++ D +G GVV+ E++ G
Sbjct: 168 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 59/320 (18%), Positives = 103/320 (32%), Gaps = 72/320 (22%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G+G +G V E + ++ K+ + + E ++EV + +L HPN+
Sbjct: 33 AIGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG---------- 194
RL +++ + LV E G L + L +K I
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 195 -------------------AAR-------GLAFLHTSDKQVIYRDFKASNILL--DGSYT 226
+ L +LH ++ + +RD K N L + S+
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFE 208
Query: 227 AKISDFGLAKL--GPSASQSHVTTRVMGTYGYAAPEYV-ATGHLY-VKSDVYGFGVVLVE 282
K+ DFGL+K + + + T GT + APE + T Y K D + GV+L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 283 ILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAY--QIAQ--- 337
+L G P+ I L + ++ ++
Sbjct: 269 LLMGAV------------------PFPGVNDA--DTISQVLNKKLCFENPNYNVLSPLAR 308
Query: 338 -LSLKCLEAEPKHRPSMREV 356
L L R
Sbjct: 309 DLLSNLLNRNVDERFDAMRA 328
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
V+G+G F V + + G+ + ++ V K S E+ + E + L HP++
Sbjct: 31 VIGKGPFSVVRRC--INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPL----AWNIRLKIAIGAARGLA 200
V LL D L +V+EFM L + R + A + +I L
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI----LEALR 144
Query: 201 FLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
+ H D +I+RD K +LL + S K+ FG+A + RV GT +
Sbjct: 145 YCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV-GTPHFM 200
Query: 258 APEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
APE V Y DV+G GV+L +L+G P+ K +
Sbjct: 201 APE-VVKREPYGKPVDVWGCGVILFILLSGCL------------------PFYGTKER-- 239
Query: 317 HIIDARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
+ + ++G+Y I++ L + L +P R ++ E +
Sbjct: 240 -LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 47/277 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNFLGRLSH 141
+G+G FGKV + +K + + A+K +N + E + E+ + L H
Sbjct: 22 AIGKGSFGKVC---IVQKN----DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 142 PNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARGL 199
P LV L Y ++D+E + +V + + G L HL + +L I + A L
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV---KLFICELVMA--L 128
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
+L ++++I+RD K NILLD I+DF +A + P + T + GT Y AP
Sbjct: 129 DYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAP 183
Query: 260 EYVAT--GHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
E ++ G Y + D + GV E+L G R PY
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR------------------PYHIRSSTSS 225
Query: 317 H-IIDARLQGQYPYKAAYQIAQLSL--KCLEAEPKHR 350
I+ Y +A+ +SL K LE P R
Sbjct: 226 KEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 71/311 (22%), Positives = 114/311 (36%), Gaps = 65/311 (20%)
Query: 73 LRAATRNFKSD----TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--- 125
+R LG G +G+V EK + A+K +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLC--KEKN-----GHSEKAIKVIKKSQFDKGRY 79
Query: 126 ----------FEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFG 175
EE +E++ L L HPN+++L + K LV EF + G L +
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 176 RGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDF 232
R + A NI +I G+ +LH +++RD K NILL + KI DF
Sbjct: 140 RHKFDECDAANIMKQI----LSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDT 292
GL+ S+ + +GT Y APE V K DV+ GV++ +L G
Sbjct: 194 GLSSF---FSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG------ 243
Query: 293 NRP-SGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAY------QIAQLSLKCLEA 345
P GQ +++ + + +G+Y + + +L L
Sbjct: 244 YPPFGGQ-----------NDQDIIKKV----EKGKYYFDFNDWKNISDEAKELIKLMLTY 288
Query: 346 EPKHRPSMREV 356
+ R + E
Sbjct: 289 DYNKRCTAEEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 68/285 (23%), Positives = 109/285 (38%), Gaps = 52/285 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHP 142
+LG+G FG+V K ++ + AVK +N S + EV L +L HP
Sbjct: 29 MLGKGSFGEVLKCK--DRI-----TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N+++L + +V E G L + + R + A I ++ G+ ++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV----FSGITYM 137
Query: 203 HTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
H +++RD K NILL + KI DFGL+ Q+ +GT Y AP
Sbjct: 138 H--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL--SEKRKFRH 317
E V G K DV+ GV+L +L+G P+ +E +
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTP------------------PFYGKNEYDILKR 233
Query: 318 IIDARLQGQYPYKAAY------QIAQLSLKCLEAEPKHRPSMREV 356
+ G+Y + L K L P R + +
Sbjct: 234 V----ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 76/304 (25%), Positives = 118/304 (38%), Gaps = 79/304 (25%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW---QSEV 133
+ F +G G FG V+ D + + V+A+KK++ Q E+W EV
Sbjct: 53 EKLFSDLREIGHGSFGAVYFA-RDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
FL +L HPN ++ G + LV E+ + + + PL ++IA
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQ---EVEIAA 158
Query: 194 ---GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL-AKLGPSASQSHVTTR 249
GA +GLA+LH+ +I+RD KA NILL K+ DFG + + P+ S
Sbjct: 159 VTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------- 209
Query: 250 VMGTYGYAAPEYVA--TGHLY-VKSDVYGFGVVLVEILTG---------LRAL---DTNR 294
+GT + APE + Y K DV+ G+ +E+ + AL N
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 295 PSGQHNLVDWIKPYLSEKR---KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP 351
P L FR+ +D CL+ P+ RP
Sbjct: 270 S-----------PALQSGHWSEYFRNFVD--------------------SCLQKIPQDRP 298
Query: 352 SMRE 355
+
Sbjct: 299 TSEV 302
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 67/358 (18%), Positives = 132/358 (36%), Gaps = 82/358 (22%)
Query: 36 GSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTV---------L 86
V R ++ E L ++F F +L ++ + L
Sbjct: 89 TELVGKGKRRPLNNNSEI-----ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTL 143
Query: 87 GEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW--------QSEVNFLGR 138
G G G+V + E+ + +A++ ++ ++E+ L +
Sbjct: 144 GSGACGEVKLAF--ERK-----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L+HP ++++ + + ++ +V E M+ G L + + G + ++
Sbjct: 197 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM----LLA 251
Query: 199 LAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
+ +LH + +I+RD K N+LL + KI+DFG +K+ ++ + + GT
Sbjct: 252 VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPT 306
Query: 256 YAAPEYVATGHLYV----KSDVYGFGVVLVEILTGLRALDTNRP-----SGQHNLVDWIK 306
Y APE V D + GV+L L+G P Q +L D I
Sbjct: 307 YLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG-------YPPFSEHRTQVSLKDQIT 358
Query: 307 PYLSEKRKFRHIIDARLQGQYPYKAAY--QIAQLSL----KCLEAEPKHRPSMREVVE 358
G+Y + ++++ +L K L +PK R + E +
Sbjct: 359 -----------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 62/284 (21%), Positives = 116/284 (40%), Gaps = 48/284 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
VLG G F +VF ++ +G + A+K + ++E+ L ++ H N+
Sbjct: 16 VLGSGAFSEVFLV--KQRL-----TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V L LV + + G L + + RG + A + ++ + +LH
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV----LSAVKYLH- 123
Query: 205 SDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
+ +++RD K N+L + + I+DFGL+K+ Q+ + + GT GY APE
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPE- 177
Query: 262 VATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
V Y K+ D + GV+ +L G P P+ E + +
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG-------YP-----------PFYEETES--KLFE 217
Query: 321 ARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
+G Y +++ + I++ LE +P R + + +
Sbjct: 218 KIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 70/212 (33%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW---QSEVNFLGR-LS 140
VLG+G FGKV L E+ G+ + AVK L + + ++ E L
Sbjct: 27 VLGKGSFGKVM---LSER----KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 141 HPNLVRLLGYCW--EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAAR 197
P L +L C+ D+ L V E++ G L H+ G +P A A I
Sbjct: 80 PPFLTQLH-SCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHA---VFYAAEIAIG- 133
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GTYGY 256
L FL K +IYRD K N++LD KI+DFG+ K TT+ GT Y
Sbjct: 134 -LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDY 187
Query: 257 AAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
APE + Y KS D + FGV+L E+L G
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 42/296 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN 143
VLGEG +V + AVK + + EV L + H N
Sbjct: 20 VLGEGAHARVQTC--INLI-----TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ L+ + E+ LV+E M+ GS+ +H+ R + A + + A L FLH
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV----ASALDFLH 128
Query: 204 TSDKQVIYRDFKASNILL---DGSYTAKISDFGLAK-LGPSASQSHVTTRVM----GTYG 255
+K + +RD K NIL + KI DF L + + S ++T + G+
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 256 YAAPE----YVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRP--SGQHNLVDWIKPY 308
Y APE + +Y K D++ GV+L +L+G P G+
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG-------YPPFVGRCGSDCGWDRG 239
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
+ + ++ +G+Y + I+ L K L + K R S +V++
Sbjct: 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 22/257 (8%)
Query: 40 SGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWL 99
G + SA GD + T + NF+ VLG G +GKVF L
Sbjct: 16 GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF---L 72
Query: 100 DEKAPGKSGSGTVIAVKKLNSESLQGFEEW----QSEVNFLGRLSH-PNLVRLLGYCWED 154
K G +G + A+K L ++ + ++E L + P LV L Y ++
Sbjct: 73 VRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQT 130
Query: 155 KE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARGLAFLHTSDKQVIYR 212
+ L L+ +++ G L HL R + ++ + I A L LH +IYR
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRERFTEHEV---QIYVGEIVLA--LEHLH--KLGIIYR 183
Query: 213 DFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKS 271
D K NILLD + ++DFGL+K + ++ GT Y AP+ V G + K+
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242
Query: 272 -DVYGFGVVLVEILTGL 287
D + GV++ E+LTG
Sbjct: 243 VDWWSLGVLMYELLTGA 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 72/216 (33%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS---EVNF 135
+F VLG+G FGKV L E+ G+ + AVK L + + ++ + E
Sbjct: 342 DFNFLMVLGKGSFGKVM---LSER----KGTDELYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 136 LGR-LSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
L P L +L C++ + L V E++ G L H+ G +P A +IAI
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-G 252
G L FL K +IYRD K N++LD KI+DFG+ K TT+ G
Sbjct: 454 G----LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCG 504
Query: 253 TYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
T Y APE + Y KS D + FGV+L E+L G
Sbjct: 505 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 38/221 (17%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS-----EV 133
++ +GEG +G VFK + +G ++A+KK + E+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCR-NRD------TGQIVAIKKFLESE---DDPVIKKIALREI 53
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGAS-VQPLAWNIRL 189
L +L HPNLV LL + L LV+E+ L+ + G V+ + W
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT-- 111
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSH-V 246
+ + F H I+RD K NIL+ K+ DFG A+L GPS V
Sbjct: 112 ------LQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 247 TTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
TR Y +PE + Y DV+ G V E+L+G
Sbjct: 164 ATR-----WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 36/274 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW---QSEVNFLGR-LS 140
V+G G + KV L + + A+K + E + E+ Q+E + + +
Sbjct: 16 VIGRGSYAKVL---LVRLK----KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARG 198
HP LV L C++ + L V E++ G L H+ + + A R A I A
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA-- 122
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GTYGYA 257
L +LH ++ +IYRD K N+LLD K++D+G+ K G TT GT Y
Sbjct: 123 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 177
Query: 258 APEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
APE + G Y S D + GV++ E++ G D S + E F+
Sbjct: 178 APE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-------EDYLFQ 229
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
I++ ++ + P + + A + L +PK R
Sbjct: 230 VILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-22
Identities = 70/290 (24%), Positives = 111/290 (38%), Gaps = 53/290 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN 143
LGEG F K K S AVK ++ ++ E+ L HPN
Sbjct: 18 PLGEGSFSICRKCV--HKK-----SNQAFAVKIISKRMEANTQK---EITALKLCEGHPN 67
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+L + LV E + G L + + + A I K+ ++ +H
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL----VSAVSHMH 123
Query: 204 TSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
D V++RD K N+L + + KI DFG A+L P +Q + T T YAAPE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPE 179
Query: 261 YVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH-- 317
+ + Y +S D++ GV+L +L+G + P+ S R
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSG-------QV-----------PFQSHDRSLTCTS 220
Query: 318 ---IIDARLQGQYPYKAAY-----QIA-QLSLKCLEAEPKHRPSMREVVE 358
I+ +G + ++ Q A L L +P R M +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-22
Identities = 73/292 (25%), Positives = 105/292 (35%), Gaps = 64/292 (21%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+G G FG + + ++AVK + + E Q E+ L HPN+V
Sbjct: 28 IGSGNFGVA-------RLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIV 79
Query: 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR-------- 197
R L ++ E+ G L + G R AR
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAG----------RFSED--EARFFFQQLLS 127
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTA--KISDFGLAKLGPSASQSHVTTRVMGTYG 255
G+++ H+ Q+ +RD K N LLDGS KI DFG +K SQ + V GT
Sbjct: 128 GVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPA 182
Query: 256 YAAPEYVATGHLYV--KSDVYGFGVVLVEILTGLRAL---DTNRPSGQHNLVDWIKPYLS 310
Y APE V Y +DV+ GV L +L G A D P + I
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG--AYPFEDPEEPRDYRKTIQRI----- 234
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQ----LSLKCLEAEPKHRPSMREVVE 358
L +Y +I+ L + A+P R S+ E+
Sbjct: 235 ------------LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-22
Identities = 77/275 (28%), Positives = 105/275 (38%), Gaps = 47/275 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW---QSEVNFLGR-LS 140
+LG+G FGKVF L E + A+K L + + ++ E L
Sbjct: 24 MLGKGSFGKVF---LAE----FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARG 198
HP L + ++ KE L V E++ G L H+ A A I
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA---TFYAAEIILG-- 130
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
L FLH K ++YRD K NILLD KI+DFG+ K T GT Y A
Sbjct: 131 LQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--MLGDAKTNTFCGTPDYIA 186
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK--F 315
PE + G Y S D + FGV+L E+L G P+ + + F
Sbjct: 187 PE-ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELF 227
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
I YP + L +K EP+ R
Sbjct: 228 HSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 59/287 (20%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--GFEEWQSEVNFLGRLSHPN 143
+G+G F KV K +G +A+K ++ L ++ EV + L+HPN
Sbjct: 23 IGKGNFAKV-------KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR------ 197
+V+L +K L L+ E+ G + ++L G R+K AR
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG----------RMKEK--EARSKFRQI 123
Query: 198 --GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
+ + H K++++RD KA N+LLD KI+DFG + + G
Sbjct: 124 VSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPP 178
Query: 256 YAAPEYVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
YAAPE + G Y + DV+ GV+L +++G +L P NL K
Sbjct: 179 YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG--SL----PFDGQNL----------KE 221
Query: 314 KFRHIIDARLQGQY--PYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ L+G+Y P+ + L + L P R ++ ++++
Sbjct: 222 LRERV----LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 63/296 (21%), Positives = 107/296 (36%), Gaps = 41/296 (13%)
Query: 8 TPHDTIGHLSSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRI 67
+ Q + + SN R S S I P
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 68 FTFVELRAATRN----FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL 123
V + N +LG G FG+V K +E A +G +A K + + +
Sbjct: 75 HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC--EETA-----TGLKLAAKIIKTRGM 127
Query: 124 QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSL------ENHLFGRG 177
+ EE ++E++ + +L H NL++L +++LV E++ G L E++
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE- 186
Query: 178 ASVQPLAWNIRLKIAIGAAR----GLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISD 231
I + G+ +H +++ D K NIL + KI D
Sbjct: 187 ------------LDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIID 232
Query: 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL 287
FGLA+ GT + APE V + +D++ GV+ +L+GL
Sbjct: 233 FGLARR---YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS-----EV 133
+++ ++GEG +G V K K +G ++A+KK ++ E+
Sbjct: 26 KYENLGLVGEGSYGMVMKCR--NKD-----TGRIVAIKKFLESD---DDKMVKKIAMREI 75
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGAS-VQPLAWNIRL 189
L +L H NLV LL C + K LV+EF+ LE G VQ + I
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-- 133
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSH-V 246
G+ F H +I+RD K NIL+ S K+ DFG A+ P V
Sbjct: 134 ------INGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185
Query: 247 TTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
TR Y APE + Y K+ DV+ G ++ E+ G
Sbjct: 186 ATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 69/211 (32%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW---QSEVNFLGR-LS 140
V+G+G FGKV L AVK L +++ +E SE N L + +
Sbjct: 45 VIGKGSFGKVL---LARH----KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARG 198
HP LV L + ++ + L V +++ G L HL ++P A R A I +A
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA---RFYAAEIASA-- 151
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GTYGYA 257
L +LH ++YRD K NILLD ++DFGL K + TT GT Y
Sbjct: 152 LGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGTPEYL 206
Query: 258 APEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
APE V Y ++ D + G VL E+L GL
Sbjct: 207 APE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 70/351 (19%), Positives = 133/351 (37%), Gaps = 71/351 (20%)
Query: 20 GISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRN 79
G S +S V RGS+++ + A+ +
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLE-----------------SQ 44
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS------EV 133
++ +LG GGFG V+ G + +A+K + + + + E + EV
Sbjct: 45 YQVGPLLGSGGFGSVYSGI-------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 134 NFLGRLSH--PNLVRLLGYCWEDKELLLVYEFMQ-KGSLENHLFGRGASVQPLAWNIRLK 190
L ++S ++RLL + +L+ E + L + + RGA + LA + +
Sbjct: 98 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFGLAKLGPSASQSHVTTR 249
+ + H + V++RD K NIL+D + K+ DFG L + T
Sbjct: 158 V----LEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDF 208
Query: 250 VMGTYGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307
GT Y+ PE++ H Y + V+ G++L +++ G + P
Sbjct: 209 D-GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCG--DI----------------P 248
Query: 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ ++ II ++ + + + + L CL P RP+ E+
Sbjct: 249 FEHDEE----IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 1e-21
Identities = 80/362 (22%), Positives = 116/362 (32%), Gaps = 97/362 (26%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPG--KSGSGTVIAVKKLNSE-SLQGFEEWQSE--- 132
K LG G FG+V + A G K+ + +AVK L + SE
Sbjct: 23 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 133 ----------VNFLGR--------------LSHPNLVRLLGYCWEDKELLLVYEFMQ--- 165
VN LG NL L +
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
Query: 166 ---KGSLENHLFGRGASV-------------------------------QPLAWNIRLKI 191
G++ L R S+ L +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
+ A+G+ FL + ++ I+RD A NILL KI DFGLA+
Sbjct: 199 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY--L 309
+ APE + ++SDV+ FGV+L EI + G PY +
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----------LGA-------SPYPGV 299
Query: 310 SEKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER-LQAS 366
+F + R++ P ++ Q L C EP RP+ E+VE L LQA+
Sbjct: 300 KIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357
Query: 367 DQ 368
Q
Sbjct: 358 AQ 359
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 44/278 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW---QSEVNFLGR-LS 140
V+G G + KV L + + A++ + E + E+ Q+E + + +
Sbjct: 59 VIGRGSYAKVL---LVRLK----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 141 HPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARG 198
HP LV L C++ + L V E++ G L H+ + + A R A I A
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA-- 165
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GTYGYA 257
L +LH ++ +IYRD K N+LLD K++D+G+ K G TT GT Y
Sbjct: 166 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 220
Query: 258 APEYVATGHLYVKS-DVYGFGVVLVEILTGL----RALDTNRPSGQHNLVDWIKPYLSEK 312
APE + G Y S D + GV++ E++ G ++ P +E
Sbjct: 221 APE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----------TED 268
Query: 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
F+ I++ ++ + P + + A + L +PK R
Sbjct: 269 YLFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 80/277 (28%), Positives = 113/277 (40%), Gaps = 51/277 (18%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW---QSEVNFLGR-LS 140
VLG+G FGKV L +G + AVK L + + ++ +E L +
Sbjct: 30 VLGKGSFGKVM---LARV----KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 141 HPNLVRLLGYCW--EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAAR 197
HP L +L C+ D+ L V EF+ G L H+ + A R A I +A
Sbjct: 83 HPFLTQLF-CCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARA---RFYAAEIISA- 136
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM-GTYGY 256
L FLH DK +IYRD K N+LLD K++DFG+ K G TT GT Y
Sbjct: 137 -LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGTPDY 190
Query: 257 AAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK- 314
APE + LY + D + GV+L E+L G P+ +E
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH------------------APFEAENEDD 231
Query: 315 -FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR 350
F I++ + YP + + P R
Sbjct: 232 LFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMR 266
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 56/288 (19%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ------GFEEWQSEVNFLGR 138
+LG+GGFG VF G + +A+K + + EV L +
Sbjct: 38 LLGKGGFGTVFAG-------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 139 LS----HPNLVRLLGYCWEDKELLLVYEFMQKGS-LENHLFGRGASVQPLAWNIRLKIAI 193
+ HP ++RLL + + +LV E L +++ +G + + ++
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV-- 148
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFGLAKLGPSASQSHVTTRVMG 252
+ H + V++RD K NIL+D AK+ DFG L T G
Sbjct: 149 --VAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD-G 200
Query: 253 TYGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
T Y+ PE+++ H Y + V+ G++L +++ G + P+
Sbjct: 201 TRVYSPPEWIS-RHQYHALPATVWSLGILLYDMVCG--DI----------------PFER 241
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
++ I++A L +P + L +CL +P RPS+ E++
Sbjct: 242 DQE----ILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 20/205 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G G +G+V +K + A KK+ ++ + ++ E+ + L HPN+
Sbjct: 16 TIGRGSWGEVKIA--VQKG-----TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
+RL ++ ++ LV E G L + + + A I + +A+ H
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV----LSAVAYCH- 123
Query: 205 SDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
V +RD K N L K+ DFGLA + +GT Y +P+
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQ- 178
Query: 262 VATGHLYVKSDVYGFGVVLVEILTG 286
V G + D + GV++ +L G
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 65/287 (22%), Positives = 106/287 (36%), Gaps = 51/287 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN 143
+G G + + KA + AVK ++ EE + L R HPN
Sbjct: 29 DIGVGSYSVCKRCI--HKA-----TNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPN 77
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ L + K + +V E M+ G L + + + + A + I + + +LH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI----TKTVEYLH 133
Query: 204 TSDKQVIYRDFKASNILL----DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
+ V++RD K SNIL + +I DFG AK A + T T + AP
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPC-YTANFVAP 189
Query: 260 EYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH- 317
E V Y + D++ GV+L +LTG P+ +
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTMLTG-------YT-----------PFANGPDDTPEE 230
Query: 318 IIDARLQGQYPYKAAY-----QIA-QLSLKCLEAEPKHRPSMREVVE 358
I+ G++ Y A L K L +P R + V+
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHPN 143
LG G F V K EK+ G + I ++ S EE + EV+ L ++ H N
Sbjct: 19 ELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ L +++L+ E + G L + L + + + A + +I G+ +LH
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLH 132
Query: 204 TSDKQVIYRDFKASNILL----DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
K++ + D K NI+L K+ DFGLA + GT + AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAP 187
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGL 287
E V L +++D++ GV+ +L+G
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-21
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G F V + K G + +I KKL++ Q E E +L HPN+
Sbjct: 13 ELGKGAFSVVRRC--VHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNI 67
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
VRL E+ LV++ + G L + R + A + +I +A+ H
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCH- 122
Query: 205 SDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
+++R+ K N+LL K++DFGLA + S GT GY +PE
Sbjct: 123 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPE- 177
Query: 262 VATGHLYVKS-DVYGFGVVL 280
V Y K D++ GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV 145
+G G +G V+K + K A+K++ + E+ L L HPN++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDK-----DYALKQIEGTGIS--MSACREIALLRELKHPNVI 81
Query: 146 RLLGYCWE--DKELLLVYEFMQ---KGSLENHLFGRGASVQ-PLAWNIRLKIAIGAARGL 199
L D+++ L++++ + ++ H + L + + G+
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTA----KISDFGLAKL--GPSASQSHVTTRVMGT 253
+LH V++RD K +NIL+ G KI+D G A+L P + + V+ T
Sbjct: 142 HYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198
Query: 254 YGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ Y APE + Y K+ D++ G + E+LT
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----EVN 134
FK LG G + V+KG K +G +A+K++ +S +G S E++
Sbjct: 6 QFKQLEKLGNGTYATVYKGL--NKT-----TGVYVALKEVKLDSEEGTP---STAIREIS 55
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGASVQPLAWNIRLKI 191
+ L H N+VRL + +L LV+EFM K +++ G L ++
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN-LVK-YF 113
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSHVTTR 249
+GLAF H + ++++RD K N+L++ K+ DFGLA+ P + S
Sbjct: 114 QWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---E 168
Query: 250 VMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
V+ T Y AP+ + Y S D++ G +L E++TG
Sbjct: 169 VV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNF 135
F LG G FG+V L + SG A+K L+ + L+ E +E
Sbjct: 42 QFDRIKTLGTGSFGRVM---LVKHK----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IG 194
L ++ P LV+L ++ L +V E++ G + +HL G +P A R A I
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIV 151
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
+LH +IYRD K N+L+D +++DFG AK T + GT
Sbjct: 152 LT--FEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTP 202
Query: 255 GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGL 287
APE + Y K+ D + GV++ E+ G
Sbjct: 203 EALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHPN 143
LG G F V K EK+ G + I ++ S EE + EV+ L ++ HPN
Sbjct: 19 ELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ L +++L+ E + G L + L + + + A + +I G+ +LH
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLH 132
Query: 204 TSDKQVIYRDFKASNILL----DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
K++ + D K NI+L K+ DFGLA + GT + AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAP 187
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGL 287
E V L +++D++ GV+ +L+G
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 42/216 (19%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG---FEEWQSEVNFLGRLSHP 142
LG G FGKV K +G +AVK LN + ++ + + E+ L HP
Sbjct: 19 LGVGTFGKV-------KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 143 NLVRLLGY-CWEDK-ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR--- 197
++++L Y + +V E++ G L +++ G R++ AR
Sbjct: 72 HIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEM--EARRLF 117
Query: 198 -----GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
+ + H V++RD K N+LLD AKI+DFGL+ + + G
Sbjct: 118 QQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---G 172
Query: 253 TYGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTG 286
+ YAAPE V +G LY + D++ GV+L +L G
Sbjct: 173 SPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----EVN 134
+ LGEG + V+KG + ++A+K++ E +G EV+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL-------TDNLVALKEIRLEHEEGAP---CTAIREVS 52
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGAS-VQPLAWNIRLK 190
L L H N+V L +K L LV+E++ K L++ V+ + +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL--- 109
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSHVTT 248
RGLA+ H ++V++RD K N+L++ K++DFGLA+ P+ + +
Sbjct: 110 -----LRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN--- 159
Query: 249 RVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
V+ T Y P+ + Y D++G G + E+ TG
Sbjct: 160 EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSH 141
LG G FG+V L +G A+K L E L+ E E L ++H
Sbjct: 13 TLGTGSFGRVH---LIRSR----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA-IGAARGLA 200
P ++R+ G + +++ ++ ++++ G L + L P+A + A + A L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA---KFYAAEVCLA--LE 120
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
+LH K +IYRD K NILLD + KI+DFG AK P VT + GT Y APE
Sbjct: 121 YLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 173
Query: 261 YVATGHLYVKS-DVYGFGVVLVEILTGL 287
V + Y KS D + FG+++ E+L G
Sbjct: 174 -VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 37/215 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V + EKA +G V K +N+ ++E++ + +L HP L
Sbjct: 58 ELGSGAFGVVHRC--VEKA-----TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSL------ENHLFGRGASVQPLAWNIRLKIAIGAAR- 197
+ L + E++L+ EF+ G L E++ I R
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-------------AEVINYMRQ 157
Query: 198 ---GLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
GL +H + +++ D K NI+ + + KI DFGLA + +
Sbjct: 158 ACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTA 212
Query: 253 TYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL 287
T +AAPE V + +D++ GV+ +L+GL
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 28/212 (13%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLG 137
LG G FG V W + VK + E + + E+ L
Sbjct: 32 LGSGAFGFV---WTAVDKE----KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGS-LENHLFGRGASVQPLAWNIRLKIAIGAA 196
R+ H N++++L LV E G L + +PLA I ++
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV---- 140
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
+ +L K +I+RD K NI++ +T K+ DFG A + GT Y
Sbjct: 141 SAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEY 195
Query: 257 AAPEYVATGHLYV--KSDVYGFGVVLVEILTG 286
APE V G+ Y + +++ GV L ++
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 58/278 (20%), Positives = 95/278 (34%), Gaps = 33/278 (11%)
Query: 22 SQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFK 81
+ R N + + + +
Sbjct: 97 TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156
Query: 82 S----DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
LG G FG V + E+A +G A K + + E + E+ +
Sbjct: 157 DHYDIHEELGTGAFGVVHRV--TERA-----TGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL--KIAIGA 195
L HP LV L +D E++++YEFM G E LF + + ++ A+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEK-----VADEHNKMSEDEAVEY 260
Query: 196 AR----GLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPSASQSHVTTR 249
R GL +H + ++ D K NI+ S K+ DFGL
Sbjct: 261 MRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKV 315
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL 287
GT +AAPE + +D++ GV+ +L+GL
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 70/347 (20%), Positives = 140/347 (40%), Gaps = 57/347 (16%)
Query: 22 SQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFK 81
++ T ++S + +A P+ I + + + F+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL---------SDFFE 56
Query: 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH 141
++ LG G V++ +K K + V+ K ++ + ++ +E+ L RLSH
Sbjct: 57 VESELGRGATSIVYRC--KQKGTQKPYALKVLK-KTVDKKIVR------TEIGVLLRLSH 107
Query: 142 PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAF 201
PN+++L E+ LV E + G L + + +G + A + +I +A+
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI----LEAVAY 163
Query: 202 LHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
LH + +++RD K N+L KI+DFGL+K+ + V GT GY A
Sbjct: 164 LH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCA 218
Query: 259 PEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
PE + G Y D++ G++ +L G P+ E+ +
Sbjct: 219 PE-ILRGCAYGPEVDMWSVGIITYILLCGFE------------------PFYDERGD-QF 258
Query: 318 IIDARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
+ L +Y + + + +++ L K + +PK R + + ++
Sbjct: 259 MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHPN 143
LG G F V K +K GK + I ++L +S EE + EVN L + HPN
Sbjct: 12 ELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ L +++L+ E + G L + L + + + A +I G+ +LH
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----LDGVHYLH 125
Query: 204 TSDKQVIYRDFKASNILL----DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
K++ + D K NI+L + K+ DFG+A + + GT + AP
Sbjct: 126 --SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAP 180
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGL 287
E V L +++D++ GV+ +L+G
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGA 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 38/274 (13%)
Query: 24 TTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSD 83
TTS S + + G+ + S + ++ TP R ++
Sbjct: 7 TTSFAESCKPVQQPSAFGSMK--VSRDKDGSKVTTVVATPG-----QGPDRPQEVSYTDT 59
Query: 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN 143
V+G G FG V++ L + SG ++A+KK+ LQ E+ + +L H N
Sbjct: 60 KVIGNGSFGVVYQAKLCD-------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 144 LVRLLGY------CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI-GAA 196
+VRL + ++ L LV +++ + ++ + Q L I +K+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF 166
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGLAK-LGPS-ASQSHVTTRVMGT 253
R LA++H+ + +RD K N+LLD + K+ DFG AK L + S++ +R
Sbjct: 167 RSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 254 YGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
Y Y APE + Y S DV+ G VL E+L G
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 70/285 (24%), Positives = 112/285 (39%), Gaps = 48/285 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLSHP 142
+LG+G FG+V K ++ + AVK +N S + EV L +L HP
Sbjct: 29 MLGKGSFGEVLKC--KDRI-----TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N+++L + +V E G L + + R + A I ++ G+ ++
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV----FSGITYM 137
Query: 203 HTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
H +++RD K NILL + KI DFGL+ Q+ +GT Y AP
Sbjct: 138 H--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319
E V G K DV+ GV+L +L+G P+ + I+
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTP------------------PFYGKNEY--DIL 231
Query: 320 DARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
G+Y + I+ L K L P R + + +E
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 61/300 (20%), Positives = 117/300 (39%), Gaps = 68/300 (22%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW--------QSEVNFL 136
LG G G+V + E+ + +A+K ++ ++E+ L
Sbjct: 17 TLGSGACGEVKLAF--ERK-----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
+L+HP ++++ + ++ ++ +V E M+ G L + + G + ++
Sbjct: 70 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM----L 124
Query: 197 RGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
+ +LH + +I+RD K N+LL + KI+DFG +K+ ++ + + GT
Sbjct: 125 LAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGT 179
Query: 254 YGYAAPEYVATGHLYV----KSDVYGFGVVLVEILTGLRALDTNRP-----SGQHNLVDW 304
Y APE V D + GV+L L+G P Q +L D
Sbjct: 180 PTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG-------YPPFSEHRTQVSLKDQ 231
Query: 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
I G+Y + ++++ L K L +PK R + E +
Sbjct: 232 IT-----------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 4e-20
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQS----EV 133
+ +GEG +G V+K ++ G A+KK+ E G S E+
Sbjct: 3 KYHGLEKIGEGTYGVVYKA--------QNNYGETFALKKIRLEKEDEGIP---STTIREI 51
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGAS-VQPLAWNIRL 189
+ L L H N+V+L K L+LV+E + K L+ G + + +
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL-- 109
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSH-V 246
G+A+ H D++V++RD K N+L++ KI+DFGLA+ P +H +
Sbjct: 110 ------LNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 247 TTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
T Y AP+ + Y + D++ G + E++ G
Sbjct: 162 VTL-----WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 5e-20
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQS----EV 133
++ +GEG +G VFK + + ++A+K++ + G S E+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAK--NRE-----THEIVALKRVRLDDDDEGVP---SSALREI 52
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGAS-VQPLAWNIRL 189
L L H N+VRL DK+L LV+EF K ++ V+ + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL-- 110
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSHVT 247
+GL F H + V++RD K N+L++ + K+++FGLA+ P S
Sbjct: 111 ------LKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-- 160
Query: 248 TRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRAL 290
V+ T Y P+ + LY S D++ G + E+ R L
Sbjct: 161 -EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 19/200 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G F V + K G + +I KKL++ Q E E +L HPN+
Sbjct: 36 ELGKGAFSVVRRC--VHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNI 90
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
VRL E+ LV++ + G L + R + A + +I +A+ H
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCH- 145
Query: 205 SDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
+++R+ K N+LL K++DFGLA + S GT GY +PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPE- 200
Query: 262 VATGHLY-VKSDVYGFGVVL 280
V Y D++ GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHPN 143
LG G F V K EK+ G + I ++ +S E+ + EV+ L + HPN
Sbjct: 18 ELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ L +++L+ E + G L + L + + + A +I G+ +LH
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLH 131
Query: 204 TSDKQVIYRDFKASNILL----DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
Q+ + D K NI+L KI DFGLA + + GT + AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAP 186
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGL 287
E V L +++D++ GV+ +L+G
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGA 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 29/229 (12%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--- 128
E+R +F+ V+G G F +V + + +G V A+K +N + E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVA---VVKM----KQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 129 WQSEVNFLGRLSHPNLVRLLGYCWEDKELL-LVYEFMQKGSLENHLFGRGASV-QPLAWN 186
++ E + L + +L + ++D+ L LV E+ G L L G + +A
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-- 164
Query: 187 IRLKIA-IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH 245
R +A I A + +H ++RD K NILLD +++DFG +
Sbjct: 165 -RFYLAEIVMA--IDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219
Query: 246 VTTRVMGTYGYAAPEYVATGHLYVKSDVYG-------FGVVLVEILTGL 287
V GT Y +PE + + YG GV E+ G
Sbjct: 220 SLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 6e-20
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQS----EV 133
++ +GEG +G V+K K G ++A+K++ ++ G S E+
Sbjct: 22 KYQKLEKVGEGTYGVVYKA--------KDSQGRIVALKRIRLDAEDEGIP---STAIREI 70
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGAS-VQPLAWNIRL 189
+ L L HPN+V L+ ++ L LV+EFM+ K L+ + G S ++ + +
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL-- 128
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSH-V 246
RG+A H ++++RD K N+L++ K++DFGLA+ P S +H V
Sbjct: 129 ------LRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 247 TTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
T Y AP+ + Y S D++ G + E++TG
Sbjct: 181 VTL-----WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 65/284 (22%), Positives = 104/284 (36%), Gaps = 44/284 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G F V + + G+ + +I KKL++ Q E E L HPN+
Sbjct: 18 ELGKGAFSVVRRC--VKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNI 72
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
VRL E+ L+++ + G L + R + A + +I + H
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI----LEAVLHCH- 127
Query: 205 SDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEY 261
V++R+ K N+LL K++DFGLA Q GT GY +PE
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA-GTPGYLSPE- 183
Query: 262 VATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
V Y D++ GV+L +L G P+ E + +
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYP------------------PFWDEDQH--RLYQ 223
Query: 321 ARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
G Y + + + L K L P R + E ++
Sbjct: 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 33/228 (14%)
Query: 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEV 133
R F+ + + G+G FG V G +G +A+KK+ + E Q +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKS-------TGMSVAIKKVIQDPRFRNRELQ-IM 70
Query: 134 NFLGRLSHPNLVRLLGY-------CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWN 186
L L HPN+V+L Y D L +V E++ +L
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 187 -IRL---KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFGLAK-LGPS 240
I++ ++ R + LH V +RD K N+L++ + T K+ DFG AK L PS
Sbjct: 130 LIKVFLFQLI----RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 241 ASQSH-VTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ +R Y Y APE + Y + D++ G + E++ G
Sbjct: 186 EPNVAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW-QSEVNFLGRLSHPN 143
LG G FG V +E++ SG +K +N + Q E ++E+ L L HPN
Sbjct: 29 KLGSGAFGDVHLV--EERS-----SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR----GL 199
++++ + + +V E + G E L R S Q + + L
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 200 AFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
A+ H + V+++D K NIL KI DFGLA+L +T GT Y
Sbjct: 138 AYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALY 192
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTG 286
APE V + K D++ GVV+ +LTG
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 25/226 (11%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--- 128
++R +F+ V+G G FG+V + + + V A+K LN + E
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVA---VVKL----KNADKVFAMKILNKWEMLKRAETAC 120
Query: 129 WQSEVNFLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNI 187
++ E + L + L Y ++D L LV ++ G L L + P
Sbjct: 121 FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM-A 177
Query: 188 RLKIA-IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHV 246
R +A + A + +H ++RD K NIL+D + +++DFG
Sbjct: 178 RFYLAEMVIA--IDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 247 TTRVMGTYGYAAPEYVATGHL----YVKS-DVYGFGVVLVEILTGL 287
+ V GT Y +PE + Y D + GV + E+L G
Sbjct: 234 SVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 34/213 (15%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--------KLNSESLQGFEE-WQSEVNF 135
+LG G V + K + AVK ++E +Q E EV+
Sbjct: 24 ILGRGVSSVVRRC--IHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 136 LGRLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L ++S HPN+++L + LV++ M+KG L ++L + + I +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL-- 134
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
+ LH +++RD K NILLD K++DFG + V GT
Sbjct: 135 --EVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 187
Query: 255 GYAAPEYVATGHLYVKSDVYGF-------GVVL 280
Y APE + + YG GV++
Sbjct: 188 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 41/210 (19%), Positives = 78/210 (37%), Gaps = 26/210 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V + E + K+ + VK + ++ E++ L H N+
Sbjct: 12 DLGRGEFGIVHRCV--ETSSKKTYMAKFVKVKGTDQVLVK------KEISILNIARHRNI 63
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR----GLA 200
+ L +EL++++EF+ + + + + L
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEALQ 116
Query: 201 FLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
FLH + + D + NI+ S T KI +FG A+ + Y A
Sbjct: 117 FLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYA 171
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLR 288
PE + +D++ G ++ +L+G+
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG---FEEWQSEVNFLGRLSHP 142
LG G FGKV K +G +AVK LN + ++ + + E+ L HP
Sbjct: 24 LGVGTFGKV-------KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR----- 197
++++L ++ +V E++ G L +++ G RL +R
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEK--ESRRLFQQ 124
Query: 198 ---GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
G+ + H V++RD K N+LLD AKI+DFGL+ + T+ G+
Sbjct: 125 ILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TS--CGSP 179
Query: 255 GYAAPEYVATGHLYV--KSDVYGFGVVLVEILTG 286
YAAPE V +G LY + D++ GV+L +L G
Sbjct: 180 NYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 58/229 (25%), Positives = 109/229 (47%), Gaps = 35/229 (15%)
Query: 71 VELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ 130
+++++ + ++ LGEG F V+K +K + ++A+KK+ ++
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKAR--DKN-----TNQIVAIKKIKLGHRSEAKDGI 55
Query: 131 S-----EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGAS-VQ 181
+ E+ L LSHPN++ LL + LV++FM+ + ++++ S ++
Sbjct: 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK 115
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GP 239
+GL +LH +++RD K +N+LLD + K++DFGLAK P
Sbjct: 116 AYMLMT--------LQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 240 SASQSH-VTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ + +H V TR Y APE + +Y D++ G +L E+L
Sbjct: 166 NRAYTHQVVTR-----WYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQS----EV 133
++ T LGEG +G+V+K + + +A+K++ E + G EV
Sbjct: 35 RYRRITKLGEGTYGEVYKAI--DTV-----TNETVAIKRIRLEHEEEGVP---GTAIREV 84
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQ---KGSLENHLFGRGASVQPLAWNIRLK 190
+ L L H N++ L + L L++E+ + K ++ + ++ + +
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL--- 141
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA-----KISDFGLAKL--GPSASQ 243
G+ F H ++ ++RD K N+LL S + KI DFGLA+ P
Sbjct: 142 -----INGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 244 SHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+H ++ T Y PE + Y S D++ + E+L
Sbjct: 195 TH---EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 40/286 (13%)
Query: 17 SSTGISQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILP-----TPNLRIFTFV 71
+++ + + + S N A +++ P G P + +
Sbjct: 28 HLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWA 87
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEW-- 129
+ + + V+G G V + +A +G AVK + + + E
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRC--VHRA-----TGHEFAVKIMEVTAERLSPEQLE 140
Query: 130 ------QSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQP 182
+ E + L +++ HP+++ L+ + LV++ M+KG L ++L + A +
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK 200
Query: 183 LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSA 241
+I + ++FLH +++RD K NILLD + ++SDFG + L P
Sbjct: 201 ETRSIMRSLL----EAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-- 252
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGF-------GVVL 280
+ GT GY APE + + YG GV+L
Sbjct: 253 -GEKLRELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 43/216 (19%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK-----KLNSESLQGFEEWQSEVNFLGRLS 140
LGEG FGKV K + +A+K L + + E+++L L
Sbjct: 17 LGEGSFGKV-------KLATHYKTQQKVALKFISRQLLKKSDMH--MRVEREISYLKLLR 67
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR--- 197
HP++++L ++++V E+ G L +++ + R+ R
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTED--EGRRFF 114
Query: 198 -----GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
+ + H ++++RD K N+LLD + KI+DFGL+ + + + G
Sbjct: 115 QQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169
Query: 253 TYGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTG 286
+ YAAPE V G LY + DV+ G+VL +L G
Sbjct: 170 SPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 54/231 (23%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
+ + S T +G G +G V +D++ SG +A+KKL+ + F+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKR------SGEKVAIKKLS----RPFQSEIFAKRAY 71
Query: 132 -EVNFLGRLSHPNLVRLL------GYCWEDKELLLVYEFMQ-------KGSL-ENHLFGR 176
E+ L + H N++ LL + LV FMQ E
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK---- 127
Query: 177 GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236
+Q L + + +GL ++H++ V++RD K N+ ++ KI DFGLA+
Sbjct: 128 ---IQYLVYQM--------LKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174
Query: 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ +V TR + Y APE + + Y ++ D++ G ++ E+LTG
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 78/303 (25%), Positives = 121/303 (39%), Gaps = 63/303 (20%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
V+G G FG VF+ L E S V A+KK+ LQ E+ + + HPN+
Sbjct: 47 VIGNGSFGVVFQAKLVE-------SDEV-AIKKV----LQDKRFKNRELQIMRIVKHPNV 94
Query: 145 VRLL------GYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPL-AWNIRL---KIAIG 194
V L G ++ L LV E++ + ++ Q + I+L ++
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL-- 151
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGLAK-LGPSASQSH-VTTRVM 251
R LA++H+ + +RD K N+LLD S K+ DFG AK L + +R
Sbjct: 152 --RSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-- 205
Query: 252 GTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRP-----SGQHNLVDWI 305
Y Y APE + Y + D++ G V+ E++ G +P SG LV+ I
Sbjct: 206 --Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-------QPLFPGESGIDQLVEII 255
Query: 306 K----PYLSE---------KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352
K P + + KF I + + L + LE P R +
Sbjct: 256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
Query: 353 MRE 355
E
Sbjct: 316 AIE 318
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 26/225 (11%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE--- 128
+LR +++ V+G G FG+V + V A+K L+ + +
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQLV-------RHKSTRKVYAMKLLSKFEMIKRSDSAF 115
Query: 129 WQSEVNFLGRLSHPNLVRLLGYCWEDKELL-LVYEFMQKGSLENHLFGRGASVQPLAWNI 187
+ E + + + P +V+L Y ++D L +V E+M G L N + + A
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWA--- 170
Query: 188 RLKIA-IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHV 246
R A + A L +H+ I+RD K N+LLD S K++DFG
Sbjct: 171 RFYTAEVVLA--LDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 247 TTRVMGTYGYAAPEYVAT---GHLYVKS-DVYGFGVVLVEILTGL 287
T V GT Y +PE + + Y + D + GV L E+L G
Sbjct: 227 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 68/293 (23%), Positives = 114/293 (38%), Gaps = 60/293 (20%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN 143
VLG G GKV + + +G A+K L + EV+ + S P+
Sbjct: 36 VLGLGVNGKVLEC--FHRR-----TGQKCALKLLYDSPKA-----RQEVDHHWQASGGPH 83
Query: 144 LVRLLGYC----WEDKELLLVYEFMQKGSLENHLFGRGASV--QPLAWNIRLKIAIGAAR 197
+V +L + LL++ E M+ G L + + RG + A I I
Sbjct: 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG----T 139
Query: 198 GLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
+ FLH + +RD K N+L + K++DFG AK +Q+ + T T
Sbjct: 140 AIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTPC-YTP 193
Query: 255 GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE-- 311
Y APE V Y KS D++ GV++ +L G P P+ S
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCG-------FP-----------PFYSNTG 234
Query: 312 KRKFRHIIDARLQGQYPYKAAY--QIAQ----LSLKCLEAEPKHRPSMREVVE 358
+ + GQY + ++++ L L+ +P R ++ + +
Sbjct: 235 QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 60/240 (25%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-----FEEWQS 131
+ + G +G V G +D + G +A+K++ + G +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG-VDSE-------GIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 132 ------EVNFLGRLSHPNLVRLL-----GYCWEDKELLLVYEFM----------QKGSLE 170
E+ L HPN++ L +L LV E M Q+ +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVIS 132
Query: 171 N-HLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229
H +Q ++I GL LH + V++RD NILL + I
Sbjct: 133 PQH-------IQYFMYHI--------LLGLHVLHEAG--VVHRDLHPGNILLADNNDITI 175
Query: 230 SDFGLAKLGPSASQS--HVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
DF LA+ + + +VT R Y APE V + K D++ G V+ E+
Sbjct: 176 CDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-18
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQS----EV 133
++ +GEG +GKVFK D K G+ +A+K++ ++ + G EV
Sbjct: 12 QYECVAEIGEGAYGKVFKAR-DLKNGGR-----FVALKRVRVQTGEEGMP---LSTIREV 62
Query: 134 NFLGRLS---HPNLVRLL-----GYCWEDKELLLVYEFMQ---KGSLENH--LFGRGASV 180
L L HPN+VRL + +L LV+E + L+ ++
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 181 QPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240
+ + + + RGL FLH +V++RD K NIL+ S K++DFGLA+
Sbjct: 123 KDMMFQL--------LRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IY 170
Query: 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ Q +T+ V+ T Y APE V Y D++ G + E+
Sbjct: 171 SFQMALTSVVV-TLWYRAPE-VLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 67/271 (24%), Positives = 105/271 (38%), Gaps = 34/271 (12%)
Query: 22 SQTTSQTTSTGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFK 81
SQ S P Q P +++ ++ A ++K
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK 64
Query: 82 -SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS 140
+ VLG G GKV + + K + A+K LQ + + EV R S
Sbjct: 65 VTSQVLGLGINGKVLQIF--NKR-----TQEKFALK-----MLQDCPKARREVELHWRAS 112
Query: 141 -HPNLVRLLGYC----WEDKELLLVYEFMQKGSLENHLFGRGASV--QPLAWNIRLKIAI 193
P++VR++ K LL+V E + G L + + RG + A I I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG- 171
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRV 250
+ +LH + +RD K N+L + K++DFG AK + S + +TT
Sbjct: 172 ---EAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC 224
Query: 251 MGTYGYAAPEYVATGHLYVKS-DVYGFGVVL 280
T Y APE V Y KS D++ GV++
Sbjct: 225 -YTPYYVAPE-VLGPEKYDKSCDMWSLGVIM 253
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 58/239 (24%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
+ +F+ ++LGEG +G V + +G ++A+KK+ F++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKP------TGEIVAIKKIEP-----FDKPLFALRTL 57
Query: 132 -EVNFLGRLSHPNLVRLL-----GYCWEDKELLLVYEFMQ--------KGSLEN-HLFGR 176
E+ L H N++ + E+ ++ E MQ L + H
Sbjct: 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH---- 113
Query: 177 GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA- 235
+Q + L R + LH S+ VI+RD K SN+L++ + K+ DFGLA
Sbjct: 114 ---IQYFIYQT-L-------RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 236 ---KLGPSASQSHVTTRVMGTY----GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ S+ M + Y APE + T Y ++ DV+ G +L E+
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 57/235 (24%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
+ + + +GEG +G V D + +A+KK++ FE
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNL------NKVRVAIKKISP-----FEHQTYCQRTL 73
Query: 132 -EVNFLGRLSHPNLVRLL-----GYCWEDKELLLVYEFM--------QKGSLEN-HLFGR 176
E+ L R H N++ + + K++ +V + M + L N H
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH---- 129
Query: 177 GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236
+ + I RGL ++H+++ V++RD K SN+LL+ + KI DFGLA+
Sbjct: 130 ---ICYFLYQI--------LRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 237 LGPSASQSHVTTRVMGTY----GYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
A H T + Y Y APE + Y KS D++ G +L E+L+
Sbjct: 177 ---VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 56/229 (24%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS-------EVNFLGR 138
+G+G FG+VFK K +G +A+KK+ E+ E + E+ L
Sbjct: 25 IGQGTFGEVFKA-RHRK------TGQKVALKKVLMEN-----EKEGFPITALREIKILQL 72
Query: 139 LSHPNLVRLLGYCWEDKE--------LLLVYEFMQ---KGSLENHLFGRGASV------Q 181
L H N+V L+ C + LV++F + G L N L S
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK---LG 238
L GL ++H ++++RD KA+N+L+ K++DFGLA+ L
Sbjct: 133 LL-------------NGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
++ + T RV+ T Y PE + Y D++G G ++ E+ T
Sbjct: 178 KNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 44/217 (20%), Positives = 83/217 (38%), Gaps = 30/217 (13%)
Query: 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH 141
+ LG G F V + K+ G+ + + ++ + E E+ L
Sbjct: 33 TSKELGRGKFAVVRQC--ISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLELAKS 87
Query: 142 -PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL--KIAIGAAR- 197
P ++ L E++L+ E+ G + + A + I +
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--------MVSENDVIRLIKQ 139
Query: 198 ---GLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAK-LGPSASQSHVTTRV 250
G+ +LH +++ D K NILL KI DFG+++ +G + +
Sbjct: 140 ILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA----CELREI 193
Query: 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL 287
MGT Y APE + + +D++ G++ +LT
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-17
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 46/230 (20%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS------- 131
++ +G G +G V+K D SG +A+K + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKA-RDPH------SGHFVALKSVR---VPNGGGGGGGLPISTV 59
Query: 132 -EVNFLGRLS---HPNLVRLL-----GYCWEDKELLLVYEFMQ---KGSLENH--LFGRG 177
EV L RL HPN+VRL+ + ++ LV+E + + L+
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 119
Query: 178 ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237
+++ L RGL FLH +++RD K NIL+ T K++DFGLA+
Sbjct: 120 ETIKDLMRQF--------LRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR- 168
Query: 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ Q +T V+ T Y APE V Y D++ G + E+
Sbjct: 169 -IYSYQMALTPVVV-TLWYRAPE-VLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 50/238 (21%), Positives = 91/238 (38%), Gaps = 59/238 (24%)
Query: 86 LGEGGFGKV----------------------FKGWLDEKAPGKSGSGTVIAVKKLNSESL 123
+G+G +G V + + P G+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 124 QGFEEWQSEVNFLGRLSHPNLVRLLGYC-WED---KELLLVYEFMQKGSLENHLFGRGAS 179
+ + E+ L +L HPN+V+L +D L +V+E + +G +
Sbjct: 81 EQVYQ---EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVME-------- 127
Query: 180 VQPLAWNIRLKIAIGAAR--------GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231
+ L AR G+ +LH +++I+RD K SN+L+ KI+D
Sbjct: 128 ---VPTLKPLSED--QARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH-LYV--KSDVYGFGVVLVEILTG 286
FG++ S + ++ V GT + APE ++ ++ DV+ GV L + G
Sbjct: 181 FGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 43/226 (19%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
+++ + +G G +G V + + +G +AVKKL+ + F+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAF-------DTKTGLRVAVKKLS----RPFQSIIHAKRTY 76
Query: 132 -EVNFLGRLSHPNLVRLL------GYCWEDKELLLVYEFMQKGSLENHLFGRGAS---VQ 181
E+ L + H N++ LL E ++ LV M L N + + + VQ
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ 135
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241
L + I RGL ++H++D +I+RD K SN+ ++ KI DFGLA+
Sbjct: 136 FLIYQI--------LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+V TR Y APE + Y ++ D++ G ++ E+LTG
Sbjct: 186 MTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 51/314 (16%), Positives = 102/314 (32%), Gaps = 75/314 (23%)
Query: 32 GVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEGGF 91
++ N S S + P + ++ ++G G +
Sbjct: 7 AAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSY 66
Query: 92 GKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS------EVNFLGRLSHPNLV 145
G V + D+ V+A+KK+ FE+ E+ L RL+H ++V
Sbjct: 67 GHVCEA-YDKL------EKRVVAIKKILRV----FEDLIDCKRILREIAILNRLNHDHVV 115
Query: 146 RLL-----GYCWEDKELLLVYEFMQ---------KGSLEN-HLFGRGASVQPLAWNIRLK 190
++L + EL +V E L H ++ L +N+
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELH-------IKTLLYNL--- 165
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRV 250
G+ ++H++ +++RD K +N L++ + K+ DFGLA+ + +
Sbjct: 166 -----LVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 251 MGTYGYAAP--------------EYVAT-----------GHLYVKS-DVYGFGVVLVEIL 284
+V T Y ++ DV+ G + E+L
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 285 TGLRALDTNRPSGQ 298
++
Sbjct: 279 NMIKENVAYHADRG 292
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 62/242 (25%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
+ LG GG G VF +D +A+KK+ + QS
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSA-VDND------CDKRVAIKKIV------LTDPQSVKHAL 56
Query: 132 -EVNFLGRLSHPNLVRLL--------------GYCWEDKELLLVYEFMQ--------KGS 168
E+ + RL H N+V++ G E + +V E+M+ +G
Sbjct: 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116
Query: 169 LEN-HLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YT 226
L H + + + RGL ++H+++ V++RD K +N+ ++
Sbjct: 117 LLEEH-------ARLFMYQL--------LRGLKYIHSAN--VLHRDLKPANLFINTEDLV 159
Query: 227 AKISDFGLAK-LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEIL 284
KI DFGLA+ + P S + + T Y +P + + + Y K+ D++ G + E+L
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 285 TG 286
TG
Sbjct: 220 TG 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 53/231 (22%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
+ +++ +G G G V D +A+KKL+ + F+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAI------LERNVAIKKLS----RPFQNQTHAKRAY 72
Query: 132 -EVNFLGRLSHPNLVRLL------GYCWEDKELLLVYEFMQ-------KGSLEN-HLFGR 176
E+ + ++H N++ LL E +++ +V E M + L++
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER---- 128
Query: 177 GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236
+ L + + G+ LH++ +I+RD K SNI++ T KI DFGLA
Sbjct: 129 ---MSYLLYQM--------LCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA- 174
Query: 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+A S + T + T Y APE + Y ++ D++ G ++ E++ G
Sbjct: 175 --RTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKG 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 53/231 (22%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
+ +++ +G G G V D +A+KKL+ + F+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA-YDAV------LDRNVAIKKLS----RPFQNQTHAKRAY 109
Query: 132 -EVNFLGRLSHPNLVRLL------GYCWEDKELLLVYEFM--------QKGSLENHLFGR 176
E+ + ++H N++ LL E +++ LV E M Q
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER---- 165
Query: 177 GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236
+ L + + G+ LH++ +I+RD K SNI++ T KI DFGLA+
Sbjct: 166 ---MSYLLYQM--------LCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+A S + T + T Y APE + Y ++ D++ G ++ E++
Sbjct: 213 ---TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRH 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 55/232 (23%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
++ +G G +G V +D + +G +A+KKL + F+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGR------TGAKVAIKKLY----RPFQSELFAKRAY 72
Query: 132 -EVNFLGRLSHPNLVRLL------GYCWEDKELLLVYEFM--------QKGSLEN-HLFG 175
E+ L + H N++ LL + + LV FM + L
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR--- 129
Query: 176 RGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235
+Q L + + +GL ++H + +I+RD K N+ ++ KI DFGLA
Sbjct: 130 ----IQFLVYQM--------LKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTG 286
+ S +V TR Y APE + Y ++ D++ G ++ E++TG
Sbjct: 176 RQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 79.9 bits (196), Expect = 4e-16
Identities = 71/415 (17%), Positives = 135/415 (32%), Gaps = 103/415 (24%)
Query: 40 SGNSRFSASSGDESYPNGQILPTPNL-RIFTFVELRAATRNFKSD---TVLGEGGFGKVF 95
S +R D Y + Q+ N+ R+ +++LR A + + G G GK
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-- 163
Query: 96 KGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE----WQSEVNFLGRLSHPNLVRLLGYC 151
T +A+ S +Q + W +N C
Sbjct: 164 ---------------TWVALDVCLSYKVQCKMDFKIFW---LNL-------------KNC 192
Query: 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIY 211
+ +L E +QK L + S + NI+L+I A L +
Sbjct: 193 NSPETVL---EMLQK--LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS------- 240
Query: 212 RDFKASNILLDGSYTAKISD-FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVK 270
+ ++ ++L AK + F L + + +TTR + + T H+ +
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNL------SCKILLTTRFKQVTDFLSAAT--TTHISLD 292
Query: 271 SDVYGFGV-----VLVEIL----TGLR--ALDTNRP--------SGQHNLVDWIKPYL-S 310
+L++ L L L TN P S + L W +
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-PRRLSIIAESIRDGLATW-DNWKHV 350
Query: 311 EKRKFRHIIDARLQGQYP--YKAAYQ---I----AQLSLKCLE---AEPKHRPSMREVVE 358
K II++ L P Y+ + + A + L + M VV
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM-VVVN 409
Query: 359 TLERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSPLHTNL----DRNRGYQHS 409
L + +++PK+ + S+ + + + L + LH ++ + + +
Sbjct: 410 KLHKYSLVEKQPKESTIS-IPSI-YLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 63/253 (24%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL 136
++ + LG G FG V + + E SG A+KK+ LQ E++ +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE-------SGKRFALKKV----LQDPRYKNRELDIM 54
Query: 137 GRLSHPNLVRLLGY--------------------------------------CWEDKELL 158
L H N+++L+ Y ++K L
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI-GAARGLAFLHTSDKQVIYRDFKAS 217
++ E++ +L L S + + + I I R + F+H+ + +RD K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQ 170
Query: 218 NILLDG-SYTAKISDFGLAK-LGPS-ASQSHVTTRVMGTYGYAAPEYVATGHLYVKS-DV 273
N+L++ T K+ DFG AK L PS S +++ +R + Y APE + Y S D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDL 225
Query: 274 YGFGVVLVEILTG 286
+ G V E++ G
Sbjct: 226 WSIGCVFGELILG 238
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 54/255 (21%), Positives = 94/255 (36%), Gaps = 70/255 (27%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
N+ ++G G +G V+ D+ + +A+KK+N FE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKN------TEKNVAIKKVNRM----FEDLIDCKRIL 73
Query: 132 -EVNFLGRLSHPNLVRLL-----GYCWEDKELLLVYEFMQ---------KGSLEN-HLFG 175
E+ L RL ++RL + EL +V E L H
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEH--- 130
Query: 176 RGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235
++ + +N+ L G F+H S +I+RD K +N LL+ + K+ DFGLA
Sbjct: 131 ----IKTILYNL-L-------LGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 236 KLGPSASQSHVTTRVMGTYGYAAP---------EYVAT-----------GHLYVKS-DVY 274
+ S +++ + +V T Y KS D++
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236
Query: 275 GFGVVLVEILTGLRA 289
G + E+L L++
Sbjct: 237 STGCIFAELLNMLQS 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 58/248 (23%), Positives = 104/248 (41%), Gaps = 66/248 (26%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS----- 131
R ++ LG+G +G V+K +D + +G V+AVKK+ F+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRR------TGEVVAVKKIF----DAFQNSTDAQRTF 56
Query: 132 -EVNFLGRLS-HPNLVRLLG--YCWEDKELLLVYEFMQ-------KGSL--ENHLFGRGA 178
E+ L LS H N+V LL D+++ LV+++M+ + ++ H
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH------ 110
Query: 179 SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLG 238
Q + + + + + + +LH+ +++RD K SNILL+ K++DFGL++
Sbjct: 111 -KQYVVYQL-I-------KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 239 PSASQSHVTTRVMGTYGYAAP--------EYVAT-----------GHLYVKS-DVYGFGV 278
+ + + +YVAT Y K D++ G
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 279 VLVEILTG 286
+L EIL G
Sbjct: 220 ILGEILCG 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 36/300 (12%), Positives = 79/300 (26%), Gaps = 61/300 (20%)
Query: 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRL 139
G + ++ D +A+ ++ + + +E S L R+
Sbjct: 36 LIFHGGVPPLQFWQAL-DTAL------DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
P + R+L L+V E+++ GSL+ + V ++ A
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------AIRAMQSLAAAA 142
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
H + V S + +S G L
Sbjct: 143 DAAHRAG--VALSIDHPSRVR--------VSIDGDVVLA--------------YPATMPD 178
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALD-TNRPSGQHNLVDWIKPYLSEKRKFRHI 318
D+ G G L +L L SG E
Sbjct: 179 ANPQ-------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRPT 378
I ++ + ++ + ++ + R + ++ +++ A + +
Sbjct: 232 IPFQI------------SAVAARSVQGDGGIRSAS-TLLNLMQQATAVADRTEVLGPIDE 278
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 42/219 (19%), Positives = 83/219 (37%), Gaps = 45/219 (20%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNL 144
LG G + +VF+ + + VK L + + + E+ L L PN+
Sbjct: 44 LGRGKYSEVFEAI-------NITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 93
Query: 145 VRLLGYCW--EDKELLLVYEFMQKGSLENHLFGRGASVQPLA-WNIR------LKIAIGA 195
+ L + LV+E + + Q L ++IR L
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEIL------ 140
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTA-KISDFGLAKLGPSASQ--SHVTTRVMG 252
+ L + H+ +++RD K N+++D + ++ D+GLA+ + V +R
Sbjct: 141 -KALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 253 TYGYAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRAL 290
+ PE + +Y S D++ G +L ++
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 28/162 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN 143
VLG G GKV + K + A+K L + + EV R S P+
Sbjct: 25 VLGLGINGKVLQI--FNKR-----TQEKFALKMLQDC-----PKARREVELHWRASQCPH 72
Query: 144 LVRLLGYC----WEDKELLLVYEFMQKGSLENHLFGRGASV--QPLAWNIRLKIAIGAAR 197
+VR++ K LL+V E + G L + + RG + A I I
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI----GE 128
Query: 198 GLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDFGLAK 236
+ +LH + +RD K N+L + K++DFG AK
Sbjct: 129 AIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 1e-10
Identities = 53/301 (17%), Positives = 83/301 (27%), Gaps = 74/301 (24%)
Query: 66 RIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL------- 118
F T + +GEG FG+VF+ D T +A+K +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIAD---------HTPVAIKIIAIEGPDL 58
Query: 119 -NSESLQGFEEWQSEVNFLGRL---------SHPNLVRLLG-YCWEDK---ELLLVYEFM 164
N + FEE E+ L + L +C + LL ++
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 165 Q--KGSLENHLFGRGASVQPLA-------------------WNIRLKIAIGAARGLAFLH 203
KGS + + I LA
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL------GPSASQSHVTTRVMGTYG-- 255
S + +RD N+LL + K+ K G S T + G
Sbjct: 179 AS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 256 ----YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
+ E + TG + D+Y G +N V W+ YL++
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLH-YLTD 288
Query: 312 K 312
K
Sbjct: 289 K 289
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 54/226 (23%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHP- 142
++G+G FG+V K + D +A+K + N ++ + Q EV L ++
Sbjct: 61 LIGKGSFGQVVKAY-DRV------EQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHD 111
Query: 143 -----NLVRLLGYCWEDK-------ELLLV--YEFMQKGSLENHLFGRGASVQPLAWNIR 188
+V L + + + E+L Y+ ++ + RG S+ R
Sbjct: 112 TEMKYYIVHLKRH-FMFRNHLCLVFEMLSYNLYDLLRNTNF------RGVSLN----LTR 160
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPSASQSHV 246
K A L FL T + +I+ D K NILL KI DFG S+ Q
Sbjct: 161 -KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG------SSCQLG- 212
Query: 247 TTRVMGTY----GYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGL 287
+ + Y Y +PE V G Y + D++ G +LVE+ TG
Sbjct: 213 --QRIYQYIQSRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 52/332 (15%), Positives = 108/332 (32%), Gaps = 88/332 (26%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS---- 140
LG G F V+ D + T +A+K + + E + E+ L R++
Sbjct: 26 KLGWGHFSTVWLAK-DMV------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADN 77
Query: 141 -------HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHL-------------FGRGASV 180
++++LL + F KG H+ +
Sbjct: 78 TKEDSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEH 125
Query: 181 QPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD------GSYTAKISDFGL 234
+ + +I+ GL ++H +I+ D K N+L++ KI+D G
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTN 293
A + + TR Y +PE V G + +D++ ++ E++TG + +
Sbjct: 185 ACWYDEHYTNSIQTRE-----YRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238
Query: 294 RPSGQHNLVD---------------------WIKPYLSEKRKFRHIIDARLQG------- 325
D + + + + + R+I +
Sbjct: 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 298
Query: 326 --QYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
++ A +I+ L+ +P+ R
Sbjct: 299 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 56/226 (24%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSH-- 141
V+G+G FG+V K + D K +A+K + N + + E+ L L
Sbjct: 104 VIGKGSFGQVVKAY-DHK------VHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQD 154
Query: 142 ----PNLVRLLGYCWEDK-------ELLL--VYEFMQKGSLENHLFGRGASVQPLAWNIR 188
N++ +L + + ELL +YE ++K +G S+ +R
Sbjct: 155 KDNTMNVIHMLEN-FTFRNHICMTFELLSMNLYELIKKNKF------QGFSLP----LVR 203
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPSASQSHV 246
K A + L LH ++I+ D K NILL G K+ DFG S+ H
Sbjct: 204 -KFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFG------SSCYEH- 253
Query: 247 TTRVMGTY----GYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGL 287
+ + TY Y APE V G Y + D++ G +L E+LTG
Sbjct: 254 --QRVYTYIQSRFYRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 42/227 (18%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFEEWQSEVNFL 136
++K +GEG FG +F+G + +A+K S++ Q +E+++
Sbjct: 11 HYKVGRRIGEGSFGVIFEGT-------NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIAI 193
G + + + E +LV + + SLE L GR SV+ + A
Sbjct: 64 GC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTV-----AMAAK 113
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK-----ISDFGLAKL-GPSASQSHVT 247
+ +H +K ++YRD K N L+ + + DFG+ K ++ H+
Sbjct: 114 QMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171
Query: 248 TR----VMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLVEILTG 286
R + GT Y + + T HL + D+ G V + L G
Sbjct: 172 YREKKNLSGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRG 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 44/232 (18%), Positives = 81/232 (34%), Gaps = 55/232 (23%)
Query: 30 STGVSRGSNVSGNSRFSASSGDESYPNGQILPTPNLRIFTFVELRAATRNFKSDTVLGEG 89
S+GV G+ + S E+ P G +L + R +K +
Sbjct: 8 SSGVDLGTENLYFQSMTTSL--EALPTGTVLT------------DKSGRQWKLKSFQTRD 53
Query: 90 GFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV---- 145
G +++ SG KL+++ + F +E NF R + P V
Sbjct: 54 NQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLF----NEQNFFQRAAKPLQVNKWK 109
Query: 146 -----------RLLGY-CWEDKELLLVYEFMQKGSLENHLF---GRGA----SVQPLAWN 186
+G+ +DK LV + + SL+ + SV
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHVLSERSV------ 161
Query: 187 IRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI--SDFGLAK 236
L++A L FLH + + ++ + A NI +D +++ + +G A
Sbjct: 162 --LQVACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 64/371 (17%), Positives = 108/371 (29%), Gaps = 122/371 (32%)
Query: 86 LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-----S 140
LG G F V+ W D + +A+K + S E E+ L + +
Sbjct: 45 LGWGHFSTVWLSW-DIQ------GKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPN 96
Query: 141 HPN---LVRLLGY-----------CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWN 186
PN +V+LL C +V+E + L + ++ Q L
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HL--LKWIIKSNYQGLPLP 146
Query: 187 IRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL------------------------- 221
KI +GL +LH + ++I+ D K NILL
Sbjct: 147 CVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 222 ------------------------DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
KI+D G A + TR Y
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YR 260
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD-------------- 303
+ E + +D++ + E+ TG + + D
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320
Query: 304 -WI------KPYLSEKRKFRHIIDARLQG---------QYPYKAAYQIAQLSLKCLEAEP 347
I K + ++K +HI + G ++ + A L LE P
Sbjct: 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP 380
Query: 348 KHRPSMREVVE 358
+ R + E +
Sbjct: 381 EKRATAAECLR 391
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 42/226 (18%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFEEWQSEVNFL 136
++ +G G FG ++ G +G +A+K + ++ Q E +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGT-------DIAAGEEVAIKLECVKTKHPQLHIESK----IY 58
Query: 137 GRLSH-PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIA 192
+ + + E ++V E + SLE LF R S++ + L +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTV-----LLLA 111
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK---ISDFGLAKL-GPSASQSHVTT 248
+ ++H K I+RD K N L+ I DFGLAK + + H+
Sbjct: 112 DQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 249 R----VMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLVEILTG 286
R + GT YA+ + T HL + + D+ G VL+ G
Sbjct: 170 RENKNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 54/244 (22%), Positives = 85/244 (34%), Gaps = 76/244 (31%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHP- 142
LGEG FGKV + D + +A+K + N E + E+N L ++
Sbjct: 26 NLGEGTFGKVVECL-DHAR-----GKSQVALKIIRNVGKY--REAARLEINVLKKIKEKD 77
Query: 143 -----NLVRLLGYCWEDK-------ELLL--VYEFMQKGSLENHLFGRGASVQPLAWNIR 188
V + + ELL +EF+++ + + + ++R
Sbjct: 78 KENKFLCVLMSD-WFNFHGHMCIAFELLGKNTFEFLKENNF------QPYPLP----HVR 126
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA-------------------KI 229
+A L FLH + Q+ + D K NIL S ++
Sbjct: 127 -HMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 230 SDFGLAKLGPSASQSH------VTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVE 282
+DFG SA+ H V TR Y PE V + DV+ G +L E
Sbjct: 184 ADFG------SATFDHEHHTTIVATRH-----YRPPE-VILELGWAQPCDVWSIGCILFE 231
Query: 283 ILTG 286
G
Sbjct: 232 YYRG 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 37/178 (20%), Positives = 71/178 (39%), Gaps = 29/178 (16%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
+K +G+GGFG ++ D + GS VK S++ F +E+ F
Sbjct: 35 AAWKVGLPIGQGGFGCIYLA--DMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQ 88
Query: 138 RLSHPNLVRLLGYCWEDKELLL--VYEFMQKGSLENH-------LFGRGASVQPL-AWNI 187
R + P ++ + K L + + FG +Q + N
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANA 146
Query: 188 R-------LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI--SDFGLAK 236
+ L++++ L ++H + + ++ D KASN+LL+ ++ D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 29/168 (17%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFEEWQSEVNFL 136
NF+ +G G FG++ G + +A+K + S + Q E++
Sbjct: 10 NFRVGKKIGCGNFGELRLGK-------NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG 62
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIAI 193
+ ++ + K +V E + SLE LF R S++ + L IAI
Sbjct: 63 S---GDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTV-----LMIAI 112
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK-----ISDFGLAK 236
+ ++H K +IYRD K N L+ I DF LAK
Sbjct: 113 QLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 42/226 (18%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVK--KLNSESLQGFEEWQSEVNFL 136
F+ +G G FG+++ G + +A+K + ++ Q E +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGT-------NIQTNEEVAIKLENVKTKHPQLLYESK----IY 56
Query: 137 GRLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLF---GRGASVQPLAWNIRLKIA 192
L + + + E +LV + + SLE LF R S++ + L +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTV-----LMLA 109
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK---ISDFGLAKL-GPSASQSHVTT 248
+ F+H K ++RD K N L+ A I DFGLAK +++ H+
Sbjct: 110 DQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 249 R----VMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLVEILTG 286
R + GT YA+ V T HL + + D+ G VL+ L G
Sbjct: 168 RENKNLTGTARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 64/244 (26%), Positives = 93/244 (38%), Gaps = 76/244 (31%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSHP- 142
LGEG FGKV + D KA G +AVK + N + E +SE+ L L+
Sbjct: 21 TLGEGAFGKVVECI-DHKA-----GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNTTD 72
Query: 143 -----NLVRLLGYCWEDK-------ELLL--VYEFMQKGSLENHLFGRGASVQPLAWNIR 188
V++L +E ELL Y+F+++ N + +IR
Sbjct: 73 PNSTFRCVQMLE-WFEHHGHICIVFELLGLSTYDFIKE----NGF--LPFRLD----HIR 121
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILL-DGSYTA------------------KI 229
K+A + + FLH ++ + D K NIL YT K+
Sbjct: 122 -KMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 230 SDFGLAKLGPSASQSH------VTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVE 282
DFG SA+ V+TR Y APE V + DV+ G +L+E
Sbjct: 179 VDFG------SATYDDEHHSTLVSTRH-----YRAPE-VILALGWSQPCDVWSIGCILIE 226
Query: 283 ILTG 286
G
Sbjct: 227 YYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 52/249 (20%), Positives = 86/249 (34%), Gaps = 82/249 (32%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL-NSESLQGFEEWQSEVNFLGRLSH-- 141
+G+G FG+V + AVK + N + + E + L ++ +
Sbjct: 42 KMGDGTFGRVLLCQ-HID------NKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDD 92
Query: 142 ---PNLVRLLGYCWEDK-------ELLL--VYEFMQKGSLENHLFGRGASVQPLAWNIRL 189
N+V+ G + E L +YE + + + G ++ +I+
Sbjct: 93 INNNNIVKYHG-KFMYYDHMCLIFEPLGPSLYEIITRNNY------NGFHIE----DIK- 140
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILL-DGSYTA--------------------- 227
I + L +L + + D K NILL D +
Sbjct: 141 LYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 228 ---KISDFGLAKLGPSASQSH------VTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFG 277
K+ DFG A+ + TR Y APE V + V SD++ FG
Sbjct: 199 TGIKLIDFG------CATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFG 246
Query: 278 VVLVEILTG 286
VL E+ TG
Sbjct: 247 CVLAELYTG 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 29/177 (16%), Positives = 65/177 (36%), Gaps = 30/177 (16%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
+ +G GGFG ++ + + + V+ V+ + L SE+ F
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAF--PTNKPEKDARHVVKVEYQENGPLF------SELKFYQ 88
Query: 138 RLSHPNLVRLLGYCWEDKELLL--VYEFMQKGSLENH-------LFGRGASVQPLAWNIR 188
R++ + ++ + L + Y G +Q ++
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKISGQNG 146
Query: 189 -------LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI--SDFGLAK 236
L++ I L ++H + + ++ D KA+N+LL ++ +D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 413 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.94 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.82 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.37 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.97 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.84 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.8 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.64 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.6 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.45 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.59 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.51 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.07 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-61 Score=453.89 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=208.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++++.||+|+||+||+|++.. +++.||||++... .....+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE-------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT-------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeEEEecCCCeEEEEEEECC-------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 589999999999999999997654 6899999998755 3345678999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|||||||+||+|.++|.... ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+|
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999996543 2367899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
+.... ........+||+.|||||++.+..|+.++|||||||++|||++|..||...+.. ..+
T Consensus 173 ~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~ 234 (350)
T 4b9d_A 173 RVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----------------NLV 234 (350)
T ss_dssp SCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHH
T ss_pred eeecC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHH
Confidence 85321 112234568999999999999999999999999999999999999999765321 111
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+..... ...+..++.++.+||.+||+.||++|||+.|+++|-+
T Consensus 235 ~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 235 LKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 12222211 2345567889999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-61 Score=450.69 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=214.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
..|++.+.||+|+||+||+|++.. +++.||||++........+.+.+|+.+|+.|+|||||+++++|.+++.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS-------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECC-------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 569999999999999999997654 6899999999766555566788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|||||||+||+|.+++... .+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+.
T Consensus 147 ~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence 9999999999999998642 58999999999999999999997 6699999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
.... .......+||+.|||||++.+..|+.++|||||||++|||++|.+||...+... .+..
T Consensus 220 ~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----------------~~~~ 281 (346)
T 4fih_A 220 VSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----------------AMKM 281 (346)
T ss_dssp CCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHH
T ss_pred cCCC--CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------HHHH
Confidence 4322 223455789999999999999999999999999999999999999997653211 1111
Q ss_pred hHHhh-hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 318 IIDAR-LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 318 ~~~~~-~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+.... .....+..+++++.+||.+||..||++|||+.|+++|-+.
T Consensus 282 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 282 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp HHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 11111 1122345678899999999999999999999999987553
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-61 Score=445.94 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=216.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++++.||+|+||+||+|++.. +++.||||++.+.. ....+.+.+|+++|+.|+|||||+++++|+++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~-------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA-------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccEEEEEEecccCeEEEEEEECC-------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 469999999999999999997654 68999999997542 23457789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 99999999999999999997654 78999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
|+..............+||+.|||||++.+..|+.++|||||||++|+|++|.+||...+.. ..
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~ 242 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----------------LI 242 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 98755444444456679999999999999999999999999999999999999999764321 11
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..+... ...++..+++++.+||.+||..||++|||++|++++-+
T Consensus 243 ~~~i~~~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~ 287 (311)
T 4aw0_A 243 FAKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287 (311)
T ss_dssp HHHHHHT--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred HHHHHcC--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence 2222222 22456678889999999999999999999999866544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-60 Score=441.60 Aligned_cols=268 Identities=28% Similarity=0.423 Sum_probs=221.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|.+.+.||+|+||+||+|.+... ....+++.||||+++.......+.|.+|+++|++|+|||||++++++.+++.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~--~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL--CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC--C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc--ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 5688899999999999999987542 23346789999999887777778899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcC---------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 158 LLVYEFMQKGSLENHLFGRG---------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
|||||||++|+|.+++...+ .....+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+|
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCcEE
Confidence 99999999999999997643 234579999999999999999999997 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----------- 237 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----------- 237 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Confidence 999999986433222223334579999999999999999999999999999999998 89999764321
Q ss_pred hhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+...+........|..++.++.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 238 ------~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 238 ------EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111222223355678889999999999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=442.06 Aligned_cols=268 Identities=29% Similarity=0.441 Sum_probs=216.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|.+.+.||+|+||+||+|.+... ....+++.||||+++.......+.|.+|+++|++|+|||||++++++.+++.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~--~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL--LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS--CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc--ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4677889999999999999987642 23346789999999887777778899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCC-----------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 158 LLVYEFMQKGSLENHLFGRGA-----------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
|||||||++|+|.+++..... ...++++..++.|+.||+.||+|||+ ++||||||||+|||++.++.
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCCCc
Confidence 999999999999999976532 22468999999999999999999997 66999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~ 305 (413)
+||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--------- 267 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--------- 267 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---------
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---------
Confidence 99999999986544333334455789999999999999999999999999999999999 89999764321
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+...+........|..+++++.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 268 --------~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 268 --------EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 01111222233456778889999999999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-60 Score=454.40 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=214.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+.|++++.||+|+||+||+|++.. +++.||||++........+.+.+|+.+|+.|+|||||+++++|.+++.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS-------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC-------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence 3579999999999999999997654 689999999977655566778999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|||||||+||+|.+++... .+++..+..++.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+|+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccce
Confidence 99999999999999998542 58999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... .......+||+.|||||++.+..|+.++|||||||++|||++|.+||....... .+.
T Consensus 296 ~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----------------~~~ 357 (423)
T 4fie_A 296 QVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----------------AMK 357 (423)
T ss_dssp ECCSS--CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHH
T ss_pred ECCCC--CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------HHH
Confidence 64322 223455789999999999999999999999999999999999999997653211 111
Q ss_pred HhHHhh-hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 317 HIIDAR-LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 317 ~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+.... .....+..++.++.+||.+||..||++|||+.|+++|-+.
T Consensus 358 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 358 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp HHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 111111 1112334678899999999999999999999999987553
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=438.31 Aligned_cols=260 Identities=25% Similarity=0.267 Sum_probs=213.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+.|++.+.||+|+||+||+|++.. +++.||||+++.+.. ..+|+.+|+.|+|||||++++++.+++.+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~-------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ-------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hheEeCcEeccCCCeEEEEEEECC-------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 457888999999999999997654 689999999976532 24699999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEccCCCcc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFGLAK 236 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~a~ 236 (413)
|||||||+||+|.+++...+ .+++..++.++.||+.||+|||+ ++||||||||+||||+.+| .+||+|||+|+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 99999999999999997654 78999999999999999999996 6699999999999999887 69999999998
Q ss_pred cCCCCCCcc---eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 237 LGPSASQSH---VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 237 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
......... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||..........
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------------- 266 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------------- 266 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-------------
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------------
Confidence 654322111 2234689999999999999999999999999999999999999998765432211
Q ss_pred hhhHhHHhhh-cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 015094 314 KFRHIIDARL-QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPK 371 (413)
Q Consensus 314 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~~~~ 371 (413)
.+..... ...++..+++++.+||.+||+.||.+|||+.|++++|.........-.
T Consensus 267 ---~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~ 322 (336)
T 4g3f_A 267 ---KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK 322 (336)
T ss_dssp ---HHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSC
T ss_pred ---HHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhcc
Confidence 1111100 112455778899999999999999999999999999998776554333
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-59 Score=425.97 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=198.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||+||+|++.. +++.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT-------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT-------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eCeEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 589999999999999999996543 68999999986543 23356789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||| +|+|.+++.+++ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~ivmEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 86 DEIIMVIEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp SEEEEEEECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred CEEEEEEeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCC
Confidence 9999999999 679999997654 79999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
|+.... .......+||+.|||||++.+..| +.++|||||||++|+|++|..||...+.. .
T Consensus 159 a~~~~~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----------------~ 219 (275)
T 3hyh_A 159 SNIMTD---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----------------V 219 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------H
T ss_pred CeecCC---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----------------H
Confidence 986332 223345789999999999988876 58999999999999999999999764211 0
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+..+... ...++..+++++.+||.+||+.||++|||++|+++|-+.
T Consensus 220 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 220 LFKNISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp HHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 11112211 123556778899999999999999999999999998664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=429.75 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=206.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.+++++.+.||+|+||+||+|.+. ..||||+++.. .....+.|.+|+.+|++|+|||||++++++. +
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~ 103 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH----------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K 103 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS----------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC----------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C
Confidence 357888999999999999999753 34899998643 3445678999999999999999999999875 4
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred CeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccC
Confidence 57899999999999999996543 368999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
|+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||........
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------------- 245 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------------- 245 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-------------
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-------------
Confidence 986544333334456789999999999864 4689999999999999999999999976532110
Q ss_pred hhhhhHhHHhhh----cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 312 KRKFRHIIDARL----QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 312 ~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+...+.... ....+..++.++.+|+.+||+.||++|||+.||+++|+.++...
T Consensus 246 ---~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 246 ---IIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ---HHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ---HHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111111111 11234567889999999999999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=429.09 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=201.5
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe----C
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE----D 154 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 154 (413)
++.+.||+|+||+||+|.+.. +++.||+|++... .....+.+.+|+.+|+.|+|||||+++++|.. +
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE-------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred EeeeEEecCcCcEEEEEEECC-------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 667789999999999997654 6789999998654 23445679999999999999999999999875 3
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEccCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDFG 233 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~DfG 233 (413)
..+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+.+.+||||||||+|||++ .+|.+||+|||
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred cEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence 56899999999999999997654 78999999999999999999997444499999999999997 47999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||..||........
T Consensus 178 la~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--------------- 237 (290)
T 3fpq_A 178 LATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--------------- 237 (290)
T ss_dssp GGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---------------
T ss_pred CCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH---------------
Confidence 9985322 23445789999999998864 699999999999999999999999975432110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+........++...++++.+||.+||..||++|||+.|+++|-+
T Consensus 238 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 238 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000111111111223345678999999999999999999999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-59 Score=432.56 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=215.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+++.+.||+|+||+||+|.+... ....+++.||||+++... ....+.|.+|+.+|++|+|||||++++++.+++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~--~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP--APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC---------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC--ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 4567789999999999999987532 233467899999997543 2345789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
+|||||||++|+|.++|..+.. ....+++..++.++.||+.||+|||+ ++||||||||+||||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEECCC
Confidence 9999999999999999965432 12368999999999999999999997 569999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVD 303 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~ 303 (413)
+.+||+|||+++..............+||+.|||||++.++.|+.++|||||||++|||+| |..||......
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------- 254 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------- 254 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-------
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 9999999999986433333333445689999999999999999999999999999999998 89999765321
Q ss_pred hhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 304 WIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+...+........|..++.++.+|+.+||+.||++|||+.||+++|+.+
T Consensus 255 ----------~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 ----------DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----------HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112222233445678889999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-58 Score=436.65 Aligned_cols=279 Identities=27% Similarity=0.378 Sum_probs=230.4
Q ss_pred ccHHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccC-CCcc
Q 015094 68 FTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSH-PNLV 145 (413)
Q Consensus 68 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h-~~i~ 145 (413)
++..++....++|++.+.||+|+||+||+|.+... ....+.+.||||.+.... ....+.+.+|+.+|.++.| ||||
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~--~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS--SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCC--CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 34455666678999999999999999999987642 344567899999997653 3345678999999999975 8999
Q ss_pred ceEeEEEeC-CeeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 015094 146 RLLGYCWED-KELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYR 212 (413)
Q Consensus 146 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHr 212 (413)
+++++|.+. +.+|||||||++|+|.++|..... ....+++..++.++.||+.||+|||+ ++||||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHR 209 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHR 209 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecC
Confidence 999998764 579999999999999999975432 13458999999999999999999997 669999
Q ss_pred CCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCC
Q 015094 213 DFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALD 291 (413)
Q Consensus 213 Dlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~ 291 (413)
||||+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986544444444556789999999999999999999999999999999998 999998
Q ss_pred CCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 292 TNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...... .+...+....+...|..+++++.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 290 ~~~~~~----------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 290 GVKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp TCCCSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 653221 12223333444556777889999999999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-59 Score=431.68 Aligned_cols=254 Identities=27% Similarity=0.332 Sum_probs=205.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++++.||+|+||+||+|+... ...+++.||||+++.... .....+.+|+.+|+.|+|||||++++++.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECS----STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cccEEEEEEecCCCeEEEEEEEcc----CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 479999999999999999997542 233678999999875432 23346788999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 9999999999999999997654 78999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
+..... .......+||+.|||||++.+..|+.++|||||||++|||++|..||...+.. ..+
T Consensus 174 ~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~ 235 (304)
T 3ubd_A 174 KESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----------------ETM 235 (304)
T ss_dssp EC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHH
T ss_pred eeccCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----------------HHH
Confidence 853221 22334578999999999999999999999999999999999999999765321 111
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVETLE 361 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~L~ 361 (413)
..+... ...+|..+++++.+||.+||+.||++|||+ +|+++|-+
T Consensus 236 ~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 236 TMILKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred HHHHcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 222222 224566788999999999999999999984 67877643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=412.94 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=191.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV-------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT-------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECC-------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 469999999999999999997654 68899999986543 334567899999999999999999999987654
Q ss_pred -----------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 156 -----------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 156 -----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
.+|+|||||.||+|.+++..+... ....+..++.++.||+.||+|||+ ++||||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCC
Confidence 379999999999999999765432 245667788999999999999997 669999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCc----------ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 225 YTAKISDFGLAKLGPSASQS----------HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
|.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 99999999999864332211 11234689999999999999999999999999999999996 664310
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCch---HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPY---KAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
. .. ..+.......+|. ..++.+.+||.+||+.||++|||+.|++++-
T Consensus 232 -----~-------------~~-~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 232 -----E-------------RV-RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp -----H-------------HH-HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -----H-------------HH-HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 0 00 0111111222332 3445678999999999999999999999763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=408.16 Aligned_cols=274 Identities=26% Similarity=0.356 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK-- 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 155 (413)
++|.+.+.||+|+||+||+|.+. ++.||||++....... ...+.|+..+..++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~---------g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---------TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC---------CEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 46888899999999999999763 6889999997654322 22345677777899999999999998764
Q ss_pred --eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCcEEEcCCCCe
Q 015094 156 --ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------DKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 156 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
.+|||||||++|+|.+++... .+++..+..++.|++.||+|||+. ..+||||||||+|||++.++.+
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred ceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 589999999999999999653 588999999999999999999963 2379999999999999999999
Q ss_pred EEccCCCcccCCCCCCc--ceeecccccccccCccccccC------CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 228 KISDFGLAKLGPSASQS--HVTTRVMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
||+|||+|+........ ......+||+.|||||++.+. .|+.++|||||||++|||+||.+||.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999864333221 122346799999999998764 4778999999999999999999887654322110
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCCc-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.................+.....+..+| ..++..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 228 -YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp -TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 0000000000000011111222222332 245678999999999999999999999999999987653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=417.05 Aligned_cols=271 Identities=22% Similarity=0.278 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+++|+.|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~-------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL-------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCeEEEEEEecccCeEEEEEEECC-------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 579999999999999999997654 68999999997542 3445678899999999999999999998764
Q ss_pred ----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 154 ----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 154 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
.+.+|||||||. |+|.+++... ..+++..+..++.||+.||.|||+ +|||||||||+|||++.+|.+||
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEE
T ss_pred ccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEEE
Confidence 367999999996 5899999543 379999999999999999999997 66999999999999999999999
Q ss_pred ccCCCcccCCCCC--CcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 230 SDFGLAKLGPSAS--QSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 230 ~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+|||+|+...... ........+||+.|||||++.+. .|+.++|||||||++|||++|.+||.+.+...+...+....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998643221 22234457899999999998875 56899999999999999999999998765332221111000
Q ss_pred hh--hhh-----hhhhhHhHHhhhc-CCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 307 PY--LSE-----KRKFRHIIDARLQ-GQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 307 ~~--~~~-----~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.. ... .......+..... ... ...++.++.+||.+||..||++|||+.|+|+|-+.
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 00 000 0000000100000 000 11346789999999999999999999999987553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-54 Score=408.08 Aligned_cols=269 Identities=19% Similarity=0.236 Sum_probs=203.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
..++|++.+.||+|+||+||+|++.. +..+++.||||++.... ...++.+|+++|+.+ +||||++++++|.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQL----QVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEB----TTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcc----cCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 45789999999999999999997642 23467899999987654 335678999999998 599999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeEEccCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFG 233 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~kl~DfG 233 (413)
+++|+|||||+|++|.+++. .+++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999982 58899999999999999999997 669999999999999876 899999999
Q ss_pred CcccCCCCCC--------------------------cceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhC
Q 015094 234 LAKLGPSASQ--------------------------SHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTG 286 (413)
Q Consensus 234 ~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG 286 (413)
+|+....... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9975432211 1112345799999999999775 588999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHhhhhhhhh---------------------hhhhhHhHHh------------------hhcCCC
Q 015094 287 LRALDTNRPSGQHNLVDWIKPYLSE---------------------KRKFRHIIDA------------------RLQGQY 327 (413)
Q Consensus 287 ~~pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~------------------~~~~~~ 327 (413)
+.||......... ...+...... .......... ......
T Consensus 244 ~~Pf~~~~~~~~~--l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 244 RYPFYKASDDLTA--LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp CSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred CCCCCCCCCHHHH--HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 9999654322110 0000000000 0000000000 000111
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 328 PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 328 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
...+++++.+||.+||..||++|+|++|+++|-+
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 2245678999999999999999999999998744
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=427.18 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=213.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++++.||+|+||+||+|.+.. +++.||||++........+.+.+|+.+|+.|+||||++++++|.++..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~-------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA-------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECC-------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4689999999999999999997654 689999999987776667789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC--CCeEEccCCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS--YTAKISDFGL 234 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~--~~~kl~DfG~ 234 (413)
+|||||||.||+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 999999999999999985432 368999999999999999999997 669999999999999754 8999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
|+.... .......+||+.|||||++.+..|+.++|||||||++|+|++|.+||...+... .
T Consensus 304 a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----------------~ 364 (573)
T 3uto_A 304 TAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------------T 364 (573)
T ss_dssp CEECCT---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------H
T ss_pred eeEccC---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----------------H
Confidence 987432 233455689999999999999999999999999999999999999998653211 1
Q ss_pred hhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..+...... ......++.++.+||.+||..||.+|||+.|+++|-+
T Consensus 365 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 1112111111 1122356788999999999999999999999998744
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-53 Score=424.04 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=206.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh------hhHHHHHHHHHHHhhccCCCccceEeEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL------QGFEEWQSEVNFLGRLSHPNLVRLLGYC 151 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 151 (413)
++|+++++||+|+||+||+|++.. +++.||||++.+... ......++++.+++.++|||||+++++|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~-------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECC-------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 679999999999999999997654 789999999865421 1122234456777788999999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.+.+.+|||||||.||+|.++|.+.+ .+++..++.++.||+.||+|||+ +|||||||||+||||+.+|.+||+|
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred EECCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecc
Confidence 99999999999999999999997654 68999999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
||+|+..... .....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||..........
T Consensus 336 FGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~---------- 401 (689)
T 3v5w_A 336 LGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------- 401 (689)
T ss_dssp CTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH----------
T ss_pred cceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----------
Confidence 9999864322 2345689999999999964 579999999999999999999999997643321110
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~ 361 (413)
....+.. ....++..++.++.+||.+||..||.+|++ ++||++|-+
T Consensus 402 ---i~~~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 402 ---IDRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp ---HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred ---HHHhhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 0111111 223456678899999999999999999998 689988755
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=382.76 Aligned_cols=281 Identities=41% Similarity=0.723 Sum_probs=232.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR--------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT--------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHhccCccceeecCCCeeEEEEEEC--------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4578999999999999999999643 46889999988776666788999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+++++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999997655445578999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
................||+.|+|||++.+..++.++|||||||++|+|++|..||....+........+.... .....+
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 265 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQL 265 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-cccccH
Confidence 8644333333334456899999999999999999999999999999999999999876665544433332211 111122
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
..+++.......+...+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 2233333444566788999999999999999999999999999999887543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=384.00 Aligned_cols=272 Identities=26% Similarity=0.397 Sum_probs=223.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+..........+..||||++.... ....+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 4689999999999999999998754322334567889999997653 34567789999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+.+|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEC
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEEEC
Confidence 999999999999999999976542 12357899999999999999999997 5699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---- 313 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 999999999999986543332223334567889999999999999999999999999999999 999997643211
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+...+........+..++.++.+||.+||+.||.+|||+.|++++|+.+....
T Consensus 314 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 -------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11122222333456677889999999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=366.90 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++........+.+.+|+.+++.++||||+++++++..++.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA-------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT-------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhceeeeeeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 4689999999999999999996543 678999999876655556778999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+.|++|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 99999999999999999653 58899999999999999999997 569999999999999999999999999987
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------------~~~ 226 (297)
T 3fxz_A 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----------------ALY 226 (297)
T ss_dssp ECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHH
T ss_pred ecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 643322 22344679999999999999999999999999999999999999997643211 000
Q ss_pred HhH-HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 317 HII-DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 317 ~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+. ........+..++..+.+||.+||+.||.+|||+.|++++-+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp HHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred HHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 111 111122345567888999999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=374.10 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=211.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL-------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3579999999999999999997643 6789999998654 334566788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++...+ .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999999997654 68999999999999999999997 5699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCcc-chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...
T Consensus 161 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------------- 221 (328)
T 3fe3_A 161 SNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---------------- 221 (328)
T ss_dssp CGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------
T ss_pred ceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----------------
Confidence 9764322 223456899999999999888775 89999999999999999999997653110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+... ....|...+.++.+||.+||..||.+|||+.|+++|-+.
T Consensus 222 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 222 LRERVLRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp HHHHHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 01111111 123455678899999999999999999999999987553
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=367.16 Aligned_cols=264 Identities=27% Similarity=0.442 Sum_probs=217.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||+||+|.+.. +++.||+|++........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~-------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE-------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT-------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhHeeccceecCCCCEEEEEEEECC-------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence 3579999999999999999997654 578999999877666677889999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 999999999999999997643 368999999999999999999997 569999999999999999999999999998
Q ss_pred cCCCCCCcc------------eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 237 LGPSASQSH------------VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 237 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-- 234 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-- 234 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--
Confidence 643322111 111457999999999999999999999999999999999999998764432211100
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.. ........+..++..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus 235 ---------~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 235 ---------NV----RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ---------CH----HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------hh----hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 111111234456678999999999999999999999999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=370.91 Aligned_cols=289 Identities=46% Similarity=0.772 Sum_probs=232.2
Q ss_pred cccccHHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-hHHHHHHHHHHHhhccCCC
Q 015094 65 LRIFTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLGRLSHPN 143 (413)
Q Consensus 65 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~ 143 (413)
...++..++....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++|||
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 88 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec--------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence 456777888899999999999999999999999532 4788999998765322 2236889999999999999
Q ss_pred ccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC-CCCeeeCCCCCCcEEEc
Q 015094 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS-DKQVIYRDFKASNILLD 222 (413)
Q Consensus 144 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~ivHrDlkp~Nil~~ 222 (413)
|+++++++...+..++||||+.+++|.+++.........+++..++.++.||+.||.|||+. ..+|+||||||+|||++
T Consensus 89 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168 (326)
T ss_dssp BCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred ccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence 99999999999999999999999999999987766666799999999999999999999973 11699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCC--CCcch
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRP--SGQHN 300 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~--~~~~~ 300 (413)
.++.+||+|||++...... .........||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp TTCCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 9999999999999864322 22234446699999999999899999999999999999999999999963211 11111
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...+...... ......+.+......++...+..+.+|+.+||+.||.+|||+.+++++|+..
T Consensus 248 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 248 LLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2222222211 1222333344445566778889999999999999999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=375.26 Aligned_cols=279 Identities=27% Similarity=0.380 Sum_probs=226.1
Q ss_pred ccHHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCcc
Q 015094 68 FTFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLV 145 (413)
Q Consensus 68 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~ 145 (413)
+...++....++|++.+.||+|+||.||+|.+... .+..+++.||||++.... ....+.+.+|+.+++.+ +||||+
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS--SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccc--cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 33455556678999999999999999999976532 244578999999997653 34456789999999999 699999
Q ss_pred ceEeEEEeCC-eeEEEEeeCCCCCHHHhhhhcCCC---------------------------------------------
Q 015094 146 RLLGYCWEDK-ELLLVYEFMQKGSLENHLFGRGAS--------------------------------------------- 179 (413)
Q Consensus 146 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------- 179 (413)
++++++.+.+ .+++||||+.+++|.+++......
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999988765 499999999999999999765421
Q ss_pred -----------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCC
Q 015094 180 -----------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242 (413)
Q Consensus 180 -----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~ 242 (413)
...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1228899999999999999999997 569999999999999999999999999998654443
Q ss_pred CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHh
Q 015094 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDA 321 (413)
Q Consensus 243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (413)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... .+...+..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~~~ 311 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLKE 311 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----------------HHHHHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----------------HHHHHHHc
Confidence 3334455678999999999999999999999999999999998 999997654321 11122222
Q ss_pred hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 322 RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 322 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
......+..++.++.+||.+||+.||.+|||+.+++++|+.+...
T Consensus 312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 333445566778999999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=369.50 Aligned_cols=252 Identities=28% Similarity=0.368 Sum_probs=211.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++++.||+|+||+||+|.... +++.||||++.... ....+.+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA-------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 3579999999999999999997543 68899999987542 2345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.|++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999997553 68999999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .
T Consensus 151 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~ 212 (337)
T 1o6l_A 151 LCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------R 212 (337)
T ss_dssp TCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------H
T ss_pred chhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----------------H
Confidence 99853221 22334568999999999999999999999999999999999999999764211 0
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
.+..+... ...++..++.++.+||.+||..||.+|| ++.++++|-.
T Consensus 213 ~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 213 LFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 11111111 2235667788999999999999999999 8999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=373.80 Aligned_cols=276 Identities=28% Similarity=0.397 Sum_probs=226.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+..........+..||||++.... ....+.+.+|+++++.+ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999998754332344566789999987653 34557789999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCC------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGAS------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+.+|+||||+.+++|.+++...... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEC
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEEEc
Confidence 9999999999999999999765421 2358999999999999999999997 5699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----- 300 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 300 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999986544333333444567899999999999999999999999999999999 99999764311
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCCCCC
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPK 371 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~~~~ 371 (413)
.+...+........+..++.++.+||.+||+.||++|||+.+++++|+.+........
T Consensus 301 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 301 ------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp ------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred ------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1112222333344556778899999999999999999999999999999987654433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=370.49 Aligned_cols=258 Identities=24% Similarity=0.285 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECC-------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3689999999999999999997653 678999999865432 23356889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeecc
Confidence 999999999999999998543 368999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
................||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------------- 217 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------- 217 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH---------------
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH---------------
Confidence 86433333333345689999999999987776 78999999999999999999999765432211
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+..+............++..+.+||.+||..||.+|||+.|++++.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 011111111111224567889999999999999999999999987664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=364.92 Aligned_cols=261 Identities=31% Similarity=0.470 Sum_probs=207.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..+|++.+.||+|+||+||+|.+. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH---------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred hhHceeeeEeecCCCeEEEEEEEC---------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 468999999999999999999653 5789999987553 34456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEcCCCCeEEccC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQ--VIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~--ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
..+|+||||+.+++|.+++..... ...+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999965431 1248899999999999999999996 56 999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 184 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--------------- 246 (309)
T 3p86_A 184 GLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------------- 246 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---------------
T ss_pred CCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------------
Confidence 999753221 112334679999999999999999999999999999999999999997643210
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
....+.........+..++.++.+||.+||..||.+|||+.++++.|+.+....
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 247 -VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111111122234456678889999999999999999999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=367.06 Aligned_cols=275 Identities=26% Similarity=0.323 Sum_probs=211.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
.++|++.+.||+|+||+||+|.+. ++.||||++..... ......+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL---------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET---------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred hhhchhhheecccCceEEEEEEEC---------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 468999999999999999999653 58899999976543 3345567999999999999999999998754
Q ss_pred ---eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC--------CCCeeeCCCCCCcEEEcCC
Q 015094 156 ---ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS--------DKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 156 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~~~ivHrDlkp~Nil~~~~ 224 (413)
.+|+||||+++++|.+++... .+++..++.++.||+.||.|||+. ..+|+||||||+|||++.+
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred CCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 479999999999999999653 589999999999999999999963 1179999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcceeecccccccccCcccccc-----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 225 YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
+.+||+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999999976544333333344679999999999876 45678899999999999999999999876554332
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
............................ ....+.++.+||.+||+.||++|||+.++++.|+.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 2221111000000000011111111111 124567799999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=365.48 Aligned_cols=265 Identities=26% Similarity=0.421 Sum_probs=216.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. ....+..||||++... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRV----PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECC----TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEec----CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4679999999999999999997753 1224567999999765 3345567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred ccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 9999999999999999996442 368999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
.......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----------------- 261 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----------------- 261 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----------------
Confidence 8654332211 2223456788999999998999999999999999999999 99999664221
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.....+........+..++..+.+||.+||..||.+|||+.++++.|+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 262 DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111112222333455677889999999999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=371.16 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=207.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh------hHHHHHHHHHHHhhccCCCccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ------GFEEWQSEVNFLGRLSHPNLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~ 150 (413)
.++|++.+.||+|+||+||+|.+.. +++.||+|++...... ..+.+.+|+.+|+.++||||++++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 83 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS-------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV 83 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC-------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence 4679999999999999999997653 6889999998754321 34678999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----C
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY----T 226 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~----~ 226 (413)
+.+...+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 84 YENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCC
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccC
Confidence 99999999999999999999999543 378999999999999999999997 5699999999999998776 7
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 158 vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--------- 225 (361)
T 2yab_A 158 IKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 225 (361)
T ss_dssp EEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------
T ss_pred EEEEecCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---------
Confidence 999999999864332 22344679999999999999999999999999999999999999997643210
Q ss_pred hhhhhhhhhhHhHHhhhcCCCc----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+.... ..++ ..++..+.+||.+||..||.+|||+.|+++|-+
T Consensus 226 -------~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 226 -------TLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp -------HHHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred -------HHHHHHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 111111110 1111 245678999999999999999999999997544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=362.46 Aligned_cols=269 Identities=28% Similarity=0.411 Sum_probs=220.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+... ....+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHL--KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETG--GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEecc--CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 46899999999999999999976431 12235689999999754 3345677899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC--------------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA--------------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
.+|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||+ ++|+|||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dik 177 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLA 177 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCCCS
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccccc
Confidence 99999999999999999976543 12358899999999999999999997 569999999
Q ss_pred CCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 015094 216 ASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNR 294 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~ 294 (413)
|+|||++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986543332222334567889999999999999999999999999999999 999997653
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
... +...+........+..++.++.+||.+||+.||.+|||+.+++++|+.+...
T Consensus 258 ~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PER-----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGG-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH-----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 221 1112222223345567788999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=371.13 Aligned_cols=252 Identities=28% Similarity=0.386 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 152 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE-------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ 94 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC-------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence 4689999999999999999997654 67899999987542 23456678899999988 6999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+.+.+|+||||+.|++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEccc
Confidence 9999999999999999999997654 68999999999999999999997 56999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|+++.... ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..
T Consensus 169 G~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------------- 230 (353)
T 3txo_A 169 GMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---------------- 230 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------
T ss_pred cceeeccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----------------
Confidence 99985322 222344568999999999999999999999999999999999999999765321
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM------REVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~------~e~l~~L~ 361 (413)
..+..+... ...++..++.++.+||.+||..||.+||++ .++++|-.
T Consensus 231 ~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 231 DLFEAILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 111222221 223456678899999999999999999998 78887644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=374.32 Aligned_cols=270 Identities=25% Similarity=0.350 Sum_probs=216.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+... .+..+++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM--PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC--CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46799999999999999999986532 23446789999998654 3344567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCC---CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---CeEE
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGA---SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY---TAKI 229 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~---~~kl 229 (413)
..|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999976542 22358999999999999999999997 6699999999999998554 5999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------------ 293 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------------ 293 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 99999974322222222334568999999999999999999999999999999998 99999764311
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.+...+........+..++..+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 294 -----~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 294 -----EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -----HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 111122222233445567788999999999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=362.81 Aligned_cols=255 Identities=18% Similarity=0.213 Sum_probs=210.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS-------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred hhceEeeeEEecCCCeEEEEEEECC-------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence 4689999999999999999997553 68999999987553 344668899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--CCCeEEccCCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG--SYTAKISDFGL 234 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~--~~~~kl~DfG~ 234 (413)
+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 999999999999999995432 368999999999999999999997 56999999999999986 78999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 151 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~ 211 (321)
T 1tki_A 151 ARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------I 211 (321)
T ss_dssp CEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------H
T ss_pred CeECCC---CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----------------H
Confidence 986432 223445679999999999998889999999999999999999999997643210 1
Q ss_pred hhHhHHhhhcCC--CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQ--YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 315 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
+..+........ ....++.++.+||.+||..||.+|||+.|++++-+.-
T Consensus 212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 111111111100 0124567899999999999999999999999988753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=371.85 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=209.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhc-cCCCccceEeEEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRL-SHPNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 152 (413)
.++|++++.||+|+||+||+|++.. +++.||||++.+... ...+.+.+|..+|+++ +||||+++++++.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK-------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 4679999999999999999997654 689999999875522 2334578899999887 7999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+.+.+|+||||+.||+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997654 68999999999999999999997 56999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|+++.... ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||............ ...
T Consensus 198 Gla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~-------~~~ 268 (396)
T 4dc2_A 198 GMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TED 268 (396)
T ss_dssp TTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C-------CHH
T ss_pred ceeeeccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh-------hHH
Confidence 99985322 222344578999999999999999999999999999999999999999754322110000 000
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM------REVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~------~e~l~~L~ 361 (413)
..+..+.. ....++..++.++.+||.+||+.||.+||++ .|+++|-.
T Consensus 269 ~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 269 YLFQVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp HHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred HHHHHHhc--cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 01111111 1234566788899999999999999999985 67776543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=368.81 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=208.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-----hhHHHHHHHHHHHhhccCCCccceEeEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-----QGFEEWQSEVNFLGRLSHPNLVRLLGYC 151 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 151 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE-------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY 95 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC-------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4579999999999999999997654 678999999864321 2356789999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eE
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT---AK 228 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~---~k 228 (413)
.+++.+|+||||++|++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +|
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEE
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEE
Confidence 99999999999999999998886654444468999999999999999999997 56999999999999976554 99
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|+|||++...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 174 l~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------- 238 (351)
T 3c0i_A 174 LGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------------- 238 (351)
T ss_dssp ECCCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------------
T ss_pred EecCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------------
Confidence 9999999864332 1223446799999999999999999999999999999999999999976311
Q ss_pred hhhhhhhhHhHHhhhcCC--CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQ--YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+..+........ ....++.++.+||.+||..||++|||+.++++|-+.
T Consensus 239 ----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 239 ----RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp ----HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ----HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 00111111111000 002356789999999999999999999999987553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=367.52 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT-------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC-------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 4679999999999999999997653 67899999986542 34556789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS---YTAKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~---~~~kl~D 231 (413)
+..|+||||+.|++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEee
Confidence 9999999999999999998544 368999999999999999999997 569999999999999754 4599999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 175 fG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------------- 236 (362)
T 2bdw_A 175 FGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------------- 236 (362)
T ss_dssp CTTCBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------
T ss_pred cCcceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---------------
Confidence 9999864322 2233467999999999999989999999999999999999999999764211
Q ss_pred hhhhhHhHHhhhcC--CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQG--QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 312 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+..+....... .....++.++.+||.+||..||.+|||+.+++++-+.
T Consensus 237 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 237 -RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp -HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred -HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 0111111111111 1113567889999999999999999999999987553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=361.10 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||+||+|.... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH-------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 3579999999999999999997543 68899999987542 2345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
...+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecC
Confidence 999999999999999999997543 68999999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. .
T Consensus 152 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~ 210 (318)
T 1fot_A 152 FAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------K 210 (318)
T ss_dssp SCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------H
T ss_pred cceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------H
Confidence 9986332 223467999999999999999999999999999999999999999764211 1
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
.+..+... ...++..++.++.+||.+||..||.+|| +++++++|-+
T Consensus 211 ~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 211 TYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHHHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 11222222 1235567788999999999999999999 8999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=373.85 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=214.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA-------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec-------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 4578899999999999999997653 57899999987553 233456889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++++|.+++...+ ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 9999999999999999997543 258899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----------------~ 323 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----------------Q 323 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----------------H
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 85322111111112235778999999998999999999999999999998 99999764211 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++.++.+||.+||+.||++|||+.++++.|+.+...
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 324 TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1122223333445667788999999999999999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=374.37 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=208.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||+||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~-------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 81 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL-------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT-------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC-------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence 45689999999999999999996553 68999999987653 2345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCCeEEc
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYTAKIS 230 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~---~~~~~kl~ 230 (413)
++..|+||||+.|++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred CCEEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEc
Confidence 999999999999999999997654 68999999999999999999997 5699999999999997 56889999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||++....... .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||......
T Consensus 156 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------------- 219 (444)
T 3soa_A 156 DFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-------------- 219 (444)
T ss_dssp CCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------------
T ss_pred cCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--------------
Confidence 999997643222 2234467999999999999999999999999999999999999999764211
Q ss_pred hhhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+..+...... ......++.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 220 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 220 --RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp --HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred --HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 011111111111 1111356788999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=360.14 Aligned_cols=278 Identities=26% Similarity=0.417 Sum_probs=216.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC--
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-- 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 154 (413)
.++|++.+.||+|+||+||+|++.. .+..+++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP---LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT---TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec---ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4689999999999999999997542 23447899999999877767778899999999999999999999998654
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 56899999999999999997653 258999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh---h
Q 015094 235 AKLGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL---S 310 (413)
Q Consensus 235 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~---~ 310 (413)
+......... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQM 236 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccch
Confidence 9864332211 1223345788899999999999999999999999999999999888643110 000000000 0
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
........+........+..++.++.+||.+||+.||++|||+.++++.|+.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00011122222333445667889999999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=366.91 Aligned_cols=271 Identities=27% Similarity=0.394 Sum_probs=218.1
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 74 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
....++|++.+.||+|+||.||+|.+... ....+++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGL--LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETS--STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCc--CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33567899999999999999999987531 112356899999997653 344567899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCC--------------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGAS--------------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYR 212 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHr 212 (413)
+++.+|+||||+.+++|.+++...... ...+++..++.++.||+.||.|||+ ++|+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence 999999999999999999999764321 1478999999999999999999997 569999
Q ss_pred CCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCC
Q 015094 213 DFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALD 291 (413)
Q Consensus 213 Dlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~ 291 (413)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999975432222222334568899999999999999999999999999999999 999997
Q ss_pred CCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 292 TNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
..... .....+........+..++.++.+||.+||..||.+|||+.+++++|+.+..
T Consensus 279 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAHE-----------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCHH-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCChH-----------------HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 54211 0001111112223455678899999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=357.81 Aligned_cols=272 Identities=29% Similarity=0.407 Sum_probs=223.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+... .+..+++.||||++.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGL--IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS--SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeec--cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 346899999999999999999975421 233467899999997653 23457789999999999 89999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCC--------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGAS--------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNI 219 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Ni 219 (413)
++..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+ .+|+||||||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Ni 176 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNI 176 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceE
Confidence 99999999999999999999765421 2258999999999999999999997 5699999999999
Q ss_pred EEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 015094 220 LLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQ 298 (413)
Q Consensus 220 l~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~ 298 (413)
|++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 999999999999999986554433333444567889999999999999999999999999999999 999997654321
Q ss_pred chhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 299 HNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.+...+........+..++.++.+||.+||..||.+|||+.+++++|+.+....
T Consensus 256 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 ---------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp ---------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---------------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 111222233333445567789999999999999999999999999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=353.48 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=208.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI-------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT-------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred hccEEEEEEEccCCCEEEEEEEECC-------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 4689999999999999999996543 6789999987543 33445778999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++.+|+||||++|++|.+++...+ ++++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999997654 68999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 157 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-- 227 (294)
T 4eqm_A 157 IAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-- 227 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS--
T ss_pred Ccccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc--
Confidence 998643221 1223345799999999999999999999999999999999999999976532110 0000000
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhcC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQASD 367 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-t~~e~l~~L~~i~~~~ 367 (413)
... ......+..++..+.++|.+||..||.+|| +++++++.|..+....
T Consensus 228 ~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 228 SVP-----NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCC-----CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cCC-----CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 000 000012234667899999999999999998 8999999988765443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=359.99 Aligned_cols=273 Identities=26% Similarity=0.401 Sum_probs=220.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+..........++.||||++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 4689999999999999999998754322334567889999997653 34567789999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCC------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGAS------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+.+|+||||+.+++|.+++...... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVT 191 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEEEc
Confidence 9999999999999999999765421 2348899999999999999999997 5699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----- 266 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 266 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-----
Confidence 999999999999986543332223334567889999999988999999999999999999999 99999764211
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
.+...+........+..++.++.+||.+||..||.+|||+.+++++|+.+.....
T Consensus 267 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 267 ------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1111122222334556678899999999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=365.69 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=210.0
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGY 150 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 150 (413)
...++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+..|..+++.+ +||||++++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~ 86 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK-------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 86 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence 345789999999999999999997654 68999999987542 23456678899999887 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
+.+.+.+|+||||+.||+|.+++.... .+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+
T Consensus 87 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 87 FQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEe
Confidence 999999999999999999999997643 68999999999999999999997 569999999999999999999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 161 DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------------- 224 (345)
T 1xjd_A 161 DFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------------- 224 (345)
T ss_dssp CCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------
T ss_pred EChhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------------
Confidence 99999853221 12244568999999999999999999999999999999999999999764321
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR-EVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~-e~l~~L~ 361 (413)
..+..+... ...++..++.++.+||.+||..||++||++. ++++|-.
T Consensus 225 --~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 225 --ELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp --HHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred --HHHHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 111111111 2234556788999999999999999999998 7876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=364.68 Aligned_cols=272 Identities=29% Similarity=0.427 Sum_probs=218.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+... .....++.||||++.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGI--SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC--SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeecc--ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 346899999999999999999976421 233467889999987542 23456789999999999 89999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCC-------------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGAS-------------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDF 214 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDl 214 (413)
.+.+|+||||+++++|.+++...... ...+++..++.++.||+.||.|||+ .+|+||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Di 198 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDL 198 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTC
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCC
Confidence 99999999999999999999764321 1247899999999999999999997 56999999
Q ss_pred CCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCC
Q 015094 215 KASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTN 293 (413)
Q Consensus 215 kp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~ 293 (413)
||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999986443333333444567889999999999999999999999999999998 99999765
Q ss_pred CCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.... .+...+........+..++.++.+||.+||..||.+|||+.+++++|+.+....
T Consensus 279 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 279 PVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CcHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 4321 112222333334455667889999999999999999999999999999876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=361.49 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=209.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+... .......||+|.+.... ....+.+.+|+.+++.++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCC---CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 35799999999999999999976541 11223457899886442 345577899999999999999999999998754
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.++|+||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -eEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcce
Confidence 789999999999999997643 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...............+|..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~ 227 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------E 227 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------G
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----------------H
Confidence 86544333333344567889999999999999999999999999999999 99999765322 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+...+........+..++.++.+|+.+||+.||.+||++.+++++|+.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 2222333333345566788999999999999999999999999999988653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=365.71 Aligned_cols=259 Identities=24% Similarity=0.297 Sum_probs=200.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL-------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT-------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC-------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence 3589999999999999999997653 678999999876532 23568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--eEEccCCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT--AKISDFGL 234 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~ 234 (413)
+|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 999999999999999996544 68999999999999999999997 66999999999999987765 99999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccch-hhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVK-SDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++... .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........
T Consensus 165 a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------------ 229 (361)
T 3uc3_A 165 SKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK------------ 229 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH------------
T ss_pred ccccc---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH------------
Confidence 97422 2222344579999999999988887655 8999999999999999999986543321110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
....+............++.++.+||.+||..||.+|||+.|+++|-+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 230 TIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 111111111111122246788999999999999999999999999977644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=360.53 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=206.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh------hhHHHHHHHHHHHhhccCCCccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL------QGFEEWQSEVNFLGRLSHPNLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 150 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+|+.++||||++++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 82 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS-------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 82 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT-------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC-------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3569999999999999999997653 678999999865432 135678999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----C
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY----T 226 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~----~ 226 (413)
+.+...+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++ .
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCC
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCC
Confidence 99999999999999999999999543 368999999999999999999997 5699999999999998877 8
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 157 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------- 224 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 224 (326)
T ss_dssp EEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------
T ss_pred EEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---------
Confidence 9999999998643221 2334579999999999998999999999999999999999999997642210
Q ss_pred hhhhhhhhhhHhHHhhhcCCCc----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+... ...++ ..++..+.+||.+||..||.+|||+.+++++-+
T Consensus 225 -------~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 225 -------TLANVSAV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp -------HHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred -------HHHHHHhc--CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00011100 01111 245678999999999999999999999998644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=361.65 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=209.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
++|++.+.||+|+||.||+|++.. +++.||||++.... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKK-------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 81 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hheEEEEEEEecCCeEEEEEEECC-------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence 579999999999999999997654 68999999987542 33456688999999988 79999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.|++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999999999997653 68999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||............ ....
T Consensus 156 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------~~~~ 226 (345)
T 3a8x_A 156 MCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDY 226 (345)
T ss_dssp GCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHH
T ss_pred ccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc-------cHHH
Confidence 99853221 22334568999999999999999999999999999999999999999753221110000 0000
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM------REVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~------~e~l~~L~ 361 (413)
.+..+... ...++..++.++.+||.+||..||.+||++ .++++|-.
T Consensus 227 ~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 227 LFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred HHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 11111111 224566778899999999999999999996 67777644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=363.96 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=210.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++++.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKE-------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred HHCEEEEEeecCcCcEEEEEEECC-------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 579999999999999999997653 67899999986542 23456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+.|++|.+++...+ .+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEccccc
Confidence 99999999999999999997654 68999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~ 246 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----------------QI 246 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----------------HH
Confidence 9864321 23467999999999999999999999999999999999999999764211 11
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~ 361 (413)
+..+... ...++..++.++.+||.+||+.||.+||+ ++++++|-.
T Consensus 247 ~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 247 YEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 1122221 22355677889999999999999999998 899988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=364.79 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK-------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3589999999999999999997654 678999999865421 234578899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred CCEEEEEEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEec
Confidence 99999999999 679999886654 68999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........
T Consensus 154 ~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------- 219 (336)
T 3h4j_B 154 LSNIMTD---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------- 219 (336)
T ss_dssp CTBTTTT---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------
T ss_pred cceeccC---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------
Confidence 9986432 222344679999999999988876 6899999999999999999999976533221100
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+ .......+..++.++.+||.+||..||.+|||+.|++++-+.
T Consensus 220 -----i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 220 -----V--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp -----C--CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred -----H--HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 0 001123445677889999999999999999999999998775
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=367.19 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=210.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++..........+.+|+.+|+.++||||+++++++.+...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA-------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECC-------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 4689999999999999999997653 678999999987765566678999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--CCCCeEEccCCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD--GSYTAKISDFGL 234 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~--~~~~~kl~DfG~ 234 (413)
+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEeccc
Confidence 999999999999999985432 368999999999999999999997 5699999999999997 457899999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 198 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----------------~ 258 (387)
T 1kob_A 198 ATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------------T 258 (387)
T ss_dssp CEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------H
T ss_pred ceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 9864322 22334579999999999999999999999999999999999999997643210 1
Q ss_pred hhHhHHhh--hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..+.... ........++.++.+||.+||..||.+|||+.+++++.+
T Consensus 259 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 11111111 111222356788999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=367.35 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=208.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND-------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3579999999999999999997654 67899999986542 2345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccc
Confidence 999999999999999999996543 68999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
++..... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||............
T Consensus 161 ~a~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-------- 229 (384)
T 4fr4_A 161 IAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-------- 229 (384)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH--------
T ss_pred eeeeccC---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH--------
Confidence 9986432 223445789999999999864 46899999999999999999999999765432211110
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-MREVVETL 360 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-~~e~l~~L 360 (413)
..+ ......++..++.++.+||.+||..||.+||+ +.+++++-
T Consensus 230 -----~~~--~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 230 -----HTF--ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp -----HHH--HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred -----HHH--hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 011 11223456677889999999999999999998 77777643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=364.33 Aligned_cols=253 Identities=28% Similarity=0.372 Sum_probs=210.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYC 151 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 151 (413)
..++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|..+|..+ +||||+++++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG-------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT-------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 34689999999999999999997653 67899999987542 23456788999999988 799999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.+.+.+|+||||+.||+|.+++...+ .+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEe
Confidence 99999999999999999999997654 68999999999999999999997 5699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||++..... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 165 FG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------------- 227 (353)
T 2i0e_A 165 FGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------------- 227 (353)
T ss_dssp CTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------
T ss_pred CCccccccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---------------
Confidence 999985322 122334568999999999999999999999999999999999999999764211
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLE 361 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~ 361 (413)
..+..+... ...++..++.++.+||.+||..||.+||+ ++++++|-.
T Consensus 228 -~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 228 -ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp -HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred -HHHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 112222222 22356678889999999999999999995 588887643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=355.08 Aligned_cols=273 Identities=21% Similarity=0.282 Sum_probs=212.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK-------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC-------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 3679999999999999999997654 57899999987543 234567889999999999999999999988765
Q ss_pred --eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeEE
Q 015094 156 --ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL----DGSYTAKI 229 (413)
Q Consensus 156 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~----~~~~~~kl 229 (413)
.+|+||||+.+++|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred CceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEE
Confidence 78999999999999999976432 2248999999999999999999997 569999999999999 77788999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccc--------cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA--------TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
+|||++....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...........
T Consensus 158 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 158 TDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 9999998643322 233457999999999886 57889999999999999999999999976443221111
Q ss_pred hHhhhhhhhhhh-----hhhHhH--------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 302 VDWIKPYLSEKR-----KFRHII--------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 302 ~~~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
. ......... .+.... .......++...+..+.+||.+||+.||++|||++|++++..+..
T Consensus 235 ~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 235 V--MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp H--HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred H--HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0 010000000 000000 001112345678889999999999999999999999999988743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=348.16 Aligned_cols=285 Identities=38% Similarity=0.648 Sum_probs=225.5
Q ss_pred cccccHHHHHHHhcCCCCC------CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc----ChhhHHHHHHHHH
Q 015094 65 LRIFTFVELRAATRNFKSD------TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE----SLQGFEEWQSEVN 134 (413)
Q Consensus 65 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~ 134 (413)
...+++.++....+.|... +.||+|+||.||+|.+ .++.||||++... .....+.+.+|+.
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~ 82 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---------NNTTVAVKKLAAMVDITTEELKQQFDQEIK 82 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---------SSCEEEEEEECCCTTSCTTTHHHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---------CCceEEEEEEecccCcchHHHHHHHHHHHH
Confidence 3557788888888877666 9999999999999964 3578999988643 2234567899999
Q ss_pred HHhhccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 015094 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDF 214 (413)
Q Consensus 135 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDl 214 (413)
+++.++||||+++++++.+.+..|+||||+++++|.+++.... ....+++..++.++.||+.||.|||+ .+|+||||
T Consensus 83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl 159 (307)
T 2nru_A 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDI 159 (307)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCC
T ss_pred HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCC
Confidence 9999999999999999999999999999999999999986533 23468999999999999999999997 56999999
Q ss_pred CCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 215 KASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 215 kp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 160 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999999999986544333333445679999999998754 58899999999999999999999998755
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
....... +..........+...+.... ...+...+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 239 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 239 EPQLLLD--IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSSBTTH--HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chHHHHH--HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 4322111 11111111112222222222 23456788899999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=349.90 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=213.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+. .++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hhhceeeheecCCCccEEEEEEec--------CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 357999999999999999999764 357799999976543 34678999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred eEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEeccccccc
Confidence 999999999999999996543 368999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----------------~~ 216 (269)
T 4hcu_A 155 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EV 216 (269)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HH
T ss_pred cccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----------------HH
Confidence 532211 111223456788999999998999999999999999999999 99999764321 11
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 217 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111122223344556678899999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=354.46 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=199.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------------------------hhHHHHH
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------------------------QGFEEWQ 130 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~ 130 (413)
.++|++.+.||+|+||.||+|++.. +++.||||++..... ...+.+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN-------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT-------TTEEEEEEEEECC-------------------------------CHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC-------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence 3589999999999999999997543 689999999865431 1235688
Q ss_pred HHHHHHhhccCCCccceEeEEEe--CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCC
Q 015094 131 SEVNFLGRLSHPNLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQ 208 (413)
Q Consensus 131 ~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ 208 (413)
+|+.+|+.++||||+++++++.+ ...+|+||||+++++|.+++. ...+++..++.++.||+.||.|||+ .+
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~--~~ 157 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHY--QK 157 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH--CC
Confidence 99999999999999999999987 578999999999999988652 2368999999999999999999997 56
Q ss_pred eeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCC---ccchhhhHHHHHHHHHHHh
Q 015094 209 VIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH---LYVKSDVYGFGVVLVEILT 285 (413)
Q Consensus 209 ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~llt 285 (413)
|+||||||+|||++.++.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999999999999999999864322 12234467999999999987655 4788999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 286 GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 286 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
|..||...... . ....+............++.++.+||.+||+.||++|||+.|+++|-+
T Consensus 236 g~~pf~~~~~~------~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 236 GQCPFMDERIM------C----------LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SSCSSCCSSHH------H----------HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred CCCCCCCccHH------H----------HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 99999754211 0 001111111111222356788999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=361.88 Aligned_cols=264 Identities=24% Similarity=0.421 Sum_probs=210.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+... .......||+|.+.... ....+.+.+|+.+++.++||||+++++++. +.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPE---GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCT---TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCC---CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 35799999999999999999986541 12223458888875442 233456778999999999999999999875 56
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred ccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcc
Confidence 7999999999999999996542 368888999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
................|+..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------- 225 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----------------- 225 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----------------
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----------------
Confidence 87654444444455678889999999999999999999999999999999 999998654321
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++.++.+||.+||..||.+|||+.+++++|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 226 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1122222223344555677899999999999999999999999999988643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=358.99 Aligned_cols=269 Identities=25% Similarity=0.391 Sum_probs=200.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+... ......||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQE----DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred hhHeEEeceecccCCeEEEEEEEccc----CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 46899999999999999999976531 112247999998765 334567889999999999999999999999877
Q ss_pred Cee------EEEEeeCCCCCHHHhhhhcC--CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 155 KEL------LLVYEFMQKGSLENHLFGRG--ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 155 ~~~------~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
... ++||||+.+++|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSC
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCCCC
Confidence 655 99999999999999986543 222358999999999999999999997 56999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~ 305 (413)
+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------- 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------- 247 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--------
Confidence 99999999986433332223334557889999999999999999999999999999999 899997653221
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
....+........+..++.++.+||.+||+.||.+|||+.++++.|+.+.....
T Consensus 248 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 248 ---------IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ---------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ---------HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 111111122233455677899999999999999999999999999999887653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=375.45 Aligned_cols=258 Identities=20% Similarity=0.247 Sum_probs=210.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
..++|++.+.||+|+||+||+|++.. +++.||||++..... ...+.+.+|+.++..++||||+++++++.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKN-------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcC-------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45789999999999999999997654 679999999865321 12234788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+++.+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999996532 368999999999999999999997 66999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+++..... ........+||+.|+|||++. +..|+.++|||||||++|||++|..||...+..
T Consensus 220 Gla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~----------- 287 (437)
T 4aw2_A 220 GSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----------- 287 (437)
T ss_dssp TTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------
T ss_pred hhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----------
Confidence 999764322 222234468999999999986 567899999999999999999999999765321
Q ss_pred hhhhhhhhhHhHHhhhcCCCc---hHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQYP---YKAAYQIAQLSLKCLEAEPKH--RPSMREVVETLER 362 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L~~ 362 (413)
..+..++.......++ ..++.++.+||.+||..+|++ |++++|+++|-+.
T Consensus 288 -----~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 288 -----ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp -----HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred -----HHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 1122222222222223 247889999999999998888 9999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=358.20 Aligned_cols=277 Identities=27% Similarity=0.377 Sum_probs=223.5
Q ss_pred HHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccce
Q 015094 70 FVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRL 147 (413)
Q Consensus 70 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~ 147 (413)
..++....++|++.+.||+|+||.||+|.+... .+..+++.||||++.... ....+.+.+|+.+++.+ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS--SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecC--CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344455668999999999999999999976431 234577999999987653 33456788999999999 69999999
Q ss_pred EeEEEeCC-eeEEEEeeCCCCCHHHhhhhcCCC------------CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 015094 148 LGYCWEDK-ELLLVYEFMQKGSLENHLFGRGAS------------VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDF 214 (413)
Q Consensus 148 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDl 214 (413)
++++...+ .+++||||+.+++|.+++...... ...+++..++.++.||+.||.|||+ .+|+||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccC
Confidence 99987754 599999999999999999765431 1238899999999999999999997 56999999
Q ss_pred CCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCC
Q 015094 215 KASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTN 293 (413)
Q Consensus 215 kp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~ 293 (413)
||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544333333445678899999999999999999999999999999998 99999765
Q ss_pred CCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.... .+...+........+..++.++.++|.+||+.||.+|||+.+++++|+.+...
T Consensus 255 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 255 KIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhH----------------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 3221 11111222222334556778899999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=363.89 Aligned_cols=264 Identities=27% Similarity=0.455 Sum_probs=205.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+|++.+.||+|+||.||+|++.. ....+..||||++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKL----PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBC----TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEec----CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3579999999999999999996542 1235678999998765 3344567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 9999999999999999996543 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+......... ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----------------- 257 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----------------- 257 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----------------
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------
Confidence 8643322111 1122345778999999999999999999999999999998 99999754211
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.....+........+..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus 258 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11112222233344556778999999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=348.38 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=212.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+. .+..||||++..... ..+.+.+|+.+++.++||||+++++++.++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK--------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeeccCCCceEEEEEec--------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 468999999999999999999654 356799999976543 34678999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred eEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccce
Confidence 999999999999999997653 258999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 153 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~ 214 (268)
T 3sxs_A 153 YVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----------------EV 214 (268)
T ss_dssp ECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HH
T ss_pred ecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----------------HH
Confidence 6433221 12233456778999999999899999999999999999999 99999754321 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 215 VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111112222233455678899999999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=360.44 Aligned_cols=281 Identities=25% Similarity=0.354 Sum_probs=220.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEE--eC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCW--ED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. .+..+++.||||++........+.+.+|+.+++.++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDP---LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECT---TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEecc---CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 3689999999999999999997542 234478999999998877667778999999999999999999999887 45
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEccccc
Confidence 67999999999999999997543 258999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+.......... ......|+..|+|||++.+..++.++|||||||++|+|++|..||........... ..........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHH
Confidence 98654332221 22335688889999999999999999999999999999999999865321100000 0000000111
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.....+........+..++..+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 222233333444556678899999999999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=354.31 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=215.0
Q ss_pred ccHHHHHHHhcC----------CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHh
Q 015094 68 FTFVELRAATRN----------FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137 (413)
Q Consensus 68 ~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~ 137 (413)
+++.++....+. |...+.||+|+||.||+|.+.. +++.||||++........+.+.+|+.+++
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~-------~g~~vavK~~~~~~~~~~~~~~~E~~~l~ 97 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH-------SGRQVAVKMMDLRKQQRRELLFNEVVIMR 97 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEETTTCCSHHHHHHHHHHHT
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC-------CCcEEEEEEEeccchhHHHHHHHHHHHHH
Confidence 555666555443 6777899999999999997653 57899999997666556678899999999
Q ss_pred hccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 015094 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKAS 217 (413)
Q Consensus 138 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~ 217 (413)
.++||||+++++++...+..|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~ 170 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSD 170 (321)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGG
T ss_pred hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHH
Confidence 99999999999999999999999999999999999853 268999999999999999999997 56999999999
Q ss_pred cEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 015094 218 NILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297 (413)
Q Consensus 218 Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~ 297 (413)
|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~ 248 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred HEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999988643221 12344679999999999999999999999999999999999999997643210
Q ss_pred cchhhHhhhhhhhhhhhhhHhHHhhh-cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 298 QHNLVDWIKPYLSEKRKFRHIIDARL-QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
....+..... .......++..+.+||.+||..||++|||+.+++++.+..
T Consensus 249 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 249 ----------------AMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp ----------------HHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred ----------------HHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 0011111100 1112335677899999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=372.53 Aligned_cols=256 Identities=22% Similarity=0.275 Sum_probs=209.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
..++|++.+.||+|+||+||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKS-------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECC-------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45789999999999999999997654 678999999865321 12335788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+++.+|+||||+.||+|.+++... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999998643 58899999999999999999997 56999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCC----ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH----LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|++....... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...+..
T Consensus 213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------------ 279 (410)
T 3v8s_A 213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------------ 279 (410)
T ss_dssp TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------------
T ss_pred ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------------
Confidence 9998643221 12234568999999999997655 889999999999999999999999765321
Q ss_pred hhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKH--RPSMREVVETLER 362 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~--Rpt~~e~l~~L~~ 362 (413)
..+..++.......++ ..++.++.+||.+||..+|.+ |++++||++|.+.
T Consensus 280 ----~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 280 ----GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp ----HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ----hHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 1222232222222233 257789999999999999988 9999999998664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=370.68 Aligned_cols=257 Identities=24% Similarity=0.301 Sum_probs=197.8
Q ss_pred hcCCCCC-CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhh-ccCCCccceEeEEEe-
Q 015094 77 TRNFKSD-TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR-LSHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~- 153 (413)
.++|.+. +.||+|+||+||+|++.. +++.||||++... ..+.+|+.++.+ ++||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR-------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECC-------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 3567776 789999999999997654 6789999998643 356788888754 579999999999876
Q ss_pred ---CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCe
Q 015094 154 ---DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTA 227 (413)
Q Consensus 154 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~ 227 (413)
...+|+||||+.||+|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCE
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccE
Confidence 567999999999999999997543 2368999999999999999999997 56999999999999987 7899
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||+|||++..... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||............
T Consensus 204 kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----- 275 (400)
T 1nxk_A 204 KLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----- 275 (400)
T ss_dssp EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH-----
T ss_pred EEEecccccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH-----
Confidence 9999999986332 22234567999999999999999999999999999999999999999875433211100
Q ss_pred hhhhhhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
...+...... ......++.++.+||.+||..||.+|||+.++++|.+...
T Consensus 276 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 276 -------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp -------HHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred -------HHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 0011111111 0111356788999999999999999999999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=349.63 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. ....+..||+|++... .....+.+.+|+.+++.++||||+++++++ .++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMS----PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC----C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEec----CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccC
Confidence 4689999999999999999997653 2234678999998754 334456789999999999999999999987 456
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred ccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECccccc
Confidence 7899999999999999996543 368899999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----------------- 225 (281)
T 1mp8_A 164 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------------- 225 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------
T ss_pred cccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----------------
Confidence 86432211 12233456789999999998999999999999999999997 999997653221
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++..+.+||.+||..||++|||+.+++++|+.+...
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 226 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0011111122334567788999999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=366.30 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=200.5
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEEe
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 162 (413)
.+.||+|+||.||+|.+.. +++.||+|++........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~-------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA-------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEECC-----CEEEEEETT-------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEecCcCEEEEEEEEcC-------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5689999999999997553 678999999987766667789999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE--cCCCCeEEccCCCcccCCC
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~--~~~~~~kl~DfG~a~~~~~ 240 (413)
|+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 167 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 167 YVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999886543 268899999999999999999997 569999999999999 5678999999999986433
Q ss_pred CCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHH
Q 015094 241 ASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320 (413)
Q Consensus 241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (413)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+..+..
T Consensus 242 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~ 302 (373)
T 2x4f_A 242 RE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE----------------TLNNILA 302 (373)
T ss_dssp TC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHH
T ss_pred cc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHh
Confidence 22 2334579999999999998999999999999999999999999997653211 1111221
Q ss_pred hhhcC--CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 321 ARLQG--QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 321 ~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..... .....++.++.+||.+||..||.+|||+.|++++-+
T Consensus 303 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp TCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 11111 111346788999999999999999999999998755
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=354.47 Aligned_cols=262 Identities=19% Similarity=0.191 Sum_probs=210.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .+.+.+|+.+++.| +||||+++++++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY-------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT-------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred cCCeEEEEEeeccCCceEEEEEECC-------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 3679999999999999999997543 689999999865532 24578999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-----eEEc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT-----AKIS 230 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~-----~kl~ 230 (413)
..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred ccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 999999999 999999997542 378999999999999999999997 56999999999999998887 9999
Q ss_pred cCCCcccCCCCCCcc-----eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 231 DFGLAKLGPSASQSH-----VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 231 DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~- 231 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK- 231 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH-
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH-
Confidence 999998643322211 12356899999999999999999999999999999999999999987643322111111
Q ss_pred hhhhhhhhhhhHhHHhhhcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 306 KPYLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+........ ....++ ++.+|+..||..||.+||++.+|++.|+.+....
T Consensus 232 ------------i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 232 ------------IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ------------HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ------------HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 111100000 001234 8999999999999999999999999999887643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=356.67 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=201.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
.++|++.+.||+|+||.||+|+... ...+++.||||++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVT----GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECS----STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEec----cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3579999999999999999997542 23468899999987653 223456788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
.++.+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeC
Confidence 9999999999999999999997654 68899999999999999999997 56999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|++..... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 166 g~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 227 (327)
T 3a62_A 166 GLCKESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---------------- 227 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------
T ss_pred Cccccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----------------
Confidence 99875321 112234467999999999999999999999999999999999999999764311
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
..+..+... ...++..++.++.+||.+||..||.+|| ++.++++|-.
T Consensus 228 ~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 228 KTIDKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp HHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred HHHHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 111112211 1234556788999999999999999999 7889988755
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=365.13 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=192.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ..+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG-------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC-------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 34689999999999999999997653 57899999987653 3356789999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~kl~Df 232 (413)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 999999999999999999544 368999999999999999999997 56999999999999975 889999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 196 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------------- 257 (349)
T 2w4o_A 196 GLSKIVEH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--------------- 257 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---------------
T ss_pred ccccccCc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---------------
Confidence 99985322 222334679999999999999999999999999999999999999997543211
Q ss_pred hhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 313 RKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+..+...... ......++.++.+||.+||..||++|||+.+++++-+
T Consensus 258 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 258 FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 001111111111 1122356788999999999999999999999998644
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=356.14 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=207.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+... .......|++|.+... .....+.+.+|+.+++.++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCT---TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCC---CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 36799999999999999999986542 1122345688877543 3345678899999999999999999999988764
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.++|+||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -ceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 889999999999999997643 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~ 227 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------E 227 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------G
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------H
Confidence 86543333333344567889999999999999999999999999999999 99999765322 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+...+........+..++.++.+||.+||..||.+||++.++++.|+.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1222233333345566788999999999999999999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=374.25 Aligned_cols=272 Identities=19% Similarity=0.253 Sum_probs=189.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL-------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC---------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC-------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 3689999999999999999997654 6789999998653 334557789999999999999999999998543
Q ss_pred -----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 155 -----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 155 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
..+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 125 DVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEE
T ss_pred CcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEee
Confidence 5799999998 56999998543 368999999999999999999997 56999999999999999999999
Q ss_pred ccCCCcccCCCCCCc-------------------------ceeecccccccccCcccc-ccCCccchhhhHHHHHHHHHH
Q 015094 230 SDFGLAKLGPSASQS-------------------------HVTTRVMGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLVEI 283 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l 283 (413)
+|||+++........ ......+||+.|+|||++ .+..|+.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999864322111 123456789999999976 566799999999999999999
Q ss_pred Hh-----------CCCCCCCCCCCCcch--------------hhHhhhhhhhh-------------hhhhhHhHHhhh--
Q 015094 284 LT-----------GLRALDTNRPSGQHN--------------LVDWIKPYLSE-------------KRKFRHIIDARL-- 323 (413)
Q Consensus 284 lt-----------G~~pf~~~~~~~~~~--------------~~~~~~~~~~~-------------~~~~~~~~~~~~-- 323 (413)
++ |.++|.+........ ..+.+...... .......+....
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 666665543210000 00000000000 000000000000
Q ss_pred -cC---CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 324 -QG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 324 -~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.. ......+.++.+||.+||..||++|||+.|+++|-+.
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 00 0112347789999999999999999999999998654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=360.63 Aligned_cols=271 Identities=30% Similarity=0.413 Sum_probs=219.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+... +.....+.||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGL--GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTC--SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCC--CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 346899999999999999999976542 223345689999987653 34456789999999999 89999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCC----------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGA----------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
++.+|+||||+++++|.+++..... ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEEG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEECC
Confidence 9999999999999999999965421 12357899999999999999999997 56999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~ 302 (413)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----- 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-----
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-----
Confidence 99999999999985433333233344567889999999999999999999999999999998 999997653221
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+...+........+..++..+.+||.+||+.||.+|||+.+++++|+.+...
T Consensus 275 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 -----------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11222233333344556678899999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=347.27 Aligned_cols=263 Identities=17% Similarity=0.180 Sum_probs=212.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ..+.+.+|+.+++.+ +|+||+++++++.++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLL-------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-------CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 4679999999999999999997543 68999999986543 234578899999999 6999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-----eEEc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT-----AKIS 230 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~-----~kl~ 230 (413)
..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred eeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 999999999 999999997543 368999999999999999999996 66999999999999987766 9999
Q ss_pred cCCCcccCCCCCCc-----ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 231 DFGLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 231 DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~- 232 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER- 232 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-
Confidence 99999865433221 123446799999999999999999999999999999999999999987544322111111
Q ss_pred hhhhhhhhhhhHhHHhhhcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 306 KPYLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+........ ....++.++.+|+.+||..||++|||+.+|++.|+.+....
T Consensus 233 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 233 ------------IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp ------------HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ------------HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 111110000 11245678999999999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=347.23 Aligned_cols=255 Identities=28% Similarity=0.552 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-------hHHHHHHHHHHHhhccCCCccceEeE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-------GFEEWQSEVNFLGRLSHPNLVRLLGY 150 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~ 150 (413)
++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|+.+++.++||||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVK-------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETT-------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceehhccccCCceeEEEEEEcC-------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 579999999999999999997654 5789999998654321 12678899999999999999999998
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC----
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT---- 226 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~---- 226 (413)
+.+.. ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+.+|+||||||+|||++.++.
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred ecCCC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence 86554 79999999999999886543 3789999999999999999999973323999999999999987776
Q ss_pred -eEEccCCCcccCCCCCCcceeecccccccccCcccc--ccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 015094 227 -AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV--ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD 303 (413)
Q Consensus 227 -~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~ 303 (413)
+||+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||.........
T Consensus 167 ~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---- 237 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---- 237 (287)
T ss_dssp CEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----
T ss_pred eEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----
Confidence 99999999974221 23446799999999998 4556789999999999999999999999765432110
Q ss_pred hhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 304 WIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
....+.........+..++.++.+||.+||+.||.+|||+.++++.|+.+
T Consensus 238 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 ----------FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 01112222333445667788999999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=346.74 Aligned_cols=251 Identities=31% Similarity=0.519 Sum_probs=197.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh----hhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----QGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
.++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI---------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET---------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc---------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357999999999999999999753 57899999865432 23567889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCC---eeeCCCCCCcEEEcC------
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQ---VIYRDFKASNILLDG------ 223 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~---ivHrDlkp~Nil~~~------ 223 (413)
+++..|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEeccccccc
Confidence 99999999999999999999842 368999999999999999999997 55 899999999999985
Q ss_pred --CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 224 --SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 224 --~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
++.+||+|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 220 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----- 220 (271)
T ss_dssp CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----
T ss_pred ccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 778999999999753322 122457999999999999999999999999999999999999999764311
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...............+..++..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 221 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 -----------AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----------HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 011111222223345567788999999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=351.73 Aligned_cols=269 Identities=23% Similarity=0.303 Sum_probs=203.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|.+. .++.||||++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS--------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET--------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC--------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 368999999999999999999753 368999999875432 2346788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEcCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcC
Confidence 999999999975 8888876543 368999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hh---
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK--PY--- 308 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~--~~--- 308 (413)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................ +.
T Consensus 166 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 166 ARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp CEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 98643221 22334578999999999876 568999999999999999999999998765543222111000 00
Q ss_pred hhhhhhhhHhHHhhhc---C----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQ---G----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~---~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+........+...... . .....++.++.+||.+||+.||++|||+.|+++|-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 0000000000000000 0 011234568999999999999999999999998644
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=369.27 Aligned_cols=257 Identities=19% Similarity=0.236 Sum_probs=207.7
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYC 151 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 151 (413)
...++|++.+.||+|+||+||+|++.. +++.||||++.+... ...+.+.+|+.++..++||||+++++++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~-------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQ-------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345789999999999999999997653 689999999865321 2334578899999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.+.+.+|+||||+.||+|.+++.+.+ ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999997643 268999999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccc-------cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-------TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
||++....... .......+||+.|+|||++. +..|+.++|||||||++|||++|..||...+..
T Consensus 206 FGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------- 276 (412)
T 2vd5_A 206 FGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------- 276 (412)
T ss_dssp CTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------
T ss_pred chhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--------
Confidence 99998643221 11223468999999999986 467899999999999999999999999765321
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCC---chHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHR---PSMREVVETLE 361 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~R---pt~~e~l~~L~ 361 (413)
..+..++.......+ +..++.++.+||.+||. +|.+| ++++|+++|-.
T Consensus 277 --------~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 277 --------ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp --------HHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred --------HHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 111122221111112 24577899999999999 99998 59999998755
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.96 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=209.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|.+.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHEL-------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETT-------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCEEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 579999999999999999997653 688999999865422 2356789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccc
Confidence 9999999999999999999543 368999999999999999999996 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 163 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------------- 223 (476)
T 2y94_A 163 SNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---------------- 223 (476)
T ss_dssp CEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----------------
T ss_pred hhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----------------
Confidence 9864322 22344679999999999988776 689999999999999999999997643210
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+..+.... ...+..++.++.+||.+||..||.+|||+.++++|-+.
T Consensus 224 ~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 224 LFKKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp HHHHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred HHHHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 111111111 12345567889999999999999999999999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=363.58 Aligned_cols=244 Identities=27% Similarity=0.353 Sum_probs=195.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHH-HhhccCCCccceEeEEEe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF-LGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~ 153 (413)
++|++++.||+|+||+||+|++.. +++.||||++.+... ...+.+.+|..+ ++.++||||+++++++.+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKA-------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETT-------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred hheEEEEEEeeCCCeEEEEEEEcC-------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 579999999999999999997654 678999999875532 233456667776 577899999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.|++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCc
Confidence 999999999999999999997643 68899999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. .
T Consensus 185 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~ 246 (373)
T 2r5t_A 185 LCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------E 246 (373)
T ss_dssp BCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----------------H
T ss_pred cccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----------------H
Confidence 99853221 12334568999999999999999999999999999999999999999764211 1
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 354 (413)
.+..++.. ...++..++.++.+||.+||+.||.+||++.
T Consensus 247 ~~~~i~~~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 247 MYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHS--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHhc--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 12222222 1234556788999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=350.58 Aligned_cols=267 Identities=22% Similarity=0.303 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE-------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEECC-------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 579999999999999999997654 67899999986543 233467889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 75 KLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEEEEECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 99999999976 6666664432 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCC-ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh--h
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE--K 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~--~ 312 (413)
...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ....+...... .
T Consensus 149 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 149 RAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCT
T ss_pred eecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence 864322 12233457899999999987765 79999999999999999998888644322110 00000000000 0
Q ss_pred hhhhHhHH------------hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 313 RKFRHIID------------ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+..... ...........+.++.+||.+||+.||++|||++|+++|-+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 00000000 00001122356788999999999999999999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=348.44 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=210.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+. .+..||||++..... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET--------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc--------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 457999999999999999999654 357899999976543 33678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred eEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEccccccc
Confidence 999999999999999996532 368999999999999999999997 569999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 169 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----------------~~ 230 (283)
T 3gen_A 169 YVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ET 230 (283)
T ss_dssp GBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HH
T ss_pred cccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----------------HH
Confidence 533211 111223456788999999998999999999999999999998 99999764321 11
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...+........+...+..+.+||.+||+.||.+|||+.+++++|..+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 231 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111222233344556678899999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=353.49 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=197.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR-------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC-------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 4689999999999999999997543 68999999987653 2345678899999999999999999999876
Q ss_pred CCe----eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 154 DKE----LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 154 ~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
... .|+||||++|++|.+++...+ .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEE
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEE
Confidence 643 499999999999999997554 68999999999999999999997 56999999999999999999999
Q ss_pred ccCCCcccCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~-- 229 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AY-- 229 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HH--
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HH--
Confidence 999999764332211 222345799999999999999999999999999999999999999976532110 00
Q ss_pred hhhhhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHH-HHHHHH
Q 015094 309 LSEKRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE-TLERLQ 364 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~-~L~~i~ 364 (413)
........ ......++.++.+||.+||+.||.+||++.+++. .|..+.
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 230 --------QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp --------HHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------HHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00000000 0001235678999999999999999997666554 444443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=351.01 Aligned_cols=269 Identities=27% Similarity=0.408 Sum_probs=207.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..++|++.+.||+|+||.||+|.+.. ...+++.||||++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQ----EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEEC----TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred CHHHeeeccceeecCCeEEEEEEEec----cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 35689999999999999999997653 3345678999998754 33445678999999999999999999999887
Q ss_pred CC-----eeEEEEeeCCCCCHHHhhhhcC--CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 154 DK-----ELLLVYEFMQKGSLENHLFGRG--ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 154 ~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
.. ..++||||+.+++|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTSC
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCc
Confidence 64 4599999999999999985432 233468999999999999999999996 66999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~ 305 (413)
+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------- 257 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------- 257 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------
Confidence 99999999986433322222334567889999999999999999999999999999999 888987653211
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
....+........+..++.++.+||.+||..||.+|||+.+++++|+.+....
T Consensus 258 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 258 ---------MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ---------HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111122223445667789999999999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=351.47 Aligned_cols=276 Identities=30% Similarity=0.442 Sum_probs=215.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
.++|++.+.||+|+||.||+|.+.. .+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDP---EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT---TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEcc---ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3568999999999999999997543 244578999999987543 33457789999999999999999999999877
Q ss_pred -CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 155 -KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
..+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccc
Confidence 67899999999999999996543 268999999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh--h
Q 015094 234 LAKLGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL--S 310 (413)
Q Consensus 234 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~--~ 310 (413)
++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+..... .......+.. .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQM 247 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGG
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCccccc
Confidence 99865433221 223345688899999999999999999999999999999999988653210 0000000000 0
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
....+...+........+..++.++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111122222333344456678889999999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=368.01 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=212.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.+..
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~---------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred hHHeEEEeeecCcCCeeEEEEEec---------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 467889999999999999999653 5789999998664 4567899999999999999999999987765
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++...+. ..++...++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 79999999999999999976542 247889999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------- 394 (450)
T 1k9a_A 337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------- 394 (450)
T ss_dssp EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----------------
T ss_pred cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence 853221 122357889999999999999999999999999999998 999998654321
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++.++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 395 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 395 VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1111222233455667889999999999999999999999999999998765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=358.46 Aligned_cols=264 Identities=21% Similarity=0.236 Sum_probs=205.4
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-----ChhhHHHHHHHHHHHhhccCCCccceE
Q 015094 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-----SLQGFEEWQSEVNFLGRLSHPNLVRLL 148 (413)
Q Consensus 74 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~ 148 (413)
....++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 94 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ-------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC-------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 3456789999999999999999997654 6789999998644 224557789999999999999999999
Q ss_pred eEEEeCCeeEEEEeeCCCCCHHHhhhhcCC------------------------------------CCCCCcHHHHHHHH
Q 015094 149 GYCWEDKELLLVYEFMQKGSLENHLFGRGA------------------------------------SVQPLAWNIRLKIA 192 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------~~~~~~~~~~~~i~ 192 (413)
+++.+.+..|+||||++|++|.+++..... ....+++..++.++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 999999999999999999999999852110 01234677888999
Q ss_pred HHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC--CeEEccCCCcccCCCCCC--cceeecccccccccCcccccc--CC
Q 015094 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSY--TAKISDFGLAKLGPSASQ--SHVTTRVMGTYGYAAPEYVAT--GH 266 (413)
Q Consensus 193 ~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~ 266 (413)
.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+ ..
T Consensus 175 ~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 175 RQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 999999999997 5699999999999998776 899999999985432211 112345679999999999865 67
Q ss_pred ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCC--chHHHHHHHHHHHHccc
Q 015094 267 LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQY--PYKAAYQIAQLSLKCLE 344 (413)
Q Consensus 267 ~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~ 344 (413)
++.++|||||||++|+|++|..||....... ....+......... ...++.++.+||.+||.
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD----------------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHH----------------HHHHHHhcccccCCcccccCCHHHHHHHHHHcC
Confidence 8899999999999999999999997653211 11111111111111 12357889999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 015094 345 AEPKHRPSMREVVETLER 362 (413)
Q Consensus 345 ~dp~~Rpt~~e~l~~L~~ 362 (413)
.||.+|||+.+++++-+.
T Consensus 317 ~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 317 RNVDERFDAMRALQHPWI 334 (345)
T ss_dssp SCTTTSCCHHHHHHSHHH
T ss_pred CChhHCCCHHHHhcChhh
Confidence 999999999999997664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=355.06 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV-------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT-------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC-------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 4579999999999999999997653 67899999987543 234577899999999999999999999986543
Q ss_pred ---------------------------------------------------------eeEEEEeeCCCCCHHHhhhhcCC
Q 015094 156 ---------------------------------------------------------ELLLVYEFMQKGSLENHLFGRGA 178 (413)
Q Consensus 156 ---------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~ 178 (413)
.+|+||||+++++|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999999999999976543
Q ss_pred CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCc----------ceee
Q 015094 179 SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS----------HVTT 248 (413)
Q Consensus 179 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----------~~~~ 248 (413)
.....+..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......... ....
T Consensus 158 -~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 -LEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp -GGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred -ccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 3345677789999999999999997 66999999999999999999999999999865433211 1223
Q ss_pred cccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc
Q 015094 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP 328 (413)
Q Consensus 249 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (413)
...||+.|+|||++.+..++.++|||||||++|+|++|..|+... ...........++
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------------------~~~~~~~~~~~~~ 292 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------------------VRIITDVRNLKFP 292 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------------------HHHHHHHHTTCCC
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------------------HHHHHHhhccCCC
Confidence 457999999999999999999999999999999999986654210 0011111112222
Q ss_pred ---hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 329 ---YKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 329 ---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...++++.+||.+||+.||.+|||+.|++++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 2445678999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=358.95 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccC--CCccceEeEEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSH--PNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~ 152 (413)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|+.++| +||+++++++.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT--------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC--------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 457999999999999999999643 4688999998654 33445778999999999986 99999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
.+..+|+|||+ .+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++ ++.+||+||
T Consensus 80 ~~~~~~lv~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 80 TDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred eCCEEEEEEeC-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeec
Confidence 99999999995 5789999997643 68899999999999999999997 5699999999999997 578999999
Q ss_pred CCcccCCCCCCcceeecccccccccCcccccc-----------CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
|++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------ 225 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------ 225 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------
Confidence 99986543333333445689999999999865 6788999999999999999999999975321
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
....+..++.......++...+.++.+||.+||..||.+|||+.+++++.+.-
T Consensus 226 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 226 ---------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp ---------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 11122223333334455556677899999999999999999999999987753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=348.88 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=205.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+++.++||||+++++++. +..
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 74 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR---------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 74 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET---------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC---------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence 57899999999999999999653 5789999997653 4567899999999999999999999876 458
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCcEEEcCCCC-eEEccCCCc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD-KQVIYRDFKASNILLDGSYT-AKISDFGLA 235 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~ivHrDlkp~Nil~~~~~~-~kl~DfG~a 235 (413)
|+||||+++++|.+++..... ...+....++.++.||+.||.|||+.. ++|+||||||+|||++.++. +||+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 999999999999999965432 224788899999999999999999632 57999999999999988886 799999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 154 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~ 213 (307)
T 2eva_A 154 CDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------------RI 213 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---------------HH
T ss_pred ccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---------------HH
Confidence 75322 12234699999999999999999999999999999999999999975432110 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQP 373 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~~~~~~ 373 (413)
............+..++..+.+||.+||..||.+|||+.++++.|+.+.........+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 214 MWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp HHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred HHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 0011111223344567788999999999999999999999999999988765444333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=353.75 Aligned_cols=274 Identities=24% Similarity=0.325 Sum_probs=193.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSS-------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 4589999999999999999996543 678999999865432 23467889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcC--CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRG--ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+|+||||+. ++|.+++.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 153 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCS
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCc
Confidence 9999999997 59999886543 222358999999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh-----
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP----- 307 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~----- 307 (413)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 154 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 154 LARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp SCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred cceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 998643221 12234578999999999876 4689999999999999999999999986543211111000000
Q ss_pred hhhhhhhhhH-----------hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 YLSEKRKFRH-----------IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+........ .+...+.......++.++.+||.+||+.||++|||+.|++++-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 0000000000 000000111122356789999999999999999999999987553
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=344.18 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=209.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ---------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC---------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 357999999999999999999753 5789999987653 34456789999999999999999999999887
Q ss_pred --CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 155 --KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 155 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
..+++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+..|+||||||+|||++.++.++|+||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred CCCCeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 78999999999999999996543 23589999999999999999999963333999999999999999999999988
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccc---hhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYV---KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
|++..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||......
T Consensus 158 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------- 217 (271)
T 3kmu_A 158 DVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------------- 217 (271)
T ss_dssp GSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------------
T ss_pred cceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------------
Confidence 88754211 2246899999999998765554 899999999999999999999754211
Q ss_pred hhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 310 SEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
...............+..++.++.+||.+||+.||++|||+.++++.|+.+..
T Consensus 218 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 ---EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11112222333345566778899999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=366.04 Aligned_cols=272 Identities=24% Similarity=0.323 Sum_probs=196.5
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhcc-CCCccceEeEE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLS-HPNLVRLLGYC 151 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 151 (413)
...++|++.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+|+.+. ||||+++++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 78 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR-------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL 78 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT-------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC-------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence 356799999999999999999997654 6789999998643 3345567889999999998 99999999999
Q ss_pred EeCC--eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 152 WEDK--ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 152 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
..++ .+|+||||+. ++|.+++... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 79 RADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp ECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred ecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEe
Confidence 7654 7999999997 4899988642 68889999999999999999997 56999999999999999999999
Q ss_pred ccCCCcccCCCCC-------------------CcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCC
Q 015094 230 SDFGLAKLGPSAS-------------------QSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRA 289 (413)
Q Consensus 230 ~DfG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~p 289 (413)
+|||+++...... ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999998643211 1112344689999999999876 6789999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhhhhhh-----------------------------hhhhhHhHHhhhcCCCchHHHHHHHHHHH
Q 015094 290 LDTNRPSGQHNLVDWIKPYLSE-----------------------------KRKFRHIIDARLQGQYPYKAAYQIAQLSL 340 (413)
Q Consensus 290 f~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 340 (413)
|.+.....+............. ...+..+............++.++.+||.
T Consensus 231 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 9875432221111000000000 00000000000000111245678999999
Q ss_pred HccccCCCCCCCHHHHHHHHH
Q 015094 341 KCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 341 ~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+||..||++|||+.|+++|-.
T Consensus 311 ~~L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKHPF 331 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTSTT
T ss_pred HhhccCcccCCCHHHHhCCHH
Confidence 999999999999999998744
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=362.99 Aligned_cols=274 Identities=20% Similarity=0.236 Sum_probs=206.9
Q ss_pred hcCCCCCCeeeec--CCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 77 TRNFKSDTVLGEG--GFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
.++|++.+.||+| +||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP-------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC-------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 3579999999999 999999997654 68899999987543 344567889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+++.+|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCG
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccc
Confidence 99999999999999999999976432 368999999999999999999997 56999999999999999999999999
Q ss_pred CCcccCCCCCC-----cceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-
Q 015094 233 GLAKLGPSASQ-----SHVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW- 304 (413)
Q Consensus 233 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~- 304 (413)
|.+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 98864321111 111223478999999999987 6799999999999999999999999987544322111000
Q ss_pred hhhhhhhh-----hh-------------hhHhH---------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 015094 305 IKPYLSEK-----RK-------------FRHII---------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV 357 (413)
Q Consensus 305 ~~~~~~~~-----~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 357 (413)
..+..... .. ..... .......++..++.++.+||.+||+.||++|||+.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 00000000 00 00000 00001123345677899999999999999999999999
Q ss_pred HHHH
Q 015094 358 ETLE 361 (413)
Q Consensus 358 ~~L~ 361 (413)
+|-+
T Consensus 333 ~hp~ 336 (389)
T 3gni_B 333 NHSF 336 (389)
T ss_dssp TSGG
T ss_pred cCHH
Confidence 8744
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=352.77 Aligned_cols=276 Identities=29% Similarity=0.438 Sum_probs=216.5
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC--Ce
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED--KE 156 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 156 (413)
|++++.||+|+||+||+|.+.. .+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDP---TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECS---CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEcc---CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 4999999999999999986643 345578999999997653 34456789999999999999999999999874 67
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++||||+++++|.+++... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccccc
Confidence 89999999999999999543 48899999999999999999997 569999999999999999999999999998
Q ss_pred cCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
........ .......++..|+|||++.+..++.++|||||||++|+|++|..||........ ....+ .........+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~ 260 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGI-AQGQMTVLRL 260 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCS-CCHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcc-cccchhHHHH
Confidence 75433221 123345688899999999999999999999999999999999999865311000 00000 0000011122
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
...+........+..++.++.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 2333344444556678899999999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=344.81 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=208.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. ++..||+|++........+.+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKG-------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCC-------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34679999999999999999997654 57889999987765556778999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~---~~~~~~kl~Df 232 (413)
..|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 9999999999999999986543 68999999999999999999997 569999999999999 78899999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......
T Consensus 154 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------- 214 (277)
T 3f3z_A 154 GLAARFKPG---KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------------- 214 (277)
T ss_dssp TTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------
T ss_pred ccceeccCc---cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---------------
Confidence 999864322 22344579999999998855 48999999999999999999999997643210
Q ss_pred hhhhHhHHhhhcCCCch----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPY----KAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+... ...++. .++..+.+||.+||+.||.+|||+.+++++-+.
T Consensus 215 -~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 215 -VMLKIREG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp -HHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred -HHHHHHhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 01111111 011121 356789999999999999999999999987664
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=347.64 Aligned_cols=261 Identities=27% Similarity=0.456 Sum_probs=218.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG-------GTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccceeEEeecCCCCceeEEEeEecC-------CCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 35679999999999999999997764 578999999876543 4567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999976432 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----------------~ 220 (288)
T 3kfa_A 159 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------Q 220 (288)
T ss_dssp GTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------G
T ss_pred eeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 8643222 222334557889999999999999999999999999999999 99999765322 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++..+.+||.+||..||.+|||+.++++.|+.+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1122233333445567788999999999999999999999999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=352.21 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=207.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+..........+..||+|++........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 46799999999999999999976542100111235799999987766677889999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--------eE
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT--------AK 228 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~--------~k 228 (413)
.|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999997643 248899999999999999999997 56999999999999988877 99
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|||++..... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..|+.......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---------- 225 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---------- 225 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH----------
Confidence 999999874211 223468899999999987 778999999999999999999654443221100
Q ss_pred hhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
...... ......+...+.++.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 226 ------~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 226 ------RKLQFY--EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ------HHHHHH--HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ------HHHHHh--hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 000001 1122334445677999999999999999999999999999877543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=344.12 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=210.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. ....+..||+|++... .....+.+.+|+.+++.++||||+++++++.+ +
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTN----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEC----TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcC----CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence 4679999999999999999997653 2335678999998765 33456778999999999999999999998765 4
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCC
Confidence 6799999999999999997643 258899999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----------------- 222 (281)
T 3cc6_A 161 RYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----------------- 222 (281)
T ss_dssp GCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----------------
T ss_pred cccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----------------
Confidence 86432211 12233457889999999988999999999999999999998 999997543211
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++..+.+||.+||..||.+|||+.+++++|+.+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 223 VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1111122222334456778899999999999999999999999999988653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=343.39 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=208.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT-------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC-------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 4689999999999999999997654 5789999998654 334556788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT---AKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~---~kl~D 231 (413)
+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||+++.++. +||+|
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEee
Confidence 99999999999999999886653 68999999999999999999997 56999999999999976655 99999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 152 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------------- 214 (284)
T 3kk8_A 152 FGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------------- 214 (284)
T ss_dssp CTTCEECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred ceeeEEcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--------------
Confidence 9999764322 22334679999999999999999999999999999999999999997642110
Q ss_pred hhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 312 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+...... ......++.++.+||.+||+.||++|||+.|++++-+.
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 215 --LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp --HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred --HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 01111111111 11113567889999999999999999999999998664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=353.23 Aligned_cols=265 Identities=26% Similarity=0.341 Sum_probs=209.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe---
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE--- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 153 (413)
.++|++.+.||+|+||.||+|.... +++.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH-------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT-------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC-------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 4689999999999999999997543 578999999877666667789999999999999999999999873
Q ss_pred -CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 154 -DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 154 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
....|+||||+.+++|.+++.........+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEec
Confidence 357899999999999999997654445579999999999999999999997 56999999999999999999999999
Q ss_pred CCcccCCCCCCcc-------eeecccccccccCccccccCC---ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 233 GLAKLGPSASQSH-------VTTRVMGTYGYAAPEYVATGH---LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 233 G~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
|++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 253 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG----- 253 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----
Confidence 9987532111110 012245799999999987554 6889999999999999999999985321100
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
...............+..++.++.+||.+||..||.+|||+.+++++|+.+..
T Consensus 254 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 ----------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ----------SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ----------chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 01111111112222334567889999999999999999999999999998763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=368.98 Aligned_cols=266 Identities=23% Similarity=0.274 Sum_probs=199.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++++.||+|+||+||+|++.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV-------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT-------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC-------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 4689999999999999999997554 6899999998754 334566788999999999999999999999655
Q ss_pred ------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 ------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
..+|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+|
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEE
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEE
Confidence 457999999976 57666632 48899999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK-- 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~-- 306 (413)
|+|||+++.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...+...+....
T Consensus 205 l~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999986332 223345689999999999999999999999999999999999999998764322211110000
Q ss_pred ---hhhhh-hhhhhHhHHhh---------------hcC---CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 ---PYLSE-KRKFRHIIDAR---------------LQG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ---~~~~~-~~~~~~~~~~~---------------~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.++.. .......+... ... ......+.++.+||.+||..||++|||++|+++|-+
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 00000 00000111000 000 001123678999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=362.23 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=202.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhcc--CCCccceEeEEEe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLS--HPNLVRLLGYCWE 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~ 153 (413)
.+|++.+.||+|+||+||+|.+. .++.||||++... .....+.+.+|+.+|+.|. ||||+++++++..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CceEEEEEEccCCCeEEEEEEcC--------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 46999999999999999999643 3688999998654 3345677899999999997 5999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++.+|+||| +.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecC
Confidence 999999999 55789999997653 67888999999999999999997 6699999999999995 5799999999
Q ss_pred CcccCCCCCCcceeecccccccccCcccccc-----------CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
++...............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------ 273 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ 273 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------
Confidence 9986443332223345679999999999865 46889999999999999999999999753211
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+..++.......++...+.++.+||.+||..||.+|||+.|++++.+.
T Consensus 274 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 274 ---------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp ---------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ---------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 011222333333334455557789999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=371.92 Aligned_cols=253 Identities=27% Similarity=0.360 Sum_probs=201.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA-------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC-------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 4679999999999999999997553 6889999998754 22334567889999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+ .+||+||||||+|||++.++.+||+|||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCC
Confidence 999999999999999999996653 68999999999999999999996 2459999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++..... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 295 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~ 356 (446)
T 4ejn_A 295 LCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------K 356 (446)
T ss_dssp CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------H
T ss_pred CceeccC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----------------H
Confidence 9975322 222234578999999999999999999999999999999999999999764321 0
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
.+..+.. ....++..++.++.+||.+||+.||.+|| +++|+++|-.
T Consensus 357 ~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 357 LFELILM--EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHHHh--CCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 1111111 12235566788999999999999999999 9999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=349.48 Aligned_cols=267 Identities=22% Similarity=0.362 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..+|++.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLL-------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETT-------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcC-------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3579999999999999999997543 5789999998753 23455678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+..++||||+.+++|.+++.........+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEecc
Confidence 999999999999999999997543344578999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..
T Consensus 182 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~---------- 245 (310)
T 2wqm_A 182 LGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS---------- 245 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HH----------
T ss_pred ceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HH----------
Confidence 987533221 12234578999999999999999999999999999999999999997543210 00
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
....+............++.++.+||.+||..||.+|||+.++++.|+.+.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0001111111111224567889999999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=373.89 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=216.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
..+|++.+.||+|+||.||+|.+.. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++.....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGG-------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcC-------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4578899999999999999998764 478999999976543 45789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999999976432 368899999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .+
T Consensus 367 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------------~~ 428 (495)
T 1opk_A 367 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QV 428 (495)
T ss_dssp CCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GH
T ss_pred eccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HH
Confidence 643221 111223456788999999999999999999999999999999 99999765321 11
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
...+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1223333344556678889999999999999999999999999998765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.77 Aligned_cols=257 Identities=24% Similarity=0.292 Sum_probs=208.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ecceEEEEEeecCCCcEEEEEEECC-------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 4679999999999999999997653 57899999986543 234567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence 999999999999999998543 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
................|++.|+|||++.+..+ +.++|||||||++|+|++|..||.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------------- 217 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------- 217 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH---------------
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH---------------
Confidence 75432222222344679999999999987765 78999999999999999999999875432110
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..+............++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 00111111111122356778999999999999999999999987533
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=344.50 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=214.0
Q ss_pred cCCCCCC-eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDT-VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|.+.+ .||+|+||.||+|.+.. ...+..||||++... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRM-----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred HHhhhhhccccccCceeEEEeEecc-----CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4566766 99999999999997542 225788999999765 334567789999999999999999999998 556
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccce
Confidence 7999999999999999996432 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------------- 221 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------------- 221 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----------------
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----------------
Confidence 864332221 11223456889999999988899999999999999999998 999997653211
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCCC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQK 369 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~~ 369 (413)
....+........+..++.++.+||.+||..||.+||++.+++++|+.+..+...
T Consensus 222 -~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 222 -VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1111222223345667788999999999999999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=356.18 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=205.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++...... ..+|++++.++ +||||+++++++.+++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA-------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 4679999999999999999997654 6899999999765432 35688888888 6999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC----CCeEEcc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS----YTAKISD 231 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~----~~~kl~D 231 (413)
.+|+||||+.|++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||+..+ +.+||+|
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999999999996543 68999999999999999999997 569999999999998433 3599999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||++....... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........
T Consensus 164 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---------- 231 (342)
T 2qr7_A 164 FGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---------- 231 (342)
T ss_dssp CTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH----------
T ss_pred CCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH----------
Confidence 99998643221 223446799999999999888899999999999999999999999976432211110
Q ss_pred hhhhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 312 KRKFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 312 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
+..+..... ...+...++.++.+||.+||..||++|||+.++++|-+...
T Consensus 232 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 232 ---LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ---HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ---HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 111111111 11223457889999999999999999999999999887643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=353.86 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=182.4
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 161 (413)
.+.||+|+||.||+|.+.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...|+||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK-------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp SCCSEEETTEEEEEEEETT-------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CCccccCCCeEEEEEEECC-------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 4789999999999997654 6789999998654 3356788999999997 999999999999999999999
Q ss_pred eeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC---CeEEccCCCcccC
Q 015094 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY---TAKISDFGLAKLG 238 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~---~~kl~DfG~a~~~ 238 (413)
||+.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++...
T Consensus 86 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 86 ELLNGGELFERIKKKK----HFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CCCCSCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999997643 68999999999999999999997 6699999999999997665 8999999999864
Q ss_pred CCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 239 PSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...+
T Consensus 160 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------------~~~~ 224 (325)
T 3kn6_A 160 PPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS-------------AVEI 224 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC-------------HHHH
T ss_pred CCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc-------------HHHH
Confidence 322 2223445789999999999999999999999999999999999999987543211110 0011
Q ss_pred HHhhhcCCC--c----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 319 IDARLQGQY--P----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 319 ~~~~~~~~~--~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+.....+.+ + ..++.++.+||.+||..||.+|||+.+++++-+.
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 111111111 1 2457889999999999999999999999876553
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=352.41 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=210.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeE--EEEEecCCc-ChhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTV--IAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~--vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
++|++.+.||+|+||.||+|.+.. ++.. ||||.+... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK-------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE-------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc-------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 579999999999999999997654 3454 599988643 223456788999999999 89999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcC------------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRG------------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~ 221 (413)
.+.+|+||||+++++|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV 175 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEE
Confidence 999999999999999999997653 233478999999999999999999997 669999999999999
Q ss_pred cCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 015094 222 DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHN 300 (413)
Q Consensus 222 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~ 300 (413)
+.++.+||+|||++..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---- 248 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---- 248 (327)
T ss_dssp CGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----
T ss_pred cCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----
Confidence 9999999999999974221 111233457889999999988899999999999999999998 99999764321
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.....+........+..++.++.+||.+||..||.+|||+.+++++|..+....
T Consensus 249 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 249 -------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -------------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 011111122223445567889999999999999999999999999999988754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=343.64 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=208.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc-------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 4679999999999999999997654 578999999865422 234568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEecc
Confidence 999999999999999999996653 68999999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++..... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 155 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------- 214 (279)
T 3fdn_A 155 WSVHAPS----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---------------- 214 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred ccccCCc----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----------------
Confidence 9864222 22334579999999999999999999999999999999999999997542110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
....+ ......++..++..+.+||.+||+.||.+|||+.|++++.+.-.
T Consensus 215 ~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 215 TYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHHHH--HHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHH--HhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 01111 11223445567788999999999999999999999999987544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=345.87 Aligned_cols=257 Identities=30% Similarity=0.491 Sum_probs=196.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+. ..||||++... .....+.+.+|+.+++.++||||++++++ ...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~ 91 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA 91 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS----------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc----------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccC
Confidence 468999999999999999999643 34999988654 33455778999999999999999999995 456
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
...++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred CccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEcccee
Confidence 67899999999999999995433 368999999999999999999997 5699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
+................||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------------- 232 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------------- 232 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--------------
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--------------
Confidence 97644333333334567999999999986 5678899999999999999999999997653221
Q ss_pred hhhhhHhHHhh-hc---CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 312 KRKFRHIIDAR-LQ---GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 312 ~~~~~~~~~~~-~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
.+...+... .. ......++.++.+||.+||+.||.+|||+.++++.|+.+..
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 233 --QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011111111 11 12234667889999999999999999999999999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=350.59 Aligned_cols=265 Identities=26% Similarity=0.448 Sum_probs=208.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+|++.+.||+|+||.||+|.+... ....+..||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTS---SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecC---CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 35788899999999999999976531 22235679999987653 334567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999996543 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----------------- 257 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------- 257 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----------------
Confidence 8643322111 1222346788999999998999999999999999999999 99999654211
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.....+........+..++..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 258 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01111122222334556778899999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=349.43 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=206.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh------hHHHHHHHHHHHhhccCCCccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ------GFEEWQSEVNFLGRLSHPNLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~ 150 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|+.+++.++||||++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS-------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC-------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4579999999999999999997653 6789999998654321 35678999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----C
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY----T 226 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~----~ 226 (413)
+.+...+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++ .
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCC
Confidence 99999999999999999999999653 368999999999999999999997 5699999999999999887 7
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 158 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------- 225 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 225 (321)
T ss_dssp EEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------
T ss_pred EEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---------
Confidence 9999999998643321 2234579999999999999999999999999999999999999997642210
Q ss_pred hhhhhhhhhhHhHHhhhcCCCc----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+..+... ...++ ...+..+.+||.+||..||++|||+.+++++-+
T Consensus 226 -------~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 226 -------TLANITSV--SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp -------HHHHHHTT--CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred -------HHHHHHhc--ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00011100 00111 235678999999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=374.27 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRA-------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeCCCEEEEEEEECC-------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 4679999999999999999997653 68999999986542 2234567899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.||+|.+++...+ ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecc
Confidence 999999999999999999986543 2358999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........
T Consensus 332 la~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~------------- 395 (576)
T 2acx_A 332 LAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE------------- 395 (576)
T ss_dssp TCEECCTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-------------
T ss_pred cceecccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-------------
Confidence 99864322 22344689999999999999999999999999999999999999998754321110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
.+...+. .....++..++.++.+||.+||..||.+|| ++.|+++|-+
T Consensus 396 ~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 396 EVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp HHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred HHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 0001111 122345567788999999999999999999 7899988744
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=346.90 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=200.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERS-------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeccCCCeEEEEEEEcc-------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 3579999999999999999997543 57899999986553 234578899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~---~~~~~~kl~Df 232 (413)
..|+||||+.+++|.+++.........+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+||
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 9999999999999999986543334578999999999999999999997 669999999999999 45678999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|++..... ........||+.|+|||++. ..++.++|||||||++|+|++|..||........
T Consensus 172 g~a~~~~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-------------- 233 (285)
T 3is5_A 172 GLAELFKS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-------------- 233 (285)
T ss_dssp CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------
T ss_pred ecceecCC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--------------
Confidence 99975332 22234467999999999874 6789999999999999999999999976431100
Q ss_pred hhhhHhHHhhhc-CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 313 RKFRHIIDARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 313 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.......... .......++++.+||.+||+.||++|||+.|++++-
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 234 --QQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp --HHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred --HhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0000000000 001112567899999999999999999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=346.04 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhcccCCCEEEEEEEcC--------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC
Confidence 57999999999999999999652 478899999865432 23467889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred eEEEEEEecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccc
Confidence 99999999976 9999886532 368899999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh--h
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE--K 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~--~ 312 (413)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... +...... .
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~ 222 (288)
T 1ob3_A 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNS 222 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCT
T ss_pred cccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCCh
Confidence 7533211 12234578999999999876 4589999999999999999999999976532211100 0000000 0
Q ss_pred hhhhHhH-----Hhhhc-------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 313 RKFRHII-----DARLQ-------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~-----~~~~~-------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+.... ..... ..+...++.++.+||.+||+.||++|||+.|++++-+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000000 00000 0112245778999999999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=353.09 Aligned_cols=270 Identities=26% Similarity=0.355 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+... .+..+++.||||++... .......+.+|+.+++.++||||+++++++.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGM--PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC----------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCC--CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 35799999999999999999975421 13346789999998654 3345567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCC---CCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeEE
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGAS---VQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTAKI 229 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~kl 229 (413)
..|+||||+++++|.+++...... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++. +..+||
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999765422 2358899999999999999999997 56999999999999984 446999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------ 252 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------------ 252 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------------
Confidence 99999875332222222334568899999999989999999999999999999998 99999764211
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.....+........+..++..+.+||.+||..||.+||++.+++++|+.+....
T Consensus 253 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 253 -----EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 111111222223345567788999999999999999999999999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=371.57 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=212.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|++.. +++.||||++..... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKA-------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hheEEEEEEeeCCCeEEEEEEECC-------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 678999999999999999997653 689999999865432 2346788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+||||+.|++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecce
Confidence 99999999999999999997765555679999999999999999999997 5699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+....... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......... ..
T Consensus 336 a~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~------------~~ 401 (543)
T 3c4z_A 336 AVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------EL 401 (543)
T ss_dssp CEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH------------HH
T ss_pred eeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH------------HH
Confidence 98643222 12334589999999999999999999999999999999999999998754321110 01
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVETL 360 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~L 360 (413)
...+... ...++..++.++.+||.+||..||.+||++ .++++|-
T Consensus 402 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 402 KQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp HHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred HHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 1111111 224556778899999999999999999964 7777654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=354.64 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.+|++.+.||+|+||.||+|.... +++.||||++.... ....+.+.+|+.+++.++||||+++++++..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR-------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hheeeeeEEccCCCEEEEEEEEcc-------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 468999999999999999997543 68999999986542 23446788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred CeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence 99999999997 58888875433 368999999999999999999997 5699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
+..... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 201 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------------- 260 (348)
T 1u5q_A 201 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------------- 260 (348)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------------
T ss_pred ceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------------
Confidence 975322 22357999999999884 5678999999999999999999999997643110
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
....+.........+..++..+.+||.+||+.||++|||+.+++++.+..
T Consensus 261 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 261 --ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp --HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred --HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 01111111111222345678899999999999999999999999987754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.83 Aligned_cols=265 Identities=27% Similarity=0.403 Sum_probs=208.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEE-eC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCW-ED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 154 (413)
..+|++.+.||+|+||.||+|.+.. .......||+|.+... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLD----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC---------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ceehhhcceeeecCCceEEEEEEec----CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 3578899999999999999997653 2224567999998754 3345577899999999999999999999854 45
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccc
Confidence 68899999999999999996533 367899999999999999999997 5699999999999999999999999999
Q ss_pred cccCCCCCC--cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQ--SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
+........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||........
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~------------- 241 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------------- 241 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-------------
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-------------
Confidence 986432221 112234567889999999999999999999999999999999 5666655433211
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 242 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 242 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111112222334556788999999999999999999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=347.52 Aligned_cols=270 Identities=25% Similarity=0.317 Sum_probs=200.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-----hhhHHHHHHHHHHHhhcc---CCCccce
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-----LQGFEEWQSEVNFLGRLS---HPNLVRL 147 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~~i~~~ 147 (413)
..++|++.+.||+|+||+||+|++.. +++.||||++.... ......+.+|+.+++.++ ||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~ 79 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH-------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT-------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred cccceEEEEEEecCCCeEEEEEEECC-------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence 35789999999999999999996443 68899999986432 112345677888877775 9999999
Q ss_pred EeEEEeCC-----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 148 LGYCWEDK-----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 148 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
++++.... .+++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVT 154 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEEC
T ss_pred eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEc
Confidence 99998765 5899999996 599999965432 248999999999999999999997 5699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
.++.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|.+||............
T Consensus 155 ~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp TTSCEEECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEeeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999986432 22234567999999999999999999999999999999999999999765432111100
Q ss_pred Hhhhhhhhhhhhhh---HhHHhhhcC-------CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 303 DWIKPYLSEKRKFR---HIIDARLQG-------QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 303 ~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
........ ...+. ......+.. .....++.++.+||.+||+.||++|||+.|+++|-+
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 232 FDLIGLPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp HHHHCCCC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred HHHhCCCC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 00000000 00000 000000000 001245678999999999999999999999997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=350.00 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=195.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++.... .........|+..+..+ +|+||+++++++.+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE-------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC-------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 3579999999999999999997654 57899999876542 23334455666666555 89999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred CCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccce
Confidence 99999999999 669999887653 368999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 203 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------------ 260 (311)
T 3p1a_A 203 LLVELGTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------------ 260 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------------
T ss_pred eeeecccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------------
Confidence 98864322 22344579999999998865 789999999999999999999766643210
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
...+........++..++.++.+||.+||+.||++|||+.+++++-
T Consensus 261 -~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 261 -WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp -HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 0001000011111234567899999999999999999999999764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=342.87 Aligned_cols=263 Identities=27% Similarity=0.399 Sum_probs=210.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
.|.+.+.||+|+||.||+|.+.. ....+..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYID----QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEEC----SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred EEccCceeccCCCceEEEEEEec----CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 46677999999999999997653 22245679999987543 34567789999999999999999999999876655
Q ss_pred -EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 158 -LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 158 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred cEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 99999999999999996532 368899999999999999999997 569999999999999999999999999997
Q ss_pred cCCCCC--CcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCC-CCCCCCCCcchhhHhhhhhhhhhh
Q 015094 237 LGPSAS--QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRA-LDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 237 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~p-f~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
...... .........+++.|+|||++.+..++.++|||||||++|+|++|..| |......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~----------------- 235 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----------------- 235 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-----------------
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-----------------
Confidence 533221 11122345688999999999999999999999999999999996555 4332211
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.....+........+..++..+.+|+.+||..||.+|||+.++++.|+.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 236 DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 111222222233445567788999999999999999999999999999987664
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.88 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhh--ccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR--LSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|.+ +++.||||++.... ...+.+|.+++.. ++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW---------QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE---------TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE---------CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 46899999999999999999965 36889999987653 3455667777666 7899999999986543
Q ss_pred ----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCcEEEcCC
Q 015094 155 ----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------DKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 155 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------~~~ivHrDlkp~Nil~~~~ 224 (413)
..+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||.. ..+|+||||||+|||++.+
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred cCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 468999999999999999943 2689999999999999999999921 2669999999999999999
Q ss_pred CCeEEccCCCcccCCCCCCcc--eeecccccccccCccccccC------CccchhhhHHHHHHHHHHHhC----------
Q 015094 225 YTAKISDFGLAKLGPSASQSH--VTTRVMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLVEILTG---------- 286 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~lltG---------- 286 (413)
+.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 999999999997533222211 12234799999999999776 566899999999999999999
Q ss_pred CCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH-HhhhcCC-----CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 287 LRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII-DARLQGQ-----YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 287 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..||............ +.... ....... ++...+.++.+|+.+||+.||++|||+.++++.|
T Consensus 230 ~~pf~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFED------------MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CCTTTTTSCSSCCHHH------------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCCCCcchhh------------hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 7777654332211100 00000 0001111 1235778999999999999999999999999999
Q ss_pred HHH
Q 015094 361 ERL 363 (413)
Q Consensus 361 ~~i 363 (413)
+.+
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=348.62 Aligned_cols=268 Identities=24% Similarity=0.276 Sum_probs=202.2
Q ss_pred cCCCCC-CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 78 RNFKSD-TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
++|++. +.||+|+||.||+|.+.. +++.||||++........+.+.+|+.+++++ +||||+++++++.+++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLI-------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSS-------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred eeEEecCceecCCceEEEEEEEEcC-------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 568885 789999999999996543 6789999999766555567889999999885 6999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---eEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT---AKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~---~kl~Df 232 (413)
.+|+||||+.+++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. +||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 9999999999999999997653 68899999999999999999997 56999999999999987766 999999
Q ss_pred CCcccCCCCCC-----cceeecccccccccCcccccc-----CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 233 GLAKLGPSASQ-----SHVTTRVMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 233 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99875332111 111223569999999999865 56889999999999999999999999876543211100
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCch----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPY----KAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+. .....+..+.... ..++. .++.++.+||.+||..||.+|||+.|++++-+
T Consensus 239 ~~~~~~-~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 239 GEACPA-CQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp --CCHH-HHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred cccchh-HHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 000000 0000011111111 11221 35678999999999999999999999998644
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=346.89 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=207.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL-------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhccceeeeeccCCCCceEEEEEECC-------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 34689999999999999999997543 67899999997665444567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~---~~~~~~kl~Df 232 (413)
.+|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||+ .+|+||||||+||++ +.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEEEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999999999999986654 68899999999999999999997 569999999999999 78899999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|++..... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 154 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------- 214 (304)
T 2jam_A 154 GLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--------------- 214 (304)
T ss_dssp STTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------------
T ss_pred CcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---------------
Confidence 99875322 12233568999999999999999999999999999999999999997642110
Q ss_pred hhhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 313 RKFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 313 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+..... .......++.++.+||.+||..||.+|||+.+++++.+.
T Consensus 215 -~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 215 -LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp -HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred -HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 0111111111 112234567889999999999999999999999987664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=340.50 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=212.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||.||+|.+. .++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeEecCCCceeEEEEEec--------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 357999999999999999999764 357899999976543 33678999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred eEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccccc
Confidence 999999999999999996543 368899999999999999999997 569999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
..... .........++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 153 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~ 214 (267)
T 3t9t_A 153 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EV 214 (267)
T ss_dssp GBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HH
T ss_pred ccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----------------HH
Confidence 64321 1111223457788999999988999999999999999999999 89999764211 00
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...+........+...+..+.+|+.+||..||.+|||+.+++++|+.+...
T Consensus 215 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 215 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111222334456678899999999999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=342.65 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=211.6
Q ss_pred hcCCCCCC-eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDT-VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
..+|++.+ .||+|+||.||+|.+.. ...++.||||++.... ....+.+.+|+.+++.++||||+++++++ .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQM-----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEEC-----SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred chhhhhccCccccccCeeeEeeeecC-----CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 46788888 99999999999996542 2257899999987653 23356789999999999999999999998 6
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+..|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 678999999999999999997643 68899999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 234 LAKLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 234 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------- 227 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------------- 227 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---------------
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---------------
Confidence 998644332211 1222456788999999988899999999999999999999 99999764321
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
.....+........+..++..+.+||.+||+.||.+||++.++++.|+.+....
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 228 --EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 111122222233455677889999999999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=367.96 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=206.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT-------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcceEEeEEEeecCCEEEEEEEECC-------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 4679999999999999999997653 67899999986432 23456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCCeEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYTAKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~---~~~~~kl~D 231 (413)
..+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEE
Confidence 99999999999999999986654 68999999999999999999997 5699999999999994 556899999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||++...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.......
T Consensus 168 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------------- 229 (486)
T 3mwu_A 168 FGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------------- 229 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred CCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------
Confidence 9999864322 22344679999999998865 59999999999999999999999997643211
Q ss_pred hhhhhHhHHhhhcCC--CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQ--YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.+..+........ ....++.++.+||.+||..||.+|||+.+++++.+.-.
T Consensus 230 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 230 --ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp --HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred --HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 1111111111111 12356788999999999999999999999999877533
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=362.10 Aligned_cols=272 Identities=22% Similarity=0.272 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|++.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN-------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC-------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 4689999999999999999997654 6899999998754 334557789999999999999999999998776
Q ss_pred -----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 155 -----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 155 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEE
Confidence 57999999996 5999999543 368999999999999999999997 56999999999999999999999
Q ss_pred ccCCCcccCCCCCCc--------------------ceeecccccccccCcccc-ccCCccchhhhHHHHHHHHHHHhCCC
Q 015094 230 SDFGLAKLGPSASQS--------------------HVTTRVMGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLVEILTGLR 288 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~lltG~~ 288 (413)
+|||+++........ ......+||++|+|||++ .+..|+.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999864332211 123557899999999986 56679999999999999999998554
Q ss_pred CCC-----------CCCCCCcc-----------hhhHhhhhhhh-------------hhhhhhHhHHhhhc-CCC-----
Q 015094 289 ALD-----------TNRPSGQH-----------NLVDWIKPYLS-------------EKRKFRHIIDARLQ-GQY----- 327 (413)
Q Consensus 289 pf~-----------~~~~~~~~-----------~~~~~~~~~~~-------------~~~~~~~~~~~~~~-~~~----- 327 (413)
||. +....... .....+...+. ........+..... ...
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 443 32211000 00000000000 00000111110000 000
Q ss_pred chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 328 PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 328 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...++.++.+||.+||..||++|||+.|+++|-..
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 02457889999999999999999999999987553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=350.15 Aligned_cols=268 Identities=24% Similarity=0.371 Sum_probs=213.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..++|++.+.||+|+||.||+|.+... ....+++.||||++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGV--VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEE--ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCc--cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 456899999999999999999976521 112246889999987553 33455788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
+..|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCEE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCCeEE
Confidence 999999999999999999865321 12357889999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----------- 247 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----------- 247 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----------
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----------
Confidence 999999975322221112223457889999999999999999999999999999999 88898754211
Q ss_pred hhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.....+........+..++..+.+||.+||..||.+|||+.+++++|+.+.
T Consensus 248 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 248 ------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp ------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 001111111122344567788999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=368.20 Aligned_cols=259 Identities=26% Similarity=0.446 Sum_probs=212.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|+.+|+.++||||+++++++. .+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET--------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred chHHeEEEEEcccCCceEEEEEEEC--------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4568999999999999999999764 25789999998654 34678999999999999999999999876 66
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+|+|.+++..... ..++...++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred ccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 79999999999999999964321 257888899999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 332 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----------------~ 393 (454)
T 1qcf_A 332 RVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----------------E 393 (454)
T ss_dssp GGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------H
T ss_pred eEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 8643211 111123346788999999998999999999999999999999 99999764211 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++.++.+||.+||..||++|||+.+|++.|+.+...
T Consensus 394 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 394 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1111222233445667888999999999999999999999999999987644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=343.63 Aligned_cols=252 Identities=29% Similarity=0.424 Sum_probs=207.5
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
...+|++.+.||+|+||.||+|.+.. +++.||||++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRI-------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETT-------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcC-------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 45679999999999999999997653 57899999987654 246789999999999999999998864
Q ss_pred --------------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 015094 154 --------------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNI 219 (413)
Q Consensus 154 --------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Ni 219 (413)
...+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Ni 153 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNI 153 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHE
Confidence 456899999999999999997543 2368899999999999999999997 5699999999999
Q ss_pred EEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 220 LLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 220 l~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
|++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 224 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------ 224 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------
T ss_pred EEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------
Confidence 99999999999999998643322 223456999999999999999999999999999999999998776321
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
. ...........+..++..+.+||.+||..||.+|||+.+++++|+.+....
T Consensus 225 ------------~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 225 ------------S----KFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ------------H----HHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ------------H----HHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0 011111122344456778999999999999999999999999999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=359.33 Aligned_cols=275 Identities=21% Similarity=0.280 Sum_probs=213.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK-------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC-------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 3579999999999999999997654 57899999987543 234567889999999999999999999998765
Q ss_pred --eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCCCCeEE
Q 015094 156 --ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL----DGSYTAKI 229 (413)
Q Consensus 156 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~----~~~~~~kl 229 (413)
..|+||||+.+++|.+++..... ...+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEE
Confidence 78999999999999999965432 2238999999999999999999997 569999999999999 77778999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCcccccc--------CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT--------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 158 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 158 TDFGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CCGGGCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ecCCCceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 99999986432 222334679999999998865 5778999999999999999999999975433221111
Q ss_pred hHhhhhhhhhhh-----hhhHhH--------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 302 VDWIKPYLSEKR-----KFRHII--------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 302 ~~~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
. ......... .+.... .......++...+..+.+||.+||..||++||++.++++.++.+...
T Consensus 235 ~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 235 V--MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp H--HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred H--HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 000000000 000000 00011234467888999999999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=355.26 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=205.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------hhHHHHHHHHHHHhhccCCCccce
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLGRLSHPNLVRL 147 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~ 147 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+|+.++||||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 94 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE-------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT-------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred cccceEEEeEEEecCCEEEEEEEECC-------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 45789999999999999999997554 689999999875531 123356789999999999999999
Q ss_pred EeEEEeCCeeEEEEeeCCCC-CHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 148 LGYCWEDKELLLVYEFMQKG-SLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
++++.+.+.+++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCc
Confidence 99999999999999998766 9999986543 68999999999999999999997 56999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
+||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 169 ~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp EEECCCTTCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred EEEeecccceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 999999999864332 22334679999999999988877 78999999999999999999999652110
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.. .....+..++.++.+||.+||+.||++|||+.+++++.+
T Consensus 237 -------------~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 237 -------------VE--AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp -------------TT--TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred -------------Hh--hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00 011223346778999999999999999999999998755
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=358.06 Aligned_cols=272 Identities=24% Similarity=0.356 Sum_probs=210.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP-------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred cccceeeeeecCCCCeEEEEEEECC-------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 3579999999999999999997654 6789999998765 3344567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++++|.+++.... .+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999999999997654 688999999999999999999962 25999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-----------
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW----------- 304 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~----------- 304 (413)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 180 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 180 GQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HHHH----HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cccc----cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 6421 1123345799999999999999999999999999999999999999976432111000000
Q ss_pred -----------h----hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 305 -----------I----KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 305 -----------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
. .+..........+............++.++.+||.+||+.||.+|||+.++++|-+.-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0 00000000111111111111222346778999999999999999999999999877543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.76 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=210.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ-------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhceeeheecCCCCeEEEEEEEcC-------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 3679999999999999999997653 57899999986542 1234678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEeccc
Confidence 999999999999999999997653 68899999999999999999996 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 160 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------- 219 (284)
T 2vgo_A 160 WSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---------------- 219 (284)
T ss_dssp TCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred ccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----------------
Confidence 98753321 2234579999999999999999999999999999999999999997642110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
....+.. ....++..++.++.+||.+||..||.+|||+.+++++-+.-
T Consensus 220 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 220 THRRIVN--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp HHHHHHT--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred HHHHHhc--cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 0111111 12234556778899999999999999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=351.56 Aligned_cols=274 Identities=24% Similarity=0.325 Sum_probs=199.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh-HHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.+.||+|+||.||+|.+.. +++.||||++....... ...+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL-------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECC-------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence 579999999999999999997653 57899999987553221 1234579999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 75 LTLVFEYLDK-DLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp EEEEEECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred EEEEeccccc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 9999999975 9999886653 368899999999999999999997 569999999999999999999999999997
Q ss_pred cCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh--------
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP-------- 307 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~-------- 307 (413)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 149 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 149 AKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 53221 122334578999999999876 5689999999999999999999999987543221111100000
Q ss_pred hhhhhhhhhHhHHhhhcC----CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 308 YLSEKRKFRHIIDARLQG----QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.......+.......... .....++.++.+||.+||+.||.+|||+.|++++-+.....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 000000000000000000 00123567889999999999999999999999987754433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=356.28 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=202.4
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEe-CCe
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-DKE 156 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 156 (413)
.|++.+.||+|+||.||+|.+.. .......||||.+... .....+.+.+|+.+++.++||||+++++++.. ++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLD----NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEE----TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEEC----CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 46778899999999999997653 1123467899998654 33456789999999999999999999998654 568
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeeccccc
Confidence 899999999999999996543 357889999999999999999997 569999999999999999999999999998
Q ss_pred cCCCCCCc--ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 237 LGPSASQS--HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 237 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
........ .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.........
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-------------- 306 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------------- 306 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--------------
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--------------
Confidence 54322211 11233467889999999999999999999999999999999 67788665432211
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
..+........+..++..+.+|+.+||..||++|||+.++++.|+.+.....
T Consensus 307 ---~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 307 ---VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1111112223345677889999999999999999999999999999886543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=365.22 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=208.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT--------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC--------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 35678999999999999999997653 46799999986542 34678999999999999999999998866 6
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred ceEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 7999999999999999996432 1258899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+...... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 328 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----------------~ 389 (452)
T 1fmk_A 328 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------E 389 (452)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------H
T ss_pred eecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 8643221 112223456789999999999999999999999999999999 99999764211 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
....+........+..++..+.+||.+||..||++|||+.++++.|+.+....
T Consensus 390 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 390 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 11112222333456678889999999999999999999999999999877544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=346.22 Aligned_cols=269 Identities=23% Similarity=0.343 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD-------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEeeEEeecCCeEEEEEEeCC-------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 689999999999999999997654 578999998865432 33466789999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 999999999999999887543 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI-KPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 313 (413)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............... ........
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 8643221 12234578999999999876 67899999999999999999999999775432211111000 00000000
Q ss_pred h-h--hHhHHhh-hc---CCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 314 K-F--RHIIDAR-LQ---GQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 314 ~-~--~~~~~~~-~~---~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
. + ....... .. ... ...++.++.+||.+||+.||.+|||++|+++|-+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 0 0 0000000 00 000 0245677999999999999999999999998744
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=359.26 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=204.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-----CCCccceEeE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-----HPNLVRLLGY 150 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~ 150 (413)
..++|++.+.||+|+||+||+|.+.. +++.||||++.... ...+.+..|+.+++.+. ||||++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHID-------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECC-------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 45789999999999999999997653 57899999987542 34456788999999996 9999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-------
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG------- 223 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~------- 223 (413)
+...+.+|+||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccccccc
Confidence 99999999999999 8899999976542 258899999999999999999997 66999999999999975
Q ss_pred ------------------CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh
Q 015094 224 ------------------SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT 285 (413)
Q Consensus 224 ------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt 285 (413)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999863322 234579999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhhhhh-------hhhHhH-Hhh-----------------hcCCC---chHHHHHHHH
Q 015094 286 GLRALDTNRPSGQHNLVDWIKPYLSEKR-------KFRHII-DAR-----------------LQGQY---PYKAAYQIAQ 337 (413)
Q Consensus 286 G~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~~-----------------~~~~~---~~~~~~~l~~ 337 (413)
|..||....................... ...... ... ..... +...+..+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999976543221111100000000000 000000 000 00000 0111267889
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 015094 338 LSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 338 li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
||.+||+.||.+|||+.|+++|-
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHhcCChhhCCCHHHHhcCc
Confidence 99999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=342.23 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
..|++.+.||+|+||.||+|.+.. ++..||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE-------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred eeEEeeeeccCCCCeEEEEeEecC-------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 457888999999999999997654 6789999988654 23455678999999999999999999998875
Q ss_pred --CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEc
Q 015094 154 --DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKIS 230 (413)
Q Consensus 154 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~ 230 (413)
...+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+.+|+||||||+|||++ .++.+||+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred CCCceEEEEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence 356899999999999999996543 68899999999999999999997333399999999999997 78999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........
T Consensus 175 Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------ 237 (290)
T 1t4h_A 175 DLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------------ 237 (290)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------------
T ss_pred eCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------------
Confidence 99999753222 233457999999999875 5689999999999999999999999976432110
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
....+........++...++++.+||.+||..||.+|||+.+++++-
T Consensus 238 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 238 ---IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp ---HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ---HHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 00001111111112233456899999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=338.53 Aligned_cols=256 Identities=25% Similarity=0.321 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE-------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT-------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECC-------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 4689999999999999999996543 67899999987543 234567899999999999999999999984
Q ss_pred --eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 153 --EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 153 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
+....|+||||+.++ |.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEee
Confidence 446899999999875 777775543 2468999999999999999999997 569999999999999999999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCC--ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|||++................|++.|+|||++.+.. ++.++|||||||++|+|++|..||...... .
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~----- 220 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------K----- 220 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-----
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------H-----
Confidence 999998754433333444567999999999987643 478999999999999999999999764211 0
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+... ...++..++..+.+||.+||..||.+|||+.+++++.+.
T Consensus 221 -----~~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 221 -----LFENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp -----HHHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred -----HHHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 01111111 123445677889999999999999999999999998664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=345.78 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=208.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS-------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECC-------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 4679999999999999999997653 67899999986542 3445678999999999999999999998754
Q ss_pred -CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCC-----eeeCCCCCCcEEEcCCCCe
Q 015094 154 -DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQ-----VIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~-----ivHrDlkp~Nil~~~~~~~ 227 (413)
...+|+||||+++++|.+++.........+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSSCE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCCCE
Confidence 578999999999999999997655444568999999999999999999997 55 9999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 156 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------- 222 (279)
T 2w5a_A 156 KLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------- 222 (279)
T ss_dssp EECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred EEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-----------
Confidence 999999998643221 1123357899999999999889999999999999999999999999764211
Q ss_pred hhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.....+........+..++.++.+||.+||..||.+|||+.+++++++.
T Consensus 223 ------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 223 ------ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------HHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0111111112224455678899999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=353.28 Aligned_cols=277 Identities=17% Similarity=0.185 Sum_probs=209.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhH-----------HHHHHHHHHHhhccCCCcc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-----------EEWQSEVNFLGRLSHPNLV 145 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~~i~ 145 (413)
.++|++.+.||+|+||.||+|.+... .....++.||||++........ ..+..|+..++.++||||+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS--ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS--SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc--cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45899999999999999999977542 2233568899999876542111 1234566677788899999
Q ss_pred ceEeEEEeC----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 015094 146 RLLGYCWED----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221 (413)
Q Consensus 146 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~ 221 (413)
++++++... ...|+||||+ |++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill 185 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLL 185 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEE
Confidence 999998765 4589999999 999999997642 368999999999999999999997 569999999999999
Q ss_pred c--CCCCeEEccCCCcccCCCCCCc-----ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 222 D--GSYTAKISDFGLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 222 ~--~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
+ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999764322111 11133569999999999999999999999999999999999999998543
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
..... ..... .........+++..+. ...++.++.+|+..||..||.+||++.++++.|+.+.....
T Consensus 266 ~~~~~--~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 266 KDPKY--VRDSK--IRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TCHHH--HHHHH--HHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHHH--HHHHH--HHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 22111 10000 0111122223332221 12456789999999999999999999999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=351.38 Aligned_cols=268 Identities=21% Similarity=0.277 Sum_probs=195.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV-------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC-------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 4689999999999999999997554 689999999975532 2245677999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-----CCCCeEE
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-----GSYTAKI 229 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-----~~~~~kl 229 (413)
+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred CEEEEEEecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEE
Confidence 999999999975 9999996554 68999999999999999999997 5699999999999994 4556999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||..................
T Consensus 179 ~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 179 GDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999999764322 1123345789999999999774 5899999999999999999999999765432111100000000
Q ss_pred hhhhhhhhHh-------------HHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 LSEKRKFRHI-------------IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.....+... ....+....+..++.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 257 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 257 -PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp -CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 000000000 0000000011225678999999999999999999999998644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=361.17 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=209.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC-CCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH-PNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .+.+.+|+++++.|.| ++|..+..++.+.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGD 76 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT-------TCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC-------CCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence 4689999999999999999997653 578999998765532 2357889999999986 56667777777888
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~---~~~~~~kl~Df 232 (413)
..||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||| +.++.+||+||
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeC
Confidence 999999999 899999996543 368999999999999999999997 569999999999999 68899999999
Q ss_pred CCcccCCCCCCcc-----eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 233 GLAKLGPSASQSH-----VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 233 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+++......... ......||+.|+|||++.+..++.++|||||||+||+|++|..||..............
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--- 227 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK--- 227 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH---
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH---
Confidence 9998654332211 12356799999999999999999999999999999999999999987654332221111
Q ss_pred hhhhhhhhhHhHHhhhcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 308 YLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+........ +...++.++.+||.+||..||++||++.+|++.|+.+...
T Consensus 228 ----------i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 228 ----------ISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp ----------HHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------HhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111111100 1124467899999999999999999999999999988654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=369.35 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=209.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI-------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCceEEeeEEecCCCEEEEEEEECC-------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4579999999999999999997553 67899999986442 2346778999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeEEc
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKIS 230 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~---~~~~~~kl~ 230 (413)
.+.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999999999986543 68999999999999999999997 569999999999999 567899999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||++....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.......
T Consensus 172 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------------- 234 (484)
T 3nyv_A 172 DFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------------- 234 (484)
T ss_dssp CTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------------
T ss_pred eeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------------
Confidence 999998643322 2334579999999998865 69999999999999999999999997653211
Q ss_pred hhhhhhHhHHhhhcCCC--chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQY--PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.+..+......... ...++.++.+||.+||+.||.+|||+.++++|-+.-.
T Consensus 235 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 235 ---ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp ---HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred ---HHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 11111111111111 1356788999999999999999999999999877533
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=350.81 Aligned_cols=262 Identities=26% Similarity=0.333 Sum_probs=192.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEE---
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCW--- 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--- 152 (413)
..+|++.+.||+|+||.||+|.+.. +++.||||++........+.+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG-------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT-------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred CceEEEEEEEccCCceEEEEEEECC-------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3579999999999999999997653 57899999987666666778899999999996 999999999984
Q ss_pred -----eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 153 -----EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 153 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
....+++||||+. |+|.+++..... ...+++..++.++.||+.||.|||+.+.+|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3345899999996 699998865322 236899999999999999999999733339999999999999999999
Q ss_pred EEccCCCcccCCCCCCcc----------eeecccccccccCcccc---ccCCccchhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 228 KISDFGLAKLGPSASQSH----------VTTRVMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
||+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998643322111 11235689999999998 56778899999999999999999999997543
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
... +.........+...+..+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 258 ~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 258 KLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 211 11111111222334456889999999999999999999999999988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=339.71 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=211.3
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+. .+..||||++..... ..+.+.+|+++++.++||||+++++++. .+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc--------CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 3468999999999999999999754 357899999876542 3567899999999999999999999876 45
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 6899999999999999995432 1258899999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~ 218 (279)
T 1qpc_A 157 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----------------E 218 (279)
T ss_dssp EECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------H
T ss_pred ccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----------------H
Confidence 8643221 111223456788999999988899999999999999999999 89999764211 0
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
....+........+..++.++.+|+.+||..||++|||+.++++.|+.+.....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111112222333455677899999999999999999999999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.88 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhc-cCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.++..+ +||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL-------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC-------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 4679999999999999999997653 57899999987542 23456788899999999 89999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---------
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS--------- 224 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~--------- 224 (413)
++.+|+||||+++++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-----------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccc
Confidence 999999999999999999997654333478999999999999999999997 569999999999999844
Q ss_pred ----------CCeEEccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCC
Q 015094 225 ----------YTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTN 293 (413)
Q Consensus 225 ----------~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~ 293 (413)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++...
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 47999999999864332 123589999999998766 5668999999999999999998776432
Q ss_pred CCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
. ....+ ........+..++.++.+||.+||..||++|||+.+++++.+
T Consensus 235 ~-------------------~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 235 D-------------------QWHEI-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp H-------------------HHHHH-HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred h-------------------HHHHH-HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 1 01111 111223345567789999999999999999999999997644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=367.02 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=201.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++++.||+|+||+||+|.+.. ++..||||++.... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV-------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK 108 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT-------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC-------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 3579999999999999999997654 67899999987543 23356788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTAKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~kl~D 231 (413)
..+|+|||||.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEE
Confidence 99999999999999999886654 68999999999999999999997 56999999999999975 45599999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||++...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.......
T Consensus 183 fG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------------- 244 (494)
T 3lij_A 183 FGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------------- 244 (494)
T ss_dssp CTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred CCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------------
Confidence 9999864322 2234467999999999875 579999999999999999999999997653211
Q ss_pred hhhhhHhHHhhhcCC--CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQ--YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+..+........ ....++..+.+||.+||+.||.+|||+.++++|-+-
T Consensus 245 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 245 --ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp --HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred --HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 1111111111111 112467889999999999999999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=346.59 Aligned_cols=278 Identities=26% Similarity=0.410 Sum_probs=216.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK- 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 155 (413)
.++|++.+.||+|+||.||+|.+.. .+..+++.||||++........+.+.+|+.+++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP---LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT---TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEecc---ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 4579999999999999999997532 233468999999998776666778999999999999999999999887654
Q ss_pred -eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 156 -ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 156 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 7899999999999999997643 358999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh---h
Q 015094 235 AKLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL---S 310 (413)
Q Consensus 235 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~---~ 310 (413)
+.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... ......... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhh
Confidence 98754332211 122345778899999999899999999999999999999999887642100 000000000 0
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+...+........+..++.++.+||.+||..||++|||+.++++.|+.+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00011122222223344567788999999999999999999999999999988653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=359.40 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=194.6
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------hhHHHHHHHHHHHhhccCCCccc
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLGRLSHPNLVR 146 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~ 146 (413)
...++|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|++++||||++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 204 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK-------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC-------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence 356799999999999999999997654 678999999865421 12234789999999999999999
Q ss_pred eEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-
Q 015094 147 LLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY- 225 (413)
Q Consensus 147 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~- 225 (413)
+++++. .+.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 205 IKNFFD-AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCEEEE-SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSS
T ss_pred EEEEEe-cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCC
Confidence 999875 45689999999999999988543 378999999999999999999997 5699999999999996544
Q ss_pred --CeEEccCCCcccCCCCCCcceeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 015094 226 --TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300 (413)
Q Consensus 226 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~ 300 (413)
.+||+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 278 ~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 354 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred cceEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence 599999999986432 223345679999999999853 678899999999999999999999997643321110
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCc---hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYP---YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+........+ ..++..+.+||.+||+.||.+|||+.++++|-+
T Consensus 355 ----------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 355 ----------------DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp ----------------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred ----------------HHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 001100000011 235678999999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=346.65 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=210.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD-------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4689999999999999999997654 5789999998654 23445678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeecc
Confidence 999999999999999999986543 68999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 187 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------- 248 (335)
T 2owb_A 187 LATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------------- 248 (335)
T ss_dssp TCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred CceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----------------
Confidence 998643221 22334679999999999999999999999999999999999999997642110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+..+.. ....++..++..+.+||.+||+.||++|||+.+++++-..
T Consensus 249 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 249 TYLRIKK--NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp HHHHHHH--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHHHhc--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0111111 1123445677889999999999999999999999987664
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=342.98 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=202.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. .......||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDA----PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEEC----TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhHeeeeeeecCCCceeEEEEEecc----CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 3579999999999999999997653 12234579999987542 3455778999999999999999999999877
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
+. .++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEcccc
Confidence 64 899999999999999997543 368899999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 234 LAKLGPSASQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 234 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------- 231 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------------- 231 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---------------
Confidence 998654332221 1233467888999999988899999999999999999999 99999765321
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.....+.........+..++.++.++|.+||..||.+|||+.++++.|+.+...
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 232 -QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 011111111122233456778999999999999999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=339.35 Aligned_cols=264 Identities=18% Similarity=0.222 Sum_probs=206.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEE-EeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYC-WED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 154 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .+.+.+|+.+++.++|++++..+..+ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA-------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC-------CCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 45789999999999999999997543 678999998655432 23578899999999988766666554 677
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeEEcc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISD 231 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~---~~~~~~kl~D 231 (413)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEec
Confidence 8899999999 899999996433 368999999999999999999997 569999999999999 7889999999
Q ss_pred CCCcccCCCCCCc-----ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 232 FGLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 232 fG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~- 230 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI- 230 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH-
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh-
Confidence 9999864433221 1223467999999999999999999999999999999999999999876544332221111
Q ss_pred hhhhhhhhhhHhHHhhhcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 307 PYLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
........ ....++.++.+||.+||+.||++|||+.++++.|+.+....
T Consensus 231 ------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 231 ------------SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ------------HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 11111100 11234678999999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=365.40 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=204.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-------------hhHHHHHHHHHHHhhccCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-------------QGFEEWQSEVNFLGRLSHP 142 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ 142 (413)
..++|++++.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+.+|+.++||
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 106 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN-------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT-------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCT
T ss_pred cccceEEEeEecccCCeEEEEEEECC-------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCC
Confidence 35689999999999999999997654 678999999865421 2346788999999999999
Q ss_pred CccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 143 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
||+++++++.+...+|+|||||.|++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 107 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLE 180 (504)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEES
T ss_pred CCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEe
Confidence 99999999999999999999999999999986654 68999999999999999999997 5699999999999998
Q ss_pred CCC---CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 223 GSY---TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 223 ~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
.++ .+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.......
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 254 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-- 254 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 776 6999999999864332 2234467999999999876 569999999999999999999999997653211
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCC--chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQY--PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
.+..+......... ...++.++.+||.+||..||.+|||+.|++++-+.-
T Consensus 255 --------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 255 --------------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp --------------HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --------------HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 01111111110000 124567899999999999999999999999987753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=379.29 Aligned_cols=252 Identities=28% Similarity=0.378 Sum_probs=210.9
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhc-cCCCccceEeEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRL-SHPNLVRLLGYC 151 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 151 (413)
..++|++++.||+|+||+||+|.+.. +++.||||++.... ....+.+..|..+|..+ +||+|+++++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG-------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS-------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccceEEEEEEccCCCEEEEEEEECC-------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 45689999999999999999997654 67899999987542 23456778899999988 599999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.+.+.+||||||+.||+|.+++...+ .+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECC
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEee
Confidence 99999999999999999999997654 68999999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
||+++..... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..
T Consensus 486 FGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------------- 548 (674)
T 3pfq_A 486 FGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------------- 548 (674)
T ss_dssp CTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------
T ss_pred cceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---------------
Confidence 9999853222 22344578999999999999999999999999999999999999999765321
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM-----REVVETL 360 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~-----~e~l~~L 360 (413)
..+..++.. ...++..++.++.+||.+||..||.+|+++ +||++|-
T Consensus 549 -~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 549 -ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp -HHHHHHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred -HHHHHHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 112222221 234566788999999999999999999997 7887654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=350.17 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=206.0
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------hhHHHHHHHHHHHhhc-cCC
Q 015094 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLGRL-SHP 142 (413)
Q Consensus 72 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~ 142 (413)
......++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.+ +||
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp 160 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRA-------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECC-------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 344456789999999999999999997653 578999998865431 1245678999999999 799
Q ss_pred CccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 143 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
||+++++++......|+||||+.|++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLD 234 (365)
T ss_dssp TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC
T ss_pred CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEC
Confidence 99999999999999999999999999999996543 68999999999999999999997 5699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCcccccc------CCccchhhhHHHHHHHHHHHhCCCCCCCCCCC
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPS 296 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~ 296 (413)
.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 235 ~~~~ikl~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp TTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCEEEEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999864322 22344679999999998853 35889999999999999999999999764211
Q ss_pred CcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 297 GQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
. ....+.........+ ...+..+.+||.+||..||++|||+.+++++-
T Consensus 312 ~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 312 L----------------MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp H----------------HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred H----------------HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 0 001111111100000 13456799999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.08 Aligned_cols=273 Identities=24% Similarity=0.281 Sum_probs=198.4
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-----hHHHHHHHHHHHhhccCCCccceEe
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-----GFEEWQSEVNFLGRLSHPNLVRLLG 149 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~ 149 (413)
...++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|+.+++.++||||+++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKN-------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 79 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSS-------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECC-------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEE
Confidence 345789999999999999999996543 6789999998754221 1246789999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 150 YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
++.+.+.+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 80 AFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp EECCTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEeeCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEE
Confidence 99999999999999976 8988885432 367888899999999999999997 56999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--h
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--K 306 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~--~ 306 (413)
+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||............... .
T Consensus 154 ~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~ 231 (346)
T 1ua2_A 154 ADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231 (346)
T ss_dssp CCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999998643221 223346789999999998664 5889999999999999999999999765322111000000 0
Q ss_pred hhhhhhhhhhHhHHhhhcCC--------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQ--------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+............+...... ....++.++.+||.+||..||.+|||+.|++++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 00000000000000000000 012446789999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=374.29 Aligned_cols=260 Identities=25% Similarity=0.358 Sum_probs=207.7
Q ss_pred CCCCC-eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 80 FKSDT-VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+.+.+ .||+|+||.||+|.+... ..+..||||+++... ....+.+.+|+++|+.++||||+++++++.. +.+
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMR-----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECS-----SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred eeEcCcEEecCCCcEEEEEEEecC-----CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34444 799999999999976531 246789999997653 3356789999999999999999999999876 569
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.+++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 411 ~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 9999999999999999643 2368999999999999999999997 5699999999999999999999999999986
Q ss_pred CCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 238 GPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... +
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~ 548 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------------V 548 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----------------H
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------H
Confidence 4322211 11122345688999999999999999999999999999998 999998653211 1
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
...+........+..++.++.+||.+||..||++||++.++++.|+.+....
T Consensus 549 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 549 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1122223334556678899999999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=341.78 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=201.6
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc--cCCCccceEeEEE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL--SHPNLVRLLGYCW 152 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~ 152 (413)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|.+++..+ +||||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR---------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC---------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 45578999999999999999999653 6889999986543 23445556665554 8999999999998
Q ss_pred eC----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCcEEEc
Q 015094 153 ED----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------DKQVIYRDFKASNILLD 222 (413)
Q Consensus 153 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------~~~ivHrDlkp~Nil~~ 222 (413)
.. ..+|+||||+.+++|.+++... .+++..++.++.|++.||.|||+. ..+|+||||||+|||++
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 87 7899999999999999999543 589999999999999999999974 12799999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcc--eeecccccccccCccccccCCccch------hhhHHHHHHHHHHHhC--------
Q 015094 223 GSYTAKISDFGLAKLGPSASQSH--VTTRVMGTYGYAAPEYVATGHLYVK------SDVYGFGVVLVEILTG-------- 286 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~~lltG-------- 286 (413)
.++.+||+|||++.......... ......||+.|+|||++.+..+... +|||||||++|+|++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999997643322211 1124579999999999977666544 9999999999999999
Q ss_pred --CCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh-HHhhhcCCCc-----hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 287 --LRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI-IDARLQGQYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 287 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
..||........... ..... ........++ ..++.++.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~p~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYE------------DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp CCCCTTTTTSCSSCCHH------------HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccHhhhcCCCCchh------------hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 445543322211100 00011 1111122222 267888999999999999999999999999
Q ss_pred HHHHHHhcC
Q 015094 359 TLERLQASD 367 (413)
Q Consensus 359 ~L~~i~~~~ 367 (413)
+|+.+....
T Consensus 325 ~L~~l~~~~ 333 (337)
T 3mdy_A 325 TLAKMSESQ 333 (337)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHhhc
Confidence 999988764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=342.61 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=201.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV-------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC-------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 4689999999999999999997553 57899999987543 2334678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred CCeEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 999999999999999999997643 68999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++....... ........|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 180 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------- 241 (309)
T 2h34_A 180 IASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----------------- 241 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----------------
T ss_pred cCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----------------
Confidence 987543221 11223457899999999999999999999999999999999999999764211
Q ss_pred hhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHhcC
Q 015094 314 KFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQASD 367 (413)
Q Consensus 314 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rp-t~~e~l~~L~~i~~~~ 367 (413)
.+...+.... ....+..++.++.+||.+||..||++|| +++++++.|+.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 242 VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0001111100 0122345677899999999999999999 9999999998865443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=337.87 Aligned_cols=264 Identities=18% Similarity=0.204 Sum_probs=209.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeE-EEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGY-CWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .+.+.+|+.+++.++|++++..+.+ +..+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC-------CCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 4689999999999999999997543 689999999865542 2468899999999998876665554 46678
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---cCCCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL---DGSYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~---~~~~~~kl~Df 232 (413)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred ceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 899999999 889999996433 368999999999999999999997 569999999999999 48889999999
Q ss_pred CCcccCCCCCCcc-----eeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 233 GLAKLGPSASQSH-----VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 233 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 230 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-- 230 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH--
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh--
Confidence 9998644332211 123467999999999999999999999999999999999999999875443322211111
Q ss_pred hhhhhhhhhHhHHhhhcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 308 YLSEKRKFRHIIDARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
........ ....++.++.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 231 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 231 -----------SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----------HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -----------cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 11111100 112456789999999999999999999999999999876643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=340.48 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=203.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC-C
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED-K 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 155 (413)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+++.++||||+++++++.+. +
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred hhhceEEeEEecCCCceEEEEEEc---------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 467999999999999999999653 5789999997654 456789999999999999999999987654 5
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecccc
Confidence 79999999999999999965431 137888999999999999999997 56999999999999999999999999998
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
...... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----------------- 222 (278)
T 1byg_A 165 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------- 222 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----------------
T ss_pred cccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence 753221 223357889999999998999999999999999999998 999997643211
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
....+........+..++..+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 223 VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 11111122223445567889999999999999999999999999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=340.36 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=212.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.+.|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNR-------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECC-------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 4579999999999999999997543 67899999986543 345678899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccc
Confidence 99999999999999999843 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------------~ 227 (303)
T 3a7i_A 167 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----------------V 227 (303)
T ss_dssp EECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----------------H
T ss_pred eecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----------------H
Confidence 7643221 12234578999999999999999999999999999999999999997542110 0
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
...+........+..++..+.+||.+||..||.+|||+.+++++......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 228 LFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01111112223445667889999999999999999999999998776543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=338.17 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh------hhHHHHHHHHHHHhhccCCCccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL------QGFEEWQSEVNFLGRLSHPNLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 150 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG-------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI 76 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC-------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence 3579999999999999999997653 578999998865422 135678999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----C
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY----T 226 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~----~ 226 (413)
+.+....++||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+||+++.++ .
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 77 FENKTDVVLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCC
T ss_pred ecCCCeEEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCc
Confidence 999999999999999999999996543 68999999999999999999997 5699999999999998877 8
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 151 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------- 218 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--------- 218 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------
T ss_pred eEEEecccceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---------
Confidence 999999999864322 12334569999999999998999999999999999999999999997643210
Q ss_pred hhhhhhhhhhHhHHhhhcCCCc----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+... ...++ ...+..+.+||.+||..||.+|||+.+++++-.
T Consensus 219 -------~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 219 -------TLTNISAV--NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp -------HHHHHHTT--CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred -------HHHHhHhc--ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 00000000 00111 234677999999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=357.87 Aligned_cols=270 Identities=22% Similarity=0.293 Sum_probs=200.9
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe-
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE- 153 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 153 (413)
...++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE-------SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT-------TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC-------CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeec
Confidence 356789999999999999999997654 678999998865532 23479999999999999999999844
Q ss_pred -------------------------------------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHH
Q 015094 154 -------------------------------------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196 (413)
Q Consensus 154 -------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~ 196 (413)
...+++||||+.+ +|.+.+.........+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 3458999999975 88887765433445799999999999999
Q ss_pred HHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhH
Q 015094 197 RGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVY 274 (413)
Q Consensus 197 ~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 274 (413)
.||.|||+ .||+||||||+|||++ .++.+||+|||++...... .......||+.|+|||++.+. .++.++|||
T Consensus 152 ~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 152 RAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 99999996 6699999999999997 6889999999999864322 223345789999999998775 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hhhhh----hhh-----hhHhHHhhhcCCCchHHHHHHHHHHHHcc
Q 015094 275 GFGVVLVEILTGLRALDTNRPSGQHNLVDWIK--PYLSE----KRK-----FRHIIDARLQGQYPYKAAYQIAQLSLKCL 343 (413)
Q Consensus 275 slG~il~~lltG~~pf~~~~~~~~~~~~~~~~--~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L 343 (413)
||||++|+|++|..||................ +.... ... +..+....+...++...+.++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999998754322111110000 00000 000 00000000111133456778999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 015094 344 EAEPKHRPSMREVVETLE 361 (413)
Q Consensus 344 ~~dp~~Rpt~~e~l~~L~ 361 (413)
..||.+|||+.|+++|-.
T Consensus 307 ~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp CSSGGGSCCHHHHHTSGG
T ss_pred cCChhhCCCHHHHhcCHH
Confidence 999999999999997644
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=342.48 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=194.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.++...++.++||||+++++++.++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVP-------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecC-------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 4689999999999999999997643 689999999876522 2223344555568888999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..|+||||+.+ +|.+++.........+++..++.++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 79 GDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp SSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred CCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999975 88888765433445799999999999999999999972 1699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccc----ccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYV----ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
+...... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------- 219 (290)
T 3fme_A 157 SGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------------- 219 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--------------
T ss_pred ccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--------------
Confidence 9763322 223334799999999996 5667889999999999999999999999753211
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
...+...............++.++.+||.+||+.||++|||+.+++++-+.-
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 220 -FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp -HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred -HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 0111112222222223345678899999999999999999999999976643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=339.67 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=210.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD-------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 4689999999999999999997653 5789999998654 23345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++..|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEecc
Confidence 999999999999999999986543 68999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 161 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------- 222 (294)
T 2rku_A 161 LATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------------- 222 (294)
T ss_dssp TCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred CceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------
Confidence 998643221 22334579999999999998899999999999999999999999997642110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+.. .....+..++..+.+||.+||+.||++|||+.+++++...
T Consensus 223 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 223 TYLRIKK--NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp HHHHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHHHhh--ccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 0111111 1123455677889999999999999999999999998664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=351.78 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=199.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR-------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT-------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC-------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 4689999999999999999997654 6789999998643 333456788999999999999999999999866
Q ss_pred C------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 K------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
. .+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEE
Confidence 3 469999999 8899999864 268899999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...+.........
T Consensus 169 l~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999986432 1334678999999999877 6899999999999999999999999987543221111100000
Q ss_pred -----hhhh--hhhhhHhHHhhh---c---CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 308 -----YLSE--KRKFRHIIDARL---Q---GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 308 -----~~~~--~~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+... .......+.... . .......+..+.+||.+||..||.+|||+.++++|-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0000 000011111100 0 0112345788999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=340.51 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=187.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH-------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred cccceeeeeecCCCceEEEEEEEcc-------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 4579999999999999999997543 578999999865422 234678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeec
Confidence 999999999999999999996542 368999999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------- 222 (278)
T 3cok_A 158 LATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------------- 222 (278)
T ss_dssp TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------
T ss_pred ceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------------
Confidence 9986432211 2234578999999999998899999999999999999999999997654321110
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+.. .....+..++.++.+||.+||+.||++|||+.+++++-.
T Consensus 223 ---~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 223 ---KVVL--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp ----CCS--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred ---HHhh--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 0000 011234456778999999999999999999999987543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=352.03 Aligned_cols=270 Identities=16% Similarity=0.143 Sum_probs=199.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-----------hHHHHHHHHHHHhhccCCCcc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-----------GFEEWQSEVNFLGRLSHPNLV 145 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~ 145 (413)
.++|++.+.||+|+||.||+|.+.. ....+..||||++...... ....+.+|+.+++.++||||+
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTN----KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESS----SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecC----CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3679999999999999999997653 1224678999998755321 112356788999999999999
Q ss_pred ceEeEEEe----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 015094 146 RLLGYCWE----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 221 (413)
Q Consensus 146 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~ 221 (413)
++++++.. ...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLL 184 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEE
Confidence 99999988 67899999999 999999996543 78999999999999999999997 569999999999999
Q ss_pred cCCC--CeEEccCCCcccCCCCCC-----cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 222 DGSY--TAKISDFGLAKLGPSASQ-----SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 222 ~~~~--~~kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
+.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8877 999999999976432111 111134579999999999999999999999999999999999999996432
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
...... ....... ...+...+.... ....++.++.+||.+||..||++|||+.+|++.|+.+.
T Consensus 265 ~~~~~~-~~~~~~~---~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDPVAV-QTAKTNL---LDELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCHHHH-HHHHHHH---HHTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccHHH-HHHHHhh---cccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 211000 0000000 000000011000 01145678999999999999999999999999988754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=351.22 Aligned_cols=262 Identities=15% Similarity=0.175 Sum_probs=208.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc---CCCccceEeEEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS---HPNLVRLLGYCW 152 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~ 152 (413)
..++|++.+.||+|+||+||+|++... .+..+++.||||++..... ..+.+|+.+++.+. |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDL--NDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC---------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCC--cccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 346799999999999999999964321 2344788999999987643 45667777777776 999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCC-CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--------
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGA-SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-------- 223 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-------- 223 (413)
..+..|+||||+.+|+|.+++..... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC---
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999975332 24479999999999999999999997 66999999999999988
Q ss_pred ---CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 015094 224 ---SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300 (413)
Q Consensus 224 ---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~ 300 (413)
++.+||+|||++...............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999997543333444556678999999999999999999999999999999999999998643221100
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHhc
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR-PSMREVVETLERLQAS 366 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~R-pt~~e~l~~L~~i~~~ 366 (413)
+...+. .+ ..+..+.+++..||+.+|.+| |+++++.+.|+.+...
T Consensus 295 ------------------~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 ------------------PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ------------------ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------------echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 000000 01 235678899999999999999 5888888888887654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=344.69 Aligned_cols=276 Identities=22% Similarity=0.326 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHH--HHHHHhhccCCCccceEeEEEe-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS--EVNFLGRLSHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--E~~~l~~l~h~~i~~~~~~~~~- 153 (413)
.++|++.+.||+|+||.||+|.+ +++.||||++..... ..+.. |+..+..++||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL---------DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE---------TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE---------CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 36899999999999999999965 358999999875532 23333 4444556899999999986542
Q ss_pred ----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC-------CCCeeeCCCCCCcEEEc
Q 015094 154 ----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS-------DKQVIYRDFKASNILLD 222 (413)
Q Consensus 154 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-------~~~ivHrDlkp~Nil~~ 222 (413)
...+|+||||+++++|.+++... ..++..++.++.||+.||.|||+. ..+|+||||||+|||++
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 23679999999999999999654 347888899999999999999973 11799999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCC------cceeecccccccccCcccccc-------CCccchhhhHHHHHHHHHHHhCCCC
Q 015094 223 GSYTAKISDFGLAKLGPSASQ------SHVTTRVMGTYGYAAPEYVAT-------GHLYVKSDVYGFGVVLVEILTGLRA 289 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~lltG~~p 289 (413)
.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 999999999999986432211 112234579999999999876 4667899999999999999999777
Q ss_pred CCCCCCCCcchhhHhh-hhhhhhhhhhhHhH-HhhhcCCC------chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 290 LDTNRPSGQHNLVDWI-KPYLSEKRKFRHII-DARLQGQY------PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 290 f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
|............... .............. .......+ ...++.++.+||.+||..||++|||+.|+++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 6544332221111000 00000000011111 11111122 2346778999999999999999999999999999
Q ss_pred HHHhcCCC
Q 015094 362 RLQASDQK 369 (413)
Q Consensus 362 ~i~~~~~~ 369 (413)
.+...-..
T Consensus 315 ~ll~~~~~ 322 (336)
T 3g2f_A 315 ELMMIWER 322 (336)
T ss_dssp HHHHCCCC
T ss_pred HHHHHHHh
Confidence 98865443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=346.51 Aligned_cols=257 Identities=19% Similarity=0.255 Sum_probs=205.4
Q ss_pred HHhcCCCCC-CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhcc-CCCccceEeE
Q 015094 75 AATRNFKSD-TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLS-HPNLVRLLGY 150 (413)
Q Consensus 75 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 150 (413)
...++|.+. +.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.+. ||||++++++
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKS-------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECC-------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 345678887 899999999999997654 578999999875432 33567889999999996 6999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCe
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTA 227 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~ 227 (413)
+.+.+.+|+||||+.+++|.+++... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999998543 23468999999999999999999997 56999999999999987 7899
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 174 kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------- 240 (327)
T 3lm5_A 174 KIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---------- 240 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------
T ss_pred EEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----------
Confidence 99999999864322 22334679999999999999999999999999999999999999997643211
Q ss_pred hhhhhhhhhHhHHhh--hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+.... ........++..+.+||.+||+.||.+|||+++++++.+
T Consensus 241 ------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 241 ------TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp ------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred ------HHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 011111111 111222356788999999999999999999999998755
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=337.55 Aligned_cols=256 Identities=24% Similarity=0.326 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeE
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELL 158 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 158 (413)
+|....+||+|+||.||+|.+.. +++.||||.+........+.+.+|+.+++.++||||+++++++...+.++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS-------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT-------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECC-------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 45555699999999999997653 57899999987766556678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCCeEEccCCCccc
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGLAKL 237 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~a~~ 237 (413)
+||||+.+++|.+++..... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||++..
T Consensus 96 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred EEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 99999999999999976432 2356788899999999999999997 56999999999999987 89999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCC--ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
..... .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||....... ...
T Consensus 173 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~~~ 235 (295)
T 2clq_A 173 LAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---------------AAM 235 (295)
T ss_dssp SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---------------HHH
T ss_pred cCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---------------HHH
Confidence 43221 1223457899999999987653 7899999999999999999999996432110 000
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
............+..++.++.+||.+||..||++||++.+++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp HHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred HhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0111112233455677889999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=334.87 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=200.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQL-------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eccEEEEeeecCCCCeEEEEEEECC-------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4689999999999999999997653 57899999986542 2345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
.+..|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecc
Confidence 999999999999999999997653 68899999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++...... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 157 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------- 218 (276)
T 2h6d_A 157 LSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------------- 218 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------
T ss_pred cccccCCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---------------
Confidence 99864322 22234578999999999987766 689999999999999999999997542110
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+.. .....+..++..+.+||.+||+.||.+|||+.+++++-..
T Consensus 219 -~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 219 -LFKKIRG--GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp -HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred -HHHHhhc--CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 0011111 1112345567889999999999999999999999997653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=352.07 Aligned_cols=264 Identities=22% Similarity=0.257 Sum_probs=205.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc--------CCCccceE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS--------HPNLVRLL 148 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~ 148 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ...+.+.+|+.+++.+. |+||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ-------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC-------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 3689999999999999999997553 67999999997553 34567889999999996 78899999
Q ss_pred eEEE----eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcC
Q 015094 149 GYCW----EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDK-QVIYRDFKASNILLDG 223 (413)
Q Consensus 149 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~ivHrDlkp~Nil~~~ 223 (413)
+++. ....+|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||+ + ||+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECC
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEec
Confidence 9987 556899999999 667777765442 2368999999999999999999997 4 6999999999999987
Q ss_pred CC-------------------------------------------------CeEEccCCCcccCCCCCCcceeecccccc
Q 015094 224 SY-------------------------------------------------TAKISDFGLAKLGPSASQSHVTTRVMGTY 254 (413)
Q Consensus 224 ~~-------------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~ 254 (413)
++ .+||+|||++...... .....||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~ 257 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR 257 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence 75 7999999999864321 23457999
Q ss_pred cccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh-------------------
Q 015094 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF------------------- 315 (413)
Q Consensus 255 ~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------- 315 (413)
.|+|||++.+..++.++|||||||++|+|++|..||.........................
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 9999999999999999999999999999999999998765443222111111110000000
Q ss_pred -------------hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 316 -------------RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 316 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
...+. .....+...+..+.+||.+||+.||++|||+.|+++|-
T Consensus 338 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLV--EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp SBSSCCCCCCCCHHHHHH--HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred ccccccccCCcchhHhhh--hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 00000 01234567788999999999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=359.76 Aligned_cols=266 Identities=24% Similarity=0.296 Sum_probs=198.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC---
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED--- 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 154 (413)
.+|++.+.||+|+||+||+|++.. +++.||||++..... ...+|+++|+.|+||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD-------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC-------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 469999999999999999997654 578999999865432 234799999999999999999988542
Q ss_pred ---CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC-CCeEEc
Q 015094 155 ---KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKIS 230 (413)
Q Consensus 155 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~-~~~kl~ 230 (413)
..+++||||+.+ +|.+++.........+++..++.++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEec
Confidence 247899999976 7777665433334578999999999999999999996 669999999999999855 678999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
|||+++..... .......||+.|+|||++.+. .|+.++|||||||++|||++|..||.......+.. ..+...-
T Consensus 200 DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~--~i~~~lg 274 (420)
T 1j1b_A 200 DFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV--EIIKVLG 274 (420)
T ss_dssp CCTTCEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHC
T ss_pred cchhhhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhC
Confidence 99999864322 223346789999999998765 78999999999999999999999998754321111 1110000
Q ss_pred hh-hhhhhHhHH------------hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 310 SE-KRKFRHIID------------ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 310 ~~-~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.. ...+..... ..+...++...+.++.+||.+||..||.+|||+.|+++|.+.
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 00 000000000 000001223456889999999999999999999999987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=336.58 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=206.1
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---------hhhHHHHHHHHHHHhhcc-CCCcc
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---------LQGFEEWQSEVNFLGRLS-HPNLV 145 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~~i~ 145 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++++. ||||+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP-------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred hhhccceeeeecCCCceEEEEEEEcC-------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34689999999999999999997653 67999999986542 123456789999999996 99999
Q ss_pred ceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 015094 146 RLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 146 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~ 225 (413)
++++++......|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+||+++.++
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDM 161 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTC
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCC
Confidence 99999999999999999999999999997643 68999999999999999999997 5699999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccc------cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA------TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
.+||+|||++...... .......|++.|+|||++. ...++.++||||||+++|+|++|..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-- 236 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-- 236 (298)
T ss_dssp CEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cEEEecccchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--
Confidence 9999999999864322 2233457899999999884 4568899999999999999999999997542110
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcC--CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQG--QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+....... .....++..+.+||.+||..||.+|||+.+++++-.
T Consensus 237 --------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 237 --------------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp --------------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred --------------HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 111111111111 112356788999999999999999999999997543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=360.04 Aligned_cols=247 Identities=17% Similarity=0.177 Sum_probs=192.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHH---HHhhccCCCccceE--
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVN---FLGRLSHPNLVRLL-- 148 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~---~l~~l~h~~i~~~~-- 148 (413)
.++|++.+.||+|+||.||+|++.. +++.||||++... .....+.+.+|+. +|+.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE-------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C-------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred CceEEEcceeecCCCEEEEEEEECC-------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 3578899999999999999996543 5789999998633 3345677899995 45555799999998
Q ss_pred -----eEEEeCC-----------------eeEEEEeeCCCCCHHHhhhhcCCC---CCCCcHHHHHHHHHHHHHHHHHhh
Q 015094 149 -----GYCWEDK-----------------ELLLVYEFMQKGSLENHLFGRGAS---VQPLAWNIRLKIAIGAARGLAFLH 203 (413)
Q Consensus 149 -----~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH 203 (413)
+++...+ ..|+||||+ +|+|.+++...... ...+++..++.++.||+.||+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 7666554 389999999 67999999754311 123456888899999999999999
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccC-----------Cccchhh
Q 015094 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-----------HLYVKSD 272 (413)
Q Consensus 204 ~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~D 272 (413)
+ ++|+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|
T Consensus 224 ~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 224 H--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp H--TTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred h--CCeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 7 569999999999999999999999999998522 23345678 999999999887 8999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC
Q 015094 273 VYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS 352 (413)
Q Consensus 273 iwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt 352 (413)
||||||++|+|++|..||.......... .+. .....++.++.+||.+||..||.+|||
T Consensus 296 vwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 296 AWALGLVIYWIWCADLPITKDAALGGSE----------------WIF------RSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHHHHHHHHHHSSCCC------CCSG----------------GGG------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHHHHHHHHHHHHCCCCCcccccccchh----------------hhh------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999999999999997654322111 000 011245678999999999999999999
Q ss_pred HHHHHHHHH
Q 015094 353 MREVVETLE 361 (413)
Q Consensus 353 ~~e~l~~L~ 361 (413)
+.+++++-+
T Consensus 354 ~~e~l~hp~ 362 (377)
T 3byv_A 354 PLQAMETPE 362 (377)
T ss_dssp HHHHHTSHH
T ss_pred HHHHhhChH
Confidence 999998544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=347.63 Aligned_cols=267 Identities=23% Similarity=0.267 Sum_probs=196.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI-------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC-------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 3689999999999999999997543 6789999998653 334456788999999999999999999999766
Q ss_pred C------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 K------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
. .+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEE
T ss_pred cccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEE
Confidence 5 78999999975 7888874 257889999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh---
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--- 305 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~--- 305 (413)
|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+...........
T Consensus 168 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999985322 22234467999999999999999999999999999999999999999875432111000000
Q ss_pred --hhhhhh-hhhhhHhHHh---------------hhcC---CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 306 --KPYLSE-KRKFRHIIDA---------------RLQG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 306 --~~~~~~-~~~~~~~~~~---------------~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+... .......... .... ......+.++.+||.+||..||.+|||++|+++|-+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 000000 0000000000 0000 0112347789999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.60 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=205.1
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 161 (413)
+.||+|+||.||+|.+... ..++.||||+++.... ...+.+.+|+.+|+.++||||+++++++.. +.+++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCC-----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEE
Confidence 4799999999999976432 2568999999976432 345789999999999999999999998864 5689999
Q ss_pred eeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCC
Q 015094 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 241 (413)
||+.+++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 449 E~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999996543 68999999999999999999997 56999999999999999999999999999864432
Q ss_pred CCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 242 SQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 242 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
... .......+|..|+|||++.+..++.++|||||||++|||++ |..||...... .+...+
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----------------~~~~~i 585 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAML 585 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHH
Confidence 221 12233457789999999999999999999999999999998 99999765321 122223
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
........+..++.++.+||.+||+.||++||++.+|++.|+.+..
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3333445566788999999999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=369.72 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=211.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.|+|+||+++++++.+ +
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT--------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred chhhhhhheecccCCCeEEEEEEECC--------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 35678899999999999999997653 46799999976542 34678999999999999999999998866 6
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+||||||+.+++|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred cceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 7999999999999999996432 1258899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... .........++..|+|||++.+..++.++|||||||+||||++ |..||...... .
T Consensus 411 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----------------~ 472 (535)
T 2h8h_A 411 RLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------E 472 (535)
T ss_dssp TTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----------------H
T ss_pred eecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 853321 1111223456788999999999999999999999999999999 99999764211 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
+...+........+..++..+.+||.+||..||++|||+.+|++.|+.+....
T Consensus 473 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 473 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11112222333455677889999999999999999999999999999876443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=339.97 Aligned_cols=267 Identities=27% Similarity=0.406 Sum_probs=208.5
Q ss_pred HHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhh--ccCCCccceEeE
Q 015094 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR--LSHPNLVRLLGY 150 (413)
Q Consensus 73 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~ 150 (413)
.....++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+++++. ++||||++++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc---------CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 3445678999999999999999999652 6889999987543 3567788888887 789999999999
Q ss_pred EEeCC----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCcEE
Q 015094 151 CWEDK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------DKQVIYRDFKASNIL 220 (413)
Q Consensus 151 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------~~~ivHrDlkp~Nil 220 (413)
+.... .+|+||||+.+++|.+++... .+++..++.++.||+.||.|||.. ..+|+||||||+|||
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEE
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEE
Confidence 98876 899999999999999999643 588999999999999999999921 266999999999999
Q ss_pred EcCCCCeEEccCCCcccCCCCCCcc--eeecccccccccCccccccC------CccchhhhHHHHHHHHHHHhC------
Q 015094 221 LDGSYTAKISDFGLAKLGPSASQSH--VTTRVMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLVEILTG------ 286 (413)
Q Consensus 221 ~~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~lltG------ 286 (413)
++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 9999999999999997643322211 12345799999999998765 344789999999999999999
Q ss_pred ----CCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCc-----hHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 015094 287 ----LRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREVV 357 (413)
Q Consensus 287 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 357 (413)
..||........... . ....+........++ ..++..+.+||.+||+.||++|||+.+++
T Consensus 260 ~~~~~~p~~~~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVE-E----------MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHH-H----------HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccccccCccccCcCcccHH-H----------HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 566655432211100 0 000111111222222 35677899999999999999999999999
Q ss_pred HHHHHHHhcC
Q 015094 358 ETLERLQASD 367 (413)
Q Consensus 358 ~~L~~i~~~~ 367 (413)
++|+.+....
T Consensus 329 ~~L~~i~~~~ 338 (342)
T 1b6c_B 329 KTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHHh
Confidence 9999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=340.64 Aligned_cols=261 Identities=17% Similarity=0.249 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEe--
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWE-- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-- 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... .+.+.+|+.+++.+. ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT-------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCceEEEEEecccCCeEEEEEEECC-------CCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 3679999999999999999997554 57899999997553 357889999999997 9999999999988
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEccC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDF 232 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~Df 232 (413)
....++||||+.+++|.+++. .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 678999999999999999883 47888999999999999999997 5699999999999999776 8999999
Q ss_pred CCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
|++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ...+......
T Consensus 176 g~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~~~~~~ 250 (330)
T 3nsz_A 176 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGT 250 (330)
T ss_dssp TTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCH
T ss_pred CCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHHHhcCC
Confidence 9998643222 2334578999999999877 67899999999999999999999999654322110 0000000000
Q ss_pred hh--------------hhhHhH--------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 312 KR--------------KFRHII--------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 312 ~~--------------~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.. .+.... ........+..++.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 00 000000 001111223346789999999999999999999999998644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=346.51 Aligned_cols=271 Identities=24% Similarity=0.365 Sum_probs=202.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD-------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT-------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhheeeeEEeecCCEEEEEEEECC-------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 3579999999999999999997654 57899999885443 23345678999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCC
Confidence 9999999999998888876433 268999999999999999999997 5699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hh-----
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI-KP----- 307 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~-~~----- 307 (413)
+...... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||............... ..
T Consensus 171 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 171 ARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ceeecCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 9753221 1223345789999999998775 7889999999999999999999999775432211110000 00
Q ss_pred --hhhhhhhhhHhHHhhhcCC-----CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 --YLSEKRKFRHIIDARLQGQ-----YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+.....+........... ....++..+.+||.+||+.||.+|||+.|++++-+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0000000000000000000 012456789999999999999999999999987553
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=339.26 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=204.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE-------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT-------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred chhhhhhheeeccCCCeEEEEEEECC-------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 45789999999999999999997653 57899999987654 3467889999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999986432 368999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..
T Consensus 173 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~ 234 (314)
T 3com_A 173 GQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR----------------AI 234 (314)
T ss_dssp EECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HH
T ss_pred hhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----------------HH
Confidence 7643221 12234578999999999999999999999999999999999999997543110 00
Q ss_pred hHhHHh-hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 316 RHIIDA-RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 316 ~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+... ......+..++..+.+||.+||..||.+|||+.+++++-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred HHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 000000 01112244567889999999999999999999999987653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=350.51 Aligned_cols=260 Identities=27% Similarity=0.363 Sum_probs=207.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhc-cCCCccceEeEEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 152 (413)
++|++.+.||+|+||.||+|+... ...+++.||||++.... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKIS----GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS----STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcc----cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 579999999999999999997642 22368899999987542 12345567899999999 5999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
.+..+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eCceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeC
Confidence 9999999999999999999997653 68899999999999999999997 56999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|+++..... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..
T Consensus 204 G~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~------ 274 (355)
T 1vzo_A 204 GLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EI------ 274 (355)
T ss_dssp SEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HH------
T ss_pred CCCeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HH------
Confidence 999853321 1122334679999999999975 357899999999999999999999997654322110 00
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLER 362 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~~ 362 (413)
...+. .....++..++..+.+||.+||..||.+|| ++.+++++...
T Consensus 275 ----~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 275 ----SRRIL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp ----HHHHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ----HHHHh--ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 00011 112345566778899999999999999999 99999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=346.18 Aligned_cols=271 Identities=23% Similarity=0.314 Sum_probs=201.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRK-------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETT-------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cceeEEEEEecCCCcEEEEEEECC-------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 589999999999999999997654 678999998865432 234567899999999999999999999887
Q ss_pred ------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 ------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
.+.+|+||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCE
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCE
Confidence 4568999999976 7777775432 368999999999999999999997 569999999999999999999
Q ss_pred EEccCCCcccCCCCCC--cceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 228 KISDFGLAKLGPSASQ--SHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999986442221 122344678999999998876 5689999999999999999999999987543221111100
Q ss_pred hhhhhhhhhhhhHh-----HHhh--hcC---CCc-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 305 IKPYLSEKRKFRHI-----IDAR--LQG---QYP-----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 305 ~~~~~~~~~~~~~~-----~~~~--~~~---~~~-----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....... ..+... .... ... ... ...++.+.+||.+||+.||++|||+.|++++-+.
T Consensus 244 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 244 LCGSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp HHCCCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCCh-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 0000000 000000 0000 000 000 0124578999999999999999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=341.73 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=202.2
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..++|++.+.||+|+||.||+|.+.. +++.||+|++........+.+.+|+.+++.++||||+++++++..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE-------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT-------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred CccceeecceeccCCCeEEEEEEEcC-------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 34689999999999999999997654 57899999998776666788999999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 9999999999999999986543 368999999999999999999997 56999999999999999999999999987
Q ss_pred ccCCCCCCcceeecccccccccCcccc-----ccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYV-----ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
..... .........|++.|+|||++ .+..++.++|||||||++|+|++|..||.......
T Consensus 165 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------- 229 (302)
T 2j7t_A 165 AKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------------- 229 (302)
T ss_dssp HHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------------
T ss_pred ccccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------------
Confidence 53110 01112335789999999988 36778899999999999999999999997643210
Q ss_pred hhhhhhHhHHhh-hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 311 EKRKFRHIIDAR-LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 311 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
....+.... .....+..++..+.+||.+||..||.+|||+.+++++-
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 230 ---VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp ---HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred ---HHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 000111110 11123456678899999999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=352.42 Aligned_cols=268 Identities=20% Similarity=0.266 Sum_probs=204.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc------cCCCccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL------SHPNLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~ 150 (413)
..+|++.+.||+|+||.||+|.+.. +++.||||++.... ...+.+.+|+.+++.+ .|+||++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHK-------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETT-------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECC-------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 4689999999999999999997654 67999999997653 3345677899988888 46799999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC--eE
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT--AK 228 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~--~k 228 (413)
+.....+|+||||+. ++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. +|
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCEE
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcceE
Confidence 999999999999995 599999876432 358999999999999999999997 56999999999999999887 99
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK-- 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~-- 306 (413)
|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||................
T Consensus 243 L~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 243 VIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp ECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999999975322 1234579999999999999999999999999999999999999998764322111110000
Q ss_pred ---hhhhhhhhhhHhHHhh------------------------------------hcCCCchHHHHHHHHHHHHccccCC
Q 015094 307 ---PYLSEKRKFRHIIDAR------------------------------------LQGQYPYKAAYQIAQLSLKCLEAEP 347 (413)
Q Consensus 307 ---~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~l~~li~~~L~~dp 347 (413)
.++.........+... +...++...+..+.+||.+||+.||
T Consensus 318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP 397 (429)
T 3kvw_A 318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397 (429)
T ss_dssp CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence 0000000000000000 0000011225678999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 015094 348 KHRPSMREVVETLER 362 (413)
Q Consensus 348 ~~Rpt~~e~l~~L~~ 362 (413)
++|||+.|+++|-+.
T Consensus 398 ~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 398 AVRMTPGQALRHPWL 412 (429)
T ss_dssp TTSCCHHHHHTSTTT
T ss_pred hhCCCHHHHhCChhh
Confidence 999999999987553
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=342.63 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=197.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------hhHHHHHHHHHHHhhccCCCccce
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLGRLSHPNLVRL 147 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~ 147 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|+.++||||+++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK-------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC-------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 45689999999999999999997654 679999999865421 123457899999999999999999
Q ss_pred EeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC-
Q 015094 148 LGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT- 226 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~- 226 (413)
++++..+. .|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSS
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCC
Confidence 99987654 89999999999999998543 378999999999999999999997 56999999999999987654
Q ss_pred --eEEccCCCcccCCCCCCcceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 227 --AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 227 --~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
+||+|||++..... ........||+.|+|||++. ...++.++|||||||++|+|++|..||..........
T Consensus 154 ~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~- 229 (322)
T 2ycf_A 154 CLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK- 229 (322)
T ss_dssp CCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH-
T ss_pred CeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH-
Confidence 99999999986432 22223457999999999874 5678899999999999999999999997654322110
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCC---chHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQY---PYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
..+........ ...++..+.+||.+||..||++|||+.+++++
T Consensus 230 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 230 ---------------DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp ---------------HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---------------HHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00000000001 12356789999999999999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.17 Aligned_cols=277 Identities=22% Similarity=0.265 Sum_probs=195.3
Q ss_pred HHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEE
Q 015094 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYC 151 (413)
Q Consensus 72 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 151 (413)
......++|++.+.||+|+||.||+|.+.. +++.||||++..... ......+|++.++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~ 88 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKS-------TGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYF 88 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETT-------TCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence 344567899999999999999999997653 578999998855432 234567788889999999999999998
Q ss_pred EeCCe-------eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-
Q 015094 152 WEDKE-------LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG- 223 (413)
Q Consensus 152 ~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~- 223 (413)
..... +++||||+.+ +|.+.+.........+++..+..++.||+.||.|||.+..+|+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence 76443 8999999976 66655544333445788999999999999999999944477999999999999986
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
++.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||............
T Consensus 168 ~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp TTEEEECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 899999999999864322 223346789999999998665 4899999999999999999999999875432111110
Q ss_pred HhhhhhhhhhhhhhHhHH----------------hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 303 DWIKPYLSEKRKFRHIID----------------ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..............+. ...........+.++.+||.+||+.||.+|||+.|+++|-+.
T Consensus 245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 245 --VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp --HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred --HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 0000000000000000 000111222367889999999999999999999999987664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=345.38 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=199.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEe-
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE- 153 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~- 153 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVK-------TGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC-------CCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 35689999999999999999997653 578999999865432 346788999999999 79999999999987
Q ss_pred -----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 154 -----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 154 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
...+|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEE
Confidence 468999999999999999997542 2368899999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD 303 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~ 303 (413)
|+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------ 241 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 241 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------
Confidence 99999987533211 1223457999999999986 5678899999999999999999999996543210
Q ss_pred hhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 304 WIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+.........+..++..+.+||.+||..||.+||++.+++++-.
T Consensus 242 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 242 ----------ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp ----------HHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred ----------HHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 001111111111223456788999999999999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=345.96 Aligned_cols=271 Identities=22% Similarity=0.284 Sum_probs=204.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
..+|++.+.||+|+||.||+|++.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL-------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred cccEEEEEEeecCCCeEEEEEEECC-------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 3589999999999999999997553 67899999987543 33456788999999999999999999998765
Q ss_pred ----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 155 ----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 155 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
..+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp TTTCCCEEEEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEE
Confidence 468999999965 999988543 58999999999999999999997 569999999999999999999999
Q ss_pred cCCCcccCCCCCCc-ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-h
Q 015094 231 DFGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK-P 307 (413)
Q Consensus 231 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~-~ 307 (413)
|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................ .
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999864322111 11234579999999998754 558999999999999999999999998765433221111000 0
Q ss_pred -hhhhh-----hhhhHhHHhhh-cCC-----CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 -YLSEK-----RKFRHIIDARL-QGQ-----YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 -~~~~~-----~~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..... ........... ... ....++.++.+||.+||..||++|||+.|++++-+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 00000 00000000000 000 012356789999999999999999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=348.62 Aligned_cols=265 Identities=25% Similarity=0.337 Sum_probs=187.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK-------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT-------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC-------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 4689999999999999999997543 6899999998654 334556788999999999999999999998754
Q ss_pred ------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 ------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
..+|+|||++ +++|.+++.. ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEE
Confidence 5689999999 7799998843 368999999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK- 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~- 306 (413)
|+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...+........
T Consensus 173 L~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999985322 1334679999999999877 678999999999999999999999998754322111110000
Q ss_pred -h---hhhh--hhhhhHhHHhhhcC-CC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 -P---YLSE--KRKFRHIIDARLQG-QY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 -~---~~~~--~~~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+ .+.. .......+...... .. ....+..+.+||.+||..||.+|||+.++++|-.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0 0000 00011111110000 00 0134578999999999999999999999998755
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.92 Aligned_cols=203 Identities=25% Similarity=0.335 Sum_probs=173.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CC-----CccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HP-----NLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~ 150 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ...+.+.+|+.+++.+. |+ +|++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRV-------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcC-------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 4689999999999999999997653 67899999997543 34566788999999886 55 49999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--CCCCeE
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD--GSYTAK 228 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~--~~~~~k 228 (413)
+...+.+|+||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+++.+|+||||||+|||++ .++.+|
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 9999999999999964 99999976532 358999999999999999999997667899999999999994 578899
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCC
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRP 295 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~ 295 (413)
|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 202 L~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 202 IVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999986432 12346799999999999999999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=344.18 Aligned_cols=275 Identities=22% Similarity=0.264 Sum_probs=199.4
Q ss_pred HHHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-----------hhHHHHHHHHHHHhh
Q 015094 70 FVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-----------QGFEEWQSEVNFLGR 138 (413)
Q Consensus 70 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~E~~~l~~ 138 (413)
..++....++|++.+.||+|+||.||+|.+. .++.||||++..... ...+.+.+|+.+++.
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 85 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS--------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT--------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC--------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence 4566778899999999999999999999643 378999998854321 223678999999999
Q ss_pred ccCCCccceEeEEEeC-----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 015094 139 LSHPNLVRLLGYCWED-----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRD 213 (413)
Q Consensus 139 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrD 213 (413)
++||||+++++++... ..+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+ .+|+|||
T Consensus 86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~D 159 (362)
T 3pg1_A 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE--AGVVHRD 159 (362)
T ss_dssp CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCC
T ss_pred CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CcCEecC
Confidence 9999999999998543 46899999997 58888886432 368999999999999999999997 5699999
Q ss_pred CCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCC
Q 015094 214 FKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDT 292 (413)
Q Consensus 214 lkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~ 292 (413)
|||+|||++.++.+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999975222 222344678999999999877 6789999999999999999999999986
Q ss_pred CCCCCcchhhHhhh--hhhh-----hhhhhhHhHHhhhcCC-------CchHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 015094 293 NRPSGQHNLVDWIK--PYLS-----EKRKFRHIIDARLQGQ-------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358 (413)
Q Consensus 293 ~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 358 (413)
.............. +... ........+....... .....+..+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 54221111000000 0000 0000000110000000 11234677999999999999999999999998
Q ss_pred HHH
Q 015094 359 TLE 361 (413)
Q Consensus 359 ~L~ 361 (413)
|-+
T Consensus 317 hp~ 319 (362)
T 3pg1_A 317 HPY 319 (362)
T ss_dssp SGG
T ss_pred Cch
Confidence 755
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=341.10 Aligned_cols=268 Identities=23% Similarity=0.351 Sum_probs=188.8
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAP-------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC-----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred chhhhhhhheeccccceEEEEEEECC-------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 45789999999999999999996543 57899999987543 23456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhc----CCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGR----GASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
+..|+||||+.+++|.+++... ......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEE
Confidence 9999999999999999998641 1123468999999999999999999997 569999999999999999999999
Q ss_pred cCCCcccCCCCCC---cceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 231 DFGLAKLGPSASQ---SHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 231 DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----- 238 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML----- 238 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----
Confidence 9999876432211 112234579999999999865 5689999999999999999999999976543211100
Q ss_pred hhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
......... ............++.++.+||.+||+.||.+|||+.+++++-
T Consensus 239 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 239 TLQNDPPSL---ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp HHTSSCCCT---TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred HhccCCCcc---ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 000000000 000001122234567899999999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=351.28 Aligned_cols=257 Identities=15% Similarity=0.046 Sum_probs=185.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhc--cCCCccceE----
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRL--SHPNLVRLL---- 148 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l--~h~~i~~~~---- 148 (413)
..|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.| +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE-------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred eeeeeeeeccCCCCEEEEEEEECC-------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 358899999999999999997654 679999999987542 3455677886655555 599988755
Q ss_pred ---eEEEeC-----------------CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHH------HHHHHHHHHHHHHh
Q 015094 149 ---GYCWED-----------------KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR------LKIAIGAARGLAFL 202 (413)
Q Consensus 149 ---~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~i~~qi~~~l~~l 202 (413)
+++... ..+|+||||+. ++|.+++..... .+....+ +.++.||+.||+||
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 555433 33899999998 799999976432 2333344 67779999999999
Q ss_pred hcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCcccccc--CCccchhhhHHHHHHH
Q 015094 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVL 280 (413)
Q Consensus 203 H~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 280 (413)
|+ ++|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++
T Consensus 211 H~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 211 QS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HH--CCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 97 5699999999999999999999999999986321 2224567799999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 281 VEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 281 ~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
|+|++|..||....+......... .................++..+.+||.+||+.||++|||+.+++++-
T Consensus 284 ~elltg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred HHHHhCCCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 999999999987643321110000 00000000111111235678899999999999999999999999765
Q ss_pred H
Q 015094 361 E 361 (413)
Q Consensus 361 ~ 361 (413)
+
T Consensus 355 ~ 355 (371)
T 3q60_A 355 E 355 (371)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=367.30 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=210.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..++|++.+.||+|+||.||+|.+.. ....+..||||++... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMS----PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECC----SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEec----CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34679999999999999999997753 2224678999998754 3344567899999999999999999999884 5
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCC
Confidence 67899999999999999997543 258899999999999999999997 5699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+....... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 538 a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---------------- 600 (656)
T 2j0j_A 538 SRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------------- 600 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------
T ss_pred CeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH----------------
Confidence 98643222 112233457789999999998999999999999999999997 999997643210
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
....+........+..++..+.+||.+||..||.+|||+.++++.|+.+...
T Consensus 601 -~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 601 -VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1111112222345567788999999999999999999999999999988643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=331.52 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=205.4
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
...++|++.+.||+|+||.||+|.... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI-------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcC-------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence 456789999999999999999997543 57899999986442 234577899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---CCeEE
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS---YTAKI 229 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~---~~~kl 229 (413)
+.+.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+||+++.+ +.+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCeEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEE
Confidence 9999999999999999999886543 68999999999999999999997 569999999999999654 47999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 166 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------ 229 (287)
T 2wei_A 166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------------ 229 (287)
T ss_dssp CSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------
T ss_pred eccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------------
Confidence 9999998643222 1233468999999998865 58999999999999999999999997643210
Q ss_pred hhhhhhhHhHHhhhcCCCc--hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQGQYP--YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
....+.........+ ..++.++.+||.+||..||.+|||+.+++++-..
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 230 ----ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp ----HHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred ----HHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 011111111111111 2457789999999999999999999999987553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=344.44 Aligned_cols=274 Identities=16% Similarity=0.179 Sum_probs=206.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCC-CCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccc---------
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAP-GKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVR--------- 146 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~--------- 146 (413)
.++|++.+.||+|+||.||+|.+..... .....++.||||++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3579999999999999999997653110 00013688999998755 35778999999999999887
Q ss_pred ------eEeEEEe-CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 015094 147 ------LLGYCWE-DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNI 219 (413)
Q Consensus 147 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Ni 219 (413)
+++++.. +..+|+||||+ +++|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHE
Confidence 6777766 68899999999 999999997542 2378999999999999999999997 5699999999999
Q ss_pred EEcCCC--CeEEccCCCcccCCCCCCc-----ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCC
Q 015094 220 LLDGSY--TAKISDFGLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDT 292 (413)
Q Consensus 220 l~~~~~--~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~ 292 (413)
|++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999764322111 112335799999999999999999999999999999999999999976
Q ss_pred CCCCCcchhhHhhhhhhhhhhhhhHhHHhhhc-CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcCC
Q 015094 293 NRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368 (413)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~~ 368 (413)
....... ...... .+......... ......++.++.+||.+||..||.+|||+.++++.|+.+.....
T Consensus 271 ~~~~~~~-~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNTED-IMKQKQ-------KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCHHH-HHHHHH-------HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCHHH-HHHHHH-------hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 5322100 000000 00000000000 00112346889999999999999999999999999999876643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=336.34 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=201.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhcc--CCCccceEeEE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLS--HPNLVRLLGYC 151 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~ 151 (413)
..++|++.+.||+|+||.||+|.+. .++.||||++... .....+.+.+|+.+++.++ |+||+++++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC--------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3467999999999999999999643 3688999998654 3345677899999999997 59999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..++.+|+|||+ .+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEECC-CSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEec-CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEee
Confidence 999999999994 5789999997643 68899999999999999999997 56999999999999965 7999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc-----------CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-----------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHN 300 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~ 300 (413)
||++................|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 245 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----
Confidence 999986443332222344579999999999865 47889999999999999999999999654211
Q ss_pred hhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 301 LVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
...+..+........++...+.++.+||.+||..||.+||++.+++++.+.
T Consensus 246 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 246 -----------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp -----------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -----------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 011122223333334455567889999999999999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=348.51 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=194.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK-- 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 155 (413)
.+|++.+.||+|+||+||+|.+.. +..||+|++..... ...+|+.+|+.++||||+++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~--------~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE--------SDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT--------TEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC--------CCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 579999999999999999997653 23488887754432 1247999999999999999999986543
Q ss_pred ----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEc
Q 015094 156 ----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKIS 230 (413)
Q Consensus 156 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~ 230 (413)
.+|+||||+.+ ++...+.........+++..++.++.||+.||+|||+ .+|+||||||+|||++ .++.+||+
T Consensus 108 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEe
Confidence 38899999977 5544443322234478999999999999999999997 5699999999999998 79999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||............ ....-
T Consensus 185 DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i--~~~~g 259 (394)
T 4e7w_A 185 DFGSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI--IKVLG 259 (394)
T ss_dssp CCTTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHC
T ss_pred eCCCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhC
Confidence 99999864322 223446789999999998765 5899999999999999999999999875432211110 00000
Q ss_pred hh-hhhhhHhHHhh------------hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 310 SE-KRKFRHIIDAR------------LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 310 ~~-~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.. ...+....... +...++...+.++.+||.+||..||.+|||+.|+++|-.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 00 00000000000 000122346678999999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=337.05 Aligned_cols=267 Identities=23% Similarity=0.323 Sum_probs=205.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCC------CccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHP------NLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~ 150 (413)
.++|++.+.||+|+||.||+|.+.. .+++.||||++.... ...+.+.+|+.+++.++|+ +|++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecC------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 4689999999999999999997532 257899999987543 3456788999999999765 49999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-------
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG------- 223 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~------- 223 (413)
+...+.+|+||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEE
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEecccccccc
Confidence 99999999999999 8899999976542 368899999999999999999997 56999999999999987
Q ss_pred ------------CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCC
Q 015094 224 ------------SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 224 ------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~ 291 (413)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 668999999999863321 234579999999999999999999999999999999999999998
Q ss_pred CCCCCCcchhhHhhhhhhhh---------------------hhhhhHhHHhh-----hcCCCchHHHHHHHHHHHHcccc
Q 015094 292 TNRPSGQHNLVDWIKPYLSE---------------------KRKFRHIIDAR-----LQGQYPYKAAYQIAQLSLKCLEA 345 (413)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~L~~ 345 (413)
.................... ........... .........+.++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 65432211111000000000 00000000000 00112345678899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 015094 346 EPKHRPSMREVVETL 360 (413)
Q Consensus 346 dp~~Rpt~~e~l~~L 360 (413)
||.+|||+.|++++-
T Consensus 316 dP~~Rpt~~ell~hp 330 (339)
T 1z57_A 316 DPAKRITLREALKHP 330 (339)
T ss_dssp STTTSCCHHHHTTSG
T ss_pred CcccccCHHHHhcCH
Confidence 999999999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=349.63 Aligned_cols=277 Identities=21% Similarity=0.306 Sum_probs=188.4
Q ss_pred hcCCCC-CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 77 TRNFKS-DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 77 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
.+.|.+ .++||+|+||+||+|.+.. ..+++.||||++..... ...+.+|+.+|+.|+||||+++++++..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKD-----GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESS-----SSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEcc-----CCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 345776 5689999999999997542 23578899999976542 3467899999999999999999999954
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcC-----CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----cCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRG-----ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL----DGS 224 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~----~~~ 224 (413)
+..+|+||||+.+ +|.+++.... .....+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.+
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTTT
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCCC
Confidence 6789999999965 8888775322 122248999999999999999999997 569999999999999 677
Q ss_pred CCeEEccCCCcccCCCCCC-cceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc---
Q 015094 225 YTAKISDFGLAKLGPSASQ-SHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH--- 299 (413)
Q Consensus 225 ~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~--- 299 (413)
+.+||+|||++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 8999999999986432211 122344679999999999877 45899999999999999999999999765432100
Q ss_pred ---hhhHhhhhhh--------hhh---hhhhHhHHh----hhcC--------CCchHHHHHHHHHHHHccccCCCCCCCH
Q 015094 300 ---NLVDWIKPYL--------SEK---RKFRHIIDA----RLQG--------QYPYKAAYQIAQLSLKCLEAEPKHRPSM 353 (413)
Q Consensus 300 ---~~~~~~~~~~--------~~~---~~~~~~~~~----~~~~--------~~~~~~~~~l~~li~~~L~~dp~~Rpt~ 353 (413)
.....+...+ ... ......... .... ......+..+.+||.+||..||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 0000000000 000 000000000 0000 0001125678999999999999999999
Q ss_pred HHHHHHHHHH
Q 015094 354 REVVETLERL 363 (413)
Q Consensus 354 ~e~l~~L~~i 363 (413)
.|+++|-+..
T Consensus 329 ~e~L~hp~f~ 338 (405)
T 3rgf_A 329 EQAMQDPYFL 338 (405)
T ss_dssp HHHHTSGGGT
T ss_pred HHHhcChhhc
Confidence 9999987653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=334.89 Aligned_cols=271 Identities=22% Similarity=0.297 Sum_probs=199.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEE----
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCW---- 152 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 152 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND-------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT-------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred CCceeEEEEeccCCCeEEEEEEECC-------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 4689999999999999999997654 67999999998776667788999999999999999999999873
Q ss_pred ----------eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 153 ----------EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 153 ----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+...+|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFIN 154 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEc
Confidence 3467899999997 599999843 368899999999999999999997 5699999999999997
Q ss_pred -CCCCeEEccCCCcccCCCCCC-cceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 223 -GSYTAKISDFGLAKLGPSASQ-SHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 223 -~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
.++.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567999999999986432211 112234567999999998865 67899999999999999999999999875432111
Q ss_pred hhhHhhhhhhhhh--h----hhhHhHHhhhc-CC-----CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 300 NLVDWIKPYLSEK--R----KFRHIIDARLQ-GQ-----YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 300 ~~~~~~~~~~~~~--~----~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.......+..... . .+...+..... .. ....++.++.+||.+||+.||.+|||+.+++++-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 1100000000000 0 00000011010 00 112457789999999999999999999999987664
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.65 Aligned_cols=266 Identities=18% Similarity=0.241 Sum_probs=202.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-----------CCCcc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-----------HPNLV 145 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~ 145 (413)
..+|++.+.||+|+||+||+|.+.. +++.||||++.... ...+.+.+|+.+++.+. |+||+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV-------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC-------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 3589999999999999999997543 67999999997543 34466889999999886 78999
Q ss_pred ceEeEEEeCC----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEE
Q 015094 146 RLLGYCWEDK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDK-QVIYRDFKASNIL 220 (413)
Q Consensus 146 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~ivHrDlkp~Nil 220 (413)
++++++...+ .+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ + +|+||||||+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVL 164 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeE
Confidence 9999988654 799999999 8899999976432 358899999999999999999997 4 6999999999999
Q ss_pred Ec------CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCC
Q 015094 221 LD------GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294 (413)
Q Consensus 221 ~~------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~ 294 (413)
++ ..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 94 444899999999986432 1233578999999999999999999999999999999999999998654
Q ss_pred CCCcchhhHhhhhhhhhhhh--------------------------------hhHhHHhhhcCCCchHHHHHHHHHHHHc
Q 015094 295 PSGQHNLVDWIKPYLSEKRK--------------------------------FRHIIDARLQGQYPYKAAYQIAQLSLKC 342 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~ 342 (413)
..........+......... ...+.. ....++...+.++.+||.+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPM 317 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGG
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHH
Confidence 32211111111000000000 000111 12235667889999999999
Q ss_pred cccCCCCCCCHHHHHHHHHH
Q 015094 343 LEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 343 L~~dp~~Rpt~~e~l~~L~~ 362 (413)
|+.||.+|||+.|++++-+.
T Consensus 318 L~~dP~~Rpt~~ell~hp~f 337 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVNHPWL 337 (373)
T ss_dssp GCSSTTTCBCHHHHHTCGGG
T ss_pred hccCccccCCHHHHhhChhh
Confidence 99999999999999987653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.74 Aligned_cols=259 Identities=20% Similarity=0.342 Sum_probs=199.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+. ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~----------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWH----------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEES----------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred HHHeEEeeEeccCCceEEEEEEEc----------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 468999999999999999999754 238999886542 22335577899999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999996432 368889999999999999999997 5699999999999998 67999999999
Q ss_pred cccCCCCC---CcceeecccccccccCcccccc---------CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 015094 235 AKLGPSAS---QSHVTTRVMGTYGYAAPEYVAT---------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302 (413)
Q Consensus 235 a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~ 302 (413)
+....... .........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 250 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----- 250 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 87532211 1112233568999999999864 457899999999999999999999997643210
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
....+............++.++.+||.+||..||.+|||+.++++.|+.+....
T Consensus 251 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 251 -----------IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -----------HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -----------HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 000111111111122245677999999999999999999999999999877543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.82 Aligned_cols=265 Identities=25% Similarity=0.310 Sum_probs=200.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR-------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC-------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 4689999999999999999997654 6899999998764 233456788999999999999999999999877
Q ss_pred Cee------EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 KEL------LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
+.. |+||||+. ++|.+++. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEE
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEE
Confidence 654 99999997 58888872 248999999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK- 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~- 306 (413)
|+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 185 L~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999975322 2334678999999999877 788999999999999999999999998654221111100000
Q ss_pred ----hhhhh--hhhhhHhHHhhhcCC------CchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 307 ----PYLSE--KRKFRHIIDARLQGQ------YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 307 ----~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
.+... ............... ....++.++.+||.+||+.||++|||+.|++++-+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 00000 000001111100000 112346789999999999999999999999987553
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=333.56 Aligned_cols=271 Identities=25% Similarity=0.346 Sum_probs=202.4
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhc---cCCCccceEeE
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRL---SHPNLVRLLGY 150 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~ 150 (413)
..++|++.+.||+|+||.||+|.+.. .+++.||||++..... .....+.+|+.+++.+ .||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecC------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 34689999999999999999997632 2578999998864321 1223466788877777 79999999999
Q ss_pred EE-----eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC
Q 015094 151 CW-----EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY 225 (413)
Q Consensus 151 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~ 225 (413)
+. ....+++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTC
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCC
Confidence 87 5578999999997 599999876432 258899999999999999999997 5699999999999999999
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
.+||+|||++.... .........|+..|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 158 ~~kl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 158 QIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEecCccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 99999999997532 122233467899999999999999999999999999999999999999865422111000000
Q ss_pred hhhhhhhhhhhH-------hHHh---hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 306 KPYLSEKRKFRH-------IIDA---RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 306 ~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
... .....+.. .... .....+...++..+.+||.+||..||.+|||+.+++++-+
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 235 IGL-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp HCC-CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cCC-CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000 00000000 0000 0001122356778999999999999999999999997644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=339.06 Aligned_cols=266 Identities=18% Similarity=0.291 Sum_probs=203.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhh-----------------HHHHHHHHHHHhhc
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-----------------FEEWQSEVNFLGRL 139 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~E~~~l~~l 139 (413)
.++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK---------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE---------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc---------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 36899999999999999999965 47899999986542211 17889999999999
Q ss_pred cCCCccceEeEEEeCCeeEEEEeeCCCCCHHHh------hhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 015094 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENH------LFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRD 213 (413)
Q Consensus 140 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrD 213 (413)
+||||+++++++.+.+.+|+||||+++++|.++ +... ....+++..++.++.||+.||.|||+ ..||+|||
T Consensus 101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~d 177 (348)
T 2pml_X 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRD 177 (348)
T ss_dssp CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCC
T ss_pred CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecC
Confidence 999999999999999999999999999999998 5321 23578999999999999999999996 25599999
Q ss_pred CCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccC-Cccc-hhhhHHHHHHHHHHHhCCCCCC
Q 015094 214 FKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYV-KSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 214 lkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~~lltG~~pf~ 291 (413)
|||+|||++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|+|++|..||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999863222 34456799999999999877 6766 9999999999999999999998
Q ss_pred CCCCCCcchhhHhhhhh-hh---hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 292 TNRPSGQHNLVDWIKPY-LS---EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 292 ~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
....... ....+... .. ....+...............++.++.+||.+||+.||.+|||+.+++++-
T Consensus 254 ~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 254 LKISLVE--LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSSCSHH--HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCCcHHH--HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 6543210 00000000 00 00000000000000001145678899999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=329.02 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=193.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe---
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE--- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 153 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL-------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred cccchhhheeccCCcEEEEEEEEcC-------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 4679999999999999999997543 5789999998654 3445778899999999999999999998865
Q ss_pred ----------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 154 ----------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 154 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
...+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECT
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcC
Confidence 357899999999999999997543 357888999999999999999997 56999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCC------------cceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCC
Q 015094 224 SYTAKISDFGLAKLGPSASQ------------SHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRAL 290 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf 290 (413)
++.+||+|||++........ ........|++.|+|||++.+. .++.++|||||||++|+|++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999986432110 1122345789999999998764 68999999999999999998 44
Q ss_pred CCCCCCCcchhhHhhhhhhhhhhhhhHhHH--hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 291 DTNRPSGQHNLVDWIKPYLSEKRKFRHIID--ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.... . .......+.. ......++...+..+.+||.+||+.||.+|||+.+++++.
T Consensus 229 ~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 229 STGM-----E----------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp SSHH-----H----------HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred CCch-----h----------HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 3210 0 0000011110 1112234455667899999999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=335.76 Aligned_cols=271 Identities=23% Similarity=0.284 Sum_probs=202.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeC-
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED- 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP-------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC-------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 4689999999999999999997653 67999999986543 33456788999999999999999999987654
Q ss_pred ----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 155 ----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 155 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
...|+||||+. ++|.+++... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEEC
T ss_pred cCccceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEE
Confidence 67999999996 5999988642 68999999999999999999997 569999999999999999999999
Q ss_pred cCCCcccCCCCCCcc--------eeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 231 DFGLAKLGPSASQSH--------VTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 231 DfG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998643221111 1223578999999998754 7789999999999999999999999987542111100
Q ss_pred hHhhhhhh--------hhhhhhhHhHHhhhcC------CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 302 VDWIKPYL--------SEKRKFRHIIDARLQG------QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 302 ~~~~~~~~--------~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
........ .........+...... .....++.++.+||.+||..||++|||+.+++++-+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 00000000 0000001111100000 0112456789999999999999999999999987553
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=336.19 Aligned_cols=257 Identities=23% Similarity=0.288 Sum_probs=178.2
Q ss_pred hcCCCCCC-eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 77 TRNFKSDT-VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 77 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
.++|++.+ +||+|+||+||+|.+.. +++.||||++..... ........++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR-------TGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC-------CCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 46899855 69999999999997654 578999999865421 11222334566789999999999876
Q ss_pred --CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCeE
Q 015094 154 --DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTAK 228 (413)
Q Consensus 154 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~k 228 (413)
+..+|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEE
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEE
Confidence 4568999999999999999975432 368999999999999999999997 56999999999999975 45699
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|+|||++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 172 l~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------ 241 (336)
T 3fhr_A 172 LTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM------ 241 (336)
T ss_dssp ECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred Eeccccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH------
Confidence 999999985332 1223457899999999998899999999999999999999999999765432110000
Q ss_pred hhhhhhhhHhHHh--hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 309 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
...+... .........++.++.+||.+||..||.+|||+.+++++.+.-.
T Consensus 242 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 242 ------KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ------HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0000000 0111112356788999999999999999999999999877543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=334.92 Aligned_cols=246 Identities=25% Similarity=0.424 Sum_probs=195.4
Q ss_pred HHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh------hHHHHHHHHHHHhhc----cCCCc
Q 015094 75 AATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ------GFEEWQSEVNFLGRL----SHPNL 144 (413)
Q Consensus 75 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l----~h~~i 144 (413)
...++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+.+|+.+++++ +|+||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i 100 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT-------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT-------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc-------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence 345789999999999999999996543 6789999998755321 223356799999999 89999
Q ss_pred cceEeEEEeCCeeEEEEee-CCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-
Q 015094 145 VRLLGYCWEDKELLLVYEF-MQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD- 222 (413)
Q Consensus 145 ~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~- 222 (413)
+++++++...+..++|||+ +.+++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDL 174 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEET
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeC
Confidence 9999999999999999999 78999999997643 68999999999999999999997 5699999999999998
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCcc-chhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||++...... ......|+..|+|||++.+..+. .++|||||||++|+|++|..||....
T Consensus 175 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------- 243 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------- 243 (312)
T ss_dssp TTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred CCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------
Confidence 8899999999999864332 22345699999999998777664 58999999999999999999996421
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+.. ....++..++.++.+||.+||..||++|||+.+++++.+
T Consensus 244 ---------------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 244 ---------------EILE--AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp ---------------HHHH--TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred ---------------HHhh--hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0111 112344567788999999999999999999999998644
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.13 Aligned_cols=268 Identities=21% Similarity=0.275 Sum_probs=203.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC------ccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN------LVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~ 150 (413)
.++|++.+.||+|+||+||+|.+... .++.||||++.... ...+.+.+|+.+++.+.|++ ++.++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 46899999999999999999976531 24789999997543 34567888999999998665 8999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---------
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL--------- 221 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~--------- 221 (413)
+...+.+|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccc
Confidence 99999999999999 6678777765432 368999999999999999999996 669999999999999
Q ss_pred ----------cCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCC
Q 015094 222 ----------DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 222 ----------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~ 291 (413)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999863221 234579999999999999999999999999999999999999998
Q ss_pred CCCCCCcchhhHhhh-hh----hhh----------------hhhhhHhHHhh-----hcCCCchHHHHHHHHHHHHcccc
Q 015094 292 TNRPSGQHNLVDWIK-PY----LSE----------------KRKFRHIIDAR-----LQGQYPYKAAYQIAQLSLKCLEA 345 (413)
Q Consensus 292 ~~~~~~~~~~~~~~~-~~----~~~----------------~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~L~~ 345 (413)
............... +. ... ........... .........+.++.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 654321111110000 00 000 00000000000 00112234567899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 015094 346 EPKHRPSMREVVETLE 361 (413)
Q Consensus 346 dp~~Rpt~~e~l~~L~ 361 (413)
||.+|||+.|++++-+
T Consensus 321 dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 321 DPAQRITLAEALLHPF 336 (355)
T ss_dssp STTTSCCHHHHTTSGG
T ss_pred ChhhCcCHHHHhcChh
Confidence 9999999999997654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=335.22 Aligned_cols=264 Identities=24% Similarity=0.314 Sum_probs=199.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|.+.+.||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR-------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC-------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 3679999999999999999997653 6899999998654 233456788999999999999999999999876
Q ss_pred Ce------eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 KE------LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
.. +|+||||+. ++|.+++. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEE
T ss_pred cccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEE
Confidence 54 499999997 58888773 258999999999999999999997 5699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK- 306 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~- 306 (413)
|+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 167 l~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999975322 1234578999999999877 678999999999999999999999998754321111000000
Q ss_pred ----hhhhh--hhhhhHhHHhhh---c---CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 ----PYLSE--KRKFRHIIDARL---Q---GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ----~~~~~--~~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+... .......+.... . ......++.++.+||.+||..||.+|||+.+++++-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 00000 000000111000 0 1122356789999999999999999999999998755
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=336.44 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=202.0
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh------hHHHHHHHHHHHhhcc--CCCccce
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ------GFEEWQSEVNFLGRLS--HPNLVRL 147 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--h~~i~~~ 147 (413)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|+.+++.+. |+||+++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVS-------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETT-------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECC-------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 45789999999999999999997543 6799999998654321 2234678999999996 5999999
Q ss_pred EeEEEeCCeeEEEEeeCCC-CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCC
Q 015094 148 LGYCWEDKELLLVYEFMQK-GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSY 225 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~ 225 (413)
++++..++..++|||++.+ ++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++ .++
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCC
Confidence 9999999999999999976 89999997643 68899999999999999999997 6699999999999998 789
Q ss_pred CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 226 TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 226 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 188 ~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------- 253 (320)
T 3a99_A 188 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------- 253 (320)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred CEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------
Confidence 9999999999864322 2234579999999999877766 688999999999999999999996421
Q ss_pred hhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.+.. ....++..++.++.+||.+||..||.+|||+.+++++.+
T Consensus 254 ------------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 254 ------------EIIR--GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp ------------HHHH--CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ------------hhhc--ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 0000 011233456778999999999999999999999997644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=333.36 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=183.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHH-HHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVN-FLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+..|+. +++.++||||+++++++..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP-------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT-------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HHHhhehheeccCCCEEEEEEEEcC-------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 3689999999999999999997653 67999999987653 233345556665 77888999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhc-CCCCCCCcHHHHHHHHHHHHHHHHHhhcCCC-CeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 155 KELLLVYEFMQKGSLENHLFGR-GASVQPLAWNIRLKIAIGAARGLAFLHTSDK-QVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+..|+||||+.+ +|.+++... ......+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999976 888877531 1123478999999999999999999997 4 6999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCcccc----ccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYV----ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
|++...... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||......... ....
T Consensus 171 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~ 242 (327)
T 3aln_A 171 GISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQV 242 (327)
T ss_dssp SSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCC
T ss_pred CCceecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHHH
Confidence 999753322 122334799999999998 4667899999999999999999999999764321100 0000
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
... ....+.......++..+.+||.+||..||.+|||+.+++++.....
T Consensus 243 ~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 243 VKG-------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCS-------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred hcC-------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 000 0000111112346778999999999999999999999998766543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.09 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=183.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+..+..+++.++||||+++++++.++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK-------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT-------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hccccccceeeecCCeeEEEEEEec-------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 3578999999999999999997654 578999999875532 2223344555678888999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+||||+ ++.+..+..... ..+++..++.++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999 556666554322 3689999999999999999999962 1699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
+...... .......|++.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 172 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------ 236 (318)
T 2dyl_A 172 SGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------------ 236 (318)
T ss_dssp C-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH------------
T ss_pred chhccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH------------
Confidence 9753221 2233457999999999984 5678899999999999999999999997532110
Q ss_pred hhhhhhhHhHHhhhc-CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 310 SEKRKFRHIIDARLQ-GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 310 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+..+...... ......++.++.+||.+||..||.+||++.+++++...
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 237 ---EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp ---HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred ---HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 001111111100 01112467889999999999999999999999987553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.31 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=186.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 156 (413)
+.|.+.+.||+|+||+||.+... +++.||||++.... .+.+.+|+.+|+.+ +||||+++++++.+++.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~--------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF--------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES--------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred heeeccCeEeeCCCeEEEEEEEE--------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 45666789999999999865221 47899999986542 34678899999887 79999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCC---cHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC---------
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPL---AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS--------- 224 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~---~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~--------- 224 (413)
+|+|||||. ++|.+++.......... .+..++.++.||+.||+|||+ .+|+||||||+|||++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCccccccccc
Confidence 999999996 59999997654322211 233457899999999999997 569999999999999654
Q ss_pred ----CCeEEccCCCcccCCCCCCcc--eeecccccccccCcccccc-------CCccchhhhHHHHHHHHHHHh-CCCCC
Q 015094 225 ----YTAKISDFGLAKLGPSASQSH--VTTRVMGTYGYAAPEYVAT-------GHLYVKSDVYGFGVVLVEILT-GLRAL 290 (413)
Q Consensus 225 ----~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~llt-G~~pf 290 (413)
+.+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 489999999998654322111 1234579999999999865 678899999999999999999 99999
Q ss_pred CCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh-----hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 291 DTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR-----LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
....... ..++... .....+..++.++.+||.+||+.||.+|||+.++++|.
T Consensus 241 ~~~~~~~------------------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 241 GDKYSRE------------------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp CSTTTHH------------------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCchhhH------------------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 6542110 0011110 11112346788999999999999999999999999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=314.29 Aligned_cols=234 Identities=13% Similarity=0.093 Sum_probs=185.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTA-------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETT-------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcEEEEEEEcccCCeEEEEEEecC-------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 579999999999999999997653 67999999997653 23456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+..|+||||++|++|.+++... .....+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~~ 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPAT 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCCC
T ss_pred CcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEeccc
Confidence 9999999999999999998431 2445678899999999999997 5699999999999999999999985432
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
++ .++.++|||||||++|+|++|..||............. ........
T Consensus 176 ----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~ 223 (286)
T 3uqc_A 176 ----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQPI 223 (286)
T ss_dssp ----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSCBC
T ss_pred ----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccCCC
Confidence 33 36889999999999999999999998765432110000 00000000
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
. .. .....++.++.+||.+||+.||++| |+.++++.|+.+....
T Consensus 224 ~----~~----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 224 E----PA----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp C----HH----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred C----hh----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 00 0112456789999999999999999 9999999999987654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=335.36 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=184.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
..+|.+.++||+|+||+||.... .+++.||||++...... .+.+|+.+|+.+ +||||+++++++.+..
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~--------~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM--------FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE--------SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred cEEEecCCeeecCcCEEEEEEEE--------eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 34688999999999999654321 14688999998765432 356899999999 7999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---C--CCeEEc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---S--YTAKIS 230 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~--~~~kl~ 230 (413)
.+|+|||||. ++|.+++..... .+....++.++.||+.||.|||+ .+|+||||||+|||++. + ..+||+
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred EEEEEEECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 9999999996 599999975542 23334557899999999999997 56999999999999943 2 357899
Q ss_pred cCCCcccCCCCCCc-ceeecccccccccCccccc---cCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 015094 231 DFGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 231 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~ 305 (413)
|||++......... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||.......
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------- 237 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------- 237 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------
Confidence 99999864322211 2234467999999999987 4567789999999999999999 899986432110
Q ss_pred hhhhhhhhhhhHhHHhh--hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 306 KPYLSEKRKFRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
........ .........+..+.+||.+||+.||.+|||+.++++|
T Consensus 238 ---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 238 ---------ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ---------HHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---------HHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00000000 0011223556778999999999999999999999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=346.81 Aligned_cols=271 Identities=24% Similarity=0.326 Sum_probs=203.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
.++|++.+.||+|+||.||+|.+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~-------~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ-------DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT-------TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 368999999999999999999543 36789999998764 33456678999999999999999999998765
Q ss_pred ----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC---
Q 015094 154 ----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT--- 226 (413)
Q Consensus 154 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~--- 226 (413)
++..|+||||+.|++|.+++..... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCcee
Confidence 6778999999999999999976432 2358888999999999999999997 56999999999999987765
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|..
T Consensus 163 vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~ 234 (676)
T 3qa8_A 163 HKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHG 234 (676)
T ss_dssp EEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSST
T ss_pred EEEcccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhh
Confidence 899999999864322 2234467999999999999999999999999999999999999999754211 00000
Q ss_pred hhhhh-----------hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHHh
Q 015094 307 PYLSE-----------KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE-----VVETLERLQA 365 (413)
Q Consensus 307 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e-----~l~~L~~i~~ 365 (413)
..... ...............+...++..+.+||.+||..||++|||+.+ +++.+..+..
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000 00000000000112244568899999999999999999999988 4556666554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.94 Aligned_cols=234 Identities=24% Similarity=0.333 Sum_probs=183.8
Q ss_pred hcCCCCC-CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHH-hhccCCCccceEeEEEe-
Q 015094 77 TRNFKSD-TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFL-GRLSHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~- 153 (413)
.++|.+. +.||+|+||.||+|.+.. +++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKR-------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcC-------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 3567777 789999999999997653 5789999998643 3567888888 55689999999999887
Q ss_pred ---CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCe
Q 015094 154 ---DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTA 227 (413)
Q Consensus 154 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~ 227 (413)
...+|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCE
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcE
Confidence 6789999999999999999976432 368999999999999999999997 56999999999999987 7899
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||+|||++... .+..++.++|||||||++|+|++|..||............. .
T Consensus 160 kl~Dfg~a~~~------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--~- 212 (299)
T 3m2w_A 160 KLTDFGFAKET------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--T- 212 (299)
T ss_dssp EECCCTTCEEC------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC--C-
T ss_pred EEecccccccc------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH--H-
Confidence 99999998641 13567889999999999999999999997653321100000 0
Q ss_pred hhhhhhhhhHhHHhhhcCCCc----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.+.. ....++ ..++.++.+||.+||+.||.+|||+.|++++.+-..
T Consensus 213 ---------~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 213 ---------RIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp ---------SSCT--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ---------HHhh--ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 0000 000111 245678999999999999999999999999877544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=348.12 Aligned_cols=242 Identities=21% Similarity=0.343 Sum_probs=193.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|++... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 36899999999999999999976531 4689999988654 3344567889999999999999999999998776
Q ss_pred e-----eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 156 E-----LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 156 ~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
. .||||||++|++|.+++.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEEC
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEEE
Confidence 5 7999999999999987632 68999999999999999999997 569999999999999875 99999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.........
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------- 285 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------- 285 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-----------
Confidence 99999864322 345799999999988665 488999999999999999999888653211100
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-MREVVETLERLQ 364 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-~~e~l~~L~~i~ 364 (413)
........+..+.+||.+||+.||.+||+ ++++...|..+.
T Consensus 286 -------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 -------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00001133467899999999999999995 566666666543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=326.20 Aligned_cols=244 Identities=18% Similarity=0.164 Sum_probs=183.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHHHHHHHHHHHhhccC-CCc---------
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNFLGRLSH-PNL--------- 144 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-~~i--------- 144 (413)
..|+..++||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+.+++.+.| .|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE-------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred eeEEEecccccCCCEEEEEEEecC-------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 357788899999999999997654 678999999874322 335778999999999987 221
Q ss_pred cceE------------eEEEe-----CCeeEEEEeeCCCCCHHHhhhhc---CCCCCCCcHHHHHHHHHHHHHHHHHhhc
Q 015094 145 VRLL------------GYCWE-----DKELLLVYEFMQKGSLENHLFGR---GASVQPLAWNIRLKIAIGAARGLAFLHT 204 (413)
Q Consensus 145 ~~~~------------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 204 (413)
+... .++.. ...++++|+++ +++|.+++... ......+++..++.++.||+.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1111 11111 22467888876 67999888421 2233468888999999999999999997
Q ss_pred CCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCcccc----------ccCCccchhhhH
Q 015094 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV----------ATGHLYVKSDVY 274 (413)
Q Consensus 205 ~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diw 274 (413)
++|+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++ .+..++.++|||
T Consensus 230 --~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 230 --YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp --TTEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred --CCcccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 6699999999999999999999999999875321 2444578 999999999 556788999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH
Q 015094 275 GFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354 (413)
Q Consensus 275 slG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 354 (413)
||||++|+|++|..||......... ..+ +.. ...++.++.+||.+||..||++||++.
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~~----------------~~~----~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGGS----------------EWI----FRS--CKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSCS----------------GGG----GSS--CCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhH----------------HHH----Hhh--cccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999999999999999765322111 001 110 113457899999999999999999998
Q ss_pred HHHHH
Q 015094 355 EVVET 359 (413)
Q Consensus 355 e~l~~ 359 (413)
+++++
T Consensus 360 ~~l~~ 364 (413)
T 3dzo_A 360 QAMET 364 (413)
T ss_dssp HHTTS
T ss_pred HHHhC
Confidence 88765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=317.89 Aligned_cols=239 Identities=18% Similarity=0.199 Sum_probs=184.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--------hhhHHHHHHHHHHHhhcc--------
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--------LQGFEEWQSEVNFLGRLS-------- 140 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~-------- 140 (413)
.++|++.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA---------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE---------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred cccchheeeecccCceEEEEEEe---------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence 46799999999999999999965 35899999987542 223477889999999986
Q ss_pred -CCCccceEeEEE------------------------------eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHH
Q 015094 141 -HPNLVRLLGYCW------------------------------EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL 189 (413)
Q Consensus 141 -h~~i~~~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 189 (413)
||||+++.+++. ..+.+|+||||+.+|++.+.+.+ ..+++..++
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~ 164 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAK 164 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHH
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHH
Confidence 777777776543 26789999999999977776632 367999999
Q ss_pred HHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEEcCCC--------------------CeEEccCCCcccCCCCCCcceee
Q 015094 190 KIAIGAARGLAFLH-TSDKQVIYRDFKASNILLDGSY--------------------TAKISDFGLAKLGPSASQSHVTT 248 (413)
Q Consensus 190 ~i~~qi~~~l~~lH-~~~~~ivHrDlkp~Nil~~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~ 248 (413)
.++.||+.||.||| + ++|+||||||+|||++.++ .+||+|||+++.... .
T Consensus 165 ~i~~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~ 235 (336)
T 2vuw_A 165 SILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred HHHHHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence 99999999999999 7 5599999999999999887 899999999986332 1
Q ss_pred cccccccccCccccccCCccchhhhHHHHHH-HHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhh-h---
Q 015094 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVV-LVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR-L--- 323 (413)
Q Consensus 249 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 323 (413)
..+||+.|+|||++.+.. +.++||||||++ .++++.|..||... .|... ....+.... .
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~------~~~~~~~~~~~~~~ 299 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHY------LTDKMLKQMTFKTK 299 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHH------HHHHHHHTCCCSSC
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhH------HHHhhhhhhccCcc
Confidence 347999999999998766 899999998777 77788898887421 00000 000111100 0
Q ss_pred -cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHH-HH
Q 015094 324 -QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV-ET 359 (413)
Q Consensus 324 -~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l-~~ 359 (413)
....+..++.++.+||.+||+.| |+.|++ +|
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 01123467889999999999987 999998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=288.41 Aligned_cols=169 Identities=18% Similarity=0.118 Sum_probs=125.7
Q ss_pred CCeEEEEEecCCcC----------hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcC
Q 015094 109 SGTVIAVKKLNSES----------LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG 177 (413)
Q Consensus 109 ~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 177 (413)
.++.|++|++.... ....+++.+|+++|+++ .|+||+++++++++++.+||||||++|++|.++|...+
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~ 337 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE 337 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence 46789999986542 12345689999999999 59999999999999999999999999999999997654
Q ss_pred CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeeccccccccc
Q 015094 178 ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257 (413)
Q Consensus 178 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~ 257 (413)
+++.. .|+.||+.||+|+|+ +|||||||||+|||++.+|.+||+|||+|+..... .......+||+.||
T Consensus 338 ----~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp~Ym 406 (569)
T 4azs_A 338 ----EIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPTNLVQSFFVF 406 (569)
T ss_dssp ----CCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHH
T ss_pred ----CCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCCC--CccccCceechhhc
Confidence 55543 588999999999997 66999999999999999999999999999864322 22334578999999
Q ss_pred CccccccCCccchhhhHHHHHHHHHHHhCCCC
Q 015094 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRA 289 (413)
Q Consensus 258 aPE~~~~~~~~~~~DiwslG~il~~lltG~~p 289 (413)
|||++.+ .+..++|+|++|+++++|.++..+
T Consensus 407 APE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 407 VNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHC------------------CCCCTTHHH
T ss_pred cHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9998865 467789999999998888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=253.21 Aligned_cols=185 Identities=15% Similarity=0.139 Sum_probs=141.3
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--------hhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--------QGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
...++||+|+||.||+|.+ .++.+++|+...... ...+.+.+|+++|++++||||+++..++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY---------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV 409 (540)
T ss_dssp ---------CCEEEEEEEC---------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE
T ss_pred CCCCEEeeCCCEEEEEEEE---------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE
Confidence 4467899999999999943 256788887543221 12345789999999999999996666666
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
..+..|+||||++|++|.+++.. +..++.||+.+|.|||+ ++|+||||||+|||++. .+||+||
T Consensus 410 ~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 410 DLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp ETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCC
T ss_pred eCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEEC
Confidence 77888999999999999999853 46899999999999997 66999999999999998 9999999
Q ss_pred CCcccCCCCCCcc-----eeecccccccccCcccccc--CCccchhhhHHHHHHHHHHHhCCCCC
Q 015094 233 GLAKLGPSASQSH-----VTTRVMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLVEILTGLRAL 290 (413)
Q Consensus 233 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltG~~pf 290 (413)
|+++......... ......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9998743321111 1235689999999999976 67888899999999888887776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=210.74 Aligned_cols=147 Identities=14% Similarity=0.054 Sum_probs=116.6
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh------------------hhHHHHHHHHHHHh
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL------------------QGFEEWQSEVNFLG 137 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~ 137 (413)
....|.+.+.||+|+||.||+|.+ . +++.||||++..... .....+.+|+.+|+
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~-------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~ 159 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-E-------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 159 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-T-------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEecCEeccCCCceEEEEEe-C-------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence 345667779999999999999976 2 578999999864321 13456889999999
Q ss_pred hccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 015094 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKAS 217 (413)
Q Consensus 138 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~ 217 (413)
.++ | +++.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||+ .||+||||||+
T Consensus 160 ~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~ 222 (282)
T 1zar_A 160 KLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQY 222 (282)
T ss_dssp HTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTT
T ss_pred hcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHH
Confidence 999 4 666665543 56799999999999998 411 1234699999999999997 66999999999
Q ss_pred cEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccc
Q 015094 218 NILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263 (413)
Q Consensus 218 Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 263 (413)
|||++ ++.+||+|||++.. +..++|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999 99999999999973 34578999774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=178.53 Aligned_cols=136 Identities=20% Similarity=0.113 Sum_probs=104.3
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeE--EEEEecCCcChh------------------------hHHHHHHHH
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTV--IAVKKLNSESLQ------------------------GFEEWQSEV 133 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~~E~ 133 (413)
|.+.+.||+|+||.||+|.+.. +++. ||||++...... ....+.+|+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~-------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 121 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF-------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF 121 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE-------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC-------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence 6788999999999999997632 4678 999986543111 113578899
Q ss_pred HHHhhccCCCc--cceEeEEEeCCeeEEEEeeCCC-C----CHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhh-cC
Q 015094 134 NFLGRLSHPNL--VRLLGYCWEDKELLLVYEFMQK-G----SLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH-TS 205 (413)
Q Consensus 134 ~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~ 205 (413)
.+|+.|.|++| +.+++. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +
T Consensus 122 ~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~- 189 (258)
T 1zth_A 122 RNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE- 189 (258)
T ss_dssp HHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-
Confidence 99999998864 444442 367899999942 3 66665421 223456789999999999999 7
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 206 ~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
.||+||||||+|||++. .++|+|||+|..
T Consensus 190 -~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 190 -AELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp -SCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred -CCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 56999999999999988 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=164.02 Aligned_cols=136 Identities=13% Similarity=0.053 Sum_probs=98.5
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh--------------hH--------HHHHHHHHHHh
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ--------------GF--------EEWQSEVNFLG 137 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~~--------~~~~~E~~~l~ 137 (413)
|.+.+.||+|+||.||+|... .++.||||+++..... .. -...+|...|.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~--------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE--------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT--------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC--------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 899999999999999999643 4789999987532100 00 11245777888
Q ss_pred hccCCCccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 015094 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKAS 217 (413)
Q Consensus 138 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~ 217 (413)
+|.+.++.-..-+... ..+|||||++|.+|.++.. .. ....++.||+.+|.+||. .|||||||||.
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~~--~~~~l~~qll~~l~~lH~--~gIVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------VP--DPASLYADLIALILRLAK--HGLIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------CS--CHHHHHHHHHHHHHHHHH--TTEECSCCSTT
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc--------cH--HHHHHHHHHHHHHHHHHH--CCCcCCCCCHH
Confidence 8865554322222222 3479999999988876541 11 235688999999999997 56999999999
Q ss_pred cEEEcCCCC----------eEEccCCCccc
Q 015094 218 NILLDGSYT----------AKISDFGLAKL 237 (413)
Q Consensus 218 Nil~~~~~~----------~kl~DfG~a~~ 237 (413)
|||++++|. +.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999987763 89999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-13 Score=125.82 Aligned_cols=145 Identities=14% Similarity=0.044 Sum_probs=112.5
Q ss_pred HHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEE
Q 015094 74 RAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCW 152 (413)
Q Consensus 74 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 152 (413)
......|++...++.|+.+.||++.. .++.+++|+...........+.+|+.+++.|. +..++++++++.
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~---------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~ 80 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG---------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC---------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC---------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence 34456798888999999999999842 24689999986532122345889999999995 677889999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC--------------------------
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD-------------------------- 206 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------------------------- 206 (413)
..+..|+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred cCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 88999999999999999876411 1112467788899999999711
Q ss_pred -------------------------------CCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 207 -------------------------------KQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 207 -------------------------------~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876666799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=4.5e-12 Score=114.57 Aligned_cols=134 Identities=21% Similarity=0.077 Sum_probs=96.6
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC--ccceEeEEEeCCee
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN--LVRLLGYCWEDKEL 157 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~ 157 (413)
|.+..+.+.|..+.||++... +++.+++|+..... ...+.+|+.+++.+.+.+ +.+++++...++..
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~--------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQ--------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECT--------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred CceEecccCCCCceEEEEecC--------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 444333345666899998422 35679999876542 245778999999997544 56789888888889
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC-------------------------------
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD------------------------------- 206 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~------------------------------- 206 (413)
++||||++|.+|. .. .... ..++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~-------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS-------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp EEEEECCSSEETT--TS-------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred EEEEEecCCcccC--cC-------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 9999999998884 21 1111 246667777777777532
Q ss_pred -------------------------CCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 207 -------------------------KQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 207 -------------------------~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
..++|+|++|.|||+++++.+.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877667799999986
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.5e-11 Score=115.36 Aligned_cols=141 Identities=16% Similarity=0.235 Sum_probs=104.7
Q ss_pred CCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecC--CcC-hhhHHHHHHHHHHHhhcc--CCCccceEeEEEeC--
Q 015094 82 SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN--SES-LQGFEEWQSEVNFLGRLS--HPNLVRLLGYCWED-- 154 (413)
Q Consensus 82 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~-- 154 (413)
.++.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+++.|. +..+++++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~---------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~ 112 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP---------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV 112 (359)
T ss_dssp EEEECCC-CCSCEEEEECS---------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred eEEEcCCcccceEEEEEEC---------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence 3567899999999998532 3568888876 332 122346788999999997 45588899887766
Q ss_pred -CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 015094 155 -KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS---------------------------- 205 (413)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------------------------- 205 (413)
+..|+||||++|..+.+.. ...++......++.++++.|..||+.
T Consensus 113 ~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp TSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 4589999999998775422 12466777788999999999999962
Q ss_pred ----------------------------CCCeeeCCCCCCcEEEcCCCC--eEEccCCCccc
Q 015094 206 ----------------------------DKQVIYRDFKASNILLDGSYT--AKISDFGLAKL 237 (413)
Q Consensus 206 ----------------------------~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~a~~ 237 (413)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987653 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=114.69 Aligned_cols=182 Identities=19% Similarity=0.175 Sum_probs=118.5
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCC--ccceEeEEEeCC---e
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN--LVRLLGYCWEDK---E 156 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~--i~~~~~~~~~~~---~ 156 (413)
++.++.|....||++ +..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... .
T Consensus 25 i~~~~~G~~n~v~~v------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~ 90 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM 90 (304)
T ss_dssp CCEEEECSSEEEEES------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred eEecCCCCcceEEEE------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence 567999999999986 145888986543 34567889999999884 333 445555433332 3
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------------------------------- 205 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------------------------------- 205 (413)
.|+|||+++|.+|.+... ..++......++.+++..|..||+.
T Consensus 91 ~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE 164 (304)
T ss_dssp SCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred ceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence 589999999988865331 1345556666777777777777741
Q ss_pred -------------------------CCCeeeCCCCCCcEEEcC--CCCeEEccCCCcccCCCCCCcceeecccccccc--
Q 015094 206 -------------------------DKQVIYRDFKASNILLDG--SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY-- 256 (413)
Q Consensus 206 -------------------------~~~ivHrDlkp~Nil~~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y-- 256 (413)
...++|+|++|.||++++ ++.+.|+||+.+........-. ....+
T Consensus 165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~ 238 (304)
T 3sg8_A 165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDE 238 (304)
T ss_dssp SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTT
T ss_pred CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhcc
Confidence 124799999999999988 5568899999987532211100 00000
Q ss_pred -cCcccccc--------------CCccchhhhHHHHHHHHHHHhCCCCC
Q 015094 257 -AAPEYVAT--------------GHLYVKSDVYGFGVVLVEILTGLRAL 290 (413)
Q Consensus 257 -~aPE~~~~--------------~~~~~~~DiwslG~il~~lltG~~pf 290 (413)
..|+.... .......+.|++|.++|.+.+|..+|
T Consensus 239 ~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 239 EYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12221100 01122368999999999999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=2.9e-08 Score=90.05 Aligned_cols=135 Identities=16% Similarity=0.097 Sum_probs=93.7
Q ss_pred eeeecCCc-eEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEEe
Q 015094 85 VLGEGGFG-KVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 85 ~lg~G~~g-~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 162 (413)
.+..|..+ .||+.... ..+..+++|+.... ....+.+|..+|+.|. +--+.+++.++.+++..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~-------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK-------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECC-------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred EccCCCcCCeEEEEEec-------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 45556555 68986422 23556888976543 3456788999999886 3347889999999999999999
Q ss_pred eCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 015094 163 FMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------------------------------------- 205 (413)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------------------------------------- 205 (413)
+++|.++.+..... ......++.++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp CCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred eeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 99998887655221 111223445555555555521
Q ss_pred -------------------CCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 206 -------------------DKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 206 -------------------~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11268999999999999887778999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=4.2e-08 Score=90.82 Aligned_cols=135 Identities=21% Similarity=0.158 Sum_probs=90.6
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCC---CccceEeEEE-eCCeeE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHP---NLVRLLGYCW-EDKELL 158 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~ 158 (413)
++.++.|....||+. +..+++|+... ......+.+|+.+|+.|.+. .+.+++.+.. ..+..|
T Consensus 24 v~~l~~G~~n~v~~v------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~ 89 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF 89 (306)
T ss_dssp EEEEEECSSEEEEEE------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred eeecCCCcceeEEEE------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence 456888888899986 24578888532 23456788999999999742 3667777664 345678
Q ss_pred EEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 015094 159 LVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT---------------------------------- 204 (413)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------- 204 (413)
+||||++|..|.+.... .++......++.++...|..||+
T Consensus 90 ~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp EEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred EEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 99999999888653210 12233333333444444443332
Q ss_pred ------------------------CCCCeeeCCCCCCcEEEcC---CCC-eEEccCCCccc
Q 015094 205 ------------------------SDKQVIYRDFKASNILLDG---SYT-AKISDFGLAKL 237 (413)
Q Consensus 205 ------------------------~~~~ivHrDlkp~Nil~~~---~~~-~kl~DfG~a~~ 237 (413)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=2e-07 Score=88.07 Aligned_cols=86 Identities=2% Similarity=-0.083 Sum_probs=54.9
Q ss_pred Cee-eecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhcc-C--CCccceEeEEEeC--
Q 015094 84 TVL-GEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLS-H--PNLVRLLGYCWED-- 154 (413)
Q Consensus 84 ~~l-g~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~-- 154 (413)
+.| +.|....+|+....... .....++.+++|+..... ......+.+|+.+|+.|. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~-~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQ-DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEE-TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EECCCCCccceEEEEEEeccc-CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 567 77888899987432000 000014678899865432 101245678999999886 3 3577888876655
Q ss_pred -CeeEEEEeeCCCCCHH
Q 015094 155 -KELLLVYEFMQKGSLE 170 (413)
Q Consensus 155 -~~~~lv~e~~~~~~L~ 170 (413)
+..|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3578999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=9.4e-07 Score=84.82 Aligned_cols=76 Identities=17% Similarity=0.179 Sum_probs=49.8
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-------hhHHHHHHHHHHHhhccC--C-CccceEeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-------QGFEEWQSEVNFLGRLSH--P-NLVRLLGYCW 152 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-~i~~~~~~~~ 152 (413)
.+.||.|.++.||++.... .++.|+||....... ...+.+..|.++|+.+.. + .+.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~-------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-- 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE-------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-- 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred EEECCCCceEEEEEEEECC-------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--
Confidence 4578999999999985432 356799997543211 123456789999988852 3 34566643
Q ss_pred eCCeeEEEEeeCCCC
Q 015094 153 EDKELLLVYEFMQKG 167 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~ 167 (413)
+....++|||++.|.
T Consensus 106 d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 DTEMAVTVMEDLSHL 120 (397)
T ss_dssp ETTTTEEEECCCTTS
T ss_pred cCCccEEEEEeCCCc
Confidence 455678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.37 E-value=4.6e-06 Score=78.01 Aligned_cols=141 Identities=15% Similarity=0.172 Sum_probs=78.8
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC--CCccceEe------EEEeCC
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH--PNLVRLLG------YCWEDK 155 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~------~~~~~~ 155 (413)
+.|+.|..+.||++... +..+++|+..... ..+..|+.+++.|.. -.+++++. +....+
T Consensus 38 ~~l~gG~~n~~~~v~~~---------~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~ 104 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD---------SGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGS 104 (346)
T ss_dssp EECC----CEEEEEEET---------TEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETT
T ss_pred eeccccccCcEEEEEeC---------CCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECC
Confidence 34655778899998532 2458899887531 334456666666641 12344443 223467
Q ss_pred eeEEEEeeCCCCCHH-----------H---hhhhcCC-C--C--C-----CCcHHH------------------------
Q 015094 156 ELLLVYEFMQKGSLE-----------N---HLFGRGA-S--V--Q-----PLAWNI------------------------ 187 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~-----------~---~l~~~~~-~--~--~-----~~~~~~------------------------ 187 (413)
..++||||++|..+. . .++.... . . . ...+..
T Consensus 105 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 184 (346)
T 2q83_A 105 FLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPF 184 (346)
T ss_dssp EEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHH
T ss_pred EEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcH
Confidence 789999999986542 0 1111000 0 0 0 001100
Q ss_pred -------HHHHHHHHHHHHHHhhc-----------CCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 188 -------RLKIAIGAARGLAFLHT-----------SDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 188 -------~~~i~~qi~~~l~~lH~-----------~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
...+..++..++.+|+. ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 185 SQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223345555542 246799999999999998788999999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.13 E-value=2.2e-05 Score=72.47 Aligned_cols=75 Identities=16% Similarity=0.095 Sum_probs=58.9
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc---CCCccceEeEEEeCCeeEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS---HPNLVRLLGYCWEDKELLL 159 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~l 159 (413)
.+.|+.|....+|+... .+..+++|+.... ....+..|+..|+.|. ...+++++.+....+..|+
T Consensus 41 ~~~l~gG~~n~~y~v~~---------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l 108 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND---------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL 108 (312)
T ss_dssp EEEECCSSSSEEEEEES---------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred eEEeCCccceeeeEEEE---------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence 35689999999999742 2467888987543 2456788999999885 2568899998888889999
Q ss_pred EEeeCCCCCH
Q 015094 160 VYEFMQKGSL 169 (413)
Q Consensus 160 v~e~~~~~~L 169 (413)
||||++|..+
T Consensus 109 vme~l~G~~~ 118 (312)
T 3jr1_A 109 LLEALNKSKN 118 (312)
T ss_dssp EEECCCCCCC
T ss_pred EEEeccCCCC
Confidence 9999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.2e-05 Score=74.66 Aligned_cols=77 Identities=13% Similarity=0.129 Sum_probs=47.3
Q ss_pred CCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccc--cccccCccccccC---CccchhhhHHHHHHH
Q 015094 206 DKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG--TYGYAAPEYVATG---HLYVKSDVYGFGVVL 280 (413)
Q Consensus 206 ~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DiwslG~il 280 (413)
...++|+|++|.|||++.++ ++|+||+.+..+.....- ..... ...|.+|+..... .-....++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 46799999999999998776 999999998753211110 00111 1345666544211 122345556777777
Q ss_pred HHHHhC
Q 015094 281 VEILTG 286 (413)
Q Consensus 281 ~~lltG 286 (413)
|+.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.98 E-value=2.2e-05 Score=72.78 Aligned_cols=157 Identities=14% Similarity=0.097 Sum_probs=84.9
Q ss_pred cHHHHHHHhcCCCCC-----CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC
Q 015094 69 TFVELRAATRNFKSD-----TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN 143 (413)
Q Consensus 69 ~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 143 (413)
+..++.....+|.+. +.|+.|....||+.... +..+++|+..... ..+.+..|+.+++.|...+
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~---------~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g 76 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT---------KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKG 76 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES---------SCCEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC---------CccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCC
Confidence 345555666667763 34566777889997532 2358899887531 1234567888888775222
Q ss_pred --ccceEe------EEEeCCeeEEEEeeCCCCCHHH--------------hhhhcC-CCCCC----Cc---HHHHHH---
Q 015094 144 --LVRLLG------YCWEDKELLLVYEFMQKGSLEN--------------HLFGRG-ASVQP----LA---WNIRLK--- 190 (413)
Q Consensus 144 --i~~~~~------~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~-~~~~~----~~---~~~~~~--- 190 (413)
+.+++. +....+..++||+|++|..+.. .++... ....+ .. +.....
T Consensus 77 ~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~ 156 (322)
T 2ppq_A 77 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE 156 (322)
T ss_dssp CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred CCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHH
Confidence 333332 1223466799999999865421 011110 00000 01 111000
Q ss_pred ---------HHHHHHHHHHHhhc-----CCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 191 ---------IAIGAARGLAFLHT-----SDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 191 ---------i~~qi~~~l~~lH~-----~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+...+...++.++. ...+++|+|+++.|||+++++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 157 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00012333444431 13569999999999999987666899998876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=5.8e-05 Score=71.54 Aligned_cols=150 Identities=15% Similarity=0.147 Sum_probs=85.1
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 161 (413)
++.|..|-...+|++............++.|++|+.... ......+.+|..+++.|. +.-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 456777888889998653211111223578999986432 223456678999999886 4344677766543 2999
Q ss_pred eeCCCCCHHHh--------------h---hhcC-CCCCCC--cHHHHHHHHHHHHH-------------------HHHHh
Q 015094 162 EFMQKGSLENH--------------L---FGRG-ASVQPL--AWNIRLKIAIGAAR-------------------GLAFL 202 (413)
Q Consensus 162 e~~~~~~L~~~--------------l---~~~~-~~~~~~--~~~~~~~i~~qi~~-------------------~l~~l 202 (413)
||++|..|..- + +... ...... -+.++..+..++-. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665311 1 1110 011111 23444545443321 12222
Q ss_pred ----hc--CCCCeeeCCCCCCcEEEcCC----CCeEEccCCCccc
Q 015094 203 ----HT--SDKQVIYRDFKASNILLDGS----YTAKISDFGLAKL 237 (413)
Q Consensus 203 ----H~--~~~~ivHrDlkp~Nil~~~~----~~~kl~DfG~a~~ 237 (413)
.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 22458999999999999876 7899999988763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=4.2e-05 Score=69.78 Aligned_cols=80 Identities=18% Similarity=0.199 Sum_probs=56.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC---CCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH---PNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~~ 154 (413)
.+..-++.+|.|..+.||+.... +|+.|++|+...........+..|+..|+.|.- --+++++.+ .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~--------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA--------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET--------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-
T ss_pred CCeEEEEecCCCCCeEEEEEEEC--------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c-
Confidence 44555778999999999998654 478899998765443333457889999998852 235566554 2
Q ss_pred CeeEEEEeeCCCCCH
Q 015094 155 KELLLVYEFMQKGSL 169 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L 169 (413)
.-++||||+.++..
T Consensus 84 -~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 -DRTLAMEWVDERPP 97 (288)
T ss_dssp -TTEEEEECCCCCCC
T ss_pred -CceEEEEeecccCC
Confidence 34789999987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.84 E-value=8e-05 Score=72.02 Aligned_cols=81 Identities=15% Similarity=0.072 Sum_probs=51.0
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC-ccceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-LVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 161 (413)
++.|+.|-...||++............++.|++|+..... ..+.+.+|+.+++.|...+ .+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567778888999986532111111234678999884421 1145567999999886333 4677765532 3899
Q ss_pred eeCCCCCH
Q 015094 162 EFMQKGSL 169 (413)
Q Consensus 162 e~~~~~~L 169 (413)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.80 E-value=9.1e-05 Score=67.98 Aligned_cols=71 Identities=8% Similarity=0.086 Sum_probs=45.9
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCc-cceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL-VRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 161 (413)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .+++.+ +.+.-++|+
T Consensus 23 i~~l~gG~tN~~~~~-------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE-------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEE
T ss_pred eeEcCCcccccccee-------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEE
Confidence 678988999999997 23788887654221 1123568888888863333 466553 344457899
Q ss_pred eeC-CCCCH
Q 015094 162 EFM-QKGSL 169 (413)
Q Consensus 162 e~~-~~~~L 169 (413)
||+ +|.+|
T Consensus 87 e~i~~g~~l 95 (301)
T 3dxq_A 87 RYIAGAQTM 95 (301)
T ss_dssp ECCTTCEEC
T ss_pred eecCCCccC
Confidence 999 66554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00019 Score=61.55 Aligned_cols=141 Identities=14% Similarity=0.024 Sum_probs=91.6
Q ss_pred CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCCCCcce
Q 015094 167 GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHV 246 (413)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~ 246 (413)
.+|.++|...+ .++++.++|.++.|.+..|.-+-. ++.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 37899997665 499999999999999999877621 01112344567999999999998764 1111
Q ss_pred eecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCC
Q 015094 247 TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQ 326 (413)
Q Consensus 247 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (413)
.....+.+||.. ....+.+.=|||||++||..+--..| ..
T Consensus 98 ----~~~~~~~~pe~~-~~~~te~~~IysLG~tLY~ALDygL~-----------------------------------e~ 137 (229)
T 2yle_A 98 ----AGEPPPVAGKLG-YSQCMETEVIESLGIIIYKALDYGLK-----------------------------------EN 137 (229)
T ss_dssp -------------CCS-SSSSCHHHHHHHHHHHHHHHHTTTCC-----------------------------------TT
T ss_pred ----ccccCCCChhhc-cccchHHHHHHHHHHHHHHHhhcCCC-----------------------------------cc
Confidence 122346788865 34556788999999999998753221 11
Q ss_pred CchHHHHHHHHHHHHcccc-------------------------CCCCCCCHHHHHHHHHH
Q 015094 327 YPYKAAYQIAQLSLKCLEA-------------------------EPKHRPSMREVVETLER 362 (413)
Q Consensus 327 ~~~~~~~~l~~li~~~L~~-------------------------dp~~Rpt~~e~l~~L~~ 362 (413)
.+..++++|.+||..|... .+..|+++++|++....
T Consensus 138 eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 138 EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 1234566777888887655 24678899999876654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00017 Score=67.14 Aligned_cols=33 Identities=39% Similarity=0.483 Sum_probs=28.2
Q ss_pred CCCeeeCCCCCCcEEEcCC----CCeEEccCCCcccC
Q 015094 206 DKQVIYRDFKASNILLDGS----YTAKISDFGLAKLG 238 (413)
Q Consensus 206 ~~~ivHrDlkp~Nil~~~~----~~~kl~DfG~a~~~ 238 (413)
...++|+|+.+.|||++.+ +.+.|+||+.+..+
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3569999999999999874 68899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00018 Score=69.96 Aligned_cols=74 Identities=12% Similarity=0.059 Sum_probs=46.6
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCc-cceEeEEEeCCeeEEEEe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL-VRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 162 (413)
+.|+.|-...+|++.... .+..+++|+......... ...+|+.+++.|...++ +++++.+. + .+|||
T Consensus 114 ~~lsgG~tN~~y~v~~~~-------~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e 181 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-------KQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEE 181 (458)
T ss_dssp EEECC--CEEEEEEEETT-------TTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred EEcCCCeEeEEEEEEECC-------CCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence 467778788999985431 246788998754321111 12579999999974444 67777662 2 35999
Q ss_pred eCCCCCH
Q 015094 163 FMQKGSL 169 (413)
Q Consensus 163 ~~~~~~L 169 (413)
|++|.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9988554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00074 Score=62.52 Aligned_cols=142 Identities=15% Similarity=0.058 Sum_probs=79.9
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC--ccceEeE-----EEeCCe
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN--LVRLLGY-----CWEDKE 156 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~-----~~~~~~ 156 (413)
+.|+ |....||++... .++.+++|+...... ..+.+..|+.+++.|.... +++++.. ...++.
T Consensus 32 ~~l~-g~~n~~y~v~~~--------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~ 101 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE--------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF 101 (328)
T ss_dssp EEEC-CSSSEEEEECCT--------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred Eeec-CcccceEEEEcC--------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCE
Confidence 4566 778899987321 245689999864321 2346677888888885222 3444432 223456
Q ss_pred eEEEEeeCCCCCHH-----H------h---hhhc----CC-CCCCCcHHH----------------------HHHHHHHH
Q 015094 157 LLLVYEFMQKGSLE-----N------H---LFGR----GA-SVQPLAWNI----------------------RLKIAIGA 195 (413)
Q Consensus 157 ~~lv~e~~~~~~L~-----~------~---l~~~----~~-~~~~~~~~~----------------------~~~i~~qi 195 (413)
.++||++++|..+. . . ++.. .. ......... ....+..+
T Consensus 102 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 181 (328)
T 1zyl_A 102 YFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDEL 181 (328)
T ss_dssp EEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHH
T ss_pred EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHH
Confidence 78999999885432 1 0 1110 00 000111110 01122222
Q ss_pred HHHHHHhh--cCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 196 ARGLAFLH--TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 196 ~~~l~~lH--~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
+..+.-+- .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 182 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 182 IAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22222211 1235689999999999998 4 899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00094 Score=63.02 Aligned_cols=82 Identities=15% Similarity=0.060 Sum_probs=45.9
Q ss_pred CCeeeecCCceEEEEEecCCC-CCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC-ccceEeEEEeCCeeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKA-PGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-LVRLLGYCWEDKELLLV 160 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 160 (413)
.+.|+.|....+|++...... ......+..+++|+...... .......|..+++.|...+ +.++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 346777888899998543100 00001235788998765322 1122467888888886333 45777544 2 3789
Q ss_pred EeeCCCCCH
Q 015094 161 YEFMQKGSL 169 (413)
Q Consensus 161 ~e~~~~~~L 169 (413)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.002 Score=60.08 Aligned_cols=31 Identities=23% Similarity=0.258 Sum_probs=27.7
Q ss_pred CCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 207 KQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 207 ~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0065 Score=58.29 Aligned_cols=82 Identities=13% Similarity=0.024 Sum_probs=49.6
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 161 (413)
++.|..|-...+|++............++.|++++...... ..-...+|..+++.|. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 34676677788999865421000011257789998754322 1223467899998886 43456666533 2 27899
Q ss_pred eeCCCCCH
Q 015094 162 EFMQKGSL 169 (413)
Q Consensus 162 e~~~~~~L 169 (413)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.015 Score=55.48 Aligned_cols=29 Identities=24% Similarity=0.316 Sum_probs=24.8
Q ss_pred eeeCCCCCCcEEE------cCCCCeEEccCCCccc
Q 015094 209 VIYRDFKASNILL------DGSYTAKISDFGLAKL 237 (413)
Q Consensus 209 ivHrDlkp~Nil~------~~~~~~kl~DfG~a~~ 237 (413)
++|+|+.+.|||+ ++++.++|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999988864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.59 E-value=0.22 Score=42.55 Aligned_cols=115 Identities=9% Similarity=0.122 Sum_probs=78.8
Q ss_pred cCCCccceEeEEEeCCeeEEEEeeCC-CCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 015094 140 SHPNLVRLLGYCWEDKELLLVYEFMQ-KGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASN 218 (413)
Q Consensus 140 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~N 218 (413)
.||+++.. .+-.+++.+.+.++.-. +-++.. + +.++....+.++.+|+....++++ =+|--|+|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecce
Confidence 48888877 56666777777666543 223333 2 257788889999999988866663 5788999999
Q ss_pred EEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCC
Q 015094 219 ILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 219 il~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~ 291 (413)
|+++.++.+++.-.|+-.. ++|. .++...=+-.+=|++..++.++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999986665331 2332 12222234467788888899877664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.51 E-value=0.48 Score=40.56 Aligned_cols=114 Identities=10% Similarity=0.060 Sum_probs=77.1
Q ss_pred cCCCccceEeEEEeCCeeEEEEeeCCCC-CHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHH-HhhcCCCCeeeCCCCCC
Q 015094 140 SHPNLVRLLGYCWEDKELLLVYEFMQKG-SLENHLFGRGASVQPLAWNIRLKIAIGAARGLA-FLHTSDKQVIYRDFKAS 217 (413)
Q Consensus 140 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~-~lH~~~~~ivHrDlkp~ 217 (413)
.||++ -..+-.+++.+.+.++.-+++ ++..+. .++....+.++.+|+.... +++. -+|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence 48888 444556778888877765333 333332 5778888999999988777 5653 688899999
Q ss_pred cEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCC
Q 015094 218 NILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALD 291 (413)
Q Consensus 218 Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~ 291 (413)
||+++.++.++|.-.|+-. -++|.-+ +..-=+-.+=|++..++.++.-|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE-------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT-------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998766643 2344322 212223356677888888766553
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.07 E-value=0.12 Score=50.07 Aligned_cols=62 Identities=3% Similarity=0.006 Sum_probs=17.9
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEE------EecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEE
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAV------KKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCW 152 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vai------K~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 152 (413)
.+.+.|| ||.||+|.+.. ....||+ |..+... .+....+.+|..+++.++|+|+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~-------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK-------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC----------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccc-------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4567777 99999997753 1245777 6554322 223345778999999999999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 413 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-73 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-70 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-67 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-62 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-59 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 1e-73
Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 29/291 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+G G FG V+KG K + + + + + Q + +++EV L +
Sbjct: 9 QITVGQRIGSGSFGTVYKG--------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
H N++ +GY + L +V ++ + SL +HL + IA A+G
Sbjct: 61 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQG 116
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+ +LH K +I+RD K++NI L T KI DFGLA + S SH ++ G+ + A
Sbjct: 117 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 259 PEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
PE + +SDVY FG+VL E++TG P N D I +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIFMVGRGYLS 228
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
+ + + +L +CL+ + RP +++ ++E L S
Sbjct: 229 PDL------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 221 bits (564), Expect = 3e-70
Identities = 82/317 (25%), Positives = 138/317 (43%), Gaps = 38/317 (11%)
Query: 68 FTFVELRAATRNF---------KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKL 118
FTF + A R F K + V+G G FG+V G L K PGK +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHL--KLPGKRE--IFVAIKTL 62
Query: 119 NSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG 177
S + + ++ SE + +G+ HPN++ L G + ++++ EFM+ GSL++ L
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN- 121
Query: 178 ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237
+ + G A G+ +L D ++RD A NIL++ + K+SDFGL++
Sbjct: 122 --DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 238 GPSASQSHVTTRV---MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNR 294
+ T + APE + SDV+ +G+V+ E+++ R
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----R 232
Query: 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR 354
P D I I+ + P + QL L C + + HRP
Sbjct: 233 PYWDMTNQDVIN-----------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 355 EVVETLERLQASDQKPK 371
++V TL+++ + K
Sbjct: 282 QIVNTLDKMIRNPNSLK 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (552), Expect = 2e-68
Identities = 74/308 (24%), Positives = 124/308 (40%), Gaps = 45/308 (14%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFE-EWQSEVNFLG 137
N + +GEG FG+VF+ T++AVK L E+ + ++Q E +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARA--PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG-------------------- 177
+PN+V+LLG C K + L++E+M G L L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 178 ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237
PL+ +L IA A G+A+L +++ ++RD N L+ + KI+DFGL++
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297
SA + PE + +SDV+ +GVVL EI +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL--------- 240
Query: 298 QHNLVDWIKPY--LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
+PY ++ + ++ D + P ++ L C P RPS
Sbjct: 241 --------QPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 356 VVETLERL 363
+ L+R+
Sbjct: 292 IHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-67
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 29/298 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPN 143
V+G G FG V+ G L + G AVK LN + G ++ +E + SHPN
Sbjct: 34 VIGRGHFGCVYHGTLLDN----DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 144 LVRLLGYCWE-DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
++ LLG C + L+V +M+ G L N + + + A+G+ FL
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFL 146
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL--GPSASQSHVTTRVMGTYGYAAPE 260
K+ ++RD A N +LD +T K++DFGLA+ H T + A E
Sbjct: 147 A--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
+ T KSDV+ FGV+L E++T P N D L +R +
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTR-----GAPPYPDVNTFDITVYLLQGRRLLQ---- 255
Query: 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRPT 378
P + ++ LKC + + RPS E+V + + ++ V T
Sbjct: 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNAT 306
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-67
Identities = 70/306 (22%), Positives = 129/306 (42%), Gaps = 39/306 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
+G+G FG+V++G G +AVK +S + + ++E+ L H N+
Sbjct: 10 SIGKGRFGEVWRGKWR---------GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 59
Query: 145 VRLLGYCWED----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
+ + +D +L LV ++ + GSL ++L + +K+A+ A GLA
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLA 114
Query: 201 FLHT------SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ--SHVTTRVMG 252
LH + +RD K+ NIL+ + T I+D GLA SA+ +G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 253 TYGYAAPEYVAT------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306
T Y APE + + ++D+Y G+V EI ++ Q D +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVP 233
Query: 307 PYLSEKRKFRHIIDARLQGQYPYK-----AAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
S + + + + +L+ P + A +A++ +C A R + + +TL
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 362 RLQASD 367
+L +
Sbjct: 294 QLSQQE 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 6e-67
Identities = 80/306 (26%), Positives = 121/306 (39%), Gaps = 44/306 (14%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLG 137
N + VLG G FGKV K+G +AVK L ++ E SE+ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATA--YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95
Query: 138 RL-SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG------------------- 177
+L SH N+V LLG C + L++E+ G L N+L +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 178 ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237
+ L + L A A+G+ FL K ++RD A N+L+ KI DFGLA+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSG 297
S S V + APE + G +KSDV+ +G++L EI +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--------- 264
Query: 298 QHNLVDWIKPY--LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
PY + F +I + P+ A +I + C + + RPS
Sbjct: 265 --------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 356 VVETLE 361
+ L
Sbjct: 317 LTSFLG 322
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 8e-67
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
+ K +G+G FG V G G +AVK + +++ + + +E + +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDATA--QAFLAEASVMT 55
Query: 138 RLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
+L H NLV+LLG E+K L +V E+M KGSL ++L RG S L + LK ++
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVC 113
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
+ +L ++RD A N+L+ AK+SDFGL K S +
Sbjct: 114 EAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKW 166
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
APE + KSDV+ FG++L EI + R P + L D +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVP---------- 211
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364
++ + P + ++ C + RPS ++ E LE ++
Sbjct: 212 -RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-66
Identities = 59/286 (20%), Positives = 113/286 (39%), Gaps = 31/286 (10%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLG 137
++ LG G FG V G +A+K + S +E+ E +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGS-MSEDEFIEEAKVMM 54
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
LSH LV+L G C + + + ++ E+M G L N+L L++
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCE 111
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
+ +L KQ ++RD A N L++ K+SDFGL++ + + ++
Sbjct: 112 AMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168
Query: 258 APEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317
PE + KSD++ FGV++ EI + + P + + +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAE----------- 212
Query: 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
I L+ P+ A+ ++ + C + RP+ + ++ + +
Sbjct: 213 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-66
Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 31/283 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
K LG G FG+V+ G+ + T +AVK L S+ + + +E N + +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSMSP-DAFLAEANLMKQ 64
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L H LVRL + + ++ E+M+ GSL + L L N L +A A G
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEG 121
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+AF+ ++ I+RD +A+NIL+ + + KI+DFGLA+L ++ + A
Sbjct: 122 MAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 178
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318
PE + G +KSDV+ FG++L EI+T R P + I+ R R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNLERGYRMVR-- 231
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
P ++ QL C + P+ RP+ + LE
Sbjct: 232 ---------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-66
Identities = 71/305 (23%), Positives = 126/305 (41%), Gaps = 30/305 (9%)
Query: 72 ELRAATRNFK-SDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEW 129
+L N +D LG G FG V +G + +A+K L + + EE
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMR-----KKQIDVAIKVLKQGTEKADTEEM 56
Query: 130 QSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL 189
E + +L +P +VRL+G C + + L+LV E G L L G+ + + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVA 112
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTT 248
++ + G+ +L +K ++RD A N+LL + AKISDFGL+K LG S +
Sbjct: 113 ELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ APE + +SDV+ +GV + E L+ + +P + + +
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMA-- 223
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQ 368
I+ + + P + ++ L C + + RP V + + S
Sbjct: 224 ---------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 369 KPKQP 373
+
Sbjct: 275 SKVEG 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-66
Identities = 79/301 (26%), Positives = 118/301 (39%), Gaps = 35/301 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLG 137
LG G FGKV + KS + +AVK L + E SE+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATA--YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81
Query: 138 RLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASV--------------QP 182
L H N+V LLG C L++ E+ G L N L + S
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 183 LAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSAS 242
L L + A+G+AFL K I+RD A NILL KI DFGLA+ + S
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302
V + APE + +SDV+ +G+ L E+ + + P
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
KF +I + P A ++ + C +A+P RP+ +++V+ +E+
Sbjct: 256 -----------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 363 L 363
Sbjct: 305 Q 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-65
Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 26/295 (8%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLG 137
V+G G FG+V+KG L +A+K L + + ++ E +G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKT---SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
+ SH N++RL G + K ++++ E+M+ G+L+ L + + + + G A
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAA 121
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGY 256
G+ +L + ++RD A NIL++ + K+SDFGL++ L ++ T+ +
Sbjct: 122 GMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
APE ++ SDV+ FG+V+ E++T RP + + + +K
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-----RPYWELSNHEVMK---------- 224
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPK 371
I+ + P I QL ++C + E RP ++V L++L + K
Sbjct: 225 -AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (531), Expect = 2e-65
Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 33/298 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+ LG G +G+V++G + +AVK L ++++ EE+ E +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKE 69
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
+ HPNLV+LLG C + ++ EFM G+L ++L Q ++ + L +A +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSA 127
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+ +L K I+RD A N L+ ++ K++DFGL++L + A
Sbjct: 128 MEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTA 184
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318
PE +A +KSDV+ FGV+L EI T + Q +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYEL 228
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL----QASDQKPKQ 372
++ + + P ++ +L C + P RPS E+ + E + SD+ K+
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-64
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 31/288 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+G G FG V G+ + +A+K + E E++ E + +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIR-EGAMSEEDFIEEAEVMMK 56
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
LSHP LV+L G C E + LV+EFM+ G L ++L + A L + + G
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEG 113
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+A+L + VI+RD A N L+ + K+SDFG+ + Q +T +A+
Sbjct: 114 MAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWAS 170
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318
PE + KSDV+ FGV++ E+ + + NR + + +V+ I FR
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI------STGFRLY 222
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366
P A+ + Q+ C + P+ RP+ ++ L + S
Sbjct: 223 K--------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-64
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 31/295 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+ + + LG+G FG+V+ G + T +A+K L + E + E + +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKK 68
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L H LV+L E+ + +V E+M KGSL + L G + L + +A A G
Sbjct: 69 LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASG 125
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+A++ ++RD +A+NIL+ + K++DFGLA+L ++ + A
Sbjct: 126 MAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 182
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318
PE G +KSDV+ FG++L E+ T R + R+
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQ 226
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQP 373
++ + P + + L +C EP+ RP+ + LE S + QP
Sbjct: 227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 70/313 (22%), Positives = 117/313 (37%), Gaps = 43/313 (13%)
Query: 73 LRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQS 131
+ +F+ + LG G G VFK SG V+A K ++ E +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKP-------SGLVMARKLIHLEIKPAIRNQIIR 53
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
E+ L + P +V G + D E+ + E M GSL+ L G + I K+
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKV 109
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
+I +GL +L ++++RD K SNIL++ K+ DFG++ + +
Sbjct: 110 SIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFV 164
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG-------------------LRALDT 292
GT Y +PE + H V+SD++ G+ LVE+ G +
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 293 NRPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSL-------KCLEA 345
P + Y + R I + SL KCL
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 346 EPKHRPSMREVVE 358
P R +++++
Sbjct: 285 NPAERADLKQLMV 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 1e-63
Identities = 75/326 (23%), Positives = 133/326 (40%), Gaps = 39/326 (11%)
Query: 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLGR 138
FK VLG G FG V+KG P +A+K+L + S + +E E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
+ +P++ RLLG C + L+ + M G L +++ + L + A+G
Sbjct: 68 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKG 123
Query: 199 LAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAA 258
+ +L D+++++RD A N+L+ KI+DFGLAKL + + + + A
Sbjct: 124 MNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 259 PEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK-RKFRH 317
E + +SDV+ +GV + E++T KPY +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGIPASEISS 224
Query: 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASDQKPKQPRVRP 377
I++ + P + + +KC + RP RE++ ++ Q+
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI---- 280
Query: 378 THSMAHRQGQQPLHHRSPLHTNLDRN 403
QG + +H SP +N R
Sbjct: 281 -------QGDERMHLPSPTDSNFYRA 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-63
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 38/288 (13%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNF 135
R K D +G G F V+KG E + +A +L L + ++ E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTE-------TTVEVAWCELQDRKLTKSERQRFKEEAEM 61
Query: 136 LGRLSHPNLVRLLGYCWE----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKI 191
L L HPN+VR K ++LV E M G+L+ +L + +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSW 117
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYTAKISDFGLAKLGPSASQSHVTTRV 250
+GL FLHT +I+RD K NI + G + + KI D GLA L ++ V
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173
Query: 251 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
+GT + APE DVY FG+ ++E+ T P + I
Sbjct: 174 IGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQI----- 221
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+R + + A ++ ++ C+ R S+++++
Sbjct: 222 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-63
Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 33/283 (11%)
Query: 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFLGRLS 140
D LG G FG V KG+ K +AVK L +E+ +E +E N + +L
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66
Query: 141 HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLA 200
+P +VR++G C + +LV E + G L +L + +++ + G+
Sbjct: 67 NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMK 121
Query: 201 FLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAAP 259
+L + ++RD A N+LL + AKISDFGL+K L + T + AP
Sbjct: 122 YLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 260 EYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK-RKFRHI 318
E + KSDV+ FGV++ E + + KPY K + +
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMKGSEVTAM 222
Query: 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361
++ + P ++ L C + ++RP V L
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-63
Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 40/299 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLG 137
+ K V+GEG FG+V K + K G A+K++ S ++ E+ L
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 138 RLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGR------------GASVQPLA 184
+L HPN++ LLG C L L E+ G+L + L ++ L+
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS 244
L A ARG+ +L KQ I+RD A NIL+ +Y AKI+DFGL++ +
Sbjct: 126 SQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK- 182
Query: 245 HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304
T + A E + SDV+ +GV+L EI++ P +
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAEL 235
Query: 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
+ + + + P ++ L +C +P RPS +++ +L R+
Sbjct: 236 YE-----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-62
Identities = 61/282 (21%), Positives = 105/282 (37%), Gaps = 30/282 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLG 137
++ LGEG +G+V + +AVK ++ + E + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAV-------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
L+H N+V+ G+ E L E+ G L + + + +
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMA 114
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYA 257
G+ +LH + +RD K N+LLD KISDFGLA + ++ + ++ GT Y
Sbjct: 115 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 258 APEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
APE + + DV+ G+VL +L G D S Q +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YS 217
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ + K L K L P R ++ ++ +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-62
Identities = 72/291 (24%), Positives = 115/291 (39%), Gaps = 29/291 (9%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVN 134
++ + LG+G FG V +G D SG +AVK L + L + +++ EVN
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWD----APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
+ L H NL+RL G + +V E GSL + L + A+
Sbjct: 64 AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQ 119
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGT 253
A G+ +L K+ I+RD A N+LL KI DFGL + L + +
Sbjct: 120 VAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 254 YGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313
+ + APE + T SD + FGV L E+ T + L+ +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---------------LNGSQ 222
Query: 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364
I + P I + ++C +P+ RP+ + + L Q
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-61
Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFL 136
+++ +G G +G+ K G ++ K+L+ S+ + SEVN L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKS-------DGKILVWKELDYGSMTEAEKQMLVSEVNLL 57
Query: 137 GRLSHPNLVRLLGYCWE--DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L HPN+VR + + L +V E+ + G L + + Q L L++
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 195 AARGLAFLH---TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
L H V++RD K +N+ LDG K+ DFGLA++ + +
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFV 175
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
GT Y +PE + KSD++ G +L E+ + S+
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----------------SQ 219
Query: 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
K I + + + + PY+ + ++ ++ + L + HRPS+ E++E
Sbjct: 220 KELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-60
Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 34/279 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG+G FGKV+K E + + A K ++++S + E++ E++ L HPN+
Sbjct: 19 ELGDGAFGKVYKAQNKE-------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
V+LL + + L ++ EF G+++ + +PL + + L +LH
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH- 127
Query: 205 SDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT 264
D ++I+RD KA NIL K++DFG++ Q +GT + APE V
Sbjct: 128 -DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMC 184
Query: 265 GHLY-----VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319
K+DV+ G+ L+E+ P + N + + +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEI------EPPHHELNPMRVLLKIAKSEPPTL--- 235
Query: 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
P + + KCLE R + ++++
Sbjct: 236 ------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 1e-60
Identities = 70/292 (23%), Positives = 130/292 (44%), Gaps = 27/292 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN-SESLQGFEEWQSEVNFLG 137
LG+G FG V++G K K T +A+K +N + S++ E+ +E + +
Sbjct: 21 KITMSRELGQGSFGMVYEGVA--KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 78
Query: 138 RLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRG------ASVQPLAWNIRLKI 191
+ ++VRLLG + + L++ E M +G L+++L + P + + +++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 192 AIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVM 251
A A G+A+L+ + ++RD A N ++ +T KI DFG+ + + +
Sbjct: 139 AGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
+ +PE + G SDV+ FGVVL EI T LS
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241
Query: 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
++ R +++ L P + +L C + PK RPS E++ +++
Sbjct: 242 EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-59
Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 28/280 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPN 143
+GEG FG V +G +A+K + + E++ E + + HP+
Sbjct: 14 CIGEGQFGDVHQGIY----MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V+L+G E+ + ++ E G L + L R L + A + LA+L
Sbjct: 70 IVKLIGVITENP-VWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLE 125
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVA 263
K+ ++RD A N+L+ + K+ DFGL++ S + ++ + APE +
Sbjct: 126 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESIN 182
Query: 264 TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDARL 323
SDV+ FGV + EIL +P D I + +R
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERL--------- 228
Query: 324 QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
P + L KC +P RP E+ L +
Sbjct: 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 32/301 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-GFEEWQSEVNFLG 137
LGEG FG+V K T +AVK L S++ + + SE+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 138 RLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASV------------QPLA 184
+ H N++ LLG C +D L ++ E+ KG+L +L R + L+
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 185 WNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQS 244
+ A ARG+ +L K+ I+RD A N+L+ KI+DFGLA+
Sbjct: 134 SKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 245 HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304
TT + APE + +SDV+ FGV+L EI T P + +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPVEEL 246
Query: 305 IKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364
K ++ + P ++ + C A P RP+ +++VE L+R+
Sbjct: 247 FK-----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 365 A 365
A
Sbjct: 296 A 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 6e-59
Identities = 70/283 (24%), Positives = 110/283 (38%), Gaps = 38/283 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+F+ LG+G FG V+ + S ++A+K L L + + EV
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L HPN++RL GY + + L+ E+ G++ L
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITEL 115
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
A L++ H K+VI+RD K N+LL + KI+DFG + P S T + GT
Sbjct: 116 ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLD 169
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
Y PE + K D++ GV+ E L G P + + K + F
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG------KPPFEANTYQETYKRISRVEFTF 223
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ + L + L+ P RP +REV+E
Sbjct: 224 PDFVTEGAR------------DLISRLLKHNPSQRPMLREVLE 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-58
Identities = 80/304 (26%), Positives = 121/304 (39%), Gaps = 35/304 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG-FEEWQSEVNFLG 137
K LG G FG+V + K+ + +AVK L + SE+ L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADA--FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 71
Query: 138 RLSH-PNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQP------------L 183
+ H N+V LLG C + L+++ EF + G+L +L + P L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 184 AWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQ 243
+ + A+G+ FL + ++ I+RD A NILL KI DFGLA+
Sbjct: 132 TLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 244 SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD 303
+ APE + ++SDV+ FGV+L EI + P + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDE 244
Query: 304 WIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER- 362
L E + R P ++ Q L C EP RP+ E+VE L
Sbjct: 245 EFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
Query: 363 LQAS 366
LQA+
Sbjct: 295 LQAN 298
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (486), Expect = 2e-58
Identities = 68/288 (23%), Positives = 106/288 (36%), Gaps = 41/288 (14%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEV 133
+ F +G G FG V+ + V+A+KK++ Q E+WQ EV
Sbjct: 14 EKLFSDLREIGHGSFGAVYFAR-------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 134 NFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
FL +L HPN ++ G + LV E+ + + + PL +
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTH 122
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
GA +GLA+LH +I+RD KA NILL K+ DFG A + +GT
Sbjct: 123 GALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 174
Query: 254 YGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310
+ APE + G K DV+ G+ +E+ L
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------------ 222
Query: 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
HI + CL+ P+ RP+ +++
Sbjct: 223 ----LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-56
Identities = 60/290 (20%), Positives = 117/290 (40%), Gaps = 31/290 (10%)
Query: 69 TFVELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE 128
+ V + + + +G+G G V+ +G +A++++N + E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAM-------DVATGQEVAIRQMNLQQQPKKEL 63
Query: 129 WQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR 188
+E+ + +PN+V L EL +V E++ GSL + +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQI 118
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
+ + L FLH QVI+RD K+ NILL + K++DFG + +
Sbjct: 119 AAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRS 174
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
++GT + APE V K D++ G++ +E++ G P N + +
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG------EPPYLNENPLRAL--- 225
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ + + Q P K + +CL+ + + R S +E+++
Sbjct: 226 ------YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-53
Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 34/289 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+FK +LGEG F V + + A+K L + E +
Sbjct: 9 DFKFGKILGEGSFSTVVLAR-------ELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
+ RL HP V+L +D++L + + G L ++ G
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEI 117
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
L +LH K +I+RD K NILL+ +I+DFG AK+ S+ +GT
Sbjct: 118 VSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
Y +PE + SD++ G ++ +++ GL +E F
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----------------NEYLIF 219
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364
+ II +L+ +P K + L K L + R E+
Sbjct: 220 QKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 4e-53
Identities = 67/339 (19%), Positives = 118/339 (34%), Gaps = 35/339 (10%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
++ LG G FG V + + +G A K + + E + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVT-------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 79
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L HP LV L +D E++++YEFM G L + ++ + ++ +G
Sbjct: 80 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKG 136
Query: 199 LAFLHTSDKQVIYRDFKASNILL--DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
L +H + ++ D K NI+ S K+ DFGL GT +
Sbjct: 137 LCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEF 191
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
AAPE + +D++ GV+ +L+GL P G N + ++ S
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMD 245
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE----TLERLQASDQKPKQ 372
+ K L A+P R ++ + +E T D +
Sbjct: 246 D--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 297
Query: 373 PRVRPTHSMAHRQGQQPLHHRSPLHTNLDRNRGYQHSPR 411
R + PL + + +H P+
Sbjct: 298 SRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQ 336
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (437), Expect = 9e-51
Identities = 63/330 (19%), Positives = 126/330 (38%), Gaps = 39/330 (11%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V + + +G V K +N+ ++E++ + +L HP L
Sbjct: 36 ELGSGAFGVVHRCV-------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
+ L + E++L+ EF+ G L + + ++ + A GL +H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH- 144
Query: 205 SDKQVIYRDFKASNILLD--GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
+ +++ D K NI+ + + + KI DFGLA + + T +AAPE V
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
+ +D++ GV+ +L+G P + ++ ++ +F
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSG------LSPFAGEDDLETLQNVKRCDWEFDE----- 249
Query: 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE------TLERLQASDQKPKQPRVR 376
+ + L+ EP+ R ++ + +E L + + ++R
Sbjct: 250 ---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIR 306
Query: 377 P--THSMAHRQGQQPLHHRSPLHTNLDRNR 404
A QP R ++L ++R
Sbjct: 307 QKIKEKYADWPAPQPAIGRIANFSSLRKHR 336
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (424), Expect = 1e-49
Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 36/289 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG---FEEWQSEVNFLGRLSH 141
+LG GG +V +AVK L ++ + + ++ E L+H
Sbjct: 14 ILGFGGMSEVHLAR-------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 142 PNLVRLLGYCWEDKE----LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAAR 197
P +V + + +V E++ +L + + G P+ +++ A +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQ 122
Query: 198 GLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGY 256
L F H +I+RD K +NI++ + K+ DFG+A+ + S + T V+GT Y
Sbjct: 123 ALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
+PE + +SDVY G VL E+LTG P + V ++ E
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVSVAYQHVREDPIPP 234
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQ 364
L + + + LK L P++R + E+ L R+
Sbjct: 235 SARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 3e-48
Identities = 60/284 (21%), Positives = 107/284 (37%), Gaps = 39/284 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG------FEEWQSE 132
+F ++G GGFG+V+ + +G + A+K L+ + ++ +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 133 VNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
++ + P +V + +L + + M G L HL G + +I
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI- 116
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMG 252
GL +H ++ V+YRD K +NILLD +ISD GLA +G
Sbjct: 117 ---ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVG 167
Query: 253 TYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
T+GY APE + G Y +D + G +L ++L G ++ +H + E
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
Query: 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
P + ++ L L+ + R
Sbjct: 228 ---------------LPDSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 163 bits (414), Expect = 3e-48
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 50/298 (16%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF---------EEW 129
N++ +LG G V + + AVK ++ F E
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKP-------TCKEYAVKIIDVTGGGSFSAEEVQELREAT 56
Query: 130 QSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR 188
EV+ L ++S HPN+++L + LV++ M+KG L ++L + L+
Sbjct: 57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKET 112
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTT 248
KI + LH +++RD K NILLD K++DFG +
Sbjct: 113 RKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLR 167
Query: 249 RVMGTYGYAAPEYVATGHLY------VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302
V GT Y APE + + D++ GV++ +L G
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------- 218
Query: 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAY--QIAQLSLKCLEAEPKHRPSMREVVE 358
+ R I+ Q P Y + L + L +P+ R + E +
Sbjct: 219 -------KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 3e-47
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 34/278 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-WQSEVNFLGRLSHPN 143
VLG G F +V + ++A+K + ++L+G E ++E+ L ++ HPN
Sbjct: 16 VLGTGAFSEVILAE-------DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
+V L L L+ + + G L + + +G ++ + +LH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLH 124
Query: 204 TSDKQVIYRDFKASNILL---DGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPE 260
D +++RD K N+L D ISDFGL+K+ V + GT GY APE
Sbjct: 125 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPE 179
Query: 261 YVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIID 320
+A D + GV+ +L G P N + L + +F
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCG------YPPFYDENDAKLFEQILKAEYEFDS--- 230
Query: 321 ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
Y + +E +P+ R + + ++
Sbjct: 231 -----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 63/290 (21%), Positives = 109/290 (37%), Gaps = 31/290 (10%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE-----WQSEVNFLGRL 139
LGEG F V+K + ++A+KK+ ++ E+ L L
Sbjct: 5 FLGEGQFATVYKARDKN-------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 140 SHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
SHPN++ LL + LV++FM+ L + + +GL
Sbjct: 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGL 113
Query: 200 AFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP 259
+LH +++RD K +N+LLD + K++DFGLAK S ++++ T + T Y AP
Sbjct: 114 EYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 260 EYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV----------DWIKPY 308
E + +Y V D++ G +L E+L + L + Q + W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
A + L P R + + ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 52/309 (16%), Positives = 104/309 (33%), Gaps = 39/309 (12%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G FG V + ++ S K + + + E++ L H N+
Sbjct: 12 DLGRGEFGIVHRCV-------ETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63
Query: 145 VRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHT 204
+ L +EL++++EF+ + + L + L FLH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH- 119
Query: 205 SDKQVIYRDFKASNILLD--GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
+ + D + NI+ S T KI +FG A+ + Y APE
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVH 175
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHIIDAR 322
+ +D++ G ++ +L+G P I+ ++ + F
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG------INPFLAETNQQIIENIMNAEYTFDE----- 224
Query: 323 LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVV------ETLERLQASDQKPKQPRVR 376
+ + + + + L E K R + E + + +ER+ + R
Sbjct: 225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS-TKVIRTLKHRR 280
Query: 377 PTHSMAHRQ 385
H++ +
Sbjct: 281 YYHTLIKKD 289
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 67/281 (23%), Positives = 99/281 (35%), Gaps = 37/281 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+F +LG+G FGKVF + + A+K L + + E E
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKK-------TNQFFAIKALKKDVVLMDDDVECTMVEKRV 55
Query: 136 LGR-LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L HP L + + L V E++ G L H+ + A
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAE 111
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
GL FLH K ++YRD K NILLD KI+DFG+ K GT
Sbjct: 112 IILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
Y APE + D + FGV+L E+L G P + + +
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG------QSPFHGQDEEELFHSIRMDNPF 221
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
+ ++ + L +K EP+ R +R
Sbjct: 222 YPRWLEKEAK------------DLLVKLFVREPEKRLGVRG 250
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-45
Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 40/284 (14%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF------EEWQSEVNFLGR 138
LG G F V K + +G A K + + E+ + EV+ L
Sbjct: 17 ELGSGQFAVVKKCR-------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
+ HPN++ L +++L+ E + G L + L + L + G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNG 125
Query: 199 LAFLHTSDKQVIYRDFKASNILLD----GSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
+ +LH Q+ + D K NI+L KI DFGLA + + GT
Sbjct: 126 VYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTP 180
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
+ APE V L +++D++ GV+ +L+G + V +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY------- 233
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ +Y + + L +PK R ++++ ++
Sbjct: 234 -------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-45
Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 26/290 (8%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGF-EEWQSEVNFLGRLSHPN 143
+GEG +G V + + + +A+KK++ Q + + E+ L R H N
Sbjct: 15 YIGEGAYGMVCSAYDNV-------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 144 LVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLH 203
++ + + ++ + L+ + Q L+ + RGL ++H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 126
Query: 204 TSDKQVIYRDFKASNILLDGSYTAKISDFGLAK-LGPSASQSHVTTRVMGTYGYAAPEYV 262
V++RD K SN+LL+ + KI DFGLA+ P + T + T Y APE +
Sbjct: 127 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 263 ATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI--KPYLSEKRKFRHII 319
Y KS D++ G +L E+L+ Q N + I P + ++
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 320 DARLQGQYPYKAAYQIAQLS-----------LKCLEAEPKHRPSMREVVE 358
P+K +L K L P R + + +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-45
Identities = 72/303 (23%), Positives = 114/303 (37%), Gaps = 35/303 (11%)
Query: 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEV 133
A + ++ +GEG +GKVFK G +A+K++ ++ + EV
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARD------LKNGGRFVALKRVRVQTGEEGMPLSTIREV 58
Query: 134 NFLGRLS---HPNLVRLLGYCWEDKE-----LLLVYEFMQKGSLENHLFGRGASVQPLAW 185
L L HPN+VRL C + L LV+E + + +
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPT 115
Query: 186 NIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSH 245
+ RGL FLH +V++RD K NIL+ S K++DFGLA++ S
Sbjct: 116 ETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQM 170
Query: 246 VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV--- 302
T V+ T Y APE + D++ G + E+ + Q +
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 303 -------DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
DW + ++ F H A+ ++ L LKCL P R S
Sbjct: 231 IGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 356 VVE 358
+
Sbjct: 290 ALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-44
Identities = 61/293 (20%), Positives = 116/293 (39%), Gaps = 26/293 (8%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFL 136
NF+ +GEG +G V+K +G V+A+KK+ ++ E++ L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR-------NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
L+HPN+V+LL + +L LV+EF+ + + F +++ + +
Sbjct: 56 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLL 112
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
+GLAF H +V++RD K N+L++ K++DFGLA+ T V+ +
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYR 169
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
A + + D++ G + E++T + Q + E
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 317 HIIDARLQGQYPYKAAYQIAQ-----------LSLKCLEAEPKHRPSMREVVE 358
+ +P A ++ L + L +P R S + +
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 2e-43
Identities = 56/293 (19%), Positives = 105/293 (35%), Gaps = 28/293 (9%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFL 136
+ +GEG +G V+K + G A+KK+ E E++ L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISIL 54
Query: 137 GRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
L H N+V+L K L+LV+E + + + G L +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLL 110
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
G+A+ H D++V++RD K N+L++ KI+DFGLA+ T ++ +
Sbjct: 111 NGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYR 167
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
A + + D++ G + E++ G + Q + I + K
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 317 HIIDARLQGQYPYKAAYQIAQLS-----------LKCLEAEPKHRPSMREVVE 358
+ + K L+ +P R + ++ +E
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-43
Identities = 75/342 (21%), Positives = 123/342 (35%), Gaps = 39/342 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
++ V+G G FG V++ L + SG ++A+KK+ + E+ + +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCD-------SGELVAIKKVLQDK----RFKNRELQIMRK 69
Query: 139 LSHPNLVRLLGYCWEDKE------LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIA 192
L H N+VRL + + E L LV +++ + A Q L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYM 128
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDFGLAKLGPSASQSHVTTRVM 251
R LA++H + +RD K N+LLD + K+ DFG AK + +
Sbjct: 129 YQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYIC 184
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
Y A DV+ G VL E+L G + Q + + +
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 312 KR-----------KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET- 359
++ KF I + + + L + LE P R + E
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 360 -LERLQASDQKPKQPRVRPTHSMAHRQGQQPLHHRSPLHTNL 400
+ L+ D K P R T ++ + Q L PL T L
Sbjct: 305 FFDELR--DPNVKLPNGRDTPALFNFT-TQELSSNPPLATIL 343
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 6e-43
Identities = 52/301 (17%), Positives = 96/301 (31%), Gaps = 35/301 (11%)
Query: 72 ELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQS 131
ELR R ++ +G G FG ++ G +G +A+K ++ +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLGT-------DIAAGEEVAIKLECVKTKH--PQLHI 51
Query: 132 EVNFLGRLSHPNLVRLLGYCWEDKE-LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK 190
E + + + +C + + ++V E + + F + L
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLL 107
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNIL---LDGSYTAKISDFGLAKLGPSAS----- 242
+A + ++H K I+RD K N L I DFGLAK A
Sbjct: 108 LADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
Query: 243 QSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV 302
+ GT YA+ + D+ G VL+ G + + +
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
Query: 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362
+ I ++K I+ +G + A C +P + +
Sbjct: 226 ERIS-----EKKMSTPIEVLCKGYPS-----EFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
Query: 363 L 363
L
Sbjct: 276 L 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (377), Expect = 2e-42
Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 39/281 (13%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVN 134
++F+ LG G FG+V +G A+K L E L+ E E
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRH-------NGRYYAMKVLKKEIVVRLKQVEHTNDERL 56
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L ++HP ++R+ G + +++ ++ ++++ G L + L P+A ++
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--- 113
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
L +LH K +IYRD K NILLD + KI+DFG AK P VT + GT
Sbjct: 114 -CLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTP 165
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
Y APE V+T D + FG+++ E+L G P N + + L+ + +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELR 219
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
F + ++ L + + + R +
Sbjct: 220 FPPFFNEDVK------------DLLSRLITRDLSQRLGNLQ 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-42
Identities = 56/284 (19%), Positives = 104/284 (36%), Gaps = 50/284 (17%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEE------WQSEVNFLGR 138
+LG GGFG V+ G + +A+K + + + + E EV L +
Sbjct: 11 LLGSGGFGSVYSGI-------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 139 LS--HPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAA 196
+S ++RLL + +L+ E + L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVL 120
Query: 197 RGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
+ H + V++RD K NIL+D + K+ DFG L + V T GT
Sbjct: 121 EAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRV 174
Query: 256 YAAPEYVATGHLYVKS-DVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314
Y+ PE++ + +S V+ G++L +++ G + + + + + +S +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--FRQRVSS--E 230
Query: 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+H+I CL P RP+ E+
Sbjct: 231 CQHLIR--------------------WCLALRPSDRPTFEEIQN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-41
Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 40/307 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQG--FEEWQSEVNFL 136
++ +G+G FG+VFK + +G +A+KK+ E+ + E+ L
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRK-------TGQKVALKKVLMENEKEGFPITALREIKIL 63
Query: 137 GRLSHPNLVRLLGYCWEDKE--------LLLVYEFMQKGSLENHLFGRGASVQPLAWNIR 188
L H N+V L+ C + LV++F + +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEI 119
Query: 189 LKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVT- 247
++ GL ++H ++++RD KA+N+L+ K++DFGLA+ A S
Sbjct: 120 KRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 248 -TRVMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305
T + T Y PE + Y D++G G ++ E+ T + N Q L+ +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 306 K--------PYLSEKRKFRHIIDARLQGQY------PYKAAYQIAQLSLKCLEAEPKHRP 351
P + + + + Q + Y L K L +P R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 352 SMREVVE 358
+ +
Sbjct: 298 DSDDALN 304
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 60/282 (21%), Positives = 102/282 (36%), Gaps = 37/282 (13%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPN 143
VLG G GKV + + + A+K L + + EV R S P+
Sbjct: 19 VLGLGINGKVLQIF-------NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 66
Query: 144 LVRLLGYC----WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGL 199
+VR++ K LL+V E + G L + + RG Q +I +
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAI 124
Query: 200 AFLHTSDKQVIYRDFKASNILLD---GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGY 256
+LH + +RD K N+L + K++DFG AK S + T Y
Sbjct: 125 QYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYY 179
Query: 257 AAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316
APE + D++ GV++ +L G P ++ + + R +
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG------YPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVE 358
+ + + L L+ EP R ++ E +
Sbjct: 234 YEFPNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 3e-41
Identities = 45/295 (15%), Positives = 90/295 (30%), Gaps = 34/295 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
++K +GEG FG +F+G + +A+K S + + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEGT-------NLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKL 56
Query: 139 LSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARG 198
L+ + + Y ++ ++ + SLE+ L G + + A
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLAR 113
Query: 199 LAFLHTSDKQVIYRDFKASNILLD-----GSYTAKISDFGLAKL-----GPSASQSHVTT 248
+ +H +K ++YRD K N L+ + + DFG+ K
Sbjct: 114 VQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 249 RVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308
+ GT Y + + D+ G V + L G + + + I
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--- 228
Query: 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363
K + L +P + + P + ++
Sbjct: 229 ---GEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-39
Identities = 58/288 (20%), Positives = 101/288 (35%), Gaps = 28/288 (9%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHP 142
+GEG +G VFK + ++A+K++ + E+ L L H
Sbjct: 9 KIGEGTYGTVFKAK-------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFL 202
N+VRL DK+L LV+EF + + G L I +GL F
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFC 117
Query: 203 HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYV 262
H + V++RD K N+L++ + K+++FGLA+ + V+ +
Sbjct: 118 H--SRNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 263 ATGHLYVKSDVYGFGVVLVEILTGLRAL---DTNRPSGQHNLVDWIKPYLSEKRKFRHII 319
D++ G + E+ R L + + P + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 320 DARLQGQYPYKAAY---------QIAQLSLKCLEAEPKHRPSMREVVE 358
D + YP + L L+ P R S E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-39
Identities = 68/280 (24%), Positives = 98/280 (35%), Gaps = 36/280 (12%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFEEWQSEVNF 135
+F +LG+G FGKV + +G A+K L E + +E
Sbjct: 6 DFDYLKLLGKGTFGKVILVR-------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L HP L L L V E+ G L HL +
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEI 114
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
L +LH + V+YRD K N++LD KI+DFGL K G S + GT
Sbjct: 115 VSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPE 170
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
Y APE + D +G GVV+ E++ G P + + L E+ +F
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG------RLPFYNQDHERLFELILMEEIRF 224
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
+ + L L+ +PK R
Sbjct: 225 PRTLSPEAK------------SLLAGLLKKDPKQRLGGGP 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 57/333 (17%), Positives = 114/333 (34%), Gaps = 34/333 (10%)
Query: 68 FTFVELRAATRNFKSD----TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL 123
F E+ ++ +G G +G V +G +A+KKL
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV-------DGRTGAKVAIKKLYRPFQ 56
Query: 124 --QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQ 181
+ E+ L + H N++ LL D+ L +F G+ +
Sbjct: 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE 116
Query: 182 PLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241
L + + +GL ++H +I+RD K N+ ++ KI DFGLA+
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----Q 170
Query: 242 SQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301
+ S +T V+ + A + D++ G ++ E++TG + Q
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 302 VDWIKPYLSEK-------------RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPK 348
+ + + K ++ + A+ L K L + +
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 349 HRPSMREVVET--LERLQASDQKPKQPRVRPTH 379
R + E + E L ++ +P+ + +
Sbjct: 291 QRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 6e-36
Identities = 60/286 (20%), Positives = 108/286 (37%), Gaps = 40/286 (13%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQ---SEVNF 135
F LG G FG+V E SG A+K L+ + + ++ + +E
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKE-------SGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 136 LGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L ++ P LV+L ++ L +V E++ G + +HL G + A
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQI 150
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYG 255
+LH +IYRD K N+L+D +++DFG AK T + GT
Sbjct: 151 VLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 256 YAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315
APE + + D + GV++ E+ G ++P + + K
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------- 255
Query: 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHR-PSMREVVETL 360
++P + + L L+ + R +++ V +
Sbjct: 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 5e-35
Identities = 50/305 (16%), Positives = 104/305 (34%), Gaps = 47/305 (15%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGR 138
+++ LG G + +VF+ + + VK L ++ + E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAI-------NITNNEKVVVKILKPVKK---KKIKREIKILEN 85
Query: 139 LS-HPNLVRLLGYCWEDKE--LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGA 195
L PN++ L + LV+E + + Q L
Sbjct: 86 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEI 138
Query: 196 ARGLAFLHTSDKQVIYRDFKASNILLDGS-YTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
+ L + H +++RD K N+++D ++ D+GLA+ + + +
Sbjct: 139 LKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASR 193
Query: 255 GYAAPEYVATGHLY-VKSDVYGFGVVLVEILTGLRALDTNRPS-----------GQHNLV 302
+ PE + +Y D++ G +L ++ + G +L
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 303 DWIKPYLSE---------KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSM 353
D+I Y E R R + + + + + + K L + + R +
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 354 REVVE 358
RE +E
Sbjct: 314 REAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-34
Identities = 70/284 (24%), Positives = 110/284 (38%), Gaps = 32/284 (11%)
Query: 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----QGFEEWQSEVN 134
NF+ VLG G +GKVF + +G + A+K L ++ + E ++E
Sbjct: 25 NFELLKVLGTGAYGKVFLV----RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 135 FLGRLSH-PNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAI 193
L + P LV L + +L L+ +++ G L HL R + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVG 136
Query: 194 GAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGT 253
L LH +IYRD K NILLD + ++DFGL+K A ++ GT
Sbjct: 137 EIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGT 193
Query: 254 YGYAAPEYVATGHLYV--KSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311
Y AP+ V G D + GV++ E+LTG + +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--------- 244
Query: 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMRE 355
R I+ + YP + + L + L +PK R
Sbjct: 245 ---SRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-33
Identities = 62/313 (19%), Positives = 116/313 (37%), Gaps = 51/313 (16%)
Query: 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNF 135
+ +++ +G G G V + + +A+KKL+ + E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY-------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 136 LGRLSHPNLVRLLGYCW------EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRL 189
+ ++H N++ LL E +++ LV E M + L
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-------MELDHERMS 122
Query: 190 KIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTR 249
+ G+ LH +I+RD K SNI++ T KI DFGLA+ +A S + T
Sbjct: 123 YLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 177
Query: 250 VMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG----------------LRALDTN 293
+ T Y APE + D++ G ++ E++ + L T
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQ--------LSLKCLEA 345
P L ++ Y+ + K+ + +L + A + + L K L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 346 EPKHRPSMREVVE 358
+P R S+ + ++
Sbjct: 298 DPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-31
Identities = 57/295 (19%), Positives = 107/295 (36%), Gaps = 28/295 (9%)
Query: 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLN--SESLQGFEEWQSEVN 134
+++ + +G G +G V + + +G +AVKKL+ +S+ + E+
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF-------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 135 FLGRLSHPNLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIG 194
L + H N++ LL + L + L Q L + +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 195 AARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTY 254
RGL ++H +I+RD K SN+ ++ KI DFGLA+ + +T V +
Sbjct: 130 ILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 255 GYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLV--------DWIK 306
A + H D++ G ++ E+LTG Q L+ +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 307 PYLSEKRKFRHIIDARLQGQYPYKAAYQIA-----QLSLKCLEAEPKHRPSMREV 356
+S + +I + + + A L K L + R + +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 1e-27
Identities = 47/317 (14%), Positives = 103/317 (32%), Gaps = 52/317 (16%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNL 144
LG G F V+ + T +A+K + + + E + E+ L R++ +
Sbjct: 20 KLGWGHFSTVWLAK-------DMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADN 71
Query: 145 VRLLGYCWED-KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIR-----------LKIA 192
+ +LL + + + LA + +I+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 193 IGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDFGLAKLGPSASQSHVTTRVM 251
GL ++H +I+ D K N+L++ + +A LG + T +
Sbjct: 132 KQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 252 GTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI------ 305
T Y +PE + +D++ ++ E++TG + + D I
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 306 ---------------KPYLSEKRKFRHIIDARLQG---------QYPYKAAYQIAQLSLK 341
+ + + + R+I + ++ A +I+
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 342 CLEAEPKHRPSMREVVE 358
L+ +P+ R +V
Sbjct: 311 MLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.8 bits (170), Expect = 1e-14
Identities = 22/166 (13%), Positives = 40/166 (24%), Gaps = 36/166 (21%)
Query: 85 VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL----------QGFEEWQSEVN 134
++GEG VF S VK G +
Sbjct: 7 LMGEGKESAVFN--------CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58
Query: 135 FLGRLSHPNLVRLLGYCWEDK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLK 190
R L +L G ++ E + L +
Sbjct: 59 RSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDE 107
Query: 191 IAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236
+ +A + + +++ D N+L+ I DF +
Sbjct: 108 VLDMILEEVAKFY--HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 413 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.49 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-59 Score=424.26 Aligned_cols=256 Identities=24% Similarity=0.281 Sum_probs=208.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++++.||+|+||+||+|++.. +++.||||++..... ...+.+.+|+.+|++++||||+++++++.+++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRV-------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 77 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence 479999999999999999997654 678999999875532 334568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhhe
Confidence 99999999999999999543 378999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
..............+||+.|||||++.+..+ +.++|||||||++|+|++|..||..........
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--------------- 216 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------- 216 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH---------------
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH---------------
Confidence 6543333333455789999999999988776 578999999999999999999997654322110
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
..+............++.++.+||.+||+.||++|||++|+++|-+
T Consensus 217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 0111111111223456788999999999999999999999987533
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-58 Score=421.97 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=213.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||+||+|.+.. +++.||||++........+.+.+|+.+|+.++||||+++++++.+++.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA-------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT-------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccEEEEEEecCcCcEEEEEEECC-------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE
Confidence 579999999999999999996543 6889999998766555667899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+|||||+||+|.+++.+. .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+++.
T Consensus 93 ~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence 9999999999999987542 68999999999999999999997 6699999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... .+..
T Consensus 166 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~ 227 (293)
T d1yhwa1 166 ITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----------------ALYL 227 (293)
T ss_dssp CCST--TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----------------HHHH
T ss_pred eccc--cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH----------------HHHH
Confidence 4322 223445689999999999999999999999999999999999999997643211 1111
Q ss_pred hHH-hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 318 IID-ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 318 ~~~-~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+.. .......+..++.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp HHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred HHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 111 11223345677889999999999999999999999987643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-58 Score=416.63 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=212.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hHeEEEEEEecCCCcEEEEEEECC-------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 479999999999999999997654 67899999986442 23456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+|||||++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred CEEEEEEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccce
Confidence 99999999999999999997654 68999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||....... .
T Consensus 153 a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~ 212 (263)
T d2j4za1 153 SVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------------T 212 (263)
T ss_dssp CSCCCC----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------H
T ss_pred eeecCC----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----------------H
Confidence 985332 22345689999999999999999999999999999999999999997643210 1
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+..+.. ....++..++.++.+||.+||+.||++|||++|+++|-+-
T Consensus 213 ~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 213 YKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp HHHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred HHHHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 111111 1223556778899999999999999999999999987653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=419.66 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=210.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++++.||+|+||+||+|.+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA-------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 469999999999999999997654 67899999986542 23456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEeccccc
Confidence 99999999999999999987654 78999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
|+..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.. ..
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~ 218 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----------------LI 218 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----------------HH
Confidence 98755444444445578999999999999999999999999999999999999999864321 01
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+..+... ...++..+++++.+||.+||+.||.+|||++|++++.+-
T Consensus 219 ~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i 264 (288)
T d1uu3a_ 219 FQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264 (288)
T ss_dssp HHHHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHH
T ss_pred HHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHH
Confidence 1112211 224566788899999999999999999999998776553
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=409.69 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=206.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|.+. ..||||+++.. .....+.+.+|+.+|++++||||+++++++. +
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~ 75 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A 75 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS----------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC----------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c
Confidence 468999999999999999999643 35999998644 3445678999999999999999999999764 5
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+|+|||||++|+|.+++.... ..+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred cEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccc
Confidence 67899999999999999996543 368999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
|+...............||+.|||||++.+ ..|+.++|||||||++|||+||..||........
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------------- 217 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------------- 217 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-------------
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-------------
Confidence 986544333344456789999999999864 3588999999999999999999999976533211
Q ss_pred hhhhhHhHHhhhc----CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 312 KRKFRHIIDARLQ----GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 312 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+...+..... ...+..++.++.+||.+||..||++|||+++|+++|+.+.+.
T Consensus 218 ---~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 218 ---IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0011111111 123446778999999999999999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-58 Score=417.16 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=200.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS-------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred hhCEEeEEEecCCCeEEEEEEECC-------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 579999999999999999997654 67899999987653 3345678999999999999999999999865
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCC---CCeeeCCCCCCcEEEcCCCCeEEc
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSD---KQVIYRDFKASNILLDGSYTAKIS 230 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~~ivHrDlkp~Nil~~~~~~~kl~ 230 (413)
++.+|+|||||+||+|.+++.+.......+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 45789999999999999999765444557999999999999999999999732 349999999999999999999999
Q ss_pred cCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 231 DFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 231 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|||+++..... ........||+.|||||++.+..|+.++|||||||++|+|++|..||...+..
T Consensus 157 DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------------- 220 (269)
T d2java1 157 DFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------------- 220 (269)
T ss_dssp CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------------
T ss_pred eccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------------
Confidence 99999864322 22234568999999999999999999999999999999999999999764221
Q ss_pred hhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 311 EKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.....+... .....+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 221 --~~~~~i~~~-~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 221 --ELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --HHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHcC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011111111 2224556788899999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=416.52 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=211.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+.|++++.||+|+||+||+|.+.. +++.||||++........+.+.+|+++|+.++||||+++++++.+++.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE-------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC-------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence 468999999999999999997654 6789999999877666778899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+|||||+||+|.+++.+.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|..
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhc
Confidence 99999999999999986543 368999999999999999999997 6699999999999999999999999999975
Q ss_pred CCCCCCcceeecccccccccCccccc-----cCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
... .........||+.|+|||++. +..|+.++|||||||++|+|++|..||.......
T Consensus 160 ~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------------- 222 (288)
T d2jfla1 160 NTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------------- 222 (288)
T ss_dssp CHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---------------
T ss_pred cCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---------------
Confidence 211 111223467999999999984 4668899999999999999999999997654321
Q ss_pred hhhhHhHHhh-hcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 313 RKFRHIIDAR-LQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 313 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+..+.... .....+..++.++.+||.+||+.||++|||+.|+++|-
T Consensus 223 -~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 223 -VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp -HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred -HHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 111111111 11233557788999999999999999999999998763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=425.96 Aligned_cols=269 Identities=25% Similarity=0.361 Sum_probs=209.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++++.||+|+||+||+|++.. +++.||+|+++... ....+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP-------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT-------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC-------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4679999999999999999997653 68999999987553 334567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+. ++|+||||||+|||++.+|.+||+|||+|
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 9999999999999999997654 689999999999999999999961 35999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhh--------
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVD-WIK-------- 306 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~-~~~-------- 306 (413)
+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+......... ...
T Consensus 153 ~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 153 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp HHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred cccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 85321 22345689999999999999999999999999999999999999998754321100000 000
Q ss_pred ----------hhh---hhhhhhhHhHHhhhc----CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 ----------PYL---SEKRKFRHIIDARLQ----GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ----------~~~---~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
... ............... .......+.++.+||.+||+.||.+|||++|+++|-.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 000 000000011111111 1111235678999999999999999999999999744
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=407.92 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=200.1
Q ss_pred CCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe----
Q 015094 80 FKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE---- 153 (413)
Q Consensus 80 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 153 (413)
|++.+.||+|+||+||+|.+.. +++.||+|++... .....+.+.+|+++|++++||||+++++++..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~-------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE-------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred EEeeeEEecCcCcEEEEEEECC-------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 3677789999999999997654 6789999998654 33455678999999999999999999999875
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc-CCCCeEEccC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD-GSYTAKISDF 232 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~-~~~~~kl~Df 232 (413)
+..+|+|||||++|+|.+++.+.. .+++..++.++.||+.||+|||+.+.+|+||||||+|||++ .++.+||+||
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCEEEEEEeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 356899999999999999997654 68999999999999999999997444499999999999996 5789999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|+++.... ......+||+.|||||++.+ .|+.++|||||||++|+|++|..||........
T Consensus 160 Gla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-------------- 220 (270)
T d1t4ha_ 160 GLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------------- 220 (270)
T ss_dssp TGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--------------
T ss_pred CcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--------------
Confidence 99985322 22345689999999998865 699999999999999999999999975432110
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.+..+........++...++++.+||.+||+.||++|||+.|+++|
T Consensus 221 -~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 221 -IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0011111111112233456789999999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-57 Score=414.85 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=218.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||+||+|.+.. +++.||||+++.... ..+.+.+|+.+|++++||||+++++++.+++.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK-------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG-------GTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC-------CCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4678999999999999999998764 578999999876543 45779999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+|||||++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999996543 2478999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... .........|++.|+|||++.+..|+.++|||||||++|||++|..||...... ....
T Consensus 164 ~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----------------~~~~ 226 (287)
T d1opja_ 164 LMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVY 226 (287)
T ss_dssp TCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HHHH
T ss_pred ecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------------HHHH
Confidence 64332 222333456899999999999999999999999999999999977665433211 1122
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
..+........+..++.++.+||.+||+.||++|||+.++++.|+.+..
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2333444556677888999999999999999999999999999988754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.1e-56 Score=419.75 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=213.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++++.||+|+||+||+|++.. +++.||||++........+.+.+|+.+|++|+||||+++++++.+++.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA-------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4589999999999999999997654 689999999987776677789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--CCCCeEEccCCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD--GSYTAKISDFGL 234 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~--~~~~~kl~DfG~ 234 (413)
+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||+ +|||||||||+|||++ .++.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 999999999999999985432 369999999999999999999997 6699999999999995 468899999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
++.... ........||+.|||||++.+..|+.++|||||||++|+|++|..||...+.. ..
T Consensus 173 a~~~~~---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~ 233 (350)
T d1koaa2 173 TAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------------ET 233 (350)
T ss_dssp CEECCT---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred heeccc---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 986432 22344568999999999999999999999999999999999999999764321 11
Q ss_pred hhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
+..+...... ......++.++.+||.+||+.||++|||++|+++|-+
T Consensus 234 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp HHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1112211111 1122356788999999999999999999999998743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-56 Score=415.53 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=194.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++..... ...+.+.+|+.+|+.++||||+++++++.+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR-------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT-------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeccCeEEEEEEECC-------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4679999999999999999997653 678999999875532 23356789999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~---~~~~~kl~Df 232 (413)
.+|+|||||+||+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+||
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEecc
Confidence 9999999999999999996543 79999999999999999999997 6699999999999994 5789999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
|+++... ........+||+.|||||++.+..|+.++|||||||++|+|++|..||.......
T Consensus 155 G~a~~~~---~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------------- 216 (307)
T d1a06a_ 155 GLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------------- 216 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------
T ss_pred ceeEEcc---CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---------------
Confidence 9998532 2223345689999999999999999999999999999999999999997642210
Q ss_pred hhhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 313 RKFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 313 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
....+..... ....+..+++++.+||.+||+.||++|||+.|+++|-+
T Consensus 217 -~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 217 -LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp -HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred -HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 1111111111 11233467889999999999999999999999998743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-56 Score=419.14 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=212.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++++.||+|+||+||+|++.. +++.||||++........+.+.+|+.+|+.|+||||++++++|.+++.+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA-------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred cceEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 579999999999999999997543 6899999999877666667889999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc--CCCCeEEccCCCc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD--GSYTAKISDFGLA 235 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~--~~~~~kl~DfG~a 235 (413)
|+|||||+||+|.+++.... .++++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccc
Confidence 99999999999999875433 369999999999999999999997 6699999999999997 6789999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
..... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... ..+
T Consensus 177 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~~ 237 (352)
T d1koba_ 177 TKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----------------ETL 237 (352)
T ss_dssp EECCT---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHH
T ss_pred eecCC---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHH
Confidence 87433 23345568999999999999999999999999999999999999999764321 111
Q ss_pred hHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 316 RHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 316 ~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
..+..... .......++.++.+||.+||+.||.+|||+.|+++|-
T Consensus 238 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 11211111 1223346788999999999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=417.66 Aligned_cols=265 Identities=30% Similarity=0.441 Sum_probs=217.4
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||+||+|++... ........||+|.+... .......+.+|+.+|.++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGI--SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESC--SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCC--CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 46799999999999999999987642 23334567999998654 333456788999999998 799999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC-------------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA-------------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
+.+|+|||||++|+|.+++..+.. ....+++..++.++.||+.||+|||+ ++|||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRDlK 191 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLA 191 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCS
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCc
Confidence 999999999999999999975432 12358899999999999999999997 669999999
Q ss_pred CCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 015094 216 ASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNR 294 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~ 294 (413)
|+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986544444444455678999999999999999999999999999999998 899997653
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
... .+..++........+..++.++.+||.+||+.||++|||++||+++|.
T Consensus 272 ~~~----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321 222334444455667788899999999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-56 Score=403.12 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=203.9
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||+||+|.+. +++.||||++..... ..+.+.+|++++++++||||+++++++..++.+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET--------TTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC--------CCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence 47889999999999999999764 357899999976543 346799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred EEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchhee
Confidence 99999999999999986543 368899999999999999999997 6699999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTG-LRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
...... .......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||..... ..+.
T Consensus 151 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----------------~~~~ 212 (263)
T d1sm2a_ 151 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVV 212 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----------------HHHH
T ss_pred ccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----------------HHHH
Confidence 433221 222345789999999999999999999999999999999995 555543211 0111
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
..+........|..++.++.+|+.+||+.||++|||+++++++|+++.+
T Consensus 213 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 213 EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1222233344566778899999999999999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-55 Score=408.81 Aligned_cols=263 Identities=25% Similarity=0.447 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|++.++||+|+||+||+|++... ......||||.+... .....+.+.+|+.+|++|+|||||++++++.+++.
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLP----GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCC----CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 5688889999999999999976531 123457999988654 33455679999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccce
Confidence 999999999999999886543 368999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcc---eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 237 LGPSASQSH---VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 237 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
......... ......||+.|||||++.+..|+.++|||||||++|||+| |..||......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---------------- 240 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---------------- 240 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----------------
Confidence 644322211 1123457899999999999999999999999999999998 89999764321
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+...+........+..++.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 -DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11112222333445667889999999999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-56 Score=411.79 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=207.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|++|+|||||++++++.++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 87 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR-------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred HhcEeeEEEecCCCeEEEEEEECC-------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC
Confidence 359999999999999999997654 68999999986543 23456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+|||||.+|+|..++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred CEEEEEEEecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeeccc
Confidence 99999999999999987765443 78999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCcccccc---CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE 311 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~ 311 (413)
+..... .....||+.|||||++.+ ..|+.++|||||||++|+|++|..||......
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------------- 220 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------------- 220 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---------------
Confidence 985322 234679999999999864 46899999999999999999999999754211
Q ss_pred hhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 312 KRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+..+.........+..++.++.+||.+||+.||.+|||+.|+++|-+-
T Consensus 221 -~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 221 -SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp -HHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred -HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 11112222222222344678899999999999999999999999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=410.97 Aligned_cols=251 Identities=28% Similarity=0.371 Sum_probs=213.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++++.||+|+||+||+|++.. +++.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~-------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA-------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 3579999999999999999997554 68999999987542 2345678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++.+|+|||||.||+|.+++...+ .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecc
Confidence 999999999999999999997654 68999999999999999999997 669999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+|+..... .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+.. .
T Consensus 151 ~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----------------~ 212 (337)
T d1o6la_ 151 LCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------R 212 (337)
T ss_dssp TCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------H
T ss_pred cccccccC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----------------H
Confidence 99864322 22344578999999999999999999999999999999999999999875321 0
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETL 360 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L 360 (413)
.+..+.. ....+|..+++++.+||.+||++||.+|++ ++|+++|-
T Consensus 213 ~~~~i~~--~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 213 LFELILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHHHhc--CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 1111211 123456778899999999999999999994 88998864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=404.54 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=207.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh------hhHHHHHHHHHHHhhccCCCccceEeE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL------QGFEEWQSEVNFLGRLSHPNLVRLLGY 150 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 150 (413)
.++|++++.||+|+||+||+|++.. +++.||||++.+... ...+.+.+|+.+|++|+|||||+++++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS-------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 81 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT-------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC-------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4679999999999999999997653 688999999864321 235779999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC----C
Q 015094 151 CWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY----T 226 (413)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~----~ 226 (413)
+.+++.+|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCC
T ss_pred EEECCEEEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccc
Confidence 999999999999999999999997654 78999999999999999999997 6699999999999998776 4
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 156 vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------- 223 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 223 (293)
T ss_dssp EEECCCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred eEecchhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---------
Confidence 999999999864322 23345679999999999999999999999999999999999999998653211
Q ss_pred hhhhhhhhhhHhHHhhhc--CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 307 PYLSEKRKFRHIIDARLQ--GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+..+...... ...+..++.++.+||.+||+.||++|||++|+++|-
T Consensus 224 -------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 224 -------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp -------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred -------HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 11111111110 011124567899999999999999999999998763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-55 Score=400.39 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=213.0
Q ss_pred cCCCCCCe-eeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTV-LGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|.+.+. ||+|+||+||+|.+.. ...+..||||+++... ....+.+.+|+++|++++|||||++++++.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~-----~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRM-----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred cCeEECCcEEecccCeEEEEEEEec-----CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 45667774 9999999999997653 2245689999987553 3456789999999999999999999998865 5
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+|||||++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhh
Confidence 6899999999999999985432 368999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 236 KLGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 236 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----------------- 219 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------- 219 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----------------
Confidence 875433222 22234568999999999999999999999999999999998 89999765321
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+...+........|..++.++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11112223334456678889999999999999999999999999999876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=393.95 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=214.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||+||+|++. +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+++.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET--------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC--------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 57999999999999999999864 467899999876543 346799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+.+|+|.+++.... ..+++..+..++.||++||.|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred EEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhee
Confidence 99999999999999975443 368889999999999999999997 6699999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ...
T Consensus 150 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----------------~~~ 211 (258)
T d1k2pa_ 150 VLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ETA 211 (258)
T ss_dssp CSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------HHH
T ss_pred ccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----------------HHH
Confidence 43322 222334679999999999999999999999999999999998 89999765321 111
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
..+........|..++.++.+||.+||+.||++|||+++++++|.+|
T Consensus 212 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12223334456677888999999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=396.92 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=205.2
Q ss_pred CeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCeeEEEE
Q 015094 84 TVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 84 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 161 (413)
+.||+|+||+||+|.+.. ..+++.||||+++... ....+.+.+|+.+|++++||||+++++++.. +..|+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-----SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CCcccCCCeEEEEEEEcc-----CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 479999999999997653 2256889999986542 2345679999999999999999999999865 5679999
Q ss_pred eeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCCC
Q 015094 162 EFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPSA 241 (413)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~~ 241 (413)
|||++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 E~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 9999999999996543 68999999999999999999997 66999999999999999999999999999865433
Q ss_pred CCcc-eeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHhH
Q 015094 242 SQSH-VTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHII 319 (413)
Q Consensus 242 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (413)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----------------~~~~~i 223 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAML 223 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHH
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----------------HHHHHH
Confidence 3222 2234578999999999999999999999999999999998 89999764311 111222
Q ss_pred HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 320 DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 320 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
........|..++.++.+||.+||+.||++|||+++|++.|+.+.
T Consensus 224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 233344566778899999999999999999999999998887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=398.65 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=210.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++.+.||+|+||+||+|.+. +++.||||+++.... ..+.+.+|+.+|++++|||||++++++. ++.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC--------CCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCC
Confidence 467899999999999999999764 357899999976543 4467999999999999999999999775 467
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceE
Confidence 899999999999999875432 2258999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFR 316 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (413)
..... .........||+.|+|||++.+..++.++|||||||++|||+||..|+...... ....
T Consensus 158 ~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------------~~~~ 220 (272)
T d1qpca_ 158 LIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVI 220 (272)
T ss_dssp ECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHH
T ss_pred EccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----------------HHHH
Confidence 64332 122233457899999999999999999999999999999999965554332111 0111
Q ss_pred HhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 317 HIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
..+........+..++.++.+|+.+||+.||++|||+++|++.|+.+..
T Consensus 221 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1222333444566788899999999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=397.89 Aligned_cols=265 Identities=25% Similarity=0.425 Sum_probs=208.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
++|++.++||+|+||.||+|.+... .......||||++.... ......+.+|+.+|++++|||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~---~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTS---SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCC---CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 4688899999999999999987642 12234679999986543 3345578899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999999886543 368999999999999999999997 669999999999999999999999999998
Q ss_pred cCCCCCCc-ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQS-HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
........ .......||+.|+|||++.++.++.++|||||||++|||++|..||...... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~~ 222 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEV 222 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHH
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------------HHH
Confidence 64432221 2233456899999999999999999999999999999999976655432211 111
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
...+....+...+..++.++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 223 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 222333444556677889999999999999999999999999999987754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-54 Score=404.39 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=210.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH-------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred hHeEEEEEEecCcCcEEEEEEECC-------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 579999999999999999997654 68899999986542 23457789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
+.+|+|||||.|++|..++.... .+.+..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCcc
Confidence 99999999999999999986654 67888899999999999999997 6799999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
|+.... .....+||+.|||||++.+..|+.++|||||||++|+|++|..||...+.. ..
T Consensus 151 a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~ 209 (316)
T d1fota_ 151 AKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KT 209 (316)
T ss_dssp CEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HH
T ss_pred ceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH----------------HH
Confidence 986432 233468999999999999999999999999999999999999999764321 11
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
...+... ...++..++.++.++|.+||..||.+|+ |++++++|-+
T Consensus 210 ~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 210 YEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 1122221 2345667888999999999999999996 8999998743
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=402.34 Aligned_cols=275 Identities=27% Similarity=0.361 Sum_probs=213.2
Q ss_pred HHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceE
Q 015094 71 VELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLL 148 (413)
Q Consensus 71 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~ 148 (413)
.++....++|++.+.||+|+||+||+|.+... .+..+++.||||+++... ....+.+.+|+.++.++ +|+||+.++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~--~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEEST--TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCC--CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 44444457899999999999999999987542 344577899999987543 33456678888888887 588999999
Q ss_pred eEEEeC-CeeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 015094 149 GYCWED-KELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFK 215 (413)
Q Consensus 149 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlk 215 (413)
+++.+. ..+++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlK 161 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLA 161 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCC
Confidence 987665 568999999999999999975432 23358899999999999999999997 669999999
Q ss_pred CCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCC-CCCCCCC
Q 015094 216 ASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL-RALDTNR 294 (413)
Q Consensus 216 p~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~-~pf~~~~ 294 (413)
|+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654444433445568999999999999999999999999999999999974 5776543
Q ss_pred CCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 295 PSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
... .+...+........+..+++++.+||.+||+.||++|||+.|++++|+.+.+
T Consensus 242 ~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 IDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 221 1222333334445666788899999999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=400.48 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=210.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.++|++++.||+|+||+||+|++.. +++.||||+++..... ...+.+|+++|+.++||||++++++|.+++.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-------~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS-------SKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-------CCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4689999999999999999997654 6899999999876533 3568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC--CCCeEEccCCC
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG--SYTAKISDFGL 234 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~--~~~~kl~DfG~ 234 (413)
+|+|||||.|++|.+++...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++. .+.+||+|||+
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccch
Confidence 999999999999999996443 368999999999999999999997 66999999999999974 45899999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... ........+|+.|+|||++.+..|+.++|||||||++|+|++|..||...... ..
T Consensus 151 ~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----------------~~ 211 (321)
T d1tkia_ 151 ARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------------QI 211 (321)
T ss_dssp CEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HH
T ss_pred hhcccc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 986432 23344567999999999999999999999999999999999999999865321 11
Q ss_pred hhHhHHhhhcCCCc----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYP----YKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 315 ~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
+..+..... .++ ..++.++.+||.+||..||.+|||+.|+++|-+.
T Consensus 212 ~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 212 IENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 111221111 112 1457789999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.6e-54 Score=393.19 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=204.9
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEe
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE 153 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 153 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+++|+.++||||+++++++..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR-------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC-------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence 4689999999999999999997654 68999999987543 3345678999999999999999999999876
Q ss_pred CC----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 154 DK----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 154 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
.+ .+|+||||++|++|.+++...+ .+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++|
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEE
T ss_pred ccCCCceEEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCcccccee
Confidence 54 4899999999999999986654 68999999999999999999997 66999999999999999999999
Q ss_pred ccCCCcccCCCCCC-cceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQ-SHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||.+........ .......+||+.|+|||++.+..|+.++|||||||++|+|+||.+||.......
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------- 221 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------- 221 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----------
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-----------
Confidence 99999875433222 223345689999999999999999999999999999999999999997643211
Q ss_pred hhhhhhhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRP-SMREVVETLERLQ 364 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rp-t~~e~l~~L~~i~ 364 (413)
.+..++.... .......++.++.+||.+||+.||.+|| |++++++.|.+++
T Consensus 222 -----~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 222 -----VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111111100 0112235678899999999999999999 8999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-54 Score=392.51 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=204.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|.+.. ....+..||||.++... ....+.+.+|+.+|++++||||+++++++. ++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~----~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMS----PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC----C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEec----CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 4579999999999999999997753 22345789999986543 334567899999999999999999999885 56
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred eEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhh
Confidence 7999999999999999876543 368999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+..... .........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.......
T Consensus 156 ~~~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----------------- 217 (273)
T d1mp8a_ 156 RYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------------- 217 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------
T ss_pred eeccCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----------------
Confidence 864322 2222344578999999999999999999999999999999998 899997654321
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+...+........+..++.++.+||.+||+.||++|||+.||+++|+.+...
T Consensus 218 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 218 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111112223345667889999999999999999999999999999988654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-53 Score=390.97 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=208.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---------hhHHHHHHHHHHHhhcc-CCCccce
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---------QGFEEWQSEVNFLGRLS-HPNLVRL 147 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~~i~~~ 147 (413)
++|++.+.||+|+||+||+|++.. +++.||||++..... ...+.+.+|+.+|++|+ ||||+++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~-------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 75 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP-------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 75 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred ccCEEceEEecCcCeEEEEEEECC-------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 589999999999999999997654 689999999865421 12345789999999997 9999999
Q ss_pred EeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 148 LGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
++++.+++.+|||||||+||+|.+++...+ .+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCE
T ss_pred EeecccCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCe
Confidence 999999999999999999999999997654 78999999999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCcccccc------CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT------GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNL 301 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~ 301 (413)
||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..
T Consensus 150 kl~DFG~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~----- 221 (277)
T d1phka_ 150 KLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----- 221 (277)
T ss_dssp EECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred EEccchheeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-----
Confidence 99999999874332 23345689999999998853 35688999999999999999999999865321
Q ss_pred hHhhhhhhhhhhhhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 302 VDWIKPYLSEKRKFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.....+..... .......+++++.+||.+||+.||++|||++|+++|-
T Consensus 222 -----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 222 -----------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp -----------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred -----------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 11112222221 1223346788999999999999999999999998763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=399.68 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=210.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKE 156 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 156 (413)
.+|+++++||+|+||+||+|.+... .......||+|.+... .....+.+.+|+.+|++++||||+++++++.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCC---CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 4699999999999999999977541 1122346999988654 334567899999999999999999999998765 5
Q ss_pred eEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 157 LLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.+++|||+.+++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 788899999999999886543 378999999999999999999997 569999999999999999999999999998
Q ss_pred cCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhhh
Q 015094 237 LGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRKF 315 (413)
Q Consensus 237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (413)
...............||+.|+|||++.++.|+.++|||||||++|||+| |.+||...... .+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----------------~~ 222 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 222 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----------------GH
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----------------HH
Confidence 7554444434445678999999999999999999999999999999998 78888764321 12
Q ss_pred hHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 316 RHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
...+........+..++.++.+|+.+||+.||.+|||+.|++++|+.+..
T Consensus 223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 22333334445667788999999999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-54 Score=405.42 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=210.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~-------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE-------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCeEEEEEeecCcCcEEEEEEECC-------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 479999999999999999997654 68899999986542 23456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+++||||+.||+|.+++...+ .+++..++.++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeecee
Confidence 99999999999999999997654 68999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 235 AKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
|+.... ......||+.|||||++.+..|+.++|||||||++|+|++|..||...+.. ..
T Consensus 188 a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~ 246 (350)
T d1rdqe_ 188 AKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----------------QI 246 (350)
T ss_dssp CEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred eeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----------------HH
Confidence 986432 223467999999999999999999999999999999999999999764221 01
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
+..+... ...++..+++++.+||.+||..||.+|+ |++++++|-+
T Consensus 247 ~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 247 YEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHHhcC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 1112211 1234567888999999999999999994 8999998643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=394.99 Aligned_cols=271 Identities=28% Similarity=0.403 Sum_probs=218.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++++.||+|+||.||+|++..........+..||||+++.... .....+.+|+..+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 46899999999999999999987653323334567899999976543 4456788899999888 699999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+.+++|||||++|+|.+++..+.. ....+++..++.++.||+.||+|||+ ++||||||||+|||++
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeecccceeec
Confidence 999999999999999999976542 23468999999999999999999997 6699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNL 301 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~ 301 (413)
.++.+||+|||+++...............|++.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-----
Confidence 999999999999986554444444555779999999999999999999999999999999998 68888654321
Q ss_pred hHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 302 VDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+...+........+..++.++.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 245 ------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11122333444556677889999999999999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-53 Score=403.52 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=204.3
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh---hhHH---HHHHHHHHHhhccCCCccceEeEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL---QGFE---EWQSEVNFLGRLSHPNLVRLLGYC 151 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~---~~~~E~~~l~~l~h~~i~~~~~~~ 151 (413)
++|++.++||+|+||+||+|++.. +++.||||++..... .... ...+|+.+++.++||||+++++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~-------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD-------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC-------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 579999999999999999997654 689999999864321 1112 233457777788899999999999
Q ss_pred EeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 152 WEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
.+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||+ ++||||||||+|||++.+|.+||+|
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECC
T ss_pred EECCEEEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEee
Confidence 99999999999999999999997654 68899999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
||+|+..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..........
T Consensus 151 FGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---------- 216 (364)
T d1omwa3 151 LGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------- 216 (364)
T ss_dssp CTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----------
T ss_pred eceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----------
Confidence 9999864322 2334679999999999864 568999999999999999999999998754332111
Q ss_pred hhhhhhHhHHhh--hcCCCchHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 015094 311 EKRKFRHIIDAR--LQGQYPYKAAYQIAQLSLKCLEAEPKHRPS-----MREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt-----~~e~l~~L~ 361 (413)
+.... ....++..+++++.+||.+||+.||++||| ++|+++|-+
T Consensus 217 -------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 217 -------IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp -------HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred -------HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 11111 122345567889999999999999999999 799988744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=392.82 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=205.6
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
++|++.+.||+|+||+||+|++.. ++.||||++..... ..+.+.+|+.+|++++|||||++++++. ++.+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~--------~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT--------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC--------CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCe
Confidence 579999999999999999997653 46799999976543 4467999999999999999999999885 4568
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
++||||+++|+|..++.... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhh
Confidence 99999999999999886532 2368999999999999999999997 6699999999999999999999999999986
Q ss_pred CCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhH
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRH 317 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (413)
..... ........||+.|+|||++.++.++.++|||||||++|||++|..||...... .....
T Consensus 163 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----------------~~~~~ 225 (285)
T d1fmka3 163 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLD 225 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHH
T ss_pred ccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----------------HHHHH
Confidence 43222 22234467899999999999999999999999999999999976665443211 01111
Q ss_pred hHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 318 IIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 318 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+........+..++.++.+||.+||+.||++||++++|++.|+.+...
T Consensus 226 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 2223334456677889999999999999999999999999988876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-53 Score=395.83 Aligned_cols=268 Identities=26% Similarity=0.376 Sum_probs=216.7
Q ss_pred HhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh-hhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 76 ATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL-QGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 76 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
..++|++.+.||+|+||+||+|++... ....+++.||||+++.... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGL--LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS--STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCC--ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 456899999999999999999986531 2334678999999976543 3456799999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC--------------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA--------------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDF 214 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDl 214 (413)
+.+++||||+.+|+|.+++..... ....+++..++.++.||+.||+|||+ ++||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivHrDl 166 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDL 166 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEeeEE
Confidence 999999999999999999965321 22357889999999999999999997 66999999
Q ss_pred CCCcEEEcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCC-CCCCCC
Q 015094 215 KASNILLDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL-RALDTN 293 (413)
Q Consensus 215 kp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~-~pf~~~ 293 (413)
||+|||++.++.+||+|||+++...............|++.|+|||++.+..|+.++|||||||++|||++|. +||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998643333333344567899999999999999999999999999999999985 567654
Q ss_pred CCCCcchhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 015094 294 RPSGQHNLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQ 364 (413)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~ 364 (413)
.... .. ..+........+..++.++.+||.+||+.||++|||+.||++.|++|.
T Consensus 247 ~~~e----------------~~-~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEE----------------VI-YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHH----------------HH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHH----------------HH-HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2210 11 111222223456677889999999999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=389.80 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=204.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc---ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE---SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
++|++.+.||+|+||.||+|.+.. .......||||++... .....+.+.+|+.+|++++||||+++++++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~----~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDA----PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEEC----TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHeEEEEEEecCCCeEEEEEEEEC----CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 579999999999999999997653 2234567999998754 23445679999999999999999999999965
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGL 234 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 234 (413)
..+++||||+++++|.+++..+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchh
Confidence 57899999999999999886543 268999999999999999999997 6699999999999999999999999999
Q ss_pred cccCCCCCCcce-eecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhh
Q 015094 235 AKLGPSASQSHV-TTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEK 312 (413)
Q Consensus 235 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 312 (413)
++.......... .....|+..|+|||++.+..++.++|||||||++|||+| |..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---------------- 221 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------- 221 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----------------
Confidence 997544433222 234567889999999999999999999999999999998 89999754321
Q ss_pred hhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 313 RKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
..+..+.........+..++.++.+||.+||+.||++|||+.+|++.|...
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112222223333345567788999999999999999999999999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=387.34 Aligned_cols=253 Identities=28% Similarity=0.434 Sum_probs=204.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEe-CC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-DK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 155 (413)
.++|++.+.||+|+||.||+|.+. ++.||||+++.+. ..+.+.+|++++++++||||+++++++.+ .+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC---------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 356889999999999999999764 5789999997654 45779999999999999999999998865 46
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+++|+|.+++..+.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccc
Confidence 78999999999999999965432 258999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhhhhh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQHNLVDWIKPYLSEKRK 314 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 314 (413)
+.... ......++..|+|||++.+..++.++|||||||++|||+| |.+||.......
T Consensus 151 ~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----------------- 208 (262)
T d1byga_ 151 KEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------- 208 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----------------
T ss_pred eecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-----------------
Confidence 85322 2233468899999999999999999999999999999998 688776543211
Q ss_pred hhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 315 FRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+...+.......++..+++++.+||.+||+.||.+|||+.+++++|+.+...
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 209 VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1112222344456677888999999999999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=396.84 Aligned_cols=249 Identities=29% Similarity=0.412 Sum_probs=207.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC---hhhHHHHHHHHHHHh-hccCCCccceEeEEEe
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES---LQGFEEWQSEVNFLG-RLSHPNLVRLLGYCWE 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~ 153 (413)
++|++++.||+|+||+||+|++.. +++.||||++.+.. ....+.+.+|+.++. .++||||+++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~-------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK-------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCeEEeeEEecCCCcEEEEEEECC-------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 479999999999999999997654 68999999986542 234456677777765 6899999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCC
Q 015094 154 DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFG 233 (413)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG 233 (413)
++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccc
Confidence 999999999999999999997654 68899999999999999999997 569999999999999999999999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhh
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKR 313 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 313 (413)
+++..... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...
T Consensus 149 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---------------- 210 (320)
T d1xjda_ 149 MCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---------------- 210 (320)
T ss_dssp TCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------
T ss_pred hhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----------------
Confidence 99864322 223345689999999999999999999999999999999999999998653211
Q ss_pred hhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 015094 314 KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMR-EVVET 359 (413)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~-e~l~~ 359 (413)
.+..+.. ....++..++.++.+||.+||..||.+||++. ++++|
T Consensus 211 ~~~~i~~--~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 211 LFHSIRM--DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHc--CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 1111111 12345667789999999999999999999996 78764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=395.45 Aligned_cols=255 Identities=24% Similarity=0.301 Sum_probs=201.9
Q ss_pred hcCCCCCC-eeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhc-cCCCccceEeEEEe-
Q 015094 77 TRNFKSDT-VLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWE- 153 (413)
Q Consensus 77 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~- 153 (413)
.++|++.. .||+|+||+||+|++.. +++.||||+++.. ..+.+|+.++.++ +||||++++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR-------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT-------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC-------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 35788874 69999999999997654 6789999998643 4567899987655 79999999999875
Q ss_pred ---CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC---CCCe
Q 015094 154 ---DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG---SYTA 227 (413)
Q Consensus 154 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~---~~~~ 227 (413)
+..+|+|||||+||+|.+++..++ ...+++..++.++.||+.||+|||+ +||+||||||+|||++. .+.+
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCE
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccc
Confidence 467999999999999999997543 2479999999999999999999997 66999999999999975 5679
Q ss_pred EEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 228 KISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|+||..||.............
T Consensus 154 Kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---- 226 (335)
T d2ozaa1 154 KLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---- 226 (335)
T ss_dssp EECCCTTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred cccccceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH----
Confidence 99999999864332 23345689999999999999999999999999999999999999997654332111000
Q ss_pred hhhhhhhhhHhHHhhh--cCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 015094 308 YLSEKRKFRHIIDARL--QGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLER 362 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~ 362 (413)
..+..... .......++.++.+||.+||+.||++|||+.|+++|-+.
T Consensus 227 --------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 227 --------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp ---------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred --------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 00000000 001113567889999999999999999999999998554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=391.32 Aligned_cols=270 Identities=29% Similarity=0.406 Sum_probs=224.5
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhc-cCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 154 (413)
.++|++.+.||+|+||.||+|.+... .+..+++.||||+++... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~--~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGL--IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS--SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEecc--ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 36889999999999999999987532 233578899999997653 34456788999999999 599999999999999
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCC--------------CCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGA--------------SVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNIL 220 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil 220 (413)
..+|+|||||++|+|.+++..... ....+++..++.++.||+.||+|||+ ++||||||||+|||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNIL 177 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccccccccc
Confidence 999999999999999999976432 23358899999999999999999997 66999999999999
Q ss_pred EcCCCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 015094 221 LDGSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILT-GLRALDTNRPSGQH 299 (413)
Q Consensus 221 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-G~~pf~~~~~~~~~ 299 (413)
++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999997655555555566789999999999999999999999999999999999 55555544321
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
..+..++........+..++.++.+||.+||+.||.+|||+.+|++.|+++...
T Consensus 255 -------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 123334445555566677889999999999999999999999999999976544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=389.84 Aligned_cols=264 Identities=24% Similarity=0.247 Sum_probs=195.0
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChh-----hHHHHHHHHHHHhhccCCCccceEeEEEeCCee
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQ-----GFEEWQSEVNFLGRLSHPNLVRLLGYCWEDKEL 157 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 157 (413)
+++||+|+||+||+|++.. +++.||||+++..... ..+.+.+|+.+|+.++||||+++++++.+++.+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKN-------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEETTEEEEEEECSS-------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred ceEeccCcCeEEEEEEECC-------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence 5789999999999996543 6889999998654321 134688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 158 LLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
|+||||+.++++..++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~ivmE~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp EEEEECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eehhhhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccc
Confidence 999999988777766532 2368888999999999999999997 6699999999999999999999999999976
Q ss_pred CCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hhhhhhhh
Q 015094 238 GPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK--PYLSEKRK 314 (413)
Q Consensus 238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~--~~~~~~~~ 314 (413)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||......+......... +.......
T Consensus 150 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 43322 22334679999999998865 467999999999999999999999997654322111100000 00000000
Q ss_pred hhHhHHhhhcC---CC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 315 FRHIIDARLQG---QY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 315 ~~~~~~~~~~~---~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
........... .. ....+.++.+||.+||+.||++|||++|+++|-+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 00000000000 00 1134678999999999999999999999997643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=387.93 Aligned_cols=262 Identities=28% Similarity=0.423 Sum_probs=209.8
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhc-cCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRL-SHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 155 (413)
++|++.++||+|+||+||+|++... +....||||.+... .....+.+.+|+++|+++ +||||+++++++.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKD-----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEET-----TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCC-----CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5788999999999999999987641 12235788887543 333556789999999999 6999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcC------------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRG------------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG 223 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~ 223 (413)
.+|+||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEEcC
Confidence 9999999999999999996542 234578999999999999999999997 66999999999999999
Q ss_pred CCCeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCC-CCCCCCCCCcchhh
Q 015094 224 SYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLR-ALDTNRPSGQHNLV 302 (413)
Q Consensus 224 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~-pf~~~~~~~~~~~~ 302 (413)
++.+||+|||+++..... .......||..|+|||.+.+..|+.++|||||||++|||++|.. ||...+..
T Consensus 163 ~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------ 233 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ 233 (309)
T ss_dssp GGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------
T ss_pred CCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------
Confidence 999999999999853222 22234568999999999999999999999999999999999764 56543211
Q ss_pred HhhhhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 303 DWIKPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.+...+........+..+++++.+||.+||+.||++|||+.+|+++|+++...
T Consensus 234 -----------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 -----------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -----------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----------HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111222233455667889999999999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=386.84 Aligned_cols=243 Identities=24% Similarity=0.378 Sum_probs=200.8
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh------hhHHHHHHHHHHHhhcc--CCCccceE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL------QGFEEWQSEVNFLGRLS--HPNLVRLL 148 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~~i~~~~ 148 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++..... ....++.+|+.+|++++ ||||++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~ 75 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS-------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC-------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEE
Confidence 3689999999999999999997654 678999999865421 11234678999999997 89999999
Q ss_pred eEEEeCCeeEEEEeeCCC-CCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-CCC
Q 015094 149 GYCWEDKELLLVYEFMQK-GSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-SYT 226 (413)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-~~~ 226 (413)
+++.+++.+|+||||+.+ +++.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 76 DWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTE
T ss_pred EEEeeCCeEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCe
Confidence 999999999999999976 57888886543 78999999999999999999997 66999999999999985 579
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCc-cchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 150 vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------- 214 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 214 (273)
T ss_dssp EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred EEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------
Confidence 999999999863322 2345689999999999987766 577899999999999999999996421
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.+.. ....++..++.++.+||.+||..||++|||++|+++|-
T Consensus 215 -----------~i~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 215 -----------EIIR--GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp -----------HHHH--CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -----------HHhh--cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 0111 11234456778999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=386.98 Aligned_cols=268 Identities=23% Similarity=0.322 Sum_probs=200.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++++.||+|+||+||+|++.. +++.||||+++.... ...+.+.+|+++|++++||||+++++++.+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL-------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCEeccEEecCcCeEEEEEEECC-------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 479999999999999999997654 678999999865432 23567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
.+|+||||+.+ ++.+++.... ...+++..+..++.||+.||+|||+ +|||||||||+|||++.++.+||+|||++
T Consensus 75 ~~~iv~e~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 75 KLYLVFEFLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp EEEEEEECCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ceeEEEeecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcc
Confidence 99999999966 5555553332 2368999999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCC-ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh--h
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE--K 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~--~ 312 (413)
+..... ........||+.|+|||++.... ++.++|||||||++|+|++|+.||...+................+ .
T Consensus 150 ~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 150 RAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 864322 22233457999999999877665 478999999999999999999999865422111100000000000 0
Q ss_pred hhhhHh---HH---hhhcCC---CchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 313 RKFRHI---ID---ARLQGQ---YPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 313 ~~~~~~---~~---~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
...... .. ...... ....++.++.+||.+||..||++|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 00 000000 011445789999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=379.04 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=207.4
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEe-CCeeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-DKELLLV 160 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 160 (413)
.++||+|+||+||+|++... ......||||+++.. .....+.+.+|+++|++++||||+++++++.+ +..+++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDN----DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC--------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECC----CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 56899999999999987541 223457999998743 44566789999999999999999999998765 4689999
Q ss_pred EeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCcccCCC
Q 015094 161 YEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKLGPS 240 (413)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~~~~ 240 (413)
||||++++|.+++.... ..+.+..++.++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 108 ~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 99999999999986543 367788899999999999999997 6699999999999999999999999999986443
Q ss_pred CCCc--ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhhhhhhhHh
Q 015094 241 ASQS--HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSEKRKFRHI 318 (413)
Q Consensus 241 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (413)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|..||....... .+...
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----------------~~~~~ 246 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----------------DITVY 246 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------------CHHH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----------------HHHHH
Confidence 2221 12233578999999999999999999999999999999999887776532111 01111
Q ss_pred HHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 319 IDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 319 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
+........+..++.++.+||.+||+.||++||++.||+++|+.+...
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112223344566788999999999999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=380.96 Aligned_cols=266 Identities=25% Similarity=0.383 Sum_probs=214.7
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc-ChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE-SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||.||+|.+... .+...++.||||+++.. .......+.+|+.++++++||||+++++++..+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~--~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGV--VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEE--ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCc--ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 46789999999999999999977531 12224578999999754 3344556899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcC------CCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 156 ELLLVYEFMQKGSLENHLFGRG------ASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
..++||||+.+|+|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCEEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceEEE
Confidence 9999999999999999986432 122357889999999999999999997 56999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCC-CCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGL-RALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~-~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||...+..
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------------ 242 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------------ 242 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------------
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 9999998644333333334457899999999999999999999999999999999985 666543211
Q ss_pred hhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 015094 309 LSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERL 363 (413)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i 363 (413)
..+..+. .......+..++..+.+||.+||+.||++|||+.+|+++|+..
T Consensus 243 ----~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 243 ----QVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ----HHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ----HHHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111 2223344567788999999999999999999999999998765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=384.85 Aligned_cols=271 Identities=25% Similarity=0.327 Sum_probs=201.0
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhc---cCCCccceEeEE
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRL---SHPNLVRLLGYC 151 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~~ 151 (413)
.++|++++.||+|+||+||+|++... .++.||||++..... .....+.+|+.+|+.| +||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 46899999999999999999976431 367899999864322 2233466788887776 699999999998
Q ss_pred Ee-----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCC
Q 015094 152 WE-----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYT 226 (413)
Q Consensus 152 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~ 226 (413)
.. ...+|++|||+.++.+...... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCC
T ss_pred cccccccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCC
Confidence 63 3578999999988766544432 22368899999999999999999997 66999999999999999999
Q ss_pred eEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 015094 227 AKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIK 306 (413)
Q Consensus 227 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~ 306 (413)
+||+|||++... ..........||+.|+|||++.+..|+.++|||||||++|||++|.+||...+............
T Consensus 155 ~kl~dfg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 155 IKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp EEECSCCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 999999998752 23333455789999999999999999999999999999999999999998654322111110000
Q ss_pred hhh-----hhhhhh-hHhHH---hhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 PYL-----SEKRKF-RHIID---ARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 ~~~-----~~~~~~-~~~~~---~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
... ...... ..... ......+...++..+.+||.+||+.||++|||+.|+++|-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 000 000000 00000 00001123356778999999999999999999999998743
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=376.54 Aligned_cols=274 Identities=25% Similarity=0.334 Sum_probs=202.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeCC--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK-- 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 155 (413)
++|.+.+.||+|+||.||+|++ +++.||||++...... ....+.|+..+..++||||+++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---------~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---------CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence 5688889999999999999975 3689999998765322 122344566667789999999999988654
Q ss_pred --eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCCCCcEEEcCCCCe
Q 015094 156 --ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------DKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 156 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
.+|+||||+++|+|.+++.+. .+++..++.++.|++.||+|||+. .++|+||||||+||||+.++.+
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred ceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 689999999999999999653 588999999999999999999963 3589999999999999999999
Q ss_pred EEccCCCcccCCCCCCcc--eeecccccccccCccccccC------CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 015094 228 KISDFGLAKLGPSASQSH--VTTRVMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQH 299 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~ 299 (413)
||+|||+++......... ......||+.|+|||++.+. .++.++|||||||+||||+||..||.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999998654332221 23356899999999998654 3678999999999999999999887554322111
Q ss_pred hhhHhhhhhhhhhhhhhHhHHhhhcCCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhcC
Q 015094 300 NLVDWIKPYLSEKRKFRHIIDARLQGQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQASD 367 (413)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~~ 367 (413)
... ....................+..+ +......+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 228 ~~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 228 YYD-LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TTT-TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhh-cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 100 000000000000111111222222 2245567999999999999999999999999999987654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.4e-51 Score=376.38 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh--hhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL--QGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++++.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.+|++++||||+++++++..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCceeccEEecCCCcEEEEEEeC--------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 58999999999999999999753 468999999866532 33578899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..|++|||+.++.+..+.... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||++
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred ceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccc
Confidence 999999999876666665332 479999999999999999999997 56999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh-----hh
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP-----YL 309 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~-----~~ 309 (413)
....... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+............. ..
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 8643222 22334578999999999865 4568999999999999999999999976543221111000000 00
Q ss_pred hhhhhhhHhH------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 015094 310 SEKRKFRHII------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVET 359 (413)
Q Consensus 310 ~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~ 359 (413)
.......... ............+.++.+||.+||+.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 0000011223456789999999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=378.47 Aligned_cols=265 Identities=23% Similarity=0.281 Sum_probs=196.5
Q ss_pred CCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCccceEeEEEeC----
Q 015094 79 NFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED---- 154 (413)
Q Consensus 79 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 154 (413)
+|+.+++||+|+||+||+|++.. +++.||||++..... ...+|+.+|++++||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD-------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-------TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred CcEeeeEEeeCcCeEEEEEEECC-------CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 58889999999999999997654 689999999876542 234799999999999999999998543
Q ss_pred --CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEcc
Q 015094 155 --KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISD 231 (413)
Q Consensus 155 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~D 231 (413)
.++|+|||||.++ +.+.+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus 90 ~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp SCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECC
T ss_pred CceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEec
Confidence 3589999999765 444443322334479999999999999999999996 6699999999999998765 899999
Q ss_pred CCCcccCCCCCCcceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 232 FGLAKLGPSASQSHVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 232 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
||++...... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||...................
T Consensus 167 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~- 242 (350)
T d1q5ka_ 167 FGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP- 242 (350)
T ss_dssp CTTCEECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC-
T ss_pred ccchhhccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC-
Confidence 9999864322 23344689999999998765 578999999999999999999999997654322111100000000
Q ss_pred hhhhhhHhHHh------------hhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 311 EKRKFRHIIDA------------RLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
........... .+........++++.+||.+||..||++|||+.|+++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 00000000000 0011122346778999999999999999999999998743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=369.03 Aligned_cols=271 Identities=22% Similarity=0.290 Sum_probs=196.7
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK-------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCEEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 689999999999999999997654 68899999986542 2345678899999999999999999998865
Q ss_pred ------CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCe
Q 015094 154 ------DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTA 227 (413)
Q Consensus 154 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~ 227 (413)
+..+|+||||+.++.+..+.. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCE
T ss_pred ccccccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcE
Confidence 346899999998766655442 23378899999999999999999997 669999999999999999999
Q ss_pred EEccCCCcccCCCCCCc--ceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 015094 228 KISDFGLAKLGPSASQS--HVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW 304 (413)
Q Consensus 228 kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~ 304 (413)
||+|||++......... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||..............
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999764432211 122345799999999998765 688999999999999999999999976543221111100
Q ss_pred hhhhhh-h------hhhhhHhHHhhhcCCC-------chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 305 IKPYLS-E------KRKFRHIIDARLQGQY-------PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 305 ~~~~~~-~------~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
...... . ................ ....+.++.+||.+||+.||++|||++|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 000000 0 0000000000000000 0122457889999999999999999999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=375.28 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=197.1
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++++.||+|+||+||+|.+.. +++.||||++... .....+.+.+|+++|+.++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR-------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT-------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 4689999999999999999997654 6899999999754 334456788999999999999999999999865
Q ss_pred C------eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeE
Q 015094 155 K------ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAK 228 (413)
Q Consensus 155 ~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~k 228 (413)
+ .+|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred ccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccc
Confidence 4 579999999 6688877643 268999999999999999999997 6699999999999999999999
Q ss_pred EccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 229 ISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 229 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|||+++.... ..+...||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+.............
T Consensus 162 l~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 999999986432 23446799999999998764 568999999999999999999999987643221111100000
Q ss_pred -----hhhh-hhhhhHhHHhhhc-------CCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 308 -----YLSE-KRKFRHIIDARLQ-------GQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 308 -----~~~~-~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
+... ...........+. .......++++.+||.+||..||++|||++|+|+|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 0000 0000000000000 011234577899999999999999999999999873
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=378.27 Aligned_cols=270 Identities=21% Similarity=0.268 Sum_probs=198.3
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC-hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES-LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
..+|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|+.|+||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV-------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT-------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC-------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 3579999999999999999997543 68899999987543 344567889999999999999999999987653
Q ss_pred ----eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEcc
Q 015094 156 ----ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISD 231 (413)
Q Consensus 156 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~D 231 (413)
..+++++|+.+++|.+++... .+++..++.++.||+.||+|||+ +|||||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcc
Confidence 234445556689999999643 58999999999999999999997 6699999999999999999999999
Q ss_pred CCCcccCCCCCCc-ceeecccccccccCcccccc-CCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 015094 232 FGLAKLGPSASQS-HVTTRVMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYL 309 (413)
Q Consensus 232 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~ 309 (413)
||++......... ......+||+.|+|||++.. ..++.++||||+||++|+|++|..||...................
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999864332211 12344679999999999844 567899999999999999999999997754322211111110000
Q ss_pred hhhh-------hhhHhHHhhh-cCCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 310 SEKR-------KFRHIIDARL-QGQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 310 ~~~~-------~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.... .......... .... ....+.++.+||.+||..||.+|||+.|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0000 0000000000 0000 123456899999999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-49 Score=369.96 Aligned_cols=260 Identities=17% Similarity=0.250 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeC--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWED-- 154 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-- 154 (413)
++|++++.||+|+||+||+|++.. +++.||||+++... .+.+.+|+.+|+.+. ||||++++++|...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT-------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC-------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 579999999999999999997654 68999999997653 457889999999996 99999999998754
Q ss_pred CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCC-CeEEccCC
Q 015094 155 KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSY-TAKISDFG 233 (413)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~-~~kl~DfG 233 (413)
..+++|||||.+++|..+. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred CceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccc
Confidence 5799999999999997764 268999999999999999999997 6699999999999998654 69999999
Q ss_pred CcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh-
Q 015094 234 LAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE- 311 (413)
Q Consensus 234 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~- 311 (413)
+++..... ......++|+.|+|||++.+. .++.++|||||||++|+|++|..||............ +...+..
T Consensus 176 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~--i~~~~g~~ 250 (328)
T d3bqca1 176 LAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR--IAKVLGTE 250 (328)
T ss_dssp GCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH--HHHHHCHH
T ss_pred cceeccCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH--HHHHHCCc
Confidence 99864332 223456799999999998765 5789999999999999999999999765432211100 0000000
Q ss_pred -------------hhhhhHhH--------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 312 -------------KRKFRHII--------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 312 -------------~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
...+.... ...........+++++.+||.+||..||++|||++|+|+|-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00000000 001111222356788999999999999999999999998643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-48 Score=360.61 Aligned_cols=265 Identities=17% Similarity=0.183 Sum_probs=209.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccC-CCccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSH-PNLVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ..+.+.+|+++++.|.| +||+.+++++.++.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL-------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 4689999999999999999997654 68999999886543 22356789999999985 89999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcC-----CCCeEEc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDG-----SYTAKIS 230 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~-----~~~~kl~ 230 (413)
..|+||||+ +++|.+++...+ ..++...+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEc
Confidence 999999999 789999986544 368999999999999999999997 66999999999999964 5789999
Q ss_pred cCCCcccCCCCCCc-----ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 015094 231 DFGLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWI 305 (413)
Q Consensus 231 DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~ 305 (413)
|||+|+........ ......+||+.|||||++.+..++.++|||||||++|+|++|..||..............+
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 99999875432221 1233468999999999999999999999999999999999999999875544322111111
Q ss_pred hhhhhhhhhhhHhHHhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHhc
Q 015094 306 KPYLSEKRKFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQAS 366 (413)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~~ 366 (413)
.. ... ..... .....+++++.+++..|+..+|++||+++.+.+.|+.+...
T Consensus 229 ~~---~~~---~~~~~----~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 229 GE---KKQ---STPLR----ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HH---HHH---HSCHH----HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Hh---ccC---CCChH----HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 00 000 00000 11124567899999999999999999999999888886543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=370.55 Aligned_cols=257 Identities=28% Similarity=0.364 Sum_probs=208.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC----hhhHHHHHHHHHHHhhccC-CCccceEeEEE
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES----LQGFEEWQSEVNFLGRLSH-PNLVRLLGYCW 152 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~ 152 (413)
++|++++.||+|+||+||+|+... ...+++.||||+++... ....+.+.+|+++|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKIS----GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS----STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECc----cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 569999999999999999997642 23468999999986542 2234567899999999987 89999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccC
Q 015094 153 EDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDF 232 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~Df 232 (413)
+...+++||||+.+++|.+++.... .+.+..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred cCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeec
Confidence 9999999999999999999997665 56788899999999999999997 66999999999999999999999999
Q ss_pred CCcccCCCCCCcceeecccccccccCccccccC--CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 015094 233 GLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLS 310 (413)
Q Consensus 233 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~ 310 (413)
|+++...... ........|++.|+|||.+.+. .++.++|||||||+||+|++|..||...........
T Consensus 174 G~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--------- 243 (322)
T d1vzoa_ 174 GLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--------- 243 (322)
T ss_dssp SEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---------
T ss_pred cchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------
Confidence 9998643322 2223446799999999998664 467899999999999999999999987654432111
Q ss_pred hhhhhhHhHHh--hhcCCCchHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHH
Q 015094 311 EKRKFRHIIDA--RLQGQYPYKAAYQIAQLSLKCLEAEPKHRP-----SMREVVETLE 361 (413)
Q Consensus 311 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~~L~ 361 (413)
+... .....++..++.++.+||.+||.+||.+|| |++|+++|-+
T Consensus 244 -------i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 244 -------ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp -------HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -------HHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 1111 112345567889999999999999999999 5889987643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=362.60 Aligned_cols=261 Identities=18% Similarity=0.200 Sum_probs=201.2
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC-ccceEeEEEeCC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN-LVRLLGYCWEDK 155 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~ 155 (413)
.++|++.+.||+|+||+||+|++.. +++.||||++..... .+.+.+|+++++.++|++ |+.+.+++.+++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIA-------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETT-------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECC-------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 3579999999999999999997654 678999998765532 235788999999998766 555566677888
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc---CCCCeEEccC
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD---GSYTAKISDF 232 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~---~~~~~kl~Df 232 (413)
..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+||
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeecc
Confidence 999999999 557777665433 368999999999999999999997 6699999999999985 4557999999
Q ss_pred CCcccCCCCCCc-----ceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 015094 233 GLAKLGPSASQS-----HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKP 307 (413)
Q Consensus 233 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~ 307 (413)
|+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..||................
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~- 229 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS- 229 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-
Confidence 999875433221 12345679999999999999999999999999999999999999998754433221111000
Q ss_pred hhhhhhhhhHhHHhhhcC---CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHh
Q 015094 308 YLSEKRKFRHIIDARLQG---QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLERLQA 365 (413)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~~i~~ 365 (413)
...... .....++.++.+|+.+||+.||++||++.++.+.|+.+..
T Consensus 230 ------------~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 230 ------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ------------HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ------------cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000000 0122456789999999999999999999999888887654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=363.19 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=205.5
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeCC
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWEDK 155 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 155 (413)
++|++++.||+|+||+||+|++.. +++.||||+++... ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE-------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT-------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEECC-------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 589999999999999999997654 67899999986442 344678899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCc
Q 015094 156 ELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKISDFGLA 235 (413)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a 235 (413)
..++|||++.+++|..++... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.+
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchh
Confidence 999999999999888887544 378899999999999999999997 66999999999999999999999999999
Q ss_pred ccCCCCCCcceeecccccccccCccccccCC-ccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhh--h
Q 015094 236 KLGPSASQSHVTTRVMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPYLSE--K 312 (413)
Q Consensus 236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~~~~--~ 312 (413)
........ ......++..|+|||++.+.. ++.++|||||||++|+|++|..||.......... ..+...... .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~ 224 (292)
T d1unla_ 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH--HHHHHHHCCCCT
T ss_pred hcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH--HHHHhhcCCCCh
Confidence 86433222 233456788999999887655 6899999999999999999999875433221110 000000000 0
Q ss_pred hh---hhHhH---------HhhhcCCCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 015094 313 RK---FRHII---------DARLQGQYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETL 360 (413)
Q Consensus 313 ~~---~~~~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L 360 (413)
.. ..... ............+..+.+||.+||+.||.+|||++|+++|-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 00 00000 00011122335567899999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=372.38 Aligned_cols=265 Identities=23% Similarity=0.272 Sum_probs=193.4
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc--ChhhHHHHHHHHHHHhhccCCCccceEeEEEe--
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE--SLQGFEEWQSEVNFLGRLSHPNLVRLLGYCWE-- 153 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 153 (413)
++|++++.||+|+||+||+|++.. +++.||||++... .....+.+.+|+.+|++++||||++++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~-------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV-------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT-------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECC-------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 689999999999999999997654 6899999998754 33445678899999999999999999999864
Q ss_pred ----CCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 154 ----DKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 154 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
...+|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|+
T Consensus 90 ~~~~~~~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEE
T ss_pred ccccCceeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceee
Confidence 36899999999765 444442 257899999999999999999997 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh--
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDW-IK-- 306 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~-~~-- 306 (413)
+|||+++... ........+||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......... ..
T Consensus 161 ~df~~~~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhccc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999988532 23334556799999999999999999999999999999999999999976542211111000 00
Q ss_pred --hhhh-hhhhhhHhHHh---------------hh-cC--CCchHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 307 --PYLS-EKRKFRHIIDA---------------RL-QG--QYPYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 307 --~~~~-~~~~~~~~~~~---------------~~-~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.++. ........... .. .. ......+.++.+||.+||..||++||||+|+|+|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 0000 00000001110 00 00 112346788999999999999999999999998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=367.09 Aligned_cols=266 Identities=23% Similarity=0.290 Sum_probs=197.6
Q ss_pred hcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcC--hhhHHHHHHHHHHHhhccCCCccceEeEEEeC
Q 015094 77 TRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSES--LQGFEEWQSEVNFLGRLSHPNLVRLLGYCWED 154 (413)
Q Consensus 77 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 154 (413)
.++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+.+|+++|+.|+||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK-------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT-------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC-------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence 4689999999999999999997554 68999999997553 34456788999999999999999999998643
Q ss_pred -----CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCCCCeEE
Q 015094 155 -----KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGSYTAKI 229 (413)
Q Consensus 155 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~~~~kl 229 (413)
...++||+|+.|++|.+++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|+
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccc
Confidence 344666777889999999843 268999999999999999999997 66999999999999999999999
Q ss_pred ccCCCcccCCCCCCcceeecccccccccCccccccC-CccchhhhHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 015094 230 SDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQHNLVDWIKPY 308 (413)
Q Consensus 230 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~~~~~~~~~~~ 308 (413)
+|||++.... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..............
T Consensus 163 ~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 163 LDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999997522 223446799999999987665 4578999999999999999999999865432211111000000
Q ss_pred -----hh--hhhhhhHhHHhhhc-CCC-----chHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 015094 309 -----LS--EKRKFRHIIDARLQ-GQY-----PYKAAYQIAQLSLKCLEAEPKHRPSMREVVETLE 361 (413)
Q Consensus 309 -----~~--~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~~L~ 361 (413)
.. .............. ... ....+.++.+||.+||..||.+|||+.|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 00 00000000000000 000 1235678999999999999999999999998744
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-43 Score=335.05 Aligned_cols=267 Identities=19% Similarity=0.235 Sum_probs=194.2
Q ss_pred cCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-----------CCCccc
Q 015094 78 RNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-----------HPNLVR 146 (413)
Q Consensus 78 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~ 146 (413)
++|++++.||+|+||+||+|++.. +++.||||+++.... ..+.+.+|+.+++.+. |+||++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~-------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV-------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC-------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 469999999999999999997554 689999999986643 3456788999998885 478999
Q ss_pred eEeEEEeC--CeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEcCC
Q 015094 147 LLGYCWED--KELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLDGS 224 (413)
Q Consensus 147 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~~~ 224 (413)
+++++... ...+++|+++..+......... .....+.+..+..++.||+.||+|||+ ..||+||||||+|||++.+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCEEEEEEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEE
T ss_pred EEEEeeeccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeecc
Confidence 99987653 5667777776555443333222 233478889999999999999999996 3569999999999999765
Q ss_pred C------CeEEccCCCcccCCCCCCcceeecccccccccCccccccCCccchhhhHHHHHHHHHHHhCCCCCCCCCCCCc
Q 015094 225 Y------TAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLVEILTGLRALDTNRPSGQ 298 (413)
Q Consensus 225 ~------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~lltG~~pf~~~~~~~~ 298 (413)
+ .++|+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++++|++|+.||........
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 5 399999999975322 23446799999999999999999999999999999999999999976543221
Q ss_pred chhhHhhhhhh---hh-------h-h---------------------hhhHhHHhhhcCCCchHHHHHHHHHHHHccccC
Q 015094 299 HNLVDWIKPYL---SE-------K-R---------------------KFRHIIDARLQGQYPYKAAYQIAQLSLKCLEAE 346 (413)
Q Consensus 299 ~~~~~~~~~~~---~~-------~-~---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 346 (413)
....+...... .. . . ...... ..........+.++.+||.+||..|
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhc--ccccccCcccCHHHHHHHHHHCCCC
Confidence 11111110000 00 0 0 000000 0122345677889999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 015094 347 PKHRPSMREVVETLE 361 (413)
Q Consensus 347 p~~Rpt~~e~l~~L~ 361 (413)
|.+|||++|+|+|-+
T Consensus 316 P~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPW 330 (362)
T ss_dssp TTTCBCHHHHHTCGG
T ss_pred hhHCcCHHHHhcCcc
Confidence 999999999998643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=9.6e-26 Score=193.79 Aligned_cols=163 Identities=12% Similarity=0.067 Sum_probs=117.1
Q ss_pred CCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcCh------------------hhHHHHHHHHHHHhhccCC
Q 015094 81 KSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESL------------------QGFEEWQSEVNFLGRLSHP 142 (413)
Q Consensus 81 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ 142 (413)
.+.+.||+|+||+||+|... +++.||||+++.... .......+|+..+.++.|.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 74 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred hhCCEeeeCcceEEEEEECC--------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC
Confidence 35789999999999999653 478999998653211 0112345788999999999
Q ss_pred CccceEeEEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEc
Q 015094 143 NLVRLLGYCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILLD 222 (413)
Q Consensus 143 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~ivHrDlkp~Nil~~ 222 (413)
+++..+++. ..+++|||+++..+.+ +....+..++.||+.+|.|||+ +||+||||||+|||++
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~ 137 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS 137 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE
T ss_pred CcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeee
Confidence 999988653 2379999998865543 2233346789999999999997 5699999999999999
Q ss_pred CCCCeEEccCCCcccCCCCCCcceeecccccccccCc------cccccCCccchhhhHHHHHHH
Q 015094 223 GSYTAKISDFGLAKLGPSASQSHVTTRVMGTYGYAAP------EYVATGHLYVKSDVYGFGVVL 280 (413)
Q Consensus 223 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwslG~il 280 (413)
++ .++|+|||+|......... .|... + +....|..++|+||+.--+
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence 65 5899999999753322111 11111 1 1246788899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=4e-09 Score=93.16 Aligned_cols=148 Identities=15% Similarity=0.063 Sum_probs=101.4
Q ss_pred HHHHHHhcCCCCCCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEe
Q 015094 71 VELRAATRNFKSDTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLG 149 (413)
Q Consensus 71 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~ 149 (413)
.++......|++.+..+-++.+.||+... .++.++||+...........+.+|...++.|. +--+.+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~---------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~ 77 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG---------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC---------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe---------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEE
Confidence 45666677888777766566678998742 34567888876554444456788999988885 444688888
Q ss_pred EEEeCCeeEEEEeeCCCCCHHHhhhhcCCCCCCCcHHHHHHHHHHHHHHHHHhhcC------------------------
Q 015094 150 YCWEDKELLLVYEFMQKGSLENHLFGRGASVQPLAWNIRLKIAIGAARGLAFLHTS------------------------ 205 (413)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~------------------------ 205 (413)
+...++..|+||++++|.++.+..... .. ...++.++.+.|..||+.
T Consensus 78 ~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 78 FERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred EEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 888889999999999998876543110 01 112333344444444411
Q ss_pred ---------------------------------CCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 206 ---------------------------------DKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 206 ---------------------------------~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987667799998886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=5.5e-06 Score=71.91 Aligned_cols=74 Identities=23% Similarity=0.113 Sum_probs=51.9
Q ss_pred eeecCC-ceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCC--CccceEeEEEeCCeeEEEEe
Q 015094 86 LGEGGF-GKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHP--NLVRLLGYCWEDKELLLVYE 162 (413)
Q Consensus 86 lg~G~~-g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e 162 (413)
+..|.. +.||+.... .+..+++|....... ..+..|+..|+.|... .+.+++.+..+++..++||+
T Consensus 18 ~~~G~s~~~v~r~~~~--------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ--------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp CSCTTSSCEEEEEECT--------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCcccCCeEEEEEeC--------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 444543 678987432 355688897665532 2467788888887633 36778888888889999999
Q ss_pred eCCCCCHH
Q 015094 163 FMQKGSLE 170 (413)
Q Consensus 163 ~~~~~~L~ 170 (413)
+++|.++.
T Consensus 87 ~i~G~~~~ 94 (255)
T d1nd4a_ 87 EVPGQDLL 94 (255)
T ss_dssp CCSSEETT
T ss_pred eeeccccc
Confidence 99987664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.18 E-value=4.5e-06 Score=77.60 Aligned_cols=78 Identities=18% Similarity=0.177 Sum_probs=49.9
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCc------C-hhhHHHHHHHHHHHhhcc-C--CCccceEeEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSE------S-LQGFEEWQSEVNFLGRLS-H--PNLVRLLGYCW 152 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~ 152 (413)
.+.||.|....||++.... .++.|+||.-... . .....+...|+..|+.+. + ..+++++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~-------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-- 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE-------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-- 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred EEEeCCCceEeEEEEEeCC-------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--
Confidence 4578999999999985332 4577889864321 1 113345667888888774 2 346666653
Q ss_pred eCCeeEEEEeeCCCCCH
Q 015094 153 EDKELLLVYEFMQKGSL 169 (413)
Q Consensus 153 ~~~~~~lv~e~~~~~~L 169 (413)
++...++|||++.+..+
T Consensus 102 d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp ETTTTEEEECCCTTSEE
T ss_pred cCCCCEEEEeccCCccc
Confidence 55667899999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.73 E-value=8.5e-05 Score=68.74 Aligned_cols=81 Identities=15% Similarity=0.055 Sum_probs=54.6
Q ss_pred CCeeeecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhcc-CCCccceEeEEEeCCeeEEEE
Q 015094 83 DTVLGEGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLS-HPNLVRLLGYCWEDKELLLVY 161 (413)
Q Consensus 83 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 161 (413)
++.|+.|-.-.+|++.............+.|++++..... ......+|..+++.+. +.-..++++++.. ++||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567777777899987664332233345678888876332 2345678999999986 5445688877642 6899
Q ss_pred eeCCCCCH
Q 015094 162 EFMQKGSL 169 (413)
Q Consensus 162 e~~~~~~L 169 (413)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99988654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.50 E-value=0.00028 Score=62.85 Aligned_cols=157 Identities=13% Similarity=0.001 Sum_probs=84.8
Q ss_pred cHHHHHHHhcCCCCCCeee-----ecCCceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCC
Q 015094 69 TFVELRAATRNFKSDTVLG-----EGGFGKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPN 143 (413)
Q Consensus 69 ~~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 143 (413)
+..++.....+|.++++.. .|---+.|+.... +..+++|++.... ..+.+..|+.++..|...+
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~---------~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT---------KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES---------SCCEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC---------CCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcc
Confidence 4567777788898876554 4444668887543 2358899986532 2245566777888775322
Q ss_pred c-----cceEe---EEEeCCeeEEEEeeCCCCCHHHhh--------------hhcC-----CCCCC--------------
Q 015094 144 L-----VRLLG---YCWEDKELLLVYEFMQKGSLENHL--------------FGRG-----ASVQP-------------- 182 (413)
Q Consensus 144 i-----~~~~~---~~~~~~~~~lv~e~~~~~~L~~~l--------------~~~~-----~~~~~-------------- 182 (413)
+ +...+ +.......+.++.++.|....... .... .....
T Consensus 73 ~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (316)
T d2ppqa1 73 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE 152 (316)
T ss_dssp CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred ccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHH
Confidence 2 21111 123345567777777664332100 0000 00000
Q ss_pred ----CcHHHHHHHHHHHHHHHHHhhc--CCCCeeeCCCCCCcEEEcCCCCeEEccCCCcc
Q 015094 183 ----LAWNIRLKIAIGAARGLAFLHT--SDKQVIYRDFKASNILLDGSYTAKISDFGLAK 236 (413)
Q Consensus 183 ----~~~~~~~~i~~qi~~~l~~lH~--~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~ 236 (413)
.........+..+...+.-.+. ...|+||+|+.++||+++.+...-|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 153 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0000111122222333333221 34679999999999999988777899999886
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.49 E-value=0.00016 Score=64.89 Aligned_cols=135 Identities=14% Similarity=0.045 Sum_probs=76.8
Q ss_pred ceEEEEEecCCCCCCCCCCeEEEEEecCCcChhhHHHHHHHHHHHhhccCCCcc--ceE-----eEEEeCCeeEEEEeeC
Q 015094 92 GKVFKGWLDEKAPGKSGSGTVIAVKKLNSESLQGFEEWQSEVNFLGRLSHPNLV--RLL-----GYCWEDKELLLVYEFM 164 (413)
Q Consensus 92 g~Vy~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~--~~~-----~~~~~~~~~~lv~e~~ 164 (413)
-.||++... .|+.|++|+..... ...+++..|+..+..|...+|. ..+ ..+..++..+.+++++
T Consensus 36 N~vy~v~~~--------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 36 NRVYQFQDE--------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp SEEEEECCT--------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ceeEEEEcC--------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 479998433 46789999986553 2346678899988888632221 111 1344567789999999
Q ss_pred CCCCHHH-----h------h---hh----cC-CCCCCCc----------------------HHHHHHHHHHHHHHHHHh-
Q 015094 165 QKGSLEN-----H------L---FG----RG-ASVQPLA----------------------WNIRLKIAIGAARGLAFL- 202 (413)
Q Consensus 165 ~~~~L~~-----~------l---~~----~~-~~~~~~~----------------------~~~~~~i~~qi~~~l~~l- 202 (413)
.|..+.. + + +. .. ....... .......+.++...+.-+
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 8744321 0 0 00 00 0000111 111222333333333222
Q ss_pred -hcCCCCeeeCCCCCCcEEEcCCCCeEEccCCCccc
Q 015094 203 -HTSDKQVIYRDFKASNILLDGSYTAKISDFGLAKL 237 (413)
Q Consensus 203 -H~~~~~ivHrDlkp~Nil~~~~~~~kl~DfG~a~~ 237 (413)
.....++||+|+.+.|||++++ ..++||+-+..
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1223568999999999999743 45899998874
|